data_2hva_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hva _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -73.81 113.68 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.36 -6.29 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 t -169.86 167.23 9.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.29 -176.6 5.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 125.51 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -128.91 -101.03 0.99 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.705 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -161.06 160.62 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -66.89 -29.7 69.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -35.49 15.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.3 107.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.28 137.81 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CE1' ' CG2' ' A' ' 154' ' ' THR . 1.8 p90 -138.93 162.23 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -145.18 137.18 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.728 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.96 114.88 23.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -131.75 128.0 37.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.92 124.85 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.7 m -106.4 134.79 48.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.98 110.87 11.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.58 -143.67 6.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.36 -60.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.01 145.57 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -138.25 154.36 49.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.77 118.72 31.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.0 p -112.46 132.01 55.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.29 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.76 125.11 67.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.92 137.65 35.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.61 116.58 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 170.49 7.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 47.4 31.41 1.88 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.395 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -152.65 132.36 7.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.7 -157.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.481 2.121 . . . . 0.0 112.161 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.6 t -84.52 -57.56 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.1 -43.38 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.14 -45.49 76.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.14 89.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.247 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 84' ' ' PHE . 4.1 mt -57.24 -34.99 69.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -63.31 -33.19 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 109.904 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 12.5 tp10 -87.94 -31.73 19.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.282 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -40.41 60.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.444 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.464 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 10.8 mmt -57.36 -45.16 99.92 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.505 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.1 Cg_exo -58.06 -45.13 33.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.263 1.975 . . . . 0.0 112.145 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -70.32 -41.76 72.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.461 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 tt -76.53 -31.9 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.476 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -66.45 -42.1 88.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -60.09 -33.25 71.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -68.77 -41.99 78.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.0 m -81.31 -30.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.15 -103.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.14 69.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.525 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -164.27 63.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.76 5.23 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.459 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 46.97 9.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -148.24 -46.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 37.16 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.457 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.23 160.1 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.68 75.11 0.3 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 mtp -74.26 -55.46 6.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.851 0.358 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -93.26 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.51 172.41 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' VAL . 69.0 m -164.0 110.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 49.79 166.1 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.673 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 80' ' ' VAL . 21.0 Cg_endo -61.7 149.32 90.4 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.981 . . . . 0.0 112.25 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.3 t -86.18 153.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -120.22 145.84 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.491 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -124.6 154.44 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.52 136.25 36.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.315 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.459 HG22 ' CE2' ' A' ' 167' ' ' TYR . 3.8 m -128.09 129.93 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' CE2' HG21 ' A' ' 166' ' ' VAL . 7.7 m-85 -102.47 95.78 6.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' CE1' ' A' ' 167' ' ' TYR . 61.7 Cg_endo -73.0 134.73 21.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.222 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.94 170.32 10.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -17.51 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.245 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -6.22 59.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -1.71 85.3 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -121.75 136.88 54.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.813 0.34 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.1 171.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.52 47.63 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 54.94 83.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -178.22 109.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 84' ' ' PHE . 5.9 tt -144.11 138.25 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.23 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -119.62 115.76 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.437 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.69 117.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.564 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -98.73 132.16 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.542 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CE2' HG11 ' A' ' 66' ' ' VAL . 39.3 t80 -114.01 136.08 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.46 107.88 19.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.1 mt -83.71 136.16 42.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 154.23 74.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.497 2.131 . . . . 0.0 112.322 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -53.95 -27.65 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -58.84 -45.53 89.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -98.71 -15.07 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.273 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -36.03 60.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.804 0.335 . . . . 0.0 111.109 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.4 -33.2 76.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.64 75.39 2.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.722 0.296 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.1 159.72 14.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.583 2.189 . . . . 0.0 112.275 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.74 148.26 58.3 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.69 2.26 . . . . 0.0 112.011 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.44 112.36 9.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.95 144.63 35.66 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.352 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -103.76 -31.18 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.94 122.03 26.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.83 -23.79 54.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 m -81.98 -28.54 32.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 t -85.19 115.58 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -121.72 149.81 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 122' ' ' ILE . 8.7 mm -113.04 126.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.85 129.11 45.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 144.13 25.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER 56.0 173.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.119 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 15.4 tp10 86.71 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.3 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -91.31 158.66 25.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.015 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -128.29 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 48.7 m -122.2 119.02 30.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.292 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.11 165.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.723 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.5 136.4 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.13 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -105.69 141.17 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.073 0.463 . . . . 0.0 111.37 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.3 t -130.33 139.64 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.586 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -116.31 124.98 51.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.97 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 14.3 p90 -131.78 165.13 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.17 79.55 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.19 175.62 43.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.36 164.28 13.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.792 0.329 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -169.72 120.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.207 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -105.87 -65.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.81 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -146.73 -70.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.5 70.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.65 -34.97 78.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.29 -40.45 95.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.437 0.637 . . . . 0.0 109.98 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.95 -38.26 28.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.658 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.67 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.647 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.5 m-70 -70.09 -42.39 72.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.757 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.94 73.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -68.41 -40.38 81.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -60.05 -46.11 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.71 -42.19 88.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.653 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.47 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.3 m -63.02 -41.58 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.417 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 6.6 m -57.29 -49.14 77.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.705 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -73.67 -10.24 59.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.296 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -46.83 -35.47 6.35 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.17 31.13 7.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.8 p -145.83 165.13 22.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 -2.81 12.29 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.909 2.406 . . . . 0.0 112.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.5 124.6 19.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.22 175.68 5.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.72 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -177.13 6.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.817 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -79.3 -76.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.2 -18.07 2.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.076 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -158.01 27.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.925 0.362 . . . . 0.0 111.613 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.41 HG21 ' CE2' ' A' ' 87' ' ' PHE . 7.0 p -161.95 132.59 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 111.572 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.459 ' CE2' HG22 ' A' ' 86' ' ' VAL . 27.7 p90 -149.73 168.17 24.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -112.82 155.24 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.152 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.79 154.0 50.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.02 136.31 47.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.791 0.329 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -108.86 134.09 52.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -138.26 143.1 39.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.2 121.88 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.476 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.056 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 10.6 mt -91.17 139.97 30.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.561 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.61 118.69 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -76.83 127.83 33.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.226 -0.892 . . . . 1.0 111.126 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.81 0.338 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.3 115.26 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -96.44 0.13 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -170.35 161.27 8.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -152.37 -45.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.48 136.41 49.27 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -136.9 175.45 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.542 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 161.09 27.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.341 . . . . 0.0 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -66.56 -32.84 74.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.7 -35.05 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -146.07 110.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -95.51 154.85 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 p90 -139.39 158.31 44.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -145.14 121.89 11.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.92 131.23 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -139.91 130.65 25.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.29 120.17 40.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 m -131.98 136.41 47.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -114.75 77.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.39 -161.92 2.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.525 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.28 -86.39 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -113.28 149.17 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.886 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -137.61 156.99 47.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.93 140.28 29.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.53 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 24.9 p -135.67 131.87 36.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.975 0.417 . . . . 0.0 111.5 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 39.8 t -128.01 125.41 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.436 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.99 136.0 38.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.4 116.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.778 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 168.17 9.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.88 33.06 3.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.526 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -153.2 121.65 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.89 -161.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.502 2.135 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -74.21 -58.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.342 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 -44.98 82.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.212 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.13 -46.0 75.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.26 89.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -32.52 74.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 tp10 -87.57 -40.36 14.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.15 -37.57 66.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 11.9 mmt -57.78 -44.12 99.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 59' ' ' MET . 49.3 Cg_endo -70.35 -36.67 8.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -70.09 -43.28 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 tt -77.08 -26.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.098 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -39.26 90.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -59.19 -31.06 68.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 31.5 t80 -71.23 -49.18 46.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 27.1 m -75.31 -30.82 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.188 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.89 -99.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.25 35.7 0.76 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -119.67 30.27 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 110.929 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.9 -14.43 36.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 78.67 -1.68 2.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -93.78 -44.25 8.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.848 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.62 39.45 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.27 -178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 88.14 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -83.21 -45.87 13.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.14 -82.55 1.54 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.87 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.794 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.14 -164.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.96 156.42 2.59 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.264 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.99 135.21 61.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 112.17 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG12 ' CD2' ' A' ' 102' ' ' PHE . 25.4 m -86.0 145.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.343 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 p -115.49 174.01 6.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.654 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -127.51 154.46 45.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.38 136.73 32.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.435 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 167' ' ' TYR . 3.0 m -131.85 109.25 15.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD2' HG22 ' A' ' 166' ' ' VAL . 11.9 m-85 -83.95 111.32 31.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.67 127.87 6.57 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.162 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 164.21 14.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.41 -15.74 62.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.361 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -5.95 59.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.523 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.59 -2.06 62.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.08 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -121.41 -169.85 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.81 169.52 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.714 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.31 34.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.142 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp 51.08 26.7 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.11 122.29 31.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.84 139.99 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.4 mtpt -118.06 115.75 25.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.133 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.9 t -78.77 116.72 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.764 0.316 . . . . 0.0 111.252 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -97.23 142.12 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.773 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 20.4 t80 -127.11 148.81 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.987 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -105.82 110.4 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.91 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 104' ' ' ILE . 23.4 mm -75.69 130.39 79.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.41 154.06 20.62 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.461 2.107 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -27.07 65.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -64.74 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 4.9 m-85 -108.16 -2.95 19.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.677 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -33.68 57.63 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.721 0.296 . . . . 0.0 111.23 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.09 -33.97 75.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.79 89.44 0.7 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.276 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 23.5 Cg_exo -63.23 160.2 35.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 112.251 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.93 153.29 63.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.597 2.198 . . . . 0.0 111.919 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 110.84 5.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 33.6 Cg_exo -61.54 132.36 40.27 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 0.0 112.061 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 t -94.99 46.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.31 112.72 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.98 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.01 -23.54 54.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -82.17 -30.32 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.37 114.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.03 150.33 27.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.0 mm -118.17 127.98 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 129.95 45.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -88.76 139.94 29.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.5 mtm105 62.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -169.14 -167.9 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.49 89.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.386 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.2 146.41 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 111.365 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.3 m -104.0 133.3 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.372 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.94 169.32 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.633 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -136.15 129.58 31.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 p -105.63 149.05 26.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 111.587 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.8 t -130.7 139.34 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.64 133.68 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.01 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.506 ' CD2' ' CE1' ' A' ' 147' ' ' HIS . 5.0 p90 -127.81 -46.27 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.59 149.63 10.33 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.73 -170.22 17.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -133.11 123.78 26.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.65 174.69 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -75.7 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.37 -61.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.774 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.93 -33.78 65.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.21 -34.92 77.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.049 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -40.51 95.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.458 0.647 . . . . 0.0 110.087 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.69 -38.57 35.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.88 77.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.715 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.506 ' CE1' ' CD2' ' A' ' 135' ' ' PHE . 47.3 m-70 -70.18 -46.01 65.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.13 -33.0 73.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.2 m -67.83 -38.25 82.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.93 -35.78 73.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.22 -40.68 86.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.542 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.434 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -60.99 -42.49 98.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.266 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.2 m -64.05 -41.81 97.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -49.23 77.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.692 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.407 HD23 ' CD2' ' A' ' 31' ' ' TYR . 7.3 mt -73.54 -9.05 58.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -47.04 -36.37 7.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.821 0.343 . . . . 0.0 111.215 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -96.34 36.09 4.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.8 p -145.29 168.28 12.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.16 17.83 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.253 2.635 . . . . 0.0 112.794 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 170.98 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.849 0.356 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -136.66 -178.07 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 161' ' ' THR . 12.6 m-85 -155.11 138.05 15.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -63.31 -68.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.1 -79.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.56 69.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.408 HG22 ' CD2' ' A' ' 87' ' ' PHE . 9.9 p -161.94 131.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.296 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 86' ' ' VAL . 7.1 p90 -140.77 170.62 15.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.447 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 24.7 m-85 -117.83 136.76 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.0 m -111.32 144.04 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.54 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -120.91 144.03 48.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -137.41 142.97 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 111.372 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.76 114.91 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -117.73 121.95 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.648 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.433 HD21 ' CG ' ' A' ' 167' ' ' TYR . 0.9 OUTLIER -92.65 140.93 29.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.565 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 14.8 t -73.89 118.81 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.947 0.404 . . . . 0.0 111.269 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.36 145.69 25.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.267 -0.873 . . . . 1.0 111.093 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.838 0.351 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.24 112.92 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.02 -22.81 18.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 t -169.85 167.03 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.868 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 p -151.41 174.58 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 123.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . -124.69 -55.56 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.549 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tptt -161.85 167.68 24.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.702 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -32.27 73.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.1 -35.33 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.356 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.32 115.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 111.574 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 158.55 15.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.766 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 4.7 p90 -138.87 155.72 47.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -146.73 130.91 17.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.07 116.41 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.03 131.69 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.5 119.54 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.14 103.13 8.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.56 129.85 50.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.97 144.46 16.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.76 178.72 16.87 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.92 141.97 50.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 8.8 m-85 -137.54 154.32 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.969 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.1 122.84 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -112.67 132.14 55.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 16.6 t -125.91 125.51 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -95.72 134.9 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.391 . . . . 0.0 111.264 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.45 116.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.8 166.96 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.991 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.78 27.67 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -152.64 129.42 5.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.68 -78.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.607 2.205 . . . . 0.0 112.675 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 39.5 t -146.73 -62.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.749 0.309 . . . . 0.0 111.236 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.57 -45.33 81.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.21 -46.28 74.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -45.07 91.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.2 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.91 -35.3 68.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -63.04 -32.16 73.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.008 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -86.87 -32.94 19.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.24 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 100' ' ' VAL . . . -73.22 -37.13 66.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.43 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 30.2 mmt -57.8 -44.09 99.16 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 59' ' ' MET . 51.3 Cg_endo -70.29 -41.19 3.79 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.938 1.758 . . . . 0.0 111.986 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -39.53 75.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tt -77.55 -40.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.683 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.432 ' HA ' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.5 -31.58 72.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.063 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' N ' ' HG3' ' A' ' 63' ' ' MET . 1.0 OUTLIER -58.84 -29.92 67.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.58 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 122' ' ' ILE . 13.7 t80 -75.36 -50.96 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 12.8 m -66.03 -29.7 47.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.19 -166.9 2.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.46 54.85 4.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 m -141.45 33.44 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -88.51 164.49 15.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.43 48.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.803 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -148.67 -46.63 0.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.38 34.09 3.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -100.46 176.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.6 -67.64 1.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mtt 62.55 146.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.25 -121.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.596 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 -45.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 m 61.02 112.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 3.9 t -65.86 -46.43 65.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 80' ' ' VAL . 29.4 Cg_exo -62.03 140.77 86.17 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.473 2.115 . . . . 0.0 112.123 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 t -153.78 144.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.282 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 t -115.73 145.95 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.489 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -133.1 154.21 50.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.87 136.66 32.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.484 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 17.7 m -135.57 133.49 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.426 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 5.8 m-85 -104.45 97.67 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.301 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 167' ' ' TYR . 92.2 Cg_endo -79.65 138.91 13.83 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.88 172.0 8.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.09 -29.12 67.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -86.36 -6.14 59.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.97 -2.06 78.9 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 124.41 41.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.81 161.24 24.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -118.58 45.78 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt 61.26 -169.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.74 114.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -143.6 130.66 20.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.5 tttp -108.04 115.89 30.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 58' ' ' ALA . 3.3 t -85.44 116.91 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.309 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -96.01 131.49 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 15.9 t80 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.267 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.58 110.27 22.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.6 mt -90.68 136.29 28.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.226 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.6 154.18 70.53 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.454 2.103 . . . . 0.0 112.344 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.86 -26.94 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -56.81 -38.29 72.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.956 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -113.02 -13.05 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -53.14 -47.13 68.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 111.179 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.08 -25.94 54.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 t -171.4 89.41 0.45 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.769 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.9 151.43 78.16 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 0.0 112.379 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.79 155.85 61.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.61 2.206 . . . . 0.0 112.111 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 111.75 8.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.993 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 32.0 Cg_exo -58.89 158.06 26.28 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.405 2.07 . . . . 0.0 112.261 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.93 -31.19 11.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.52 114.81 13.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -24.5 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.12 -33.03 29.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.885 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.43 121.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 157.04 39.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 65' ' ' TYR . 29.3 mm -107.25 129.31 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -98.86 130.7 45.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.43 16.81 8.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.43 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.91 132.46 23.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -168.57 86.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.15 92.82 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.51 145.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.88 130.8 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 186' ' ' TRP . 26.2 m -143.84 164.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.317 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 4.3 m-85 -107.8 135.43 49.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.8 p -105.68 133.65 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 139.25 52.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.86 138.87 51.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 20.7 p90 -153.32 29.64 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.99 -76.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 138' ' ' TYR . . . 134.62 79.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 137' ' ' GLY . 63.6 m-85 -157.18 82.45 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.322 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.43 26.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.219 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.65 66.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 63.6 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.52 58.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -67.27 -35.97 80.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.105 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.02 -40.52 98.0 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.444 0.64 . . . . 0.0 109.94 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.78 -38.88 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.497 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.81 -35.03 69.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.826 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 40.0 m-70 -68.94 -38.8 79.68 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.93 72.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.743 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.7 m -72.86 -43.3 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -59.51 -36.65 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.1 -43.63 87.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.415 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -59.37 -47.51 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 94.6 m -60.91 -41.99 97.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.356 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.7 m -57.67 -48.97 78.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 mt -72.89 -11.22 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -46.87 129.74 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.241 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.68 9.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.434 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 4.3 p -94.76 173.75 4.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.54 0.21 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 4.4 Cg_exo -77.57 13.97 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.012 2.474 . . . . 0.0 112.939 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.93 130.44 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.334 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.08 172.68 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 161' ' ' THR . 5.3 m-85 -155.68 160.24 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -104.11 -51.83 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.51 53.66 7.31 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.264 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -158.7 -37.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.596 0.236 . . . . 0.0 111.275 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 12.5 p -159.2 140.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 111.424 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 14.7 p90 -142.88 170.43 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.09 143.81 43.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.3 m -119.42 137.94 53.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 156.09 46.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.075 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -108.95 145.57 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -145.7 154.42 42.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.93 124.48 73.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.641 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.06 122.26 46.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.106 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.6 140.35 29.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.65 118.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -75.05 116.25 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.17 -0.919 . . . . 1.0 110.986 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -74.3 113.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mt -86.42 -24.33 25.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -169.98 167.1 9.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.6 168.07 26.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.82 -175.67 21.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.426 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.89 -106.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -161.02 167.44 26.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.0 110.916 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -66.6 -28.02 68.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.43 -33.12 16.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.094 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.99 142.38 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -135.12 139.84 44.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -138.36 162.22 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -144.53 126.46 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.0 129.43 34.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -140.71 135.82 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.74 130.08 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.13 -50.05 21.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.07 70.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.68 29.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.95 139.6 5.02 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -92.0 146.68 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -137.54 161.23 36.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.87 140.3 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.655 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -133.49 131.88 40.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.476 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -132.88 125.68 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.679 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.94 132.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.272 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 t -138.41 116.87 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 175.43 5.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t0 48.41 28.25 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.436 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.97 133.97 8.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.46 -165.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.474 2.116 . . . . 0.0 112.099 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.83 -48.81 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.333 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.71 -45.17 83.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.231 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -46.15 74.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.126 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.258 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -56.97 -35.55 69.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.259 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.507 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 tp10 -87.21 -34.15 19.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.355 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.77 62.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.474 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.63 -43.95 99.17 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -57.47 -47.15 23.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.107 1.872 . . . . 0.0 112.189 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -70.43 -41.95 72.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.828 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 tt -76.09 -37.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.5 mtp -66.32 -40.48 89.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -59.6 -31.06 69.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 9.9 t80 -74.99 -50.09 17.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.804 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 22.1 m -72.54 -29.52 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.404 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.12 -64.33 2.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.626 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.1 76.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -164.52 55.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 110.747 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.53 6.73 6.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.366 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 58.47 18.56 5.75 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.448 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -95.2 -43.47 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.11 24.32 8.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.474 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -101.08 -178.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.62 -55.46 0.39 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 61.7 mtp 62.64 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.657 0.265 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.79 80.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.656 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 55.28 -176.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t 179.87 -39.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.4 m -162.23 163.67 18.3 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.855 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -59.21 149.65 79.14 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.29 1.994 . . . . 0.0 111.898 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.33 137.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.684 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 m -119.11 145.86 45.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.07 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -133.15 154.28 50.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.694 0.283 . . . . 0.0 111.452 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.97 136.67 32.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.534 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' A' ' 167' ' ' TYR . 5.2 m -130.25 130.81 65.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 10.6 m-85 -102.51 97.43 8.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.19 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 139.8 24.24 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.507 2.138 . . . . 0.0 112.148 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -90.18 161.92 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.41 -21.97 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.23 -6.19 59.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.63 -16.09 60.99 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.829 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -98.66 133.35 43.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.0 mt -57.89 178.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.875 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -143.37 44.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 62.1 -166.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.74 108.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.702 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 tt -141.35 139.52 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.78 115.89 27.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.525 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.23 116.86 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.536 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -100.23 137.96 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.441 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 24.8 t80 -127.07 132.44 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.684 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.34 109.75 21.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.36 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.19 139.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.468 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.34 154.14 15.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.624 2.216 . . . . 0.0 112.409 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -57.68 -31.02 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.42 -47.13 87.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -90.9 -13.49 33.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -53.19 -43.69 67.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 111.08 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.75 -27.43 66.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t -167.27 85.87 0.8 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 42.8 Cg_endo -68.02 152.26 76.86 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.613 2.209 . . . . 0.0 112.307 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.92 156.24 60.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.01 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.83 110.89 6.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 69.1 Cg_endo -74.04 145.0 34.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.304 2.003 . . . . 0.0 112.453 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -86.12 -176.41 5.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 64.16 120.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.995 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.4 -16.89 25.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.599 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.6 m -80.16 -34.72 37.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 111.233 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.42 113.83 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -128.06 157.13 41.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.8 mm -106.1 129.09 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.85 129.83 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 18.88 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.342 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -69.58 164.35 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -70.91 169.11 15.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.64 176.27 4.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.68 145.25 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.0 m -103.99 118.93 37.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.769 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.18 166.74 21.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD2' HD13 ' A' ' 155' ' ' LEU . 3.7 m-85 -107.83 133.42 52.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.583 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 p -105.89 122.29 45.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.977 0.417 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -116.38 139.1 50.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.732 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -116.99 154.16 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -166.87 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.64 127.93 4.49 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.64 147.0 4.49 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -67.14 118.21 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.58 126.04 45.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 -43.43 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -176.04 -66.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.62 -33.77 66.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -67.67 -34.9 77.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.074 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.67 -40.49 95.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.093 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.75 -38.86 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.549 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.56 -33.45 69.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.648 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -70.11 -44.43 68.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.89 72.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.4 m -67.44 -38.0 83.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -64.61 -36.25 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.9 tp -70.03 -37.17 75.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 110.437 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.01 -48.08 63.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.2 t -61.25 -40.96 96.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 98.3 m -57.52 -47.08 82.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.695 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.447 ' CD2' ' CE2' ' A' ' 31' ' ' TYR . 83.4 mt -72.75 -13.79 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.312 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.18 115.38 1.08 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.84 18.03 8.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.559 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.1 p -146.58 165.15 20.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.57 -13.25 35.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.765 2.31 . . . . 0.0 112.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.5 110.51 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 111.267 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.48 -177.74 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.82 20.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.332 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 67.72 -66.58 0.21 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.162 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.35 48.88 2.93 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.116 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -158.05 -33.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.505 0.193 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.429 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 14.0 p -159.13 138.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.548 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.43 ' CD1' HG23 ' A' ' 86' ' ' VAL . 15.0 p90 -136.99 171.55 14.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 37.5 m-85 -112.87 150.83 31.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.18 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.3 m -129.92 157.79 41.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.07 139.35 49.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.555 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.771 0.32 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -130.97 133.84 46.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -146.14 157.06 43.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.49 126.24 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.825 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -107.91 121.69 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.155 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 12.7 mt -94.41 134.3 37.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.805 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.451 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 21.5 t -74.88 118.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -63.58 139.35 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.201 -0.904 . . . . 1.0 111.133 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.28 113.19 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.031 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.99 -27.78 18.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -170.09 167.09 8.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -151.65 160.52 43.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.44 71.85 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.364 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.97 -132.24 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.607 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.28 164.89 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -66.49 -28.7 68.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 -34.47 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 118.82 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 p -95.38 130.69 42.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 6.2 p90 -138.53 154.57 48.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -145.19 135.03 23.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.66 124.7 33.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.4 ' HB3' ' NH1' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -142.05 136.84 30.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.21 130.41 56.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.38 164.78 25.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.03 73.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.58 118.44 6.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.569 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.37 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.571 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 11.5 mttt -111.01 147.93 33.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.74 153.29 49.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.13 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.39 119.11 32.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.5 p -112.66 147.31 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.0 t -131.82 125.97 56.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.153 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -95.95 131.54 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.693 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.18 116.98 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 169.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.738 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 79.59 -49.11 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.492 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -85.65 141.63 36.43 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 110.877 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.51 -80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.481 2.121 . . . . 0.0 112.626 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 98' ' ' LEU . 43.0 t -142.65 -66.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.851 0.358 . . . . 0.0 111.334 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.76 -45.33 78.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -46.07 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.12 85.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.1 -35.07 68.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -31.28 71.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.285 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 34.2 tp10 -87.81 -33.66 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.12 -38.83 66.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.427 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.566 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 6.9 mmt -57.72 -43.97 99.12 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.8 Cg_endo -70.14 -37.62 8.03 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.994 1.796 . . . . 0.0 112.128 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -70.14 -42.68 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 tt -77.71 -28.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.341 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -41.06 90.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -58.93 -31.21 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 115' ' ' PRO . 40.9 t80 -70.59 -53.35 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.42 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 27.1 m -67.25 -26.36 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.288 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.0 -126.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.645 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.06 68.2 0.52 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -155.11 52.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' OD1' ' CD1' ' A' ' 65' ' ' TYR . 2.6 m-80 -112.2 22.47 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 t70 54.56 34.34 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.027 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -148.3 -61.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.29 81.92 1.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.47 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.63 146.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.37 71.77 0.7 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.6 mtp -62.24 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.03 120.49 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.57 154.14 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.87 148.2 25.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 21.7 t -56.75 -47.7 98.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.413 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 80' ' ' VAL . 84.4 Cg_endo -80.91 154.76 19.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.36 2.04 . . . . 0.0 112.499 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -153.91 138.74 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.465 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 29.6 t -115.63 149.21 38.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -133.06 154.23 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.69 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.428 HG21 ' CE1' ' A' ' 167' ' ' TYR . 30.7 m -134.68 128.75 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.195 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -98.61 99.33 7.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.24 128.01 15.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.471 2.114 . . . . 0.0 112.248 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.13 168.06 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -19.63 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.185 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.45 2.95 42.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.487 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.0 -15.45 60.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.878 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.84 177.63 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.37 -12.91 12.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.62 165.53 0.2 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.003 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -80.52 88.13 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.22 110.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.643 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD12 ' CD2' ' A' ' 84' ' ' PHE . 7.4 tt -143.97 128.62 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.449 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -110.98 115.66 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.082 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.8 t -71.46 141.12 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -120.85 124.03 44.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 57.5 t80 -108.17 153.68 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.127 0.489 . . . . 0.0 111.69 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.1 109.18 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.493 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 mt -83.04 139.12 42.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.314 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.61 154.21 16.56 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 112.314 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -27.46 56.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -59.53 -47.14 86.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.92 -8.28 31.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -53.4 -36.16 61.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.16 -28.57 73.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 t -177.03 88.12 0.25 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 34.0 Cg_exo -59.17 161.27 16.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.229 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.82 154.75 63.38 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.634 2.223 . . . . 0.0 111.864 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 114.58 19.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.2 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HG3' ' CE1' ' A' ' 65' ' ' TYR . 48.6 Cg_exo -55.17 178.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 35.78 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.9 120.89 11.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.89 -26.8 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.003 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.2 t -82.01 -34.79 29.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -85.43 117.16 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.23 152.82 40.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.425 HD11 ' CZ ' ' A' ' 65' ' ' TYR . 16.3 mm -107.98 133.77 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.86 157.25 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.79 167.71 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -66.71 171.06 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -169.91 -38.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.63 107.18 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.95 142.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.354 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.418 ' HB ' ' HE3' ' A' ' 189' ' ' LYS . 82.0 m -107.31 132.08 53.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.508 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.33 149.51 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 5.6 m-85 -107.78 132.41 53.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.198 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.7 p -105.61 144.41 32.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.48 . . . . 0.0 111.637 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.7 t -130.85 139.13 50.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.8 138.78 51.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 39.1 p90 -143.58 -178.67 6.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.789 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.58 88.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.46 -176.44 40.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -58.73 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.11 164.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -132.84 -75.51 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -139.8 -48.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.97 66.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.09 -35.0 77.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.022 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -63.87 -39.8 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.041 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.85 -38.61 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.76 74.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.597 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.496 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.23 -46.05 65.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.878 0.37 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.09 73.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -71.14 -37.94 72.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -59.01 -39.61 82.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.35 -40.99 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.523 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -62.74 -45.24 93.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 179.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -40.73 98.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.191 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.0 m -57.65 -49.2 77.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.511 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -74.0 -9.25 58.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -47.16 -32.72 4.57 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.788 0.328 . . . . 0.0 111.282 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.42 28.29 12.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.5 p -145.84 159.29 47.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.312 . . . . 0.0 110.64 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.58 8.43 3.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 113.029 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.53 137.36 57.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.194 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -100.88 151.57 21.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -158.64 171.18 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.36 102.54 10.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.45 65.01 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.046 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -157.69 -27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.4 p -158.27 141.4 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.892 0.377 . . . . 0.0 111.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 86' ' ' VAL . 31.1 p90 -146.64 168.24 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.534 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -114.38 144.06 43.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.177 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.14 142.81 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.08 154.34 49.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.572 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -108.94 152.88 24.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.06 147.12 31.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.9 118.12 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.84 123.27 48.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.0 mt -91.43 140.61 29.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.516 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 17.7 t -73.98 131.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.801 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.418 ' HE3' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -73.02 -0.94 15.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 1.0 111.065 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.763 0.315 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.32 112.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -84.9 -12.07 54.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.415 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.8 159.03 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.85 155.35 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.79 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.85 145.02 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.368 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 31' ' ' TYR . . . -135.88 -146.63 5.29 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.478 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -78.37 164.48 24.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.407 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.54 -26.45 67.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.02 -32.32 16.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.92 111.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.188 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -95.78 141.76 28.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.4 p90 -139.35 162.13 35.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -145.57 126.16 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.33 122.51 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -123.95 135.28 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.11 121.03 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.194 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.52 173.46 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.88 -47.19 26.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -178.03 28.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.87 -127.32 2.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.426 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.95 139.14 38.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -137.58 148.68 46.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.16 28.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.636 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 p -112.82 149.52 32.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 41.9 t -128.92 125.61 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -97.38 130.93 44.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.18 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.4 t -138.25 116.84 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 175.92 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 43.08 36.38 0.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.565 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -152.43 134.15 8.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.22 -157.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.75 -53.25 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -68.15 -44.98 74.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -46.26 81.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.202 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.26 90.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 84' ' ' PHE . 6.2 mt -57.49 -35.28 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -31.67 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.511 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 tp10 -87.66 -32.59 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.18 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.65 -42.63 61.13 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.791 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 mmt -57.6 -43.54 98.93 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.8 Cg_exo -59.77 -45.16 26.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.248 1.965 . . . . 0.0 111.953 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -70.32 -40.47 74.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.445 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.407 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 7.1 tt -76.57 -40.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 0.0 111.494 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.27 -31.8 72.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -63.67 -29.84 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -74.04 -30.63 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 63' ' ' MET . 15.0 m -89.74 -31.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.97 -74.16 0.95 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.573 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.07 71.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -160.59 70.35 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -119.65 -5.63 10.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.452 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.85 39.81 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -144.4 -45.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.64 31.98 1.54 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.25 145.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.85 4.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.425 ' HG2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 62.87 143.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.4 -119.5 3.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -156.85 -171.56 3.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -159.13 -163.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.526 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.8 m -45.04 161.99 0.22 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.3 Cg_endo -59.31 132.38 46.24 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.186 1.924 . . . . 0.0 111.863 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.81 146.81 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 p -115.41 173.91 6.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.7 154.16 44.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.931 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB1' ' CG ' ' A' ' 99' ' ' LYS . . . -87.23 136.58 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.486 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 27.2 m -131.86 112.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.816 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CD2' ' CG2' ' A' ' 166' ' ' VAL . 4.4 m-85 -93.35 107.13 23.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.24 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.62 156.29 28.02 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.562 2.175 . . . . 0.0 112.189 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.05 168.34 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -22.27 47.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -85.88 -6.04 59.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.21 -16.07 61.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.806 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 130.07 47.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 177.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.02 81.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.57 -166.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.054 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 64.6 96.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -144.03 127.86 17.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' CG ' ' HB1' ' A' ' 85' ' ' ALA . 20.6 ptmt -110.59 115.8 30.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.38 141.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.332 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -116.38 141.97 47.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.679 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 54.1 t80 -125.0 159.87 30.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 2.5 mtt85 -115.97 108.09 15.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.323 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mt -85.5 136.41 37.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.297 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.45 152.02 75.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.359 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -57.23 -26.98 61.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -47.1 82.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.197 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CE2' ' HG2' ' A' ' 76' ' ' MET . 3.2 m-85 -89.18 -16.24 31.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -54.4 -39.05 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.781 0.324 . . . . 0.0 111.197 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.91 79.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 p -159.97 71.67 3.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 110.63 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 32.5 Cg_exo -58.37 139.03 88.98 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.551 2.167 . . . . 0.0 112.324 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 13.0 Cg_exo -70.54 149.27 61.67 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.598 2.199 . . . . 0.0 112.036 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 124.57 89.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.12 170.49 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.383 2.055 . . . . 0.0 112.269 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -40.03 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 131.46 35.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -57.71 -22.46 46.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.105 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -81.97 -31.97 30.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 t -85.64 114.02 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.59 157.0 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.7 mm -107.57 117.59 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -98.98 136.39 39.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.826 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.7 49.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -71.89 -132.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -177.91 4.0 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.79 153.57 20.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.858 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.96 148.78 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.7 m -103.9 130.46 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -144.81 170.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.48 133.08 41.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.626 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -105.96 137.78 43.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.046 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -124.87 139.05 54.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -116.91 141.38 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -153.62 -50.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.45 170.59 38.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -112.94 67.59 0.24 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.48 100.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.98 32.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -61.66 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -161.12 -61.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.657 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.84 -33.8 72.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.412 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -67.33 -34.74 77.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.8 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -42.05 99.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.513 0.673 . . . . 0.0 109.82 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.02 -38.8 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.717 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.02 68.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.752 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -70.0 -39.7 75.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.01 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.761 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -67.42 -39.92 85.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.08 -45.95 89.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.1 -40.45 97.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -44.22 96.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -65.17 -41.16 94.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.532 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.419 HG23 ' CD1' ' A' ' 31' ' ' TYR . 86.4 m -57.64 -48.05 80.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 31' ' ' TYR . 12.7 mt -73.22 -16.63 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -47.23 -40.18 15.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.45 32.11 6.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.65 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.9 p -146.09 166.7 16.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 0.0 110.936 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.86 4.72 4.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.031 2.487 . . . . 0.0 112.812 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.47 125.37 22.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.78 152.63 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.553 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -158.42 173.88 15.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.276 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -85.76 -67.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.76 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.062 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.11 -28.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.62 0.247 . . . . 0.0 111.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 87' ' ' PHE . 14.6 p -157.98 137.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.425 ' CZ ' HG21 ' A' ' 86' ' ' VAL . 17.2 p90 -135.82 179.34 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CE2' HG22 ' A' ' 188' ' ' VAL . 25.8 m-85 -116.27 150.78 37.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 m -124.04 136.94 54.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.54 125.06 52.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.781 0.324 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.45 141.07 45.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -145.97 153.01 40.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.0 133.15 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.957 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -107.65 121.71 45.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 36.9 mt -94.03 139.2 31.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.434 HG22 ' CE2' ' A' ' 168' ' ' TYR . 43.0 t -83.37 127.26 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.05 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -73.76 160.43 31.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.286 -0.864 . . . . 1.0 111.141 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.823 0.345 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -74.2 112.97 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.56 -16.33 22.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -169.66 166.96 9.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.85 -173.89 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.041 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.98 -119.53 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 98.82 132.45 7.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.774 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 168.69 19.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.729 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -26.88 67.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.28 -35.13 15.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.23 113.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.887 0.375 . . . . 0.0 111.194 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' CA ' ' A' ' 25' ' ' GLY . 1.3 m -98.22 143.68 28.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.454 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 3.8 p90 -138.55 158.92 43.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.7 132.24 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -86.32 120.04 27.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.6 148.65 44.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.65 116.61 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.61 127.32 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.17 -172.93 2.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.708 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.31 -19.99 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.735 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.19 -90.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.54 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 141.16 28.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.776 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -137.63 155.02 49.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.427 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.74 115.9 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.403 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 17.5 p -112.67 147.41 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.998 0.427 . . . . 0.0 111.482 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.29 125.66 60.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.939 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -98.68 140.98 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -138.38 116.79 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.921 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 167.25 10.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 46.23 35.41 2.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.439 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.78 142.92 15.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.761 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 53' ' ' GLU . 53.6 Cg_endo -68.58 -163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.403 2.069 . . . . 0.0 112.107 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.04 -54.31 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.59 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -61.18 -45.52 94.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.488 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.416 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 5.4 tt0 -67.33 -42.9 82.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.23 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.61 -44.8 90.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.425 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 84' ' ' PHE . 5.3 mt -56.92 -35.63 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.761 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -33.02 74.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 17.1 tp10 -88.42 -30.89 19.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.384 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -44.8 58.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 32.5 mmt -57.68 -43.88 99.09 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 31.9 Cg_exo -58.9 -46.09 24.98 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.17 1.913 . . . . 0.0 112.221 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -70.29 -41.39 73.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.707 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.0 tt -76.41 -35.06 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 111.586 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.4 mtt -66.28 -36.59 83.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -49.01 79.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 23.1 t80 -58.45 -54.11 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 33.7 m -66.48 -28.29 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.5 -141.12 0.89 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.614 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.51 43.22 1.92 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.3 m -131.19 87.13 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.39 143.32 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -73.59 -9.16 58.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -91.21 -39.82 11.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.04 62.4 1.01 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.409 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 m -139.66 159.48 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.92 -46.13 38.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mtp 61.43 117.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 111.051 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.72 127.62 25.73 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.402 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.48 176.05 8.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 18.7 p -147.63 114.05 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 31.2 m -57.61 -33.11 15.72 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 80' ' ' VAL . 11.1 Cg_exo -71.48 152.3 60.05 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.082 1.855 . . . . 0.0 111.823 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -153.07 147.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 t -143.02 145.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.646 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -133.25 154.15 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.51 136.72 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 110.481 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 167' ' ' TYR . 15.4 m -136.1 141.0 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CD2' HG21 ' A' ' 166' ' ' VAL . 3.7 m-85 -108.63 107.97 60.51 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.35 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.02 129.49 7.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.549 2.166 . . . . 0.0 112.391 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.82 158.43 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -28.78 69.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -2.69 58.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.432 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.45 57.3 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.969 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.02 163.21 28.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -117.51 -9.51 10.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.417 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 62.47 153.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 110.958 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -80.78 88.34 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.035 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.72 118.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 84' ' ' PHE . 2.2 tt -143.94 135.8 26.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -123.25 115.67 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.203 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.2 t -81.98 141.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.308 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -120.23 131.25 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 56.5 t80 -110.08 161.25 15.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.464 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' O ' ' CE2' ' A' ' 102' ' ' PHE . 40.9 mmt-85 -116.08 121.57 42.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.64 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.5 mt -102.22 137.01 19.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.21 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.23 154.09 72.87 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.511 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -26.55 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.269 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -56.6 -47.02 80.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.07 -5.04 41.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.321 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -54.39 -47.73 72.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.9 -26.08 39.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.99 91.38 0.3 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.92 150.85 73.67 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.417 2.078 . . . . 0.0 112.22 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.83 152.97 64.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.633 2.222 . . . . 0.0 112.047 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.54 127.97 93.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.095 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 74.5 Cg_endo -75.53 169.71 21.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.521 2.147 . . . . 0.0 112.401 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 -31.8 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.18 116.17 19.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.68 -19.64 41.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.85 -22.01 40.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.209 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.7 t -84.77 113.9 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.96 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -108.11 147.62 30.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.27 123.89 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.78 142.73 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.46 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -169.3 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -43.89 109.28 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.966 0.413 . . . . 0.0 111.594 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.16 56.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.719 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.67 168.57 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.72 142.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.6 m -111.04 119.8 40.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.691 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 m -138.86 168.74 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.255 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.428 ' CD2' HD11 ' A' ' 155' ' ' LEU . 10.8 m-85 -107.73 141.1 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.526 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.7 p -105.96 127.93 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.281 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 t -125.1 137.11 54.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.644 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.84 125.01 45.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.919 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 8.5 p90 -123.06 -41.67 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.99 84.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . -147.09 -89.21 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.6 OUTLIER -175.71 108.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.0 110.814 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 144' ' ' TYR . . . -105.66 132.72 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 58.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 67.16 -72.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.86 76.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -67.84 -34.77 77.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.982 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 139' ' ' ALA . 1.2 m-85 -62.63 -39.53 94.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.439 0.638 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.87 -38.82 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.68 -35.61 70.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.787 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 47.4 m-70 -70.05 -42.7 72.54 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.925 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -32.92 72.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.694 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.4 m -69.64 -39.28 77.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.714 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.83 -46.01 91.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.9 tp -58.57 -40.67 83.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.656 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.06 95.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.3 m -64.84 -39.37 93.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.364 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -45.67 84.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.822 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 131' ' ' TYR . 15.6 mt -72.78 -17.83 61.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.258 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.96 111.56 0.41 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.171 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 106.25 30.37 4.46 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.289 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.414 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 64.6 p -145.23 168.07 12.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.7 0.286 . . . . 0.0 110.807 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 16.5 Cg_exo -67.93 -3.43 10.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.808 2.339 . . . . 0.0 112.978 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.29 124.56 18.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.339 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -99.57 176.32 5.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.32 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 161' ' ' THR . 3.5 m-85 -154.58 161.25 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.035 0.445 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -92.87 -172.26 2.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.819 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.81 63.19 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 57.08 77.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.743 0.306 . . . . 0.0 111.308 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 87' ' ' PHE . 13.9 p -161.37 112.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' HG22 ' A' ' 86' ' ' VAL . 13.8 p90 -119.14 173.28 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.724 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.89 150.49 31.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.82 149.62 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.564 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.94 152.54 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.06 154.84 42.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.07 128.35 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -108.04 122.0 45.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.368 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 13.1 mt -93.09 134.49 35.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 167' ' ' TYR . 43.4 t -74.76 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -107.51 111.97 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.227 -0.892 . . . . 1.0 111.028 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.0 112.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.73 -10.88 25.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.354 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -170.01 164.83 9.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.33 . . . . 0.0 110.966 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.9 -49.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.96 137.64 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.462 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -139.11 -156.16 6.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -78.4 158.37 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.51 -27.38 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -90.11 -35.01 15.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.08 114.82 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -95.38 150.8 19.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 p90 -139.05 160.32 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -143.33 124.97 14.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -85.86 122.1 29.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -130.3 128.13 40.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.35 132.77 55.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.1 p -139.65 162.22 35.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.85 170.91 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.935 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.8 -119.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.01 -170.76 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.34 137.72 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 103' ' ' ARG . 10.8 m-85 -137.49 159.85 40.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.29 127.07 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.7 p -112.79 131.79 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 39.0 t -127.7 125.35 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.59 139.92 31.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.28 116.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.52 168.35 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 t0 47.56 28.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -152.87 115.72 2.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.41 -172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.507 2.138 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.71 -62.24 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.542 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -45.08 79.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -67.1 -45.36 77.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.169 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.42 90.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.344 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.96 -35.75 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.743 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -64.79 -32.17 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.944 0.402 . . . . 0.0 110.479 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.5 tp10 -87.8 -35.45 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.821 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.52 -42.02 62.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -57.64 -44.11 99.27 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.494 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.0 Cg_exo -63.95 -40.29 28.48 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.243 1.962 . . . . 0.0 111.76 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -70.14 -43.39 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 tt -76.35 -34.16 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.318 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mmt -66.28 -37.83 86.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 110.957 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.2 81.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.409 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 62.5 t80 -68.99 -42.1 76.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.437 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 30.3 m -82.24 -23.37 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.32 -82.09 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.79 51.86 0.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -132.06 92.21 3.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.769 0.318 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -155.09 170.81 20.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -96.09 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -148.33 -47.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.31 42.96 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.26 174.07 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 111.182 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.1 116.41 1.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.528 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 30.6 mtp -112.56 -161.7 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.69 -120.37 1.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -56.43 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.509 ' O ' ' CG1' ' A' ' 80' ' ' VAL . 2.1 m 60.45 102.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.991 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 79' ' ' THR . 9.7 p 53.78 142.72 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.801 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 31.2 Cg_exo -59.79 138.2 81.4 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.304 2.003 . . . . 0.0 112.128 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.01 153.96 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.649 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.408 ' OG ' ' CH2' ' A' ' 186' ' ' TRP . 0.6 OUTLIER -122.26 167.6 13.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -133.18 140.52 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.162 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.7 136.65 39.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.432 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' CE1' ' A' ' 167' ' ' TYR . 3.6 m -131.38 102.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.857 0.361 . . . . 0.0 111.09 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -70.7 111.76 10.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.94 137.85 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.724 2.283 . . . . 0.0 112.503 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.11 155.14 18.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.839 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.28 -19.0 61.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -85.24 -6.02 59.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.94 59.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.051 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -95.56 165.39 12.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.348 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.0 mt -112.2 140.64 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 163.09 24.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -79.95 -11.83 59.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 124.7 33.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.703 0.287 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.7 141.21 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.067 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -121.88 115.98 23.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.63 128.12 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.329 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -103.37 142.07 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.708 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 62.9 t80 -126.07 150.73 47.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 0.0 111.519 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.411 ' HD3' ' CE2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -108.77 108.04 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.514 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.5 mt -80.25 136.05 53.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.343 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.56 154.23 70.08 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.664 2.242 . . . . 0.0 112.511 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 69.3 m-80 -55.87 -26.87 49.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.284 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -56.98 -40.38 76.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.405 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -101.86 -8.07 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.749 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -53.95 -37.58 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.332 . . . . 0.0 111.055 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.23 -31.13 61.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -174.53 85.37 0.34 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.4 Cg_exo -56.88 145.53 83.8 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.6 Cg_exo -70.88 151.85 63.0 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.489 2.126 . . . . 0.0 112.081 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 111.59 7.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.995 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 33.0 Cg_exo -58.36 158.87 21.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.479 2.119 . . . . 0.0 112.192 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -110.44 30.83 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -130.26 112.15 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.02 -29.07 65.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.3 -27.54 32.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 t -85.11 125.47 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.153 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 157.11 33.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.7 mm -105.73 119.48 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.83 21.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.51 156.07 39.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 58.8 103.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.24 -66.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 111.184 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.3 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.088 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.26 142.98 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.007 0.432 . . . . 0.0 111.629 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.0 m -115.42 128.98 56.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.252 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.47 160.02 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.433 ' CZ ' HD12 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.93 136.3 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.205 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.1 p -105.67 131.08 53.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 111.396 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -125.34 139.25 53.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -116.85 137.17 52.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 6.1 p90 -134.57 140.75 46.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.36 93.9 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 159.1 161.1 10.86 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.581 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -65.79 167.86 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.52 147.99 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -135.79 -175.91 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -58.35 -69.43 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.83 72.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.688 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.15 -34.85 78.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.031 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.77 -40.75 98.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.87 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -38.88 36.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.61 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.53 -36.27 70.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.919 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 48.0 m-70 -70.14 -43.28 71.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.901 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.92 72.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 m -65.55 -37.84 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -58.76 -45.83 88.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.59 -38.79 78.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.428 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -64.29 -43.25 95.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -68.13 -38.57 82.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 56.1 m -57.49 -49.08 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.433 HD12 ' CZ ' ' A' ' 131' ' ' TYR . 47.3 mt -73.56 -19.5 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.17 102.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 113.08 32.7 2.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.3 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.0 p -145.52 165.42 21.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.82 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.06 -17.33 30.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.666 2.244 . . . . 0.0 112.674 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.28 41.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.445 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -101.94 -171.21 1.93 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.933 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.43 154.0 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.06 -164.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -56.68 -86.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.17 77.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.3 p -161.67 132.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 86' ' ' VAL . 14.7 p90 -141.17 163.63 32.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.447 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 22.1 m-85 -112.94 157.49 21.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.87 136.98 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.01 138.53 48.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.026 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.89 0.376 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -115.63 133.89 55.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.585 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.36 156.89 44.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 29.3 t -121.43 114.85 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.562 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.11 125.68 51.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.346 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 167' ' ' TYR . 5.3 mt -92.54 140.51 29.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.593 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 18.6 t -74.59 131.14 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.358 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -79.95 163.43 24.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.206 -0.902 . . . . 1.0 111.096 179.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.55 113.0 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mt -96.67 -12.94 23.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.442 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.48 166.29 10.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 p -152.47 -176.78 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.47 141.95 1.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.422 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -154.67 -173.74 23.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -78.81 158.98 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -66.59 -30.38 70.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.06 -35.03 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m -146.08 107.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.006 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 p -97.29 156.14 16.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.8 p90 -140.12 162.05 36.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -145.52 136.38 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.77 130.8 34.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 127.98 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.58 139.1 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 111.255 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -133.71 132.21 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.794 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.67 149.21 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 118.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.92 148.93 5.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.603 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -105.36 158.18 16.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -137.63 157.6 46.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.94 140.3 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.434 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.9 p -137.03 143.43 42.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.687 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.25 125.87 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -95.85 131.18 42.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.024 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.34 116.85 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.32 169.04 8.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 47.46 37.86 6.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -152.5 137.38 10.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.869 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.89 -160.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.509 2.14 . . . . 0.0 112.278 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 98' ' ' LEU . 46.2 t -92.76 -63.38 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.28 -42.83 92.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.9 -45.96 76.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.99 75.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 84' ' ' PHE . 8.3 mt -58.31 -35.4 71.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.27 -33.61 74.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.533 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.5 tp10 -87.48 -28.67 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.57 -44.01 58.37 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.485 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 32.0 mmt -57.67 -43.46 98.81 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.533 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.92 -45.54 23.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.23 1.953 . . . . 0.0 111.884 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -70.34 -42.25 72.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.661 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.04 -37.48 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.432 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -66.12 -31.77 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.001 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 63' ' ' MET . 4.2 mtmm -60.89 -29.96 69.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.385 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -73.13 -49.05 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 14.9 m -66.01 -22.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.44 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.81 83.18 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.97 -43.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 t -172.43 100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.016 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -127.34 3.36 6.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.22 41.15 17.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -148.31 -50.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.89 43.96 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 m -100.92 -179.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 117.68 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.337 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.1 mtp -120.15 118.43 30.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.42 -26.19 50.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.3 ttt 63.92 132.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 t -58.13 177.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.479 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -95.29 -54.79 0.22 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.204 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 76.2 Cg_endo -93.86 130.35 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.645 2.23 . . . . 0.0 112.585 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -93.07 148.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.43 148.95 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -133.05 154.25 50.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.201 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 101' ' ' TRP . . . -94.36 136.69 34.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.39 134.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.071 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 166' ' ' VAL . 3.8 m-85 -111.04 95.79 26.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.28 164.3 32.95 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -90.23 172.28 8.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.52 -22.16 20.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.292 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.46 -6.12 59.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.466 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.14 61.51 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.883 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -174.73 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.776 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mt -123.54 164.31 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -161.0 87.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp 51.96 -167.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.19 99.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 84' ' ' PHE . 6.1 tt -144.08 128.01 17.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.167 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 115.57 29.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.973 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.7 t -71.68 141.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.731 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.423 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 25.9 m95 -119.35 130.99 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.13 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 60.5 t80 -114.76 158.9 21.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 111.63 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -116.08 107.9 15.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.482 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mt -84.92 137.1 38.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.356 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.31 154.09 25.06 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 3.9 m-20 -58.24 -26.89 63.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -47.12 87.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.482 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -86.31 -11.06 53.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.598 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.83 -42.81 68.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.634 0.255 . . . . 0.0 111.017 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.86 -29.05 58.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.8 85.48 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.607 0.242 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -60.82 160.94 23.27 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.573 2.182 . . . . 0.0 112.239 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.41 155.66 32.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.861 2.374 . . . . 0.0 111.972 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.08 22.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.97 168.6 22.66 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.377 2.051 . . . . 0.0 112.392 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.2 p -110.25 168.92 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 t70 66.74 126.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.75 -16.01 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.66 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -79.81 -29.14 40.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.68 0.276 . . . . 0.0 111.253 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.73 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -123.02 156.92 33.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.9 mm -113.71 128.46 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.8 153.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.27 179.86 6.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -58.66 98.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.67 -21.86 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.9 74.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.55 145.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.31 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -103.78 137.45 41.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 186' ' ' TRP . 27.0 m -139.17 145.63 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 186' ' ' TRP . 0.4 OUTLIER -107.79 128.81 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.4 p -105.51 142.29 35.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.141 0.496 . . . . 0.0 111.707 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.0 t -127.67 139.6 52.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 125.0 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.404 . . . . 0.0 111.023 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 12.5 p90 -131.03 -177.88 4.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -117.58 130.22 8.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.566 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.31 -177.37 20.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.568 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -94.43 166.9 11.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -177.18 121.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.245 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.22 -73.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.778 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -141.4 -47.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.785 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -73.03 -33.95 66.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 110.605 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -35.09 76.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.927 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -64.22 -39.08 93.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.245 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.63 -38.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.2 70.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.78 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.499 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.7 m-70 -70.0 -42.79 72.58 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.807 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.94 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.4 m -67.66 -39.44 84.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.704 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.25 -46.05 92.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 tp -58.28 -38.88 77.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -64.12 -42.56 96.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.5 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.7 m -69.15 -37.07 78.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.4 m -57.54 -38.9 75.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 162' ' ' TYR . 32.1 mt -72.4 -22.71 61.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.23 95.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.216 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.93 33.12 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 64.9 p -145.54 155.26 53.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.09 -12.99 37.33 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.615 2.21 . . . . 0.0 112.605 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.41 159.8 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 156.54 47.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.6 OUTLIER -154.48 155.81 35.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -79.38 -61.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.03 -16.69 58.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.687 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.58 -27.47 34.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.066 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 87' ' ' PHE . 8.4 p -160.76 118.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -119.03 171.38 8.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 33.5 m-85 -113.15 140.16 48.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.82 147.58 35.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.04 127.82 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.582 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.907 0.384 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -108.93 158.01 18.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.515 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.38 144.18 34.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.7 124.64 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.5 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -122.14 132.37 54.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 111.725 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 16.8 mt -92.33 140.21 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.656 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 19.6 t -74.69 131.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.462 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 69.1 tttt -69.53 154.21 42.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 1.0 111.077 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.675 0.274 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.11 112.83 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.857 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.88 -12.99 22.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.79 167.09 9.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.69 154.49 36.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.23 164.26 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -161.17 -58.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -161.95 164.48 28.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.785 0.326 . . . . 0.0 110.748 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -33.74 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -91.08 -35.29 14.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.44 108.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.83 0.348 . . . . 0.0 111.723 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.31 158.06 16.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -139.07 162.35 35.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.92 0.39 . . . . 0.0 111.114 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.76 132.85 21.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -85.98 126.96 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.97 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.93 127.35 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -152.88 96.18 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.48 -50.65 72.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.77 -119.77 19.57 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.622 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.96 -119.46 1.01 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -91.91 159.34 15.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.832 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HB3' ' O ' ' A' ' 102' ' ' PHE . 38.4 m-85 -137.44 148.93 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.042 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.81 140.34 29.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 66.5 p -132.1 136.02 46.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 111.576 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.9 t -125.9 125.56 68.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.662 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -96.88 131.45 43.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.095 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.26 116.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.41 174.11 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.51 25.99 3.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.398 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -152.95 130.02 5.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.06 177.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.313 2.009 . . . . 0.0 112.23 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.2 -57.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -58.24 -45.25 88.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.17 -46.21 74.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.0 91.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.194 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.1 -35.59 69.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.77 -31.81 73.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.1 tp10 -87.27 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.66 61.62 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 6.0 mmt -57.69 -44.15 99.27 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.3 Cg_exo -63.29 -40.54 31.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.21 1.94 . . . . 0.0 111.718 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -70.24 -44.03 69.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.035 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.1 -31.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -42.79 87.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -58.92 -42.27 89.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 7.0 t80 -59.63 -50.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 35.7 m -72.54 -27.62 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.37 -105.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.594 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.46 67.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.6 m -164.4 71.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 0.0 110.761 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.94 10.41 3.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.372 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 57.05 38.94 29.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 111.025 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -52.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.46 79.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.552 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.0 143.65 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.896 0.379 . . . . 0.0 111.169 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.87 -42.66 94.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.411 ' HA ' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 65.48 -76.4 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.89 -23.16 8.37 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.412 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 64.46 162.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.04 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 7.8 m -122.29 131.63 54.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 1.5 t -68.43 -53.05 18.6 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 84.3 Cg_endo -81.1 130.78 7.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.417 2.078 . . . . 0.0 112.354 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -154.37 134.61 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.975 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -114.96 167.99 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.91 154.22 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.416 ' HA ' ' CD1' ' A' ' 168' ' ' TYR . . . -92.35 136.57 33.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.307 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.445 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 33.3 m -131.28 128.35 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 111.132 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CE2' HG23 ' A' ' 166' ' ' VAL . 21.9 m-85 -98.95 104.25 24.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.84 128.31 18.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.412 2.074 . . . . 0.0 112.202 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -90.29 156.88 17.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -66.02 -15.9 63.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.314 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.04 5.18 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.552 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.59 -16.0 60.16 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.752 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 162.87 13.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 27.1 mt -87.8 -4.91 58.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.509 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 62.33 162.34 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -80.75 84.15 6.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -175.68 106.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -138.22 127.96 25.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.64 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.8 t -76.22 141.15 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.95 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.409 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 50.6 t80 -120.98 150.26 41.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.518 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.74 114.5 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 104' ' ' ILE . 27.8 mt -92.75 134.51 27.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.286 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.82 154.06 28.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.622 2.215 . . . . 0.0 112.405 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -60.49 -26.75 67.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.07 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -56.96 -32.81 66.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.409 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 76' ' ' MET . 57.9 m-85 -106.03 -9.71 16.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.799 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.95 -33.8 52.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.17 77.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 76.28 3.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.658 0.266 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.72 148.23 88.84 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.635 2.223 . . . . 0.0 112.303 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.57 159.24 49.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.59 133.26 94.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 27.6 Cg_endo -62.9 -22.24 73.7 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.129 . . . . 0.0 112.417 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 m 52.97 28.46 6.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.75 122.83 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.06 -24.01 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.177 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.07 -35.81 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.96 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.05 123.67 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 157.03 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.2 mm -112.2 118.58 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.934 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.94 129.48 45.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.38 -152.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 67.92 71.85 0.32 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.727 0.299 . . . . 0.0 111.458 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 38.3 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.93 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -97.7 -145.31 18.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.427 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -144.15 145.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.324 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.3 m -103.91 118.93 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.499 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.72 170.38 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.379 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.4 ' CE2' HD21 ' A' ' 155' ' ' LEU . 5.0 m-85 -107.32 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.329 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.452 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 98.1 p -130.23 136.28 49.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -131.09 139.15 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.344 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -116.88 140.59 49.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.32 173.55 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.23 -30.01 8.07 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.555 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.02 118.0 12.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.59 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.46 121.77 25.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.87 150.89 32.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.278 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -106.36 -59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.68 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -152.02 -67.73 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -33.78 73.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.76 -34.59 77.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.8 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.4 OUTLIER -62.56 -40.25 96.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.54 0.686 . . . . 0.0 109.742 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.89 -38.72 37.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.709 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.26 -33.8 72.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.795 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.12 -46.1 65.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.88 73.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.972 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.4 m -62.99 -43.99 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -62.45 -46.07 90.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.1 -39.68 83.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.83 -48.11 82.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.308 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.5 m -62.23 -45.27 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.166 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.1 m -57.53 -44.56 85.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' A' ' 131' ' ' TYR . 12.4 mt -72.89 -17.01 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.143 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.79 -38.06 14.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 111.445 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.63 -14.18 82.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.407 ' CB ' ' CD ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -93.89 176.38 2.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.806 0.303 . . . . 0.0 111.064 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 158' ' ' THR . 13.4 Cg_exo -70.02 -1.04 8.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.25 143.0 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.708 0.29 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.431 ' O ' ' CG2' ' A' ' 161' ' ' THR . 16.1 m -130.39 2.06 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.766 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.409 ' O ' ' CB ' ' A' ' 190' ' ' ALA . 8.0 m-85 56.92 159.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.62 -80.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.24 38.6 1.23 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.276 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.13 71.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 110.713 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 87' ' ' PHE . 14.0 p -161.76 124.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.454 ' CD2' ' CG1' ' A' ' 185' ' ' VAL . 30.5 p90 -126.0 175.0 8.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CD1' ' HA ' ' A' ' 85' ' ' ALA . 68.3 m-85 -119.6 162.03 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 94.6 m -130.82 130.86 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.016 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.02 156.02 46.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.674 0.273 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.432 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 44.7 m-80 -133.11 138.39 46.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 111.469 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -146.09 157.29 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.628 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.454 ' CG1' ' CD2' ' A' ' 167' ' ' TYR . 10.6 t -134.85 114.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.888 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 44.0 m0 -109.33 121.53 45.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.207 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.53 140.08 30.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.666 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.08 123.59 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.3 150.34 40.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 1.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.29 112.88 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.802 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.98 -9.42 37.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.478 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.83 158.95 7.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.843 0.354 . . . . 0.0 110.937 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.1 p -152.64 164.22 38.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.8 -137.25 13.22 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . 133.04 -170.38 22.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.518 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -78.56 162.04 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 0.0 110.839 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -25.21 66.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.78 -32.64 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.04 122.51 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.068 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.44 147.63 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.417 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 8.4 p90 -139.17 155.74 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.59 128.8 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -86.75 127.29 34.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.11 134.45 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.06 127.43 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.48 128.55 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.61 -66.84 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.61 178.34 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.528 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.48 -111.14 1.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtmt -92.01 157.61 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 23.4 m-85 -137.4 157.38 46.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.94 135.3 43.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 38.7 p -137.31 151.49 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.509 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.66 125.96 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.703 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -95.88 130.27 42.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.26 116.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.018 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.81 176.86 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.03 31.01 1.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -152.36 138.2 11.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.8 -160.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.432 2.088 . . . . 0.0 112.205 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 98' ' ' LEU . 62.3 t -90.28 -48.07 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.13 -45.12 74.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -46.38 74.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.94 92.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.11 -35.46 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -62.67 -29.91 70.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.12 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 tp10 -89.84 -32.9 16.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.316 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.89 -43.85 62.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.475 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 9.4 mmt -57.69 -44.05 99.19 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 59' ' ' MET . 42.9 Cg_endo -69.06 -36.26 13.02 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.984 1.789 . . . . 0.0 112.207 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -70.16 -43.6 70.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.653 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.91 -27.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.328 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -37.14 84.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.037 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -58.78 -37.1 75.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 19.1 t80 -67.12 -56.43 10.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 31.9 m -65.87 -30.72 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.8 -100.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 64.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.509 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -147.76 65.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.1 165.5 28.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.717 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.02 46.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 4.57 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.677 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.52 32.01 5.3 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.747 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 p -96.66 140.57 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.879 -0.66 . . . . 0.0 111.67 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.4 49.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 14.3 ptm -52.17 -48.89 64.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.59 -161.85 35.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.547 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 tpt -92.23 147.74 22.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 m -151.37 120.8 6.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.0 t 64.27 136.43 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.56 130.69 34.54 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.27 1.98 . . . . 0.0 112.184 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -88.91 154.05 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.321 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 t -117.89 173.73 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -131.8 154.21 49.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.003 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.04 136.82 32.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.402 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 ' CZ ' ' A' ' 167' ' ' TYR . 23.9 m -132.89 132.98 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.173 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -106.27 98.16 18.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.416 ' HD3' ' CD1' ' A' ' 167' ' ' TYR . 73.3 Cg_endo -75.59 138.89 22.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -90.26 161.77 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.86 -19.12 62.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.2 -5.87 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.65 -3.44 78.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.882 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.48 139.52 51.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.14 144.09 33.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.98 48.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.82 96.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -179.64 107.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 84' ' ' PHE . 7.8 tt -142.82 128.13 18.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.489 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -115.54 115.65 26.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.248 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.3 t -74.24 141.35 16.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 0.0 111.594 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -121.64 126.05 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.276 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.418 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 52.9 t80 -110.13 155.18 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 111.612 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 107.88 15.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.585 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 139.68 92.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.35 153.99 73.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.489 2.126 . . . . 0.0 112.319 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -56.63 -26.8 56.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.284 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -56.98 -32.81 66.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 107' ' ' GLN . 11.3 m-85 -116.8 20.22 14.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.426 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -55.09 -33.85 63.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.46 -25.82 67.13 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.01 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -177.73 107.95 0.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.736 0.268 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 108' ' ' PHE . 52.6 Cg_endo -69.08 161.12 47.16 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.41 2.074 . . . . 0.0 112.187 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.7 150.49 62.58 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.584 2.189 . . . . 0.0 112.003 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.98 114.13 16.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 58.8 Cg_endo -73.04 165.95 31.36 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.352 2.034 . . . . 0.0 112.335 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.2 m -127.68 33.19 4.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.44 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.91 -26.53 62.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.12 -26.93 33.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.89 115.5 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.13 156.93 19.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.817 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.16 127.4 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -98.76 160.16 14.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -147.45 129.15 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 63.55 123.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -169.08 -80.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.8 110.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.369 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.49 142.91 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 111.253 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 m -107.86 119.03 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.55 161.11 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.382 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.93 138.23 44.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 p -108.75 142.39 39.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.1 t -129.68 139.0 51.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -116.86 130.44 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.95 144.59 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.09 95.66 1.99 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.52 159.0 28.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -72.17 174.87 6.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.34 144.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.33 -60.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -159.85 -66.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.58 70.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.491 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.93 -34.89 78.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.945 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -41.62 99.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 109.893 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.95 -38.8 38.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.559 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.03 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.897 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -67.76 -41.93 82.55 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.798 0.333 . . . . 0.0 111.044 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.001 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -67.79 -39.48 84.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -57.95 -43.39 86.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.703 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -59.83 -40.0 87.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.368 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.97 -42.54 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.51 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.9 m -57.58 -49.46 76.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.85 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 162' ' ' TYR . 11.5 mt -75.12 -10.36 59.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.74 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.55 -29.0 2.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.787 0.327 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -98.51 26.68 22.87 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.587 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.9 p -146.05 160.51 42.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.77 -5.54 17.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.95 2.433 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.75 119.8 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 157.28 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.755 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.432 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -156.02 -176.02 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -115.5 156.77 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.56 -4.02 10.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.713 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -81.92 -22.78 36.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.609 0.242 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 p -160.46 158.11 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 111.406 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.42 ' CZ ' HG22 ' A' ' 86' ' ' VAL . 14.9 p90 -166.25 163.13 17.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.538 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -112.94 158.82 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.968 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 m -142.25 158.93 43.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.61 139.28 49.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -108.92 157.98 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.517 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.47 145.53 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.287 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.99 133.49 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.564 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -107.76 121.54 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.8 mt -97.08 134.53 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.576 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.96 119.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -69.76 140.69 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 1.0 111.141 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.878 0.37 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.24 115.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.53 -2.4 38.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -170.24 165.85 8.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.28 -175.93 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.69 152.79 17.34 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -155.34 178.1 32.16 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.64 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -78.85 158.48 28.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.49 -29.16 69.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -89.86 -31.01 17.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t -145.98 117.02 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 m -95.33 137.45 34.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.458 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.4 p90 -139.04 162.13 35.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -144.94 140.69 28.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.35 126.58 34.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.921 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.99 127.91 39.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.91 135.08 50.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -159.9 79.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 41' ' ' PHE . 8.8 mp0 -142.25 137.33 30.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.14 -99.74 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.91 -59.99 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 24.5 mttm -109.33 145.88 35.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 37' ' ' GLU . 5.2 m-85 -137.58 147.34 44.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.87 139.07 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.55 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 16.6 p -137.35 155.33 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.983 0.421 . . . . 0.0 111.7 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.3 125.82 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -95.83 132.93 40.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.32 122.45 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.86 170.53 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.24 38.72 1.72 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -152.56 128.16 5.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.895 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.71 -167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.412 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.5 t -78.54 -60.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.195 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.72 -44.78 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.48 -46.31 83.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.832 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.94 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -58.7 -35.94 73.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -66.37 -32.98 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 tp10 -87.19 -41.74 13.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -37.01 66.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 10.9 mmt -57.85 -44.03 99.08 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.5 Cg_endo -70.09 -32.52 17.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.919 1.746 . . . . 0.0 112.16 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -70.25 -45.16 67.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 tt -77.48 -36.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.8 mtt -66.21 -41.88 89.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.761 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -58.85 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.727 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -67.88 -46.62 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.46 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 32.3 m -69.85 -27.77 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.32 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.32 99.63 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.98 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 t -164.19 88.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.815 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -113.06 -12.49 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.14 40.9 8.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.966 0.413 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -147.76 -46.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.42 30.45 4.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.009 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.44 153.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.333 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.12 81.43 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mtt -63.1 -48.05 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.46 53.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.6 tpt 62.39 147.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -164.02 130.67 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.7 t 64.02 136.67 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.12 134.06 50.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.454 2.102 . . . . 0.0 112.121 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.22 136.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.241 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.01 160.29 19.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.357 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -127.03 154.27 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.106 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.17 136.7 32.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 HG22 ' CE1' ' A' ' 167' ' ' TYR . 33.7 m -132.23 123.7 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -98.31 102.98 15.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 140.76 19.37 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.485 2.124 . . . . 0.0 112.271 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.35 163.0 14.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -15.9 63.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.354 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -85.23 4.22 35.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.589 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 -16.04 59.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.849 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -95.84 162.93 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.91 171.72 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -103.82 157.8 16.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -80.51 61.06 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -161.96 109.24 1.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.97 146.16 49.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.236 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.26 115.72 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.339 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.1 t -81.19 141.36 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -121.67 132.16 54.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 19.3 t80 -121.57 134.86 55.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.016 0.436 . . . . 0.0 111.377 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.65 118.06 34.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mt -84.44 136.35 40.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.68 154.25 74.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 109' ' ' GLN . 34.2 m120 -51.6 -26.63 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -56.9 -32.9 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.04 -1.09 12.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 106' ' ' ASN . 1.2 pp0? -54.06 -34.26 59.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.815 0.341 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.58 -34.04 88.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.765 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.91 84.08 0.52 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.316 . . . . 0.0 110.972 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 32.5 Cg_exo -58.97 160.37 18.62 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.174 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.98 152.13 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.686 2.257 . . . . 0.0 112.004 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 121.11 79.54 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.318 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 119.9 6.2 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.473 2.115 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -64.55 -39.81 94.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.32 112.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.402 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -26.73 61.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -81.73 -28.81 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.28 115.91 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -120.83 156.95 30.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.6 mm -103.44 131.37 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.249 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.95 129.93 45.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -89.01 126.44 35.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.8 ttm180 58.05 -173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 10.2 tt0 84.86 78.08 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 169.41 52.81 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.195 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.98 142.99 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -119.22 134.0 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.051 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.7 164.61 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.675 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -107.77 133.48 52.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.265 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -105.76 140.23 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.273 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -130.99 139.13 49.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.74 130.31 56.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 31.5 p90 -139.29 -177.81 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.56 110.87 1.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.469 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -176.74 -133.28 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.4 103.31 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.753 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.06 150.11 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.98 -47.89 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.683 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -162.05 -69.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.62 72.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.522 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.95 -34.98 78.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.011 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -40.6 98.17 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.76 -38.71 36.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.54 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.45 -37.86 74.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.774 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 24.0 m-70 -70.23 -43.69 70.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.891 0.377 . . . . 0.0 110.804 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.28 -32.92 72.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.615 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -68.47 -43.36 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.681 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -61.88 -46.1 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.45 -36.95 81.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.42 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.17 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.5 m -69.08 -34.86 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.64 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.0 m -57.51 -47.03 83.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.857 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.51 -21.21 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.89 -44.91 20.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.335 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.92 35.26 4.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.695 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.2 p -146.32 156.47 49.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.747 0.308 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 -11.05 29.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.696 2.264 . . . . 0.0 112.701 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.23 139.68 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 0.0 111.158 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.2 m -100.51 140.87 34.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.731 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -159.6 156.9 28.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -90.43 136.65 32.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.29 56.98 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.17 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.85 -23.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.12 143.79 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.913 0.387 . . . . 0.0 111.271 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.432 ' CE1' HG22 ' A' ' 86' ' ' VAL . 30.2 p90 -142.88 174.07 10.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.8 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.79 152.57 30.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.15 146.1 49.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.93 133.38 44.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.465 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.952 0.405 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 7.2 m-80 -133.0 138.97 47.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.632 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -142.92 145.98 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 111.241 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.09 134.44 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -108.07 121.62 45.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.274 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.35 139.37 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.433 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.85 129.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 11.6 tttm -88.46 48.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.252 -0.88 . . . . 1.0 111.472 179.817 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.442 ' HG3' ' HB3' ' A' ' 35' ' ' ALA . 8.0 pt20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.802 0.334 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 t -74.47 112.82 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.586 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.26 -4.03 46.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.27 158.85 6.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.809 0.338 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -153.29 174.15 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.65 168.96 8.01 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.47 -162.23 28.24 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -78.39 157.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -66.56 -26.27 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.96 -34.97 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.08 110.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.6 m -95.16 148.3 22.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.4 p90 -138.5 153.11 48.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -146.37 130.45 17.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.18 114.88 23.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 147.52 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 19' ' ' GLN . . . -124.98 130.74 52.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -144.01 144.91 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.32 89.19 3.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -148.63 3.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.89 -111.85 0.69 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.99 152.72 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.343 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -137.7 153.73 49.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.11 124.0 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.8 p -112.7 131.94 55.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.418 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.06 125.41 57.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.1 135.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -138.31 116.82 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 173.81 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.23 28.05 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.358 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -152.73 121.58 3.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.71 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.477 2.118 . . . . 0.0 112.177 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.03 -52.83 55.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -63.44 -45.25 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.1 -46.03 75.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -45.14 90.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -58.34 -35.41 71.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 mtm105 -63.12 -31.55 72.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 109.942 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.7 tp10 -86.97 -33.47 19.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.147 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.67 63.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.76 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.47 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 6.3 mmt -57.61 -44.02 99.23 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 23.3 Cg_exo -64.58 -42.93 14.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.257 1.972 . . . . 0.0 111.913 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.2 -41.28 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 tt -76.26 -42.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.372 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.449 ' HA ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -65.04 -31.76 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 63' ' ' MET . 16.4 mtpt -69.75 -29.81 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.434 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -71.37 -42.81 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 63' ' ' MET . 33.8 m -65.96 -28.17 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.11 93.34 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.67 -40.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.37 84.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -125.02 0.43 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.401 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 61.75 39.05 14.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 -47.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.38 52.03 3.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.06 -178.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.133 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.99 78.47 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.6 mtp -82.0 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.364 . . . . 0.0 110.735 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 78' ' ' MET . . . 75.72 46.13 15.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.759 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 17.8 mmt 67.47 -62.08 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.563 0.221 . . . . 0.0 111.498 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m 78.75 -60.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.94 158.11 76.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.052 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 130.77 36.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.395 2.063 . . . . 0.0 112.118 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 102' ' ' PHE . 6.1 m -87.24 154.06 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.321 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 t -130.72 160.23 34.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -121.3 154.3 36.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.213 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.43 136.65 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' CE2' ' A' ' 167' ' ' TYR . 15.7 m -124.81 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.414 ' CE2' HG21 ' A' ' 166' ' ' VAL . 4.8 m-85 -113.24 93.82 27.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.39 138.79 62.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.598 2.199 . . . . 0.0 112.077 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.97 171.95 9.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.94 -22.11 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.41 -6.07 59.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.442 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.46 -16.05 61.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.767 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.45 133.5 33.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.41 -30.0 70.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.57 -175.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -80.67 90.23 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.34 100.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 tt -144.13 135.53 25.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 111.365 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HD2' ' CD1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -119.53 115.79 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.032 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.54 141.15 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.429 ' CD1' ' HD2' ' A' ' 99' ' ' LYS . 18.5 m95 -122.39 138.61 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.464 ' CD2' ' CG1' ' A' ' 82' ' ' VAL . 38.5 t80 -119.47 146.18 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 111.485 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -102.04 111.1 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.718 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.0 mt -92.25 136.34 25.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 154.16 75.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.57 2.18 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -55.46 -26.71 43.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.323 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -56.84 -32.89 66.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.22 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -100.54 -4.7 28.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.54 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -45.42 72.69 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.761 0.315 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.13 -26.58 43.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.633 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.74 91.55 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.19 161.1 41.77 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.383 2.055 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 141.75 42.26 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.311 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.0 121.43 79.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.37 141.55 71.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.442 2.095 . . . . 0.0 112.275 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 84.4 p -90.58 -33.4 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 125.18 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.78 -22.15 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.223 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -31.36 30.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.44 123.93 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -127.86 156.92 41.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -102.67 111.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.38 130.04 46.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 113.1 24.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.97 126.09 50.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.96 60.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.314 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.77 161.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.96 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -144.25 148.95 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.935 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -103.85 118.67 37.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.581 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.34 160.65 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.295 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.5 OUTLIER -107.89 143.66 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.101 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.9 p -105.96 148.45 27.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.5 t -130.46 139.82 50.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.418 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.26 125.24 51.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.156 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 15.2 p90 -143.04 -169.6 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.421 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -46.58 138.48 7.96 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.83 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.17 170.32 55.08 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.722 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 61.05 100.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -127.2 152.93 46.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -105.62 -82.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -154.83 -61.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.93 -33.83 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.61 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.99 -34.96 77.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.987 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -42.4 96.32 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.917 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.2 t -53.9 -38.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.671 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.12 70.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.716 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 18.3 m170 -70.06 -46.1 65.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.41 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . . . -61.82 -32.92 73.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -73.01 -42.16 63.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -46.06 89.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.24 -37.07 81.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.5 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -43.2 93.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -68.94 -34.18 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.95 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.3 m -57.49 -49.28 76.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -73.94 -13.92 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.352 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -46.62 -37.61 8.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.4 36.98 3.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 17.6 p -146.19 155.07 50.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.49 -7.75 21.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.839 2.359 . . . . 0.0 112.622 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 127.11 30.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.905 0.383 . . . . 0.0 111.28 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -102.52 141.83 34.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -155.03 -177.94 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.988 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.82 -58.44 2.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.27 -16.48 57.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.941 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.82 -87.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.723 0.262 . . . . 0.0 111.015 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.414 HG21 ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -81.06 138.4 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.841 0.353 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.436 ' CE2' HG23 ' A' ' 86' ' ' VAL . 48.7 p90 -144.96 174.7 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.359 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.38 161.99 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.669 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 m -139.36 151.65 46.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 128.45 38.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.168 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.804 179.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -120.69 148.94 43.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -142.81 155.62 44.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.3 t -129.6 115.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.462 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.49 124.4 50.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.968 0.413 . . . . 0.0 110.968 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 8.1 mt -91.19 140.34 29.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.75 126.76 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -177.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 1.0 111.094 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.776 0.322 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.49 113.63 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.03 -14.56 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.503 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -169.63 164.06 10.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 p -152.23 -178.35 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.764 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.98 -125.43 7.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 131.97 -95.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.626 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -161.52 163.98 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.3 69.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.77 -35.16 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.315 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.18 108.07 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.364 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.34 140.89 31.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -138.68 162.31 34.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.775 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -143.83 127.7 17.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -86.29 115.01 23.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -132.93 129.39 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.93 139.18 42.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 m -138.28 -178.23 5.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER 63.74 134.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.0 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.24 -41.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.64 -118.51 3.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.65 142.74 51.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.882 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 37' ' ' GLU . 49.9 m-85 -137.69 161.85 35.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.95 140.3 35.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.766 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.8 p -133.76 137.87 45.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 111.146 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 62' ' ' ILE . 11.3 t -125.94 125.89 68.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -95.98 127.7 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.17 116.92 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 176.51 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.25 30.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.319 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -152.63 121.91 3.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.82 -179.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.464 2.109 . . . . 0.0 112.246 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 44.3 t -61.87 -55.26 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.315 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.74 -43.82 92.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -46.06 75.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.186 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.15 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.271 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.6 mt -58.77 -35.59 73.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -63.81 -34.58 78.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.96 0.41 . . . . 0.0 109.964 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.6 tp10 -87.14 -28.81 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.63 -42.7 61.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.558 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.485 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 7.5 mmt -57.76 -43.6 98.83 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.527 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.65 -43.5 38.32 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.105 1.87 . . . . 0.0 111.863 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -70.37 -42.18 72.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 ' CD1' HG21 ' A' ' 44' ' ' VAL . 1.3 tt -76.22 -35.12 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.476 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mtp -66.31 -31.97 73.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -64.3 -47.6 78.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 21.3 t80 -60.26 -53.92 51.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.594 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.24 -28.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.012 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.78 -89.05 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.356 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.62 55.06 0.47 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.536 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -126.69 38.14 4.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -126.58 167.24 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.98 10.46 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.28 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -92.56 -30.4 15.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 43.29 38.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.27 -178.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.168 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.21 88.4 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.1 mtm -96.71 107.57 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.66 -24.67 12.92 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.749 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 65.89 147.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 111.05 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.48 168.78 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 17.6 t -85.84 -45.9 0.6 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.512 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 24.2 Cg_exo -63.63 144.69 90.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.309 2.006 . . . . 0.0 112.025 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.4 t -152.98 143.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 111.302 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.4 p -117.21 146.08 43.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -128.98 154.4 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.195 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 168' ' ' TYR . . . -99.69 136.69 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.453 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 167' ' ' TYR . 22.6 m -125.24 135.3 64.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -103.0 95.79 7.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.297 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.55 148.89 38.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.082 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 171.99 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -6.16 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.415 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.22 -16.04 59.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.7 p -81.3 113.03 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.811 0.338 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 148.97 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -125.85 68.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mttt 56.07 -163.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.4 109.45 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 84' ' ' PHE . 2.7 tt -144.07 134.41 24.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -110.51 115.57 29.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 43' ' ' THR . 3.3 t -78.8 141.21 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 111.508 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -119.48 121.91 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -105.59 155.41 19.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.614 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -116.04 107.8 15.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.407 ' CG2' ' HD2' ' A' ' 105' ' ' PRO . 31.7 mt -79.46 136.59 56.04 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.267 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.407 ' HD2' ' CG2' ' A' ' 104' ' ' ILE . 27.7 Cg_endo -62.09 154.13 64.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.322 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -55.57 -27.47 49.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -62.68 -33.21 74.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -107.26 -14.48 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -53.15 -44.04 67.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.741 0.305 . . . . 0.0 111.061 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.16 66.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.455 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.78 91.18 0.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 160.98 47.69 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.542 2.161 . . . . 0.0 112.266 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.85 149.87 60.66 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.697 2.265 . . . . 0.0 111.973 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.21 111.71 7.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 32.2 Cg_exo -59.59 167.39 6.65 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.506 2.138 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.5 m -145.92 34.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.6 123.61 17.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.0 -26.01 61.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.0 -30.52 31.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.39 114.01 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 150.98 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 122' ' ' ILE . 28.0 mm -114.4 132.72 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.78 160.12 14.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -149.4 140.82 23.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.082 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.57 18.27 9.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.27 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.11 160.21 32.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.92 119.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.458 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.23 143.9 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -103.87 123.54 47.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.512 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.13 170.16 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.008 0.433 . . . . 0.0 111.729 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -134.46 125.94 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.945 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.4 p -105.76 143.88 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.104 0.478 . . . . 0.0 111.785 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -122.69 139.28 54.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.086 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -116.63 143.64 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 13.2 p90 -143.14 -46.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.603 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.99 -131.32 1.62 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -148.37 33.12 1.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.04 62.15 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 143' ' ' ASP . . . -136.5 135.57 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 71.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.867 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 64.36 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.24 63.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.02 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 2.1 t70 -69.06 -34.88 75.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.174 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 185' ' ' VAL . 0.9 OUTLIER -62.75 -38.95 92.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.466 0.65 . . . . 0.0 109.652 179.203 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 51.2 t -53.91 -38.99 38.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.597 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.45 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.801 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 37.1 m-70 -68.74 -40.91 79.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.21 -32.75 72.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.78 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -62.95 -44.14 96.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.01 -46.04 90.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.706 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.1 tp -59.23 -42.23 90.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -59.29 -48.07 83.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.401 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.4 m -63.76 -47.01 82.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.173 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.7 m -57.82 -40.96 81.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.755 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.443 ' CD1' ' CE1' ' A' ' 131' ' ' TYR . 11.5 mt -72.73 -14.57 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.491 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.77 126.9 11.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.67 34.72 11.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.206 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 16.1 p -145.55 159.89 46.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.561 0.22 . . . . 0.0 110.66 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 5.7 Cg_endo -47.88 -22.95 3.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.868 2.379 . . . . 0.0 112.541 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.58 106.13 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.4 m -101.94 -0.66 33.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 59.67 147.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.52 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.68 -173.5 4.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.54 62.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.776 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.64 75.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.762 0.315 . . . . 0.0 111.389 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 166' ' ' VAL . 9.7 p -161.72 81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.233 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 86' ' ' VAL . 45.5 p90 -99.54 166.22 11.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.846 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.454 ' HB2' ' CH2' ' A' ' 186' ' ' TRP . 16.5 m-85 -115.6 161.95 17.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.3 m -121.33 130.85 53.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.722 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 184' ' ' GLU . . . -132.07 156.33 46.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.33 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 4.2 m-80 -133.16 134.97 44.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.965 0.412 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 4.6 mt-10 -146.01 157.12 43.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.11 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.455 ' CG2' ' CD1' ' A' ' 144' ' ' TYR . 11.3 t -136.68 138.03 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.808 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -140.78 121.79 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt -91.57 140.09 30.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 6.6 t -75.69 131.0 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.403 ' CG ' ' CE2' ' A' ' 131' ' ' TYR . 32.2 mtpt -74.34 150.16 40.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.36 -0.829 . . . . 1.0 111.112 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.02 112.94 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.4 -9.7 29.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -169.9 163.15 9.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.16 -173.28 4.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.7 -114.63 4.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 116.19 -112.03 2.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.57 162.69 30.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -30.21 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.195 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -90.66 -35.06 15.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.192 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.21 110.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.907 0.384 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.9 m -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -138.78 158.84 43.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -143.98 138.68 28.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.79 117.56 25.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -131.98 144.04 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.05 110.29 13.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.3 t -82.58 151.57 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.03 139.53 49.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.32 -106.96 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.2 -60.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -104.46 134.46 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.002 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -137.63 153.14 49.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.89 117.97 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.2 p -112.7 133.49 54.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.323 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.95 125.45 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -100.81 133.93 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.48 116.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.41 175.79 5.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.21 34.21 0.66 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.509 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -152.17 135.46 9.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.83 -158.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.528 2.152 . . . . 0.0 112.207 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.11 -53.53 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.066 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.24 -43.23 87.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -46.42 74.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.99 92.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 4.3 mt -57.76 -35.24 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -62.65 -30.93 71.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.979 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.7 tp10 -88.18 -33.19 18.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -43.21 60.46 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.655 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 23.0 mmt -57.75 -43.63 98.86 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.5 Cg_exo -57.28 -45.6 33.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.106 1.87 . . . . 0.0 112.262 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -70.33 -42.59 71.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.518 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 tt -76.48 -32.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.446 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -41.06 91.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.715 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -40.88 91.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 64.8 t80 -59.63 -50.7 72.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 34.7 m -66.0 -27.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.66 104.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.01 -54.33 0.51 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -144.99 87.75 1.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -110.9 -29.17 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.0 m-20 84.63 -22.09 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.582 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -32.09 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.65 64.24 1.01 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.414 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.61 141.06 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.53 55.62 0.58 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.347 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -34.75 71.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.67 -159.38 42.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 mtt -97.55 112.98 24.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.359 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 m -111.01 122.87 48.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t 63.85 141.6 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.75 130.82 36.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.272 1.981 . . . . 0.0 112.257 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.0 m -87.29 139.28 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.9 149.75 36.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -123.99 144.34 49.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 98' ' ' LEU . . . -82.72 140.44 33.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG22 ' CZ ' ' A' ' 167' ' ' TYR . 29.1 m -109.95 -28.09 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.44 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 96.8 m-85 55.91 91.77 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.529 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 71.9 Cg_endo -77.18 141.61 20.83 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.637 2.224 . . . . 0.0 112.007 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.61 166.15 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.36 -15.89 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.278 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 3.48 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.92 -1.84 86.94 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.976 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 p -131.52 161.72 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 88' ' ' PRO . 1.2 mt -87.54 154.32 20.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.531 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -140.57 84.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 45.53 93.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.6 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.71 101.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.555 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -143.72 143.87 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.91 115.66 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.914 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.68 137.35 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.579 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -117.96 141.04 48.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.307 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 48.5 t80 -124.2 151.47 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.975 0.417 . . . . 0.0 111.388 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtp180 -115.96 107.84 15.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.654 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mt -82.08 136.4 47.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.32 154.14 65.61 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.555 2.17 . . . . 0.0 112.334 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -52.48 -26.8 13.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.15 66.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 110.976 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -115.95 -9.75 11.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.33 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.08 -48.08 71.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.765 0.317 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -26.54 56.33 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 t -174.5 88.08 0.33 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 160.45 49.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.552 2.168 . . . . 0.0 112.353 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.19 159.29 44.25 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 112.026 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.34 111.24 6.19 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.978 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 65' ' ' TYR . 60.8 Cg_endo -72.62 162.36 41.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.513 2.142 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.52 179.73 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.66 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.46 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -16.88 30.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.1 p -80.2 -28.57 38.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.673 0.273 . . . . 0.0 111.213 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.62 114.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 111.157 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 156.97 32.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.19 125.25 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.9 129.94 45.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -89.14 125.27 34.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.9 OUTLIER 58.9 -177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.8 tt0 83.09 76.99 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.5 -175.12 50.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -143.99 143.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.249 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.9 m -115.31 118.98 34.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.11 163.99 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.434 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CZ ' ' CD1' ' A' ' 155' ' ' LEU . 0.6 OUTLIER -107.78 137.85 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.212 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.43 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -105.87 146.47 29.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 0.0 111.56 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -131.19 139.23 49.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.438 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -116.6 132.09 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 4.3 p90 -139.72 156.28 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.36 33.57 5.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -107.02 -36.48 2.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.83 133.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.19 -175.86 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -133.59 -66.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -141.72 -72.92 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.82 75.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -34.56 77.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -40.33 96.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.568 0.699 . . . . 0.0 109.807 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.84 -38.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.668 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.29 -35.78 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.719 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.509 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.17 -42.45 72.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.0 m -63.4 -42.28 98.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.801 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.16 94.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.871 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.55 -40.45 91.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.69 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -42.38 94.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.8 m -68.64 -35.72 77.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 41.5 m -57.61 -49.09 77.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.436 ' CD1' ' CZ ' ' A' ' 131' ' ' TYR . 5.6 mt -73.62 -11.12 60.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.259 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -47.03 -43.16 19.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.59 36.56 3.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 30.8 p -145.64 154.29 52.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.78 -10.79 30.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.621 2.214 . . . . 0.0 112.633 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 126.86 29.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.4 m -101.95 160.08 14.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -155.27 151.46 28.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.035 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -55.5 -56.53 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.295 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.91 50.96 11.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.103 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 -22.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.8 p -158.81 141.95 5.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.436 ' CZ ' HG22 ' A' ' 86' ' ' VAL . 12.2 p90 -140.79 166.59 24.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -118.37 159.38 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.405 ' O ' ' CE1' ' A' ' 84' ' ' PHE . 42.9 m -127.53 130.89 49.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.99 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -107.9 142.98 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.62 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.772 0.32 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -108.67 145.23 35.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.18 157.19 43.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.22 114.9 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.43 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 5.6 m0 -110.03 124.35 51.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 63.5 mt -91.65 140.41 29.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.471 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.58 123.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.937 0.399 . . . . 0.0 111.168 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -72.07 149.81 44.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.173 -0.918 . . . . 1.0 111.089 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.743 0.306 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.28 112.98 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.92 -19.12 29.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.78 167.08 9.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.784 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -168.69 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.57 -118.69 5.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.28 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 99.72 158.81 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.74 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -78.8 163.69 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.6 -29.83 69.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.031 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -35.35 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.102 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.24 107.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.277 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.1 m -100.58 157.95 16.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.9 p90 -139.49 160.97 38.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.9 125.74 12.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -86.1 135.1 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 136.34 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.96 126.5 47.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.86 163.46 27.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.56 -77.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.99 -174.14 54.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.522 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.89 -89.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mptt -96.84 137.68 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.808 0.337 . . . . 0.0 110.857 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 24.0 m-85 -137.49 157.66 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.065 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.99 140.21 29.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.54 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 p -133.44 131.83 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 111.252 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.62 125.49 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.906 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.97 139.48 34.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -138.24 118.04 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 166.93 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.55 33.85 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 123.6 3.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.771 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.85 -69.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.332 2.021 . . . . 0.0 112.353 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -156.5 -63.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.05 -45.14 79.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -67.09 -46.15 75.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.012 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.25 89.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.281 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 2.2 mt -56.88 -35.31 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.08 -31.56 72.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -88.12 -34.01 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.64 -42.46 61.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.762 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.473 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 22.9 mmt -57.67 -43.81 99.05 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 39.3 Cg_exo -60.52 -43.45 33.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.433 2.089 . . . . 0.0 112.313 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -70.22 -43.63 70.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -76.27 -41.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.612 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.438 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -64.87 -31.88 73.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.01 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' N ' ' HG3' ' A' ' 63' ' ' MET . 20.3 mmtt -66.34 -32.27 73.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.975 0.417 . . . . 0.0 110.324 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 76' ' ' MET . 90.4 t80 -67.9 -32.6 73.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.597 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 102' ' ' PHE . 18.1 m -90.08 -10.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.66 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.2 44.47 2.81 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.836 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.11 44.98 51.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.999 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -126.91 61.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -111.93 -22.3 11.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.191 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.25 4.57 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.1 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -94.02 -29.59 15.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.18 37.73 4.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.187 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.48 -178.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.078 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.29 76.1 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.413 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.416 ' HE2' ' CE2' ' A' ' 65' ' ' TYR . 63.1 mtp -96.13 106.17 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 29.59 11.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt 61.25 156.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 m -164.65 124.99 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 38.4 t 64.07 137.3 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 19.2 Cg_endo -60.06 147.73 91.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.583 2.189 . . . . 0.0 112.098 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.93 153.76 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.519 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.444 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 1.8 t -135.69 168.16 19.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.418 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -132.07 154.1 49.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.06 136.68 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.45 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.14 141.9 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.416 ' CD2' HG21 ' A' ' 166' ' ' VAL . 5.4 m-85 -115.21 89.81 22.05 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.089 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.99 149.66 85.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.68 2.253 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.7 161.87 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.27 -19.71 55.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -5.97 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.364 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.05 66.78 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 m -94.57 155.17 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -105.72 131.46 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -82.06 170.93 14.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 65.99 5.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -144.35 96.03 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.564 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' CD2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -122.94 136.96 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.242 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 115.87 19.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.301 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.7 t -87.37 116.82 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.174 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -98.16 142.02 30.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.822 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 12.9 t80 -123.88 145.6 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 6.5 ptp180 -108.75 110.51 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CG2' ' HD2' ' A' ' 105' ' ' PRO . 21.9 mt -89.59 137.78 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 104' ' ' ILE . 7.8 Cg_endo -49.91 154.04 5.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 m-80 -58.79 -27.04 64.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.301 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -61.19 -33.01 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -102.01 -8.98 21.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.751 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.73 -34.2 58.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.798 0.332 . . . . 0.0 111.093 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.57 -33.36 81.57 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.1 p -177.5 98.1 0.23 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.583 0.23 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.36 152.97 75.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.41 159.0 52.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.602 2.201 . . . . 0.0 112.44 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.43 118.38 56.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 47.6 Cg_endo -68.37 146.71 69.75 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.422 2.081 . . . . 0.0 112.365 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -77.34 -40.05 45.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.81 114.89 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.021 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.59 -19.11 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 m -80.65 -17.06 52.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.321 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 t -84.74 113.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 157.02 18.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.931 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 mm -122.56 123.5 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.82 129.85 45.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.56 130.95 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 60.33 111.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.98 90.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.48 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.381 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.66 142.94 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.21 42.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.77 168.63 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.554 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 12.4 m-85 -107.73 160.24 15.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.0 p -124.4 130.32 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.252 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -131.08 138.31 49.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -122.13 142.65 50.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -152.11 167.76 27.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.47 96.94 1.82 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.7 15.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -95.89 -177.66 4.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -157.41 148.56 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.265 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -134.35 65.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 67.33 -72.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.027 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.13 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.37 -34.88 76.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -62.9 -39.12 93.54 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.427 0.632 . . . . 0.0 109.881 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.03 -38.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.457 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.24 69.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.715 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -70.1 -45.33 67.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.82 72.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.0 m -69.31 -38.24 78.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -44.81 91.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 tp -58.02 -38.35 76.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.394 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -61.28 -43.82 98.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -40.34 94.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.018 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 31' ' ' TYR . 1.7 m -57.82 -46.14 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.779 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 31' ' ' TYR . 7.7 mt -73.65 -10.34 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.796 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.3 106.03 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 141.18 -39.05 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.44 ' CB ' ' CD ' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -94.9 -179.15 0.9 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 158' ' ' THR . 83.9 Cg_endo -85.52 35.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.414 2.076 . . . . 0.0 112.803 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.47 109.24 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.241 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 165.71 11.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -154.7 16.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.713 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.52 -83.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.6 0.238 . . . . 0.0 111.397 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -127.84 34.36 3.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.78 25.54 12.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.681 0.277 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.416 HG21 ' CD2' ' A' ' 87' ' ' PHE . 14.5 p -79.71 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.103 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.461 ' CD2' ' CG1' ' A' ' 185' ' ' VAL . 50.2 p90 -140.4 -176.72 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -119.25 159.83 23.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.295 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 3.7 m -134.6 152.8 52.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.89 155.91 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.759 0.314 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.78 149.39 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.73 148.6 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.408 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.461 ' CG1' ' CD2' ' A' ' 167' ' ' TYR . 15.2 t -135.11 116.27 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.93 125.5 51.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.386 . . . . 0.0 111.103 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 167' ' ' TYR . 73.0 mt -91.68 137.23 32.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 23.5 t -74.89 131.18 35.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -101.43 103.54 14.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.186 -0.911 . . . . 1.0 111.146 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.844 0.354 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.64 125.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.19 -16.53 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.392 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -169.75 165.41 9.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.05 -176.55 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.72 -110.86 2.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.4 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 105.65 -133.01 11.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.563 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -161.56 165.41 28.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.737 0.303 . . . . 0.0 110.809 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.45 -29.44 69.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.79 -35.14 15.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.223 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.21 108.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.1 140.31 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -139.24 161.96 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.17 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -147.24 130.23 16.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.768 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.71 121.76 29.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 133.37 34.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.76 113.3 19.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -127.63 156.21 42.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.0 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.22 84.31 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.54 -151.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.8 -86.11 1.88 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -123.62 149.1 45.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.946 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -137.58 153.58 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.08 132.0 52.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.793 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.431 HG23 ' CD2' ' A' ' 101' ' ' TRP . 65.0 p -112.53 140.43 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.782 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 17.6 t -128.44 125.47 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -100.07 134.06 43.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.652 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 t -138.19 116.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.9 0.381 . . . . 0.0 111.208 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.99 167.03 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 t0 58.84 31.79 21.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.15 124.93 4.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.794 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.76 -67.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.282 1.988 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.1 t -156.2 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.805 0.335 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.85 -40.86 73.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.79 -46.44 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 110.335 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.74 -36.81 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.387 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -56.79 -35.7 69.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.945 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.33 69.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.451 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.7 tp10 -86.89 -43.57 12.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.517 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.34 -33.7 65.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 23.6 mmt -58.03 -43.85 98.82 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -66.44 -30.95 43.41 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.952 1.768 . . . . 0.0 112.12 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -38.81 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.427 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 36.2 mm -77.65 -38.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.783 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -46.09 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -30.41 71.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -65.35 -47.37 76.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -84.25 -30.22 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.53 -115.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.04 47.3 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.443 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -152.68 76.19 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -134.09 11.32 3.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.352 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.09 30.21 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -148.68 -47.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.56 33.62 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 m -100.66 149.7 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.13 76.3 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mtp -60.09 -42.92 95.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.387 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.09 -126.77 13.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmt -120.55 146.65 46.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -157.14 107.82 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t 64.12 141.67 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.73 130.79 36.68 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.323 2.016 . . . . 0.0 112.133 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 m -87.36 136.71 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.6 p -126.15 163.44 23.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -133.0 153.41 51.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.718 0.294 . . . . 0.0 111.3 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 168' ' ' TYR . . . -89.55 136.86 32.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.145 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' CG2' ' CZ ' ' A' ' 167' ' ' TYR . 31.6 m -120.06 136.71 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.413 ' CD1' HG23 ' A' ' 166' ' ' VAL . 89.2 m-85 -106.44 96.82 14.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.23 135.72 15.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.217 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -90.26 172.07 9.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.63 -15.98 63.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.12 -6.24 59.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.386 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.08 -16.01 56.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.998 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -96.54 117.13 30.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.5 114.48 2.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -57.56 172.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -80.53 73.76 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 117.27 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.603 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 84' ' ' PHE . 1.1 tt -144.05 140.15 29.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.453 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -123.92 115.91 22.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.782 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 3.2 p -98.72 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.431 ' CD2' HG23 ' A' ' 43' ' ' THR . 25.4 m95 -113.03 142.28 45.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.492 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -108.8 160.71 15.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 111.362 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 108.01 15.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.544 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.0 mt -80.54 136.68 52.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 154.04 69.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.699 2.266 . . . . 0.0 112.597 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -58.72 -26.68 64.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.302 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -32.83 65.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.65 9.3 29.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.788 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -55.43 -42.81 74.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.64 -34.04 68.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 100.77 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.541 0.21 . . . . 0.0 110.934 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.29 160.76 47.58 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.363 2.042 . . . . 0.0 112.257 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.68 153.38 54.12 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.692 2.261 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.66 119.01 62.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.05 146.69 36.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.329 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 t -88.04 -33.54 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.75 122.43 31.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -22.23 47.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -81.66 -25.85 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.1 t -85.21 125.48 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -121.79 157.05 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.5 mm -111.67 121.75 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.92 160.29 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.6 151.25 33.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.022 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.2 ttt180 62.33 166.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.3 tm-20 83.49 129.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.64 155.33 16.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.438 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.11 142.92 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -110.07 118.8 37.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.666 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.36 166.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.261 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.414 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.81 137.72 45.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.2 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 p -105.95 143.1 34.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -131.05 139.19 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.628 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.95 141.44 48.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.028 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 52.0 p90 -161.43 134.64 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.89 91.56 1.69 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.19 177.32 44.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.98 160.13 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -160.96 133.38 6.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.75 76.55 1.59 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 67.53 -71.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -33.92 62.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.194 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -68.48 -37.56 80.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -62.95 -41.02 99.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.322 0.582 . . . . 0.0 110.08 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.99 -38.64 37.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.245 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.28 70.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.806 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-70 -70.16 -44.57 68.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.83 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.806 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.3 m -70.58 -43.3 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -58.96 -46.17 88.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.4 -41.75 98.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -46.17 89.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 98.1 m -61.85 -43.63 98.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.999 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 m -57.82 -38.85 76.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.859 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' A' ' 131' ' ' TYR . 23.7 mt -73.52 -16.6 61.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.881 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' THR . 47.1 mt-10 -46.94 144.16 2.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.838 0.352 . . . . 0.0 111.269 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.7 -30.89 8.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.103 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 1.2 p -94.93 176.15 2.46 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.1 Cg_endo -85.77 12.22 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.562 2.174 . . . . 0.0 112.916 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.35 116.29 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.2 m -100.1 175.44 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -155.47 22.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.595 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 48.66 -87.74 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.504 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -120.96 29.14 5.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.245 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 69.3 21.18 7.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.641 0.258 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 87' ' ' PHE . 13.6 p -80.23 139.0 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 111.061 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.446 ' CD2' ' CG1' ' A' ' 185' ' ' VAL . 24.8 p90 -139.27 178.11 7.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.448 ' CE2' ' CB ' ' A' ' 85' ' ' ALA . 97.4 m-85 -119.6 151.4 38.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 m -126.87 130.91 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -113.27 129.19 56.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.583 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.898 0.38 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -126.47 133.98 51.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -142.96 156.4 44.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.446 ' CG1' ' CD2' ' A' ' 167' ' ' TYR . 15.5 t -138.98 116.14 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -107.76 121.86 45.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 167' ' ' TYR . 43.0 mt -92.91 136.01 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 21.9 t -74.74 131.53 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 36.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.242 -0.885 . . . . 1.0 111.369 179.846 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.839 0.352 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.36 119.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.51 -3.93 21.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.498 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.14 166.88 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -152.34 -57.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.82 170.0 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.63 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.53 -85.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.5 162.99 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -66.53 -33.21 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -33.2 16.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.97 141.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.33 154.47 50.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.483 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -139.07 159.77 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.43 121.8 12.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.52 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 39.0 mt-10 -87.02 132.07 33.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -141.98 130.9 23.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.46 124.38 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 p -127.74 -178.33 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.45 167.65 14.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.15 167.29 38.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.61 -85.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.9 146.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 6.2 m-85 -137.59 148.04 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.11 123.49 37.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.697 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -112.64 136.59 52.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.776 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 22.9 t -125.96 125.54 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.64 131.32 44.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.154 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 t -138.46 116.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.009 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 167.1 13.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.98 23.45 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -152.55 133.22 7.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.3 -177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.518 2.145 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.71 -70.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -56.15 -40.61 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.92 -46.85 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 110.36 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.71 83.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.18 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -56.91 -35.43 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.074 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -63.57 -27.91 69.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.712 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 tp10 -87.62 -44.35 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.28 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.593 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 mmt -57.75 -43.79 98.97 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 59' ' ' MET . 30.8 Cg_endo -65.01 -29.49 57.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.763 1.642 . . . . 0.0 112.062 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.18 -37.42 75.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.373 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 mm -77.32 -44.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -43.97 97.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -65.07 -30.69 71.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.7 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.63 -56.87 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.61 -30.14 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.22 -90.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.405 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.13 71.71 0.24 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -153.52 47.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -110.97 -22.36 11.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.52 2.34 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.475 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -93.55 -35.78 12.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.819 0.343 . . . . 0.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.14 29.98 8.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.42 165.99 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.84 0.353 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.96 2.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.76 135.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.21 169.48 32.65 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.57 155.95 17.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -135.43 -45.07 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -156.58 164.07 22.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.1 Cg_endo -59.46 130.62 36.48 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.123 1.882 . . . . 0.0 111.668 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -87.58 126.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.889 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.0 m -119.82 153.14 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.558 ' HB3' ' CB ' ' A' ' 100' ' ' VAL . 0.2 OUTLIER -118.62 154.12 33.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 111.591 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.18 136.8 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.613 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 167' ' ' TYR . 28.8 m -129.47 132.51 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -99.41 100.32 10.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.99 140.95 29.17 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.515 2.143 . . . . 0.0 112.279 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.11 158.6 17.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.839 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -19.04 61.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.239 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -85.55 -6.07 59.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.44 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.6 64.7 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.018 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -99.98 153.31 19.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -97.42 132.55 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 174.07 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.793 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -80.42 -13.99 58.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.275 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.8 123.85 29.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.762 0.315 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.05 127.95 17.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 115.9 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.776 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 4.5 p -96.5 139.91 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.445 ' CD2' ' CG2' ' A' ' 43' ' ' THR . 24.9 m95 -116.85 142.37 47.02 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 62.2 t80 -112.51 161.11 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.807 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.433 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -112.59 107.92 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.864 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.1 mt -84.4 137.2 39.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.163 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.32 152.78 64.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.586 2.191 . . . . 0.0 112.388 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -62.07 -26.81 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -56.76 -42.58 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.279 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -95.87 5.5 51.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.462 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -45.93 75.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.739 0.304 . . . . 0.0 111.187 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.06 -26.03 40.7 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.688 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 p -177.09 90.14 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.64 0.257 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.19 146.72 70.9 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.12 . . . . 0.0 112.198 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.87 157.4 58.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.497 2.132 . . . . 0.0 111.998 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.95 126.51 92.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.23 6.11 5.81 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.642 2.228 . . . . 0.0 113.007 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m 58.12 -177.2 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.781 0.324 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.0 t0 62.01 117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -20.2 42.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.281 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.6 t -81.07 -31.72 34.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.49 118.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.938 0.399 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.05 157.21 41.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.0 mm -110.69 112.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -98.9 130.12 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -88.58 91.42 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.36 152.89 39.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.86 166.48 21.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.73 172.29 4.06 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -138.31 143.03 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -108.73 123.22 48.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.515 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.32 169.76 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.966 0.412 . . . . 0.0 111.408 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 7.5 m-85 -107.79 137.14 46.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.82 135.53 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.5 t -128.87 139.08 52.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.0 148.01 41.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 183' ' ' ASN . 22.4 p90 -172.26 -176.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -99.04 -145.2 18.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.37 163.88 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.85 141.81 42.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -125.43 159.34 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.466 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -45.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -167.35 -66.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.69 73.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.493 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.89 79.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -40.76 98.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 109.909 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.6 t -53.85 -38.75 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.707 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -34.73 71.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.778 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -70.22 -46.09 65.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.02 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.84 74.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.7 m -70.43 -49.98 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.01 -38.65 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.803 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.48 -39.01 78.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -41.35 89.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -41.02 83.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.458 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.74 -43.71 85.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.533 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 31' ' ' TYR . 2.6 mt -73.02 -13.24 61.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -47.01 -47.15 22.21 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.71 -33.06 62.36 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.446 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.0 p -94.51 167.75 12.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 110.744 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.75 40.46 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.197 2.598 . . . . 0.0 112.695 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.29 170.66 1.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.403 ' C ' ' CG ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -138.56 163.95 30.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 161' ' ' THR . 1.2 m-85 -156.23 175.2 14.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -92.93 -55.34 3.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.03 -74.0 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.399 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -159.66 71.08 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.7 p -160.81 136.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.295 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' HG21 ' A' ' 86' ' ' VAL . 19.1 p90 -139.61 -177.83 5.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -120.66 156.39 31.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.3 131.0 46.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.66 130.21 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.616 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 135' ' ' PHE . 2.9 p30 -119.9 133.84 55.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.781 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -146.26 147.4 31.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.225 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.84 129.73 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.441 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -107.9 121.56 45.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.33 139.96 32.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 38.4 t -74.94 128.92 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -100.63 125.91 47.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.098 179.889 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.694 0.283 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.09 112.86 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.37 -7.15 39.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.725 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.4 167.17 8.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.388 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 p -151.64 -178.59 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.761 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.19 -104.04 0.97 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.44 -94.8 0.55 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.683 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -160.43 163.03 33.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 0.0 110.791 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -66.44 -30.56 70.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.033 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.61 -35.23 15.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.27 115.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.384 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -95.98 145.2 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -140.92 162.26 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 127.27 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.562 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 17.2 mt-10 -85.86 126.3 33.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -142.03 128.04 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.62 122.16 47.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.7 p -132.14 149.96 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -71.66 -63.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.38 -77.85 1.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.45 -89.78 1.12 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -114.67 146.28 41.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -137.63 140.17 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.75 115.9 28.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.115 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.3 p -112.77 155.48 24.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 112.004 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.6 t -136.7 125.9 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -96.07 130.35 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.27 116.72 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.58 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.89 32.15 2.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -153.15 127.57 4.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.24 -169.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.476 2.117 . . . . 0.0 112.224 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.5 -53.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.211 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.89 -43.68 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.03 -46.17 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.28 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.234 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.0 mt -57.46 -35.57 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -62.92 -35.12 79.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.927 0.394 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 tp10 -87.49 -28.29 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.388 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.33 -45.17 56.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.476 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 34.1 mmt -57.61 -43.46 98.86 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.0 Cg_exo -57.96 -41.55 67.48 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.07 1.847 . . . . 0.0 112.067 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -70.29 -45.5 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.351 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' HG21 ' A' ' 44' ' ' VAL . 7.1 tt -75.59 -27.84 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.418 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -38.67 88.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.907 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 25.4 t80 -69.24 -56.38 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.41 -29.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.11 -124.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.622 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.17 48.01 0.98 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -142.94 62.54 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -108.99 -24.12 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 79.31 -3.47 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.668 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 -40.56 10.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.84 67.6 1.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.45 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.88 -179.45 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.81 117.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.388 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 1.3 mtm -112.73 -161.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.32 -37.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 63.18 120.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.046 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 167.86 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.53 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 13.5 t -87.25 -48.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.404 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 66.7 Cg_endo -91.42 130.38 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.512 2.141 . . . . 0.0 112.528 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.4 t -92.86 152.31 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.01 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.6 p -125.1 145.93 49.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.664 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -132.93 153.99 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.937 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 101' ' ' TRP . . . -95.04 136.67 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 167' ' ' TYR . 27.7 m -131.34 126.83 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 166' ' ' VAL . 43.3 m-85 -97.8 99.62 7.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 122.35 9.43 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.39 2.06 . . . . 0.0 112.105 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -89.74 170.81 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.35 -15.81 62.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -0.1 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.23 67.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.887 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.5 p -122.82 160.12 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.09 160.42 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 44.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 52.5 28.36 5.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.326 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -117.49 99.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 tt -127.56 127.73 44.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.978 0.418 . . . . 0.0 111.48 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' A' ' 85' ' ' ALA . 11.3 ptmt -117.58 116.62 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.469 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.1 t -66.79 141.47 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.42 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.8 m95 -120.37 119.17 32.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.332 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -106.02 153.78 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -112.77 121.83 45.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.5 mt -96.91 136.75 21.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.6 154.1 56.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.555 2.17 . . . . 0.0 112.357 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.57 -26.85 65.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -56.94 -45.22 82.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.041 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 64.3 m-85 -94.62 -9.79 33.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.395 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.46 -37.4 62.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.11 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -28.88 72.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -171.66 75.93 0.5 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.769 0.319 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.05 154.58 32.57 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.533 2.155 . . . . 0.0 112.355 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.31 152.14 44.08 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.685 2.257 . . . . 0.0 112.094 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.35 93.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 61.1 Cg_endo -73.44 135.82 22.9 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.316 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -91.45 50.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.028 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.2 118.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.93 -21.75 45.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.193 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 p -81.71 -31.67 32.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t -85.78 122.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -124.84 152.57 43.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.7 mm -105.09 117.62 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.82 137.06 37.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 104.5 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -169.07 73.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.938 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 30.9 tt0 82.23 139.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.065 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -70.34 -179.96 27.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.241 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.05 142.9 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 111.433 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.6 m -112.75 126.74 55.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.331 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.8 m -133.96 157.49 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 111.54 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 12.0 m-85 -107.72 141.8 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.7 p -111.91 126.99 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.882 0.372 . . . . 0.0 111.136 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.7 t -123.69 138.82 54.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -116.83 143.68 45.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 12.8 p90 -142.15 -44.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.26 109.47 0.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.1 -137.04 2.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -145.56 92.35 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.933 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.89 136.02 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -105.04 -48.44 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -166.24 -68.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.82 67.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -67.98 -34.98 77.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.1 -40.48 96.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 109.998 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.72 -38.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.541 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.1 73.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.761 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.493 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 44.0 m-70 -70.02 -41.42 74.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.761 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.85 73.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.4 m -63.02 -42.62 99.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.708 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -59.07 -45.94 89.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.62 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.51 -39.68 91.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.25 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -59.12 -36.32 75.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.271 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -46.2 68.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -49.11 77.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.789 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 131' ' ' TYR . 11.5 mt -74.02 -9.12 58.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.431 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -47.55 -43.24 24.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.261 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.4 -15.08 77.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.762 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 12.3 p -93.65 169.23 10.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.003 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.78 0.58 7.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.046 2.498 . . . . 0.0 112.913 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.12 121.91 11.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.204 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.1 m -101.38 -2.21 31.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.115 0.483 . . . . 0.0 111.077 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 50.92 16.26 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.054 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -75.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.162 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.58 -78.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.74 68.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 87' ' ' PHE . 11.0 p -161.91 122.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 86' ' ' VAL . 37.0 p90 -132.91 170.21 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.449 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 18.5 m-85 -112.74 157.16 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.56 130.95 39.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.27 52.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.943 0.401 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -132.94 133.9 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.33 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.88 157.11 43.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.732 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 39.0 t -124.55 139.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.48 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -107.62 121.49 44.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.086 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.2 mt -98.75 133.41 43.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.743 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.449 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 25.7 t -75.8 118.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.05 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -79.95 147.25 31.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.277 -0.868 . . . . 1.0 111.098 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.03 115.15 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.14 -16.24 20.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.417 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 t -169.72 167.05 9.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 -175.82 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.72 -173.2 47.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.414 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 172.44 -93.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.608 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' VAL . 1.2 mtmm -161.28 166.39 27.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.849 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -66.62 -31.66 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.294 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -31.33 17.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.278 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.7 t -146.03 142.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -134.74 148.82 50.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.456 ' CD2' ' CD2' ' A' ' 155' ' ' LEU . 1.9 p90 -139.17 162.2 35.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.31 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -144.54 122.27 11.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.389 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -85.98 118.37 25.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.994 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.07 127.93 35.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.58 128.2 55.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.3 p -100.19 158.93 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -60.2 -52.08 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.96 -158.05 22.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.86 -173.29 20.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -98.49 149.8 22.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -137.65 153.93 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.96 140.03 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.592 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -112.46 143.55 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.08 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.75 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.1 t -132.17 125.32 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.65 140.09 36.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 54' ' ' ALA . 3.2 t -138.42 123.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.313 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 167.04 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 t0 51.2 33.91 10.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.413 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 128.5 5.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.711 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.46 -69.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.357 2.038 . . . . 0.0 112.585 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.12 -66.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.82 0.343 . . . . 0.0 111.287 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.91 -45.08 78.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.09 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.6 -42.7 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 46' ' ' VAL . . . -58.95 -44.01 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' CD1' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.97 -35.41 69.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -62.48 -33.44 74.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -87.73 -29.29 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.158 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.47 59.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.726 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.483 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.6 -43.87 99.14 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.3 Cg_exo -60.22 -37.33 83.83 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.176 1.918 . . . . 0.0 111.784 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -70.38 -44.9 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -28.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.211 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.13 74.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.662 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -65.43 -39.82 92.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.658 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 14.4 t80 -64.82 -57.9 7.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -67.06 -29.61 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -137.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.84 35.26 4.89 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.5 m -125.09 32.72 5.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 5.5 p30 -88.25 -16.58 32.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.278 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 1.5 m-20 82.44 -9.25 1.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -93.04 -36.74 12.55 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.75 43.17 6.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.02 163.56 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.75 58.2 0.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -74.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.967 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.95 -118.08 4.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.61 118.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.344 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 102' ' ' PHE . 13.7 t -67.93 145.51 54.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 16.8 t -67.57 -53.52 22.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.466 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 69.9 Cg_endo -73.54 146.94 40.01 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.209 1.939 . . . . 0.0 112.183 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -153.54 125.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 t -114.98 145.98 41.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.038 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.51 ' HB3' ' CB ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -128.59 149.31 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.764 0.316 . . . . 0.0 111.636 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -88.22 136.81 32.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.523 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.47 139.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.216 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.419 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 2.4 m-85 -108.99 103.92 53.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.029 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.36 137.65 37.13 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.397 2.065 . . . . 0.0 112.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -89.88 171.98 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.036 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.04 -15.88 62.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.394 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.49 -1.07 55.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.491 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.77 82.68 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.867 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 m -119.74 171.5 8.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.937 0.398 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.27 96.88 6.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -95.0 102.23 14.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.77 86.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.597 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 175.5 81.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.412 HD12 ' CD1' ' A' ' 84' ' ' PHE . 6.9 tt -144.1 135.56 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 111.493 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.48 115.63 20.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.75 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 6.0 p -91.74 136.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.123 0.487 . . . . 0.0 111.888 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -110.58 142.27 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.81 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE2' HG21 ' A' ' 79' ' ' THR . 32.7 t80 -105.78 145.54 31.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 102' ' ' PHE . 7.1 ttt180 -95.66 113.62 25.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.75 136.65 27.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.38 153.99 56.26 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.532 2.155 . . . . 0.0 112.238 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.65 -26.88 62.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.268 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.85 -47.11 81.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.431 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -90.25 1.31 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -39.75 68.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.58 -34.06 68.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.609 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.6 p -178.35 93.53 0.22 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.83 161.07 10.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.567 2.178 . . . . 0.0 112.179 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.71 155.85 61.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.255 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 112.33 9.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 47.0 Cg_exo -56.0 158.34 14.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.355 2.036 . . . . 0.0 112.292 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -116.12 -37.77 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.01 125.81 29.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -24.5 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 -30.67 31.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.32 115.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 157.02 38.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 124.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 133.81 45.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -88.47 130.74 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -132.06 22.52 4.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ARG . 2.5 pt-20 30.28 42.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.79 159.87 3.24 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -142.19 146.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.219 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.1 m -103.94 120.29 40.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.9 163.26 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.321 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -107.76 128.44 54.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.534 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 m -105.82 135.69 46.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -129.56 139.1 51.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.756 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -116.91 153.83 31.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.37 -177.96 6.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.54 93.03 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.541 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 177.2 149.96 8.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 177.98 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.335 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.86 156.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -133.34 -72.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -152.4 -46.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.775 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -71.85 -33.83 68.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.58 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.5 -35.03 78.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.874 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.23 -40.82 98.53 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.999 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.3 t -53.83 -38.58 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.561 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.27 -34.78 73.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.554 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -70.18 -42.87 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.88 -32.92 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 m -72.22 -41.59 66.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.35 -43.34 92.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.712 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.04 -44.6 91.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.555 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -46.76 88.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.302 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -46.21 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 88.0 m -57.63 -45.86 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.629 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.456 ' CD2' ' CD2' ' A' ' 31' ' ' TYR . 48.0 mt -73.26 -9.92 59.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.329 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.58 -42.06 22.97 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.048 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.09 -27.11 71.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 6.9 p -93.98 163.55 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.595 0.236 . . . . 0.0 110.643 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 85.0 Cg_endo -82.92 20.08 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.72 2.28 . . . . 0.0 112.967 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.96 148.14 31.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.091 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -101.19 176.57 5.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.51 158.2 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.39 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.27 -36.05 14.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.48 49.29 74.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -158.42 -42.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 111.122 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.0 p -160.12 137.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.264 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -129.21 172.18 11.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.682 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 51.9 m-85 -112.98 155.42 24.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.26 149.26 41.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -118.89 125.59 49.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.896 179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.869 0.366 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -120.82 135.25 55.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -143.81 154.16 43.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.6 129.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -107.89 121.61 45.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.13 134.93 36.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.5 t -81.22 120.38 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -88.67 115.12 25.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.187 -0.911 . . . . 1.0 111.145 179.92 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.54 112.95 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.461 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 mt -93.99 -17.61 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.4 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -169.96 162.1 9.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -151.99 179.43 8.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 135.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.423 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' CA ' ' CE1' ' A' ' 31' ' ' TYR . . . -145.11 -149.62 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.443 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 158.97 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.947 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -29.38 69.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.9 -32.36 16.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.09 110.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.4 155.61 16.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -139.58 156.85 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -147.04 124.38 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.765 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -86.2 117.39 24.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -139.26 128.66 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 109.72 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 p -151.23 85.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.03 167.85 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.28 110.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.94 -154.54 25.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.459 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' CG ' ' HG3' ' A' ' 112' ' ' PRO . 14.5 mttt -104.72 150.86 24.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 41' ' ' PHE . 3.6 m-85 -137.71 163.46 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.013 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.52 140.37 29.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.0 p -131.07 132.09 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.833 -179.133 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.4 ' CG2' ' CD1' ' A' ' 62' ' ' ILE . 63.2 t -130.88 125.39 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.212 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.12 138.76 33.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 111.418 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.5 116.96 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.79 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.78 168.35 9.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.33 31.11 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -153.28 117.77 2.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.997 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.28 -173.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.467 2.111 . . . . 0.0 112.137 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 61.3 t -61.28 -57.6 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -59.29 -45.23 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.16 -46.44 74.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.62 -45.06 93.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 1.3 mt -58.85 -35.17 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -62.06 -30.7 71.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.042 0.449 . . . . 0.0 109.906 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.0 tp10 -86.79 -37.51 17.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.161 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' O ' HG12 ' A' ' 62' ' ' ILE . . . -73.68 -29.97 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.462 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.596 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 5.2 mmt -57.43 -43.63 99.12 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 59' ' ' MET . 33.3 Cg_endo -64.69 -47.35 5.46 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.635 1.557 . . . . 0.0 111.835 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -70.47 -32.81 70.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.704 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 58' ' ' ALA . 16.9 mm -77.1 -43.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.3 81.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.735 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -59.98 -29.83 68.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 37.0 t80 -58.54 -41.36 85.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.806 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 102' ' ' PHE . 14.2 m -85.61 -30.65 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.75 -105.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.46 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.62 67.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -155.49 52.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 4.6 p30 -110.96 -15.3 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.179 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 2.5 t70 83.63 -13.86 0.73 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.607 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 4.9 53.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.29 32.93 5.41 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.448 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 113' ' ' PRO . 3.1 p -96.83 155.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.688 -0.756 . . . . 0.0 111.821 -177.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.79 108.51 1.77 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.185 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -104.72 -77.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.356 . . . . 0.0 111.072 -179.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 -144.81 16.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.33 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.45 128.59 37.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m -139.0 119.86 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.418 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 38.4 t 64.72 137.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.938 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.418 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 17.8 Cg_endo -59.86 143.7 99.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.334 2.023 . . . . 0.0 112.16 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.71 137.53 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.414 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.69 157.27 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -117.99 154.15 32.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.19 136.61 33.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.094 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.433 HG22 ' CZ ' ' A' ' 167' ' ' TYR . 5.9 m -125.85 92.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.175 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 166' ' ' VAL . 17.1 m-85 -70.75 112.24 12.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.95 167.24 9.69 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.682 2.255 . . . . 0.0 112.419 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.36 172.19 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.78 -21.34 18.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.315 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.14 -6.14 59.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 -16.06 61.96 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.95 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -84.44 165.17 18.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.971 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.85 167.17 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.56 81.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 50.77 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.346 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 68.57 104.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.67 127.97 21.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -109.48 116.05 31.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.7 t -77.58 141.09 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.231 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -122.08 128.38 51.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.793 179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.443 ' CE2' ' CG1' ' A' ' 66' ' ' VAL . 36.7 t80 -113.05 130.93 55.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 -83.9 115.18 22.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.3 mt -97.77 139.26 21.22 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 154.06 25.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.391 2.061 . . . . 0.0 112.361 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.26 -26.89 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -32.95 70.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.42 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 19.5 m-85 -93.16 -17.71 23.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.517 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -53.11 -33.65 53.21 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 111.042 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 109' ' ' GLN . . . -73.67 -30.11 62.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.95 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 m -150.53 77.42 8.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.572 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HG3' ' CG ' ' A' ' 40' ' ' LYS . 36.2 Cg_endo -65.37 149.23 88.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.602 2.202 . . . . 0.0 112.161 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HB3' HG13 ' A' ' 74' ' ' VAL . 12.5 Cg_exo -70.86 158.94 54.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.634 2.223 . . . . 0.0 112.116 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.7 136.58 92.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 59.6 Cg_endo -72.52 -20.15 23.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.436 2.091 . . . . 0.0 112.41 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.73 -67.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.04 125.88 25.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.69 -22.53 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 p -81.86 -32.68 31.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -85.36 116.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.2 156.58 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.38 116.08 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -98.82 144.84 27.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -89.43 51.64 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -76.12 120.45 21.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 177.16 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.97 156.69 23.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 pt -143.93 154.02 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -107.86 126.66 52.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.33 159.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.419 ' CD2' HD22 ' A' ' 155' ' ' LEU . 11.0 m-85 -107.7 129.45 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 p -105.92 128.84 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 0.0 111.061 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.9 t -129.7 139.19 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -116.9 147.83 41.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 1.0 OUTLIER -137.59 -57.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.88 -109.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.655 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . 175.02 78.37 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -176.84 106.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.46 134.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.277 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -106.53 -38.69 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.741 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.18 -61.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.85 71.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.63 -34.91 76.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.939 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.7 OUTLIER -63.44 -39.04 93.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.579 0.704 . . . . 0.0 110.131 179.138 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.66 -38.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.001 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.87 75.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.462 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 13.7 m170 -70.35 -44.11 68.83 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.07 -32.9 72.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -68.57 -42.74 77.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.863 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -61.97 -46.05 90.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.2 -41.57 88.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.623 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -59.61 -47.73 84.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.268 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 95.3 m -62.48 -45.56 92.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 17.1 m -57.61 -38.92 75.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 131' ' ' TYR . 92.1 mt -74.02 -16.5 61.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 153' ' ' THR . 8.2 pt-20 -48.69 -28.41 3.54 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.792 0.33 . . . . 0.0 111.331 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.89 -17.94 62.34 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.583 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -92.51 170.97 8.18 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.607 0.241 . . . . 0.0 110.801 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.4 Cg_endo -80.95 14.26 2.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.651 2.234 . . . . 0.0 113.151 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.72 132.43 53.83 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 162' ' ' TYR . 69.3 m -102.06 -2.29 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 161' ' ' THR . 59.5 m-85 57.44 124.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.39 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -66.94 -173.92 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.89 61.88 0.94 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.877 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.35 70.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.438 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 87' ' ' PHE . 9.3 p -161.9 119.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.244 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CZ ' HG22 ' A' ' 86' ' ' VAL . 3.7 p90 -133.55 177.17 7.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.754 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 186' ' ' TRP . 13.5 m-85 -126.27 151.07 47.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.084 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 71.2 m -140.07 153.53 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.05 55.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.473 179.967 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.876 0.369 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 2.1 m120 -109.41 135.51 50.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.0 147.93 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.2 t -128.84 116.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.89 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.56 121.88 43.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.984 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.09 140.06 30.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.15 120.43 30.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -65.53 153.57 41.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.114 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.839 0.352 . . . . 1.0 111.228 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 26.6 mt 63.83 29.6 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.5 -125.49 29.18 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.703 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 21.73 14.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 111.207 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -98.99 37.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.054 0.455 . . . . 0.0 110.587 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -94.75 141.57 28.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.305 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.401 ' O ' HD22 ' A' ' 9' ' ' LEU . 9.1 m-80 -101.44 176.15 5.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 126.62 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.695 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -169.83 -150.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.703 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' LEU . 1.3 t80 92.33 -37.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.878 0.471 . . . . 0.0 111.071 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.1 -72.23 0.59 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.085 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.63 123.21 48.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.28 146.11 26.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.94 0.4 . . . . 0.0 111.581 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -113.14 124.87 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.637 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -115.95 119.76 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -68.14 145.66 97.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.415 ' HG2' ' CE3' ' A' ' 18' ' ' TRP . 19.8 Cg_endo -60.59 -18.61 55.73 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.459 2.106 . . . . 0.0 112.235 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.415 ' CE3' ' HG2' ' A' ' 17' ' ' PRO . 19.0 p90 -151.3 142.9 23.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.97 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -110.79 107.81 17.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.712 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -73.81 113.68 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.36 -6.29 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 t -169.86 167.23 9.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.29 -176.6 5.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 125.51 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -128.91 -101.03 0.99 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.705 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -161.06 160.62 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -66.89 -29.7 69.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -35.49 15.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.3 107.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.28 137.81 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CE1' ' CG2' ' A' ' 154' ' ' THR . 1.8 p90 -138.93 162.23 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -145.18 137.18 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.728 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.96 114.88 23.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -131.75 128.0 37.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.92 124.85 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.7 m -106.4 134.79 48.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.98 110.87 11.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.58 -143.67 6.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.36 -60.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.01 145.57 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -138.25 154.36 49.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.77 118.72 31.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.0 p -112.46 132.01 55.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.29 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.5 t -125.76 125.11 67.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.605 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.92 137.65 35.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 t -138.61 116.58 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 170.49 7.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 47.4 31.41 1.88 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.395 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -152.65 132.36 7.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.7 -157.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.481 2.121 . . . . 0.0 112.161 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.6 t -84.52 -57.56 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.1 -43.38 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.14 -45.49 76.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.14 89.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.247 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.448 HD13 ' CE1' ' A' ' 84' ' ' PHE . 4.1 mt -57.24 -34.99 69.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -63.31 -33.19 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 109.904 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 12.5 tp10 -87.94 -31.73 19.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.282 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.94 -40.41 60.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.444 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.464 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 10.8 mmt -57.36 -45.16 99.92 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.505 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.1 Cg_exo -58.06 -45.13 33.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.263 1.975 . . . . 0.0 112.145 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -70.32 -41.76 72.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.461 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.2 tt -76.53 -31.9 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.476 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -66.45 -42.1 88.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -60.09 -33.25 71.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -68.77 -41.99 78.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.0 m -81.31 -30.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.15 -103.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.14 69.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.525 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.0 m -164.27 63.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.76 5.23 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.459 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 46.97 9.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -148.24 -46.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 37.16 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.457 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.23 160.1 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.68 75.11 0.3 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 mtp -74.26 -55.46 6.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.851 0.358 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -93.26 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.51 172.41 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' VAL . 69.0 m -164.0 110.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 49.79 166.1 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.673 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 80' ' ' VAL . 21.0 Cg_endo -61.7 149.32 90.4 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.981 . . . . 0.0 112.25 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.3 t -86.18 153.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -120.22 145.84 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.491 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -124.6 154.44 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.52 136.25 36.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.315 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.459 HG22 ' CE2' ' A' ' 167' ' ' TYR . 3.8 m -128.09 129.93 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' CE2' HG21 ' A' ' 166' ' ' VAL . 7.7 m-85 -102.47 95.78 6.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' CE1' ' A' ' 167' ' ' TYR . 61.7 Cg_endo -73.0 134.73 21.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.222 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.94 170.32 10.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -17.51 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.245 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -6.22 59.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.89 -1.71 85.3 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -121.75 136.88 54.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.813 0.34 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.1 171.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.52 47.63 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 54.94 83.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -178.22 109.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 84' ' ' PHE . 5.9 tt -144.11 138.25 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.23 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -119.62 115.76 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.437 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.69 117.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.564 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -98.73 132.16 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.542 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CE2' HG11 ' A' ' 66' ' ' VAL . 39.3 t80 -114.01 136.08 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.46 107.88 19.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.1 mt -83.71 136.16 42.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.96 154.23 74.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.497 2.131 . . . . 0.0 112.322 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -53.95 -27.65 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -58.84 -45.53 89.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -98.71 -15.07 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.273 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -36.03 60.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.804 0.335 . . . . 0.0 111.109 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.4 -33.2 76.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.64 75.39 2.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.722 0.296 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.1 159.72 14.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.583 2.189 . . . . 0.0 112.275 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.74 148.26 58.3 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.69 2.26 . . . . 0.0 112.011 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.44 112.36 9.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.95 144.63 35.66 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.352 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -103.76 -31.18 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.94 122.03 26.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.83 -23.79 54.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 m -81.98 -28.54 32.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 t -85.19 115.58 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -121.72 149.81 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 122' ' ' ILE . 8.7 mm -113.04 126.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.85 129.11 45.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 144.13 25.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER 56.0 173.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.119 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 15.4 tp10 86.71 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.3 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -91.31 158.66 25.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.015 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -128.29 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 48.7 m -122.2 119.02 30.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.292 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.11 165.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.723 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.5 136.4 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.13 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -105.69 141.17 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.073 0.463 . . . . 0.0 111.37 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.3 t -130.33 139.64 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.586 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -116.31 124.98 51.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.97 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 14.3 p90 -131.78 165.13 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.17 79.55 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.19 175.62 43.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.419 ' CD2' ' HB2' ' A' ' 175' ' ' PRO . 3.2 m-85 -91.36 164.28 13.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.792 0.329 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -169.72 120.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.207 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -105.87 -65.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.81 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -146.73 -70.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.5 70.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.65 -34.97 78.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.29 -40.45 95.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.437 0.637 . . . . 0.0 109.98 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -52.95 -38.26 28.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.658 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.67 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.647 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.5 m-70 -70.09 -42.39 72.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.757 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.94 73.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -68.41 -40.38 81.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -60.05 -46.11 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.71 -42.19 88.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.653 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.47 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.3 m -63.02 -41.58 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.417 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 6.6 m -57.29 -49.14 77.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.705 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -73.67 -10.24 59.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.296 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -46.83 -35.47 6.35 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.17 31.13 7.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.8 p -145.83 165.13 22.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 -2.81 12.29 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.909 2.406 . . . . 0.0 112.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.5 124.6 19.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.22 175.68 5.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.72 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.45 -177.13 6.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.817 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -79.3 -76.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.2 -18.07 2.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.076 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -158.01 27.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.925 0.362 . . . . 0.0 111.613 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.41 HG21 ' CE2' ' A' ' 87' ' ' PHE . 7.0 p -161.95 132.59 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 111.572 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.459 ' CE2' HG22 ' A' ' 86' ' ' VAL . 27.7 p90 -149.73 168.17 24.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -112.82 155.24 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.152 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.79 154.0 50.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.02 136.31 47.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -172.69 -65.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.77 -67.88 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.94 135.97 87.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 152.49 33.18 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.527 2.152 . . . . 0.0 112.4 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.419 ' HB2' ' CD2' ' A' ' 138' ' ' TYR . 60.6 Cg_endo -72.84 85.58 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.522 2.148 . . . . 0.0 112.253 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 mtp -120.85 -76.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.81 120.21 62.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.65 177.12 7.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.084 . . . . 0.0 112.291 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 59.73 19.82 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.07 -19.76 0.22 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.196 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -108.58 148.58 30.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? -131.5 125.49 32.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.815 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -108.86 134.09 52.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -138.26 143.1 39.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.2 121.88 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.476 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.056 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 10.6 mt -91.17 139.97 30.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.561 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.61 118.69 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -76.83 127.83 33.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.226 -0.892 . . . . 1.0 111.126 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.914 0.387 . . . . 1.0 111.191 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.76 156.73 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.43 74.13 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.6 ttp -102.22 152.58 20.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 132.76 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.59 133.42 52.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.78 126.53 55.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -88.11 156.0 19.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 mp 59.93 173.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.7 32.58 20.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -89.49 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.523 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 t -64.79 127.63 32.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.81 142.71 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -132.73 151.01 52.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 t -96.94 119.98 36.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.479 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -102.47 164.63 15.3 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.522 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 16' ' ' TRP . 28.9 Cg_endo -63.24 112.42 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.449 2.099 . . . . 0.0 112.142 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 t90 62.47 69.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -123.84 114.81 20.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.3 115.26 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -96.44 0.13 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -170.35 161.27 8.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -152.37 -45.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.48 136.41 49.27 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -136.9 175.45 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.542 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 161.09 27.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.341 . . . . 0.0 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -66.56 -32.84 74.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.7 -35.05 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 m -146.07 110.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -95.51 154.85 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 p90 -139.39 158.31 44.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -145.14 121.89 11.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.92 131.23 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -139.91 130.65 25.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.29 120.17 40.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 m -131.98 136.41 47.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -114.75 77.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.39 -161.92 2.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.525 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.28 -86.39 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -113.28 149.17 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.886 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -137.61 156.99 47.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.93 140.28 29.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.53 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 24.9 p -135.67 131.87 36.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.975 0.417 . . . . 0.0 111.5 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 39.8 t -128.01 125.41 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.436 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.99 136.0 38.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.4 116.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.778 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 168.17 9.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.88 33.06 3.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.526 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -153.2 121.65 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.89 -161.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.502 2.135 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 t -74.21 -58.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.342 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 -44.98 82.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.212 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.13 -46.0 75.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.26 89.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -32.52 74.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 tp10 -87.57 -40.36 14.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.15 -37.57 66.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 11.9 mmt -57.78 -44.12 99.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 59' ' ' MET . 49.3 Cg_endo -70.35 -36.67 8.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -70.09 -43.28 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 tt -77.08 -26.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.098 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -39.26 90.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -59.19 -31.06 68.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 31.5 t80 -71.23 -49.18 46.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 27.1 m -75.31 -30.82 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.188 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.89 -99.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.25 35.7 0.76 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.0 m -119.67 30.27 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 110.929 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.9 -14.43 36.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 78.67 -1.68 2.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -93.78 -44.25 8.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.848 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.62 39.45 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.27 -178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 88.14 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -83.21 -45.87 13.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.14 -82.55 1.54 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.87 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.794 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.14 -164.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.96 156.42 2.59 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.264 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.99 135.21 61.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 112.17 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG12 ' CD2' ' A' ' 102' ' ' PHE . 25.4 m -86.0 145.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.343 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 p -115.49 174.01 6.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.654 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -127.51 154.46 45.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.38 136.73 32.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.435 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 167' ' ' TYR . 3.0 m -131.85 109.25 15.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD2' HG22 ' A' ' 166' ' ' VAL . 11.9 m-85 -83.95 111.32 31.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.67 127.87 6.57 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.162 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 164.21 14.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.41 -15.74 62.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.361 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -5.95 59.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.523 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.59 -2.06 62.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.08 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -121.41 -169.85 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.81 169.52 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.714 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.31 34.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.142 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp 51.08 26.7 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.11 122.29 31.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.84 139.99 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.4 mtpt -118.06 115.75 25.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.133 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.9 t -78.77 116.72 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.764 0.316 . . . . 0.0 111.252 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -97.23 142.12 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.773 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 20.4 t80 -127.11 148.81 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.987 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -105.82 110.4 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.91 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 104' ' ' ILE . 23.4 mm -75.69 130.39 79.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.41 154.06 20.62 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.461 2.107 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -27.07 65.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -64.74 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 4.9 m-85 -108.16 -2.95 19.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.677 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -33.68 57.63 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.721 0.296 . . . . 0.0 111.23 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.09 -33.97 75.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.79 89.44 0.7 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.276 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 23.5 Cg_exo -63.23 160.2 35.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 112.251 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.93 153.29 63.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.597 2.198 . . . . 0.0 111.919 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 110.84 5.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 33.6 Cg_exo -61.54 132.36 40.27 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 0.0 112.061 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 t -94.99 46.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.31 112.72 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.98 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.01 -23.54 54.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -82.17 -30.32 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.37 114.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.03 150.33 27.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.0 mm -118.17 127.98 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 129.95 45.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -88.76 139.94 29.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.5 mtm105 62.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -169.14 -167.9 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.49 89.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.386 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.2 146.41 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 111.365 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.3 m -104.0 133.3 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.372 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.94 169.32 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.633 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -136.15 129.58 31.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 p -105.63 149.05 26.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 111.587 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.8 t -130.7 139.34 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.64 133.68 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.01 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.506 ' CD2' ' CE1' ' A' ' 147' ' ' HIS . 5.0 p90 -127.81 -46.27 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.59 149.63 10.33 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.73 -170.22 17.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -133.11 123.78 26.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.65 174.69 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -75.7 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.37 -61.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.774 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.93 -33.78 65.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.21 -34.92 77.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.049 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -40.51 95.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.458 0.647 . . . . 0.0 110.087 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.69 -38.57 35.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.732 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.88 77.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.715 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.506 ' CE1' ' CD2' ' A' ' 135' ' ' PHE . 47.3 m-70 -70.18 -46.01 65.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.13 -33.0 73.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.2 m -67.83 -38.25 82.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.93 -35.78 73.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.6 tp -59.22 -40.68 86.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.542 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.434 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -60.99 -42.49 98.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.266 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.2 m -64.05 -41.81 97.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -49.23 77.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.692 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.407 HD23 ' CD2' ' A' ' 31' ' ' TYR . 7.3 mt -73.54 -9.05 58.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -47.04 -36.37 7.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.821 0.343 . . . . 0.0 111.215 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -96.34 36.09 4.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 15.8 p -145.29 168.28 12.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.928 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.16 17.83 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.253 2.635 . . . . 0.0 112.794 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 170.98 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.849 0.356 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -136.66 -178.07 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 161' ' ' THR . 12.6 m-85 -155.11 138.05 15.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -63.31 -68.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.1 -79.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.56 69.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.408 HG22 ' CD2' ' A' ' 87' ' ' PHE . 9.9 p -161.94 131.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.296 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 86' ' ' VAL . 7.1 p90 -140.77 170.62 15.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.447 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 24.7 m-85 -117.83 136.76 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.0 m -111.32 144.04 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.54 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 101.37 99.29 2.38 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -122.31 130.93 53.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -154.72 142.1 13.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.11 123.42 7.25 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.228 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.83 109.81 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.457 2.105 . . . . 0.0 112.492 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mmm -151.32 -55.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.792 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 118.59 15.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.05 175.31 9.98 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.528 2.152 . . . . 0.0 112.327 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 59.95 34.83 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.184 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -155.6 22.93 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.767 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.0 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -139.05 123.89 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -120.91 144.03 48.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -137.41 142.97 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 111.372 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.76 114.91 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.362 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -117.73 121.95 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.648 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.433 HD21 ' CG ' ' A' ' 167' ' ' TYR . 0.9 OUTLIER -92.65 140.93 29.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.565 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 14.8 t -73.89 118.81 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.947 0.404 . . . . 0.0 111.269 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.36 145.69 25.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.267 -0.873 . . . . 1.0 111.093 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.847 0.356 . . . . 1.0 111.156 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.37 -61.69 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.07 29.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.4 mtm -163.12 129.42 3.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.79 85.11 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.79 121.99 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -118.24 160.34 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 139.64 49.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.3 mt -142.29 -68.9 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.64 109.87 21.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.04 -102.54 2.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 m -102.7 129.78 49.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 110.962 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.02 139.08 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -112.98 150.99 31.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 p -96.47 119.95 35.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.433 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -136.69 165.72 32.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 18' ' ' TRP . 18.0 Cg_endo -59.59 115.32 2.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.547 2.165 . . . . 0.0 111.938 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' PRO . 4.2 p90 54.21 123.94 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.285 0.564 . . . . 0.0 111.429 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.6 109.18 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.0 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.24 112.92 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.02 -22.81 18.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 t -169.85 167.03 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.868 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 p -151.41 174.58 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 123.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . -124.69 -55.56 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.549 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tptt -161.85 167.68 24.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.702 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -32.27 73.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.1 -35.33 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.356 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.32 115.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 111.574 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 158.55 15.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.766 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 4.7 p90 -138.87 155.72 47.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -146.73 130.91 17.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.07 116.41 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.03 131.69 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.5 119.54 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.14 103.13 8.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.56 129.85 50.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.97 144.46 16.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.76 178.72 16.87 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.92 141.97 50.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 8.8 m-85 -137.54 154.32 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.969 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.1 122.84 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -112.67 132.14 55.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 16.6 t -125.91 125.51 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -95.72 134.9 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.391 . . . . 0.0 111.264 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.45 116.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.8 166.96 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.991 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.78 27.67 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -152.64 129.42 5.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.68 -78.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.607 2.205 . . . . 0.0 112.675 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 39.5 t -146.73 -62.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.749 0.309 . . . . 0.0 111.236 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.57 -45.33 81.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.21 -46.28 74.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.04 -45.07 91.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.2 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -56.91 -35.3 68.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -63.04 -32.16 73.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.008 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -86.87 -32.94 19.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.24 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 100' ' ' VAL . . . -73.22 -37.13 66.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.43 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 30.2 mmt -57.8 -44.09 99.16 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 59' ' ' MET . 51.3 Cg_endo -70.29 -41.19 3.79 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.938 1.758 . . . . 0.0 111.986 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -39.53 75.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 tt -77.55 -40.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.683 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.432 ' HA ' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.5 -31.58 72.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.063 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' N ' ' HG3' ' A' ' 63' ' ' MET . 1.0 OUTLIER -58.84 -29.92 67.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.58 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 122' ' ' ILE . 13.7 t80 -75.36 -50.96 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 12.8 m -66.03 -29.7 47.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.19 -166.9 2.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.46 54.85 4.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.5 m -141.45 33.44 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -88.51 164.49 15.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.43 48.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.803 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -148.67 -46.63 0.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.38 34.09 3.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.5 m -100.46 176.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.6 -67.64 1.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mtt 62.55 146.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.25 -121.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.596 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 -45.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 m 61.02 112.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 3.9 t -65.86 -46.43 65.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 80' ' ' VAL . 29.4 Cg_exo -62.03 140.77 86.17 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.473 2.115 . . . . 0.0 112.123 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 t -153.78 144.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.282 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 t -115.73 145.95 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.489 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -133.1 154.21 50.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.87 136.66 32.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.484 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 17.7 m -135.57 133.49 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.426 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 5.8 m-85 -104.45 97.67 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.301 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 167' ' ' TYR . 92.2 Cg_endo -79.65 138.91 13.83 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.88 172.0 8.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.09 -29.12 67.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -86.36 -6.14 59.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.97 -2.06 78.9 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 124.41 41.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.81 161.24 24.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -118.58 45.78 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt 61.26 -169.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.74 114.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -143.6 130.66 20.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.5 tttp -108.04 115.89 30.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 58' ' ' ALA . 3.3 t -85.44 116.91 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.309 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -96.01 131.49 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 15.9 t80 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.267 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.58 110.27 22.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.6 mt -90.68 136.29 28.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.226 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.6 154.18 70.53 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.454 2.103 . . . . 0.0 112.344 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.86 -26.94 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -56.81 -38.29 72.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.956 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -113.02 -13.05 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -53.14 -47.13 68.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 111.179 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.08 -25.94 54.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 t -171.4 89.41 0.45 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.769 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.9 151.43 78.16 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 0.0 112.379 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.79 155.85 61.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.61 2.206 . . . . 0.0 112.111 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 111.75 8.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.993 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 32.0 Cg_exo -58.89 158.06 26.28 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.405 2.07 . . . . 0.0 112.261 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.93 -31.19 11.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.52 114.81 13.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -24.5 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.12 -33.03 29.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.885 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.43 121.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 157.04 39.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 65' ' ' TYR . 29.3 mm -107.25 129.31 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -98.86 130.7 45.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.43 16.81 8.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.43 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.91 132.46 23.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -168.57 86.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.15 92.82 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.51 145.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.88 130.8 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 186' ' ' TRP . 26.2 m -143.84 164.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.317 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 4.3 m-85 -107.8 135.43 49.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.8 p -105.68 133.65 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 139.25 52.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.86 138.87 51.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 20.7 p90 -153.32 29.64 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.99 -76.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 138' ' ' TYR . . . 134.62 79.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 137' ' ' GLY . 63.6 m-85 -157.18 82.45 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.322 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.43 26.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.219 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.65 66.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 63.6 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.52 58.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -67.27 -35.97 80.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.105 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.02 -40.52 98.0 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.444 0.64 . . . . 0.0 109.94 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.78 -38.88 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.497 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.81 -35.03 69.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.826 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 40.0 m-70 -68.94 -38.8 79.68 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.93 72.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.743 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.7 m -72.86 -43.3 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -59.51 -36.65 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.1 -43.63 87.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.415 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -59.37 -47.51 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 94.6 m -60.91 -41.99 97.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.356 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.7 m -57.67 -48.97 78.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 mt -72.89 -11.22 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -46.87 129.74 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.241 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.68 9.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.434 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 4.3 p -94.76 173.75 4.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.54 0.21 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 4.4 Cg_exo -77.57 13.97 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.012 2.474 . . . . 0.0 112.939 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.93 130.44 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.334 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.08 172.68 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 161' ' ' THR . 5.3 m-85 -155.68 160.24 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -104.11 -51.83 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.51 53.66 7.31 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.264 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -158.7 -37.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.596 0.236 . . . . 0.0 111.275 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 12.5 p -159.2 140.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 111.424 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 14.7 p90 -142.88 170.43 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.09 143.81 43.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.3 m -119.42 137.94 53.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 156.09 46.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.075 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 127.66 -101.8 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.91 94.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.789 0.328 . . . . 0.0 110.939 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 3.2 p30 -147.42 135.26 10.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 31.9 Cg_exo -58.38 146.7 88.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.393 2.062 . . . . 0.0 112.344 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 17.0 Cg_exo -66.95 64.57 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.104 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 2.7 mtm -135.27 106.92 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.981 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.8 mttm 60.79 114.38 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.2 -16.89 49.78 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.525 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -90.48 106.96 18.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.968 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 158.53 -74.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.423 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -111.0 158.61 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.724 0.297 . . . . 0.0 110.799 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 145.33 34.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.097 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -108.95 145.57 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -145.7 154.42 42.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.93 124.48 73.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.641 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.06 122.26 46.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.106 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.6 140.35 29.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.65 118.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -75.05 116.25 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.17 -0.919 . . . . 1.0 110.986 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.879 0.371 . . . . 1.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.15 -49.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.25 103.49 1.76 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.457 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -101.34 -30.13 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 pt -58.54 167.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -87.66 136.02 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.26 163.17 30.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -76.07 150.32 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.1 123.56 26.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.411 ' CZ ' HG12 ' A' ' 13' ' ' VAL . 4.3 t80 -151.49 -45.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.014 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.56 -132.93 52.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -103.31 129.8 50.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.411 HG12 ' CZ ' ' A' ' 10' ' ' PHE . 6.4 m -120.59 136.42 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.99 138.58 50.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -105.06 134.93 47.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.99 112.76 45.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.6 -60.92 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.411 2.074 . . . . 0.0 112.249 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -79.28 165.78 22.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -136.86 113.09 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -74.3 113.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mt -86.42 -24.33 25.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -169.98 167.1 9.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.6 168.07 26.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.82 -175.67 21.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.426 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.89 -106.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -161.02 167.44 26.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.0 110.916 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -66.6 -28.02 68.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.43 -33.12 16.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.094 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.99 142.38 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -135.12 139.84 44.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -138.36 162.22 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -144.53 126.46 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.761 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.0 129.43 34.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -140.71 135.82 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.74 130.08 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.13 -50.05 21.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.07 70.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.68 29.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.95 139.6 5.02 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -92.0 146.68 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -137.54 161.23 36.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.87 140.3 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.655 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -133.49 131.88 40.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.476 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -132.88 125.68 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.679 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.94 132.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.272 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 t -138.41 116.87 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 175.43 5.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t0 48.41 28.25 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.436 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.97 133.97 8.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.46 -165.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.474 2.116 . . . . 0.0 112.099 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.83 -48.81 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.333 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.71 -45.17 83.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.231 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -46.15 74.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.126 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.258 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -56.97 -35.55 69.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.259 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 tp10 -87.21 -34.15 19.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.355 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.7 -41.77 62.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.474 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.63 -43.95 99.17 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -57.47 -47.15 23.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.107 1.872 . . . . 0.0 112.189 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -70.43 -41.95 72.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.828 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.2 tt -76.09 -37.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 58.5 mtp -66.32 -40.48 89.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -59.6 -31.06 69.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 9.9 t80 -74.99 -50.09 17.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.804 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 22.1 m -72.54 -29.52 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.404 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.12 -64.33 2.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.626 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.1 76.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -164.52 55.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 110.747 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.53 6.73 6.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.366 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 58.47 18.56 5.75 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.448 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -95.2 -43.47 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.11 24.32 8.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.474 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -101.08 -178.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.62 -55.46 0.39 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 61.7 mtp 62.64 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.657 0.265 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.79 80.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.656 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 55.28 -176.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t 179.87 -39.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 2.4 m -162.23 163.67 18.3 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.855 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -59.21 149.65 79.14 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.29 1.994 . . . . 0.0 111.898 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.33 137.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.684 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 m -119.11 145.86 45.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.07 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -133.15 154.28 50.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.694 0.283 . . . . 0.0 111.452 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.97 136.67 32.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.534 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' A' ' 167' ' ' TYR . 5.2 m -130.25 130.81 65.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 10.6 m-85 -102.51 97.43 8.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.19 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.18 139.8 24.24 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.507 2.138 . . . . 0.0 112.148 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -90.18 161.92 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.41 -21.97 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.23 -6.19 59.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.63 -16.09 60.99 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.829 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -98.66 133.35 43.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.0 mt -57.89 178.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.875 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -143.37 44.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 62.1 -166.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.74 108.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.702 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 tt -141.35 139.52 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.78 115.89 27.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.525 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.23 116.86 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.536 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -100.23 137.96 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.441 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 24.8 t80 -127.07 132.44 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.684 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.34 109.75 21.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.36 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.19 139.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.468 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.34 154.14 15.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.624 2.216 . . . . 0.0 112.409 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -57.68 -31.02 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.42 -47.13 87.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -90.9 -13.49 33.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -53.19 -43.69 67.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 111.08 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.75 -27.43 66.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t -167.27 85.87 0.8 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 42.8 Cg_endo -68.02 152.26 76.86 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.613 2.209 . . . . 0.0 112.307 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.92 156.24 60.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.01 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.83 110.89 6.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 69.1 Cg_endo -74.04 145.0 34.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.304 2.003 . . . . 0.0 112.453 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -86.12 -176.41 5.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 64.16 120.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.995 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.4 -16.89 25.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.599 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.6 m -80.16 -34.72 37.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 111.233 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.42 113.83 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.149 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -128.06 157.13 41.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.8 mm -106.1 129.09 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.85 129.83 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 18.88 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.342 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -69.58 164.35 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -70.91 169.11 15.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.64 176.27 4.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.68 145.25 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.0 m -103.99 118.93 37.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.769 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.18 166.74 21.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD2' HD13 ' A' ' 155' ' ' LEU . 3.7 m-85 -107.83 133.42 52.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.583 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 p -105.89 122.29 45.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.977 0.417 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -116.38 139.1 50.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.732 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -116.99 154.16 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -166.87 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.64 127.93 4.49 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.64 147.0 4.49 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -67.14 118.21 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.58 126.04 45.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 -43.43 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -176.04 -66.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.62 -33.77 66.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -67.67 -34.9 77.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.074 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.67 -40.49 95.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.093 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.75 -38.86 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.549 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.56 -33.45 69.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.648 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -70.11 -44.43 68.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.89 72.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.4 m -67.44 -38.0 83.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -64.61 -36.25 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.9 tp -70.03 -37.17 75.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 110.437 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.01 -48.08 63.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.2 t -61.25 -40.96 96.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 98.3 m -57.52 -47.08 82.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.695 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.447 ' CD2' ' CE2' ' A' ' 31' ' ' TYR . 83.4 mt -72.75 -13.79 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.312 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.18 115.38 1.08 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.84 18.03 8.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.559 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.1 p -146.58 165.15 20.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.57 -13.25 35.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.765 2.31 . . . . 0.0 112.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.5 110.51 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 111.267 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.48 -177.74 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.82 20.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.332 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 67.72 -66.58 0.21 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.162 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.35 48.88 2.93 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.116 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -158.05 -33.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.505 0.193 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.429 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 14.0 p -159.13 138.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.548 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.43 ' CD1' HG23 ' A' ' 86' ' ' VAL . 15.0 p90 -136.99 171.55 14.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 37.5 m-85 -112.87 150.83 31.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.18 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.3 m -129.92 157.79 41.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.07 139.35 49.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.37 -144.02 3.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.555 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -142.26 -174.26 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.964 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.51 168.84 1.58 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.04 152.52 14.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.554 2.169 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.61 127.77 25.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.565 2.176 . . . . 0.0 112.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.3 ttt -160.25 -54.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.94 92.87 47.92 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 179' ' ' TYR . 32.0 Cg_exo -57.8 -160.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.514 2.143 . . . . 0.0 112.202 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 178' ' ' PRO . 48.3 m-85 60.06 94.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 104.38 50.9 0.95 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.491 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 138.92 49.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.831 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -133.21 128.07 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -130.97 133.84 46.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -146.14 157.06 43.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.49 126.24 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.825 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -107.91 121.69 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.155 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 12.7 mt -94.41 134.3 37.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.805 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.451 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 21.5 t -74.88 118.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -63.58 139.35 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.201 -0.904 . . . . 1.0 111.133 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.806 0.336 . . . . 1.0 111.211 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.66 158.51 23.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.38 -78.22 1.08 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -56.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 110.952 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.05 117.55 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.29 118.81 37.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.76 126.96 55.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -87.99 129.37 35.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.98 -72.73 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 59.8 -177.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.975 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.73 -97.78 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.273 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 t -101.82 124.93 48.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 110.725 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.07 122.05 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.218 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -133.08 147.96 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.5 p -111.66 120.05 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.442 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -129.9 165.56 32.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 16' ' ' TRP . 20.6 Cg_endo -60.85 -54.1 2.18 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -117.88 142.12 47.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.55 118.32 27.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.28 113.19 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.031 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.99 -27.78 18.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -170.09 167.09 8.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -151.65 160.52 43.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.44 71.85 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.364 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.97 -132.24 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.607 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.28 164.89 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -66.49 -28.7 68.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 -34.47 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 118.82 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 p -95.38 130.69 42.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 6.2 p90 -138.53 154.57 48.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -145.19 135.03 23.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.66 124.7 33.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.4 ' HB3' ' NH1' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -142.05 136.84 30.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.21 130.41 56.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.38 164.78 25.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.03 73.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.58 118.44 6.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.569 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.37 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.571 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 11.5 mttt -111.01 147.93 33.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.74 153.29 49.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.13 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.39 119.11 32.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.637 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.5 p -112.66 147.31 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.0 t -131.82 125.97 56.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.153 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -95.95 131.54 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.693 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 t -138.18 116.98 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 169.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.738 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 79.59 -49.11 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.492 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -85.65 141.63 36.43 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 110.877 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.51 -80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.481 2.121 . . . . 0.0 112.626 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 98' ' ' LEU . 43.0 t -142.65 -66.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.851 0.358 . . . . 0.0 111.334 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.76 -45.33 78.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -46.07 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.12 85.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.1 -35.07 68.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.013 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -31.28 71.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.285 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 34.2 tp10 -87.81 -33.66 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.12 -38.83 66.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.427 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.566 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 6.9 mmt -57.72 -43.97 99.12 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.8 Cg_endo -70.14 -37.62 8.03 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.994 1.796 . . . . 0.0 112.128 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -70.14 -42.68 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 tt -77.71 -28.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.341 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -41.06 90.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -58.93 -31.21 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CE1' ' HG3' ' A' ' 115' ' ' PRO . 40.9 t80 -70.59 -53.35 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.42 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 27.1 m -67.25 -26.36 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.288 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.0 -126.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.645 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.06 68.2 0.52 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -155.11 52.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' OD1' ' CD1' ' A' ' 65' ' ' TYR . 2.6 m-80 -112.2 22.47 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 t70 54.56 34.34 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.027 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -148.3 -61.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.29 81.92 1.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.47 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.63 146.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.37 71.77 0.7 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.6 mtp -62.24 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.03 120.49 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.57 154.14 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.87 148.2 25.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 21.7 t -56.75 -47.7 98.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.413 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 80' ' ' VAL . 84.4 Cg_endo -80.91 154.76 19.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.36 2.04 . . . . 0.0 112.499 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -153.91 138.74 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.465 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 29.6 t -115.63 149.21 38.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.498 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -133.06 154.23 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.69 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.428 HG21 ' CE1' ' A' ' 167' ' ' TYR . 30.7 m -134.68 128.75 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.195 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -98.61 99.33 7.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.24 128.01 15.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.471 2.114 . . . . 0.0 112.248 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.13 168.06 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -19.63 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.185 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.45 2.95 42.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.487 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.0 -15.45 60.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.878 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.84 177.63 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.37 -12.91 12.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.62 165.53 0.2 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.003 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -80.52 88.13 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.22 110.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.643 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD12 ' CD2' ' A' ' 84' ' ' PHE . 7.4 tt -143.97 128.62 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.449 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -110.98 115.66 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.082 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.8 t -71.46 141.12 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -120.85 124.03 44.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.42 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 57.5 t80 -108.17 153.68 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.127 0.489 . . . . 0.0 111.69 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.1 109.18 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.493 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 mt -83.04 139.12 42.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.314 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.61 154.21 16.56 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 112.314 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -27.46 56.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -59.53 -47.14 86.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.92 -8.28 31.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -53.4 -36.16 61.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.16 -28.57 73.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 t -177.03 88.12 0.25 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 34.0 Cg_exo -59.17 161.27 16.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.229 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.82 154.75 63.38 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.634 2.223 . . . . 0.0 111.864 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 114.58 19.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.2 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HG3' ' CE1' ' A' ' 65' ' ' TYR . 48.6 Cg_exo -55.17 178.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 35.78 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.9 120.89 11.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.89 -26.8 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.003 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.2 t -82.01 -34.79 29.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -85.43 117.16 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.23 152.82 40.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.425 HD11 ' CZ ' ' A' ' 65' ' ' TYR . 16.3 mm -107.98 133.77 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.86 157.25 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.79 167.71 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -66.71 171.06 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -169.91 -38.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.63 107.18 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.95 142.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.354 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.418 ' HB ' ' HE3' ' A' ' 189' ' ' LYS . 82.0 m -107.31 132.08 53.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.508 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.33 149.51 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 5.6 m-85 -107.78 132.41 53.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.198 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.7 p -105.61 144.41 32.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.48 . . . . 0.0 111.637 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.7 t -130.85 139.13 50.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.8 138.78 51.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 39.1 p90 -143.58 -178.67 6.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.789 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.58 88.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.46 -176.44 40.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -58.73 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.11 164.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -132.84 -75.51 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -139.8 -48.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.97 66.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.09 -35.0 77.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.022 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -63.87 -39.8 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.041 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.85 -38.61 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.76 74.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.597 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.496 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.23 -46.05 65.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.878 0.37 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.09 73.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.746 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -71.14 -37.94 72.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -59.01 -39.61 82.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.5 tp -58.35 -40.99 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.523 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -62.74 -45.24 93.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 179.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -40.73 98.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.191 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.0 m -57.65 -49.2 77.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.511 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -74.0 -9.25 58.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -47.16 -32.72 4.57 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.788 0.328 . . . . 0.0 111.282 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.42 28.29 12.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.5 p -145.84 159.29 47.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.312 . . . . 0.0 110.64 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.58 8.43 3.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 113.029 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.53 137.36 57.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.194 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -100.88 151.57 21.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -158.64 171.18 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.36 102.54 10.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.45 65.01 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.046 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -157.69 -27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.4 p -158.27 141.4 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.892 0.377 . . . . 0.0 111.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 86' ' ' VAL . 31.1 p90 -146.64 168.24 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.534 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -114.38 144.06 43.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.177 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.14 142.81 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.08 154.34 49.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.7 55.94 1.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.3 105.66 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -109.07 166.03 11.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.86 139.85 87.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.448 2.098 . . . . 0.0 112.178 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.79 73.54 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.486 2.124 . . . . 0.0 112.275 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 -46.37 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.761 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.55 92.47 20.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.63 -35.3 29.48 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.281 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -90.93 89.26 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.956 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.26 -41.93 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.525 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 167.04 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.21 163.33 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -108.94 152.88 24.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.06 147.12 31.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.9 118.12 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.84 123.27 48.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.0 mt -91.43 140.61 29.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.516 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 17.7 t -73.98 131.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.801 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.418 ' HE3' ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -73.02 -0.94 15.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 1.0 111.065 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.748 0.309 . . . . 1.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.23 144.29 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.019 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.96 92.72 0.38 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.462 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 ptm -96.61 166.1 11.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mt 68.56 12.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.512 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -115.09 107.93 15.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -108.63 164.15 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -69.47 134.28 48.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.67 82.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.45 90.16 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 -82.51 1.11 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.542 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.27 132.8 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.933 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.06 117.95 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -116.02 146.7 41.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.3 t -115.98 142.02 47.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.966 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.92 98.92 32.73 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 149.54 64.01 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.435 2.09 . . . . 0.0 112.32 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -63.66 174.98 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.995 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.01 107.93 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.93 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.32 112.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -84.9 -12.07 54.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.415 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.8 159.03 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.85 155.35 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.79 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.85 145.02 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.368 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 31' ' ' TYR . . . -135.88 -146.63 5.29 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.478 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -78.37 164.48 24.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.407 . . . . 0.0 110.837 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.54 -26.45 67.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.02 -32.32 16.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.92 111.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.188 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -95.78 141.76 28.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.4 p90 -139.35 162.13 35.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -145.57 126.16 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.33 122.51 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -123.95 135.28 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.11 121.03 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.194 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.52 173.46 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.88 -47.19 26.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -178.03 28.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.87 -127.32 2.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.426 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.95 139.14 38.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -137.58 148.68 46.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.16 28.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.636 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 p -112.82 149.52 32.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 41.9 t -128.92 125.61 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -97.38 130.93 44.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.18 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.4 t -138.25 116.84 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 175.92 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 43.08 36.38 0.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.565 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -152.43 134.15 8.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.22 -157.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.75 -53.25 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -68.15 -44.98 74.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -46.26 81.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.202 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.26 90.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 84' ' ' PHE . 6.2 mt -57.49 -35.28 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -31.67 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 tp10 -87.66 -32.59 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.18 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.65 -42.63 61.13 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.791 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 3.0 mmt -57.6 -43.54 98.93 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.511 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.8 Cg_exo -59.77 -45.16 26.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.248 1.965 . . . . 0.0 111.953 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -70.32 -40.47 74.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.445 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 7.1 tt -76.57 -40.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 0.0 111.494 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.27 -31.8 72.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -63.67 -29.84 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -74.04 -30.63 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 63' ' ' MET . 15.0 m -89.74 -31.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.97 -74.16 0.95 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.573 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.07 71.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -160.59 70.35 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -119.65 -5.63 10.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.452 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.85 39.81 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -144.4 -45.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.64 31.98 1.54 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.25 145.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.85 4.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.425 ' HG2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 62.87 143.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.4 -119.5 3.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -156.85 -171.56 3.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -159.13 -163.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.526 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.8 m -45.04 161.99 0.22 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.3 Cg_endo -59.31 132.38 46.24 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.186 1.924 . . . . 0.0 111.863 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.81 146.81 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 p -115.41 173.91 6.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.7 154.16 44.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.931 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB1' ' CG ' ' A' ' 99' ' ' LYS . . . -87.23 136.58 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.486 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 27.2 m -131.86 112.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.816 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CD2' ' CG2' ' A' ' 166' ' ' VAL . 4.4 m-85 -93.35 107.13 23.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.24 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.62 156.29 28.02 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.562 2.175 . . . . 0.0 112.189 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.05 168.34 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -22.27 47.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -85.88 -6.04 59.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.21 -16.07 61.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.806 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 130.07 47.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 177.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.02 81.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.57 -166.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.054 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 64.6 96.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -144.03 127.86 17.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' CG ' ' HB1' ' A' ' 85' ' ' ALA . 20.6 ptmt -110.59 115.8 30.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.38 141.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.332 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -116.38 141.97 47.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.679 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 54.1 t80 -125.0 159.87 30.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.473 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 2.5 mtt85 -115.97 108.09 15.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.323 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.7 mt -85.5 136.41 37.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.297 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.45 152.02 75.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.359 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -57.23 -26.98 61.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -47.1 82.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.197 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CE2' ' HG2' ' A' ' 76' ' ' MET . 3.2 m-85 -89.18 -16.24 31.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -54.4 -39.05 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.781 0.324 . . . . 0.0 111.197 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.91 79.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 p -159.97 71.67 3.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 110.63 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 32.5 Cg_exo -58.37 139.03 88.98 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.551 2.167 . . . . 0.0 112.324 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 13.0 Cg_exo -70.54 149.27 61.67 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.598 2.199 . . . . 0.0 112.036 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 124.57 89.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.12 170.49 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.383 2.055 . . . . 0.0 112.269 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -40.03 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 131.46 35.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -57.71 -22.46 46.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.105 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -81.97 -31.97 30.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 t -85.64 114.02 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.59 157.0 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.7 mm -107.57 117.59 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -98.98 136.39 39.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.826 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.7 49.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -71.89 -132.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -177.91 4.0 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.79 153.57 20.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.858 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.96 148.78 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.7 m -103.9 130.46 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -144.81 170.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.48 133.08 41.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.626 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -105.96 137.78 43.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.046 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -124.87 139.05 54.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -116.91 141.38 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -153.62 -50.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.45 170.59 38.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -112.94 67.59 0.24 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.48 100.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -160.33 163.98 32.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -61.66 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -161.12 -61.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.657 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.84 -33.8 72.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.412 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -67.33 -34.74 77.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.8 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.03 -42.05 99.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.513 0.673 . . . . 0.0 109.82 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.5 t -54.02 -38.8 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.717 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.02 68.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.752 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -70.0 -39.7 75.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.01 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.761 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -67.42 -39.92 85.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.08 -45.95 89.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.5 tp -63.1 -40.45 97.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -44.22 96.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -65.17 -41.16 94.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.532 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.419 HG23 ' CD1' ' A' ' 31' ' ' TYR . 86.4 m -57.64 -48.05 80.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 31' ' ' TYR . 12.7 mt -73.22 -16.63 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -47.23 -40.18 15.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.45 32.11 6.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.65 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 51.9 p -146.09 166.7 16.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 0.0 110.936 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.86 4.72 4.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.031 2.487 . . . . 0.0 112.812 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.47 125.37 22.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -101.78 152.63 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.553 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -158.42 173.88 15.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.276 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -85.76 -67.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.76 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.062 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.11 -28.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.62 0.247 . . . . 0.0 111.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 87' ' ' PHE . 14.6 p -157.98 137.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.425 ' CZ ' HG21 ' A' ' 86' ' ' VAL . 17.2 p90 -135.82 179.34 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CE2' HG22 ' A' ' 188' ' ' VAL . 25.8 m-85 -116.27 150.78 37.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 m -124.04 136.94 54.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.54 125.06 52.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 122.17 140.69 5.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -154.0 36.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.75 136.26 37.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.11 158.56 33.92 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.511 2.141 . . . . 0.0 112.385 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.97 136.14 26.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.567 2.178 . . . . 0.0 112.35 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.4 mtm -168.34 -64.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -153.12 134.75 8.63 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.18 -176.14 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.317 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 60.22 68.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.98 -54.93 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.4 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -115.52 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.825 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -139.71 141.13 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.45 141.07 45.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -145.97 153.01 40.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.0 133.15 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.957 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -107.65 121.71 45.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 36.9 mt -94.03 139.2 31.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.434 HG22 ' CE2' ' A' ' 168' ' ' TYR . 43.0 t -83.37 127.26 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.05 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -73.76 160.43 31.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.286 -0.864 . . . . 1.0 111.141 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.651 0.262 . . . . 1.0 111.299 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -121.19 173.2 7.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.16 -167.56 28.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.451 ' O ' HG13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.19 -166.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.529 0.204 . . . . 0.0 110.831 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 4' ' ' MET . 1.7 pt 30.7 86.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.386 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 114.86 23.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -117.6 146.89 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 143.32 27.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.37 164.21 19.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -70.03 125.02 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.49 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.44 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.5 p -99.21 125.09 44.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.04 128.94 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.83 124.9 17.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 t -116.1 132.51 56.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -177.06 82.38 0.25 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.68 166.5 25.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.653 2.235 . . . . 0.0 112.391 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -173.68 163.5 4.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.022 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.26 109.14 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -74.2 112.97 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.56 -16.33 22.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -169.66 166.96 9.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.85 -173.89 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.041 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.98 -119.53 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 98.82 132.45 7.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.774 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 168.69 19.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.729 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -26.88 67.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.28 -35.13 15.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.23 113.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.887 0.375 . . . . 0.0 111.194 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' CA ' ' A' ' 25' ' ' GLY . 1.3 m -98.22 143.68 28.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.454 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 3.8 p90 -138.55 158.92 43.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.7 132.24 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -86.32 120.04 27.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.6 148.65 44.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.65 116.61 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.61 127.32 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.17 -172.93 2.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.708 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.31 -19.99 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.735 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.19 -90.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.54 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 141.16 28.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.776 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -137.63 155.02 49.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.427 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.74 115.9 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.403 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 17.5 p -112.67 147.41 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.998 0.427 . . . . 0.0 111.482 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.0 t -130.29 125.66 60.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.939 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -98.68 140.98 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -138.38 116.79 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.921 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 167.25 10.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 46.23 35.41 2.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.439 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.78 142.92 15.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.761 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 53' ' ' GLU . 53.6 Cg_endo -68.58 -163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.403 2.069 . . . . 0.0 112.107 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -81.04 -54.31 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.59 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -61.18 -45.52 94.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.488 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.416 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 5.4 tt0 -67.33 -42.9 82.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.23 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.61 -44.8 90.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.425 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 84' ' ' PHE . 5.3 mt -56.92 -35.63 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.761 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -33.02 74.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 17.1 tp10 -88.42 -30.89 19.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.384 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -44.8 58.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 32.5 mmt -57.68 -43.88 99.09 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 31.9 Cg_exo -58.9 -46.09 24.98 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.17 1.913 . . . . 0.0 112.221 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -70.29 -41.39 73.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.707 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.0 tt -76.41 -35.06 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 111.586 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.4 mtt -66.28 -36.59 83.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -49.01 79.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 23.1 t80 -58.45 -54.11 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 33.7 m -66.48 -28.29 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.5 -141.12 0.89 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.614 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.51 43.22 1.92 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.3 m -131.19 87.13 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.39 143.32 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -73.59 -9.16 58.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -91.21 -39.82 11.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.04 62.4 1.01 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.409 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.0 m -139.66 159.48 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.92 -46.13 38.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.2 mtp 61.43 117.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 111.051 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.72 127.62 25.73 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.402 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.48 176.05 8.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 18.7 p -147.63 114.05 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 31.2 m -57.61 -33.11 15.72 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 80' ' ' VAL . 11.1 Cg_exo -71.48 152.3 60.05 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.082 1.855 . . . . 0.0 111.823 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -153.07 147.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 111.433 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 t -143.02 145.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.646 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -133.25 154.15 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.51 136.72 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 110.481 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 167' ' ' TYR . 15.4 m -136.1 141.0 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CD2' HG21 ' A' ' 166' ' ' VAL . 3.7 m-85 -108.63 107.97 60.51 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.35 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.02 129.49 7.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.549 2.166 . . . . 0.0 112.391 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.82 158.43 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -28.78 69.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -2.69 58.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.432 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.45 57.3 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.969 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.02 163.21 28.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -117.51 -9.51 10.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.417 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 62.47 153.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 110.958 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -80.78 88.34 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.035 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.72 118.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 84' ' ' PHE . 2.2 tt -143.94 135.8 26.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -123.25 115.67 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.203 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.2 t -81.98 141.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.308 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -120.23 131.25 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 56.5 t80 -110.08 161.25 15.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.464 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' O ' ' CE2' ' A' ' 102' ' ' PHE . 40.9 mmt-85 -116.08 121.57 42.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.64 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.5 mt -102.22 137.01 19.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.21 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.23 154.09 72.87 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.511 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -26.55 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.269 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -56.6 -47.02 80.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.07 -5.04 41.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.321 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -54.39 -47.73 72.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.9 -26.08 39.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.99 91.38 0.3 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.92 150.85 73.67 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.417 2.078 . . . . 0.0 112.22 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.83 152.97 64.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.633 2.222 . . . . 0.0 112.047 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.54 127.97 93.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.095 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 74.5 Cg_endo -75.53 169.71 21.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.521 2.147 . . . . 0.0 112.401 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 -31.8 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.18 116.17 19.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.68 -19.64 41.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.85 -22.01 40.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.209 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.7 t -84.77 113.9 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.96 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -108.11 147.62 30.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.27 123.89 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.78 142.73 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.46 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -169.3 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -43.89 109.28 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.966 0.413 . . . . 0.0 111.594 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.16 56.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.719 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.67 168.57 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.72 142.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.6 m -111.04 119.8 40.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.691 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.4 m -138.86 168.74 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.255 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.428 ' CD2' HD11 ' A' ' 155' ' ' LEU . 10.8 m-85 -107.73 141.1 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.526 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.7 p -105.96 127.93 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.281 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 t -125.1 137.11 54.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.644 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.84 125.01 45.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.919 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 8.5 p90 -123.06 -41.67 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.99 84.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . -147.09 -89.21 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.6 OUTLIER -175.71 108.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.0 110.814 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 144' ' ' TYR . . . -105.66 132.72 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 58.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 67.16 -72.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.86 76.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -67.84 -34.77 77.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.982 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 139' ' ' ALA . 1.2 m-85 -62.63 -39.53 94.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.439 0.638 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.87 -38.82 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.477 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.68 -35.61 70.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.787 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 47.4 m-70 -70.05 -42.7 72.54 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.925 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -32.92 72.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.694 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.4 m -69.64 -39.28 77.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.714 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.83 -46.01 91.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.9 tp -58.57 -40.67 83.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.656 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.06 95.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.3 m -64.84 -39.37 93.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.364 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -45.67 84.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.822 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 131' ' ' TYR . 15.6 mt -72.78 -17.83 61.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.258 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.96 111.56 0.41 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.171 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 106.25 30.37 4.46 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.289 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.414 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 64.6 p -145.23 168.07 12.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.7 0.286 . . . . 0.0 110.807 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.414 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 16.5 Cg_exo -67.93 -3.43 10.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.808 2.339 . . . . 0.0 112.978 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.29 124.56 18.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.339 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -99.57 176.32 5.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.32 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 161' ' ' THR . 3.5 m-85 -154.58 161.25 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.035 0.445 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -92.87 -172.26 2.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.819 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.81 63.19 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 57.08 77.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.743 0.306 . . . . 0.0 111.308 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 87' ' ' PHE . 13.9 p -161.37 112.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' HG22 ' A' ' 86' ' ' VAL . 13.8 p90 -119.14 173.28 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.724 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -112.89 150.49 31.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.81 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.82 149.62 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -178.21 162.37 29.77 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.564 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -99.25 -70.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -120.5 160.31 44.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.06 154.57 74.12 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.542 2.161 . . . . 0.0 112.275 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.01 87.33 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.543 2.162 . . . . 0.0 112.273 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.87 -38.27 3.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.33 138.02 30.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.403 ' HB2' ' CD1' ' A' ' 179' ' ' TYR . 74.8 Cg_endo -77.41 170.88 18.61 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.499 2.133 . . . . 0.0 112.401 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.403 ' CD1' ' HB2' ' A' ' 178' ' ' PRO . 60.6 m-85 61.98 121.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.5 29.08 12.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.9 139.03 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 130.9 30.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.94 152.54 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.06 154.84 42.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.07 128.35 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -108.04 122.0 45.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.368 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 13.1 mt -93.09 134.49 35.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.535 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 167' ' ' TYR . 43.4 t -74.76 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -107.51 111.97 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.227 -0.892 . . . . 1.0 111.028 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.861 0.362 . . . . 1.0 111.268 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tt -138.38 142.15 39.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.31 -100.65 0.24 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 32.5 mtt 60.5 95.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 pt -97.01 97.38 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.39 119.33 37.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -133.35 128.63 36.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.6 t -83.33 135.48 34.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tt -169.3 82.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -150.31 97.88 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.804 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.02 -116.05 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.2 m -88.73 126.66 35.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.15 145.57 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.77 132.32 52.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -115.8 129.5 56.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.16 102.25 8.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.57 143.9 58.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.477 2.118 . . . . 0.0 112.246 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 t90 56.63 92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -135.09 108.43 7.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.0 112.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.73 -10.88 25.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.354 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -170.01 164.83 9.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.33 . . . . 0.0 110.966 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.9 -49.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.96 137.64 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.462 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -139.11 -156.16 6.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -78.4 158.37 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.51 -27.38 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -90.11 -35.01 15.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.08 114.82 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -95.38 150.8 19.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.5 p90 -139.05 160.32 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -143.33 124.97 14.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -85.86 122.1 29.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -130.3 128.13 40.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.35 132.77 55.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.1 p -139.65 162.22 35.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.85 170.91 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.935 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.8 -119.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.01 -170.76 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.34 137.72 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 103' ' ' ARG . 10.8 m-85 -137.49 159.85 40.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.29 127.07 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.7 p -112.79 131.79 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 99' ' ' LYS . 39.0 t -127.7 125.35 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.59 139.92 31.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.28 116.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.52 168.35 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 t0 47.56 28.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -152.87 115.72 2.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.41 -172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.507 2.138 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.71 -62.24 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.542 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -45.08 79.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -67.1 -45.36 77.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.169 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.69 -44.42 90.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.344 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.96 -35.75 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.743 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -64.79 -32.17 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.944 0.402 . . . . 0.0 110.479 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.5 tp10 -87.8 -35.45 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.821 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.52 -42.02 62.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -57.64 -44.11 99.27 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.494 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.0 Cg_exo -63.95 -40.29 28.48 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.243 1.962 . . . . 0.0 111.76 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -70.14 -43.39 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 tt -76.35 -34.16 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.318 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mmt -66.28 -37.83 86.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 110.957 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.2 81.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.409 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 62.5 t80 -68.99 -42.1 76.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.437 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 30.3 m -82.24 -23.37 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.32 -82.09 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.79 51.86 0.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -132.06 92.21 3.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.769 0.318 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -155.09 170.81 20.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -96.09 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -148.33 -47.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.31 42.96 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.26 174.07 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 111.182 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.1 116.41 1.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.528 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 30.6 mtp -112.56 -161.7 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.69 -120.37 1.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -56.43 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.509 ' O ' ' CG1' ' A' ' 80' ' ' VAL . 2.1 m 60.45 102.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.991 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 79' ' ' THR . 9.7 p 53.78 142.72 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.801 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 80' ' ' VAL . 31.2 Cg_exo -59.79 138.2 81.4 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.304 2.003 . . . . 0.0 112.128 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.01 153.96 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.649 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.408 ' OG ' ' CH2' ' A' ' 186' ' ' TRP . 0.6 OUTLIER -122.26 167.6 13.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -133.18 140.52 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.162 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.7 136.65 39.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.432 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.438 ' O ' ' CE1' ' A' ' 167' ' ' TYR . 3.6 m -131.38 102.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.857 0.361 . . . . 0.0 111.09 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -70.7 111.76 10.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.94 137.85 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.724 2.283 . . . . 0.0 112.503 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.11 155.14 18.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.839 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.28 -19.0 61.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -85.24 -6.02 59.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.94 59.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.051 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -95.56 165.39 12.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.348 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.0 mt -112.2 140.64 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 163.09 24.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -79.95 -11.83 59.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 124.7 33.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.703 0.287 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.7 141.21 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.067 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -121.88 115.98 23.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.63 128.12 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.329 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -103.37 142.07 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.708 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 62.9 t80 -126.07 150.73 47.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 0.0 111.519 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.411 ' HD3' ' CE2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -108.77 108.04 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.514 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.5 mt -80.25 136.05 53.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.343 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.56 154.23 70.08 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.664 2.242 . . . . 0.0 112.511 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.414 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 69.3 m-80 -55.87 -26.87 49.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.284 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -56.98 -40.38 76.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.405 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -101.86 -8.07 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.749 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -53.95 -37.58 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.332 . . . . 0.0 111.055 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.23 -31.13 61.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -174.53 85.37 0.34 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.4 Cg_exo -56.88 145.53 83.8 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.6 Cg_exo -70.88 151.85 63.0 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.489 2.126 . . . . 0.0 112.081 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 111.59 7.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.995 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 33.0 Cg_exo -58.36 158.87 21.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.479 2.119 . . . . 0.0 112.192 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -110.44 30.83 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -130.26 112.15 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.02 -29.07 65.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.3 -27.54 32.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.5 t -85.11 125.47 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.153 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 157.11 33.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.7 mm -105.73 119.48 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.83 21.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.51 156.07 39.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 58.8 103.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.24 -66.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 111.184 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.3 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.088 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.26 142.98 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.007 0.432 . . . . 0.0 111.629 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.0 m -115.42 128.98 56.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.252 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.47 160.02 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 111.737 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.433 ' CZ ' HD12 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.93 136.3 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.205 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.1 p -105.67 131.08 53.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 111.396 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -125.34 139.25 53.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -116.85 137.17 52.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 6.1 p90 -134.57 140.75 46.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.36 93.9 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 159.1 161.1 10.86 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.581 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 175' ' ' PRO . 82.2 m-85 -65.79 167.86 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.52 147.99 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -135.79 -175.91 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -58.35 -69.43 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.83 72.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.688 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.15 -34.85 78.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.031 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.77 -40.75 98.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.87 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.2 t -53.76 -38.88 36.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.61 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.53 -36.27 70.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.919 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 48.0 m-70 -70.14 -43.28 71.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.901 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.92 72.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 m -65.55 -37.84 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -58.76 -45.83 88.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.59 -38.79 78.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.428 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -64.29 -43.25 95.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -68.13 -38.57 82.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 56.1 m -57.49 -49.08 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.433 HD12 ' CZ ' ' A' ' 131' ' ' TYR . 47.3 mt -73.56 -19.5 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.17 102.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 113.08 32.7 2.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.3 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 44.0 p -145.52 165.42 21.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.82 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.06 -17.33 30.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.666 2.244 . . . . 0.0 112.674 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.28 41.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.445 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -101.94 -171.21 1.93 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.933 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.445 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.43 154.0 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.06 -164.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -56.68 -86.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.17 77.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.3 p -161.67 132.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 86' ' ' VAL . 14.7 p90 -141.17 163.63 32.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.447 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 22.1 m-85 -112.94 157.49 21.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 11.1 m -143.87 136.98 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.01 138.53 48.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.026 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 172' ' ' TYR . . . 168.19 155.52 9.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 171' ' ' GLY . 5.7 m-85 -165.8 91.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 0.0 110.955 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -140.06 134.86 15.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.52 132.8 11.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.144 . . . . 0.0 112.271 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.427 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 70.4 Cg_exo -51.82 -25.25 20.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.473 2.115 . . . . 0.0 112.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.6 mtt -59.87 -44.87 93.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 115.37 65.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.832 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 -7.88 21.29 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.477 2.118 . . . . 0.0 112.652 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -148.49 121.08 8.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.777 0.322 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.04 -70.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.05 167.06 10.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -112.11 132.1 55.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.058 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -115.63 133.89 55.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.585 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.36 156.89 44.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 29.3 t -121.43 114.85 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.562 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.11 125.68 51.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.346 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 167' ' ' TYR . 5.3 mt -92.54 140.51 29.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.593 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.447 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 18.6 t -74.59 131.14 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.358 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -79.95 163.43 24.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.206 -0.902 . . . . 1.0 111.096 179.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.735 0.302 . . . . 1.0 111.11 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.09 166.97 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.28 -121.74 4.48 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.567 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.5 35.48 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.3 mm -98.92 40.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -77.01 129.22 35.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.26 150.7 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -87.93 132.93 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 -45.12 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 62.79 18.3 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.21 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.0 -78.69 0.47 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.008 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 p -106.93 124.87 50.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.677 0.275 . . . . 0.0 110.494 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.84 142.39 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -134.91 124.9 25.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -92.05 120.2 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.025 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.29 126.2 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -41.35 2.77 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.045 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -131.56 -178.07 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.725 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.87 113.17 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.55 113.0 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mt -96.67 -12.94 23.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.442 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.48 166.29 10.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 p -152.47 -176.78 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.47 141.95 1.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.422 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -154.67 -173.74 23.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -78.81 158.98 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -66.59 -30.38 70.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.06 -35.03 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.6 m -146.08 107.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.006 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 p -97.29 156.14 16.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.8 p90 -140.12 162.05 36.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -145.52 136.38 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.77 130.8 34.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 127.98 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.58 139.1 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 111.255 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -133.71 132.21 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.794 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.67 149.21 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 118.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.92 148.93 5.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.603 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -105.36 158.18 16.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -137.63 157.6 46.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.94 140.3 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.434 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.9 p -137.03 143.43 42.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.687 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.25 125.87 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -95.85 131.18 42.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.024 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.34 116.85 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.32 169.04 8.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 47.46 37.86 6.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -152.5 137.38 10.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.869 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.89 -160.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.509 2.14 . . . . 0.0 112.278 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 98' ' ' LEU . 46.2 t -92.76 -63.38 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.28 -42.83 92.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.9 -45.96 76.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.99 75.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 84' ' ' PHE . 8.3 mt -58.31 -35.4 71.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.27 -33.61 74.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.533 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.5 tp10 -87.48 -28.67 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.57 -44.01 58.37 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.485 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 32.0 mmt -57.67 -43.46 98.81 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.533 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.92 -45.54 23.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.23 1.953 . . . . 0.0 111.884 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -70.34 -42.25 72.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.661 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.04 -37.48 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.432 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -66.12 -31.77 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.001 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 63' ' ' MET . 4.2 mtmm -60.89 -29.96 69.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.385 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -73.13 -49.05 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 102' ' ' PHE . 14.9 m -66.01 -22.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.44 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.81 83.18 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.97 -43.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 t -172.43 100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.016 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -127.34 3.36 6.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.22 41.15 17.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -148.31 -50.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.89 43.96 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.9 m -100.92 -179.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 117.68 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.337 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.1 mtp -120.15 118.43 30.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.42 -26.19 50.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.3 ttt 63.92 132.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 t -58.13 177.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.479 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -95.29 -54.79 0.22 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.204 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 76.2 Cg_endo -93.86 130.35 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.645 2.23 . . . . 0.0 112.585 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -93.07 148.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.43 148.95 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -133.05 154.25 50.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.201 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 101' ' ' TRP . . . -94.36 136.69 34.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.39 134.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.071 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 166' ' ' VAL . 3.8 m-85 -111.04 95.79 26.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.28 164.3 32.95 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -90.23 172.28 8.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.52 -22.16 20.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.292 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.46 -6.12 59.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.466 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.14 61.51 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.883 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -174.73 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.776 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mt -123.54 164.31 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -161.0 87.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp 51.96 -167.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.19 99.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 84' ' ' PHE . 6.1 tt -144.08 128.01 17.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.167 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 115.57 29.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.973 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.7 t -71.68 141.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.731 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.423 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 25.9 m95 -119.35 130.99 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.13 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 60.5 t80 -114.76 158.9 21.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 111.63 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -116.08 107.9 15.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.482 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mt -84.92 137.1 38.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.356 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.31 154.09 25.06 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 3.9 m-20 -58.24 -26.89 63.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -47.12 87.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.482 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -86.31 -11.06 53.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.598 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.83 -42.81 68.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.634 0.255 . . . . 0.0 111.017 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.86 -29.05 58.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.8 85.48 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.607 0.242 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -60.82 160.94 23.27 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.573 2.182 . . . . 0.0 112.239 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.41 155.66 32.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.861 2.374 . . . . 0.0 111.972 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.08 22.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.97 168.6 22.66 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.377 2.051 . . . . 0.0 112.392 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.2 p -110.25 168.92 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.4 t70 66.74 126.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.75 -16.01 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.66 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -79.81 -29.14 40.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.68 0.276 . . . . 0.0 111.253 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.73 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -123.02 156.92 33.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 11.9 mm -113.71 128.46 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.8 153.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.27 179.86 6.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -58.66 98.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.67 -21.86 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.9 74.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.55 145.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.31 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -103.78 137.45 41.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 186' ' ' TRP . 27.0 m -139.17 145.63 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 186' ' ' TRP . 0.4 OUTLIER -107.79 128.81 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.4 p -105.51 142.29 35.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.141 0.496 . . . . 0.0 111.707 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.0 t -127.67 139.6 52.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 125.0 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.404 . . . . 0.0 111.023 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 12.5 p90 -131.03 -177.88 4.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -117.58 130.22 8.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.566 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.31 -177.37 20.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.568 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 178' ' ' PRO . 58.5 m-85 -94.43 166.9 11.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.805 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -177.18 121.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.245 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.22 -73.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.778 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -141.4 -47.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.785 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -73.03 -33.95 66.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 110.605 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -35.09 76.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.927 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -64.22 -39.08 93.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.245 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.63 -38.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.452 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.2 70.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.78 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.499 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.7 m-70 -70.0 -42.79 72.58 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.807 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.94 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.4 m -67.66 -39.44 84.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.704 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.25 -46.05 92.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 tp -58.28 -38.88 77.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -64.12 -42.56 96.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.5 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.7 m -69.15 -37.07 78.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.4 m -57.54 -38.9 75.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 162' ' ' TYR . 32.1 mt -72.4 -22.71 61.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.23 95.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.216 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.93 33.12 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 64.9 p -145.54 155.26 53.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.09 -12.99 37.33 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.615 2.21 . . . . 0.0 112.605 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.41 159.8 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 156.54 47.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.6 OUTLIER -154.48 155.81 35.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -79.38 -61.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.03 -16.69 58.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.687 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.58 -27.47 34.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.066 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 87' ' ' PHE . 8.4 p -160.76 118.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -119.03 171.38 8.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.45 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 33.5 m-85 -113.15 140.16 48.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.82 147.58 35.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.04 127.82 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.71 103.69 0.24 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.582 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -131.13 105.87 7.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -162.69 147.03 9.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.61 125.47 9.55 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.557 2.171 . . . . 0.0 112.299 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.78 94.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.413 2.075 . . . . 0.0 112.283 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.67 -65.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.04 149.09 70.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 138' ' ' TYR . 30.1 Cg_endo -64.07 -54.3 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.283 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -91.5 108.72 20.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.95 -53.49 0.16 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.88 167.0 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -141.19 146.15 36.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.127 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -108.93 158.01 18.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.515 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.38 144.18 34.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.7 124.64 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.5 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -122.14 132.37 54.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 111.725 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 16.8 mt -92.33 140.21 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.656 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 19.6 t -74.69 131.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.462 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 69.1 tttt -69.53 154.21 42.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 1.0 111.077 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.675 0.274 . . . . 1.0 111.22 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.23 -31.89 30.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.854 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.02 -175.13 25.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.433 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 ttt -124.97 99.98 6.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -90.74 -31.52 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -78.67 119.32 21.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -131.65 156.87 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -80.4 151.8 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.8 31.38 3.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.016 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.44 16.18 25.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.72 -100.1 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.627 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -106.97 124.93 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.63 146.1 29.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.56 125.53 44.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -85.05 136.72 33.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -126.81 80.16 71.18 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.798 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.62 155.74 21.19 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.67 2.247 . . . . 0.0 112.405 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -62.67 -179.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -111.15 111.52 22.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.11 112.83 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.857 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.88 -12.99 22.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.79 167.09 9.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.69 154.49 36.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.23 164.26 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -161.17 -58.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -161.95 164.48 28.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.785 0.326 . . . . 0.0 110.748 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -33.74 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -91.08 -35.29 14.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.44 108.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.83 0.348 . . . . 0.0 111.723 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.31 158.06 16.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -139.07 162.35 35.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.92 0.39 . . . . 0.0 111.114 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.76 132.85 21.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -85.98 126.96 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.97 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.93 127.35 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -152.88 96.18 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.48 -50.65 72.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.77 -119.77 19.57 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.622 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.96 -119.46 1.01 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -91.91 159.34 15.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.832 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HB3' ' O ' ' A' ' 102' ' ' PHE . 38.4 m-85 -137.44 148.93 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.042 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.81 140.34 29.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 66.5 p -132.1 136.02 46.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 111.576 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.9 t -125.9 125.56 68.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.662 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -96.88 131.45 43.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.095 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.26 116.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.002 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.41 174.11 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.51 25.99 3.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.398 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -152.95 130.02 5.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.06 177.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.313 2.009 . . . . 0.0 112.23 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.7 t -62.2 -57.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.024 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -58.24 -45.25 88.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.17 -46.21 74.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.0 91.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.194 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.1 -35.59 69.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.77 -31.81 73.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.1 tp10 -87.27 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.66 61.62 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 6.0 mmt -57.69 -44.15 99.27 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.3 Cg_exo -63.29 -40.54 31.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.21 1.94 . . . . 0.0 111.718 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -70.24 -44.03 69.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.035 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tt -76.1 -31.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -42.79 87.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -58.92 -42.27 89.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 7.0 t80 -59.63 -50.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 35.7 m -72.54 -27.62 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.37 -105.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.594 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.46 67.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.6 m -164.4 71.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 0.0 110.761 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.94 10.41 3.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.372 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 57.05 38.94 29.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 111.025 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -52.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.46 79.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.552 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.0 143.65 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.896 0.379 . . . . 0.0 111.169 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.87 -42.66 94.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.411 ' HA ' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 65.48 -76.4 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.89 -23.16 8.37 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.412 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 64.46 162.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.04 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' A' ' 81' ' ' PRO . 7.8 m -122.29 131.63 54.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 1.5 t -68.43 -53.05 18.6 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 84.3 Cg_endo -81.1 130.78 7.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.417 2.078 . . . . 0.0 112.354 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -154.37 134.61 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.975 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 t -114.96 167.99 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -126.91 154.22 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.416 ' HA ' ' CD1' ' A' ' 168' ' ' TYR . . . -92.35 136.57 33.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.307 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.445 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 33.3 m -131.28 128.35 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 111.132 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CE2' HG23 ' A' ' 166' ' ' VAL . 21.9 m-85 -98.95 104.25 24.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.84 128.31 18.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.412 2.074 . . . . 0.0 112.202 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -90.29 156.88 17.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -66.02 -15.9 63.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.314 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.04 5.18 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.552 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.59 -16.0 60.16 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.752 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 162.87 13.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 27.1 mt -87.8 -4.91 58.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.509 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 62.33 162.34 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -80.75 84.15 6.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -175.68 106.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 tt -138.22 127.96 25.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.64 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.8 t -76.22 141.15 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.95 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.409 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 50.6 t80 -120.98 150.26 41.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.518 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.74 114.5 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 104' ' ' ILE . 27.8 mt -92.75 134.51 27.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.286 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.82 154.06 28.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.622 2.215 . . . . 0.0 112.405 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -60.49 -26.75 67.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.07 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -56.96 -32.81 66.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.409 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 76' ' ' MET . 57.9 m-85 -106.03 -9.71 16.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.799 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.95 -33.8 52.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.17 77.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 76.28 3.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.658 0.266 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.72 148.23 88.84 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.635 2.223 . . . . 0.0 112.303 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -72.57 159.24 49.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.59 133.26 94.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 27.6 Cg_endo -62.9 -22.24 73.7 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.129 . . . . 0.0 112.417 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 m 52.97 28.46 6.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.75 122.83 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.06 -24.01 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.177 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.07 -35.81 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.96 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.05 123.67 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 157.03 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.2 mm -112.2 118.58 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.934 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.94 129.48 45.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -95.38 -152.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.608 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 67.92 71.85 0.32 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.727 0.299 . . . . 0.0 111.458 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 38.3 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.93 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -97.7 -145.31 18.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.427 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -144.15 145.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.324 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.3 m -103.91 118.93 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.499 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.72 170.38 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.379 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.4 ' CE2' HD21 ' A' ' 155' ' ' LEU . 5.0 m-85 -107.32 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.329 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.452 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 98.1 p -130.23 136.28 49.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -131.09 139.15 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.344 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -116.88 140.59 49.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.32 173.55 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.23 -30.01 8.07 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.555 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.02 118.0 12.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.59 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.481 ' CE2' ' HB3' ' A' ' 177' ' ' LYS . 23.7 m-85 -79.46 121.77 25.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -113.87 150.89 32.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.278 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -106.36 -59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.68 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -152.02 -67.73 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -33.78 73.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.76 -34.59 77.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.8 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.4 OUTLIER -62.56 -40.25 96.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.54 0.686 . . . . 0.0 109.742 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.89 -38.72 37.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.709 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.26 -33.8 72.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.795 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -70.12 -46.1 65.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.88 73.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.972 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.4 m -62.99 -43.99 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -62.45 -46.07 90.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.1 -39.68 83.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.83 -48.11 82.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.308 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.5 m -62.23 -45.27 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.166 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.1 m -57.53 -44.56 85.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.4 HD21 ' CE2' ' A' ' 131' ' ' TYR . 12.4 mt -72.89 -17.01 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.143 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.79 -38.06 14.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 111.445 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.63 -14.18 82.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.407 ' CB ' ' CD ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -93.89 176.38 2.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.806 0.303 . . . . 0.0 111.064 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 158' ' ' THR . 13.4 Cg_exo -70.02 -1.04 8.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.25 143.0 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.708 0.29 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.431 ' O ' ' CG2' ' A' ' 161' ' ' THR . 16.1 m -130.39 2.06 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.766 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.409 ' O ' ' CB ' ' A' ' 190' ' ' ALA . 8.0 m-85 56.92 159.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.62 -80.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.24 38.6 1.23 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.276 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.13 71.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 110.713 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.406 HG23 ' CE2' ' A' ' 87' ' ' PHE . 14.0 p -161.76 124.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.454 ' CD2' ' CG1' ' A' ' 185' ' ' VAL . 30.5 p90 -126.0 175.0 8.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CD1' ' HA ' ' A' ' 85' ' ' ALA . 68.3 m-85 -119.6 162.03 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 94.6 m -130.82 130.86 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.016 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.02 156.02 46.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -114.55 78.29 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -119.9 -174.43 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.3 154.94 0.11 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.88 129.78 10.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.525 2.15 . . . . 0.0 112.41 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 123.17 7.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.531 2.154 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -97.16 31.04 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.722 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.481 ' HB3' ' CE2' ' A' ' 138' ' ' TYR . 9.1 mptt -144.67 178.49 1.43 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 177' ' ' LYS . 35.0 Cg_exo -56.53 -162.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.286 1.991 . . . . 0.0 112.345 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.459 ' CD1' ' HB2' ' A' ' 178' ' ' PRO . 52.0 m-85 55.18 -169.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -141.11 42.06 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.499 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.16 166.18 25.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.38 . . . . 0.0 111.12 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.37 156.05 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.432 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 44.7 m-80 -133.11 138.39 46.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 111.469 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -146.09 157.29 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.628 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.454 ' CG1' ' CD2' ' A' ' 167' ' ' TYR . 10.6 t -134.85 114.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.888 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 44.0 m0 -109.33 121.53 45.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.207 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.53 140.08 30.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.666 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.08 123.59 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.3 150.34 40.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 1.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.834 0.349 . . . . 1.0 111.161 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 pp -119.9 152.79 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.97 95.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -131.47 36.89 3.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.9 168.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.247 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -90.37 108.24 19.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -120.96 150.91 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -84.17 137.63 33.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.48 102.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -154.85 -67.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.06 -153.01 39.29 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -81.27 130.77 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 138.99 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.82 124.94 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.04 120.0 37.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.0 m0 61.43 154.4 0.11 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.26 168.02 22.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.511 2.141 . . . . 0.0 112.258 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.2 t90 60.32 92.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -138.77 116.07 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.29 112.88 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.802 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.98 -9.42 37.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.478 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.83 158.95 7.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.843 0.354 . . . . 0.0 110.937 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.1 p -152.64 164.22 38.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.8 -137.25 13.22 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . 133.04 -170.38 22.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.518 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -78.56 162.04 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 0.0 110.839 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -25.21 66.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.78 -32.64 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.04 122.51 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.068 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.44 147.63 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.417 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 8.4 p90 -139.17 155.74 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.59 128.8 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -86.75 127.29 34.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.11 134.45 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.06 127.43 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.48 128.55 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.61 -66.84 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.61 178.34 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.528 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.48 -111.14 1.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtmt -92.01 157.61 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 23.4 m-85 -137.4 157.38 46.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.94 135.3 43.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 38.7 p -137.31 151.49 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.509 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.66 125.96 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.703 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -95.88 130.27 42.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.26 116.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.018 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.81 176.86 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.03 31.01 1.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -152.36 138.2 11.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.8 -160.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.432 2.088 . . . . 0.0 112.205 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 98' ' ' LEU . 62.3 t -90.28 -48.07 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.13 -45.12 74.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -46.38 74.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.94 92.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.11 -35.46 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -62.67 -29.91 70.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.12 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 tp10 -89.84 -32.9 16.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.316 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.89 -43.85 62.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.475 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 9.4 mmt -57.69 -44.05 99.19 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 59' ' ' MET . 42.9 Cg_endo -69.06 -36.26 13.02 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.984 1.789 . . . . 0.0 112.207 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -70.16 -43.6 70.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.653 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 tt -77.91 -27.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.328 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -37.14 84.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.037 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -58.78 -37.1 75.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 19.1 t80 -67.12 -56.43 10.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 102' ' ' PHE . 31.9 m -65.87 -30.72 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.8 -100.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 64.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.509 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -147.76 65.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.1 165.5 28.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.717 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.02 46.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 4.57 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.677 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.52 32.01 5.3 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.747 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 p -96.66 140.57 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.879 -0.66 . . . . 0.0 111.67 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.4 49.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 14.3 ptm -52.17 -48.89 64.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.59 -161.85 35.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.547 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 tpt -92.23 147.74 22.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 m -151.37 120.8 6.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.0 t 64.27 136.43 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.56 130.69 34.54 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.27 1.98 . . . . 0.0 112.184 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -88.91 154.05 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.321 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 t -117.89 173.73 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -131.8 154.21 49.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.003 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -93.04 136.82 32.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.402 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 ' CZ ' ' A' ' 167' ' ' TYR . 23.9 m -132.89 132.98 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.173 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -106.27 98.16 18.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.416 ' HD3' ' CD1' ' A' ' 167' ' ' TYR . 73.3 Cg_endo -75.59 138.89 22.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -90.26 161.77 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.86 -19.12 62.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.2 -5.87 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.65 -3.44 78.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.882 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.48 139.52 51.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.14 144.09 33.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.98 48.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.82 96.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -179.64 107.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 84' ' ' PHE . 7.8 tt -142.82 128.13 18.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.489 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -115.54 115.65 26.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.248 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.3 t -74.24 141.35 16.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 0.0 111.594 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -121.64 126.05 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.276 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.418 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 52.9 t80 -110.13 155.18 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 111.612 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 107.88 15.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.585 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 139.68 92.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.35 153.99 73.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.489 2.126 . . . . 0.0 112.319 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -56.63 -26.8 56.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.284 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -56.98 -32.81 66.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.443 ' CD1' ' HB3' ' A' ' 107' ' ' GLN . 11.3 m-85 -116.8 20.22 14.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.426 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -55.09 -33.85 63.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.46 -25.82 67.13 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.01 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -177.73 107.95 0.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.736 0.268 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 108' ' ' PHE . 52.6 Cg_endo -69.08 161.12 47.16 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.41 2.074 . . . . 0.0 112.187 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.7 150.49 62.58 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.584 2.189 . . . . 0.0 112.003 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.98 114.13 16.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 58.8 Cg_endo -73.04 165.95 31.36 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.352 2.034 . . . . 0.0 112.335 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.2 m -127.68 33.19 4.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.71 114.44 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.91 -26.53 62.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.12 -26.93 33.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.89 115.5 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.13 156.93 19.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.817 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.16 127.4 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -98.76 160.16 14.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -147.45 129.15 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 63.55 123.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -169.08 -80.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.8 110.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.369 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.49 142.91 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 111.253 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 m -107.86 119.03 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.55 161.11 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.382 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.93 138.23 44.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 p -108.75 142.39 39.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.1 t -129.68 139.0 51.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -116.86 130.44 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.95 144.59 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.09 95.66 1.99 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.52 159.0 28.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -72.17 174.87 6.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.34 144.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.33 -60.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -159.85 -66.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.58 70.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.491 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.93 -34.89 78.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.945 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -41.62 99.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 109.893 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.95 -38.8 38.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.559 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.03 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.897 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -67.76 -41.93 82.55 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.798 0.333 . . . . 0.0 111.044 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.001 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -67.79 -39.48 84.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.9 tp -57.95 -43.39 86.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.703 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -59.83 -40.0 87.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.368 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.97 -42.54 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.51 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 97.9 m -57.58 -49.46 76.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.85 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 162' ' ' TYR . 11.5 mt -75.12 -10.36 59.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.74 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -47.55 -29.0 2.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.787 0.327 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -98.51 26.68 22.87 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.587 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.9 p -146.05 160.51 42.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.77 -5.54 17.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.95 2.433 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.75 119.8 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.57 157.28 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.755 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.432 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -156.02 -176.02 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -115.5 156.77 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.56 -4.02 10.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.713 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -81.92 -22.78 36.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.609 0.242 . . . . 0.0 111.255 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.9 p -160.46 158.11 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 111.406 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.42 ' CZ ' HG22 ' A' ' 86' ' ' VAL . 14.9 p90 -166.25 163.13 17.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.538 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -112.94 158.82 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.968 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.4 m -142.25 158.93 43.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.61 139.28 49.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 172' ' ' TYR . . . 172.25 144.96 4.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 171' ' ' GLY . 80.5 m-85 -159.4 -177.93 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 62.57 145.76 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.54 162.84 37.27 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.55 2.167 . . . . 0.0 112.34 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.63 138.71 32.65 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.547 2.165 . . . . 0.0 112.315 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 -52.88 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -121.13 151.68 55.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 179' ' ' TYR . 31.0 Cg_endo -63.76 -13.96 40.05 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.601 2.201 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' A' ' 178' ' ' PRO . 13.1 p90 -147.62 31.54 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.986 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -84.64 -43.24 6.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.287 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -127.57 139.08 52.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.278 . . . . 0.0 110.663 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -111.3 154.89 23.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.065 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -108.92 157.98 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.517 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.47 145.53 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.287 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.99 133.49 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.564 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -107.76 121.54 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.8 mt -97.08 134.53 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.576 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.96 119.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -69.76 140.69 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 1.0 111.141 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.803 0.335 . . . . 1.0 111.161 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.31 -43.37 8.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.07 87.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.5 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -96.89 -39.18 9.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.769 0.318 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.94 117.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 126.96 39.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.35 141.46 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.5 p -74.89 150.04 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 31.55 5.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.59 78.28 1.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.6 -120.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.458 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -105.21 126.34 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -123.39 126.08 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.38 145.45 48.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.046 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.781 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.492 ' HB3' ' CD ' ' A' ' 17' ' ' PRO . 13.8 t-105 -169.17 -60.52 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.379 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.492 ' CD ' ' HB3' ' A' ' 16' ' ' TRP . 9.4 Cg_endo -52.53 102.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.312 2.008 . . . . 0.0 112.175 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.79 -177.25 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.026 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 108.53 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.957 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.24 115.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.53 -2.4 38.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -170.24 165.85 8.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.28 -175.93 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.69 152.79 17.34 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -155.34 178.1 32.16 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.64 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -78.85 158.48 28.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.49 -29.16 69.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -89.86 -31.01 17.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t -145.98 117.02 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 m -95.33 137.45 34.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.4 p90 -139.04 162.13 35.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -144.94 140.69 28.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.35 126.58 34.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.921 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.99 127.91 39.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.91 135.08 50.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -159.9 79.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' HG3' ' CE2' ' A' ' 41' ' ' PHE . 8.8 mp0 -142.25 137.33 30.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.14 -99.74 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.91 -59.99 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 24.5 mttm -109.33 145.88 35.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 37' ' ' GLU . 5.2 m-85 -137.58 147.34 44.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.87 139.07 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.55 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 16.6 p -137.35 155.33 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.983 0.421 . . . . 0.0 111.7 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.3 125.82 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -95.83 132.93 40.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.32 122.45 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.86 170.53 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.24 38.72 1.72 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -152.56 128.16 5.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.895 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.71 -167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.412 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 36.5 t -78.54 -60.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.195 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.72 -44.78 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.48 -46.31 83.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.832 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.94 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -58.7 -35.94 73.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -66.37 -32.98 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 tp10 -87.19 -41.74 13.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.14 -37.01 66.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 10.9 mmt -57.85 -44.03 99.08 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.5 Cg_endo -70.09 -32.52 17.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.919 1.746 . . . . 0.0 112.16 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -70.25 -45.16 67.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 tt -77.48 -36.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.8 mtt -66.21 -41.88 89.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.761 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -58.85 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.727 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -67.88 -46.62 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.46 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 32.3 m -69.85 -27.77 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.32 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.32 99.63 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.98 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.7 t -164.19 88.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.815 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -113.06 -12.49 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.14 40.9 8.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.966 0.413 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -147.76 -46.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.42 30.45 4.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.009 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.44 153.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.333 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.12 81.43 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mtt -63.1 -48.05 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.46 53.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.6 tpt 62.39 147.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -164.02 130.67 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.7 t 64.02 136.67 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.12 134.06 50.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.454 2.102 . . . . 0.0 112.121 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.22 136.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.241 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.01 160.29 19.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.357 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -127.03 154.27 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.106 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.17 136.7 32.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 HG22 ' CE1' ' A' ' 167' ' ' TYR . 33.7 m -132.23 123.7 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -98.31 102.98 15.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.5 140.76 19.37 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.485 2.124 . . . . 0.0 112.271 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.35 163.0 14.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -15.9 63.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.354 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -85.23 4.22 35.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.589 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.67 -16.04 59.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.849 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -95.84 162.93 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.91 171.72 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -103.82 157.8 16.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -80.51 61.06 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -161.96 109.24 1.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.97 146.16 49.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.236 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.26 115.72 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.339 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.1 t -81.19 141.36 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -121.67 132.16 54.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 19.3 t80 -121.57 134.86 55.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.016 0.436 . . . . 0.0 111.377 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.65 118.06 34.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mt -84.44 136.35 40.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.68 154.25 74.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 109' ' ' GLN . 34.2 m120 -51.6 -26.63 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -56.9 -32.9 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -116.04 -1.09 12.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 106' ' ' ASN . 1.2 pp0? -54.06 -34.26 59.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.815 0.341 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.58 -34.04 88.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.765 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.91 84.08 0.52 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.316 . . . . 0.0 110.972 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 32.5 Cg_exo -58.97 160.37 18.62 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.174 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.98 152.13 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.686 2.257 . . . . 0.0 112.004 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 121.11 79.54 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.318 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 119.9 6.2 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.473 2.115 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -64.55 -39.81 94.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.32 112.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.402 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -26.73 61.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -81.73 -28.81 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.28 115.91 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -120.83 156.95 30.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.6 mm -103.44 131.37 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.249 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.95 129.93 45.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -89.01 126.44 35.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.8 ttm180 58.05 -173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 10.2 tt0 84.86 78.08 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 169.41 52.81 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.195 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.98 142.99 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -119.22 134.0 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.051 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.7 164.61 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.675 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -107.77 133.48 52.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.265 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -105.76 140.23 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.273 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -130.99 139.13 49.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.74 130.31 56.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 31.5 p90 -139.29 -177.81 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.56 110.87 1.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.469 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -176.74 -133.28 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.4 103.31 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.753 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.06 150.11 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.98 -47.89 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.683 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -162.05 -69.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.511 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.62 72.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.522 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.95 -34.98 78.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.011 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -40.6 98.17 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.76 -38.71 36.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.54 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.45 -37.86 74.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.774 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 24.0 m-70 -70.23 -43.69 70.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.891 0.377 . . . . 0.0 110.804 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.28 -32.92 72.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.615 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -68.47 -43.36 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.681 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -61.88 -46.1 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.45 -36.95 81.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.42 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.17 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.5 m -69.08 -34.86 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.64 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.0 m -57.51 -47.03 83.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.857 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.51 -21.21 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.89 -44.91 20.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.335 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.92 35.26 4.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.695 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.2 p -146.32 156.47 49.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.747 0.308 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 -11.05 29.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.696 2.264 . . . . 0.0 112.701 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.23 139.68 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 0.0 111.158 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.2 m -100.51 140.87 34.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.731 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -159.6 156.9 28.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -90.43 136.65 32.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.29 56.98 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.17 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.85 -23.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.12 143.79 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.913 0.387 . . . . 0.0 111.271 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.432 ' CE1' HG22 ' A' ' 86' ' ' VAL . 30.2 p90 -142.88 174.07 10.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.8 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.79 152.57 30.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.15 146.1 49.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.93 133.38 44.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 167.32 77.07 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.465 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -61.12 -32.95 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 110.787 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.57 120.51 60.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.85 131.2 19.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.416 2.077 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.14 90.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.404 2.069 . . . . 0.0 112.234 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ttt -174.88 149.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.64 113.47 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.455 ' HB2' ' H ' ' A' ' 179' ' ' TYR . 85.2 Cg_endo -74.76 -145.22 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.651 2.234 . . . . 0.0 111.693 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.455 ' H ' ' HB2' ' A' ' 178' ' ' PRO . 3.6 m-85 66.39 39.34 4.01 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 123.37 106.25 1.78 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.907 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -139.03 138.86 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.62 0.248 . . . . 0.0 110.484 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -137.5 130.99 31.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.405 . . . . 0.0 111.278 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 7.2 m-80 -133.0 138.97 47.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.632 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -142.92 145.98 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 111.241 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.09 134.44 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -108.07 121.62 45.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.274 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.35 139.37 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.433 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.85 129.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 11.6 tttm -88.46 48.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.252 -0.88 . . . . 1.0 111.472 179.817 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.791 0.329 . . . . 1.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -69.78 -178.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.5 64.97 0.68 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.34 70.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 0.0 110.851 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.52 108.13 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.49 133.05 34.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -124.84 174.11 8.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -63.82 147.29 52.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.734 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.21 -56.18 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 13' ' ' VAL . 0.2 OUTLIER 176.65 -31.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.359 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.43 -113.77 3.71 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.595 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 m -107.06 123.29 48.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 10' ' ' PHE . 1.6 p -140.25 146.36 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.927 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -112.8 124.82 53.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.639 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -97.01 133.36 41.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.29 76.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.03 125.22 13.27 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.479 2.12 . . . . 0.0 112.304 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.8 t90 62.4 81.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.442 ' HG3' ' HB3' ' A' ' 35' ' ' ALA . 8.0 pt20 -128.58 111.48 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.177 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 t -74.47 112.82 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.586 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.26 -4.03 46.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.27 158.85 6.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.809 0.338 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 p -153.29 174.15 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.65 168.96 8.01 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.47 -162.23 28.24 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -78.39 157.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -66.56 -26.27 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.96 -34.97 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.08 110.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.6 m -95.16 148.3 22.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.4 p90 -138.5 153.11 48.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -146.37 130.45 17.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.18 114.88 23.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 147.52 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 19' ' ' GLN . . . -124.98 130.74 52.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -144.01 144.91 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.32 89.19 3.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -148.63 3.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.89 -111.85 0.69 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.99 152.72 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.343 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -137.7 153.73 49.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.11 124.0 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.8 p -112.7 131.94 55.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.418 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.06 125.41 57.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.768 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.1 135.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 t -138.31 116.82 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 173.81 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.23 28.05 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.358 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -152.73 121.58 3.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.71 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.477 2.118 . . . . 0.0 112.177 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.03 -52.83 55.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -63.44 -45.25 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.1 -46.03 75.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -45.14 90.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.34 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -58.34 -35.41 71.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 mtm105 -63.12 -31.55 72.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 109.942 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.7 tp10 -86.97 -33.47 19.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.147 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.67 63.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.76 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.47 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 6.3 mmt -57.61 -44.02 99.23 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 23.3 Cg_exo -64.58 -42.93 14.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.257 1.972 . . . . 0.0 111.913 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.2 -41.28 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 tt -76.26 -42.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.372 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.449 ' HA ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -65.04 -31.76 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 63' ' ' MET . 16.4 mtpt -69.75 -29.81 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.434 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -71.37 -42.81 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 63' ' ' MET . 33.8 m -65.96 -28.17 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.11 93.34 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.67 -40.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.37 84.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -125.02 0.43 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.401 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 61.75 39.05 14.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 -47.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.38 52.03 3.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.06 -178.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.133 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.99 78.47 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.6 mtp -82.0 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.364 . . . . 0.0 110.735 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 78' ' ' MET . . . 75.72 46.13 15.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.759 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 17.8 mmt 67.47 -62.08 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.563 0.221 . . . . 0.0 111.498 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m 78.75 -60.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.94 158.11 76.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.052 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 130.77 36.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.395 2.063 . . . . 0.0 112.118 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 102' ' ' PHE . 6.1 m -87.24 154.06 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.321 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 t -130.72 160.23 34.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -121.3 154.3 36.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.213 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.43 136.65 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' CE2' ' A' ' 167' ' ' TYR . 15.7 m -124.81 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.414 ' CE2' HG21 ' A' ' 166' ' ' VAL . 4.8 m-85 -113.24 93.82 27.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.39 138.79 62.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.598 2.199 . . . . 0.0 112.077 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.97 171.95 9.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.94 -22.11 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.41 -6.07 59.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.442 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.46 -16.05 61.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.767 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.45 133.5 33.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.41 -30.0 70.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.57 -175.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -80.67 90.23 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.34 100.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 tt -144.13 135.53 25.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 111.365 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HD2' ' CD1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -119.53 115.79 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.032 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.54 141.15 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.429 ' CD1' ' HD2' ' A' ' 99' ' ' LYS . 18.5 m95 -122.39 138.61 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' CD2' ' CG1' ' A' ' 82' ' ' VAL . 38.5 t80 -119.47 146.18 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 111.485 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -102.04 111.1 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.718 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.0 mt -92.25 136.34 25.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.36 154.16 75.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.57 2.18 . . . . 0.0 112.437 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -55.46 -26.71 43.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.323 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -56.84 -32.89 66.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.22 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -100.54 -4.7 28.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.54 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -45.42 72.69 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.761 0.315 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.13 -26.58 43.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.633 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.74 91.55 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.19 161.1 41.77 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.383 2.055 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 141.75 42.26 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.311 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.0 121.43 79.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.37 141.55 71.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.442 2.095 . . . . 0.0 112.275 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 84.4 p -90.58 -33.4 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 125.18 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.78 -22.15 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.223 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -31.36 30.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.44 123.93 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -127.86 156.92 41.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -102.67 111.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -100.38 130.04 46.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 113.1 24.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.97 126.09 50.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.96 60.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.314 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.77 161.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.96 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -144.25 148.95 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.935 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -103.85 118.67 37.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.581 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.3 m -143.34 160.65 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.295 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.5 OUTLIER -107.89 143.66 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.101 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.9 p -105.96 148.45 27.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.5 t -130.46 139.82 50.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.418 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.26 125.24 51.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.156 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 15.2 p90 -143.04 -169.6 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.421 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -46.58 138.48 7.96 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.83 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.17 170.32 55.08 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.722 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 61.05 100.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -127.2 152.93 46.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -105.62 -82.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -154.83 -61.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.93 -33.83 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.61 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.99 -34.96 77.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.987 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -42.4 96.32 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.917 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.2 t -53.9 -38.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.671 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.12 70.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.716 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 18.3 m170 -70.06 -46.1 65.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.41 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . . . -61.82 -32.92 73.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -73.01 -42.16 63.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -46.06 89.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.24 -37.07 81.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.5 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -43.2 93.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -68.94 -34.18 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.95 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.3 m -57.49 -49.28 76.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -73.94 -13.92 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.352 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -46.62 -37.61 8.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.4 36.98 3.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 17.6 p -146.19 155.07 50.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.49 -7.75 21.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.839 2.359 . . . . 0.0 112.622 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 127.11 30.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.905 0.383 . . . . 0.0 111.28 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.9 m -102.52 141.83 34.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -155.03 -177.94 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.988 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.82 -58.44 2.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.27 -16.48 57.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.941 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.82 -87.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.723 0.262 . . . . 0.0 111.015 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.414 HG21 ' CE2' ' A' ' 87' ' ' PHE . 7.9 p -81.06 138.4 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.841 0.353 . . . . 0.0 111.63 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.436 ' CE2' HG23 ' A' ' 86' ' ' VAL . 48.7 p90 -144.96 174.7 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.359 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.38 161.99 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.669 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 m -139.36 151.65 46.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 128.45 38.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.168 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.76 -130.27 2.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.804 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 64.46 -101.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.909 0.083 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.55 171.77 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 111.315 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.7 129.65 11.01 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.433 2.089 . . . . 0.0 112.124 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.68 136.12 34.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.492 2.128 . . . . 0.0 112.431 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.96 116.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.66 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.44 163.6 37.41 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.4 2.067 . . . . 0.0 112.254 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 60.01 34.53 21.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.28 32.31 1.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -128.27 144.09 51.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.96 127.19 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -120.69 148.94 43.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -142.81 155.62 44.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 9.3 t -129.6 115.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.462 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.49 124.4 50.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.968 0.413 . . . . 0.0 110.968 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 8.1 mt -91.19 140.34 29.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.75 126.76 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -177.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 1.0 111.094 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.804 0.335 . . . . 1.0 111.108 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.87 -31.55 45.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.79 -90.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.535 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.4 mtt -140.75 177.8 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.939 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 tt -68.1 -30.52 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.014 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -105.83 139.78 39.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -121.91 126.01 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 p -80.03 130.09 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.91 41.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -63.62 166.23 7.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.49 -91.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.68 124.81 45.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.9 t -139.05 145.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.5 139.54 53.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -97.97 131.93 43.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -78.49 151.92 77.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.2 -28.15 34.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.558 2.172 . . . . 0.0 112.232 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -162.63 110.79 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.09 118.3 12.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.49 113.63 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.03 -14.56 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.503 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -169.63 164.06 10.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 p -152.23 -178.35 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.764 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.98 -125.43 7.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 131.97 -95.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.626 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -161.52 163.98 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.3 69.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.77 -35.16 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.315 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.18 108.07 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.364 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.34 140.89 31.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -138.68 162.31 34.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.775 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -143.83 127.7 17.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -86.29 115.01 23.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -132.93 129.39 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.93 139.18 42.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 m -138.28 -178.23 5.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER 63.74 134.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.0 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.24 -41.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.64 -118.51 3.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.65 142.74 51.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.882 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 37' ' ' GLU . 49.9 m-85 -137.69 161.85 35.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.95 140.3 35.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.766 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.8 p -133.76 137.87 45.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 111.146 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 62' ' ' ILE . 11.3 t -125.94 125.89 68.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -95.98 127.7 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.17 116.92 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 176.51 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.819 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.25 30.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.319 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -152.63 121.91 3.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.82 -179.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.464 2.109 . . . . 0.0 112.246 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 44.3 t -61.87 -55.26 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.315 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.74 -43.82 92.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -46.06 75.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.186 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.15 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.271 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.6 mt -58.77 -35.59 73.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -63.81 -34.58 78.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.96 0.41 . . . . 0.0 109.964 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.6 tp10 -87.14 -28.81 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.63 -42.7 61.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.558 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.485 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 7.5 mmt -57.76 -43.6 98.83 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.527 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.65 -43.5 38.32 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.105 1.87 . . . . 0.0 111.863 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -70.37 -42.18 72.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' CD1' HG21 ' A' ' 44' ' ' VAL . 1.3 tt -76.22 -35.12 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.476 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mtp -66.31 -31.97 73.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -64.3 -47.6 78.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 21.3 t80 -60.26 -53.92 51.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.594 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.24 -28.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.012 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.78 -89.05 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.356 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.62 55.06 0.47 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.536 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.1 m -126.69 38.14 4.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -126.58 167.24 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.98 10.46 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.28 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -92.56 -30.4 15.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 43.29 38.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.27 -178.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.168 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.21 88.4 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.1 mtm -96.71 107.57 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.66 -24.67 12.92 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.749 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 65.89 147.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 111.05 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.48 168.78 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 17.6 t -85.84 -45.9 0.6 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.512 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 24.2 Cg_exo -63.63 144.69 90.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.309 2.006 . . . . 0.0 112.025 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.4 t -152.98 143.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 111.302 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.4 p -117.21 146.08 43.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -128.98 154.4 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.195 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.427 ' CB ' ' CE1' ' A' ' 168' ' ' TYR . . . -99.69 136.69 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.453 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 167' ' ' TYR . 22.6 m -125.24 135.3 64.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -103.0 95.79 7.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.297 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.55 148.89 38.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.082 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 171.99 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -6.16 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.415 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.22 -16.04 59.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.751 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.7 p -81.3 113.03 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.811 0.338 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.07 148.97 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -125.85 68.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mttt 56.07 -163.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.4 109.45 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 84' ' ' PHE . 2.7 tt -144.07 134.41 24.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -110.51 115.57 29.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 43' ' ' THR . 3.3 t -78.8 141.21 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 111.508 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -119.48 121.91 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -105.59 155.41 19.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.614 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -116.04 107.8 15.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.407 ' CG2' ' HD2' ' A' ' 105' ' ' PRO . 31.7 mt -79.46 136.59 56.04 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.267 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.407 ' HD2' ' CG2' ' A' ' 104' ' ' ILE . 27.7 Cg_endo -62.09 154.13 64.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.322 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -55.57 -27.47 49.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -62.68 -33.21 74.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -107.26 -14.48 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -53.15 -44.04 67.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.741 0.305 . . . . 0.0 111.061 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.16 66.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.455 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.78 91.18 0.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 160.98 47.69 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.542 2.161 . . . . 0.0 112.266 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.85 149.87 60.66 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.697 2.265 . . . . 0.0 111.973 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.21 111.71 7.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 32.2 Cg_exo -59.59 167.39 6.65 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.506 2.138 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.5 m -145.92 34.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.6 123.61 17.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.0 -26.01 61.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.0 -30.52 31.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.39 114.01 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 150.98 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 122' ' ' ILE . 28.0 mm -114.4 132.72 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.78 160.12 14.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -149.4 140.82 23.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.082 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.57 18.27 9.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.27 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.11 160.21 32.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.92 119.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.458 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.23 143.9 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 28.1 m -103.87 123.54 47.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.512 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.13 170.16 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.008 0.433 . . . . 0.0 111.729 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -134.46 125.94 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.945 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.4 p -105.76 143.88 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.104 0.478 . . . . 0.0 111.785 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -122.69 139.28 54.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.086 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -116.63 143.64 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 13.2 p90 -143.14 -46.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.603 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.99 -131.32 1.62 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -148.37 33.12 1.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 178' ' ' PRO . 4.7 m-85 -107.04 62.15 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' A' ' 143' ' ' ASP . . . -136.5 135.57 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 71.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.867 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 64.36 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.24 63.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.02 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 2.1 t70 -69.06 -34.88 75.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.174 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.455 ' CD1' ' CG2' ' A' ' 185' ' ' VAL . 0.9 OUTLIER -62.75 -38.95 92.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.466 0.65 . . . . 0.0 109.652 179.203 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 51.2 t -53.91 -38.99 38.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.597 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.45 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.801 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 37.1 m-70 -68.74 -40.91 79.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.21 -32.75 72.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.78 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -62.95 -44.14 96.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.01 -46.04 90.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.706 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.1 tp -59.23 -42.23 90.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -59.29 -48.07 83.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.401 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.4 m -63.76 -47.01 82.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.173 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.7 m -57.82 -40.96 81.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.755 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.443 ' CD1' ' CE1' ' A' ' 131' ' ' TYR . 11.5 mt -72.73 -14.57 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.491 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.77 126.9 11.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.67 34.72 11.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.206 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 16.1 p -145.55 159.89 46.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.561 0.22 . . . . 0.0 110.66 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 5.7 Cg_endo -47.88 -22.95 3.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.868 2.379 . . . . 0.0 112.541 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.58 106.13 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 53.4 m -101.94 -0.66 33.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 59.67 147.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.52 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.68 -173.5 4.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.54 62.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.776 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.64 75.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.762 0.315 . . . . 0.0 111.389 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 166' ' ' VAL . 9.7 p -161.72 81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.233 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 86' ' ' VAL . 45.5 p90 -99.54 166.22 11.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.846 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.454 ' HB2' ' CH2' ' A' ' 186' ' ' TRP . 16.5 m-85 -115.6 161.95 17.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 67.3 m -121.33 130.85 53.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.722 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 184' ' ' GLU . . . -132.07 156.33 46.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -121.08 121.41 4.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.72 79.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.783 0.325 . . . . 0.0 111.289 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.4 142.78 0.19 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.928 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -86.02 110.38 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.918 2.412 . . . . 0.0 112.778 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.33 -155.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.873 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.79 51.37 2.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.958 0.409 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.572 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 0.3 OUTLIER 48.91 50.63 9.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.804 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 177' ' ' LYS . 69.5 Cg_endo -88.57 -59.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.583 2.188 . . . . 0.0 112.171 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 178' ' ' PRO . 0.0 OUTLIER -151.93 -163.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.187 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -97.04 45.7 1.77 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.429 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -139.03 163.01 33.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 111.385 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 147.58 36.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 4.2 m-80 -133.16 134.97 44.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.965 0.412 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 4.6 mt-10 -146.01 157.12 43.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.11 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.455 ' CG2' ' CD1' ' A' ' 144' ' ' TYR . 11.3 t -136.68 138.03 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.808 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.51 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -140.78 121.79 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 11.8 mt -91.57 140.09 30.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 6.6 t -75.69 131.0 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.403 ' CG ' ' CE2' ' A' ' 131' ' ' TYR . 32.2 mtpt -74.34 150.16 40.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.36 -0.829 . . . . 1.0 111.112 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.869 0.366 . . . . 1.0 111.214 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.6 tp -162.4 -44.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.81 -172.64 44.13 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.49 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -117.19 -33.75 4.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.715 0.293 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt 67.13 118.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.094 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 140.03 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.09 132.99 55.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -71.57 156.82 38.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.998 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -69.21 70.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.05 -89.3 2.11 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.347 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -98.07 125.0 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.769 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.2 m -136.34 145.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -129.68 125.0 34.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 p -101.92 132.36 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.47 81.08 17.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.84 -61.68 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.514 2.143 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.14 175.6 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -123.39 108.22 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.02 112.94 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.4 -9.7 29.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -169.9 163.15 9.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.16 -173.28 4.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.7 -114.63 4.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 116.19 -112.03 2.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.57 162.69 30.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -30.21 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.195 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -90.66 -35.06 15.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.192 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.21 110.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.907 0.384 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.9 m -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -138.78 158.84 43.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -143.98 138.68 28.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.79 117.56 25.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -131.98 144.04 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.05 110.29 13.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.3 t -82.58 151.57 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.03 139.53 49.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.32 -106.96 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.2 -60.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -104.46 134.46 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.002 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -137.63 153.14 49.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.89 117.97 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.2 p -112.7 133.49 54.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.323 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.95 125.45 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -100.81 133.93 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.48 116.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.41 175.79 5.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.21 34.21 0.66 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.509 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -152.17 135.46 9.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.83 -158.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.528 2.152 . . . . 0.0 112.207 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.11 -53.53 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.066 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.24 -43.23 87.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -46.42 74.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.99 92.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD12 ' CZ ' ' A' ' 84' ' ' PHE . 4.3 mt -57.76 -35.24 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -62.65 -30.93 71.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.979 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.7 tp10 -88.18 -33.19 18.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -43.21 60.46 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.655 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 23.0 mmt -57.75 -43.63 98.86 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.5 Cg_exo -57.28 -45.6 33.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.106 1.87 . . . . 0.0 112.262 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -70.33 -42.59 71.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.518 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 tt -76.48 -32.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.446 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -41.06 91.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.715 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -40.88 91.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 64.8 t80 -59.63 -50.7 72.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 34.7 m -66.0 -27.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.66 104.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.01 -54.33 0.51 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -144.99 87.75 1.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -110.9 -29.17 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.0 m-20 84.63 -22.09 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.582 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -32.09 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.65 64.24 1.01 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.414 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.61 141.06 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.53 55.62 0.58 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.347 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -34.75 71.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.67 -159.38 42.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 mtt -97.55 112.98 24.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.359 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 m -111.01 122.87 48.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.0 t 63.85 141.6 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.75 130.82 36.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.272 1.981 . . . . 0.0 112.257 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.0 m -87.29 139.28 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.9 149.75 36.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -123.99 144.34 49.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 98' ' ' LEU . . . -82.72 140.44 33.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG22 ' CZ ' ' A' ' 167' ' ' TYR . 29.1 m -109.95 -28.09 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.44 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 96.8 m-85 55.91 91.77 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.529 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 71.9 Cg_endo -77.18 141.61 20.83 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.637 2.224 . . . . 0.0 112.007 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.61 166.15 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.36 -15.89 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.278 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 3.48 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.92 -1.84 86.94 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.976 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 p -131.52 161.72 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 88' ' ' PRO . 1.2 mt -87.54 154.32 20.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.531 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -140.57 84.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 45.53 93.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.6 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.71 101.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.555 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -143.72 143.87 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.91 115.66 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.914 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.68 137.35 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.579 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -117.96 141.04 48.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.307 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 48.5 t80 -124.2 151.47 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.975 0.417 . . . . 0.0 111.388 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtp180 -115.96 107.84 15.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.654 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mt -82.08 136.4 47.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.32 154.14 65.61 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.555 2.17 . . . . 0.0 112.334 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -52.48 -26.8 13.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.15 66.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 110.976 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -115.95 -9.75 11.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.33 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.08 -48.08 71.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.765 0.317 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -26.54 56.33 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 t -174.5 88.08 0.33 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.36 160.45 49.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.552 2.168 . . . . 0.0 112.353 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -74.19 159.29 44.25 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 112.026 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.34 111.24 6.19 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.978 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 65' ' ' TYR . 60.8 Cg_endo -72.62 162.36 41.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.513 2.142 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.52 179.73 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.66 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.46 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -16.88 30.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.1 p -80.2 -28.57 38.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.673 0.273 . . . . 0.0 111.213 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.62 114.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 111.157 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 156.97 32.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.19 125.25 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.9 129.94 45.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -89.14 125.27 34.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.9 OUTLIER 58.9 -177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.8 tt0 83.09 76.99 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.5 -175.12 50.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -143.99 143.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.249 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.9 m -115.31 118.98 34.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.11 163.99 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.434 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.436 ' CZ ' ' CD1' ' A' ' 155' ' ' LEU . 0.6 OUTLIER -107.78 137.85 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.212 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.43 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -105.87 146.47 29.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 0.0 111.56 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -131.19 139.23 49.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.438 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -116.6 132.09 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 4.3 p90 -139.72 156.28 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.36 33.57 5.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -107.02 -36.48 2.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 178' ' ' PRO . 16.4 m-85 63.83 133.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.19 -175.86 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -133.59 -66.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -141.72 -72.92 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.82 75.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -34.56 77.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -40.33 96.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.568 0.699 . . . . 0.0 109.807 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -53.84 -38.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.668 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.29 -35.78 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.719 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.509 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.17 -42.45 72.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.0 m -63.4 -42.28 98.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.801 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.16 94.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.871 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.55 -40.45 91.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.69 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -42.38 94.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.8 m -68.64 -35.72 77.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 41.5 m -57.61 -49.09 77.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.436 ' CD1' ' CZ ' ' A' ' 131' ' ' TYR . 5.6 mt -73.62 -11.12 60.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.259 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -47.03 -43.16 19.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.59 36.56 3.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 30.8 p -145.64 154.29 52.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.78 -10.79 30.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.621 2.214 . . . . 0.0 112.633 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 126.86 29.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.4 m -101.95 160.08 14.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -155.27 151.46 28.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.035 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -55.5 -56.53 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.295 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.91 50.96 11.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.103 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 -22.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.8 p -158.81 141.95 5.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.436 ' CZ ' HG22 ' A' ' 86' ' ' VAL . 12.2 p90 -140.79 166.59 24.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -118.37 159.38 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.405 ' O ' ' CE1' ' A' ' 84' ' ' PHE . 42.9 m -127.53 130.89 49.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.99 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -107.9 142.98 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.96 86.94 0.19 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -176.0 68.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 3.4 m-20 -152.2 152.82 30.19 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.703 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.91 109.18 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.598 2.199 . . . . 0.0 112.352 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 82.7 Cg_endo -92.25 -172.68 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.907 2.405 . . . . 0.0 112.352 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -60.42 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.354 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 13.3 pttt 179.24 60.54 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 177' ' ' LYS . 43.0 Cg_endo -94.17 -68.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.012 2.475 . . . . 0.0 112.299 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 181' ' ' ARG . 26.4 p90 -149.98 -44.92 0.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.12 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.83 -48.91 0.03 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.016 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 179' ' ' TYR . 12.0 ptt180 -124.05 167.55 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.286 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.51 164.45 12.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -108.67 145.23 35.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.18 157.19 43.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.22 114.9 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.43 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 5.6 m0 -110.03 124.35 51.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 131' ' ' TYR . 63.5 mt -91.65 140.41 29.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.471 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.58 123.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.937 0.399 . . . . 0.0 111.168 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -72.07 149.81 44.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.173 -0.918 . . . . 1.0 111.089 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.851 0.357 . . . . 1.0 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.21 177.8 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -141.85 63.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.374 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.19 150.17 22.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mt -134.36 -48.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.51 140.01 32.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -121.03 128.94 53.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.951 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -82.02 141.57 33.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.24 167.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.81 -43.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.43 -129.93 11.24 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.233 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -106.99 124.22 49.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 110.382 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.59 133.98 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -140.5 126.28 19.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 m -92.45 127.15 37.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 62.89 146.98 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.01 -3.42 13.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -130.55 176.81 7.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.87 110.77 12.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.28 112.98 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.92 -19.12 29.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.78 167.08 9.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.784 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -168.69 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.57 -118.69 5.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.28 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.429 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 99.72 158.81 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.74 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -78.8 163.69 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.6 -29.83 69.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.031 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -35.35 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.102 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.24 107.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.277 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.1 m -100.58 157.95 16.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.9 p90 -139.49 160.97 38.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.9 125.74 12.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -86.1 135.1 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 136.34 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.96 126.5 47.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.86 163.46 27.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.56 -77.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.99 -174.14 54.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.522 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.89 -89.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mptt -96.84 137.68 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.808 0.337 . . . . 0.0 110.857 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 24.0 m-85 -137.49 157.66 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.065 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.99 140.21 29.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.54 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 p -133.44 131.83 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 111.252 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.62 125.49 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.906 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.97 139.48 34.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -138.24 118.04 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 166.93 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.55 33.85 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.93 123.6 3.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.771 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.85 -69.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.332 2.021 . . . . 0.0 112.353 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -156.5 -63.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.05 -45.14 79.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -67.09 -46.15 75.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.012 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.25 89.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.281 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 2.2 mt -56.88 -35.31 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.08 -31.56 72.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -88.12 -34.01 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.64 -42.46 61.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.762 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.473 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 22.9 mmt -57.67 -43.81 99.05 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 39.3 Cg_exo -60.52 -43.45 33.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.433 2.089 . . . . 0.0 112.313 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -70.22 -43.63 70.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -76.27 -41.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.612 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.438 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -64.87 -31.88 73.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.01 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' N ' ' HG3' ' A' ' 63' ' ' MET . 20.3 mmtt -66.34 -32.27 73.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.975 0.417 . . . . 0.0 110.324 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 76' ' ' MET . 90.4 t80 -67.9 -32.6 73.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.597 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 102' ' ' PHE . 18.1 m -90.08 -10.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.66 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.2 44.47 2.81 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.836 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.11 44.98 51.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.999 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -126.91 61.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -111.93 -22.3 11.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.191 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.25 4.57 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.1 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -94.02 -29.59 15.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.18 37.73 4.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.187 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.48 -178.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.078 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.29 76.1 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.413 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.416 ' HE2' ' CE2' ' A' ' 65' ' ' TYR . 63.1 mtp -96.13 106.17 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 29.59 11.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt 61.25 156.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.8 m -164.65 124.99 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.407 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 38.4 t 64.07 137.3 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 19.2 Cg_endo -60.06 147.73 91.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.583 2.189 . . . . 0.0 112.098 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.93 153.76 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.519 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.444 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 1.8 t -135.69 168.16 19.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.418 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -132.07 154.1 49.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.06 136.68 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.45 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.14 141.9 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.003 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.416 ' CD2' HG21 ' A' ' 166' ' ' VAL . 5.4 m-85 -115.21 89.81 22.05 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.089 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.99 149.66 85.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.68 2.253 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.7 161.87 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.27 -19.71 55.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -5.97 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.364 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.05 66.78 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 m -94.57 155.17 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -105.72 131.46 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -82.06 170.93 14.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 65.99 5.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -144.35 96.03 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.564 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' CD2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -122.94 136.96 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.242 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 115.87 19.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.301 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.7 t -87.37 116.82 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.174 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -98.16 142.02 30.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.822 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 12.9 t80 -123.88 145.6 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 6.5 ptp180 -108.75 110.51 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CG2' ' HD2' ' A' ' 105' ' ' PRO . 21.9 mt -89.59 137.78 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' CG2' ' A' ' 104' ' ' ILE . 7.8 Cg_endo -49.91 154.04 5.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 m-80 -58.79 -27.04 64.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.301 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -61.19 -33.01 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -102.01 -8.98 21.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.751 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.73 -34.2 58.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.798 0.332 . . . . 0.0 111.093 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.57 -33.36 81.57 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.1 p -177.5 98.1 0.23 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.583 0.23 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.36 152.97 75.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.41 159.0 52.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.602 2.201 . . . . 0.0 112.44 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.43 118.38 56.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 47.6 Cg_endo -68.37 146.71 69.75 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.422 2.081 . . . . 0.0 112.365 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -77.34 -40.05 45.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.81 114.89 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.021 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.59 -19.11 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 m -80.65 -17.06 52.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.321 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.7 t -84.74 113.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 157.02 18.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.931 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 mm -122.56 123.5 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.82 129.85 45.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.56 130.95 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 60.33 111.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.98 90.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.48 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.381 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.66 142.94 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.21 42.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.77 168.63 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.554 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 12.4 m-85 -107.73 160.24 15.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.0 p -124.4 130.32 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.252 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 t -131.08 138.31 49.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.705 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -122.13 142.65 50.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -152.11 167.76 27.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.47 96.94 1.82 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.7 15.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -95.89 -177.66 4.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -157.41 148.56 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.265 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -134.35 65.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 67.33 -72.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.027 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.13 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.37 -34.88 76.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -62.9 -39.12 93.54 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.427 0.632 . . . . 0.0 109.881 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.03 -38.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.457 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.24 69.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.715 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -70.1 -45.33 67.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.82 72.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.0 m -69.31 -38.24 78.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -44.81 91.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.4 tp -58.02 -38.35 76.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.394 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -61.28 -43.82 98.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -40.34 94.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.018 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 31' ' ' TYR . 1.7 m -57.82 -46.14 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.779 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 31' ' ' TYR . 7.7 mt -73.65 -10.34 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.796 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.3 106.03 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 141.18 -39.05 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.44 ' CB ' ' CD ' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -94.9 -179.15 0.9 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 158' ' ' THR . 83.9 Cg_endo -85.52 35.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.414 2.076 . . . . 0.0 112.803 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.47 109.24 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.241 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.83 165.71 11.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -154.7 16.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.713 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 53.52 -83.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.6 0.238 . . . . 0.0 111.397 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -127.84 34.36 3.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.78 25.54 12.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.681 0.277 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.416 HG21 ' CD2' ' A' ' 87' ' ' PHE . 14.5 p -79.71 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.103 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.461 ' CD2' ' CG1' ' A' ' 185' ' ' VAL . 50.2 p90 -140.4 -176.72 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -119.25 159.83 23.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.295 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 3.7 m -134.6 152.8 52.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.89 155.91 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 134.05 174.34 13.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -166.82 -67.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.688 0.28 . . . . 0.0 111.154 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -72.3 139.26 81.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.092 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.26 -177.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.15 126.98 23.2 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.551 2.167 . . . . 0.0 112.206 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.48 -44.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -129.4 105.83 17.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.18 37.48 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.755 2.303 . . . . 0.0 112.833 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -150.33 -47.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 110.813 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -70.33 -44.11 60.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.422 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.76 145.22 37.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.852 0.358 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 163.95 31.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.78 149.39 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.73 148.6 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.408 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.461 ' CG1' ' CD2' ' A' ' 167' ' ' TYR . 15.2 t -135.11 116.27 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.93 125.5 51.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.386 . . . . 0.0 111.103 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 167' ' ' TYR . 73.0 mt -91.68 137.23 32.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 23.5 t -74.89 131.18 35.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -101.43 103.54 14.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.186 -0.911 . . . . 1.0 111.146 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.775 0.321 . . . . 1.0 111.146 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.39 35.48 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.844 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.99 -78.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.532 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 mpp? 62.95 122.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.878 0.37 . . . . 0.0 110.837 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.74 -30.53 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.215 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.43 34.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -123.77 137.09 54.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -73.82 142.47 46.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.17 100.07 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -79.19 -161.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.24 -86.79 1.1 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.8 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -107.04 124.51 49.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.23 142.43 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 111.338 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -140.92 127.75 20.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 t -86.34 120.8 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 62.71 145.28 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 18' ' ' TRP . 50.0 Cg_exo -55.36 136.28 72.93 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.474 2.116 . . . . 0.0 112.239 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.472 ' CG ' ' O ' ' A' ' 17' ' ' PRO . 13.8 p90 46.02 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.545 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -139.16 110.34 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.64 125.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.19 -16.53 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.392 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -169.75 165.41 9.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.05 -176.55 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.72 -110.86 2.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.4 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 105.65 -133.01 11.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.563 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -161.56 165.41 28.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.737 0.303 . . . . 0.0 110.809 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.45 -29.44 69.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.79 -35.14 15.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.223 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.21 108.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.1 140.31 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -139.24 161.96 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.17 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -147.24 130.23 16.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.768 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.71 121.76 29.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 133.37 34.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.76 113.3 19.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -127.63 156.21 42.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.0 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.22 84.31 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.54 -151.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.8 -86.11 1.88 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -123.62 149.1 45.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.946 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -137.58 153.58 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -106.08 132.0 52.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.793 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.431 HG23 ' CD2' ' A' ' 101' ' ' TRP . 65.0 p -112.53 140.43 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.782 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 17.6 t -128.44 125.47 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -100.07 134.06 43.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.652 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 t -138.19 116.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.9 0.381 . . . . 0.0 111.208 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.99 167.03 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 t0 58.84 31.79 21.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -151.15 124.93 4.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.794 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.76 -67.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.282 1.988 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.1 t -156.2 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.805 0.335 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.85 -40.86 73.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.79 -46.44 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 110.335 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.74 -36.81 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.387 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -56.79 -35.7 69.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.945 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -28.33 69.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.621 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.451 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.7 tp10 -86.89 -43.57 12.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.517 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.34 -33.7 65.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 23.6 mmt -58.03 -43.85 98.82 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -66.44 -30.95 43.41 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.952 1.768 . . . . 0.0 112.12 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -38.81 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.427 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 36.2 mm -77.65 -38.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.783 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -46.09 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -30.41 71.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -65.35 -47.37 76.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -84.25 -30.22 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.53 -115.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.04 47.3 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.443 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -152.68 76.19 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 110.935 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -134.09 11.32 3.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.352 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.09 30.21 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -148.68 -47.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.56 33.62 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 m -100.66 149.7 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.13 76.3 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mtp -60.09 -42.92 95.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.387 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.09 -126.77 13.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmt -120.55 146.65 46.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -157.14 107.82 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 t 64.12 141.67 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.73 130.79 36.68 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.323 2.016 . . . . 0.0 112.133 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 m -87.36 136.71 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.6 p -126.15 163.44 23.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -133.0 153.41 51.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.718 0.294 . . . . 0.0 111.3 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 168' ' ' TYR . . . -89.55 136.86 32.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.145 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' CG2' ' CZ ' ' A' ' 167' ' ' TYR . 31.6 m -120.06 136.71 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.413 ' CD1' HG23 ' A' ' 166' ' ' VAL . 89.2 m-85 -106.44 96.82 14.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.23 135.72 15.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.217 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -90.26 172.07 9.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.63 -15.98 63.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.12 -6.24 59.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.386 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.08 -16.01 56.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.998 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -96.54 117.13 30.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.5 114.48 2.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -57.56 172.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -80.53 73.76 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 117.27 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.603 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.409 HD11 ' CD2' ' A' ' 84' ' ' PHE . 1.1 tt -144.05 140.15 29.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.453 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -123.92 115.91 22.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.782 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 3.2 p -98.72 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.431 ' CD2' HG23 ' A' ' 43' ' ' THR . 25.4 m95 -113.03 142.28 45.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.492 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -108.8 160.71 15.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 111.362 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 108.01 15.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.544 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.0 mt -80.54 136.68 52.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 154.04 69.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.699 2.266 . . . . 0.0 112.597 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -58.72 -26.68 64.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.302 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -32.83 65.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.65 9.3 29.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.788 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -55.43 -42.81 74.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.64 -34.04 68.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 100.77 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.541 0.21 . . . . 0.0 110.934 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.29 160.76 47.58 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.363 2.042 . . . . 0.0 112.257 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.68 153.38 54.12 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.692 2.261 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.66 119.01 62.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.05 146.69 36.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.329 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 t -88.04 -33.54 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.75 122.43 31.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -22.23 47.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -81.66 -25.85 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.1 t -85.21 125.48 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -121.79 157.05 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.5 mm -111.67 121.75 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.92 160.29 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.6 151.25 33.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.022 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.2 ttt180 62.33 166.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.3 tm-20 83.49 129.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.64 155.33 16.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.438 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.11 142.92 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -110.07 118.8 37.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.666 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.36 166.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.261 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.414 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.81 137.72 45.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.2 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 p -105.95 143.1 34.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -131.05 139.19 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.628 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.95 141.44 48.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.028 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 52.0 p90 -161.43 134.64 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.89 91.56 1.69 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.19 177.32 44.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.98 160.13 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -160.96 133.38 6.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.75 76.55 1.59 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 67.53 -71.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -33.92 62.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.194 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -68.48 -37.56 80.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -62.95 -41.02 99.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.322 0.582 . . . . 0.0 110.08 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.99 -38.64 37.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.245 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.28 70.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.806 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-70 -70.16 -44.57 68.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.83 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.806 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.3 m -70.58 -43.3 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -58.96 -46.17 88.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.4 -41.75 98.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -46.17 89.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 98.1 m -61.85 -43.63 98.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.999 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.9 m -57.82 -38.85 76.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.859 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' A' ' 131' ' ' TYR . 23.7 mt -73.52 -16.6 61.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.881 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' THR . 47.1 mt-10 -46.94 144.16 2.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.838 0.352 . . . . 0.0 111.269 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.7 -30.89 8.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.103 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 1.2 p -94.93 176.15 2.46 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.1 Cg_endo -85.77 12.22 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.562 2.174 . . . . 0.0 112.916 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.35 116.29 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.2 m -100.1 175.44 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -155.47 22.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.595 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 48.66 -87.74 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.504 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -120.96 29.14 5.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.245 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 69.3 21.18 7.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.641 0.258 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 87' ' ' PHE . 13.6 p -80.23 139.0 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 111.061 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.446 ' CD2' ' CG1' ' A' ' 185' ' ' VAL . 24.8 p90 -139.27 178.11 7.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.448 ' CE2' ' CB ' ' A' ' 85' ' ' ALA . 97.4 m-85 -119.6 151.4 38.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 m -126.87 130.91 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -113.27 129.19 56.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.73 -164.91 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.693 0.282 . . . . 0.0 110.7 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -50.92 163.0 0.52 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.26 170.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.282 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.41 92.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.576 2.184 . . . . 0.0 112.596 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -32.44 14.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -144.36 143.25 21.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.26 34.73 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.86 2.374 . . . . 0.0 112.839 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -149.74 -46.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.781 0.324 . . . . 0.0 110.928 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.16 60.59 4.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.04 140.75 51.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.774 0.321 . . . . 0.0 110.941 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.03 132.92 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -126.47 133.98 51.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -142.96 156.4 44.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.446 ' CG1' ' CD2' ' A' ' 167' ' ' TYR . 15.5 t -138.98 116.14 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -107.76 121.86 45.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 167' ' ' TYR . 43.0 mt -92.91 136.01 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 162' ' ' TYR . 21.9 t -74.74 131.53 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 36.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.242 -0.885 . . . . 1.0 111.369 179.846 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpp . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.851 0.358 . . . . 1.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.52 129.1 45.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.94 -137.78 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.0 mtm 62.82 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 0.0 111.055 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 tp -166.29 144.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -100.37 137.64 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.41 139.21 39.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.98 152.72 21.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -104.93 -9.53 17.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.324 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 61.8 32.01 18.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 -83.23 0.39 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 p -96.68 134.75 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.711 0.291 . . . . 0.0 110.841 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.98 118.19 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.141 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -140.65 151.02 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.762 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -88.59 119.75 29.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 176.48 73.18 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.12 60.91 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.898 2.399 . . . . 0.0 112.752 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' A' ' 18' ' ' TRP . 6.4 p90 -82.6 134.28 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.701 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.38 107.7 10.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.36 119.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.51 -3.93 21.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.498 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.14 166.88 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -152.34 -57.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.82 170.0 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.63 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.53 -85.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.5 162.99 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -66.53 -33.21 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -33.2 16.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.97 141.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.33 154.47 50.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.483 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -139.07 159.77 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.43 121.8 12.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.52 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 39.0 mt-10 -87.02 132.07 33.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -141.98 130.9 23.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.46 124.38 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 p -127.74 -178.33 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.45 167.65 14.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.15 167.29 38.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.61 -85.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.9 146.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 110.888 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 6.2 m-85 -137.59 148.04 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.11 123.49 37.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.697 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -112.64 136.59 52.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.776 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 22.9 t -125.96 125.54 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.64 131.32 44.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.154 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 t -138.46 116.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.009 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.22 167.1 13.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.98 23.45 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -152.55 133.22 7.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.3 -177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.518 2.145 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.71 -70.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -56.15 -40.61 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.92 -46.85 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 110.36 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.71 83.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.18 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -56.91 -35.43 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.074 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -63.57 -27.91 69.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.712 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 tp10 -87.62 -44.35 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.28 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.593 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 mmt -57.75 -43.79 98.97 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 59' ' ' MET . 30.8 Cg_endo -65.01 -29.49 57.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.763 1.642 . . . . 0.0 112.062 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.18 -37.42 75.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.373 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.8 mm -77.32 -44.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -43.97 97.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -65.07 -30.69 71.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.7 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.63 -56.87 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.61 -30.14 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.22 -90.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.405 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.13 71.71 0.24 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -153.52 47.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -110.97 -22.36 11.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.52 2.34 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.475 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -93.55 -35.78 12.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.819 0.343 . . . . 0.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.14 29.98 8.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.42 165.99 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.84 0.353 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.96 2.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.76 135.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.21 169.48 32.65 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.57 155.95 17.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.8 m -135.43 -45.07 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -156.58 164.07 22.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.1 Cg_endo -59.46 130.62 36.48 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.123 1.882 . . . . 0.0 111.668 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -87.58 126.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.889 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.0 m -119.82 153.14 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.986 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.558 ' HB3' ' CB ' ' A' ' 100' ' ' VAL . 0.2 OUTLIER -118.62 154.12 33.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 111.591 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.18 136.8 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.613 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 167' ' ' TYR . 28.8 m -129.47 132.51 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -99.41 100.32 10.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.99 140.95 29.17 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.515 2.143 . . . . 0.0 112.279 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.11 158.6 17.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.839 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -19.04 61.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.239 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -85.55 -6.07 59.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.44 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 -3.6 64.7 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.018 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -99.98 153.31 19.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -97.42 132.55 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 174.07 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.793 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -80.42 -13.99 58.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.275 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.8 123.85 29.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.762 0.315 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.05 127.95 17.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 115.9 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.776 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 4.5 p -96.5 139.91 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.445 ' CD2' ' CG2' ' A' ' 43' ' ' THR . 24.9 m95 -116.85 142.37 47.02 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 103' ' ' ARG . 62.2 t80 -112.51 161.11 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.807 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.433 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -112.59 107.92 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.864 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.1 mt -84.4 137.2 39.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.163 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.32 152.78 64.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.586 2.191 . . . . 0.0 112.388 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -62.07 -26.81 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -56.76 -42.58 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.279 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -95.87 5.5 51.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.462 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -45.93 75.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.739 0.304 . . . . 0.0 111.187 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.06 -26.03 40.7 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.688 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 p -177.09 90.14 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.64 0.257 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.19 146.72 70.9 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.12 . . . . 0.0 112.198 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -70.87 157.4 58.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.497 2.132 . . . . 0.0 111.998 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.95 126.51 92.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.23 6.11 5.81 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.642 2.228 . . . . 0.0 113.007 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m 58.12 -177.2 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.781 0.324 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.0 t0 62.01 117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -20.2 42.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.281 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.6 t -81.07 -31.72 34.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.49 118.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.938 0.399 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.05 157.21 41.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.0 mm -110.69 112.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -98.9 130.12 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -88.58 91.42 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.36 152.89 39.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.86 166.48 21.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.73 172.29 4.06 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -138.31 143.03 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -108.73 123.22 48.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.515 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.7 m -131.32 169.76 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.966 0.412 . . . . 0.0 111.408 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.427 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 7.5 m-85 -107.79 137.14 46.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.82 135.53 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.5 t -128.87 139.08 52.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.0 148.01 41.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 183' ' ' ASN . 22.4 p90 -172.26 -176.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -99.04 -145.2 18.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.37 163.88 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.539 ' CE1' ' O ' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -109.85 141.81 42.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -125.43 159.34 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.466 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -45.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -167.35 -66.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.485 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.69 73.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.493 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.89 79.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -40.76 98.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 109.909 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.6 t -53.85 -38.75 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.707 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -34.73 71.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.778 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -70.22 -46.09 65.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.02 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.84 74.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.7 m -70.43 -49.98 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.01 -38.65 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.803 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.48 -39.01 78.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -41.35 89.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -41.02 83.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.458 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.74 -43.71 85.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.533 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 31' ' ' TYR . 2.6 mt -73.02 -13.24 61.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -47.01 -47.15 22.21 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.71 -33.06 62.36 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.446 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 26.0 p -94.51 167.75 12.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 110.744 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.75 40.46 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.197 2.598 . . . . 0.0 112.695 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.29 170.66 1.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.403 ' C ' ' CG ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -138.56 163.95 30.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.403 ' CG ' ' C ' ' A' ' 161' ' ' THR . 1.2 m-85 -156.23 175.2 14.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -92.93 -55.34 3.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.03 -74.0 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.399 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -159.66 71.08 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.7 p -160.81 136.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.295 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' HG21 ' A' ' 86' ' ' VAL . 19.1 p90 -139.61 -177.83 5.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -120.66 156.39 31.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.3 131.0 46.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.66 130.21 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.31 -71.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.616 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' TYR . 5.2 t80 57.62 41.63 25.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 110.825 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.6 p30 169.35 161.12 0.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.305 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.407 ' HB2' ' HG3' ' A' ' 178' ' ' PRO . 82.0 Cg_exo -41.4 97.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.58 2.186 . . . . 0.0 112.502 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.539 ' O ' ' CE1' ' A' ' 138' ' ' TYR . 15.1 Cg_exo -68.41 -148.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.935 2.423 . . . . 0.0 112.877 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 62.37 -87.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.074 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt 173.15 75.73 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.685 0.279 . . . . 0.0 110.832 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.423 ' HG2' ' CD2' ' A' ' 179' ' ' TYR . 83.9 Cg_endo -80.42 -40.28 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.664 2.242 . . . . 0.0 111.751 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.423 ' CD2' ' HG2' ' A' ' 178' ' ' PRO . 54.0 p90 -149.54 -45.3 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 179' ' ' TYR . . . -165.52 44.99 0.28 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.431 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.66 165.26 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -142.1 159.46 42.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.875 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 175' ' ' PRO . 2.9 p30 -119.9 133.84 55.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.781 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -146.26 147.4 31.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.225 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.84 129.73 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.441 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -107.9 121.56 45.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 73.4 mt -97.33 139.96 32.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 38.4 t -74.94 128.92 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -100.63 125.91 47.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.098 179.889 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 mtm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.793 0.33 . . . . 1.0 111.238 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.81 -73.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.994 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.8 -148.47 27.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.607 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 168.72 19.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.856 0.36 . . . . 0.0 110.779 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 tt -167.73 47.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.94 122.59 48.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.819 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -128.56 169.16 14.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -68.82 130.65 43.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.5 -38.08 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.17 84.69 7.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.97 -116.53 1.06 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.467 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -75.79 125.05 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.89 141.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.41 143.56 49.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 t -115.46 131.06 57.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -106.58 162.94 18.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -167.99 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 112.351 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -52.71 99.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -129.55 112.91 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.039 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.09 112.86 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.37 -7.15 39.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.725 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.4 167.17 8.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.388 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 p -151.64 -178.59 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.761 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.19 -104.04 0.97 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.44 -94.8 0.55 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.683 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -160.43 163.03 33.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 0.0 110.791 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -66.44 -30.56 70.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.033 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.61 -35.23 15.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.27 115.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.384 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -95.98 145.2 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -140.92 162.26 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 127.27 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.562 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 17.2 mt-10 -85.86 126.3 33.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -142.03 128.04 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.62 122.16 47.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.7 p -132.14 149.96 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -71.66 -63.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.38 -77.85 1.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.45 -89.78 1.12 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -114.67 146.28 41.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -137.63 140.17 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.75 115.9 28.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.115 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.3 p -112.77 155.48 24.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 112.004 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.6 t -136.7 125.9 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -96.07 130.35 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.27 116.72 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.58 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.89 32.15 2.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -153.15 127.57 4.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.24 -169.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.476 2.117 . . . . 0.0 112.224 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.5 -53.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.211 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.89 -43.68 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.03 -46.17 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.28 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.234 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.0 mt -57.46 -35.57 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -62.92 -35.12 79.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.927 0.394 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 tp10 -87.49 -28.29 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.388 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.33 -45.17 56.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.476 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 34.1 mmt -57.61 -43.46 98.86 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.0 Cg_exo -57.96 -41.55 67.48 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.07 1.847 . . . . 0.0 112.067 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -70.29 -45.5 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.351 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' HG21 ' A' ' 44' ' ' VAL . 7.1 tt -75.59 -27.84 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.418 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -38.67 88.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.907 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 25.4 t80 -69.24 -56.38 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.41 -29.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.11 -124.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.622 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.17 48.01 0.98 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -142.94 62.54 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -108.99 -24.12 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 79.31 -3.47 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.668 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 -40.56 10.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.84 67.6 1.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.45 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.4 m -138.88 -179.45 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.81 117.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.388 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 1.3 mtm -112.73 -161.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.32 -37.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 63.18 120.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.046 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 167.86 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.53 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 13.5 t -87.25 -48.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.404 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 66.7 Cg_endo -91.42 130.38 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.512 2.141 . . . . 0.0 112.528 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.4 t -92.86 152.31 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.01 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.6 p -125.1 145.93 49.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.664 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.543 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -132.93 153.99 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.937 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 101' ' ' TRP . . . -95.04 136.67 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 167' ' ' TYR . 27.7 m -131.34 126.83 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 166' ' ' VAL . 43.3 m-85 -97.8 99.62 7.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 122.35 9.43 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.39 2.06 . . . . 0.0 112.105 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -89.74 170.81 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.35 -15.81 62.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -0.1 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.23 67.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.887 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.5 p -122.82 160.12 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.09 160.42 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 44.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 52.5 28.36 5.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.326 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -117.49 99.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 tt -127.56 127.73 44.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.978 0.418 . . . . 0.0 111.48 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' CG ' ' HB3' ' A' ' 85' ' ' ALA . 11.3 ptmt -117.58 116.62 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.469 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.1 t -66.79 141.47 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.42 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.8 m95 -120.37 119.17 32.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.332 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -106.02 153.78 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -112.77 121.83 45.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.5 mt -96.91 136.75 21.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.6 154.1 56.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.555 2.17 . . . . 0.0 112.357 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.57 -26.85 65.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -56.94 -45.22 82.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.041 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 64.3 m-85 -94.62 -9.79 33.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.395 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.46 -37.4 62.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.11 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -28.88 72.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -171.66 75.93 0.5 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.769 0.319 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.05 154.58 32.57 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.533 2.155 . . . . 0.0 112.355 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.31 152.14 44.08 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.685 2.257 . . . . 0.0 112.094 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.35 93.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 61.1 Cg_endo -73.44 135.82 22.9 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.316 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -91.45 50.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.028 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.2 118.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.93 -21.75 45.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.193 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 p -81.71 -31.67 32.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t -85.78 122.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -124.84 152.57 43.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.7 mm -105.09 117.62 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.82 137.06 37.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 104.5 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -169.07 73.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.938 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 30.9 tt0 82.23 139.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.065 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -70.34 -179.96 27.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.241 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.05 142.9 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 111.433 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.6 m -112.75 126.74 55.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.331 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.8 m -133.96 157.49 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 111.54 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 12.0 m-85 -107.72 141.8 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.7 p -111.91 126.99 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.882 0.372 . . . . 0.0 111.136 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.7 t -123.69 138.82 54.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -116.83 143.68 45.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 12.8 p90 -142.15 -44.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.26 109.47 0.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.1 -137.04 2.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.474 ' CE1' ' HG2' ' A' ' 175' ' ' PRO . 41.6 m-85 -145.56 92.35 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.89 136.02 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -105.04 -48.44 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -166.24 -68.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.82 67.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -67.98 -34.98 77.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.1 -40.48 96.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 109.998 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.72 -38.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.541 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.1 73.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.761 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.493 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 44.0 m-70 -70.02 -41.42 74.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.761 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.85 73.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.4 m -63.02 -42.62 99.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.708 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -59.07 -45.94 89.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.62 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.51 -39.68 91.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.25 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -59.12 -36.32 75.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.271 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -46.2 68.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -49.11 77.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.789 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 131' ' ' TYR . 11.5 mt -74.02 -9.12 58.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.431 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -47.55 -43.24 24.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.261 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.4 -15.08 77.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.762 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 12.3 p -93.65 169.23 10.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.003 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.78 0.58 7.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.046 2.498 . . . . 0.0 112.913 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.12 121.91 11.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.204 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.1 m -101.38 -2.21 31.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.115 0.483 . . . . 0.0 111.077 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 50.92 16.26 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.054 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 65.11 -75.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.162 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.58 -78.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.74 68.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 87' ' ' PHE . 11.0 p -161.91 122.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.469 ' CZ ' ' CG2' ' A' ' 86' ' ' VAL . 37.0 p90 -132.91 170.21 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.449 ' CE2' ' CG2' ' A' ' 188' ' ' VAL . 18.5 m-85 -112.74 157.16 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.7 m -133.56 130.95 39.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.27 52.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.84 -153.69 15.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -141.52 -174.83 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.83 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.26 153.64 9.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.19 108.14 2.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.776 2.317 . . . . 0.0 112.412 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.474 ' HG2' ' CE1' ' A' ' 138' ' ' TYR . 23.0 Cg_endo -62.97 -165.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.318 2.012 . . . . 0.0 112.586 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.5 mmm -129.65 -45.18 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 108.71 36.06 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -165.77 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.44 2.093 . . . . 0.0 112.167 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 61.68 28.7 17.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.33 33.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -133.05 166.86 21.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.29 . . . . 0.0 110.724 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -142.15 126.29 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.943 0.401 . . . . 0.0 111.408 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -132.94 133.9 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.33 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.88 157.11 43.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.732 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 39.0 t -124.55 139.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.48 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 24.9 m0 -107.62 121.49 44.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.086 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 5.2 mt -98.75 133.41 43.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.743 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.449 ' CG2' ' CE2' ' A' ' 168' ' ' TYR . 25.7 t -75.8 118.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.05 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -79.95 147.25 31.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.277 -0.868 . . . . 1.0 111.098 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.776 0.322 . . . . 1.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.37 116.79 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -134.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mmt -130.02 122.39 28.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.26 -58.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.39 123.18 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -105.01 133.61 49.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.04 128.9 35.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -168.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -85.5 -82.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.5 -137.44 30.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.722 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -91.24 127.38 36.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.74 144.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -140.97 135.89 31.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 t -83.91 133.59 34.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -150.64 146.73 19.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.41 ' HB2' ' CE3' ' A' ' 18' ' ' TRP . 58.1 Cg_endo -71.57 -45.36 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.434 2.09 . . . . 0.0 112.299 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.41 ' CE3' ' HB2' ' A' ' 17' ' ' PRO . 6.3 p90 -165.0 166.43 19.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -125.47 109.69 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.03 115.15 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.14 -16.24 20.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.417 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 t -169.72 167.05 9.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 -175.82 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.72 -173.2 47.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.414 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 172.44 -93.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.608 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' VAL . 1.2 mtmm -161.28 166.39 27.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.849 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -66.62 -31.66 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.294 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -31.33 17.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.278 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.7 t -146.03 142.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -134.74 148.82 50.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.456 ' CD2' ' CD2' ' A' ' 155' ' ' LEU . 1.9 p90 -139.17 162.2 35.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.31 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -144.54 122.27 11.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.389 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -85.98 118.37 25.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.994 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.07 127.93 35.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.58 128.2 55.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.3 p -100.19 158.93 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -60.2 -52.08 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.96 -158.05 22.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.86 -173.29 20.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -98.49 149.8 22.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -137.65 153.93 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.96 140.03 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.592 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -112.46 143.55 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.08 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.75 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.1 t -132.17 125.32 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.65 140.09 36.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 54' ' ' ALA . 3.2 t -138.42 123.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.313 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 167.04 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 t0 51.2 33.91 10.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.413 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.6 128.5 5.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.711 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.46 -69.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.357 2.038 . . . . 0.0 112.585 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.4 t -156.12 -66.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.82 0.343 . . . . 0.0 111.287 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.91 -45.08 78.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.09 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.6 -42.7 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 46' ' ' VAL . . . -58.95 -44.01 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 ' CD1' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.97 -35.41 69.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -62.48 -33.44 74.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -87.73 -29.29 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.158 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.51 -43.47 59.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.726 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.483 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -57.6 -43.87 99.14 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.3 Cg_exo -60.22 -37.33 83.83 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.176 1.918 . . . . 0.0 111.784 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -70.38 -44.9 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -28.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.211 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.13 74.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.662 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -65.43 -39.82 92.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.658 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 14.4 t80 -64.82 -57.9 7.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -67.06 -29.61 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -137.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.84 35.26 4.89 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.5 m -125.09 32.72 5.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 5.5 p30 -88.25 -16.58 32.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.278 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 1.5 m-20 82.44 -9.25 1.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -93.04 -36.74 12.55 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.75 43.17 6.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.02 163.56 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.75 58.2 0.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -74.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.967 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.95 -118.08 4.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.61 118.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.344 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.419 HG21 ' CE2' ' A' ' 102' ' ' PHE . 13.7 t -67.93 145.51 54.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 16.8 t -67.57 -53.52 22.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.466 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 69.9 Cg_endo -73.54 146.94 40.01 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.209 1.939 . . . . 0.0 112.183 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -153.54 125.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 t -114.98 145.98 41.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.038 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.51 ' HB3' ' CB ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -128.59 149.31 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.764 0.316 . . . . 0.0 111.636 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' A' ' 168' ' ' TYR . . . -88.22 136.81 32.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.523 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.47 139.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.216 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.419 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 2.4 m-85 -108.99 103.92 53.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.029 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.36 137.65 37.13 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.397 2.065 . . . . 0.0 112.243 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -89.88 171.98 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.036 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.04 -15.88 62.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.394 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.49 -1.07 55.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.491 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.03 -6.77 82.68 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.867 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 m -119.74 171.5 8.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.937 0.398 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.27 96.88 6.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -95.0 102.23 14.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.77 86.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.597 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 175.5 81.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.412 HD12 ' CD1' ' A' ' 84' ' ' PHE . 6.9 tt -144.1 135.56 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 111.493 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.48 115.63 20.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.75 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 6.0 p -91.74 136.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.123 0.487 . . . . 0.0 111.888 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -110.58 142.27 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.81 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE2' HG21 ' A' ' 79' ' ' THR . 32.7 t80 -105.78 145.54 31.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 102' ' ' PHE . 7.1 ttt180 -95.66 113.62 25.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.75 136.65 27.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.38 153.99 56.26 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.532 2.155 . . . . 0.0 112.238 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.65 -26.88 62.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.268 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.85 -47.11 81.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.431 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -90.25 1.31 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -39.75 68.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.58 -34.06 68.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.609 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.6 p -178.35 93.53 0.22 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.83 161.07 10.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.567 2.178 . . . . 0.0 112.179 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.71 155.85 61.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.255 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 112.33 9.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 47.0 Cg_exo -56.0 158.34 14.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.355 2.036 . . . . 0.0 112.292 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -116.12 -37.77 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.01 125.81 29.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -24.5 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 -30.67 31.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.6 t -85.32 115.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 157.02 38.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 124.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 133.81 45.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -88.47 130.74 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -132.06 22.52 4.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ARG . 2.5 pt-20 30.28 42.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.79 159.87 3.24 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -142.19 146.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.219 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.1 m -103.94 120.29 40.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.9 163.26 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.321 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -107.76 128.44 54.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.534 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 m -105.82 135.69 46.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -129.56 139.1 51.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.756 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -116.91 153.83 31.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.37 -177.96 6.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.54 93.03 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.541 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 177.2 149.96 8.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 177.98 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.335 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.86 156.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -133.34 -72.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -152.4 -46.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.775 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -71.85 -33.83 68.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.58 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.5 -35.03 78.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.874 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.23 -40.82 98.53 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.999 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.3 t -53.83 -38.58 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.561 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.27 -34.78 73.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.554 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -70.18 -42.87 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.69 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.88 -32.92 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.759 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 m -72.22 -41.59 66.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.35 -43.34 92.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.712 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.04 -44.6 91.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.555 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -46.76 88.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.302 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -46.21 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 88.0 m -57.63 -45.86 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.629 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.456 ' CD2' ' CD2' ' A' ' 31' ' ' TYR . 48.0 mt -73.26 -9.92 59.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.329 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.58 -42.06 22.97 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.048 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.09 -27.11 71.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 6.9 p -93.98 163.55 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.595 0.236 . . . . 0.0 110.643 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 85.0 Cg_endo -82.92 20.08 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.72 2.28 . . . . 0.0 112.967 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.96 148.14 31.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.091 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -101.19 176.57 5.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.51 158.2 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.39 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.27 -36.05 14.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.48 49.29 74.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -158.42 -42.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 111.122 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 13.0 p -160.12 137.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.264 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -129.21 172.18 11.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.682 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 85' ' ' ALA . 51.9 m-85 -112.98 155.42 24.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.26 149.26 41.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -118.89 125.59 49.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -122.64 -4.1 9.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.896 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 62.8 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.771 0.32 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -123.3 136.76 27.43 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.74 164.52 7.58 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 112.386 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.73 118.91 5.87 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.672 2.248 . . . . 0.0 112.215 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -176.98 -46.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -106.83 92.57 7.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.06 168.62 21.42 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.486 2.124 . . . . 0.0 112.127 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 60.18 75.54 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.72 42.95 0.16 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.559 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.31 156.35 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.28 124.01 22.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -120.82 135.25 55.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -143.81 154.16 43.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.6 129.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -107.89 121.61 45.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.13 134.93 36.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 25.5 t -81.22 120.38 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -88.67 115.12 25.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.187 -0.911 . . . . 1.0 111.145 179.92 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.724 0.297 . . . . 1.0 111.078 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.62 156.69 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 110.45 0.23 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.545 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.48 131.89 43.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -138.86 27.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -115.02 107.96 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -126.44 141.56 51.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.1 t -85.64 156.5 20.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.86 105.07 16.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.74 116.31 30.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.39 -97.27 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -101.37 125.87 48.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.982 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.72 130.55 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -136.05 124.85 23.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.8 p -116.06 129.13 56.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.767 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.587 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 4.8 t-105 -69.7 -51.8 15.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 16' ' ' TRP . 66.6 Cg_endo -85.92 -171.46 0.87 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.655 2.236 . . . . 0.0 112.37 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -107.26 139.86 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -120.81 108.0 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.4 t -74.54 112.95 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.461 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 mt -93.99 -17.61 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.4 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -169.96 162.1 9.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -151.99 179.43 8.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 135.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.423 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' CA ' ' CE1' ' A' ' 31' ' ' TYR . . . -145.11 -149.62 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.443 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 158.97 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.947 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -29.38 69.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.9 -32.36 16.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.09 110.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.4 155.61 16.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.47 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 p90 -139.58 156.85 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -147.04 124.38 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.765 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -86.2 117.39 24.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -139.26 128.66 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 109.72 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 p -151.23 85.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.03 167.85 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.28 110.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.94 -154.54 25.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.459 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' CG ' ' HG3' ' A' ' 112' ' ' PRO . 14.5 mttt -104.72 150.86 24.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 41' ' ' PHE . 3.6 m-85 -137.71 163.46 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.013 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.52 140.37 29.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.0 p -131.07 132.09 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.833 -179.133 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.4 ' CG2' ' CD1' ' A' ' 62' ' ' ILE . 63.2 t -130.88 125.39 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.212 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.12 138.76 33.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 111.418 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -138.5 116.96 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.79 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.78 168.35 9.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.33 31.11 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -153.28 117.77 2.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.997 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.28 -173.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.467 2.111 . . . . 0.0 112.137 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 61.3 t -61.28 -57.6 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -59.29 -45.23 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.16 -46.44 74.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.62 -45.06 93.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 1.3 mt -58.85 -35.17 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -62.06 -30.7 71.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.042 0.449 . . . . 0.0 109.906 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.436 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.0 tp10 -86.79 -37.51 17.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.161 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' O ' HG12 ' A' ' 62' ' ' ILE . . . -73.68 -29.97 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.462 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.596 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 5.2 mmt -57.43 -43.63 99.12 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 59' ' ' MET . 33.3 Cg_endo -64.69 -47.35 5.46 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.635 1.557 . . . . 0.0 111.835 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -70.47 -32.81 70.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.704 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 58' ' ' ALA . 16.9 mm -77.1 -43.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.3 81.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.735 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -59.98 -29.83 68.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 37.0 t80 -58.54 -41.36 85.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.806 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.443 ' CG1' ' CE2' ' A' ' 102' ' ' PHE . 14.2 m -85.61 -30.65 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.75 -105.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.46 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.62 67.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -155.49 52.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 4.6 p30 -110.96 -15.3 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.179 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 2.5 t70 83.63 -13.86 0.73 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.607 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 4.9 53.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.29 32.93 5.41 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.448 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 113' ' ' PRO . 3.1 p -96.83 155.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.688 -0.756 . . . . 0.0 111.821 -177.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.79 108.51 1.77 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.185 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.42 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -104.72 -77.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.356 . . . . 0.0 111.072 -179.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 -144.81 16.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.33 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.45 128.59 37.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.6 m -139.0 119.86 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.418 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 38.4 t 64.72 137.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.938 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.418 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 17.8 Cg_endo -59.86 143.7 99.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.334 2.023 . . . . 0.0 112.16 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.71 137.53 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.414 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.69 157.27 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -117.99 154.15 32.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.19 136.61 33.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.094 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.433 HG22 ' CZ ' ' A' ' 167' ' ' TYR . 5.9 m -125.85 92.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.175 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 166' ' ' VAL . 17.1 m-85 -70.75 112.24 12.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.95 167.24 9.69 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.682 2.255 . . . . 0.0 112.419 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.36 172.19 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.78 -21.34 18.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.315 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.14 -6.14 59.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 -16.06 61.96 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.95 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -84.44 165.17 18.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.971 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.8 mt -90.85 167.17 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.56 81.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 50.77 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.346 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 68.57 104.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.67 127.97 21.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -109.48 116.05 31.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.7 t -77.58 141.09 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.231 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -122.08 128.38 51.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.793 179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.443 ' CE2' ' CG1' ' A' ' 66' ' ' VAL . 36.7 t80 -113.05 130.93 55.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 -83.9 115.18 22.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.3 mt -97.77 139.26 21.22 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.16 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 154.06 25.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.391 2.061 . . . . 0.0 112.361 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.26 -26.89 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -32.95 70.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.42 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 19.5 m-85 -93.16 -17.71 23.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.517 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -53.11 -33.65 53.21 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 111.042 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 109' ' ' GLN . . . -73.67 -30.11 62.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.95 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 m -150.53 77.42 8.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.572 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HG3' ' CG ' ' A' ' 40' ' ' LYS . 36.2 Cg_endo -65.37 149.23 88.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.602 2.202 . . . . 0.0 112.161 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.401 ' HB3' HG13 ' A' ' 74' ' ' VAL . 12.5 Cg_exo -70.86 158.94 54.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.634 2.223 . . . . 0.0 112.116 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.7 136.58 92.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 59.6 Cg_endo -72.52 -20.15 23.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.436 2.091 . . . . 0.0 112.41 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.73 -67.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.04 125.88 25.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.69 -22.53 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 p -81.86 -32.68 31.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -85.36 116.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.2 156.58 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.38 116.08 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -98.82 144.84 27.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -89.43 51.64 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -76.12 120.45 21.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 177.16 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.97 156.69 23.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 pt -143.93 154.02 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -107.86 126.66 52.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.33 159.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.419 ' CD2' HD22 ' A' ' 155' ' ' LEU . 11.0 m-85 -107.7 129.45 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 p -105.92 128.84 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 0.0 111.061 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.9 t -129.7 139.19 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -116.9 147.83 41.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 1.0 OUTLIER -137.59 -57.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.942 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.88 -109.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.655 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . 175.02 78.37 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -176.84 106.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.46 134.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.277 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -106.53 -38.69 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.741 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.18 -61.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.85 71.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.63 -34.91 76.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.939 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.7 OUTLIER -63.44 -39.04 93.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.579 0.704 . . . . 0.0 110.131 179.138 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.66 -38.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.001 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.87 75.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.462 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 13.7 m170 -70.35 -44.11 68.83 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.07 -32.9 72.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -68.57 -42.74 77.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.863 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -61.97 -46.05 90.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.2 -41.57 88.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.623 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -59.61 -47.73 84.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.268 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 95.3 m -62.48 -45.56 92.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 17.1 m -57.61 -38.92 75.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 131' ' ' TYR . 92.1 mt -74.02 -16.5 61.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 153' ' ' THR . 8.2 pt-20 -48.69 -28.41 3.54 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.792 0.33 . . . . 0.0 111.331 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.89 -17.94 62.34 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.583 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -92.51 170.97 8.18 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.607 0.241 . . . . 0.0 110.801 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.4 Cg_endo -80.95 14.26 2.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.651 2.234 . . . . 0.0 113.151 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.72 132.43 53.83 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 162' ' ' TYR . 69.3 m -102.06 -2.29 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 161' ' ' THR . 59.5 m-85 57.44 124.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.39 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -66.94 -173.92 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.89 61.88 0.94 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.877 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.35 70.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.438 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 87' ' ' PHE . 9.3 p -161.9 119.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.244 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.433 ' CZ ' HG22 ' A' ' 86' ' ' VAL . 3.7 p90 -133.55 177.17 7.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.754 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 186' ' ' TRP . 13.5 m-85 -126.27 151.07 47.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.084 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 71.2 m -140.07 153.53 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.05 55.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.49 154.85 11.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.473 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -153.66 161.87 41.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.6 143.92 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.88 169.31 22.46 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.567 2.178 . . . . 0.0 112.34 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.44 110.85 2.96 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.658 2.238 . . . . 0.0 112.334 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -150.07 -70.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.8 111.35 20.76 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.72 146.62 84.36 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.692 2.261 . . . . 0.0 112.09 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.12 76.49 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -138.29 -65.81 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.462 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -122.87 160.69 25.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.29 146.49 35.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 2.1 m120 -109.41 135.51 50.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.0 147.93 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.2 t -128.84 116.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.89 179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.56 121.88 43.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.984 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 13.0 mt -91.09 140.06 30.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.15 120.43 30.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -65.53 153.57 41.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.114 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 2.7 tp60 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -73.81 113.68 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.36 -6.29 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 t -169.86 167.23 9.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.29 -176.6 5.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 125.51 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -128.91 -101.03 0.99 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.705 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -161.06 160.62 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -66.89 -29.7 69.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -35.49 15.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.3 107.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.28 137.81 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.8 p90 -138.93 162.23 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -145.18 137.18 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.728 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.96 114.88 23.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -131.75 128.0 37.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -106.92 124.85 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.7 m -106.4 134.79 48.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.98 110.87 11.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.58 -143.67 6.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.36 -60.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -130.01 145.57 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -138.25 154.36 49.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.77 118.72 31.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.0 p -112.46 132.01 55.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.29 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' ILE . 39.5 t -125.76 125.11 67.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.92 137.65 35.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 54' ' ' ALA . 14.8 t -138.61 116.58 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 170.49 7.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 47.4 31.41 1.88 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.395 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -152.65 132.36 7.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 35.2 Cg_exo -57.7 -157.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.481 2.121 . . . . 0.0 112.161 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.927 HG13 ' CD1' ' A' ' 98' ' ' LEU . 69.6 t -84.52 -57.56 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.1 -43.38 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.14 -45.49 76.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.63 -45.14 89.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.1 mt -57.24 -34.99 69.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -63.31 -33.19 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 109.904 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 12.5 tp10 -87.94 -31.73 19.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.282 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -74.94 -40.41 60.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.444 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' ILE . 10.8 mmt -57.36 -45.16 99.92 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.1 Cg_exo -58.06 -45.13 33.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.263 1.975 . . . . 0.0 112.145 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -70.32 -41.76 72.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.461 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 44' ' ' VAL . 3.2 tt -76.53 -31.9 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.476 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -66.45 -42.1 88.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HD3' HG21 ' A' ' 69' ' ' THR . 15.5 mttp -60.09 -33.25 71.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -68.77 -41.99 78.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.0 m -81.31 -30.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.15 -103.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.14 69.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.525 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 69' ' ' THR . 90.0 m -164.27 63.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.76 5.23 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.459 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 46.97 9.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -148.24 -46.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 37.16 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.457 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 113' ' ' PRO . 26.8 m -100.23 160.1 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.68 75.11 0.3 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 mtp -74.26 -55.46 6.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.851 0.358 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -93.26 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.51 172.41 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 m -164.0 110.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 49.79 166.1 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.673 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD2' HG12 ' A' ' 80' ' ' VAL . 21.0 Cg_endo -61.7 149.32 90.4 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.981 . . . . 0.0 112.25 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.431 HG21 ' HE1' ' A' ' 59' ' ' MET . 1.3 t -86.18 153.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -120.22 145.84 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.491 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -124.6 154.44 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.52 136.25 36.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.315 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 167' ' ' TYR . 3.8 m -128.09 129.93 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -102.47 95.78 6.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' CE1' ' A' ' 167' ' ' TYR . 61.7 Cg_endo -73.0 134.73 21.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.222 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.94 170.32 10.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -17.51 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.245 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -6.22 59.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.737 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.89 -1.71 85.3 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.89 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -121.75 136.88 54.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.813 0.34 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.578 HD12 ' CG ' ' A' ' 141' ' ' GLU . 35.0 mt -59.1 171.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.52 47.63 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 54.94 83.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -178.22 109.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.927 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.9 tt -144.11 138.25 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.23 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 5.3 tttp -119.62 115.76 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.437 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -81.69 117.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.564 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -98.73 132.16 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.542 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.755 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.3 t80 -114.01 136.08 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.46 107.88 19.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.421 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.1 mt -83.71 136.16 42.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.0 Cg_endo -64.96 154.23 74.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.497 2.131 . . . . 0.0 112.322 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -53.95 -27.65 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -58.84 -45.53 89.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -98.71 -15.07 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.273 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -36.03 60.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.804 0.335 . . . . 0.0 111.109 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.4 -33.2 76.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.64 75.39 2.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.722 0.296 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.1 Cg_exo -57.1 159.72 14.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.583 2.189 . . . . 0.0 112.275 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.74 148.26 58.3 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.69 2.26 . . . . 0.0 112.011 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.44 112.36 9.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.95 144.63 35.66 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.352 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -103.76 -31.18 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' HG23 ' A' ' 120' ' ' VAL . 3.1 m-20 -80.94 122.03 26.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.83 -23.79 54.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 m -81.98 -28.54 32.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 117' ' ' ASP . 27.7 t -85.19 115.58 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -121.72 149.81 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.7 mm -113.04 126.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.85 129.11 45.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 144.13 25.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER 56.0 173.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.119 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 15.4 tp10 86.71 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.3 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -91.31 158.66 25.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.015 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -128.29 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 35' ' ' ALA . 48.7 m -122.2 119.02 30.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.292 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 187' ' ' LEU . 35.1 m -134.11 165.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.723 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -107.5 136.4 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.13 179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -105.69 141.17 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.073 0.463 . . . . 0.0 111.37 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.3 t -130.33 139.64 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.586 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -116.31 124.98 51.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.97 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.656 ' CE2' ' CD2' ' A' ' 147' ' ' HIS . 14.3 p90 -131.78 165.13 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.17 79.55 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.19 175.62 43.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.36 164.28 13.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.792 0.329 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -169.72 120.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.207 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -105.87 -65.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.81 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.578 ' CG ' HD12 ' A' ' 94' ' ' LEU . 7.5 tt0 -146.73 -70.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.5 70.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.65 -34.97 78.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.29 -40.45 95.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.437 0.637 . . . . 0.0 109.98 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.737 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -52.95 -38.26 28.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.658 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.67 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.647 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.656 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 m80 -70.09 -42.39 72.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.757 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.56 -32.94 73.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -68.41 -40.38 81.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -60.05 -46.11 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 31' ' ' TYR . 8.1 tp -58.71 -42.19 88.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.47 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.3 m -63.02 -41.58 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.417 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 31' ' ' TYR . 6.6 m -57.29 -49.14 77.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.705 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 0.8 OUTLIER -73.67 -10.24 59.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.296 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -46.83 -35.47 6.35 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.17 31.13 7.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.8 p -145.83 165.13 22.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 -2.81 12.29 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.909 2.406 . . . . 0.0 112.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.5 124.6 19.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -102.22 175.68 5.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.648 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -157.45 -177.13 6.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.817 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -79.3 -76.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.2 -18.07 2.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.076 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -158.01 27.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.925 0.362 . . . . 0.0 111.613 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -161.95 132.59 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.486 ' HA ' HG23 ' A' ' 188' ' ' VAL . 27.7 p90 -149.73 168.17 24.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.656 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 98.3 m-85 -112.82 155.24 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.152 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 185' ' ' VAL . 1.3 m -132.79 154.0 50.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.02 136.31 47.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.791 0.329 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -108.86 134.09 52.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -138.26 143.1 39.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.7 t -123.2 121.88 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.619 ' CZ2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.056 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.736 ' O ' HG12 ' A' ' 130' ' ' VAL . 10.6 mt -91.17 139.97 30.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.561 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' CE2' ' A' ' 168' ' ' TYR . 15.2 t -74.61 118.69 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -76.83 127.83 33.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.226 -0.892 . . . . 1.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.81 0.338 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.3 115.26 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -96.44 0.13 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -170.35 161.27 8.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -152.37 -45.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.48 136.41 49.27 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -136.9 175.45 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.542 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 161.09 27.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.341 . . . . 0.0 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -66.56 -32.84 74.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.7 -35.05 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 29' ' ' VAL . 6.9 m -146.07 110.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.054 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -95.51 154.85 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.1 p90 -139.39 158.31 44.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -145.14 121.89 11.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.92 131.23 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -139.91 130.65 25.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.29 120.17 40.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 m -131.98 136.41 47.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -114.75 77.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.39 -161.92 2.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.525 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.28 -86.39 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -113.28 149.17 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.886 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -137.61 156.99 47.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.93 140.28 29.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.53 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 24.9 p -135.67 131.87 36.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.975 0.417 . . . . 0.0 111.5 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 120' ' ' VAL . 39.8 t -128.01 125.41 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.436 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.99 136.0 38.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.4 116.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.778 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 168.17 9.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.88 33.06 3.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.526 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -153.2 121.65 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.89 -161.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.502 2.135 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 141' ' ' GLU . 28.7 t -74.21 -58.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 -44.98 82.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.212 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.13 -46.0 75.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.26 89.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.634 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -32.52 74.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 tp10 -87.57 -40.36 14.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.15 -37.57 66.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 11.9 mmt -57.78 -44.12 99.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' MET . 49.3 Cg_endo -70.35 -36.67 8.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -70.09 -43.28 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 44' ' ' VAL . 5.2 tt -77.08 -26.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -39.26 90.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -59.19 -31.06 68.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.23 -49.18 46.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.1 m -75.31 -30.82 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.188 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.89 -99.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.25 35.7 0.76 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 69' ' ' THR . 21.0 m -119.67 30.27 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 110.929 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.774 HD21 HG22 ' A' ' 74' ' ' VAL . 40.7 p-10 -88.9 -14.43 36.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 78.67 -1.68 2.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -93.78 -44.25 8.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.848 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.62 39.45 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 70' ' ' ASN . 27.0 m -100.27 -178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 88.14 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -83.21 -45.87 13.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.14 -82.55 1.54 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.87 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.794 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.14 -164.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.96 156.42 2.59 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.264 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.99 135.21 61.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 112.17 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 102' ' ' PHE . 25.4 m -86.0 145.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.343 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.454 ' HG ' ' HH2' ' A' ' 186' ' ' TRP . 1.1 p -115.49 174.01 6.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.654 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -127.51 154.46 45.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.38 136.73 32.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.435 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.0 m -131.85 109.25 15.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CD2' HG23 ' A' ' 166' ' ' VAL . 11.9 m-85 -83.95 111.32 31.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.4 Cg_endo -80.67 127.87 6.57 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.162 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 164.21 14.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.41 -15.74 62.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.361 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -5.95 59.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.523 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.512 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 96.59 -2.06 62.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.08 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -121.41 -169.85 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 141' ' ' GLU . 88.4 mt -105.81 169.52 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.714 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.31 34.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.142 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp 51.08 26.7 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.11 122.29 31.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 84' ' ' PHE . 1.1 tt -133.84 139.99 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 111.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.4 mtpt -118.06 115.75 25.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.133 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.9 t -78.77 116.72 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.764 0.316 . . . . 0.0 111.252 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -97.23 142.12 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.773 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.71 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 20.4 t80 -127.11 148.81 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.987 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -105.82 110.4 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.91 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -75.69 130.39 79.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.41 154.06 20.62 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.461 2.107 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -27.07 65.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -64.74 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 74' ' ' VAL . 4.9 m-85 -108.16 -2.95 19.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.677 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.68 57.63 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.721 0.296 . . . . 0.0 111.23 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.09 -33.97 75.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.79 89.44 0.7 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.276 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 23.5 Cg_exo -63.23 160.2 35.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 112.251 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.93 153.29 63.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.597 2.198 . . . . 0.0 111.919 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 110.84 5.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 132.36 40.27 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 0.0 112.061 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 t -94.99 46.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.668 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -149.31 112.72 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.98 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.01 -23.54 54.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -82.17 -30.32 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.7 t -85.37 114.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.03 150.33 27.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 42' ' ' ALA . 26.0 mm -118.17 127.98 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 129.95 45.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -88.76 139.94 29.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.5 mtm105 62.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -169.14 -167.9 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.49 89.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.386 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.422 HD12 HG13 ' A' ' 130' ' ' VAL . 2.1 pp -135.2 146.41 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.3 m -104.0 133.3 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.372 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.894 HG12 ' HA ' ' A' ' 188' ' ' VAL . 34.1 m -136.94 169.32 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.633 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -136.15 129.58 31.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 p -105.63 149.05 26.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 111.587 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.8 t -130.7 139.34 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.64 133.68 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.01 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.81 -46.27 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.59 149.63 10.33 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.73 -170.22 17.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -133.11 123.78 26.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -112.65 174.69 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -75.7 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -153.37 -61.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.774 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.93 -33.78 65.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.604 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.5 t70 -68.21 -34.92 77.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.049 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -40.51 95.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.458 0.647 . . . . 0.0 110.087 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.69 -38.57 35.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.88 77.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.715 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -70.18 -46.01 65.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -62.13 -33.0 73.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.2 m -67.83 -38.25 82.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.93 -35.78 73.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.571 HD23 HD12 ' A' ' 187' ' ' LEU . 7.6 tp -59.22 -40.68 86.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -60.99 -42.49 98.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.266 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.2 m -64.05 -41.81 97.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -49.23 77.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.692 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.54 -9.05 58.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -47.04 -36.37 7.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.821 0.343 . . . . 0.0 111.215 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -96.34 36.09 4.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 15.8 p -145.29 168.28 12.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.3 Cg_endo -85.16 17.83 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.253 2.635 . . . . 0.0 112.794 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 170.98 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.849 0.356 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -136.66 -178.07 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.503 ' H ' HG22 ' A' ' 161' ' ' THR . 12.6 m-85 -155.11 138.05 15.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 190' ' ' ALA . 3.3 mm-40 -63.31 -68.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.1 -79.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.56 69.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 87' ' ' PHE . 9.9 p -161.94 131.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.296 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.858 ' HB3' HD23 ' A' ' 187' ' ' LEU . 7.1 p90 -140.77 170.62 15.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.507 ' CE2' HG22 ' A' ' 188' ' ' VAL . 24.7 m-85 -117.83 136.76 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.0 m -111.32 144.04 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.54 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -120.91 144.03 48.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -137.41 142.97 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 111.372 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.2 t -128.76 114.91 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -117.73 121.95 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.648 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -92.65 140.93 29.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.565 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.8 t -73.89 118.81 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.947 0.404 . . . . 0.0 111.269 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.36 145.69 25.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.267 -0.873 . . . . 1.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.838 0.351 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.24 112.92 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.02 -22.81 18.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 t -169.85 167.03 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.868 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 p -151.41 174.58 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 123.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . -124.69 -55.56 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.549 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tptt -161.85 167.68 24.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.702 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -32.27 73.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.1 -35.33 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.356 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 154' ' ' THR . 3.3 m -146.32 115.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 111.574 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 158.55 15.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.766 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 4.7 p90 -138.87 155.72 47.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -146.73 130.91 17.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.07 116.41 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.03 131.69 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.5 119.54 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.14 103.13 8.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.56 129.85 50.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.97 144.46 16.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.76 178.72 16.87 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.92 141.97 50.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 8.8 m-85 -137.54 154.32 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.969 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.1 122.84 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -112.67 132.14 55.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.794 HG21 ' HB ' ' A' ' 62' ' ' ILE . 16.6 t -125.91 125.51 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -95.72 134.9 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.391 . . . . 0.0 111.264 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 54' ' ' ALA . 9.6 t -138.45 116.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.8 166.96 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.991 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.78 27.67 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -152.64 129.42 5.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.68 -78.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.607 2.205 . . . . 0.0 112.675 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.5 t -146.73 -62.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.749 0.309 . . . . 0.0 111.236 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.57 -45.33 81.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.21 -46.28 74.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.04 -45.07 91.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.2 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.9 mt -56.91 -35.3 68.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.407 ' HB3' ' NH1' ' A' ' 56' ' ' ARG . 1.2 ttp-105 -63.04 -32.16 73.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.008 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -86.87 -32.94 19.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.24 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.728 ' CB ' HG21 ' A' ' 100' ' ' VAL . . . -73.22 -37.13 66.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.43 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 30.2 mmt -57.8 -44.09 99.16 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 51.3 Cg_endo -70.29 -41.19 3.79 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.938 1.758 . . . . 0.0 111.986 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -70.21 -39.53 75.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.794 ' HB ' HG21 ' A' ' 44' ' ' VAL . 9.3 tt -77.55 -40.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.683 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.471 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.5 -31.58 72.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.063 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' HG21 ' A' ' 69' ' ' THR . 1.0 OUTLIER -58.84 -29.92 67.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.58 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 122' ' ' ILE . 13.7 t80 -75.36 -50.96 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.8 m -66.03 -29.7 47.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.19 -166.9 2.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.46 54.85 4.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 30.5 m -141.45 33.44 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -88.51 164.49 15.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 4.7 t0 -92.43 48.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -148.67 -46.63 0.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.38 34.09 3.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 108' ' ' PHE . 17.5 m -100.46 176.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.6 -67.64 1.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mtt 62.55 146.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.25 -121.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.596 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 -45.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' HD2' ' A' ' 81' ' ' PRO . 1.4 m 61.02 112.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 3.9 t -65.86 -46.43 65.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 79' ' ' THR . 29.4 Cg_exo -62.03 140.77 86.17 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.473 2.115 . . . . 0.0 112.123 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 t -153.78 144.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.282 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 t -115.73 145.95 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.489 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.1 154.21 50.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.87 136.66 32.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.484 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG23 ' CE1' ' A' ' 167' ' ' TYR . 17.7 m -135.57 133.49 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 5.8 m-85 -104.45 97.67 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.301 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.2 Cg_endo -79.65 138.91 13.83 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.88 172.0 8.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.09 -29.12 67.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -86.36 -6.14 59.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.97 -2.06 78.9 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 124.41 41.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 88' ' ' PRO . 15.6 mt -66.81 161.24 24.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -118.58 45.78 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt 61.26 -169.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.74 114.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.736 HD11 ' CD2' ' A' ' 84' ' ' PHE . 1.3 tt -143.6 130.66 20.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.5 tttp -108.04 115.89 30.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.728 HG21 ' CB ' ' A' ' 58' ' ' ALA . 3.3 t -85.44 116.91 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.309 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -96.01 131.49 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 15.9 t80 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.267 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.58 110.27 22.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.411 HG23 ' HD2' ' A' ' 105' ' ' PRO . 40.6 mt -90.68 136.29 28.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.226 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' A' ' 104' ' ' ILE . 31.7 Cg_endo -63.6 154.18 70.53 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.454 2.103 . . . . 0.0 112.344 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.86 -26.94 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -56.81 -38.29 72.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.956 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.55 ' HE2' HG11 ' A' ' 74' ' ' VAL . 85.9 m-85 -113.02 -13.05 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -53.14 -47.13 68.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 111.179 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.08 -25.94 54.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 t -171.4 89.41 0.45 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.769 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 122' ' ' ILE . 45.0 Cg_endo -67.9 151.43 78.16 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 0.0 112.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 11.2 Cg_exo -70.79 155.85 61.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.61 2.206 . . . . 0.0 112.111 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -67.5 111.75 8.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.993 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.89 158.06 26.28 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.405 2.07 . . . . 0.0 112.261 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.93 -31.19 11.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.52 114.81 13.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -24.5 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.12 -33.03 29.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.885 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 61' ' ' LYS . 38.6 t -85.43 121.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 157.04 39.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.538 HG21 ' HG3' ' A' ' 112' ' ' PRO . 29.3 mm -107.25 129.31 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -98.86 130.7 45.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.43 16.81 8.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.43 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.91 132.46 23.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -168.57 86.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.15 92.82 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.51 145.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.88 130.8 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 187' ' ' LEU . 26.2 m -143.84 164.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.317 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 4.3 m-85 -107.8 135.43 49.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.8 p -105.68 133.65 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 139.25 52.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.86 138.87 51.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 20.7 p90 -153.32 29.64 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.99 -76.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 138' ' ' TYR . . . 134.62 79.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 137' ' ' GLY . 63.6 m-85 -157.18 82.45 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.322 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.43 26.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.219 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.65 66.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 63.6 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.52 58.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -67.27 -35.97 80.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.105 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.02 -40.52 98.0 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.444 0.64 . . . . 0.0 109.94 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.78 -38.88 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.497 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.81 -35.03 69.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.826 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 40.0 m-70 -68.94 -38.8 79.68 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -61.3 -32.93 72.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.743 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.7 m -72.86 -43.3 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -59.51 -36.65 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 151' ' ' LEU . 12.5 tp -58.1 -43.63 87.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -59.37 -47.51 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 94.6 m -60.91 -41.99 97.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.356 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 29' ' ' VAL . 6.7 m -57.67 -48.97 78.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 mt -72.89 -11.22 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -46.87 129.74 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.241 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.68 9.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.476 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 4.3 p -94.76 173.75 4.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.54 0.21 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 4.4 Cg_exo -77.57 13.97 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.012 2.474 . . . . 0.0 112.939 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.93 130.44 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.334 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.08 172.68 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 152' ' ' ARG . 5.3 m-85 -155.68 160.24 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -104.11 -51.83 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.51 53.66 7.31 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.264 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -158.7 -37.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.596 0.236 . . . . 0.0 111.275 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 12.5 p -159.2 140.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 111.424 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.7 p90 -142.88 170.43 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.09 143.81 43.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.3 m -119.42 137.94 53.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.03 156.09 46.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.075 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -108.95 145.57 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -145.7 154.42 42.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.93 124.48 73.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.641 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.06 122.26 46.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.106 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 130' ' ' VAL . 62.3 mt -91.6 140.35 29.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.65 118.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -75.05 116.25 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.17 -0.919 . . . . 1.0 110.986 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -74.3 113.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 35' ' ' ALA . 6.8 mt -86.42 -24.33 25.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -169.98 167.1 9.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -151.6 168.07 26.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.82 -175.67 21.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.426 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.89 -106.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -161.02 167.44 26.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.0 110.916 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -66.6 -28.02 68.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.43 -33.12 16.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.094 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.99 142.38 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -135.12 139.84 44.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 155' ' ' LEU . 1.2 p90 -138.36 162.22 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.726 ' HG2' HG22 ' A' ' 23' ' ' THR . 74.7 mt-10 -144.53 126.46 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.0 129.43 34.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -140.71 135.82 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -112.74 130.08 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.242 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.13 -50.05 21.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.07 70.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.68 29.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.95 139.6 5.02 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HD3' ' CG ' ' A' ' 112' ' ' PRO . 15.8 mttm -92.0 146.68 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -137.54 161.23 36.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 140.3 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.655 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -133.49 131.88 40.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.476 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 120' ' ' VAL . 20.8 t -132.88 125.68 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.679 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.94 132.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.272 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.7 t -138.41 116.87 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 175.43 5.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t0 48.41 28.25 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.436 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.97 133.97 8.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 28.6 Cg_endo -62.46 -165.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.474 2.116 . . . . 0.0 112.099 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 98' ' ' LEU . 42.6 t -74.83 -48.81 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.333 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.71 -45.17 83.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.231 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -67.23 -46.15 74.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.258 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD22 ' CE ' ' A' ' 59' ' ' MET . 3.2 mt -56.97 -35.55 69.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.259 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 tp10 -87.21 -34.15 19.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.355 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.799 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.7 -41.77 62.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.633 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -57.63 -43.95 99.17 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -57.47 -47.15 23.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.107 1.872 . . . . 0.0 112.189 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -70.43 -41.95 72.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.828 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 59' ' ' MET . 6.2 tt -76.09 -37.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 66' ' ' VAL . 58.5 mtp -66.32 -40.48 89.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -59.6 -31.06 69.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.472 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 9.9 t80 -74.99 -50.09 17.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.804 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' CE2' ' A' ' 102' ' ' PHE . 22.1 m -72.54 -29.52 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.404 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.12 -64.33 2.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.626 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.1 76.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -164.52 55.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 110.747 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.53 6.73 6.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.366 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 58.47 18.56 5.75 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.448 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -95.2 -43.47 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.11 24.32 8.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.474 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -101.08 -178.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.62 -55.46 0.39 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 61.7 mtp 62.64 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.657 0.265 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.79 80.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.656 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 55.28 -176.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.624 ' O ' HG13 ' A' ' 80' ' ' VAL . 1.6 t 179.87 -39.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 103' ' ' ARG . 2.4 m -162.23 163.67 18.3 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.855 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -59.21 149.65 79.14 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.29 1.994 . . . . 0.0 111.898 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.33 137.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.684 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 m -119.11 145.86 45.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.07 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -133.15 154.28 50.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.694 0.283 . . . . 0.0 111.452 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.97 136.67 32.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.534 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' A' ' 167' ' ' TYR . 5.2 m -130.25 130.81 65.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 10.6 m-85 -102.51 97.43 8.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.19 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.7 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.1 Cg_endo -75.18 139.8 24.24 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.507 2.138 . . . . 0.0 112.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -90.18 161.92 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.41 -21.97 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.23 -6.19 59.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.42 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.63 -16.09 60.99 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.829 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -98.66 133.35 43.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 88' ' ' PRO . 71.0 mt -57.89 178.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -143.37 44.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 62.1 -166.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.74 108.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.702 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 84' ' ' PHE . 3.7 tt -141.35 139.52 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.12 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -115.78 115.89 27.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.525 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.1 t -82.23 116.86 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.536 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -100.23 137.96 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.809 ' CE2' HG11 ' A' ' 66' ' ' VAL . 24.8 t80 -127.07 132.44 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.684 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.694 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -94.34 109.75 21.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.36 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 108' ' ' PHE . 31.8 mt -82.19 139.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.468 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 79' ' ' THR . 50.5 Cg_exo -53.34 154.14 15.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.624 2.216 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -57.68 -31.02 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.42 -47.13 87.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 104' ' ' ILE . 26.9 m-85 -90.9 -13.49 33.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.199 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.19 -43.69 67.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.75 -27.43 66.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t -167.27 85.87 0.8 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 42.8 Cg_endo -68.02 152.26 76.86 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.613 2.209 . . . . 0.0 112.307 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.92 156.24 60.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.01 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.83 110.89 6.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 122' ' ' ILE . 69.1 Cg_endo -74.04 145.0 34.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.304 2.003 . . . . 0.0 112.453 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -86.12 -176.41 5.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 64.16 120.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.995 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.4 -16.89 25.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.599 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.6 m -80.16 -34.72 37.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 111.233 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 44' ' ' VAL . 38.5 t -85.42 113.83 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.149 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -128.06 157.13 41.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 115' ' ' PRO . 27.8 mm -106.1 129.09 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.85 129.83 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 18.88 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.342 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -69.58 164.35 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -70.91 169.11 15.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.64 176.27 4.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.68 145.25 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.0 m -103.99 118.93 37.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.769 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.18 166.74 21.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.494 ' HB2' HD21 ' A' ' 151' ' ' LEU . 3.7 m-85 -107.83 133.42 52.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.583 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 p -105.89 122.29 45.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.977 0.417 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.484 ' HB ' HD13 ' A' ' 151' ' ' LEU . 5.6 t -116.38 139.1 50.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.732 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -116.99 154.16 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -166.87 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.64 127.93 4.49 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.64 147.0 4.49 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -67.14 118.21 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.58 126.04 45.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 -43.43 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.556 ' CD ' HD12 ' A' ' 94' ' ' LEU . 28.2 tt0 -176.04 -66.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.62 -33.77 66.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -67.67 -34.9 77.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.074 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.67 -40.49 95.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.093 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.8 t -53.75 -38.86 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.549 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.56 -33.45 69.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.648 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -70.11 -44.43 68.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.89 72.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.4 m -67.44 -38.0 83.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.468 ' O ' HG22 ' A' ' 153' ' ' THR . 11.5 mt-30 -64.61 -36.25 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 131' ' ' TYR . 11.9 tp -70.03 -37.17 75.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 110.437 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.01 -48.08 63.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 150' ' ' GLN . 4.2 t -61.25 -40.96 96.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.472 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 98.3 m -57.52 -47.08 82.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.695 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.677 HD21 ' CE2' ' A' ' 31' ' ' TYR . 83.4 mt -72.75 -13.79 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.312 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.18 115.38 1.08 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.84 18.03 8.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.559 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.1 p -146.58 165.15 20.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.57 -13.25 35.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.765 2.31 . . . . 0.0 112.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -57.5 110.51 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -102.48 -177.74 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.534 ' H ' HG22 ' A' ' 161' ' ' THR . 0.0 OUTLIER -156.82 20.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.332 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 67.72 -66.58 0.21 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.162 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.35 48.88 2.93 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.116 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -158.05 -33.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.505 0.193 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 14.0 p -159.13 138.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.548 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 86' ' ' VAL . 15.0 p90 -136.99 171.55 14.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.779 ' CE2' HG22 ' A' ' 188' ' ' VAL . 37.5 m-85 -112.87 150.83 31.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.18 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.3 m -129.92 157.79 41.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.07 139.35 49.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.555 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.771 0.32 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -130.97 133.84 46.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -146.14 157.06 43.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.49 126.24 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.825 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -107.91 121.69 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.155 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 167' ' ' TYR . 12.7 mt -94.41 134.3 37.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.805 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 168' ' ' TYR . 21.5 t -74.88 118.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -63.58 139.35 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.201 -0.904 . . . . 1.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.28 113.19 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.031 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.99 -27.78 18.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -170.09 167.09 8.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -151.65 160.52 43.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.44 71.85 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.364 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.97 -132.24 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.607 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.28 164.89 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -66.49 -28.7 68.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 -34.47 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 118.82 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 p -95.38 130.69 42.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 6.2 p90 -138.53 154.57 48.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -145.19 135.03 23.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.66 124.7 33.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 136.84 30.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.21 130.41 56.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.38 164.78 25.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.03 73.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.58 118.44 6.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.569 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.37 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.571 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' O ' HD12 ' A' ' 104' ' ' ILE . 11.5 mttt -111.01 147.93 33.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.74 153.29 49.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.13 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . . . -94.39 119.11 32.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.5 p -112.66 147.31 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.861 HG23 HD12 ' A' ' 62' ' ' ILE . 23.0 t -131.82 125.97 56.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.153 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -95.95 131.54 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.693 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 17.5 t -138.18 116.98 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 169.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.738 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 79.59 -49.11 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.492 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HB3' ' N ' ' A' ' 54' ' ' ALA . 19.5 mttt -85.65 141.63 36.43 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 110.877 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.51 -80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.481 2.121 . . . . 0.0 112.626 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.939 HG13 ' CD1' ' A' ' 98' ' ' LEU . 43.0 t -142.65 -66.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.851 0.358 . . . . 0.0 111.334 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.76 -45.33 78.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -46.07 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.77 -41.12 85.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 55' ' ' LEU . 5.7 mt -57.1 -35.07 68.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.013 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -31.28 71.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.285 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 34.2 tp10 -87.81 -33.66 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.12 -38.83 66.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.631 ' HE1' HG21 ' A' ' 82' ' ' VAL . 6.9 mmt -57.72 -43.97 99.12 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.8 Cg_endo -70.14 -37.62 8.03 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.994 1.796 . . . . 0.0 112.128 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -70.14 -42.68 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.861 HD12 HG23 ' A' ' 44' ' ' VAL . 1.5 tt -77.71 -28.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -41.06 90.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -58.93 -31.21 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 40.9 t80 -70.59 -53.35 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.503 HG21 ' CG ' ' A' ' 78' ' ' MET . 27.1 m -67.25 -26.36 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.288 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.0 -126.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.645 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.06 68.2 0.52 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 69' ' ' THR . 28.7 m -155.11 52.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' OD1' ' CD1' ' A' ' 65' ' ' TYR . 2.6 m-80 -112.2 22.47 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 t70 54.56 34.34 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.027 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -148.3 -61.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.29 81.92 1.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.47 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 113' ' ' PRO . 5.3 m -139.63 146.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.37 71.77 0.7 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.6 mtp -62.24 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.03 120.49 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.503 ' CG ' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -75.57 154.14 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.594 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.87 148.2 25.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 21.7 t -56.75 -47.7 98.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.413 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.4 Cg_endo -80.91 154.76 19.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.36 2.04 . . . . 0.0 112.499 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.631 HG21 ' HE1' ' A' ' 59' ' ' MET . 41.7 t -153.91 138.74 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.465 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 29.6 t -115.63 149.21 38.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.759 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.06 154.23 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -89.15 136.69 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 94' ' ' LEU . 30.7 m -134.68 128.75 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.195 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -98.61 99.33 7.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.724 ' HA ' HD23 ' A' ' 94' ' ' LEU . 54.2 Cg_endo -69.24 128.01 15.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.471 2.114 . . . . 0.0 112.248 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.13 168.06 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -19.63 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.185 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.45 2.95 42.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.487 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 145' ' ' VAL . . . 91.0 -15.45 60.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.878 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.84 177.63 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 88' ' ' PRO . 53.6 mt -114.37 -12.91 12.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.62 165.53 0.2 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.003 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -80.52 88.13 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.22 110.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.643 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.4 tt -143.97 128.62 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.449 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -110.98 115.66 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.082 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.677 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -71.46 141.12 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -120.85 124.03 44.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 66' ' ' VAL . 57.5 t80 -108.17 153.68 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.127 0.489 . . . . 0.0 111.69 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.1 109.18 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.493 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 112' ' ' PRO . 33.3 mt -83.04 139.12 42.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.314 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.61 154.21 16.56 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 112.314 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -27.46 56.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -59.53 -47.14 86.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.92 -8.28 31.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -53.4 -36.16 61.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.16 -28.57 73.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 t -177.03 88.12 0.25 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 104' ' ' ILE . 34.0 Cg_exo -59.17 161.27 16.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.229 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.619 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.5 Cg_exo -70.82 154.75 63.38 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.634 2.223 . . . . 0.0 111.864 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 114.58 19.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.2 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 65' ' ' TYR . 48.6 Cg_exo -55.17 178.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 35.78 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.9 120.89 11.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.89 -26.8 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.003 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.2 t -82.01 -34.79 29.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -85.43 117.16 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.23 152.82 40.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.3 mm -107.98 133.77 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.86 157.25 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.79 167.71 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -66.71 171.06 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -169.91 -38.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.63 107.18 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.95 142.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.354 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 82.0 m -107.31 132.08 53.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.508 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 187' ' ' LEU . 34.8 m -142.33 149.51 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 5.6 m-85 -107.78 132.41 53.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.198 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.7 p -105.61 144.41 32.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.48 . . . . 0.0 111.637 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.7 t -130.85 139.13 50.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.8 138.78 51.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.611 ' CE1' ' CD2' ' A' ' 147' ' ' HIS . 39.1 p90 -143.58 -178.67 6.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.789 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.58 88.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.46 -176.44 40.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -58.73 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.11 164.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -132.84 -75.51 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.632 ' HB2' HD12 ' A' ' 94' ' ' LEU . 9.9 pt-20 -139.8 -48.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.97 66.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.09 -35.0 77.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.022 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -63.87 -39.8 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.041 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 92' ' ' GLY . 61.5 t -53.85 -38.61 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.345 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.76 74.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.597 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.611 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 31.3 m80 -70.23 -46.05 65.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.878 0.37 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.94 -33.09 73.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.746 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -71.14 -37.94 72.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -59.01 -39.61 82.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.5 tp -58.35 -40.99 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.523 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -62.74 -45.24 93.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -40.73 98.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.191 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.0 m -57.65 -49.2 77.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.511 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -74.0 -9.25 58.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -47.16 -32.72 4.57 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.788 0.328 . . . . 0.0 111.282 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.42 28.29 12.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 71.5 p -145.84 159.29 47.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.312 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.5 Cg_endo -79.58 8.43 3.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 113.029 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.53 137.36 57.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.194 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -100.88 151.57 21.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.0 OUTLIER -158.64 171.18 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -112.36 102.54 10.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.45 65.01 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.046 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -157.69 -27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.4 p -158.27 141.4 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.892 0.377 . . . . 0.0 111.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 31.1 p90 -146.64 168.24 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.534 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 35.6 m-85 -114.38 144.06 43.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.177 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.14 142.81 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.08 154.34 49.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.572 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -108.94 152.88 24.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.06 147.12 31.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.9 118.12 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.84 123.27 48.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.734 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.0 mt -91.43 140.61 29.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.516 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 190' ' ' ALA . 17.7 t -73.98 131.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.801 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -73.02 -0.94 15.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 188' ' ' VAL . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 1.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.763 0.315 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.32 112.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -84.9 -12.07 54.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.415 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.8 159.03 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.85 155.35 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.79 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.85 145.02 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.368 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.431 ' HA3' ' CD1' ' A' ' 31' ' ' TYR . . . -135.88 -146.63 5.29 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.478 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.732 ' HD3' HG23 ' A' ' 154' ' ' THR . 1.6 mtpt -78.37 164.48 24.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.407 . . . . 0.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.54 -26.45 67.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.02 -32.32 16.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.92 111.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.188 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -95.78 141.76 28.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.35 162.13 35.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -145.57 126.16 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.33 122.51 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -123.95 135.28 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.11 121.03 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.194 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.52 173.46 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.88 -47.19 26.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -178.03 28.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.87 -127.32 2.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.426 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -102.95 139.14 38.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -137.58 148.68 46.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.16 28.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.636 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 p -112.82 149.52 32.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 62' ' ' ILE . 41.9 t -128.92 125.61 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -97.38 130.93 44.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.18 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 58' ' ' ALA . 17.4 t -138.25 116.84 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 175.92 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 43.08 36.38 0.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.565 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 14.8 mttt -152.43 134.15 8.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 37.6 Cg_exo -57.22 -157.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.757 HG13 HD13 ' A' ' 98' ' ' LEU . 38.8 t -84.75 -53.25 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -68.15 -44.98 74.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -46.26 81.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.202 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.26 90.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.75 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.2 mt -57.49 -35.28 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -31.67 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 tp10 -87.66 -32.59 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.18 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.65 -42.63 61.13 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.791 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.0 mmt -57.6 -43.54 98.93 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.8 Cg_exo -59.77 -45.16 26.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.248 1.965 . . . . 0.0 111.953 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 120' ' ' VAL . 19.6 mttp -70.32 -40.47 74.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.445 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.722 ' HB ' HG21 ' A' ' 44' ' ' VAL . 7.1 tt -76.57 -40.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 0.0 111.494 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.516 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.27 -31.8 72.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -63.67 -29.84 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -74.04 -30.63 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 63' ' ' MET . 15.0 m -89.74 -31.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.97 -74.16 0.95 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.573 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.07 71.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 116' ' ' SER . 5.3 m -160.59 70.35 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -119.65 -5.63 10.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.452 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.85 39.81 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -144.4 -45.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.64 31.98 1.54 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.25 145.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.85 4.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.451 ' HG2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 62.87 143.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.4 -119.5 3.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -156.85 -171.56 3.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 103' ' ' ARG . 8.3 t -159.13 -163.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.8 m -45.04 161.99 0.22 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.3 Cg_endo -59.31 132.38 46.24 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.186 1.924 . . . . 0.0 111.863 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 102' ' ' PHE . 33.8 m -84.81 146.81 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 p -115.41 173.91 6.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.75 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.7 154.16 44.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.931 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . . . -87.23 136.58 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.486 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 98' ' ' LEU . 27.2 m -131.86 112.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.816 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE2' HG21 ' A' ' 166' ' ' VAL . 4.4 m-85 -93.35 107.13 23.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.24 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.62 156.29 28.02 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.562 2.175 . . . . 0.0 112.189 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.05 168.34 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -22.27 47.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -85.88 -6.04 59.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.712 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.21 -16.07 61.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.806 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 130.07 47.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -72.09 177.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.02 81.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.57 -166.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.054 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 64.6 96.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.757 HD13 HG13 ' A' ' 51' ' ' VAL . 1.7 tt -144.03 127.86 17.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 85' ' ' ALA . 20.6 ptmt -110.59 115.8 30.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -73.38 141.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.332 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -116.38 141.97 47.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.679 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.659 ' CD2' HG11 ' A' ' 82' ' ' VAL . 54.1 t80 -125.0 159.87 30.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.587 ' O ' HG21 ' A' ' 79' ' ' THR . 2.5 mtt85 -115.97 108.09 15.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.323 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.7 mt -85.5 136.41 37.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.297 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 24.6 Cg_endo -61.45 152.02 75.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.359 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -57.23 -26.98 61.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -47.1 82.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.197 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CE2' ' HG2' ' A' ' 76' ' ' MET . 3.2 m-85 -89.18 -16.24 31.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -54.4 -39.05 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.781 0.324 . . . . 0.0 111.197 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.91 79.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 p -159.97 71.67 3.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 110.63 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 32.5 Cg_exo -58.37 139.03 88.98 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.551 2.167 . . . . 0.0 112.324 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 13.0 Cg_exo -70.54 149.27 61.67 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.598 2.199 . . . . 0.0 112.036 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 124.57 89.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.12 170.49 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.383 2.055 . . . . 0.0 112.269 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.591 ' CB ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -113.14 -40.03 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 131.46 35.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -57.71 -22.46 46.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.105 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -81.97 -31.97 30.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 44' ' ' VAL . 33.5 t -85.64 114.02 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.052 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.59 157.0 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.7 mm -107.57 117.59 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -98.98 136.39 39.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.826 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.7 49.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -71.89 -132.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -177.91 4.0 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.79 153.57 20.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.858 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.96 148.78 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.407 HG21 ' HD2' ' A' ' 189' ' ' LYS . 9.7 m -103.9 130.46 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 187' ' ' LEU . 29.4 m -144.81 170.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.48 133.08 41.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.626 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -105.96 137.78 43.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.046 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -124.87 139.05 54.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -116.91 141.38 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -153.62 -50.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.45 170.59 38.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -112.94 67.59 0.24 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.48 100.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 147' ' ' HIS . . . -160.33 163.98 32.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -61.66 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -161.12 -61.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.657 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.84 -33.8 72.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.412 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -67.33 -34.74 77.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.8 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.4 OUTLIER -63.03 -42.05 99.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.513 0.673 . . . . 0.0 109.82 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 92' ' ' GLY . 42.5 t -54.02 -38.8 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.717 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.02 68.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.752 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.516 ' HB2' HG21 ' A' ' 185' ' ' VAL . 18.5 m170 -70.0 -39.7 75.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.819 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.01 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.761 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -67.42 -39.92 85.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.08 -45.95 89.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 151' ' ' LEU . 11.5 tp -63.1 -40.45 97.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -44.22 96.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -65.17 -41.16 94.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.532 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.732 HG23 ' HD3' ' A' ' 26' ' ' LYS . 86.4 m -57.64 -48.05 80.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 12.7 mt -73.22 -16.63 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -47.23 -40.18 15.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.45 32.11 6.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.65 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 51.9 p -146.09 166.7 16.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.8 Cg_exo -75.86 4.72 4.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.031 2.487 . . . . 0.0 112.812 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.47 125.37 22.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.87 HG22 ' HB3' ' A' ' 190' ' ' ALA . 2.7 m -101.78 152.63 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.553 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.616 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -158.42 173.88 15.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.276 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -85.76 -67.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.76 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.062 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.11 -28.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.62 0.247 . . . . 0.0 111.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.612 HG21 ' CE2' ' A' ' 87' ' ' PHE . 14.6 p -157.98 137.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -135.82 179.34 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.542 ' CE2' HG22 ' A' ' 188' ' ' VAL . 25.8 m-85 -116.27 150.78 37.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 m -124.04 136.94 54.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.54 125.06 52.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.781 0.324 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.45 141.07 45.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -145.97 153.01 40.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 147' ' ' HIS . 21.6 t -119.0 133.15 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.957 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -107.65 121.71 45.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.555 ' O ' HG12 ' A' ' 130' ' ' VAL . 36.9 mt -94.03 139.2 31.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 168' ' ' TYR . 43.0 t -83.37 127.26 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.05 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HD2' HG21 ' A' ' 129' ' ' THR . 1.4 mtpt -73.76 160.43 31.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.286 -0.864 . . . . 1.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.823 0.345 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -74.2 112.97 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.56 -16.33 22.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -169.66 166.96 9.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.85 -173.89 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.041 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.98 -119.53 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 98.82 132.45 7.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.774 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 168.69 19.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.729 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -26.88 67.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.28 -35.13 15.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.23 113.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.887 0.375 . . . . 0.0 111.194 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' CA ' ' A' ' 25' ' ' GLY . 1.3 m -98.22 143.68 28.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.674 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.8 p90 -138.55 158.92 43.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.7 132.24 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -86.32 120.04 27.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.6 148.65 44.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.65 116.61 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.61 127.32 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.17 -172.93 2.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.708 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.31 -19.99 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.735 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.19 -90.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.54 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.592 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -93.87 141.16 28.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.776 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -137.63 155.02 49.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.427 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.74 115.9 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.403 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 17.5 p -112.67 147.41 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.998 0.427 . . . . 0.0 111.482 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.69 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.0 t -130.29 125.66 60.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.939 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -98.68 140.98 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 54' ' ' ALA . 21.8 t -138.38 116.79 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 167.25 10.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 46.23 35.41 2.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.439 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -152.78 142.92 15.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.761 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 53.6 Cg_endo -68.58 -163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.403 2.069 . . . . 0.0 112.107 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.878 HG13 ' CD1' ' A' ' 98' ' ' LEU . 47.1 t -81.04 -54.31 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.59 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -61.18 -45.52 94.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.488 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 5.4 tt0 -67.33 -42.9 82.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.23 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 46' ' ' VAL . . . -58.61 -44.8 90.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.425 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.714 HD11 ' CE1' ' A' ' 84' ' ' PHE . 5.3 mt -56.92 -35.63 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.761 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -33.02 74.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 17.1 tp10 -88.42 -30.89 19.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.384 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.32 -44.8 58.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.5 mmt -57.68 -43.88 99.09 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 31.9 Cg_exo -58.9 -46.09 24.98 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.17 1.913 . . . . 0.0 112.221 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -70.29 -41.39 73.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.707 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG21 ' A' ' 44' ' ' VAL . 11.0 tt -76.41 -35.06 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 111.586 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.42 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.4 mtt -66.28 -36.59 83.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -49.01 79.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.513 ' HE1' HD22 ' A' ' 70' ' ' ASN . 23.1 t80 -58.45 -54.11 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 102' ' ' PHE . 33.7 m -66.48 -28.29 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.5 -141.12 0.89 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.614 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.51 43.22 1.92 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.3 m -131.19 87.13 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.513 HD22 ' HE1' ' A' ' 65' ' ' TYR . 1.1 m120 -142.39 143.32 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -73.59 -9.16 58.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -91.21 -39.82 11.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.04 62.4 1.01 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.409 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.68 HG23 ' HG3' ' A' ' 76' ' ' MET . 30.0 m -139.66 159.48 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.92 -46.13 38.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.68 ' HG3' HG23 ' A' ' 74' ' ' VAL . 5.2 mtp 61.43 117.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 111.051 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.72 127.62 25.73 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.402 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.48 176.05 8.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 18.7 p -147.63 114.05 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 31.2 m -57.61 -33.11 15.72 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 11.1 Cg_exo -71.48 152.3 60.05 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.082 1.855 . . . . 0.0 111.823 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 59' ' ' MET . 21.7 t -153.07 147.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 111.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 t -143.02 145.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.646 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.831 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.25 154.15 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -85.51 136.72 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 110.481 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 167' ' ' TYR . 15.4 m -136.1 141.0 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -108.63 107.97 60.51 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.35 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HA ' HD23 ' A' ' 94' ' ' LEU . 81.8 Cg_endo -80.02 129.49 7.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.549 2.166 . . . . 0.0 112.391 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.82 158.43 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -28.78 69.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -2.69 58.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.432 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.45 57.3 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.969 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.02 163.21 28.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.646 HD12 ' HG2' ' A' ' 141' ' ' GLU . 19.5 mt -117.51 -9.51 10.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.417 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 62.47 153.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 110.958 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -80.78 88.34 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.035 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.72 118.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.878 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.2 tt -143.94 135.8 26.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -123.25 115.67 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.203 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.2 t -81.98 141.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.308 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -120.23 131.25 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 62' ' ' ILE . 56.5 t80 -110.08 161.25 15.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.464 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' O ' ' CE2' ' A' ' 102' ' ' PHE . 40.9 mmt-85 -116.08 121.57 42.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.64 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 40' ' ' LYS . 40.5 mt -102.22 137.01 19.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.21 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' HG23 ' A' ' 104' ' ' ILE . 32.6 Cg_endo -64.23 154.09 72.87 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.511 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -26.55 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.269 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -56.6 -47.02 80.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.07 -5.04 41.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.321 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -54.39 -47.73 72.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.9 -26.08 39.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.99 91.38 0.3 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.92 150.85 73.67 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.417 2.078 . . . . 0.0 112.22 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.631 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.83 152.97 64.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.633 2.222 . . . . 0.0 112.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.54 127.97 93.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.095 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 74.5 Cg_endo -75.53 169.71 21.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.521 2.147 . . . . 0.0 112.401 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 -31.8 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.667 ' HB3' HG23 ' A' ' 120' ' ' VAL . 2.7 t70 -79.18 116.17 19.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.68 -19.64 41.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.85 -22.01 40.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.209 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 117' ' ' ASP . 69.7 t -84.77 113.9 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -108.11 147.62 30.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.27 123.89 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.78 142.73 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.46 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -169.3 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -43.89 109.28 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.966 0.413 . . . . 0.0 111.594 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.16 56.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.719 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.67 168.57 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.72 142.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.6 m -111.04 119.8 40.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.691 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 188' ' ' VAL . 21.4 m -138.86 168.74 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.255 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.453 ' CE2' HD13 ' A' ' 155' ' ' LEU . 10.8 m-85 -107.73 141.1 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.526 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.7 p -105.96 127.93 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.281 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.441 ' CG2' HD22 ' A' ' 151' ' ' LEU . 1.5 t -125.1 137.11 54.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.644 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.84 125.01 45.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.919 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 8.5 p90 -123.06 -41.67 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.99 84.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . -147.09 -89.21 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.6 OUTLIER -175.71 108.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.0 110.814 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 144' ' ' TYR . . . -105.66 132.72 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 58.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.646 ' HG2' HD12 ' A' ' 94' ' ' LEU . 1.2 tm-20 67.16 -72.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.86 76.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -67.84 -34.77 77.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.982 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 139' ' ' ALA . 1.2 m-85 -62.63 -39.53 94.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.439 0.638 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.593 HG22 HD21 ' A' ' 94' ' ' LEU . 21.4 t -53.87 -38.82 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.477 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.68 -35.61 70.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.787 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 47.4 m-70 -70.05 -42.7 72.54 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.925 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -32.92 72.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.694 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.4 m -69.64 -39.28 77.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.714 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.83 -46.01 91.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.674 HD11 ' HB3' ' A' ' 31' ' ' TYR . 13.9 tp -58.57 -40.67 83.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.656 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.06 95.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.3 m -64.84 -39.37 93.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.364 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -45.67 84.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.822 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.455 HD23 ' CE2' ' A' ' 31' ' ' TYR . 15.6 mt -72.78 -17.83 61.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.258 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.96 111.56 0.41 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.171 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 106.25 30.37 4.46 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.289 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.472 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 64.6 p -145.23 168.07 12.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.7 0.286 . . . . 0.0 110.807 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 16.5 Cg_exo -67.93 -3.43 10.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.808 2.339 . . . . 0.0 112.978 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.29 124.56 18.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.339 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -99.57 176.32 5.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.32 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 161' ' ' THR . 3.5 m-85 -154.58 161.25 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.035 0.445 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -92.87 -172.26 2.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.819 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.81 63.19 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 57.08 77.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.743 0.306 . . . . 0.0 111.308 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 166' ' ' VAL . 13.9 p -161.37 112.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.604 ' HB3' HD23 ' A' ' 187' ' ' LEU . 13.8 p90 -119.14 173.28 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.724 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 69.3 m-85 -112.89 150.49 31.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.81 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.82 149.62 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.564 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.94 152.54 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.06 154.84 42.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.07 128.35 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.424 ' HB3' HG21 ' A' ' 130' ' ' VAL . 40.7 m0 -108.04 122.0 45.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.368 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.1 mt -93.09 134.49 35.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.535 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 130' ' ' VAL . 43.4 t -74.76 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -107.51 111.97 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.227 -0.892 . . . . 1.0 111.028 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.0 112.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.73 -10.88 25.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.354 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -170.01 164.83 9.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.33 . . . . 0.0 110.966 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.487 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -151.9 -49.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.96 137.64 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.462 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -139.11 -156.16 6.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -78.4 158.37 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.51 -27.38 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -90.11 -35.01 15.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.08 114.82 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -95.38 150.8 19.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.5 p90 -139.05 160.32 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' THR . 3.1 mp0 -143.33 124.97 14.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -85.86 122.1 29.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 129' ' ' THR . 11.3 ptm180 -130.3 128.13 40.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.35 132.77 55.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.1 p -139.65 162.22 35.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.85 170.91 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.935 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.8 -119.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.01 -170.76 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -99.34 137.72 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' HD3' ' A' ' 103' ' ' ARG . 10.8 m-85 -137.49 159.85 40.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -103.29 127.07 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.7 p -112.79 131.79 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' ILE . 39.0 t -127.7 125.35 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.59 139.92 31.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.2 t -138.28 116.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.52 168.35 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 t0 47.56 28.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -152.87 115.72 2.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.41 -172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.507 2.138 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.525 ' HA ' HD13 ' A' ' 98' ' ' LEU . 40.3 t -59.71 -62.24 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.542 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -45.08 79.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -67.1 -45.36 77.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.169 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.872 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.69 -44.42 90.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.344 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.96 -35.75 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.743 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -64.79 -32.17 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.944 0.402 . . . . 0.0 110.479 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.5 tp10 -87.8 -35.45 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.821 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.52 -42.02 62.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -57.64 -44.11 99.27 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.0 Cg_exo -63.95 -40.29 28.48 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.243 1.962 . . . . 0.0 111.76 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -70.14 -43.39 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.736 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.35 -34.16 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.318 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.6 mmt -66.28 -37.83 86.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 110.957 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.2 81.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 62.5 t80 -68.99 -42.1 76.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 102' ' ' PHE . 30.3 m -82.24 -23.37 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.32 -82.09 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.79 51.86 0.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -132.06 92.21 3.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.769 0.318 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -155.09 170.81 20.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.59 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 14.9 p30 -96.09 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -148.33 -47.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.31 42.96 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.26 174.07 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 111.182 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.1 116.41 1.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.528 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 30.6 mtp -112.56 -161.7 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.69 -120.37 1.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -56.43 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.735 ' O ' HG12 ' A' ' 80' ' ' VAL . 2.1 m 60.45 102.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.991 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 79' ' ' THR . 9.7 p 53.78 142.72 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.801 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 80' ' ' VAL . 31.2 Cg_exo -59.79 138.2 81.4 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.304 2.003 . . . . 0.0 112.128 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.9 m -86.01 153.96 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.649 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.26 167.6 13.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.18 140.52 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.162 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.497 ' HB2' ' HE1' ' A' ' 168' ' ' TYR . . . -76.7 136.65 39.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.432 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.616 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.6 m -131.38 102.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.857 0.361 . . . . 0.0 111.09 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -70.7 111.76 10.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.628 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.5 Cg_endo -87.94 137.85 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.724 2.283 . . . . 0.0 112.503 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.11 155.14 18.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.839 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.28 -19.0 61.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -85.24 -6.02 59.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.491 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.94 -1.94 59.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -95.56 165.39 12.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.348 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 88' ' ' PRO . 55.0 mt -112.2 140.64 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 163.09 24.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -79.95 -11.83 59.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 124.7 33.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.703 0.287 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.7 141.21 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.067 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -121.88 115.98 23.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -90.63 128.12 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.329 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -103.37 142.07 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.708 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 66' ' ' VAL . 62.9 t80 -126.07 150.73 47.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 0.0 111.519 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' CE2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -108.77 108.04 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.514 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 40' ' ' LYS . 34.5 mt -80.25 136.05 53.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.343 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 30.5 Cg_endo -63.56 154.23 70.08 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.664 2.242 . . . . 0.0 112.511 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 69.3 m-80 -55.87 -26.87 49.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.284 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -56.98 -40.38 76.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.405 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 40.5 m-85 -101.86 -8.07 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.749 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -53.95 -37.58 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.332 . . . . 0.0 111.055 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.23 -31.13 61.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -174.53 85.37 0.34 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.4 Cg_exo -56.88 145.53 83.8 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.6 Cg_exo -70.88 151.85 63.0 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.489 2.126 . . . . 0.0 112.081 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . . . -67.33 111.59 7.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 33.0 Cg_exo -58.36 158.87 21.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.479 2.119 . . . . 0.0 112.192 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -110.44 30.83 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 120' ' ' VAL . 37.3 m-20 -130.26 112.15 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.02 -29.07 65.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.3 -27.54 32.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 117' ' ' ASP . 29.5 t -85.11 125.47 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 157.11 33.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.408 ' CG2' ' HG2' ' A' ' 40' ' ' LYS . 20.7 mm -105.73 119.48 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.83 21.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.51 156.07 39.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 58.8 103.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.24 -66.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 111.184 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.3 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.088 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.409 HD13 ' HE2' ' A' ' 168' ' ' TYR . 1.5 pt -129.26 142.98 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.007 0.432 . . . . 0.0 111.629 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 34' ' ' ARG . 84.0 m -115.42 128.98 56.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.252 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 188' ' ' VAL . 35.8 m -134.47 160.02 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 111.737 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.432 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.93 136.3 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.205 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.1 p -105.67 131.08 53.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 111.396 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -125.34 139.25 53.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -116.85 137.17 52.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 6.1 p90 -134.57 140.75 46.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.36 93.9 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 159.1 161.1 10.86 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.581 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -65.79 167.86 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.52 147.99 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -135.79 -175.91 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.616 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.2 tt0 -58.35 -69.43 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.83 72.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.688 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.15 -34.85 78.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.031 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.77 -40.75 98.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.87 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.76 -38.88 36.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.61 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.53 -36.27 70.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.919 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 48.0 m-70 -70.14 -43.28 71.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.901 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.92 72.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 m -65.55 -37.84 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -58.76 -45.83 88.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 187' ' ' LEU . 11.0 tp -58.59 -38.79 78.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -64.29 -43.25 95.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -68.13 -38.57 82.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 56.1 m -57.49 -49.08 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 131' ' ' TYR . 47.3 mt -73.56 -19.5 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.17 102.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 113.08 32.7 2.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.3 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.0 p -145.52 165.42 21.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.82 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 32.6 Cg_exo -58.06 -17.33 30.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.666 2.244 . . . . 0.0 112.674 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.28 41.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.94 -171.21 1.93 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.933 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.746 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 6.6 m-85 -155.43 154.0 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.06 -164.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -56.68 -86.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.17 77.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.3 p -161.67 132.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.879 ' HB3' HD23 ' A' ' 187' ' ' LEU . 14.7 p90 -141.17 163.63 32.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.508 ' CE2' HG22 ' A' ' 188' ' ' VAL . 22.1 m-85 -112.94 157.49 21.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.532 ' SG ' HG13 ' A' ' 185' ' ' VAL . 11.1 m -143.87 136.98 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.01 138.53 48.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.026 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.89 0.376 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -115.63 133.89 55.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.585 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.36 156.89 44.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.532 HG13 ' SG ' ' A' ' 169' ' ' CYS . 29.3 t -121.43 114.85 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.11 125.68 51.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.346 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.3 mt -92.54 140.51 29.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.593 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' VAL . 18.6 t -74.59 131.14 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.358 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -79.95 163.43 24.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.206 -0.902 . . . . 1.0 111.096 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.55 113.0 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mt -96.67 -12.94 23.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.442 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.48 166.29 10.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 p -152.47 -176.78 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.47 141.95 1.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.422 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -154.67 -173.74 23.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -78.81 158.98 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -66.59 -30.38 70.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.06 -35.03 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.6 m -146.08 107.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.006 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 5.7 p -97.29 156.14 16.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p90 -140.12 162.05 36.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 28.2 mt-10 -145.52 136.38 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.77 130.8 34.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 127.98 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -112.58 139.1 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 111.255 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -133.71 132.21 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.794 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.67 149.21 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 118.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' CA ' ' HG3' ' A' ' 109' ' ' GLN . . . 141.92 148.93 5.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.603 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HG2' HG22 ' A' ' 122' ' ' ILE . 2.2 mttm -105.36 158.18 16.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.854 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -137.63 157.6 46.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.94 140.3 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.434 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.9 p -137.03 143.43 42.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.687 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 62' ' ' ILE . 21.3 t -129.25 125.87 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.687 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -95.85 131.18 42.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.024 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.34 116.85 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.435 HG23 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -107.32 169.04 8.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 47.46 37.86 6.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 mttm -152.5 137.38 10.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.869 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 32.3 Cg_exo -57.89 -160.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.509 2.14 . . . . 0.0 112.278 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 46.2 t -92.76 -63.38 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.28 -42.83 92.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.9 -45.96 76.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.99 75.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.3 mt -58.31 -35.4 71.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.27 -33.61 74.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.5 tp10 -87.48 -28.67 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.811 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.57 -44.01 58.37 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.602 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.0 mmt -57.67 -43.46 98.81 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.92 -45.54 23.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.23 1.953 . . . . 0.0 111.884 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -70.34 -42.25 72.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.661 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.753 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.04 -37.48 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -31.77 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.001 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 63' ' ' MET . 4.2 mtmm -60.89 -29.96 69.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.385 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -73.13 -49.05 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 63' ' ' MET . 14.9 m -66.01 -22.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.44 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.81 83.18 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.97 -43.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 t -172.43 100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.016 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 70' ' ' ASN . 0.1 OUTLIER -127.34 3.36 6.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.22 41.15 17.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -148.31 -50.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.89 43.96 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 70' ' ' ASN . 12.9 m -100.92 -179.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 117.68 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.337 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.1 mtp -120.15 118.43 30.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.42 -26.19 50.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.3 ttt 63.92 132.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 t -58.13 177.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -95.29 -54.79 0.22 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.204 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 76.2 Cg_endo -93.86 130.35 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.645 2.23 . . . . 0.0 112.585 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' CE ' ' A' ' 59' ' ' MET . 53.6 t -93.07 148.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.43 148.95 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.05 154.25 50.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.201 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.36 136.69 34.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 98' ' ' LEU . 30.0 m -129.39 134.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.071 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -111.04 95.79 26.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.28 164.3 32.95 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -90.23 172.28 8.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.52 -22.16 20.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.292 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.46 -6.12 59.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.466 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.14 61.51 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.883 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -174.73 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.776 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mt -123.54 164.31 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -161.0 87.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp 51.96 -167.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD3' HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER 63.19 99.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.1 tt -144.08 128.01 17.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.167 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 115.57 29.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.973 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.811 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -71.68 141.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.731 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.9 m95 -119.35 130.99 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.13 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.5 t80 -114.76 158.9 21.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 111.63 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -116.08 107.9 15.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.482 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mt -84.92 137.1 38.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.356 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.31 154.09 25.06 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 3.9 m-20 -58.24 -26.89 63.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -47.12 87.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.482 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -86.31 -11.06 53.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.598 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.83 -42.81 68.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.634 0.255 . . . . 0.0 111.017 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.86 -29.05 58.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.8 85.48 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.607 0.242 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 40' ' ' LYS . 30.8 Cg_exo -60.82 160.94 23.27 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.573 2.182 . . . . 0.0 112.239 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.41 155.66 32.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.861 2.374 . . . . 0.0 111.972 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.08 22.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.97 168.6 22.66 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.377 2.051 . . . . 0.0 112.392 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.2 p -110.25 168.92 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' VAL . 4.4 t70 66.74 126.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.75 -16.01 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.66 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -79.81 -29.14 40.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.68 0.276 . . . . 0.0 111.253 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.4 t -85.73 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -123.02 156.92 33.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.467 HG22 ' HG2' ' A' ' 40' ' ' LYS . 11.9 mm -113.71 128.46 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.8 153.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.27 179.86 6.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -58.66 98.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.67 -21.86 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.9 74.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 188' ' ' VAL . 1.1 pp -138.55 145.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -103.78 137.45 41.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -139.17 145.63 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.496 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.4 OUTLIER -107.79 128.81 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.4 p -105.51 142.29 35.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.141 0.496 . . . . 0.0 111.707 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.0 t -127.67 139.6 52.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -116.15 125.0 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.404 . . . . 0.0 111.023 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 12.5 p90 -131.03 -177.88 4.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -117.58 130.22 8.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.566 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.31 -177.37 20.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.568 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -94.43 166.9 11.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -177.18 121.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.245 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.22 -73.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.778 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -141.4 -47.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.785 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -73.03 -33.95 66.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 110.605 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -35.09 76.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.927 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -64.22 -39.08 93.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.245 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 141' ' ' GLU . 57.4 t -53.63 -38.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.452 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.2 70.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.78 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.499 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.7 m-70 -70.0 -42.79 72.58 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.807 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.94 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.4 m -67.66 -39.44 84.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.704 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.25 -46.05 92.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 tp -58.28 -38.88 77.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -64.12 -42.56 96.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.5 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.7 m -69.15 -37.07 78.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.4 m -57.54 -38.9 75.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 162' ' ' TYR . 32.1 mt -72.4 -22.71 61.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.23 95.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.216 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.93 33.12 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 p -145.54 155.26 53.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 36.3 Cg_endo -65.09 -12.99 37.33 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.615 2.21 . . . . 0.0 112.605 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.496 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -58.41 159.8 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 156.54 47.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CD1' HD13 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -154.48 155.81 35.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -79.38 -61.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.03 -16.69 58.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.687 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.58 -27.47 34.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.066 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 166' ' ' VAL . 8.4 p -160.76 118.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.797 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.3 p90 -119.03 171.38 8.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.625 ' CE2' HG22 ' A' ' 188' ' ' VAL . 33.5 m-85 -113.15 140.16 48.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.82 147.58 35.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 184' ' ' GLU . . . -132.04 127.82 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.582 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.907 0.384 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -108.93 158.01 18.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.515 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.825 ' CG ' ' HB3' ' A' ' 170' ' ' ALA . 0.7 OUTLIER -141.38 144.18 34.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.7 124.64 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.727 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.14 132.37 54.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 111.725 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 167' ' ' TYR . 16.8 mt -92.33 140.21 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.656 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 130' ' ' VAL . 19.6 t -74.69 131.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.462 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 69.1 tttt -69.53 154.21 42.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 1.0 111.077 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.675 0.274 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.11 112.83 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.857 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.88 -12.99 22.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.79 167.09 9.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.69 154.49 36.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.23 164.26 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -161.17 -58.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -161.95 164.48 28.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.785 0.326 . . . . 0.0 110.748 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -33.74 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -91.08 -35.29 14.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CB ' ' A' ' 150' ' ' GLN . 3.5 m -146.44 108.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.83 0.348 . . . . 0.0 111.723 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.31 158.06 16.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 154' ' ' THR . 0.2 OUTLIER -139.07 162.35 35.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.92 0.39 . . . . 0.0 111.114 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.76 132.85 21.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -85.98 126.96 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.97 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.93 127.35 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -152.88 96.18 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.48 -50.65 72.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.77 -119.77 19.57 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.622 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.96 -119.46 1.01 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -91.91 159.34 15.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.832 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 102' ' ' PHE . 38.4 m-85 -137.44 148.93 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.042 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.81 140.34 29.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 66.5 p -132.1 136.02 46.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 111.576 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.517 HG21 ' HB ' ' A' ' 62' ' ' ILE . 39.9 t -125.9 125.56 68.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.662 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -96.88 131.45 43.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.095 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 54' ' ' ALA . 16.6 t -138.26 116.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.002 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.41 174.11 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.51 25.99 3.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.398 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -152.95 130.02 5.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.06 177.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.313 2.009 . . . . 0.0 112.23 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 82.7 t -62.2 -57.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.024 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -58.24 -45.25 88.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.17 -46.21 74.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.91 -45.0 91.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.194 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.8 mt -57.1 -35.59 69.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.77 -31.81 73.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.1 tp10 -87.27 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.672 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.47 -42.66 61.62 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.509 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.0 mmt -57.69 -44.15 99.27 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.3 Cg_exo -63.29 -40.54 31.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.21 1.94 . . . . 0.0 111.718 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -70.24 -44.03 69.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.035 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.5 tt -76.1 -31.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -42.79 87.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.6 mttt -58.92 -42.27 89.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 7.0 t80 -59.63 -50.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.54 -27.62 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.37 -105.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.594 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.46 67.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.4 HG21 ' HD3' ' A' ' 64' ' ' LYS . 68.6 m -164.4 71.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 0.0 110.761 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.498 ' N ' ' ND2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -134.94 10.41 3.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.372 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 57.05 38.94 29.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 111.025 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -52.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.46 79.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.552 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.455 HG22 ' OD1' ' A' ' 70' ' ' ASN . 26.8 m -139.0 143.65 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.896 0.379 . . . . 0.0 111.169 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.87 -42.66 94.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.419 ' HA ' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 65.48 -76.4 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.89 -23.16 8.37 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.412 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 64.46 162.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.04 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.76 HG22 ' HD2' ' A' ' 81' ' ' PRO . 7.8 m -122.29 131.63 54.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 1.5 t -68.43 -53.05 18.6 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.76 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.3 Cg_endo -81.1 130.78 7.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.417 2.078 . . . . 0.0 112.354 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -154.37 134.61 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.975 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 1.8 t -114.96 167.99 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -126.91 154.22 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.729 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.35 136.57 33.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.307 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.69 HG12 HD12 ' A' ' 98' ' ' LEU . 33.3 m -131.28 128.35 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 111.132 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -98.95 104.25 24.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 94' ' ' LEU . 41.4 Cg_endo -66.84 128.31 18.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.412 2.074 . . . . 0.0 112.202 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -90.29 156.88 17.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -66.02 -15.9 63.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.314 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.04 5.18 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.552 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.59 -16.0 60.16 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.752 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 162.87 13.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 88' ' ' PRO . 27.1 mt -87.8 -4.91 58.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.509 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 62.33 162.34 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -80.75 84.15 6.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -175.68 106.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.7 tt -138.22 127.96 25.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.64 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.672 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -76.22 141.15 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.95 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.409 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 50.6 t80 -120.98 150.26 41.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.518 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.74 114.5 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 mt -92.75 134.51 27.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.82 154.06 28.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.622 2.215 . . . . 0.0 112.405 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -60.49 -26.75 67.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.07 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -56.96 -32.81 66.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.409 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 76' ' ' MET . 57.9 m-85 -106.03 -9.71 16.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.799 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.95 -33.8 52.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.17 77.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 76.28 3.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.658 0.266 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 33.0 Cg_exo -59.72 148.23 88.84 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.635 2.223 . . . . 0.0 112.303 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.44 ' CG ' HG21 ' A' ' 74' ' ' VAL . 6.9 Cg_exo -72.57 159.24 49.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.59 133.26 94.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 27.6 Cg_endo -62.9 -22.24 73.7 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.129 . . . . 0.0 112.417 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 m 52.97 28.46 6.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.75 122.83 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.06 -24.01 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.177 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.07 -35.81 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.96 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 44' ' ' VAL . 43.6 t -85.05 123.67 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 157.03 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.2 mm -112.2 118.58 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.934 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.94 129.48 45.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 125' ' ' ARG . 5.7 tt0 -95.38 -152.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.608 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 6.4 mtt180 67.92 71.85 0.32 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.727 0.299 . . . . 0.0 111.458 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 38.3 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.93 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -97.7 -145.31 18.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.427 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -144.15 145.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.324 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.3 m -103.91 118.93 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.499 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.908 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.5 m -140.72 170.38 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.379 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.549 ' CE2' HD22 ' A' ' 155' ' ' LEU . 5.0 m-85 -107.32 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.329 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 98.1 p -130.23 136.28 49.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -131.09 139.15 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.344 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -116.88 140.59 49.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.32 173.55 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.23 -30.01 8.07 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.555 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.02 118.0 12.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.59 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.46 121.77 25.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -113.87 150.89 32.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.278 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -106.36 -59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.68 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 94' ' ' LEU . 27.4 tt0 -152.02 -67.73 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -33.78 73.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.8 t70 -67.76 -34.59 77.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.8 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.4 OUTLIER -62.56 -40.25 96.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.54 0.686 . . . . 0.0 109.742 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.89 -38.72 37.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.709 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.26 -33.8 72.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.795 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.415 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.0 m-70 -70.12 -46.1 65.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -62.14 -32.88 73.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.4 m -62.99 -43.99 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.401 ' CB ' HG11 ' A' ' 29' ' ' VAL . 3.9 mt-30 -62.45 -46.07 90.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.694 ' HB3' HD11 ' A' ' 187' ' ' LEU . 11.2 tp -59.1 -39.68 83.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.83 -48.11 82.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.308 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.5 m -62.23 -45.27 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.166 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 31' ' ' TYR . 4.1 m -57.53 -44.56 85.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.614 ' CD1' HD12 ' A' ' 187' ' ' LEU . 12.4 mt -72.89 -17.01 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.143 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.79 -38.06 14.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 111.445 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.63 -14.18 82.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.465 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -93.89 176.38 2.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.806 0.303 . . . . 0.0 111.064 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.465 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 13.4 Cg_exo -70.02 -1.04 8.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.25 143.0 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.708 0.29 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 16.1 m -130.39 2.06 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.766 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.95 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 8.0 m-85 56.92 159.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.62 -80.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.24 38.6 1.23 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.276 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.13 71.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 110.713 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 166' ' ' VAL . 14.0 p -161.76 124.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.852 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.5 p90 -126.0 175.0 8.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.729 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 68.3 m-85 -119.6 162.03 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 94.6 m -130.82 130.86 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.016 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 83' ' ' SER . . . -132.02 156.02 46.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.674 0.273 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 44.7 m-80 -133.11 138.39 46.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 111.469 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -146.09 157.29 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.628 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.804 HG13 ' CD2' ' A' ' 167' ' ' TYR . 10.6 t -134.85 114.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.888 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 44.0 m0 -109.33 121.53 45.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.207 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.852 HD23 ' HB3' ' A' ' 167' ' ' TYR . 72.2 mt -94.53 140.08 30.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.666 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.908 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.3 t -87.08 123.59 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.3 150.34 40.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.95 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 1.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 23' ' ' THR . 23.8 t -74.29 112.88 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.802 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.98 -9.42 37.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.478 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.83 158.95 7.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.843 0.354 . . . . 0.0 110.937 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.41 ' CG2' HG11 ' A' ' 20' ' ' VAL . 79.1 p -152.64 164.22 38.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.8 -137.25 13.22 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . 133.04 -170.38 22.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.518 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' HG23 ' A' ' 154' ' ' THR . 6.0 mtpt -78.56 162.04 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 0.0 110.839 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -25.21 66.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.78 -32.64 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.04 122.51 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.068 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.44 147.63 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.433 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 8.4 p90 -139.17 155.74 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.59 128.8 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -86.75 127.29 34.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.11 134.45 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.06 127.43 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.48 128.55 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.61 -66.84 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.61 178.34 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.528 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.48 -111.14 1.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtmt -92.01 157.61 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 23.4 m-85 -137.4 157.38 46.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -101.94 135.3 43.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 38.7 p -137.31 151.49 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.509 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG23 HD12 ' A' ' 62' ' ' ILE . 22.0 t -131.66 125.96 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.703 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -95.88 130.27 42.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.26 116.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.018 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.58 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -111.81 176.86 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.974 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.03 31.01 1.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -152.36 138.2 11.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.8 -160.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.432 2.088 . . . . 0.0 112.205 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.945 HG13 ' CD1' ' A' ' 98' ' ' LEU . 62.3 t -90.28 -48.07 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.13 -45.12 74.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -46.38 74.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.94 92.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.3 mt -57.11 -35.46 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -62.67 -29.91 70.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.12 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 tp10 -89.84 -32.9 16.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.316 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -72.89 -43.85 62.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.475 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.598 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 9.4 mmt -57.69 -44.05 99.19 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 59' ' ' MET . 42.9 Cg_endo -69.06 -36.26 13.02 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.984 1.789 . . . . 0.0 112.207 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -70.16 -43.6 70.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.653 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 44' ' ' VAL . 9.4 tt -77.91 -27.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.328 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -37.14 84.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.037 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -58.78 -37.1 75.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 19.1 t80 -67.12 -56.43 10.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.612 HG11 ' CE2' ' A' ' 102' ' ' PHE . 31.9 m -65.87 -30.72 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.8 -100.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 64.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.509 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -147.76 65.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -145.1 165.5 28.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.717 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.1 m-20 -90.02 46.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -145.8 4.57 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.677 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.52 32.01 5.3 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.747 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 108' ' ' PHE . 1.4 p -96.66 140.57 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.879 -0.66 . . . . 0.0 111.67 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.4 49.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.421 ' HE3' ' HD2' ' A' ' 105' ' ' PRO . 14.3 ptm -52.17 -48.89 64.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.59 -161.85 35.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.547 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 tpt -92.23 147.74 22.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.636 HG22 HG23 ' A' ' 80' ' ' VAL . 7.2 m -151.37 120.8 6.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.636 HG23 HG22 ' A' ' 79' ' ' THR . 14.0 t 64.27 136.43 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.56 130.69 34.54 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.27 1.98 . . . . 0.0 112.184 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.671 HG11 ' CD2' ' A' ' 102' ' ' PHE . 32.9 m -88.91 154.05 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.321 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 t -117.89 173.73 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -131.8 154.21 49.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.003 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.04 136.82 32.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.402 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' CE1' ' A' ' 167' ' ' TYR . 23.9 m -132.89 132.98 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.173 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -106.27 98.16 18.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.808 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.3 Cg_endo -75.59 138.89 22.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -90.26 161.77 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.86 -19.12 62.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.2 -5.87 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.65 -3.44 78.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.882 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.48 139.52 51.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.6 mt -80.14 144.09 33.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -96.98 48.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.82 96.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -179.64 107.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.945 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.8 tt -142.82 128.13 18.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.489 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -115.54 115.65 26.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.248 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -74.24 141.35 16.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 0.0 111.594 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HA ' HG22 ' A' ' 43' ' ' THR . 13.8 m95 -121.64 126.05 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.276 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CD2' HG11 ' A' ' 82' ' ' VAL . 52.9 t80 -110.13 155.18 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 111.612 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 107.88 15.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.585 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.434 HG13 ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.13 139.68 92.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD2' HG13 ' A' ' 104' ' ' ILE . 32.5 Cg_endo -64.35 153.99 73.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.489 2.126 . . . . 0.0 112.319 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -56.63 -26.8 56.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.284 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.446 ' HB3' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -56.98 -32.81 66.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 74' ' ' VAL . 11.3 m-85 -116.8 20.22 14.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.426 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -55.09 -33.85 63.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.46 -25.82 67.13 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.01 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -177.73 107.95 0.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.736 0.268 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 108' ' ' PHE . 52.6 Cg_endo -69.08 161.12 47.16 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.41 2.074 . . . . 0.0 112.187 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.512 ' CG ' HG11 ' A' ' 74' ' ' VAL . 10.2 Cg_exo -70.7 150.49 62.58 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.584 2.189 . . . . 0.0 112.003 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . . . -66.98 114.13 16.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 58.8 Cg_endo -73.04 165.95 31.36 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.352 2.034 . . . . 0.0 112.335 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.2 m -127.68 33.19 4.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.739 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -125.71 114.44 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.91 -26.53 62.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.12 -26.93 33.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 117' ' ' ASP . 42.9 t -84.89 115.5 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.13 156.93 19.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.817 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.16 127.4 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -98.76 160.16 14.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -147.45 129.15 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 63.55 123.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -169.08 -80.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.8 110.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.369 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.49 142.91 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 111.253 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 m -107.86 119.03 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -129.55 161.11 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.382 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 151' ' ' LEU . 5.3 m-85 -107.93 138.23 44.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 p -108.75 142.39 39.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.1 t -129.68 139.0 51.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -116.86 130.44 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.95 144.59 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.09 95.66 1.99 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.52 159.0 28.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -72.17 174.87 6.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.34 144.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.33 -60.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 94' ' ' LEU . 70.9 tt0 -159.85 -66.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.58 70.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.491 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.93 -34.89 78.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.945 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -41.62 99.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 109.893 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.95 -38.8 38.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.559 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.03 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.897 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -67.76 -41.93 82.55 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.798 0.333 . . . . 0.0 111.044 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.001 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -67.79 -39.48 84.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 131' ' ' TYR . 7.9 tp -57.95 -43.39 86.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . 18.0 mtt85 -59.83 -40.0 87.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.368 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' OE1' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -68.97 -42.54 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.51 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' ' 26' ' ' LYS . 97.9 m -57.58 -49.46 76.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.85 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 162' ' ' TYR . 11.5 mt -75.12 -10.36 59.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.74 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.481 ' OE1' HG22 ' A' ' 153' ' ' THR . 9.4 pt-20 -47.55 -29.0 2.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.787 0.327 . . . . 0.0 111.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -98.51 26.68 22.87 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.587 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.9 p -146.05 160.51 42.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.77 -5.54 17.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.95 2.433 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.75 119.8 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -103.57 157.28 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.755 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.432 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -156.02 -176.02 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -115.5 156.77 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.56 -4.02 10.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.713 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.673 ' OD1' HG12 ' A' ' 166' ' ' VAL . 2.0 p30 -81.92 -22.78 36.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.609 0.242 . . . . 0.0 111.255 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.673 HG12 ' OD1' ' A' ' 165' ' ' ASP . 14.9 p -160.46 158.11 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 111.406 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.9 p90 -166.25 163.13 17.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.538 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 10.0 m-85 -112.94 158.82 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.671 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.4 m -142.25 158.93 43.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.61 139.28 49.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -108.92 157.98 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.517 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.47 145.53 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.287 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.671 HG13 ' SG ' ' A' ' 169' ' ' CYS . 17.7 t -124.99 133.49 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.564 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -107.76 121.54 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 130' ' ' VAL . 21.8 mt -97.08 134.53 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.576 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.96 119.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -69.76 140.69 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.604 ' HB3' ' OG1' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 1.0 111.141 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.878 0.37 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.24 115.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.53 -2.4 38.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -170.24 165.85 8.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.28 -175.93 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.69 152.79 17.34 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -155.34 178.1 32.16 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.64 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -78.85 158.48 28.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.49 -29.16 69.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -89.86 -31.01 17.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 150' ' ' GLN . 22.1 t -145.98 117.02 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 m -95.33 137.45 34.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.04 162.13 35.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -144.94 140.69 28.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.35 126.58 34.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.921 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.99 127.91 39.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.91 135.08 50.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -159.9 79.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HG3' ' CE2' ' A' ' 41' ' ' PHE . 8.8 mp0 -142.25 137.33 30.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.14 -99.74 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.91 -59.99 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 104' ' ' ILE . 24.5 mttm -109.33 145.88 35.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 37' ' ' GLU . 5.2 m-85 -137.58 147.34 44.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 139.07 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.55 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 16.6 p -137.35 155.33 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.983 0.421 . . . . 0.0 111.7 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 62' ' ' ILE . 21.5 t -135.3 125.82 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -95.83 132.93 40.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 58' ' ' ALA . 22.4 t -138.32 122.45 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.86 170.53 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.24 38.72 1.72 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -152.56 128.16 5.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.895 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.71 -167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.412 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 HD13 ' A' ' 98' ' ' LEU . 36.5 t -78.54 -60.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.195 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.72 -44.78 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.48 -46.31 83.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.832 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.94 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.841 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -58.7 -35.94 73.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -66.37 -32.98 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 tp10 -87.19 -41.74 13.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.14 -37.01 66.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 10.9 mmt -57.85 -44.03 99.08 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.5 Cg_endo -70.09 -32.52 17.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.919 1.746 . . . . 0.0 112.16 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -70.25 -45.16 67.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 HG23 ' A' ' 44' ' ' VAL . 1.1 tt -77.48 -36.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.249 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.645 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 mtt -66.21 -41.88 89.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.761 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -58.85 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.727 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -67.88 -46.62 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 63' ' ' MET . 32.3 m -69.85 -27.77 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.32 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.32 99.63 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.98 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 69' ' ' THR . 3.7 t -164.19 88.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -113.06 -12.49 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.14 40.9 8.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.966 0.413 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -147.76 -46.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.42 30.45 4.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.009 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 108' ' ' PHE . 27.0 m -100.44 153.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.333 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.12 81.43 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mtt -63.1 -48.05 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.46 53.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.6 tpt 62.39 147.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 80' ' ' VAL . 7.3 m -164.02 130.67 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 79' ' ' THR . 36.7 t 64.02 136.67 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 80' ' ' VAL . 22.0 Cg_endo -61.12 134.06 50.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.454 2.102 . . . . 0.0 112.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.22 136.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.241 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.01 160.29 19.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.357 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -127.03 154.27 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.106 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -90.17 136.7 32.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 98' ' ' LEU . 33.7 m -132.23 123.7 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -98.31 102.98 15.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.767 ' HA ' HD23 ' A' ' 94' ' ' LEU . 85.6 Cg_endo -77.5 140.76 19.37 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.485 2.124 . . . . 0.0 112.271 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.35 163.0 14.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -15.9 63.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.354 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -85.23 4.22 35.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.589 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 90.67 -16.04 59.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.849 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -95.84 162.93 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 88' ' ' PRO . 95.9 mt -92.91 171.72 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -103.82 157.8 16.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -80.51 61.06 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -161.96 109.24 1.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -125.97 146.16 49.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.236 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.26 115.72 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.339 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -81.19 141.36 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -121.67 132.16 54.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 19.3 t80 -121.57 134.86 55.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.016 0.436 . . . . 0.0 111.377 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.65 118.06 34.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 40' ' ' LYS . 28.1 mt -84.44 136.35 40.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.7 Cg_endo -65.68 154.25 74.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 109' ' ' GLN . 34.2 m120 -51.6 -26.63 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -56.9 -32.9 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HE2' HG11 ' A' ' 74' ' ' VAL . 32.7 m-85 -116.04 -1.09 12.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 106' ' ' ASN . 1.2 pp0? -54.06 -34.26 59.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.815 0.341 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.58 -34.04 88.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.765 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.91 84.08 0.52 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.316 . . . . 0.0 110.972 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 32.5 Cg_exo -58.97 160.37 18.62 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.174 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 3.5 Cg_exo -73.98 152.13 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.686 2.257 . . . . 0.0 112.004 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 121.11 79.54 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.318 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 119.9 6.2 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.473 2.115 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -64.55 -39.81 94.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.407 ' CB ' HG23 ' A' ' 120' ' ' VAL . 2.0 m-20 -58.32 112.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.402 . . . . 0.0 110.875 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -26.73 61.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -81.73 -28.81 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 44' ' ' VAL . 39.2 t -85.28 115.91 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -120.83 156.95 30.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 40' ' ' LYS . 24.6 mm -103.44 131.37 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.95 129.93 45.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -89.01 126.44 35.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.8 ttm180 58.05 -173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 10.2 tt0 84.86 78.08 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 169.41 52.81 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.195 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.98 142.99 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -119.22 134.0 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.051 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 187' ' ' LEU . 36.0 m -139.7 164.61 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.675 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -107.77 133.48 52.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.265 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -105.76 140.23 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.273 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -130.99 139.13 49.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.74 130.31 56.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.645 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 31.5 p90 -139.29 -177.81 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.56 110.87 1.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.469 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -176.74 -133.28 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.4 103.31 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.753 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.06 150.11 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.98 -47.89 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.683 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.509 ' CG ' HD12 ' A' ' 94' ' ' LEU . 72.1 tt0 -162.05 -69.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.511 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.62 72.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.522 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.95 -34.98 78.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.011 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -40.6 98.17 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.3 t -53.76 -38.71 36.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.54 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.45 -37.86 74.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.774 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.645 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -70.23 -43.69 70.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.891 0.377 . . . . 0.0 110.804 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.28 -32.92 72.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.615 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -68.47 -43.36 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.681 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 29' ' ' VAL . 2.7 tp-100 -61.88 -46.1 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.425 ' HG ' HD12 ' A' ' 187' ' ' LEU . 13.3 tp -61.45 -36.95 81.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.42 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.17 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.5 m -69.08 -34.86 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.64 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.431 HG22 ' CE1' ' A' ' 31' ' ' TYR . 5.0 m -57.51 -47.03 83.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.857 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 31' ' ' TYR . 6.4 mt -72.51 -21.21 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.89 -44.91 20.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.335 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.92 35.26 4.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.695 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.2 p -146.32 156.47 49.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.747 0.308 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 -11.05 29.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.696 2.264 . . . . 0.0 112.701 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.23 139.68 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 0.0 111.158 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.2 m -100.51 140.87 34.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.731 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -159.6 156.9 28.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -90.43 136.65 32.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.29 56.98 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.17 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.85 -23.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.12 143.79 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.913 0.387 . . . . 0.0 111.271 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.637 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.2 p90 -142.88 174.07 10.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.8 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 94.9 m-85 -113.79 152.57 30.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.15 146.1 49.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.93 133.38 44.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.465 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.952 0.405 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 7.2 m-80 -133.0 138.97 47.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.632 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -142.92 145.98 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 111.241 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.09 134.44 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.7 m0 -108.07 121.62 45.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.274 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.679 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.4 mt -96.35 139.37 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.433 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.85 129.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 11.6 tttm -88.46 48.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.252 -0.88 . . . . 1.0 111.472 179.817 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.82 ' CG ' ' HB3' ' A' ' 35' ' ' ALA . 8.0 pt20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.802 0.334 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.424 HG11 HG23 ' A' ' 23' ' ' THR . 29.2 t -74.47 112.82 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.586 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.26 -4.03 46.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.27 158.85 6.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.809 0.338 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.424 HG23 HG11 ' A' ' 20' ' ' VAL . 3.0 p -153.29 174.15 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.65 168.96 8.01 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.47 -162.23 28.24 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.691 ' HD2' HG23 ' A' ' 154' ' ' THR . 7.7 mttt -78.39 157.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.932 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -66.56 -26.27 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.96 -34.97 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.08 110.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.6 m -95.16 148.3 22.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -138.5 153.11 48.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 23' ' ' THR . 1.3 mt-10 -146.37 130.45 17.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.18 114.88 23.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 147.52 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.82 ' HB3' ' CG ' ' A' ' 19' ' ' GLN . . . -124.98 130.74 52.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -144.01 144.91 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.32 89.19 3.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -148.63 3.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.89 -111.85 0.69 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.99 152.72 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.343 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -137.7 153.73 49.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 124.0 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 123' ' ' GLU . 81.8 p -112.7 131.94 55.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.418 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.521 HG23 HD12 ' A' ' 62' ' ' ILE . 21.7 t -131.06 125.41 57.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.768 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.1 135.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.566 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.6 t -138.31 116.82 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 173.81 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.23 28.05 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.358 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -152.73 121.58 3.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.71 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.477 2.118 . . . . 0.0 112.177 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.99 HG13 HD13 ' A' ' 98' ' ' LEU . 49.0 t -62.03 -52.83 55.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -63.44 -45.25 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.1 -46.03 75.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.86 -45.14 90.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.34 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -58.34 -35.41 71.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 mtm105 -63.12 -31.55 72.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 109.942 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.7 tp10 -86.97 -33.47 19.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.147 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.71 -40.67 63.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.76 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.507 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.3 mmt -57.61 -44.02 99.23 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 23.3 Cg_exo -64.58 -42.93 14.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.257 1.972 . . . . 0.0 111.913 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.2 -41.28 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.521 HD12 HG23 ' A' ' 44' ' ' VAL . 2.3 tt -76.26 -42.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.372 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -65.04 -31.76 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -69.75 -29.81 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.434 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -71.37 -42.81 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 102' ' ' PHE . 33.8 m -65.96 -28.17 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.11 93.34 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.67 -40.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.37 84.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.726 ' ND2' HG22 ' A' ' 74' ' ' VAL . 34.2 p-10 -125.02 0.43 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.401 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 61.75 39.05 14.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 -47.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.38 52.03 3.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.726 HG22 ' ND2' ' A' ' 70' ' ' ASN . 27.8 m -101.06 -178.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.99 78.47 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.6 mtp -82.0 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.364 . . . . 0.0 110.735 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 78' ' ' MET . . . 75.72 46.13 15.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.759 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 17.8 mmt 67.47 -62.08 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.563 0.221 . . . . 0.0 111.498 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m 78.75 -60.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.94 158.11 76.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.052 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 130.77 36.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.395 2.063 . . . . 0.0 112.118 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 102' ' ' PHE . 6.1 m -87.24 154.06 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.321 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 t -130.72 160.23 34.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.61 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -121.3 154.3 36.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.213 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.43 136.65 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.813 ' HB ' HD22 ' A' ' 94' ' ' LEU . 15.7 m -124.81 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -113.24 93.82 27.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.39 138.79 62.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.598 2.199 . . . . 0.0 112.077 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.97 171.95 9.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.94 -22.11 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.41 -6.07 59.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.442 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.46 -16.05 61.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.767 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.45 133.5 33.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.813 HD22 ' HB ' ' A' ' 86' ' ' VAL . 13.3 mt -62.41 -30.0 70.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.57 -175.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -80.67 90.23 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.34 100.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.99 HD13 HG13 ' A' ' 51' ' ' VAL . 1.6 tt -144.13 135.53 25.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 111.365 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.442 ' HD2' ' CD1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -119.53 115.79 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.032 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.4 t -78.54 141.15 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 99' ' ' LYS . 18.5 m95 -122.39 138.61 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.5 t80 -119.47 146.18 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 111.485 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -102.04 111.1 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.718 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.0 mt -92.25 136.34 25.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 38.0 Cg_endo -66.36 154.16 75.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.57 2.18 . . . . 0.0 112.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -55.46 -26.71 43.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.323 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -56.84 -32.89 66.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.22 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -100.54 -4.7 28.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.54 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -45.42 72.69 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.761 0.315 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.13 -26.58 43.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.633 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.74 91.55 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.19 161.1 41.77 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.383 2.055 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 141.75 42.26 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.311 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.0 121.43 79.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.37 141.55 71.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.442 2.095 . . . . 0.0 112.275 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 84.4 p -90.58 -33.4 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -86.98 125.18 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.78 -22.15 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.223 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -31.36 30.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 117' ' ' ASP . 26.0 t -85.44 123.93 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -127.86 156.92 41.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -102.67 111.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HG3' HG21 ' A' ' 43' ' ' THR . 4.7 mm-40 -100.38 130.04 46.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 113.1 24.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.97 126.09 50.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.96 60.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.314 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.77 161.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.96 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -144.25 148.95 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.935 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -103.85 118.67 37.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.581 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 188' ' ' VAL . 13.3 m -143.34 160.65 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.295 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.581 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER -107.89 143.66 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.101 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.9 p -105.96 148.45 27.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.465 ' HB ' HD13 ' A' ' 151' ' ' LEU . 7.5 t -130.46 139.82 50.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.418 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.26 125.24 51.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.156 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 15.2 p90 -143.04 -169.6 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.421 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -46.58 138.48 7.96 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.83 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.17 170.32 55.08 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.722 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 61.05 100.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -127.2 152.93 46.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -105.62 -82.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 94' ' ' LEU . 53.5 tt0 -154.83 -61.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.93 -33.83 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.61 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.99 -34.96 77.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.987 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -42.4 96.32 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.917 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.2 t -53.9 -38.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.671 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.12 70.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.716 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 18.3 m170 -70.06 -46.1 65.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.82 -32.92 73.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -73.01 -42.16 63.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -46.06 89.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 133' ' ' THR . 11.6 tp -61.24 -37.07 81.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.5 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -43.2 93.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -68.94 -34.18 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.95 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 26' ' ' LYS . 5.3 m -57.49 -49.28 76.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.581 HD11 ' CE1' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -73.94 -13.92 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.352 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -46.62 -37.61 8.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.4 36.98 3.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 17.6 p -146.19 155.07 50.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.49 -7.75 21.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.839 2.359 . . . . 0.0 112.622 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 127.11 30.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.905 0.383 . . . . 0.0 111.28 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 190' ' ' ALA . 4.9 m -102.52 141.83 34.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -155.03 -177.94 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.988 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.82 -58.44 2.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.27 -16.48 57.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.941 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.82 -87.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.723 0.262 . . . . 0.0 111.015 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.06 138.4 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.841 0.353 . . . . 0.0 111.63 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.888 ' HB3' HD23 ' A' ' 187' ' ' LEU . 48.7 p90 -144.96 174.7 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.359 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.719 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 58.1 m-85 -119.38 161.99 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.669 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 m -139.36 151.65 46.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 128.45 38.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.168 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.804 179.759 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -120.69 148.94 43.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -142.81 155.62 44.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 133' ' ' THR . 9.3 t -129.6 115.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.462 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.49 124.4 50.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.968 0.413 . . . . 0.0 110.968 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 167' ' ' TYR . 8.1 mt -91.19 140.34 29.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.6 t -74.75 126.76 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -177.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 1.0 111.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.776 0.322 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.49 113.63 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 129' ' ' THR . 12.4 mt -95.03 -14.56 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.503 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -169.63 164.06 10.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 p -152.23 -178.35 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.764 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.98 -125.43 7.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 131.97 -95.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.626 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -161.52 163.98 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.3 69.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.77 -35.16 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.315 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.18 108.07 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.364 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.34 140.89 31.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -138.68 162.31 34.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.775 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -143.83 127.7 17.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -86.29 115.01 23.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -132.93 129.39 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.93 139.18 42.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 m -138.28 -178.23 5.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER 63.74 134.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.0 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.24 -41.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.64 -118.51 3.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.65 142.74 51.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.882 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 37' ' ' GLU . 49.9 m-85 -137.69 161.85 35.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -100.95 140.3 35.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.766 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.8 p -133.76 137.87 45.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 111.146 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.925 HG23 HD12 ' A' ' 62' ' ' ILE . 11.3 t -125.94 125.89 68.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -95.98 127.7 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 58' ' ' ALA . 11.6 t -138.17 116.92 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -109.11 176.51 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.819 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.25 30.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.319 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -152.63 121.91 3.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.82 -179.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.464 2.109 . . . . 0.0 112.246 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.3 t -61.87 -55.26 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.315 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.74 -43.82 92.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -46.06 75.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.186 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.15 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.271 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.6 mt -58.77 -35.59 73.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -63.81 -34.58 78.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.96 0.41 . . . . 0.0 109.964 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.6 tp10 -87.14 -28.81 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.63 -42.7 61.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.558 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.712 ' HE1' HG11 ' A' ' 82' ' ' VAL . 7.5 mmt -57.76 -43.6 98.83 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.65 -43.5 38.32 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.105 1.87 . . . . 0.0 111.863 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -70.37 -42.18 72.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 44' ' ' VAL . 1.3 tt -76.22 -35.12 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.476 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mtp -66.31 -31.97 73.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -64.3 -47.6 78.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 21.3 t80 -60.26 -53.92 51.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.594 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.788 HG21 ' HG3' ' A' ' 78' ' ' MET . 29.3 m -66.24 -28.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.012 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.78 -89.05 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.356 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.62 55.06 0.47 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.536 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' THR . 21.1 m -126.69 38.14 4.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.841 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -126.58 167.24 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.98 10.46 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.28 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -92.56 -30.4 15.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 43.29 38.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 113' ' ' PRO . 31.3 m -101.27 -178.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.21 88.4 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.1 mtm -96.71 107.57 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.66 -24.67 12.92 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.749 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.788 ' HG3' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER 65.89 147.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 111.05 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -93.48 168.78 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.483 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 17.6 t -85.84 -45.9 0.6 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.512 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD2' HG22 ' A' ' 79' ' ' THR . 24.2 Cg_exo -63.63 144.69 90.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.309 2.006 . . . . 0.0 112.025 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.712 HG11 ' HE1' ' A' ' 59' ' ' MET . 10.4 t -152.98 143.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.4 p -117.21 146.08 43.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.711 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -128.98 154.4 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.195 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -99.69 136.69 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.453 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HD12 ' A' ' 98' ' ' LEU . 22.6 m -125.24 135.3 64.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -103.0 95.79 7.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.297 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.803 ' HA ' HD23 ' A' ' 94' ' ' LEU . 74.4 Cg_endo -74.55 148.89 38.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.082 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 171.99 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -6.16 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.415 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 91.22 -16.04 59.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.751 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.7 p -81.3 113.03 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.811 0.338 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -73.07 148.97 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -125.85 68.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mttt 56.07 -163.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 69.4 109.45 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.759 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.7 tt -144.07 134.41 24.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -110.51 115.57 29.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.725 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.3 t -78.8 141.21 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 111.508 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -119.48 121.91 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 64.8 t80 -105.59 155.41 19.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.614 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -116.04 107.8 15.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.7 mt -79.46 136.59 56.04 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.267 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 104' ' ' ILE . 27.7 Cg_endo -62.09 154.13 64.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.322 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -55.57 -27.47 49.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -62.68 -33.21 74.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -107.26 -14.48 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -53.15 -44.04 67.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.741 0.305 . . . . 0.0 111.061 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.16 66.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.455 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.78 91.18 0.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 160.98 47.69 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.542 2.161 . . . . 0.0 112.266 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.687 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.6 Cg_exo -70.85 149.87 60.66 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.697 2.265 . . . . 0.0 111.973 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.21 111.71 7.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 32.2 Cg_exo -59.59 167.39 6.65 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.506 2.138 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.5 m -145.92 34.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.6 123.61 17.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.0 -26.01 61.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.0 -30.52 31.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.39 114.01 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 150.98 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.4 132.72 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.78 160.12 14.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -149.4 140.82 23.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.082 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.57 18.27 9.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.27 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.11 160.21 32.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.92 119.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.458 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.23 143.9 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.756 HG21 HD12 ' A' ' 21' ' ' LEU . 28.1 m -103.87 123.54 47.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.512 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.905 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.9 m -133.13 170.16 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.008 0.433 . . . . 0.0 111.729 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.751 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -134.46 125.94 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.945 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.4 p -105.76 143.88 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.104 0.478 . . . . 0.0 111.785 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -122.69 139.28 54.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.086 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -116.63 143.64 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' A' ' 147' ' ' HIS . 13.2 p90 -143.14 -46.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.603 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.99 -131.32 1.62 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -148.37 33.12 1.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.04 62.15 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 183' ' ' ASN . . . -136.5 135.57 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 71.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.867 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.514 ' HG2' HD12 ' A' ' 94' ' ' LEU . 27.1 tt0 64.36 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.24 63.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.02 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 2.1 t70 -69.06 -34.88 75.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.174 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.469 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.9 OUTLIER -62.75 -38.95 92.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.466 0.65 . . . . 0.0 109.652 179.203 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.2 t -53.91 -38.99 38.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.597 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.45 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.801 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.54 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 22.1 m80 -68.74 -40.91 79.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.21 -32.75 72.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.78 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -62.95 -44.14 96.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.01 -46.04 90.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.706 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 151' ' ' LEU . 8.1 tp -59.23 -42.23 90.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -59.29 -48.07 83.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.401 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.4 m -63.76 -47.01 82.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.173 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 31' ' ' TYR . 6.7 m -57.82 -40.96 81.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.755 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.496 HD11 ' CE1' ' A' ' 131' ' ' TYR . 11.5 mt -72.73 -14.57 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.491 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.77 126.9 11.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.67 34.72 11.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.206 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 16.1 p -145.55 159.89 46.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.561 0.22 . . . . 0.0 110.66 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 5.7 Cg_endo -47.88 -22.95 3.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.868 2.379 . . . . 0.0 112.541 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.751 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -56.58 106.13 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 53.4 m -101.94 -0.66 33.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.735 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 9.3 m-85 59.67 147.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.52 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.68 -173.5 4.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.54 62.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.776 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.64 75.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.762 0.315 . . . . 0.0 111.389 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.7 p -161.72 81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.233 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.483 ' CZ ' HG21 ' A' ' 86' ' ' VAL . 45.5 p90 -99.54 166.22 11.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.846 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.804 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 16.5 m-85 -115.6 161.95 17.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 67.3 m -121.33 130.85 53.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 184' ' ' GLU . . . -132.07 156.33 46.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.33 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 4.2 m-80 -133.16 134.97 44.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.965 0.412 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 4.6 mt-10 -146.01 157.12 43.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.11 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 144' ' ' TYR . 11.3 t -136.68 138.03 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.808 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -140.78 121.79 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 167' ' ' TYR . 11.8 mt -91.57 140.09 30.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.905 ' HA ' HG12 ' A' ' 130' ' ' VAL . 6.6 t -75.69 131.0 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.403 ' CG ' ' CE2' ' A' ' 131' ' ' TYR . 32.2 mtpt -74.34 150.16 40.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.36 -0.829 . . . . 1.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.02 112.94 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.4 -9.7 29.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -169.9 163.15 9.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -152.16 -173.28 4.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.7 -114.63 4.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 116.19 -112.03 2.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.57 162.69 30.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -30.21 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.195 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -90.66 -35.06 15.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.192 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.21 110.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.907 0.384 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.9 m -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.2 p90 -138.78 158.84 43.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 23' ' ' THR . 6.1 mt-10 -143.98 138.68 28.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.79 117.56 25.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -131.98 144.04 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.05 110.29 13.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.3 t -82.58 151.57 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.03 139.53 49.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.32 -106.96 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.2 -60.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -104.46 134.46 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.002 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -137.63 153.14 49.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.89 117.97 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.2 p -112.7 133.49 54.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.323 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.654 HG23 HD12 ' A' ' 62' ' ' ILE . 21.8 t -125.95 125.45 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -100.81 133.93 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.48 116.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.41 175.79 5.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.21 34.21 0.66 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.509 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -152.17 135.46 9.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.83 -158.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.528 2.152 . . . . 0.0 112.207 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.4 t -87.11 -53.53 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.24 -43.23 87.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -46.42 74.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.99 92.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 84' ' ' PHE . 4.3 mt -57.76 -35.24 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -62.65 -30.93 71.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.979 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.7 tp10 -88.18 -33.19 18.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.55 -43.21 60.46 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.655 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.0 mmt -57.75 -43.63 98.86 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.5 Cg_exo -57.28 -45.6 33.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.106 1.87 . . . . 0.0 112.262 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -70.33 -42.59 71.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.518 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.654 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.48 -32.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.446 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -41.06 91.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -40.88 91.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 64.8 t80 -59.63 -50.7 72.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 63' ' ' MET . 34.7 m -66.0 -27.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.66 104.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.01 -54.33 0.51 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -144.99 87.75 1.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -110.9 -29.17 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.0 m-20 84.63 -22.09 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.582 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -32.09 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.65 64.24 1.01 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.414 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' HG2' ' A' ' 113' ' ' PRO . 18.2 m -139.61 141.06 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.53 55.62 0.58 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.347 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.405 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -58.61 -34.75 71.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.67 -159.38 42.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 mtt -97.55 112.98 24.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.359 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 HG23 ' A' ' 80' ' ' VAL . 12.5 m -111.01 122.87 48.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 79' ' ' THR . 22.0 t 63.85 141.6 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 33.7 Cg_exo -59.75 130.82 36.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.272 1.981 . . . . 0.0 112.257 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' A' ' 102' ' ' PHE . 7.0 m -87.29 139.28 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.9 149.75 36.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.566 ' HD2' HD11 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -123.99 144.34 49.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -82.72 140.44 33.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.663 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 29.1 m -109.95 -28.09 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.44 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' HG21 ' A' ' 166' ' ' VAL . 96.8 m-85 55.91 91.77 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.529 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HA ' HD23 ' A' ' 94' ' ' LEU . 71.9 Cg_endo -77.18 141.61 20.83 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.637 2.224 . . . . 0.0 112.007 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.61 166.15 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.36 -15.89 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.278 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 3.48 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 86.92 -1.84 86.94 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.976 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 p -131.52 161.72 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.86 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.2 mt -87.54 154.32 20.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.531 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -140.57 84.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 45.53 93.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.6 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.71 101.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.555 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.683 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -143.72 143.87 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.91 115.66 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.914 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.563 HG21 ' HB1' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -86.68 137.35 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.579 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -117.96 141.04 48.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.307 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.677 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 48.5 t80 -124.2 151.47 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.975 0.417 . . . . 0.0 111.388 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtp180 -115.96 107.84 15.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.654 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.406 HG23 ' HD2' ' A' ' 105' ' ' PRO . 28.1 mt -82.08 136.4 47.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 104' ' ' ILE . 28.3 Cg_endo -62.32 154.14 65.61 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.555 2.17 . . . . 0.0 112.334 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -52.48 -26.8 13.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.15 66.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 110.976 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.618 ' HE2' HG11 ' A' ' 74' ' ' VAL . 88.9 m-85 -115.95 -9.75 11.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.33 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.08 -48.08 71.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.765 0.317 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -26.54 56.33 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 t -174.5 88.08 0.33 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 44.0 Cg_endo -68.36 160.45 49.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.552 2.168 . . . . 0.0 112.353 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.681 ' HG2' HG21 ' A' ' 74' ' ' VAL . 5.0 Cg_exo -74.19 159.29 44.25 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 112.026 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.34 111.24 6.19 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.978 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 65' ' ' TYR . 60.8 Cg_endo -72.62 162.36 41.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.513 2.142 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.52 179.73 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.66 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.46 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -16.88 30.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.1 p -80.2 -28.57 38.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.673 0.273 . . . . 0.0 111.213 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.62 114.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 111.157 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 156.97 32.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.19 125.25 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.9 129.94 45.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -89.14 125.27 34.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.9 OUTLIER 58.9 -177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.8 tt0 83.09 76.99 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.5 -175.12 50.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -143.99 143.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.249 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.9 m -115.31 118.98 34.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 188' ' ' VAL . 36.0 m -144.11 163.99 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.434 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -107.78 137.85 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.212 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -105.87 146.47 29.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 0.0 111.56 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -131.19 139.23 49.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.438 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -116.6 132.09 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -139.72 156.28 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.36 33.57 5.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -107.02 -36.48 2.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.83 133.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.19 -175.86 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -133.59 -66.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.563 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.7 tt0 -141.72 -72.92 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.82 75.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -34.56 77.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -40.33 96.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.568 0.699 . . . . 0.0 109.807 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -53.84 -38.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.668 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.29 -35.78 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.719 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -70.17 -42.45 72.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.0 m -63.4 -42.28 98.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.801 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.16 94.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.871 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 187' ' ' LEU . 8.2 tp -60.55 -40.45 91.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -42.38 94.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.8 m -68.64 -35.72 77.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 41.5 m -57.61 -49.09 77.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 5.6 mt -73.62 -11.12 60.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.259 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -47.03 -43.16 19.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.59 36.56 3.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 30.8 p -145.64 154.29 52.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 48.3 Cg_endo -68.78 -10.79 30.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.621 2.214 . . . . 0.0 112.633 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 126.86 29.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.4 m -101.95 160.08 14.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -155.27 151.46 28.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.035 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -55.5 -56.53 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.295 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.91 50.96 11.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.103 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 -22.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.452 HG21 ' CE1' ' A' ' 87' ' ' PHE . 12.8 p -158.81 141.95 5.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.7 ' HB3' HD23 ' A' ' 187' ' ' LEU . 12.2 p90 -140.79 166.59 24.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 36.2 m-85 -118.37 159.38 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.405 ' O ' ' CE1' ' A' ' 84' ' ' PHE . 42.9 m -127.53 130.89 49.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.99 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -107.9 142.98 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.62 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.772 0.32 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -108.67 145.23 35.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.18 157.19 43.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.473 HG13 ' HD2' ' A' ' 167' ' ' TYR . 21.4 t -139.22 114.9 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.428 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 5.6 m0 -110.03 124.35 51.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 ' HB3' ' A' ' 167' ' ' TYR . 63.5 mt -91.65 140.41 29.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.471 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.677 ' HA ' HG12 ' A' ' 130' ' ' VAL . 24.2 t -74.58 123.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.937 0.399 . . . . 0.0 111.168 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 7.0 tttp -72.07 149.81 44.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.173 -0.918 . . . . 1.0 111.089 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.743 0.306 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.28 112.98 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 35' ' ' ALA . 8.7 mt -86.92 -19.12 29.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.78 167.08 9.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.784 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -168.69 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.57 -118.69 5.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.28 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 99.72 158.81 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.74 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -78.8 163.69 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.6 -29.83 69.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.031 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -35.35 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.102 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.24 107.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.277 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 64.1 m -100.58 157.95 16.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.9 p90 -139.49 160.97 38.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.9 125.74 12.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -86.1 135.1 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 136.34 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -122.96 126.5 47.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.86 163.46 27.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.56 -77.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.99 -174.14 54.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.522 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.89 -89.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mptt -96.84 137.68 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.808 0.337 . . . . 0.0 110.857 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 24.0 m-85 -137.49 157.66 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.065 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.99 140.21 29.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.0 p -133.44 131.83 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 111.252 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.605 HG23 HD12 ' A' ' 62' ' ' ILE . 23.2 t -126.62 125.49 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.906 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.97 139.48 34.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.1 t -138.24 118.04 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.11 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 166.93 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.55 33.85 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.93 123.6 3.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.771 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.85 -69.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.332 2.021 . . . . 0.0 112.353 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG13 ' CD1' ' A' ' 98' ' ' LEU . 45.0 t -156.5 -63.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.05 -45.14 79.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -67.09 -46.15 75.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.012 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.822 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.96 -42.25 89.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.281 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.861 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.2 mt -56.88 -35.31 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.08 -31.56 72.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -88.12 -34.01 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.75 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.64 -42.46 61.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.762 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.473 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 22.9 mmt -57.67 -43.81 99.05 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 39.3 Cg_exo -60.52 -43.45 33.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.433 2.089 . . . . 0.0 112.313 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -70.22 -43.63 70.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.27 -41.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.612 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.52 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.87 -31.88 73.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.01 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 63' ' ' MET . 20.3 mmtt -66.34 -32.27 73.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.975 0.417 . . . . 0.0 110.324 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 90.4 t80 -67.9 -32.6 73.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.597 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.591 HG11 ' CE2' ' A' ' 102' ' ' PHE . 18.1 m -90.08 -10.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.66 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.2 44.47 2.81 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.836 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.11 44.98 51.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.999 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -126.91 61.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -111.93 -22.3 11.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.191 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.25 4.57 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.1 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -94.02 -29.59 15.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.18 37.73 4.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.187 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.744 HG21 ' HG3' ' A' ' 113' ' ' PRO . 28.4 m -98.48 -178.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.078 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.29 76.1 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.413 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.1 mtp -96.13 106.17 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 29.59 11.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt 61.25 156.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 80' ' ' VAL . 4.8 m -164.65 124.99 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.07 137.3 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 80' ' ' VAL . 19.2 Cg_endo -60.06 147.73 91.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.583 2.189 . . . . 0.0 112.098 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.93 153.76 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.519 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.444 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 1.8 t -135.69 168.16 19.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.418 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.861 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.07 154.1 49.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -97.06 136.68 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.45 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 166' ' ' VAL . 28.7 m -123.14 141.9 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.003 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -115.21 89.81 22.05 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.089 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.725 ' HA ' HD23 ' A' ' 94' ' ' LEU . 19.4 Cg_exo -65.99 149.66 85.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.68 2.253 . . . . 0.0 112.188 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.7 161.87 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.27 -19.71 55.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -5.97 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.364 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.05 66.78 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 m -94.57 155.17 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 88' ' ' PRO . 16.5 mt -105.72 131.46 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -82.06 170.93 14.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 65.99 5.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -144.35 96.03 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.564 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.85 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -122.94 136.96 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.242 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 115.87 19.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.301 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.75 HG21 ' HB1' ' A' ' 58' ' ' ALA . 1.7 t -87.37 116.82 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.174 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -98.16 142.02 30.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.822 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.9 t80 -123.88 145.6 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 6.5 ptp180 -108.75 110.51 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 108' ' ' PHE . 21.9 mt -89.59 137.78 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HD2' HG23 ' A' ' 104' ' ' ILE . 7.8 Cg_endo -49.91 154.04 5.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 2.6 m120 -58.79 -27.04 64.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.301 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -61.19 -33.01 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.488 ' HB2' HG22 ' A' ' 104' ' ' ILE . 72.6 m-85 -102.01 -8.98 21.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.751 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.73 -34.2 58.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.798 0.332 . . . . 0.0 111.093 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.57 -33.36 81.57 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.1 p -177.5 98.1 0.23 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.583 0.23 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.36 152.97 75.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.744 ' HG3' HG21 ' A' ' 74' ' ' VAL . 56.2 Cg_endo -71.41 159.0 52.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.602 2.201 . . . . 0.0 112.44 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.43 118.38 56.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 47.6 Cg_endo -68.37 146.71 69.75 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.422 2.081 . . . . 0.0 112.365 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -77.34 -40.05 45.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.865 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -77.81 114.89 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.021 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.59 -19.11 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 m -80.65 -17.06 52.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.321 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HB3' ' A' ' 117' ' ' ASP . 35.7 t -84.74 113.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 157.02 18.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.931 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 mm -122.56 123.5 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.82 129.85 45.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.56 130.95 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 60.33 111.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.98 90.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.48 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.381 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.66 142.94 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.21 42.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.89 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -132.77 168.63 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.554 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 12.4 m-85 -107.73 160.24 15.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.0 p -124.4 130.32 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.252 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.478 ' HB ' HD13 ' A' ' 151' ' ' LEU . 9.4 t -131.08 138.31 49.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.705 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -122.13 142.65 50.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CZ ' ' CD2' ' A' ' 147' ' ' HIS . 20.4 p90 -152.11 167.76 27.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.47 96.94 1.82 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.7 15.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -95.89 -177.66 4.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -157.41 148.56 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.265 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -134.35 65.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.654 ' HG2' HD12 ' A' ' 94' ' ' LEU . 12.3 tt0 67.33 -72.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.027 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.13 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.37 -34.88 76.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -62.9 -39.12 93.54 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.427 0.632 . . . . 0.0 109.881 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.5 t -54.03 -38.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.457 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.24 69.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.715 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.445 ' CD2' ' CZ ' ' A' ' 135' ' ' PHE . 4.0 m-70 -70.1 -45.33 67.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.82 72.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.0 m -69.31 -38.24 78.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -44.81 91.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 31' ' ' TYR . 12.4 tp -58.02 -38.35 76.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.394 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -61.28 -43.82 98.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -61.71 -40.34 94.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.018 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.7 m -57.82 -46.14 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.779 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.419 HD13 ' HB1' ' A' ' 160' ' ' ALA . 7.7 mt -73.65 -10.34 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.796 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.8 OUTLIER -47.3 106.03 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 141.18 -39.05 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -94.9 -179.15 0.9 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.491 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.9 Cg_endo -85.52 35.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.414 2.076 . . . . 0.0 112.803 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -60.47 109.24 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.241 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.83 165.71 11.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -154.7 16.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.713 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.681 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 3.6 mt-30 53.52 -83.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.6 0.238 . . . . 0.0 111.397 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -127.84 34.36 3.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.78 25.54 12.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.681 0.277 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 86' ' ' VAL . 14.5 p -79.71 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.103 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 187' ' ' LEU . 50.2 p90 -140.4 -176.72 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.696 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 44.8 m-85 -119.25 159.83 23.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 3.7 m -134.6 152.8 52.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.89 155.91 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.759 0.314 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.78 149.39 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.73 148.6 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.408 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.557 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.2 t -135.11 116.27 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.93 125.5 51.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.386 . . . . 0.0 111.103 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 167' ' ' TYR . 73.0 mt -91.68 137.23 32.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HA ' HG12 ' A' ' 130' ' ' VAL . 23.5 t -74.89 131.18 35.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -101.43 103.54 14.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.186 -0.911 . . . . 1.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.844 0.354 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.64 125.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.19 -16.53 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.392 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -169.75 165.41 9.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -152.05 -176.55 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.72 -110.86 2.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.4 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 105.65 -133.01 11.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.563 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -161.56 165.41 28.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.737 0.303 . . . . 0.0 110.809 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.45 -29.44 69.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.79 -35.14 15.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.223 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.21 108.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.1 140.31 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -139.24 161.96 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.17 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG2' HG22 ' A' ' 23' ' ' THR . 26.1 mt-10 -147.24 130.23 16.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.71 121.76 29.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 133.37 34.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.76 113.3 19.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -127.63 156.21 42.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.0 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.22 84.31 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.54 -151.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.8 -86.11 1.88 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.9 mttm -123.62 149.1 45.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -137.58 153.58 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -106.08 132.0 52.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.793 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 101' ' ' TRP . 65.0 p -112.53 140.43 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.79 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 17.6 t -128.44 125.47 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -100.07 134.06 43.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.652 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 54' ' ' ALA . 11.3 t -138.19 116.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.9 0.381 . . . . 0.0 111.208 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.99 167.03 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 t0 58.84 31.79 21.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -151.15 124.93 4.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.794 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.76 -67.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.282 1.988 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.458 ' O ' HD23 ' A' ' 55' ' ' LEU . 61.1 t -156.2 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.805 0.335 . . . . 0.0 111.183 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.85 -40.86 73.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.79 -46.44 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 110.335 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -60.74 -36.81 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.387 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.821 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -56.79 -35.7 69.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.945 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -64.79 -28.33 69.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.621 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.7 tp10 -86.89 -43.57 12.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.517 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 44' ' ' VAL . . . -73.34 -33.7 65.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.605 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 23.6 mmt -58.03 -43.85 98.82 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -66.44 -30.95 43.41 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.952 1.768 . . . . 0.0 112.12 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -38.81 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.427 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 44' ' ' VAL . 36.2 mm -77.65 -38.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.783 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -46.09 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -64.43 -30.41 71.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -65.35 -47.37 76.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 15.7 m -84.25 -30.22 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.53 -115.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.04 47.3 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.443 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 4.9 m -152.68 76.19 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -134.09 11.32 3.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.352 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.09 30.21 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -148.68 -47.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.56 33.62 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 m -100.66 149.7 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.13 76.3 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mtp -60.09 -42.92 95.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.387 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.09 -126.77 13.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmt -120.55 146.65 46.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 105' ' ' PRO . 1.1 m -157.14 107.82 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 21.1 t 64.12 141.67 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 34.5 Cg_exo -59.73 130.79 36.68 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.323 2.016 . . . . 0.0 112.133 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 m -87.36 136.71 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.6 p -126.15 163.44 23.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.821 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -133.0 153.41 51.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.718 0.294 . . . . 0.0 111.3 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.99 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -89.55 136.86 32.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.145 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.807 HG12 HD12 ' A' ' 98' ' ' LEU . 31.6 m -120.06 136.71 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.44 96.82 14.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 94' ' ' LEU . 80.5 Cg_endo -77.23 135.72 15.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -90.26 172.07 9.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.63 -15.98 63.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.12 -6.24 59.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.386 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.08 -16.01 56.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.998 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -96.54 117.13 30.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD12 ' OE2' ' A' ' 141' ' ' GLU . 6.9 mt -56.5 114.48 2.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -57.56 172.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -80.53 73.76 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 117.27 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.603 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 86' ' ' VAL . 1.1 tt -144.05 140.15 29.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.453 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -123.92 115.91 22.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.79 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 3.2 p -98.72 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CD2' HG22 ' A' ' 43' ' ' THR . 25.4 m95 -113.03 142.28 45.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.492 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 85.8 t80 -108.8 160.71 15.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 111.362 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 108.01 15.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.544 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.524 HD12 ' HB2' ' A' ' 40' ' ' LYS . 33.0 mt -80.54 136.68 52.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.516 ' HA ' HG21 ' A' ' 79' ' ' THR . 29.0 Cg_endo -62.87 154.04 69.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.699 2.266 . . . . 0.0 112.597 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -58.72 -26.68 64.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.302 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -32.83 65.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.65 9.3 29.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.788 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -55.43 -42.81 74.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.64 -34.04 68.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 100.77 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.541 0.21 . . . . 0.0 110.934 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.29 160.76 47.58 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.363 2.042 . . . . 0.0 112.257 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.68 153.38 54.12 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.692 2.261 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.66 119.01 62.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.05 146.69 36.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.329 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 t -88.04 -33.54 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.796 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -87.75 122.43 31.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -22.23 47.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -81.66 -25.85 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.796 HG23 ' HB3' ' A' ' 117' ' ' ASP . 31.1 t -85.21 125.48 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.099 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -121.79 157.05 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.419 ' CG2' ' HD2' ' A' ' 40' ' ' LYS . 26.5 mm -111.67 121.75 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.92 160.29 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.6 151.25 33.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.022 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.2 ttt180 62.33 166.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.3 tm-20 83.49 129.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.64 155.33 16.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.438 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.11 142.92 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -110.07 118.8 37.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.666 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 188' ' ' VAL . 28.1 m -140.36 166.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.261 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.827 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -107.81 137.72 45.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.2 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 p -105.95 143.1 34.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -131.05 139.19 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.628 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.95 141.44 48.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.028 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.544 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 52.0 p90 -161.43 134.64 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.89 91.56 1.69 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.19 177.32 44.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.98 160.13 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -160.96 133.38 6.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.75 76.55 1.59 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' OE2' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 67.53 -71.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.104 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -33.92 62.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.194 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 4.8 m-20 -68.48 -37.56 80.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -62.95 -41.02 99.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.322 0.582 . . . . 0.0 110.08 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.99 -38.64 37.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.245 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.28 70.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.806 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.544 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 21.4 m80 -70.16 -44.57 68.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.83 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.806 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.3 m -70.58 -43.3 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -58.96 -46.17 88.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 187' ' ' LEU . 13.3 tp -62.4 -41.75 98.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -46.17 89.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.724 HG23 ' OE1' ' A' ' 156' ' ' GLU . 98.1 m -61.85 -43.63 98.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.999 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.495 HG22 ' HE2' ' A' ' 31' ' ' TYR . 2.9 m -57.82 -38.85 76.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.859 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -16.6 61.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.881 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.724 ' OE1' HG23 ' A' ' 153' ' ' THR . 47.1 mt-10 -46.94 144.16 2.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.838 0.352 . . . . 0.0 111.269 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.7 -30.89 8.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.103 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 1.2 p -94.93 176.15 2.46 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.1 Cg_endo -85.77 12.22 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.562 2.174 . . . . 0.0 112.916 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.827 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -59.35 116.29 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 162' ' ' TYR . 1.2 m -100.1 175.44 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -155.47 22.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.595 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 48.66 -87.74 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.504 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -120.96 29.14 5.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.245 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 69.3 21.18 7.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.641 0.258 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.6 p -80.23 139.0 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 111.061 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.895 ' HB3' HD23 ' A' ' 187' ' ' LEU . 24.8 p90 -139.27 178.11 7.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.99 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 97.4 m-85 -119.6 151.4 38.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 m -126.87 130.91 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -113.27 129.19 56.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.583 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.898 0.38 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -126.47 133.98 51.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -142.96 156.4 44.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.626 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.5 t -138.98 116.14 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -107.76 121.86 45.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' A' ' 167' ' ' TYR . 43.0 mt -92.91 136.01 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.9 t -74.74 131.53 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 36.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.242 -0.885 . . . . 1.0 111.369 179.846 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.839 0.352 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.36 119.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.51 -3.93 21.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.498 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.14 166.88 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -152.34 -57.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.82 170.0 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.63 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.53 -85.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.5 162.99 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -66.53 -33.21 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -33.2 16.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.97 141.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.33 154.47 50.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.574 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.07 159.77 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.43 121.8 12.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.52 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 39.0 mt-10 -87.02 132.07 33.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -141.98 130.9 23.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.46 124.38 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 p -127.74 -178.33 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.45 167.65 14.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.15 167.29 38.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.61 -85.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -100.9 146.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 110.888 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 6.2 m-85 -137.59 148.04 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 123.49 37.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.697 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -112.64 136.59 52.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.793 ' CG2' HD11 ' A' ' 62' ' ' ILE . 22.9 t -125.96 125.54 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.64 131.32 44.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.154 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 54' ' ' ALA . 12.5 t -138.46 116.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.009 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.424 HG23 ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.22 167.1 13.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.98 23.45 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -152.55 133.22 7.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.3 -177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.518 2.145 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 55' ' ' LEU . 48.3 t -62.71 -70.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -56.15 -40.61 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.92 -46.85 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 110.36 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 46' ' ' VAL . . . -62.35 -36.71 83.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.18 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.974 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -56.91 -35.43 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.074 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -63.57 -27.91 69.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.712 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 tp10 -87.62 -44.35 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.19 -37.28 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.612 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 mmt -57.75 -43.79 98.97 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 59' ' ' MET . 30.8 Cg_endo -65.01 -29.49 57.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.763 1.642 . . . . 0.0 112.062 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HE2' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -70.18 -37.42 75.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.373 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.793 HD11 ' CG2' ' A' ' 44' ' ' VAL . 29.8 mm -77.32 -44.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -43.97 97.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -65.07 -30.69 71.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.7 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.63 -56.87 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.566 HG12 ' SD ' ' A' ' 76' ' ' MET . 26.8 m -72.61 -30.14 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.22 -90.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.405 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.13 71.71 0.24 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 52.4 m -153.52 47.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -110.97 -22.36 11.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.52 2.34 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.475 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -93.55 -35.78 12.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.819 0.343 . . . . 0.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.14 29.98 8.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.42 165.99 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.84 0.353 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.96 2.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.566 ' SD ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 63.76 135.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.917 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.21 169.48 32.65 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.57 155.95 17.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' HG13 ' A' ' 80' ' ' VAL . 97.8 m -135.43 -45.07 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -156.58 164.07 22.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.1 Cg_endo -59.46 130.62 36.48 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.123 1.882 . . . . 0.0 111.668 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.529 HG11 ' HD2' ' A' ' 102' ' ' PHE . 3.6 m -87.58 126.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.889 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 170' ' ' ALA . 16.0 m -119.82 153.14 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.986 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.974 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.62 154.12 33.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 111.591 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -87.18 136.8 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.613 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.897 HG12 HD12 ' A' ' 98' ' ' LEU . 28.8 m -129.47 132.51 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -99.41 100.32 10.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.793 ' HA ' HD23 ' A' ' 94' ' ' LEU . 72.4 Cg_endo -73.99 140.95 29.17 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.515 2.143 . . . . 0.0 112.279 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.11 158.6 17.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.839 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -19.04 61.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.239 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -85.55 -6.07 59.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.44 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.573 ' HA2' HG11 ' A' ' 145' ' ' VAL . . . 96.03 -3.6 64.7 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.018 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -99.98 153.31 19.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 88' ' ' PRO . 58.0 mt -97.42 132.55 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 174.07 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.793 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -80.42 -13.99 58.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.275 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 47' ' ' THR . 0.3 OUTLIER -82.8 123.85 29.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.762 0.315 . . . . 0.0 111.038 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.897 HD12 HG12 ' A' ' 86' ' ' VAL . 2.2 tt -144.05 127.95 17.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 115.9 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.783 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 4.5 p -96.5 139.91 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.445 ' CD2' ' CG2' ' A' ' 43' ' ' THR . 24.9 m95 -116.85 142.37 47.02 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 62.2 t80 -112.51 161.11 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.807 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HG2' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.59 107.92 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.864 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 40' ' ' LYS . 38.1 mt -84.4 137.2 39.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.463 ' HD2' HG23 ' A' ' 104' ' ' ILE . 19.8 Cg_endo -60.32 152.78 64.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.586 2.191 . . . . 0.0 112.388 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 24.5 p-10 -62.07 -26.81 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.259 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -56.76 -42.58 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.279 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -95.87 5.5 51.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.462 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -55.01 -45.93 75.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.739 0.304 . . . . 0.0 111.187 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.06 -26.03 40.7 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.688 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 p -177.09 90.14 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.64 0.257 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 43.9 Cg_endo -68.19 146.72 70.9 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.12 . . . . 0.0 112.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.87 157.4 58.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.497 2.132 . . . . 0.0 111.998 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.95 126.51 92.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HB2' HG11 ' A' ' 120' ' ' VAL . 86.2 Cg_endo -81.23 6.11 5.81 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.642 2.228 . . . . 0.0 113.007 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m 58.12 -177.2 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.781 0.324 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 120' ' ' VAL . 24.0 t0 62.01 117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -20.2 42.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.281 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.6 t -81.07 -31.72 34.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.9 t -85.49 118.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.938 0.399 . . . . 0.0 111.153 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.05 157.21 41.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.0 mm -110.69 112.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -98.9 130.12 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -88.58 91.42 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.36 152.89 39.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.86 166.48 21.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.73 172.29 4.06 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -138.31 143.03 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -108.73 123.22 48.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.515 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 187' ' ' LEU . 13.7 m -131.32 169.76 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.966 0.412 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 7.5 m-85 -107.79 137.14 46.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.82 135.53 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.5 t -128.87 139.08 52.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.0 148.01 41.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.552 ' CZ ' ' ND2' ' A' ' 183' ' ' ASN . 22.4 p90 -172.26 -176.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -99.04 -145.2 18.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.37 163.88 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.85 141.81 42.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -125.43 159.34 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.466 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -45.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.686 ' CG ' HD12 ' A' ' 94' ' ' LEU . 32.9 tt0 -167.35 -66.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.485 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.69 73.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.493 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.89 79.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -40.76 98.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 109.909 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.573 HG11 ' HA2' ' A' ' 92' ' ' GLY . 45.6 t -53.85 -38.75 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.707 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -34.73 71.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.778 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 135' ' ' PHE . 4.8 m-70 -70.22 -46.09 65.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.02 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.84 74.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.7 m -70.43 -49.98 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.01 -38.65 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.803 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.71 ' HB3' HD11 ' A' ' 187' ' ' LEU . 12.0 tp -58.48 -39.01 78.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -41.35 89.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -41.02 83.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.458 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.574 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.74 -43.71 85.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.533 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 31' ' ' TYR . 2.6 mt -73.02 -13.24 61.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -47.01 -47.15 22.21 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.71 -33.06 62.36 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.446 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.411 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 26.0 p -94.51 167.75 12.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 110.744 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.411 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 0.9 OUTLIER -83.75 40.46 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.197 2.598 . . . . 0.0 112.695 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.29 170.66 1.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.676 HG22 ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -138.56 163.95 30.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 1.2 m-85 -156.23 175.2 14.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -92.93 -55.34 3.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.03 -74.0 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.399 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -159.66 71.08 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.7 p -160.81 136.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.295 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.476 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.1 p90 -139.61 -177.83 5.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 25.7 m-85 -120.66 156.39 31.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.3 131.0 46.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' OG ' ' A' ' 83' ' ' SER . . . -119.66 130.21 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.616 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.552 ' ND2' ' CZ ' ' A' ' 135' ' ' PHE . 8.7 p-10 -119.9 133.84 55.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.781 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -146.26 147.4 31.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.225 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 167' ' ' TYR . 17.3 t -118.84 129.73 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.441 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' HB3' HG21 ' A' ' 130' ' ' VAL . 46.0 m0 -107.9 121.56 45.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.735 ' O ' HG12 ' A' ' 130' ' ' VAL . 73.4 mt -97.33 139.96 32.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 38.4 t -74.94 128.92 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -100.63 125.91 47.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.676 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.694 0.283 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.09 112.86 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.37 -7.15 39.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.725 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.4 167.17 8.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.388 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 p -151.64 -178.59 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.761 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.19 -104.04 0.97 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.44 -94.8 0.55 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.683 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -160.43 163.03 33.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 0.0 110.791 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -66.44 -30.56 70.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.033 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.61 -35.23 15.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 150' ' ' GLN . 3.5 m -146.27 115.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.384 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -95.98 145.2 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -140.92 162.26 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 127.27 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.562 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.433 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 17.2 mt-10 -85.86 126.3 33.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 129' ' ' THR . 8.3 ptp180 -142.03 128.04 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.62 122.16 47.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.7 p -132.14 149.96 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -71.66 -63.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.38 -77.85 1.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.45 -89.78 1.12 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 11.0 mptt -114.67 146.28 41.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -137.63 140.17 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.75 115.9 28.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.115 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.3 p -112.77 155.48 24.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 112.004 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.6 t -136.7 125.9 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -96.07 130.35 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.402 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.0 t -138.27 116.72 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.58 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.89 32.15 2.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -153.15 127.57 4.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.24 -169.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.476 2.117 . . . . 0.0 112.224 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.806 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.9 t -72.5 -53.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.211 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.89 -43.68 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.03 -46.17 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.91 -41.28 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.703 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.0 mt -57.46 -35.57 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -62.92 -35.12 79.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.927 0.394 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 tp10 -87.49 -28.29 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.388 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.783 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.33 -45.17 56.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.679 ' CE ' HG11 ' A' ' 82' ' ' VAL . 34.1 mmt -57.61 -43.46 98.86 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.0 Cg_exo -57.96 -41.55 67.48 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.07 1.847 . . . . 0.0 112.067 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -70.29 -45.5 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.351 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.1 tt -75.59 -27.84 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.418 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -38.67 88.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.907 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -69.24 -56.38 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.41 -29.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.11 -124.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.622 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.17 48.01 0.98 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -142.94 62.54 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -108.99 -24.12 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 79.31 -3.47 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.668 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 -40.56 10.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.84 67.6 1.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.45 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.519 HG21 ' HG3' ' A' ' 113' ' ' PRO . 25.4 m -138.88 -179.45 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.81 117.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.388 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 1.3 mtm -112.73 -161.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.32 -37.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 63.18 120.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.046 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.537 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -60.3 167.86 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.633 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.541 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 13.5 t -87.25 -48.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.404 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 66.7 Cg_endo -91.42 130.38 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.512 2.141 . . . . 0.0 112.528 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' CE ' ' A' ' 59' ' ' MET . 34.4 t -92.86 152.31 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.01 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.6 p -125.1 145.93 49.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.664 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.703 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -132.93 153.99 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.937 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 99' ' ' LYS . . . -95.04 136.67 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 HD12 ' A' ' 98' ' ' LEU . 27.7 m -131.34 126.83 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 166' ' ' VAL . 43.3 m-85 -97.8 99.62 7.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 122.35 9.43 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.39 2.06 . . . . 0.0 112.105 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -89.74 170.81 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.35 -15.81 62.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -0.1 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.23 67.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.887 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.5 p -122.82 160.12 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.518 HD12 ' HG3' ' A' ' 141' ' ' GLU . 5.8 mt -79.09 160.42 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 44.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 52.5 28.36 5.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.326 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -117.49 99.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.806 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.5 tt -127.56 127.73 44.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.978 0.418 . . . . 0.0 111.48 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 85' ' ' ALA . 11.3 ptmt -117.58 116.62 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.469 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.783 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -66.79 141.47 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -120.37 119.17 32.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 61.6 t80 -106.02 153.78 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -112.77 121.83 45.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 105' ' ' PRO . 33.5 mt -96.91 136.75 21.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.6 154.1 56.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.555 2.17 . . . . 0.0 112.357 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.57 -26.85 65.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -56.94 -45.22 82.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.041 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 64.3 m-85 -94.62 -9.79 33.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.395 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.46 -37.4 62.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.11 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -28.88 72.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -171.66 75.93 0.5 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.769 0.319 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.9 Cg_exo -57.05 154.58 32.57 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.533 2.155 . . . . 0.0 112.355 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG3' HG21 ' A' ' 74' ' ' VAL . 5.6 Cg_exo -74.31 152.14 44.08 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.685 2.257 . . . . 0.0 112.094 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.35 93.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.44 135.82 22.9 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.316 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -91.45 50.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.028 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -162.2 118.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.93 -21.75 45.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.193 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 p -81.71 -31.67 32.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.1 t -85.78 122.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.968 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -124.84 152.57 43.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.7 mm -105.09 117.62 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.82 137.06 37.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 104.5 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -169.07 73.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.938 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 30.9 tt0 82.23 139.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.065 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -70.34 -179.96 27.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.241 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.05 142.9 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 111.433 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 5.6 m -112.75 126.74 55.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.331 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 188' ' ' VAL . 22.8 m -133.96 157.49 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 111.54 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' A' ' 155' ' ' LEU . 12.0 m-85 -107.72 141.8 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.7 p -111.91 126.99 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.882 0.372 . . . . 0.0 111.136 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.7 t -123.69 138.82 54.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -116.83 143.68 45.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CE2' ' CD2' ' A' ' 147' ' ' HIS . 12.8 p90 -142.15 -44.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.26 109.47 0.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.1 -137.04 2.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -145.56 92.35 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.933 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.89 136.02 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -105.04 -48.44 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.518 ' HG3' HD12 ' A' ' 94' ' ' LEU . 1.6 tm-20 -166.24 -68.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.694 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.82 67.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -67.98 -34.98 77.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.1 -40.48 96.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 109.998 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.72 -38.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.541 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.1 73.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.761 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.625 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 26.0 m80 -70.02 -41.42 74.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.761 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.85 73.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.4 m -63.02 -42.62 99.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.708 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB3' HG11 ' A' ' 29' ' ' VAL . 57.4 mm-40 -59.07 -45.94 89.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.593 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.9 tp -61.51 -39.68 91.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.25 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -59.12 -36.32 75.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.271 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -46.2 68.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -49.11 77.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.789 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 131' ' ' TYR . 11.5 mt -74.02 -9.12 58.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.431 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -47.55 -43.24 24.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.261 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.4 -15.08 77.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.762 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 p -93.65 169.23 10.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.003 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 7.9 Cg_exo -72.78 0.58 7.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.046 2.498 . . . . 0.0 112.913 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.12 121.91 11.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.204 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 1.1 m -101.38 -2.21 31.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.115 0.483 . . . . 0.0 111.077 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 50.92 16.26 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.054 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.649 ' H ' ' HB2' ' A' ' 190' ' ' ALA . 1.0 OUTLIER 65.11 -75.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.162 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.58 -78.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.74 68.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 166' ' ' VAL . 11.0 p -161.91 122.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.632 ' HB3' HD23 ' A' ' 187' ' ' LEU . 37.0 p90 -132.91 170.21 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.858 ' CE2' HG22 ' A' ' 188' ' ' VAL . 18.5 m-85 -112.74 157.16 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' CYS . . . . . 0.44 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.7 m -133.56 130.95 39.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.27 52.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.943 0.401 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -132.94 133.9 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.33 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.88 157.11 43.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.732 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.44 HG13 ' SG ' ' A' ' 169' ' ' CYS . 39.0 t -124.55 139.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.48 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.677 ' CE3' HG21 ' A' ' 130' ' ' VAL . 24.9 m0 -107.62 121.49 44.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.086 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.632 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.2 mt -98.75 133.41 43.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.743 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 168' ' ' TYR . 25.7 t -75.8 118.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.05 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -79.95 147.25 31.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.277 -0.868 . . . . 1.0 111.098 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.03 115.15 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.14 -16.24 20.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.417 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 t -169.72 167.05 9.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -151.86 -175.82 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.72 -173.2 47.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 172.44 -93.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.608 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' VAL . 1.2 mtmm -161.28 166.39 27.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.849 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -66.62 -31.66 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.294 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -31.33 17.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.278 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.7 t -146.03 142.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -134.74 148.82 50.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.724 ' CD2' HD21 ' A' ' 155' ' ' LEU . 1.9 p90 -139.17 162.2 35.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.31 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 23' ' ' THR . 4.5 mt-10 -144.54 122.27 11.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -85.98 118.37 25.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.994 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.07 127.93 35.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.58 128.2 55.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.3 p -100.19 158.93 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -60.2 -52.08 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.96 -158.05 22.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.86 -173.29 20.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 104' ' ' ILE . 25.3 mttt -98.49 149.8 22.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -137.65 153.93 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -93.96 140.03 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.592 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -112.46 143.55 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.08 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.758 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.1 t -132.17 125.32 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.65 140.09 36.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.2 t -138.42 123.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.313 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 167.04 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 t0 51.2 33.91 10.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.413 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.6 128.5 5.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.711 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.46 -69.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.357 2.038 . . . . 0.0 112.585 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 98' ' ' LEU . 48.4 t -156.12 -66.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.82 0.343 . . . . 0.0 111.287 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.91 -45.08 78.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.09 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.6 -42.7 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.852 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.95 -44.01 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.916 HD11 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.97 -35.41 69.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -62.48 -33.44 74.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -87.73 -29.29 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.158 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' CA ' HG11 ' A' ' 44' ' ' VAL . . . -73.51 -43.47 59.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.726 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -57.6 -43.87 99.14 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.3 Cg_exo -60.22 -37.33 83.83 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.176 1.918 . . . . 0.0 111.784 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -70.38 -44.9 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -76.13 -28.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.211 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.13 74.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.662 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.8 ttmt -65.43 -39.82 92.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.658 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.82 -57.9 7.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' CE2' ' A' ' 102' ' ' PHE . 28.6 m -67.06 -29.61 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -137.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.84 35.26 4.89 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 69' ' ' THR . 32.5 m -125.09 32.72 5.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 5.5 p30 -88.25 -16.58 32.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.278 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 1.5 m-20 82.44 -9.25 1.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -93.04 -36.74 12.55 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.75 43.17 6.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.02 163.56 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.75 58.2 0.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -74.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.967 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.95 -118.08 4.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.61 118.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.344 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -67.93 145.51 54.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 16.8 t -67.57 -53.52 22.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.466 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 69.9 Cg_endo -73.54 146.94 40.01 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.209 1.939 . . . . 0.0 112.183 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 59' ' ' MET . 45.4 t -153.54 125.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 t -114.98 145.98 41.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.038 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CE2' HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -128.59 149.31 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.764 0.316 . . . . 0.0 111.636 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.787 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -88.22 136.81 32.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.523 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.764 HG12 HD12 ' A' ' 98' ' ' LEU . 34.3 m -125.47 139.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.216 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 2.4 m-85 -108.99 103.92 53.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.029 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 94' ' ' LEU . 53.3 Cg_endo -69.36 137.65 37.13 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.397 2.065 . . . . 0.0 112.243 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -89.88 171.98 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.036 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.04 -15.88 62.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.394 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.49 -1.07 55.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.491 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.03 -6.77 82.68 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.867 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 m -119.74 171.5 8.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.937 0.398 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.2 OUTLIER -112.27 96.88 6.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -95.0 102.23 14.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.77 86.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.597 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 175.5 81.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.922 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.9 tt -144.1 135.56 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 111.493 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.48 115.63 20.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.758 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 6.0 p -91.74 136.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.123 0.487 . . . . 0.0 111.888 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 24.7 m95 -110.58 142.27 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.81 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 66' ' ' VAL . 32.7 t80 -105.78 145.54 31.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 102' ' ' PHE . 7.1 ttt180 -95.66 113.62 25.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 40' ' ' LYS . 35.9 mt -90.75 136.65 27.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.38 153.99 56.26 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.532 2.155 . . . . 0.0 112.238 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 t30 -57.65 -26.88 62.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.268 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.85 -47.11 81.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.431 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -90.25 1.31 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -54.78 -39.75 68.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 111.041 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.58 -34.06 68.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.609 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.6 p -178.35 93.53 0.22 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.83 161.07 10.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.567 2.178 . . . . 0.0 112.179 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.71 155.85 61.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.255 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 112.33 9.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.0 158.34 14.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.355 2.036 . . . . 0.0 112.292 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -116.12 -37.77 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 120' ' ' VAL . 1.4 t70 -74.01 125.81 29.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -24.5 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 -30.67 31.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 117' ' ' ASP . 33.6 t -85.32 115.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 157.02 38.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 124.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 133.81 45.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -88.47 130.74 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -132.06 22.52 4.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ARG . 2.5 pt-20 30.28 42.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.79 159.87 3.24 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -142.19 146.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.219 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.1 m -103.94 120.29 40.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -138.9 163.26 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.321 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 151' ' ' LEU . 11.0 m-85 -107.76 128.44 54.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 m -105.82 135.69 46.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -129.56 139.1 51.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.756 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -116.91 153.83 31.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.37 -177.96 6.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.54 93.03 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.541 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 177.2 149.96 8.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 177.98 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.335 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.86 156.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -133.34 -72.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -152.4 -46.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.775 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -71.85 -33.83 68.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.58 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.5 -35.03 78.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.874 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.23 -40.82 98.53 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.999 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.3 t -53.83 -38.58 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.561 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.27 -34.78 73.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.554 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.669 ' HB2' HG21 ' A' ' 185' ' ' VAL . 24.5 m170 -70.18 -42.87 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.88 -32.92 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.759 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 m -72.22 -41.59 66.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.35 -43.34 92.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.712 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' TYR . 18.4 tp -59.04 -44.6 91.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.555 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -46.76 88.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.302 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -46.21 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.55 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.63 -45.86 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.629 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.724 HD21 ' CD2' ' A' ' 31' ' ' TYR . 48.0 mt -73.26 -9.92 59.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.329 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.58 -42.06 22.97 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.048 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.09 -27.11 71.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 6.9 p -93.98 163.55 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.595 0.236 . . . . 0.0 110.643 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 85.0 Cg_endo -82.92 20.08 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.72 2.28 . . . . 0.0 112.967 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.96 148.14 31.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.091 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.549 HG21 ' OXT' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -101.19 176.57 5.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.51 158.2 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.39 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.27 -36.05 14.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.48 49.29 74.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -158.42 -42.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 111.122 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.0 p -160.12 137.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.264 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 86' ' ' VAL . 6.4 p90 -129.21 172.18 11.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.787 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 51.9 m-85 -112.98 155.42 24.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.26 149.26 41.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -118.89 125.59 49.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.896 179.928 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.869 0.366 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -120.82 135.25 55.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -143.81 154.16 43.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' A' ' 147' ' ' HIS . 25.2 t -124.6 129.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.43 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.2 m0 -107.89 121.61 45.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.917 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 130' ' ' VAL . 14.2 mt -94.13 134.93 36.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 130' ' ' VAL . 25.5 t -81.22 120.38 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -88.67 115.12 25.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.549 ' OXT' HG21 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.187 -0.911 . . . . 1.0 111.145 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 ' HD3' ' A' ' 34' ' ' ARG . 40.4 t -74.54 112.95 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.461 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 mt -93.99 -17.61 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.4 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -169.96 162.1 9.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -151.99 179.43 8.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 135.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.423 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' CA ' ' CE1' ' A' ' 31' ' ' TYR . . . -145.11 -149.62 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.443 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 158.97 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.947 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -29.38 69.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.9 -32.36 16.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.09 110.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.4 155.61 16.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.58 156.85 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -147.04 124.38 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.765 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -86.2 117.39 24.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.696 ' HD3' HG22 ' A' ' 20' ' ' VAL . 2.9 mmm-85 -139.26 128.66 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 109.72 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 p -151.23 85.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.03 167.85 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.28 110.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.94 -154.54 25.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.459 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' ILE . 14.5 mttt -104.72 150.86 24.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 3.6 m-85 -137.71 163.46 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.013 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.52 140.37 29.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.503 HG21 ' HE2' ' A' ' 99' ' ' LYS . 41.0 p -131.07 132.09 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.833 -179.133 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 120' ' ' VAL . 63.2 t -130.88 125.39 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.212 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.12 138.76 33.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 111.418 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 54' ' ' ALA . 4.1 t -138.5 116.96 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.79 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.78 168.35 9.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.33 31.11 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG12 ' A' ' 46' ' ' VAL . 31.4 mtmt -153.28 117.77 2.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.997 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.28 -173.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.467 2.111 . . . . 0.0 112.137 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 98' ' ' LEU . 61.3 t -61.28 -57.6 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -59.29 -45.23 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.16 -46.44 74.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.62 -45.06 93.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.802 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.3 mt -58.85 -35.17 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -62.06 -30.7 71.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.042 0.449 . . . . 0.0 109.906 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.0 tp10 -86.79 -37.51 17.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.161 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.68 -29.97 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.462 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.617 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 5.2 mmt -57.43 -43.63 99.12 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 59' ' ' MET . 33.3 Cg_endo -64.69 -47.35 5.46 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.635 1.557 . . . . 0.0 111.835 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -70.47 -32.81 70.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.704 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.612 HD11 HG23 ' A' ' 44' ' ' VAL . 16.9 mm -77.1 -43.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.424 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.09 -45.3 81.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.735 179.778 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -59.98 -29.83 68.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 37.0 t80 -58.54 -41.36 85.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.806 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.536 HG11 ' CE2' ' A' ' 102' ' ' PHE . 14.2 m -85.61 -30.65 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.75 -105.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.46 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.62 67.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -155.49 52.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 4.6 p30 -110.96 -15.3 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.179 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 2.5 t70 83.63 -13.86 0.73 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.607 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 4.9 53.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.29 32.93 5.41 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.448 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 113' ' ' PRO . 3.1 p -96.83 155.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.688 -0.756 . . . . 0.0 111.821 -177.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.79 108.51 1.77 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.185 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -104.72 -77.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.356 . . . . 0.0 111.072 -179.706 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 -144.81 16.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.33 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.45 128.59 37.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 80' ' ' VAL . 5.6 m -139.0 119.86 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.525 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.72 137.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.938 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 80' ' ' VAL . 17.8 Cg_endo -59.86 143.7 99.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.334 2.023 . . . . 0.0 112.16 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.71 137.53 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.414 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.69 157.27 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.802 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.99 154.15 32.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.19 136.61 33.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.094 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.57 HG12 HG22 ' A' ' 51' ' ' VAL . 5.9 m -125.85 92.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.175 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 166' ' ' VAL . 17.1 m-85 -70.75 112.24 12.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.95 167.24 9.69 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.682 2.255 . . . . 0.0 112.419 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.36 172.19 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.78 -21.34 18.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.315 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.14 -6.14 59.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 -16.06 61.96 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.95 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -84.44 165.17 18.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.971 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 ' OH ' ' A' ' 167' ' ' TYR . 54.8 mt -90.85 167.17 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.56 81.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 50.77 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.346 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 68.57 104.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' CD2' ' A' ' 84' ' ' PHE . 2.3 tt -140.67 127.97 21.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HE2' HG21 ' A' ' 43' ' ' THR . 1.3 tttt -109.48 116.05 31.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.716 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -77.58 141.09 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.231 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -122.08 128.38 51.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.793 179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CE2' HG11 ' A' ' 66' ' ' VAL . 36.7 t80 -113.05 130.93 55.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 -83.9 115.18 22.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 40' ' ' LYS . 30.3 mt -97.77 139.26 21.22 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 154.06 25.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.391 2.061 . . . . 0.0 112.361 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.26 -26.89 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -32.95 70.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.423 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 19.5 m-85 -93.16 -17.71 23.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.517 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -33.65 53.21 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.67 -30.11 62.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.95 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 m -150.53 77.42 8.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.572 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 36.2 Cg_endo -65.37 149.23 88.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.602 2.202 . . . . 0.0 112.161 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HB3' HG11 ' A' ' 74' ' ' VAL . 12.5 Cg_exo -70.86 158.94 54.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.634 2.223 . . . . 0.0 112.116 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 70' ' ' ASN . . . -67.7 136.58 92.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 59.6 Cg_endo -72.52 -20.15 23.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.436 2.091 . . . . 0.0 112.41 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.73 -67.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.04 125.88 25.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.69 -22.53 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 p -81.86 -32.68 31.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 44' ' ' VAL . 31.3 t -85.36 116.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.2 156.58 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.38 116.08 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -98.82 144.84 27.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -89.43 51.64 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -76.12 120.45 21.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 177.16 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.97 156.69 23.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 pt -143.93 154.02 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -107.86 126.66 52.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.8 m -135.33 159.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.401 ' CD2' HD21 ' A' ' 155' ' ' LEU . 11.0 m-85 -107.7 129.45 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 p -105.92 128.84 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 0.0 111.061 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.9 t -129.7 139.19 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -116.9 147.83 41.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 1.0 OUTLIER -137.59 -57.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.88 -109.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.655 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . 175.02 78.37 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -176.84 106.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.46 134.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.277 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -106.53 -38.69 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.741 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.414 ' HG2' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -176.18 -61.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.85 71.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.63 -34.91 76.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.939 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.7 OUTLIER -63.44 -39.04 93.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.579 0.704 . . . . 0.0 110.131 179.138 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 94' ' ' LEU . 48.7 t -53.66 -38.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.87 75.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 185' ' ' VAL . 13.7 m170 -70.35 -44.11 68.83 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.07 -32.9 72.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -68.57 -42.74 77.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.863 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -61.97 -46.05 90.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 151' ' ' LEU . 12.1 tp -59.2 -41.57 88.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.623 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -59.61 -47.73 84.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.268 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 95.3 m -62.48 -45.56 92.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 31' ' ' TYR . 17.1 m -57.61 -38.92 75.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.401 HD21 ' CD2' ' A' ' 131' ' ' TYR . 92.1 mt -74.02 -16.5 61.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 153' ' ' THR . 8.2 pt-20 -48.69 -28.41 3.54 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.792 0.33 . . . . 0.0 111.331 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.89 -17.94 62.34 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.583 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -92.51 170.97 8.18 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.607 0.241 . . . . 0.0 110.801 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.4 Cg_endo -80.95 14.26 2.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.651 2.234 . . . . 0.0 113.151 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.72 132.43 53.83 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.707 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 69.3 m -102.06 -2.29 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.488 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 59.5 m-85 57.44 124.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.39 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.454 ' HG3' HG12 ' A' ' 188' ' ' VAL . 1.3 mm-40 -66.94 -173.92 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.89 61.88 0.94 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.877 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.35 70.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.438 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.3 p -161.9 119.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.244 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.816 ' HB3' HD23 ' A' ' 187' ' ' LEU . 3.7 p90 -133.55 177.17 7.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.754 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 186' ' ' TRP . 13.5 m-85 -126.27 151.07 47.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.084 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 71.2 m -140.07 153.53 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.05 55.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.473 179.967 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.876 0.369 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 2.1 m120 -109.41 135.51 50.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.0 147.93 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 147' ' ' HIS . 24.2 t -128.84 116.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.89 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.56 121.88 43.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.984 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 167' ' ' TYR . 13.0 mt -91.09 140.06 30.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.855 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.8 t -79.15 120.43 30.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -65.53 153.57 41.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.839 0.352 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 26.6 mt 63.83 29.6 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.5 -125.49 29.18 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.703 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 21.73 14.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 111.207 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -98.99 37.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.054 0.455 . . . . 0.0 110.587 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -94.75 141.57 28.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.305 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.545 ' O ' HD22 ' A' ' 9' ' ' LEU . 9.1 m-80 -101.44 176.15 5.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 126.62 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.695 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -169.83 -150.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.703 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' LEU . 1.3 t80 92.33 -37.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.878 0.471 . . . . 0.0 111.071 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.1 -72.23 0.59 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.085 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.63 123.21 48.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.28 146.11 26.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.94 0.4 . . . . 0.0 111.581 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -113.14 124.87 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.637 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -115.95 119.76 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -68.14 145.66 97.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 18' ' ' TRP . 19.8 Cg_endo -60.59 -18.61 55.73 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.459 2.106 . . . . 0.0 112.235 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 17' ' ' PRO . 19.0 p90 -151.3 142.9 23.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.97 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 2.7 tp60 -110.79 107.81 17.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -73.81 113.68 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.36 -6.29 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 t -169.86 167.23 9.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.29 -176.6 5.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 125.51 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -128.91 -101.03 0.99 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.705 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -161.06 160.62 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -66.89 -29.7 69.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -35.49 15.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.3 107.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.28 137.81 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.8 p90 -138.93 162.23 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -145.18 137.18 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.728 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.96 114.88 23.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 18' ' ' TRP . 6.3 ptm180 -131.75 128.0 37.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.865 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -106.92 124.85 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.7 m -106.4 134.79 48.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.98 110.87 11.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.58 -143.67 6.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.36 -60.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -130.01 145.57 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -138.25 154.36 49.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.77 118.72 31.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.0 p -112.46 132.01 55.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.29 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' ILE . 39.5 t -125.76 125.11 67.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.92 137.65 35.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 54' ' ' ALA . 14.8 t -138.61 116.58 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 170.49 7.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 47.4 31.41 1.88 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.395 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -152.65 132.36 7.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 35.2 Cg_exo -57.7 -157.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.481 2.121 . . . . 0.0 112.161 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.927 HG13 ' CD1' ' A' ' 98' ' ' LEU . 69.6 t -84.52 -57.56 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.1 -43.38 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.14 -45.49 76.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.63 -45.14 89.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.1 mt -57.24 -34.99 69.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -63.31 -33.19 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 109.904 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 12.5 tp10 -87.94 -31.73 19.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.282 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -74.94 -40.41 60.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.444 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' ILE . 10.8 mmt -57.36 -45.16 99.92 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.1 Cg_exo -58.06 -45.13 33.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.263 1.975 . . . . 0.0 112.145 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -70.32 -41.76 72.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.461 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 44' ' ' VAL . 3.2 tt -76.53 -31.9 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.476 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -66.45 -42.1 88.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HD3' HG21 ' A' ' 69' ' ' THR . 15.5 mttp -60.09 -33.25 71.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -68.77 -41.99 78.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.0 m -81.31 -30.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.15 -103.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.14 69.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.525 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 69' ' ' THR . 90.0 m -164.27 63.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.76 5.23 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.459 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 46.97 9.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -148.24 -46.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 37.16 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.457 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 113' ' ' PRO . 26.8 m -100.23 160.1 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.68 75.11 0.3 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 mtp -74.26 -55.46 6.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.851 0.358 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -93.26 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.51 172.41 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 m -164.0 110.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 49.79 166.1 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.673 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD2' HG12 ' A' ' 80' ' ' VAL . 21.0 Cg_endo -61.7 149.32 90.4 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.981 . . . . 0.0 112.25 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.431 HG21 ' HE1' ' A' ' 59' ' ' MET . 1.3 t -86.18 153.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -120.22 145.84 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.491 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -124.6 154.44 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.52 136.25 36.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.315 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 167' ' ' TYR . 3.8 m -128.09 129.93 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -102.47 95.78 6.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' CE1' ' A' ' 167' ' ' TYR . 61.7 Cg_endo -73.0 134.73 21.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.222 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.94 170.32 10.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -17.51 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.245 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -6.22 59.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.737 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.89 -1.71 85.3 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.89 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -121.75 136.88 54.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.813 0.34 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.578 HD12 ' CG ' ' A' ' 141' ' ' GLU . 35.0 mt -59.1 171.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.52 47.63 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 54.94 83.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -178.22 109.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.927 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.9 tt -144.11 138.25 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.23 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 5.3 tttp -119.62 115.76 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.437 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -81.69 117.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.564 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -98.73 132.16 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.542 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.755 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.3 t80 -114.01 136.08 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.46 107.88 19.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.421 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.1 mt -83.71 136.16 42.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.0 Cg_endo -64.96 154.23 74.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.497 2.131 . . . . 0.0 112.322 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -53.95 -27.65 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -58.84 -45.53 89.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -98.71 -15.07 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.273 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -36.03 60.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.804 0.335 . . . . 0.0 111.109 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.4 -33.2 76.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.64 75.39 2.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.722 0.296 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.1 Cg_exo -57.1 159.72 14.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.583 2.189 . . . . 0.0 112.275 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.74 148.26 58.3 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.69 2.26 . . . . 0.0 112.011 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.44 112.36 9.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.95 144.63 35.66 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.352 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -103.76 -31.18 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' HG23 ' A' ' 120' ' ' VAL . 3.1 m-20 -80.94 122.03 26.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.83 -23.79 54.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 m -81.98 -28.54 32.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 117' ' ' ASP . 27.7 t -85.19 115.58 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -121.72 149.81 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.7 mm -113.04 126.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.85 129.11 45.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 144.13 25.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER 56.0 173.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.119 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 15.4 tp10 86.71 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.3 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -91.31 158.66 25.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.015 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -128.29 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 35' ' ' ALA . 48.7 m -122.2 119.02 30.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.292 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 187' ' ' LEU . 35.1 m -134.11 165.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.723 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -107.5 136.4 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.13 179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -105.69 141.17 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.073 0.463 . . . . 0.0 111.37 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.3 t -130.33 139.64 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.586 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -116.31 124.98 51.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.97 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.656 ' CE2' ' CD2' ' A' ' 147' ' ' HIS . 14.3 p90 -131.78 165.13 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.17 79.55 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.19 175.62 43.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 175' ' ' PRO . 3.2 m-85 -91.36 164.28 13.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.792 0.329 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -169.72 120.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.207 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -105.87 -65.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.81 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.578 ' CG ' HD12 ' A' ' 94' ' ' LEU . 7.5 tt0 -146.73 -70.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.5 70.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.65 -34.97 78.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.29 -40.45 95.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.437 0.637 . . . . 0.0 109.98 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.737 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -52.95 -38.26 28.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.658 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.67 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.647 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.656 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 m80 -70.09 -42.39 72.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.757 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.56 -32.94 73.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -68.41 -40.38 81.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -60.05 -46.11 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 31' ' ' TYR . 8.1 tp -58.71 -42.19 88.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.47 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.3 m -63.02 -41.58 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.417 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 31' ' ' TYR . 6.6 m -57.29 -49.14 77.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.705 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 0.8 OUTLIER -73.67 -10.24 59.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.296 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -46.83 -35.47 6.35 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.17 31.13 7.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.8 p -145.83 165.13 22.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 -2.81 12.29 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.909 2.406 . . . . 0.0 112.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.5 124.6 19.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -102.22 175.68 5.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.648 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -157.45 -177.13 6.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.817 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -79.3 -76.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.2 -18.07 2.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.076 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -158.01 27.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.925 0.362 . . . . 0.0 111.613 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -161.95 132.59 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.486 ' HA ' HG23 ' A' ' 188' ' ' VAL . 27.7 p90 -149.73 168.17 24.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.656 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 98.3 m-85 -112.82 155.24 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.152 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 185' ' ' VAL . 1.3 m -132.79 154.0 50.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.02 136.31 47.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -172.69 -65.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.77 -67.88 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.94 135.97 87.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 152.49 33.18 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.527 2.152 . . . . 0.0 112.4 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.436 ' HB2' ' CD2' ' A' ' 138' ' ' TYR . 60.6 Cg_endo -72.84 85.58 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.522 2.148 . . . . 0.0 112.253 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 mtp -120.85 -76.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.81 120.21 62.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.65 177.12 7.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.084 . . . . 0.0 112.291 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 59.73 19.82 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.07 -19.76 0.22 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.196 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -108.58 148.58 30.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? -131.5 125.49 32.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.815 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -108.86 134.09 52.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -138.26 143.1 39.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.7 t -123.2 121.88 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.619 ' CZ2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.056 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.736 ' O ' HG12 ' A' ' 130' ' ' VAL . 10.6 mt -91.17 139.97 30.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.561 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' CE2' ' A' ' 168' ' ' TYR . 15.2 t -74.61 118.69 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -76.83 127.83 33.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.226 -0.892 . . . . 1.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.914 0.387 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.407 HD13 ' H ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -82.76 156.73 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.407 ' H ' HD13 ' A' ' 2' ' ' LEU . . . -161.43 74.13 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.6 ttp -102.22 152.58 20.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 132.76 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.59 133.42 52.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.78 126.53 55.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.535 ' HB3' HD12 ' A' ' 9' ' ' LEU . 1.2 m -88.11 156.0 19.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD12 ' HB3' ' A' ' 8' ' ' SER . 2.8 mp 59.93 173.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.7 32.58 20.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -89.49 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.523 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 t -64.79 127.63 32.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.81 142.71 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -132.73 151.01 52.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 t -96.94 119.98 36.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -102.47 164.63 15.3 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.522 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 16' ' ' TRP . 28.9 Cg_endo -63.24 112.42 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.449 2.099 . . . . 0.0 112.142 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 t90 62.47 69.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -123.84 114.81 20.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.3 115.26 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -96.44 0.13 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -170.35 161.27 8.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -152.37 -45.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.48 136.41 49.27 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -136.9 175.45 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.542 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 161.09 27.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.341 . . . . 0.0 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -66.56 -32.84 74.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.7 -35.05 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 29' ' ' VAL . 6.9 m -146.07 110.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.054 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -95.51 154.85 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.1 p90 -139.39 158.31 44.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -145.14 121.89 11.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.92 131.23 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -139.91 130.65 25.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.29 120.17 40.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 m -131.98 136.41 47.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -114.75 77.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.39 -161.92 2.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.525 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.28 -86.39 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -113.28 149.17 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.886 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -137.61 156.99 47.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.93 140.28 29.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.53 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 24.9 p -135.67 131.87 36.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.975 0.417 . . . . 0.0 111.5 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 120' ' ' VAL . 39.8 t -128.01 125.41 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.436 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.99 136.0 38.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.4 116.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.778 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 168.17 9.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.88 33.06 3.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.526 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -153.2 121.65 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.89 -161.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.502 2.135 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 141' ' ' GLU . 28.7 t -74.21 -58.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 -44.98 82.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.212 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.13 -46.0 75.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.26 89.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.634 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -32.52 74.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 tp10 -87.57 -40.36 14.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.15 -37.57 66.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 11.9 mmt -57.78 -44.12 99.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' MET . 49.3 Cg_endo -70.35 -36.67 8.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -70.09 -43.28 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 44' ' ' VAL . 5.2 tt -77.08 -26.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -39.26 90.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -59.19 -31.06 68.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.23 -49.18 46.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.1 m -75.31 -30.82 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.188 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.89 -99.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.25 35.7 0.76 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 69' ' ' THR . 21.0 m -119.67 30.27 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 110.929 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.774 HD21 HG22 ' A' ' 74' ' ' VAL . 40.7 p-10 -88.9 -14.43 36.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 78.67 -1.68 2.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -93.78 -44.25 8.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.848 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.62 39.45 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 70' ' ' ASN . 27.0 m -100.27 -178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 88.14 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -83.21 -45.87 13.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.14 -82.55 1.54 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.87 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.794 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.14 -164.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.96 156.42 2.59 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.264 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.99 135.21 61.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 112.17 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 102' ' ' PHE . 25.4 m -86.0 145.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.343 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.454 ' HG ' ' HH2' ' A' ' 186' ' ' TRP . 1.1 p -115.49 174.01 6.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.654 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -127.51 154.46 45.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.38 136.73 32.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.435 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.0 m -131.85 109.25 15.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CD2' HG23 ' A' ' 166' ' ' VAL . 11.9 m-85 -83.95 111.32 31.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.4 Cg_endo -80.67 127.87 6.57 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.162 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 164.21 14.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.41 -15.74 62.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.361 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -5.95 59.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.523 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.512 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 96.59 -2.06 62.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.08 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -121.41 -169.85 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 141' ' ' GLU . 88.4 mt -105.81 169.52 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.714 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.31 34.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.142 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp 51.08 26.7 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.11 122.29 31.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 84' ' ' PHE . 1.1 tt -133.84 139.99 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 111.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.4 mtpt -118.06 115.75 25.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.133 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.9 t -78.77 116.72 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.764 0.316 . . . . 0.0 111.252 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -97.23 142.12 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.773 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.71 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 20.4 t80 -127.11 148.81 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.987 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -105.82 110.4 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.91 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -75.69 130.39 79.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.41 154.06 20.62 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.461 2.107 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -27.07 65.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -64.74 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 74' ' ' VAL . 4.9 m-85 -108.16 -2.95 19.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.677 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.97 -33.68 57.63 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.721 0.296 . . . . 0.0 111.23 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.09 -33.97 75.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.79 89.44 0.7 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.276 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 23.5 Cg_exo -63.23 160.2 35.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 112.251 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.93 153.29 63.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.597 2.198 . . . . 0.0 111.919 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 110.84 5.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 132.36 40.27 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 0.0 112.061 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 t -94.99 46.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.668 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -149.31 112.72 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.98 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.01 -23.54 54.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -82.17 -30.32 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.7 t -85.37 114.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.03 150.33 27.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 42' ' ' ALA . 26.0 mm -118.17 127.98 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 129.95 45.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -88.76 139.94 29.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.5 mtm105 62.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -169.14 -167.9 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.49 89.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.386 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.422 HD12 HG13 ' A' ' 130' ' ' VAL . 2.1 pp -135.2 146.41 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.3 m -104.0 133.3 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.372 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.894 HG12 ' HA ' ' A' ' 188' ' ' VAL . 34.1 m -136.94 169.32 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.633 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -136.15 129.58 31.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 p -105.63 149.05 26.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 111.587 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.8 t -130.7 139.34 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.64 133.68 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.01 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -127.81 -46.27 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.59 149.63 10.33 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.73 -170.22 17.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -133.11 123.78 26.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -112.65 174.69 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -75.7 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -153.37 -61.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.774 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.93 -33.78 65.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.604 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.5 t70 -68.21 -34.92 77.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.049 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -40.51 95.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.458 0.647 . . . . 0.0 110.087 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.69 -38.57 35.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.88 77.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.715 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -70.18 -46.01 65.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -62.13 -33.0 73.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.2 m -67.83 -38.25 82.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.93 -35.78 73.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.571 HD23 HD12 ' A' ' 187' ' ' LEU . 7.6 tp -59.22 -40.68 86.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -60.99 -42.49 98.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.266 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.2 m -64.05 -41.81 97.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -49.23 77.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.692 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.54 -9.05 58.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -47.04 -36.37 7.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.821 0.343 . . . . 0.0 111.215 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -96.34 36.09 4.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 15.8 p -145.29 168.28 12.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.3 Cg_endo -85.16 17.83 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.253 2.635 . . . . 0.0 112.794 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 170.98 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.849 0.356 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -136.66 -178.07 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.503 ' H ' HG22 ' A' ' 161' ' ' THR . 12.6 m-85 -155.11 138.05 15.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 190' ' ' ALA . 3.3 mm-40 -63.31 -68.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.1 -79.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.56 69.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 87' ' ' PHE . 9.9 p -161.94 131.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.296 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.858 ' HB3' HD23 ' A' ' 187' ' ' LEU . 7.1 p90 -140.77 170.62 15.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.507 ' CE2' HG22 ' A' ' 188' ' ' VAL . 24.7 m-85 -117.83 136.76 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.0 m -111.32 144.04 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.54 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 101.37 99.29 2.38 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -122.31 130.93 53.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -154.72 142.1 13.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.11 123.42 7.25 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.228 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.83 109.81 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.457 2.105 . . . . 0.0 112.492 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mmm -151.32 -55.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.792 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 118.59 15.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.05 175.31 9.98 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.528 2.152 . . . . 0.0 112.327 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 59.95 34.83 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.184 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -155.6 22.93 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.767 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.0 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -139.05 123.89 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -120.91 144.03 48.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -137.41 142.97 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 111.372 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.2 t -128.76 114.91 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -117.73 121.95 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.648 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -92.65 140.93 29.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.565 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.8 t -73.89 118.81 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.947 0.404 . . . . 0.0 111.269 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.36 145.69 25.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.267 -0.873 . . . . 1.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.847 0.356 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.37 -61.69 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.07 29.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.4 mtm -163.12 129.42 3.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 5' ' ' ILE . 2.1 tt -103.79 85.11 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.79 121.99 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -118.24 160.34 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 139.64 49.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.3 mt -142.29 -68.9 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.64 109.87 21.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.04 -102.54 2.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 m -102.7 129.78 49.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 110.962 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.02 139.08 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -112.98 150.99 31.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 p -96.47 119.95 35.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -136.69 165.72 32.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 18' ' ' TRP . 18.0 Cg_endo -59.59 115.32 2.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.547 2.165 . . . . 0.0 111.938 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' PRO . 4.2 p90 54.21 123.94 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.285 0.564 . . . . 0.0 111.429 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.6 109.18 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.0 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.24 112.92 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.02 -22.81 18.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 t -169.85 167.03 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.868 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 p -151.41 174.58 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 123.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . -124.69 -55.56 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.549 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tptt -161.85 167.68 24.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.702 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -32.27 73.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.1 -35.33 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.356 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 154' ' ' THR . 3.3 m -146.32 115.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 111.574 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 158.55 15.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.766 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 4.7 p90 -138.87 155.72 47.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -146.73 130.91 17.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.07 116.41 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.03 131.69 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.5 119.54 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.14 103.13 8.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.56 129.85 50.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.97 144.46 16.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.76 178.72 16.87 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.92 141.97 50.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 8.8 m-85 -137.54 154.32 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.969 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.1 122.84 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -112.67 132.14 55.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.794 HG21 ' HB ' ' A' ' 62' ' ' ILE . 16.6 t -125.91 125.51 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -95.72 134.9 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.391 . . . . 0.0 111.264 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 54' ' ' ALA . 9.6 t -138.45 116.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.8 166.96 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.991 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.78 27.67 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -152.64 129.42 5.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.68 -78.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.607 2.205 . . . . 0.0 112.675 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.5 t -146.73 -62.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.749 0.309 . . . . 0.0 111.236 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.57 -45.33 81.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.21 -46.28 74.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.04 -45.07 91.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.2 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.9 mt -56.91 -35.3 68.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' HB3' ' NH1' ' A' ' 56' ' ' ARG . 1.2 ttp-105 -63.04 -32.16 73.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.008 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -86.87 -32.94 19.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.24 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.728 ' CB ' HG21 ' A' ' 100' ' ' VAL . . . -73.22 -37.13 66.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.43 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 30.2 mmt -57.8 -44.09 99.16 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 51.3 Cg_endo -70.29 -41.19 3.79 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.938 1.758 . . . . 0.0 111.986 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -70.21 -39.53 75.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.794 ' HB ' HG21 ' A' ' 44' ' ' VAL . 9.3 tt -77.55 -40.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.683 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.471 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.5 -31.58 72.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.063 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' HG21 ' A' ' 69' ' ' THR . 1.0 OUTLIER -58.84 -29.92 67.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.58 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 122' ' ' ILE . 13.7 t80 -75.36 -50.96 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.8 m -66.03 -29.7 47.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.19 -166.9 2.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.46 54.85 4.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 30.5 m -141.45 33.44 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -88.51 164.49 15.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 4.7 t0 -92.43 48.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -148.67 -46.63 0.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.38 34.09 3.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 108' ' ' PHE . 17.5 m -100.46 176.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.6 -67.64 1.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mtt 62.55 146.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.25 -121.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.596 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 -45.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' HD2' ' A' ' 81' ' ' PRO . 1.4 m 61.02 112.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 3.9 t -65.86 -46.43 65.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 79' ' ' THR . 29.4 Cg_exo -62.03 140.77 86.17 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.473 2.115 . . . . 0.0 112.123 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 t -153.78 144.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.282 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 t -115.73 145.95 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.489 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.1 154.21 50.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.87 136.66 32.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.484 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG23 ' CE1' ' A' ' 167' ' ' TYR . 17.7 m -135.57 133.49 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 5.8 m-85 -104.45 97.67 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.301 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.2 Cg_endo -79.65 138.91 13.83 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -90.88 172.0 8.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.09 -29.12 67.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -86.36 -6.14 59.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.97 -2.06 78.9 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 124.41 41.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 88' ' ' PRO . 15.6 mt -66.81 161.24 24.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -118.58 45.78 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt 61.26 -169.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.74 114.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.736 HD11 ' CD2' ' A' ' 84' ' ' PHE . 1.3 tt -143.6 130.66 20.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.5 tttp -108.04 115.89 30.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.728 HG21 ' CB ' ' A' ' 58' ' ' ALA . 3.3 t -85.44 116.91 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.309 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -96.01 131.49 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 15.9 t80 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.267 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.58 110.27 22.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.411 HG23 ' HD2' ' A' ' 105' ' ' PRO . 40.6 mt -90.68 136.29 28.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.226 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' A' ' 104' ' ' ILE . 31.7 Cg_endo -63.6 154.18 70.53 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.454 2.103 . . . . 0.0 112.344 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.86 -26.94 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -56.81 -38.29 72.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.956 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.55 ' HE2' HG11 ' A' ' 74' ' ' VAL . 85.9 m-85 -113.02 -13.05 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -53.14 -47.13 68.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 111.179 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.08 -25.94 54.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 t -171.4 89.41 0.45 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.769 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 122' ' ' ILE . 45.0 Cg_endo -67.9 151.43 78.16 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 0.0 112.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 11.2 Cg_exo -70.79 155.85 61.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.61 2.206 . . . . 0.0 112.111 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -67.5 111.75 8.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.993 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.89 158.06 26.28 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.405 2.07 . . . . 0.0 112.261 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.93 -31.19 11.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.52 114.81 13.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -24.5 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.12 -33.03 29.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.885 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 61' ' ' LYS . 38.6 t -85.43 121.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 157.04 39.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.538 HG21 ' HG3' ' A' ' 112' ' ' PRO . 29.3 mm -107.25 129.31 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -98.86 130.7 45.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.43 16.81 8.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.43 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.91 132.46 23.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -168.57 86.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.15 92.82 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.51 145.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.88 130.8 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 187' ' ' LEU . 26.2 m -143.84 164.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.317 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 4.3 m-85 -107.8 135.43 49.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.8 p -105.68 133.65 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 139.25 52.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.86 138.87 51.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 20.7 p90 -153.32 29.64 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.99 -76.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 138' ' ' TYR . . . 134.62 79.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 137' ' ' GLY . 63.6 m-85 -157.18 82.45 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.322 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.43 26.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.219 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.65 66.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 63.6 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.52 58.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -67.27 -35.97 80.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.105 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.02 -40.52 98.0 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.444 0.64 . . . . 0.0 109.94 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.78 -38.88 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.497 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.81 -35.03 69.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.826 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 40.0 m-70 -68.94 -38.8 79.68 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -61.3 -32.93 72.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.743 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.7 m -72.86 -43.3 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -59.51 -36.65 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 151' ' ' LEU . 12.5 tp -58.1 -43.63 87.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -59.37 -47.51 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 94.6 m -60.91 -41.99 97.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.356 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 29' ' ' VAL . 6.7 m -57.67 -48.97 78.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 mt -72.89 -11.22 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -46.87 129.74 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.241 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.68 9.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.476 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 4.3 p -94.76 173.75 4.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.54 0.21 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 4.4 Cg_exo -77.57 13.97 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.012 2.474 . . . . 0.0 112.939 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.93 130.44 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.334 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.08 172.68 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 152' ' ' ARG . 5.3 m-85 -155.68 160.24 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -104.11 -51.83 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.51 53.66 7.31 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.264 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -158.7 -37.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.596 0.236 . . . . 0.0 111.275 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 12.5 p -159.2 140.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 111.424 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.7 p90 -142.88 170.43 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.09 143.81 43.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.3 m -119.42 137.94 53.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.03 156.09 46.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.075 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 127.66 -101.8 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.91 94.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.789 0.328 . . . . 0.0 110.939 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 3.2 p30 -147.42 135.26 10.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 31.9 Cg_exo -58.38 146.7 88.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.393 2.062 . . . . 0.0 112.344 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 17.0 Cg_exo -66.95 64.57 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.104 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 2.7 mtm -135.27 106.92 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.981 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.8 mttm 60.79 114.38 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.2 -16.89 49.78 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.525 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -90.48 106.96 18.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.968 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 158.53 -74.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.423 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -111.0 158.61 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.724 0.297 . . . . 0.0 110.799 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 145.33 34.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.097 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -108.95 145.57 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -145.7 154.42 42.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.93 124.48 73.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.641 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.06 122.26 46.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.106 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 130' ' ' VAL . 62.3 mt -91.6 140.35 29.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.65 118.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -75.05 116.25 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.17 -0.919 . . . . 1.0 110.986 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.15 -49.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.25 103.49 1.76 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.457 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -101.34 -30.13 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 pt -58.54 167.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -87.66 136.02 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.26 163.17 30.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -76.07 150.32 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.1 123.56 26.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -151.49 -45.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.014 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.56 -132.93 52.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -103.31 129.8 50.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.59 136.42 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.99 138.58 50.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -105.06 134.93 47.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.99 112.76 45.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.6 -60.92 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.411 2.074 . . . . 0.0 112.249 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -79.28 165.78 22.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -136.86 113.09 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -74.3 113.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 35' ' ' ALA . 6.8 mt -86.42 -24.33 25.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -169.98 167.1 9.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -151.6 168.07 26.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.82 -175.67 21.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.426 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.89 -106.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -161.02 167.44 26.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.0 110.916 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -66.6 -28.02 68.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.43 -33.12 16.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.094 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.99 142.38 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -135.12 139.84 44.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 155' ' ' LEU . 1.2 p90 -138.36 162.22 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.726 ' HG2' HG22 ' A' ' 23' ' ' THR . 74.7 mt-10 -144.53 126.46 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.0 129.43 34.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -140.71 135.82 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -112.74 130.08 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.242 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.13 -50.05 21.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.07 70.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.68 29.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.95 139.6 5.02 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HD3' ' CG ' ' A' ' 112' ' ' PRO . 15.8 mttm -92.0 146.68 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -137.54 161.23 36.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 140.3 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.655 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -133.49 131.88 40.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.476 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 120' ' ' VAL . 20.8 t -132.88 125.68 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.679 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.94 132.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.272 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.7 t -138.41 116.87 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 175.43 5.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t0 48.41 28.25 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.436 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.97 133.97 8.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 28.6 Cg_endo -62.46 -165.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.474 2.116 . . . . 0.0 112.099 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 98' ' ' LEU . 42.6 t -74.83 -48.81 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.333 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.71 -45.17 83.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.231 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -67.23 -46.15 74.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.258 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD22 ' CE ' ' A' ' 59' ' ' MET . 3.2 mt -56.97 -35.55 69.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.259 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 tp10 -87.21 -34.15 19.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.355 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.799 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.7 -41.77 62.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.633 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -57.63 -43.95 99.17 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -57.47 -47.15 23.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.107 1.872 . . . . 0.0 112.189 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -70.43 -41.95 72.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.828 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 59' ' ' MET . 6.2 tt -76.09 -37.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 66' ' ' VAL . 58.5 mtp -66.32 -40.48 89.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -59.6 -31.06 69.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.472 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 9.9 t80 -74.99 -50.09 17.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.804 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' CE2' ' A' ' 102' ' ' PHE . 22.1 m -72.54 -29.52 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.404 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.12 -64.33 2.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.626 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.1 76.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -164.52 55.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 110.747 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.53 6.73 6.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.366 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 58.47 18.56 5.75 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.448 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -95.2 -43.47 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.11 24.32 8.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.474 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -101.08 -178.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.62 -55.46 0.39 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 61.7 mtp 62.64 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.657 0.265 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.79 80.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.656 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 55.28 -176.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.624 ' O ' HG13 ' A' ' 80' ' ' VAL . 1.6 t 179.87 -39.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 103' ' ' ARG . 2.4 m -162.23 163.67 18.3 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.855 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -59.21 149.65 79.14 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.29 1.994 . . . . 0.0 111.898 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.33 137.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.684 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 m -119.11 145.86 45.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.07 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -133.15 154.28 50.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.694 0.283 . . . . 0.0 111.452 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.97 136.67 32.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.534 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' A' ' 167' ' ' TYR . 5.2 m -130.25 130.81 65.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 10.6 m-85 -102.51 97.43 8.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.19 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.7 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.1 Cg_endo -75.18 139.8 24.24 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.507 2.138 . . . . 0.0 112.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -90.18 161.92 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.41 -21.97 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.23 -6.19 59.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.42 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.63 -16.09 60.99 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.829 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -98.66 133.35 43.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 88' ' ' PRO . 71.0 mt -57.89 178.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -143.37 44.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 62.1 -166.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.74 108.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.702 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 84' ' ' PHE . 3.7 tt -141.35 139.52 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.12 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -115.78 115.89 27.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.525 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.1 t -82.23 116.86 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.536 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -100.23 137.96 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.809 ' CE2' HG11 ' A' ' 66' ' ' VAL . 24.8 t80 -127.07 132.44 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.684 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.694 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -94.34 109.75 21.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.36 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 108' ' ' PHE . 31.8 mt -82.19 139.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.468 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 79' ' ' THR . 50.5 Cg_exo -53.34 154.14 15.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.624 2.216 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -57.68 -31.02 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.42 -47.13 87.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 104' ' ' ILE . 26.9 m-85 -90.9 -13.49 33.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.199 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.19 -43.69 67.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 111.08 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.75 -27.43 66.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t -167.27 85.87 0.8 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 42.8 Cg_endo -68.02 152.26 76.86 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.613 2.209 . . . . 0.0 112.307 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.92 156.24 60.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.01 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.83 110.89 6.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 122' ' ' ILE . 69.1 Cg_endo -74.04 145.0 34.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.304 2.003 . . . . 0.0 112.453 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -86.12 -176.41 5.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 64.16 120.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.995 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.4 -16.89 25.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.599 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.6 m -80.16 -34.72 37.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 111.233 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 44' ' ' VAL . 38.5 t -85.42 113.83 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.149 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -128.06 157.13 41.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 115' ' ' PRO . 27.8 mm -106.1 129.09 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.85 129.83 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 18.88 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.342 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -69.58 164.35 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -70.91 169.11 15.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.64 176.27 4.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.68 145.25 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.0 m -103.99 118.93 37.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.769 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.18 166.74 21.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.494 ' HB2' HD21 ' A' ' 151' ' ' LEU . 3.7 m-85 -107.83 133.42 52.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.583 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 p -105.89 122.29 45.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.977 0.417 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.484 ' HB ' HD13 ' A' ' 151' ' ' LEU . 5.6 t -116.38 139.1 50.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.732 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -116.99 154.16 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -166.87 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.64 127.93 4.49 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.64 147.0 4.49 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -67.14 118.21 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.58 126.04 45.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 -43.43 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.556 ' CD ' HD12 ' A' ' 94' ' ' LEU . 28.2 tt0 -176.04 -66.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.62 -33.77 66.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -67.67 -34.9 77.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.074 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.67 -40.49 95.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.093 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.8 t -53.75 -38.86 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.549 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.56 -33.45 69.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.648 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -70.11 -44.43 68.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.89 72.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.4 m -67.44 -38.0 83.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.468 ' O ' HG22 ' A' ' 153' ' ' THR . 11.5 mt-30 -64.61 -36.25 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 131' ' ' TYR . 11.9 tp -70.03 -37.17 75.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 110.437 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.01 -48.08 63.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 150' ' ' GLN . 4.2 t -61.25 -40.96 96.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.472 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 98.3 m -57.52 -47.08 82.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.695 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.677 HD21 ' CE2' ' A' ' 31' ' ' TYR . 83.4 mt -72.75 -13.79 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.312 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.18 115.38 1.08 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.84 18.03 8.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.559 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.1 p -146.58 165.15 20.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.57 -13.25 35.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.765 2.31 . . . . 0.0 112.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -57.5 110.51 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -102.48 -177.74 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.534 ' H ' HG22 ' A' ' 161' ' ' THR . 0.0 OUTLIER -156.82 20.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.332 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 67.72 -66.58 0.21 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.162 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.35 48.88 2.93 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.116 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -158.05 -33.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.505 0.193 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 14.0 p -159.13 138.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.548 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 86' ' ' VAL . 15.0 p90 -136.99 171.55 14.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.779 ' CE2' HG22 ' A' ' 188' ' ' VAL . 37.5 m-85 -112.87 150.83 31.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.18 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.3 m -129.92 157.79 41.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.07 139.35 49.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.37 -144.02 3.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.555 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -142.26 -174.26 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.964 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.51 168.84 1.58 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.04 152.52 14.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.554 2.169 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.61 127.77 25.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.565 2.176 . . . . 0.0 112.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.3 ttt -160.25 -54.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.94 92.87 47.92 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 179' ' ' TYR . 32.0 Cg_exo -57.8 -160.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.514 2.143 . . . . 0.0 112.202 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 178' ' ' PRO . 48.3 m-85 60.06 94.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 104.38 50.9 0.95 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.491 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 138.92 49.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.831 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -133.21 128.07 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -130.97 133.84 46.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -146.14 157.06 43.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.49 126.24 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.825 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -107.91 121.69 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.155 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 167' ' ' TYR . 12.7 mt -94.41 134.3 37.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.805 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 168' ' ' TYR . 21.5 t -74.88 118.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -63.58 139.35 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.201 -0.904 . . . . 1.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.66 158.51 23.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.38 -78.22 1.08 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -56.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 110.952 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -64.05 117.55 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.29 118.81 37.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.76 126.96 55.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -87.99 129.37 35.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.98 -72.73 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 59.8 -177.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.975 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.73 -97.78 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.273 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 t -101.82 124.93 48.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 110.725 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.07 122.05 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.218 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -133.08 147.96 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.5 p -111.66 120.05 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -129.9 165.56 32.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 16' ' ' TRP . 20.6 Cg_endo -60.85 -54.1 2.18 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -117.88 142.12 47.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -122.55 118.32 27.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.28 113.19 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.031 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.99 -27.78 18.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -170.09 167.09 8.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -151.65 160.52 43.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.44 71.85 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.364 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.97 -132.24 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.607 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.28 164.89 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -66.49 -28.7 68.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 -34.47 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 118.82 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 p -95.38 130.69 42.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 6.2 p90 -138.53 154.57 48.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -145.19 135.03 23.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.66 124.7 33.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 136.84 30.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.21 130.41 56.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.38 164.78 25.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.03 73.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.58 118.44 6.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.569 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.37 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.571 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' O ' HD12 ' A' ' 104' ' ' ILE . 11.5 mttt -111.01 147.93 33.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.74 153.29 49.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.13 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . . . -94.39 119.11 32.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.5 p -112.66 147.31 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.861 HG23 HD12 ' A' ' 62' ' ' ILE . 23.0 t -131.82 125.97 56.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.153 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -95.95 131.54 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.693 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 17.5 t -138.18 116.98 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 169.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.738 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 79.59 -49.11 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.492 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HB3' ' N ' ' A' ' 54' ' ' ALA . 19.5 mttt -85.65 141.63 36.43 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 110.877 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.51 -80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.481 2.121 . . . . 0.0 112.626 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.939 HG13 ' CD1' ' A' ' 98' ' ' LEU . 43.0 t -142.65 -66.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.851 0.358 . . . . 0.0 111.334 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.76 -45.33 78.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -46.07 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.77 -41.12 85.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 55' ' ' LEU . 5.7 mt -57.1 -35.07 68.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.013 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -31.28 71.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.285 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 34.2 tp10 -87.81 -33.66 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.12 -38.83 66.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.631 ' HE1' HG21 ' A' ' 82' ' ' VAL . 6.9 mmt -57.72 -43.97 99.12 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.8 Cg_endo -70.14 -37.62 8.03 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.994 1.796 . . . . 0.0 112.128 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -70.14 -42.68 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.861 HD12 HG23 ' A' ' 44' ' ' VAL . 1.5 tt -77.71 -28.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -41.06 90.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -58.93 -31.21 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 40.9 t80 -70.59 -53.35 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.503 HG21 ' CG ' ' A' ' 78' ' ' MET . 27.1 m -67.25 -26.36 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.288 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.0 -126.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.645 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.06 68.2 0.52 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 69' ' ' THR . 28.7 m -155.11 52.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' OD1' ' CD1' ' A' ' 65' ' ' TYR . 2.6 m-80 -112.2 22.47 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 t70 54.56 34.34 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.027 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -148.3 -61.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.29 81.92 1.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.47 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 113' ' ' PRO . 5.3 m -139.63 146.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.37 71.77 0.7 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.6 mtp -62.24 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.03 120.49 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.503 ' CG ' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -75.57 154.14 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.594 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.87 148.2 25.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 21.7 t -56.75 -47.7 98.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.413 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.4 Cg_endo -80.91 154.76 19.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.36 2.04 . . . . 0.0 112.499 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.631 HG21 ' HE1' ' A' ' 59' ' ' MET . 41.7 t -153.91 138.74 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.465 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 29.6 t -115.63 149.21 38.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.759 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.06 154.23 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -89.15 136.69 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 94' ' ' LEU . 30.7 m -134.68 128.75 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.195 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -98.61 99.33 7.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.724 ' HA ' HD23 ' A' ' 94' ' ' LEU . 54.2 Cg_endo -69.24 128.01 15.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.471 2.114 . . . . 0.0 112.248 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.13 168.06 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -19.63 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.185 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.45 2.95 42.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.487 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 145' ' ' VAL . . . 91.0 -15.45 60.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.878 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.84 177.63 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 88' ' ' PRO . 53.6 mt -114.37 -12.91 12.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.62 165.53 0.2 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.003 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -80.52 88.13 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.22 110.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.643 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.4 tt -143.97 128.62 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.449 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -110.98 115.66 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.082 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.677 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -71.46 141.12 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -120.85 124.03 44.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 66' ' ' VAL . 57.5 t80 -108.17 153.68 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.127 0.489 . . . . 0.0 111.69 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.1 109.18 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.493 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 112' ' ' PRO . 33.3 mt -83.04 139.12 42.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.314 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.61 154.21 16.56 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 112.314 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -27.46 56.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -59.53 -47.14 86.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.92 -8.28 31.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -53.4 -36.16 61.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.16 -28.57 73.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 t -177.03 88.12 0.25 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 104' ' ' ILE . 34.0 Cg_exo -59.17 161.27 16.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.229 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.619 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.5 Cg_exo -70.82 154.75 63.38 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.634 2.223 . . . . 0.0 111.864 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 114.58 19.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.2 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 65' ' ' TYR . 48.6 Cg_exo -55.17 178.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 35.78 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.9 120.89 11.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.89 -26.8 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.003 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.2 t -82.01 -34.79 29.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -85.43 117.16 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.23 152.82 40.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.3 mm -107.98 133.77 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.86 157.25 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.79 167.71 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -66.71 171.06 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -169.91 -38.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.63 107.18 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.95 142.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.354 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 82.0 m -107.31 132.08 53.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.508 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 187' ' ' LEU . 34.8 m -142.33 149.51 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 5.6 m-85 -107.78 132.41 53.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.198 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.7 p -105.61 144.41 32.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.48 . . . . 0.0 111.637 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.7 t -130.85 139.13 50.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.8 138.78 51.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.611 ' CE1' ' CD2' ' A' ' 147' ' ' HIS . 39.1 p90 -143.58 -178.67 6.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.789 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.58 88.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.46 -176.44 40.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -58.73 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.11 164.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -132.84 -75.51 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.632 ' HB2' HD12 ' A' ' 94' ' ' LEU . 9.9 pt-20 -139.8 -48.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.97 66.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.09 -35.0 77.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.022 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -63.87 -39.8 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.041 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 92' ' ' GLY . 61.5 t -53.85 -38.61 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.345 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.76 74.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.597 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.611 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 31.3 m80 -70.23 -46.05 65.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.878 0.37 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.94 -33.09 73.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.746 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -71.14 -37.94 72.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -59.01 -39.61 82.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.5 tp -58.35 -40.99 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.523 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -62.74 -45.24 93.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -40.73 98.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.191 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.0 m -57.65 -49.2 77.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.511 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -74.0 -9.25 58.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -47.16 -32.72 4.57 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.788 0.328 . . . . 0.0 111.282 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.42 28.29 12.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 71.5 p -145.84 159.29 47.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.312 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.5 Cg_endo -79.58 8.43 3.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 113.029 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.53 137.36 57.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.194 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -100.88 151.57 21.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.0 OUTLIER -158.64 171.18 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -112.36 102.54 10.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.45 65.01 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.046 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -157.69 -27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.4 p -158.27 141.4 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.892 0.377 . . . . 0.0 111.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 31.1 p90 -146.64 168.24 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.534 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 35.6 m-85 -114.38 144.06 43.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.177 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.14 142.81 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.08 154.34 49.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.7 55.94 1.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.3 105.66 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -109.07 166.03 11.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 20.6 Cg_endo -60.86 139.85 87.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.448 2.098 . . . . 0.0 112.178 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 23.5 Cg_exo -63.79 73.54 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.486 2.124 . . . . 0.0 112.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 -46.37 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.761 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.55 92.47 20.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.63 -35.3 29.48 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.281 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -90.93 89.26 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.956 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.26 -41.93 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.525 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 167.04 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.21 163.33 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -108.94 152.88 24.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.06 147.12 31.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.9 118.12 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.84 123.27 48.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.734 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.0 mt -91.43 140.61 29.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.516 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 190' ' ' ALA . 17.7 t -73.98 131.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.801 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -73.02 -0.94 15.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 188' ' ' VAL . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 1.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.23 144.29 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.019 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.96 92.72 0.38 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.462 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 ptm -96.61 166.1 11.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.6 mt 68.56 12.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.512 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -115.09 107.93 15.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -108.63 164.15 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -69.47 134.28 48.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.67 82.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.45 90.16 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 -82.51 1.11 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.542 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.27 132.8 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.933 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.06 117.95 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -116.02 146.7 41.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.3 t -115.98 142.02 47.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.966 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.92 98.92 32.73 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 149.54 64.01 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.435 2.09 . . . . 0.0 112.32 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -63.66 174.98 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.995 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.01 107.93 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.93 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.32 112.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -84.9 -12.07 54.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.415 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.8 159.03 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.85 155.35 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.79 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.85 145.02 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.368 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.431 ' HA3' ' CD1' ' A' ' 31' ' ' TYR . . . -135.88 -146.63 5.29 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.478 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.732 ' HD3' HG23 ' A' ' 154' ' ' THR . 1.6 mtpt -78.37 164.48 24.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.407 . . . . 0.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.54 -26.45 67.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.02 -32.32 16.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.92 111.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.188 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -95.78 141.76 28.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.35 162.13 35.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -145.57 126.16 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.33 122.51 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -123.95 135.28 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.11 121.03 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.194 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.52 173.46 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.88 -47.19 26.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -178.03 28.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.87 -127.32 2.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.426 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -102.95 139.14 38.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -137.58 148.68 46.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.16 28.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.636 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 p -112.82 149.52 32.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 62' ' ' ILE . 41.9 t -128.92 125.61 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -97.38 130.93 44.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.18 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 58' ' ' ALA . 17.4 t -138.25 116.84 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 175.92 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 43.08 36.38 0.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.565 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 14.8 mttt -152.43 134.15 8.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 37.6 Cg_exo -57.22 -157.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.757 HG13 HD13 ' A' ' 98' ' ' LEU . 38.8 t -84.75 -53.25 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -68.15 -44.98 74.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -46.26 81.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.202 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.26 90.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.75 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.2 mt -57.49 -35.28 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -31.67 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 tp10 -87.66 -32.59 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.18 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.65 -42.63 61.13 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.791 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.0 mmt -57.6 -43.54 98.93 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.8 Cg_exo -59.77 -45.16 26.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.248 1.965 . . . . 0.0 111.953 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 120' ' ' VAL . 19.6 mttp -70.32 -40.47 74.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.445 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.722 ' HB ' HG21 ' A' ' 44' ' ' VAL . 7.1 tt -76.57 -40.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 0.0 111.494 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.516 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.27 -31.8 72.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -63.67 -29.84 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -74.04 -30.63 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 63' ' ' MET . 15.0 m -89.74 -31.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.97 -74.16 0.95 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.573 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.07 71.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 116' ' ' SER . 5.3 m -160.59 70.35 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -119.65 -5.63 10.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.452 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.85 39.81 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -144.4 -45.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.64 31.98 1.54 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.25 145.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.85 4.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.451 ' HG2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 62.87 143.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.4 -119.5 3.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -156.85 -171.56 3.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 103' ' ' ARG . 8.3 t -159.13 -163.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.8 m -45.04 161.99 0.22 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.3 Cg_endo -59.31 132.38 46.24 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.186 1.924 . . . . 0.0 111.863 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 102' ' ' PHE . 33.8 m -84.81 146.81 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 p -115.41 173.91 6.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.75 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.7 154.16 44.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.931 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . . . -87.23 136.58 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.486 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 98' ' ' LEU . 27.2 m -131.86 112.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.816 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE2' HG21 ' A' ' 166' ' ' VAL . 4.4 m-85 -93.35 107.13 23.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.24 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.62 156.29 28.02 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.562 2.175 . . . . 0.0 112.189 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.05 168.34 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -22.27 47.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -85.88 -6.04 59.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.712 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.21 -16.07 61.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.806 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 130.07 47.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -72.09 177.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.02 81.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.57 -166.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.054 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 64.6 96.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.757 HD13 HG13 ' A' ' 51' ' ' VAL . 1.7 tt -144.03 127.86 17.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 85' ' ' ALA . 20.6 ptmt -110.59 115.8 30.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -73.38 141.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.332 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -116.38 141.97 47.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.679 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.659 ' CD2' HG11 ' A' ' 82' ' ' VAL . 54.1 t80 -125.0 159.87 30.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.587 ' O ' HG21 ' A' ' 79' ' ' THR . 2.5 mtt85 -115.97 108.09 15.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.323 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.7 mt -85.5 136.41 37.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.297 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 24.6 Cg_endo -61.45 152.02 75.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.359 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -57.23 -26.98 61.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -47.1 82.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.197 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CE2' ' HG2' ' A' ' 76' ' ' MET . 3.2 m-85 -89.18 -16.24 31.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -54.4 -39.05 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.781 0.324 . . . . 0.0 111.197 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.91 79.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 p -159.97 71.67 3.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 110.63 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 32.5 Cg_exo -58.37 139.03 88.98 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.551 2.167 . . . . 0.0 112.324 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 13.0 Cg_exo -70.54 149.27 61.67 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.598 2.199 . . . . 0.0 112.036 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 124.57 89.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.12 170.49 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.383 2.055 . . . . 0.0 112.269 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.591 ' CB ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -113.14 -40.03 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 131.46 35.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -57.71 -22.46 46.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.105 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -81.97 -31.97 30.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 44' ' ' VAL . 33.5 t -85.64 114.02 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.052 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.59 157.0 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.7 mm -107.57 117.59 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -98.98 136.39 39.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.826 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.7 49.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -71.89 -132.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -177.91 4.0 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.79 153.57 20.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.858 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.96 148.78 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.407 HG21 ' HD2' ' A' ' 189' ' ' LYS . 9.7 m -103.9 130.46 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 187' ' ' LEU . 29.4 m -144.81 170.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.48 133.08 41.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.626 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -105.96 137.78 43.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.046 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -124.87 139.05 54.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -116.91 141.38 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -153.62 -50.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.45 170.59 38.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -112.94 67.59 0.24 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.48 100.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 147' ' ' HIS . . . -160.33 163.98 32.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -61.66 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -161.12 -61.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.657 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.84 -33.8 72.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.412 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -67.33 -34.74 77.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.8 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.4 OUTLIER -63.03 -42.05 99.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.513 0.673 . . . . 0.0 109.82 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 92' ' ' GLY . 42.5 t -54.02 -38.8 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.717 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.02 68.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.752 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.516 ' HB2' HG21 ' A' ' 185' ' ' VAL . 18.5 m170 -70.0 -39.7 75.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.819 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.01 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.761 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -67.42 -39.92 85.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.08 -45.95 89.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 151' ' ' LEU . 11.5 tp -63.1 -40.45 97.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -44.22 96.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -65.17 -41.16 94.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.532 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.732 HG23 ' HD3' ' A' ' 26' ' ' LYS . 86.4 m -57.64 -48.05 80.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 12.7 mt -73.22 -16.63 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -47.23 -40.18 15.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.45 32.11 6.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.65 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 51.9 p -146.09 166.7 16.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.8 Cg_exo -75.86 4.72 4.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.031 2.487 . . . . 0.0 112.812 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.47 125.37 22.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.87 HG22 ' HB3' ' A' ' 190' ' ' ALA . 2.7 m -101.78 152.63 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.553 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.616 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -158.42 173.88 15.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.276 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -85.76 -67.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.76 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.062 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.11 -28.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.62 0.247 . . . . 0.0 111.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.612 HG21 ' CE2' ' A' ' 87' ' ' PHE . 14.6 p -157.98 137.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -135.82 179.34 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.542 ' CE2' HG22 ' A' ' 188' ' ' VAL . 25.8 m-85 -116.27 150.78 37.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 m -124.04 136.94 54.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.54 125.06 52.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 122.17 140.69 5.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -154.0 36.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.75 136.26 37.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.11 158.56 33.92 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.511 2.141 . . . . 0.0 112.385 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.97 136.14 26.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.567 2.178 . . . . 0.0 112.35 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.4 mtm -168.34 -64.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -153.12 134.75 8.63 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.18 -176.14 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.317 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 60.22 68.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.98 -54.93 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.4 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -115.52 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.825 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -139.71 141.13 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.45 141.07 45.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -145.97 153.01 40.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 147' ' ' HIS . 21.6 t -119.0 133.15 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.957 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -107.65 121.71 45.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.555 ' O ' HG12 ' A' ' 130' ' ' VAL . 36.9 mt -94.03 139.2 31.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 168' ' ' TYR . 43.0 t -83.37 127.26 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.05 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HD2' HG21 ' A' ' 129' ' ' THR . 1.4 mtpt -73.76 160.43 31.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.286 -0.864 . . . . 1.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.651 0.262 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.682 ' N ' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -121.19 173.2 7.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.16 -167.56 28.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.473 ' O ' HG13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.19 -166.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.529 0.204 . . . . 0.0 110.831 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 4' ' ' MET . 1.7 pt 30.7 86.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.386 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 114.86 23.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -117.6 146.89 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 143.32 27.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.37 164.21 19.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -70.03 125.02 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.49 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.44 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.5 p -99.21 125.09 44.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.04 128.94 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.83 124.9 17.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 t -116.1 132.51 56.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -177.06 82.38 0.25 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.68 166.5 25.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.653 2.235 . . . . 0.0 112.391 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -173.68 163.5 4.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.022 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.26 109.14 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -74.2 112.97 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.56 -16.33 22.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -169.66 166.96 9.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.85 -173.89 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.041 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.98 -119.53 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 98.82 132.45 7.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.774 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 168.69 19.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.729 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -26.88 67.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.28 -35.13 15.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.23 113.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.887 0.375 . . . . 0.0 111.194 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' CA ' ' A' ' 25' ' ' GLY . 1.3 m -98.22 143.68 28.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.674 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.8 p90 -138.55 158.92 43.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.7 132.24 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -86.32 120.04 27.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.6 148.65 44.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.65 116.61 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.61 127.32 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.17 -172.93 2.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.708 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.31 -19.99 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.735 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.19 -90.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.54 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.592 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -93.87 141.16 28.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.776 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -137.63 155.02 49.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.427 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.74 115.9 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.403 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 17.5 p -112.67 147.41 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.998 0.427 . . . . 0.0 111.482 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.69 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.0 t -130.29 125.66 60.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.939 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -98.68 140.98 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 54' ' ' ALA . 21.8 t -138.38 116.79 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 167.25 10.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 46.23 35.41 2.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.439 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -152.78 142.92 15.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.761 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 53.6 Cg_endo -68.58 -163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.403 2.069 . . . . 0.0 112.107 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.878 HG13 ' CD1' ' A' ' 98' ' ' LEU . 47.1 t -81.04 -54.31 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.59 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -61.18 -45.52 94.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.488 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 5.4 tt0 -67.33 -42.9 82.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.23 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 46' ' ' VAL . . . -58.61 -44.8 90.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.425 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.714 HD11 ' CE1' ' A' ' 84' ' ' PHE . 5.3 mt -56.92 -35.63 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.761 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -33.02 74.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 17.1 tp10 -88.42 -30.89 19.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.384 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.32 -44.8 58.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.5 mmt -57.68 -43.88 99.09 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 31.9 Cg_exo -58.9 -46.09 24.98 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.17 1.913 . . . . 0.0 112.221 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -70.29 -41.39 73.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.707 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG21 ' A' ' 44' ' ' VAL . 11.0 tt -76.41 -35.06 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 111.586 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.42 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.4 mtt -66.28 -36.59 83.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -49.01 79.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.513 ' HE1' HD22 ' A' ' 70' ' ' ASN . 23.1 t80 -58.45 -54.11 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 102' ' ' PHE . 33.7 m -66.48 -28.29 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.5 -141.12 0.89 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.614 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.51 43.22 1.92 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.3 m -131.19 87.13 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.513 HD22 ' HE1' ' A' ' 65' ' ' TYR . 1.1 m120 -142.39 143.32 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -73.59 -9.16 58.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -91.21 -39.82 11.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.04 62.4 1.01 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.409 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.68 HG23 ' HG3' ' A' ' 76' ' ' MET . 30.0 m -139.66 159.48 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.92 -46.13 38.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.68 ' HG3' HG23 ' A' ' 74' ' ' VAL . 5.2 mtp 61.43 117.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 111.051 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.72 127.62 25.73 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.402 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.48 176.05 8.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 18.7 p -147.63 114.05 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 31.2 m -57.61 -33.11 15.72 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 11.1 Cg_exo -71.48 152.3 60.05 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.082 1.855 . . . . 0.0 111.823 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 59' ' ' MET . 21.7 t -153.07 147.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 111.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 t -143.02 145.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.646 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.831 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.25 154.15 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -85.51 136.72 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 110.481 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 167' ' ' TYR . 15.4 m -136.1 141.0 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -108.63 107.97 60.51 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.35 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HA ' HD23 ' A' ' 94' ' ' LEU . 81.8 Cg_endo -80.02 129.49 7.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.549 2.166 . . . . 0.0 112.391 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.82 158.43 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -28.78 69.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -2.69 58.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.432 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.45 57.3 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.969 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.02 163.21 28.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.646 HD12 ' HG2' ' A' ' 141' ' ' GLU . 19.5 mt -117.51 -9.51 10.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.417 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 62.47 153.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 110.958 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -80.78 88.34 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.035 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.72 118.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.878 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.2 tt -143.94 135.8 26.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -123.25 115.67 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.203 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.2 t -81.98 141.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.308 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -120.23 131.25 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 62' ' ' ILE . 56.5 t80 -110.08 161.25 15.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.464 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' O ' ' CE2' ' A' ' 102' ' ' PHE . 40.9 mmt-85 -116.08 121.57 42.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.64 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 40' ' ' LYS . 40.5 mt -102.22 137.01 19.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.21 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' HG23 ' A' ' 104' ' ' ILE . 32.6 Cg_endo -64.23 154.09 72.87 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.511 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -26.55 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.269 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -56.6 -47.02 80.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.07 -5.04 41.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.321 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -54.39 -47.73 72.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.9 -26.08 39.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.99 91.38 0.3 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.92 150.85 73.67 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.417 2.078 . . . . 0.0 112.22 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.631 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.83 152.97 64.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.633 2.222 . . . . 0.0 112.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.54 127.97 93.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.095 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 74.5 Cg_endo -75.53 169.71 21.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.521 2.147 . . . . 0.0 112.401 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 -31.8 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.667 ' HB3' HG23 ' A' ' 120' ' ' VAL . 2.7 t70 -79.18 116.17 19.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.68 -19.64 41.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.85 -22.01 40.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.209 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 117' ' ' ASP . 69.7 t -84.77 113.9 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -108.11 147.62 30.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.27 123.89 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.78 142.73 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.46 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -169.3 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -43.89 109.28 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.966 0.413 . . . . 0.0 111.594 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.16 56.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.719 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.67 168.57 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.72 142.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.6 m -111.04 119.8 40.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.691 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 188' ' ' VAL . 21.4 m -138.86 168.74 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.255 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.453 ' CE2' HD13 ' A' ' 155' ' ' LEU . 10.8 m-85 -107.73 141.1 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.526 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.7 p -105.96 127.93 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.281 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.441 ' CG2' HD22 ' A' ' 151' ' ' LEU . 1.5 t -125.1 137.11 54.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.644 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.84 125.01 45.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.919 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 8.5 p90 -123.06 -41.67 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.99 84.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . -147.09 -89.21 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.6 OUTLIER -175.71 108.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.0 110.814 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 144' ' ' TYR . . . -105.66 132.72 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 58.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.646 ' HG2' HD12 ' A' ' 94' ' ' LEU . 1.2 tm-20 67.16 -72.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.86 76.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -67.84 -34.77 77.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.982 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 139' ' ' ALA . 1.2 m-85 -62.63 -39.53 94.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.439 0.638 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.593 HG22 HD21 ' A' ' 94' ' ' LEU . 21.4 t -53.87 -38.82 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.477 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.68 -35.61 70.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.787 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 47.4 m-70 -70.05 -42.7 72.54 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.925 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -32.92 72.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.694 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.4 m -69.64 -39.28 77.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.714 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.83 -46.01 91.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.674 HD11 ' HB3' ' A' ' 31' ' ' TYR . 13.9 tp -58.57 -40.67 83.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.656 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.06 95.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.3 m -64.84 -39.37 93.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.364 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -45.67 84.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.822 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.455 HD23 ' CE2' ' A' ' 31' ' ' TYR . 15.6 mt -72.78 -17.83 61.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.258 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.96 111.56 0.41 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.171 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 106.25 30.37 4.46 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.289 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.472 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 64.6 p -145.23 168.07 12.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.7 0.286 . . . . 0.0 110.807 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 16.5 Cg_exo -67.93 -3.43 10.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.808 2.339 . . . . 0.0 112.978 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.29 124.56 18.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.339 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -99.57 176.32 5.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.32 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 161' ' ' THR . 3.5 m-85 -154.58 161.25 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.035 0.445 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -92.87 -172.26 2.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.819 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.81 63.19 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 57.08 77.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.743 0.306 . . . . 0.0 111.308 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 166' ' ' VAL . 13.9 p -161.37 112.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.604 ' HB3' HD23 ' A' ' 187' ' ' LEU . 13.8 p90 -119.14 173.28 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.724 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 69.3 m-85 -112.89 150.49 31.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.81 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.82 149.62 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -178.21 162.37 29.77 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.564 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -99.25 -70.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -120.5 160.31 44.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.06 154.57 74.12 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.542 2.161 . . . . 0.0 112.275 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.01 87.33 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.543 2.162 . . . . 0.0 112.273 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.87 -38.27 3.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.33 138.02 30.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.41 170.88 18.61 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.499 2.133 . . . . 0.0 112.401 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 61.98 121.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.5 29.08 12.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.9 139.03 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 130.9 30.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.94 152.54 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.06 154.84 42.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.07 128.35 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.424 ' HB3' HG21 ' A' ' 130' ' ' VAL . 40.7 m0 -108.04 122.0 45.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.368 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.1 mt -93.09 134.49 35.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.535 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 130' ' ' VAL . 43.4 t -74.76 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -107.51 111.97 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.227 -0.892 . . . . 1.0 111.028 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.861 0.362 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tt -138.38 142.15 39.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.31 -100.65 0.24 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 32.5 mtt 60.5 95.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 pt -97.01 97.38 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.39 119.33 37.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -133.35 128.63 36.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.6 t -83.33 135.48 34.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tt -169.3 82.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -150.31 97.88 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.804 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.02 -116.05 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.2 m -88.73 126.66 35.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.15 145.57 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.77 132.32 52.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -115.8 129.5 56.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.16 102.25 8.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.57 143.9 58.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.477 2.118 . . . . 0.0 112.246 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 t90 56.63 92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -135.09 108.43 7.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.0 112.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.73 -10.88 25.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.354 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -170.01 164.83 9.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.33 . . . . 0.0 110.966 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.487 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -151.9 -49.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.96 137.64 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.462 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -139.11 -156.16 6.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -78.4 158.37 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.51 -27.38 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -90.11 -35.01 15.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.08 114.82 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -95.38 150.8 19.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.5 p90 -139.05 160.32 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' THR . 3.1 mp0 -143.33 124.97 14.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -85.86 122.1 29.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 129' ' ' THR . 11.3 ptm180 -130.3 128.13 40.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.35 132.77 55.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.1 p -139.65 162.22 35.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.85 170.91 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.935 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.8 -119.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.01 -170.76 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -99.34 137.72 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' HD3' ' A' ' 103' ' ' ARG . 10.8 m-85 -137.49 159.85 40.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -103.29 127.07 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.7 p -112.79 131.79 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' ILE . 39.0 t -127.7 125.35 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.59 139.92 31.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.2 t -138.28 116.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.52 168.35 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 t0 47.56 28.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -152.87 115.72 2.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.41 -172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.507 2.138 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.525 ' HA ' HD13 ' A' ' 98' ' ' LEU . 40.3 t -59.71 -62.24 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.542 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -45.08 79.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -67.1 -45.36 77.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.169 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.872 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.69 -44.42 90.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.344 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.96 -35.75 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.743 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -64.79 -32.17 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.944 0.402 . . . . 0.0 110.479 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.5 tp10 -87.8 -35.45 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.821 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.52 -42.02 62.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -57.64 -44.11 99.27 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.0 Cg_exo -63.95 -40.29 28.48 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.243 1.962 . . . . 0.0 111.76 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -70.14 -43.39 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.736 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.35 -34.16 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.318 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.6 mmt -66.28 -37.83 86.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 110.957 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.2 81.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 62.5 t80 -68.99 -42.1 76.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 102' ' ' PHE . 30.3 m -82.24 -23.37 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.32 -82.09 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.79 51.86 0.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -132.06 92.21 3.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.769 0.318 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -155.09 170.81 20.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.59 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 14.9 p30 -96.09 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -148.33 -47.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.31 42.96 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.26 174.07 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 111.182 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.1 116.41 1.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.528 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 30.6 mtp -112.56 -161.7 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.69 -120.37 1.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -56.43 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.735 ' O ' HG12 ' A' ' 80' ' ' VAL . 2.1 m 60.45 102.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.991 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 79' ' ' THR . 9.7 p 53.78 142.72 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.801 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 80' ' ' VAL . 31.2 Cg_exo -59.79 138.2 81.4 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.304 2.003 . . . . 0.0 112.128 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.9 m -86.01 153.96 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.649 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.26 167.6 13.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.18 140.52 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.162 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.497 ' HB2' ' HE1' ' A' ' 168' ' ' TYR . . . -76.7 136.65 39.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.432 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.616 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.6 m -131.38 102.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.857 0.361 . . . . 0.0 111.09 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -70.7 111.76 10.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.628 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.5 Cg_endo -87.94 137.85 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.724 2.283 . . . . 0.0 112.503 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.11 155.14 18.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.839 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.28 -19.0 61.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -85.24 -6.02 59.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.491 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.94 -1.94 59.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -95.56 165.39 12.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.348 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 88' ' ' PRO . 55.0 mt -112.2 140.64 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 163.09 24.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -79.95 -11.83 59.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 124.7 33.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.703 0.287 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.7 141.21 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.067 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -121.88 115.98 23.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -90.63 128.12 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.329 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -103.37 142.07 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.708 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 66' ' ' VAL . 62.9 t80 -126.07 150.73 47.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 0.0 111.519 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' CE2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -108.77 108.04 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.514 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 40' ' ' LYS . 34.5 mt -80.25 136.05 53.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.343 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 30.5 Cg_endo -63.56 154.23 70.08 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.664 2.242 . . . . 0.0 112.511 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 69.3 m-80 -55.87 -26.87 49.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.284 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -56.98 -40.38 76.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.405 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 40.5 m-85 -101.86 -8.07 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.749 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -53.95 -37.58 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.332 . . . . 0.0 111.055 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.23 -31.13 61.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -174.53 85.37 0.34 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.4 Cg_exo -56.88 145.53 83.8 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.6 Cg_exo -70.88 151.85 63.0 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.489 2.126 . . . . 0.0 112.081 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . . . -67.33 111.59 7.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 33.0 Cg_exo -58.36 158.87 21.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.479 2.119 . . . . 0.0 112.192 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -110.44 30.83 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 120' ' ' VAL . 37.3 m-20 -130.26 112.15 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.02 -29.07 65.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.3 -27.54 32.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 117' ' ' ASP . 29.5 t -85.11 125.47 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 157.11 33.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.408 ' CG2' ' HG2' ' A' ' 40' ' ' LYS . 20.7 mm -105.73 119.48 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.83 21.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.51 156.07 39.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 58.8 103.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.24 -66.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 111.184 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.3 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.088 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.409 HD13 ' HE2' ' A' ' 168' ' ' TYR . 1.5 pt -129.26 142.98 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.007 0.432 . . . . 0.0 111.629 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 34' ' ' ARG . 84.0 m -115.42 128.98 56.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.252 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 188' ' ' VAL . 35.8 m -134.47 160.02 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 111.737 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.432 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.93 136.3 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.205 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.1 p -105.67 131.08 53.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 111.396 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -125.34 139.25 53.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -116.85 137.17 52.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 6.1 p90 -134.57 140.75 46.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.36 93.9 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 159.1 161.1 10.86 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.581 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' ' 175' ' ' PRO . 82.2 m-85 -65.79 167.86 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.52 147.99 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -135.79 -175.91 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.616 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.2 tt0 -58.35 -69.43 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.83 72.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.688 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.15 -34.85 78.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.031 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.77 -40.75 98.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.87 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.76 -38.88 36.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.61 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.53 -36.27 70.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.919 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 48.0 m-70 -70.14 -43.28 71.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.901 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.92 72.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 m -65.55 -37.84 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -58.76 -45.83 88.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 187' ' ' LEU . 11.0 tp -58.59 -38.79 78.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -64.29 -43.25 95.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -68.13 -38.57 82.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 56.1 m -57.49 -49.08 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 131' ' ' TYR . 47.3 mt -73.56 -19.5 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.17 102.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 113.08 32.7 2.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.3 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.0 p -145.52 165.42 21.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.82 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 32.6 Cg_exo -58.06 -17.33 30.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.666 2.244 . . . . 0.0 112.674 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.28 41.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.94 -171.21 1.93 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.933 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.746 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 6.6 m-85 -155.43 154.0 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.06 -164.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -56.68 -86.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.17 77.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.3 p -161.67 132.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.879 ' HB3' HD23 ' A' ' 187' ' ' LEU . 14.7 p90 -141.17 163.63 32.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.508 ' CE2' HG22 ' A' ' 188' ' ' VAL . 22.1 m-85 -112.94 157.49 21.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.532 ' SG ' HG13 ' A' ' 185' ' ' VAL . 11.1 m -143.87 136.98 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.01 138.53 48.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.026 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 172' ' ' TYR . . . 168.19 155.52 9.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 171' ' ' GLY . 5.7 m-85 -165.8 91.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 0.0 110.955 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -140.06 134.86 15.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 89.0 Cg_endo -78.52 132.8 11.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.144 . . . . 0.0 112.271 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.456 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 70.4 Cg_exo -51.82 -25.25 20.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.473 2.115 . . . . 0.0 112.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.6 mtt -59.87 -44.87 93.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 115.37 65.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.832 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 -7.88 21.29 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.477 2.118 . . . . 0.0 112.652 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -148.49 121.08 8.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.777 0.322 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.04 -70.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.05 167.06 10.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -112.11 132.1 55.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.058 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -115.63 133.89 55.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.585 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.36 156.89 44.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.532 HG13 ' SG ' ' A' ' 169' ' ' CYS . 29.3 t -121.43 114.85 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.11 125.68 51.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.346 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.3 mt -92.54 140.51 29.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.593 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' VAL . 18.6 t -74.59 131.14 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.358 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -79.95 163.43 24.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.206 -0.902 . . . . 1.0 111.096 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.09 166.97 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.28 -121.74 4.48 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.567 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.5 35.48 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 5' ' ' ILE . 23.3 mm -98.92 40.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -77.01 129.22 35.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.26 150.7 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -87.93 132.93 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 -45.12 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 62.79 18.3 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.21 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.0 -78.69 0.47 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.008 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 p -106.93 124.87 50.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.677 0.275 . . . . 0.0 110.494 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.84 142.39 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -134.91 124.9 25.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -92.05 120.2 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.025 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.29 126.2 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -41.35 2.77 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.045 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -131.56 -178.07 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.725 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -126.87 113.17 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.55 113.0 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mt -96.67 -12.94 23.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.442 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.48 166.29 10.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 p -152.47 -176.78 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.47 141.95 1.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.422 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -154.67 -173.74 23.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -78.81 158.98 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -66.59 -30.38 70.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.06 -35.03 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.6 m -146.08 107.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.006 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 5.7 p -97.29 156.14 16.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p90 -140.12 162.05 36.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 28.2 mt-10 -145.52 136.38 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.77 130.8 34.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 127.98 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -112.58 139.1 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 111.255 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -133.71 132.21 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.794 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.67 149.21 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 118.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' CA ' ' HG3' ' A' ' 109' ' ' GLN . . . 141.92 148.93 5.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.603 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HG2' HG22 ' A' ' 122' ' ' ILE . 2.2 mttm -105.36 158.18 16.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.854 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -137.63 157.6 46.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.94 140.3 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.434 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.9 p -137.03 143.43 42.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.687 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 62' ' ' ILE . 21.3 t -129.25 125.87 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.687 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -95.85 131.18 42.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.024 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.34 116.85 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.435 HG23 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -107.32 169.04 8.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 47.46 37.86 6.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 mttm -152.5 137.38 10.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.869 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 32.3 Cg_exo -57.89 -160.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.509 2.14 . . . . 0.0 112.278 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 46.2 t -92.76 -63.38 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.28 -42.83 92.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.9 -45.96 76.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.99 75.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.3 mt -58.31 -35.4 71.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.27 -33.61 74.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.5 tp10 -87.48 -28.67 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.811 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.57 -44.01 58.37 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.602 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.0 mmt -57.67 -43.46 98.81 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.92 -45.54 23.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.23 1.953 . . . . 0.0 111.884 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -70.34 -42.25 72.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.661 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.753 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.04 -37.48 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -31.77 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.001 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 63' ' ' MET . 4.2 mtmm -60.89 -29.96 69.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.385 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -73.13 -49.05 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 63' ' ' MET . 14.9 m -66.01 -22.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.44 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.81 83.18 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.97 -43.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 t -172.43 100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.016 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 70' ' ' ASN . 0.1 OUTLIER -127.34 3.36 6.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.22 41.15 17.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -148.31 -50.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.89 43.96 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 70' ' ' ASN . 12.9 m -100.92 -179.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 117.68 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.337 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.1 mtp -120.15 118.43 30.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.42 -26.19 50.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.3 ttt 63.92 132.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 t -58.13 177.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -95.29 -54.79 0.22 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.204 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 76.2 Cg_endo -93.86 130.35 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.645 2.23 . . . . 0.0 112.585 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' CE ' ' A' ' 59' ' ' MET . 53.6 t -93.07 148.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.43 148.95 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.05 154.25 50.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.201 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.36 136.69 34.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 98' ' ' LEU . 30.0 m -129.39 134.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.071 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -111.04 95.79 26.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.28 164.3 32.95 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -90.23 172.28 8.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.52 -22.16 20.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.292 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.46 -6.12 59.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.466 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.14 61.51 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.883 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -174.73 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.776 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mt -123.54 164.31 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -161.0 87.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp 51.96 -167.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD3' HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER 63.19 99.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.1 tt -144.08 128.01 17.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.167 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 115.57 29.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.973 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.811 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -71.68 141.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.731 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.9 m95 -119.35 130.99 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.13 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.5 t80 -114.76 158.9 21.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 111.63 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -116.08 107.9 15.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.482 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mt -84.92 137.1 38.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.356 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.31 154.09 25.06 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 3.9 m-20 -58.24 -26.89 63.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -47.12 87.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.482 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -86.31 -11.06 53.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.598 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.83 -42.81 68.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.634 0.255 . . . . 0.0 111.017 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.86 -29.05 58.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.8 85.48 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.607 0.242 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 40' ' ' LYS . 30.8 Cg_exo -60.82 160.94 23.27 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.573 2.182 . . . . 0.0 112.239 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.41 155.66 32.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.861 2.374 . . . . 0.0 111.972 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.08 22.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.97 168.6 22.66 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.377 2.051 . . . . 0.0 112.392 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.2 p -110.25 168.92 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' VAL . 4.4 t70 66.74 126.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.75 -16.01 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.66 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -79.81 -29.14 40.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.68 0.276 . . . . 0.0 111.253 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.4 t -85.73 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -123.02 156.92 33.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.467 HG22 ' HG2' ' A' ' 40' ' ' LYS . 11.9 mm -113.71 128.46 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.8 153.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.27 179.86 6.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -58.66 98.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.67 -21.86 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.9 74.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 188' ' ' VAL . 1.1 pp -138.55 145.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -103.78 137.45 41.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -139.17 145.63 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.496 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.4 OUTLIER -107.79 128.81 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.4 p -105.51 142.29 35.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.141 0.496 . . . . 0.0 111.707 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.0 t -127.67 139.6 52.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -116.15 125.0 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.404 . . . . 0.0 111.023 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 12.5 p90 -131.03 -177.88 4.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -117.58 130.22 8.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.566 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.31 -177.37 20.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.568 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -94.43 166.9 11.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -177.18 121.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.245 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.22 -73.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.778 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -141.4 -47.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.785 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -73.03 -33.95 66.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 110.605 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -35.09 76.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.927 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -64.22 -39.08 93.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.245 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 141' ' ' GLU . 57.4 t -53.63 -38.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.452 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.2 70.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.78 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.499 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.7 m-70 -70.0 -42.79 72.58 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.807 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.94 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.4 m -67.66 -39.44 84.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.704 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.25 -46.05 92.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 tp -58.28 -38.88 77.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -64.12 -42.56 96.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.5 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.7 m -69.15 -37.07 78.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.4 m -57.54 -38.9 75.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 162' ' ' TYR . 32.1 mt -72.4 -22.71 61.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.23 95.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.216 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.93 33.12 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 p -145.54 155.26 53.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 36.3 Cg_endo -65.09 -12.99 37.33 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.615 2.21 . . . . 0.0 112.605 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.496 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -58.41 159.8 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 156.54 47.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CD1' HD13 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -154.48 155.81 35.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -79.38 -61.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.03 -16.69 58.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.687 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.58 -27.47 34.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.066 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 166' ' ' VAL . 8.4 p -160.76 118.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.797 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.3 p90 -119.03 171.38 8.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.625 ' CE2' HG22 ' A' ' 188' ' ' VAL . 33.5 m-85 -113.15 140.16 48.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.82 147.58 35.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 184' ' ' GLU . . . -132.04 127.82 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.71 103.69 0.24 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.582 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -131.13 105.87 7.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -162.69 147.03 9.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.61 125.47 9.55 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.557 2.171 . . . . 0.0 112.299 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.78 94.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.413 2.075 . . . . 0.0 112.283 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.67 -65.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.04 149.09 70.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.07 -54.3 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.283 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -91.5 108.72 20.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.95 -53.49 0.16 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.88 167.0 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -141.19 146.15 36.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.127 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -108.93 158.01 18.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.515 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.825 ' CG ' ' HB3' ' A' ' 170' ' ' ALA . 0.7 OUTLIER -141.38 144.18 34.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.7 124.64 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.727 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.14 132.37 54.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 111.725 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 167' ' ' TYR . 16.8 mt -92.33 140.21 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.656 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 130' ' ' VAL . 19.6 t -74.69 131.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.462 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 69.1 tttt -69.53 154.21 42.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 1.0 111.077 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.675 0.274 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.23 -31.89 30.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.854 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.02 -175.13 25.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.433 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 ttt -124.97 99.98 6.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -90.74 -31.52 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -78.67 119.32 21.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -131.65 156.87 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -80.4 151.8 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.8 31.38 3.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.016 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.44 16.18 25.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.72 -100.1 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.627 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -106.97 124.93 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.63 146.1 29.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.56 125.53 44.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -85.05 136.72 33.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -126.81 80.16 71.18 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.798 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.62 155.74 21.19 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.67 2.247 . . . . 0.0 112.405 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -62.67 -179.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -111.15 111.52 22.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.11 112.83 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.857 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.88 -12.99 22.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.79 167.09 9.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.69 154.49 36.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.23 164.26 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -161.17 -58.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -161.95 164.48 28.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.785 0.326 . . . . 0.0 110.748 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -33.74 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -91.08 -35.29 14.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CB ' ' A' ' 150' ' ' GLN . 3.5 m -146.44 108.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.83 0.348 . . . . 0.0 111.723 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.31 158.06 16.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 154' ' ' THR . 0.2 OUTLIER -139.07 162.35 35.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.92 0.39 . . . . 0.0 111.114 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.76 132.85 21.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -85.98 126.96 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.97 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.93 127.35 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -152.88 96.18 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.48 -50.65 72.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.77 -119.77 19.57 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.622 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.96 -119.46 1.01 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -91.91 159.34 15.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.832 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 102' ' ' PHE . 38.4 m-85 -137.44 148.93 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.042 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.81 140.34 29.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 66.5 p -132.1 136.02 46.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 111.576 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.517 HG21 ' HB ' ' A' ' 62' ' ' ILE . 39.9 t -125.9 125.56 68.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.662 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -96.88 131.45 43.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.095 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 54' ' ' ALA . 16.6 t -138.26 116.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.002 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.41 174.11 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.51 25.99 3.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.398 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -152.95 130.02 5.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.06 177.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.313 2.009 . . . . 0.0 112.23 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 82.7 t -62.2 -57.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.024 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -58.24 -45.25 88.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.17 -46.21 74.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.91 -45.0 91.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.194 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.8 mt -57.1 -35.59 69.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.77 -31.81 73.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.1 tp10 -87.27 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.672 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.47 -42.66 61.62 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.509 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.0 mmt -57.69 -44.15 99.27 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.3 Cg_exo -63.29 -40.54 31.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.21 1.94 . . . . 0.0 111.718 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -70.24 -44.03 69.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.035 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.5 tt -76.1 -31.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -42.79 87.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.6 mttt -58.92 -42.27 89.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 7.0 t80 -59.63 -50.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.54 -27.62 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.37 -105.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.594 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.46 67.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.4 HG21 ' HD3' ' A' ' 64' ' ' LYS . 68.6 m -164.4 71.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 0.0 110.761 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.498 ' N ' ' ND2' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -134.94 10.41 3.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.372 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 57.05 38.94 29.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 111.025 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -52.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.46 79.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.552 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.455 HG22 ' OD1' ' A' ' 70' ' ' ASN . 26.8 m -139.0 143.65 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.896 0.379 . . . . 0.0 111.169 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.87 -42.66 94.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.419 ' HA ' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 65.48 -76.4 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.89 -23.16 8.37 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.412 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 64.46 162.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.04 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.76 HG22 ' HD2' ' A' ' 81' ' ' PRO . 7.8 m -122.29 131.63 54.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 1.5 t -68.43 -53.05 18.6 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.76 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.3 Cg_endo -81.1 130.78 7.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.417 2.078 . . . . 0.0 112.354 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -154.37 134.61 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.975 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 1.8 t -114.96 167.99 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -126.91 154.22 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.729 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.35 136.57 33.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.307 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.69 HG12 HD12 ' A' ' 98' ' ' LEU . 33.3 m -131.28 128.35 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 111.132 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -98.95 104.25 24.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 94' ' ' LEU . 41.4 Cg_endo -66.84 128.31 18.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.412 2.074 . . . . 0.0 112.202 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -90.29 156.88 17.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -66.02 -15.9 63.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.314 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.04 5.18 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.552 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.59 -16.0 60.16 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.752 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 162.87 13.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 88' ' ' PRO . 27.1 mt -87.8 -4.91 58.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.509 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 62.33 162.34 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -80.75 84.15 6.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -175.68 106.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.7 tt -138.22 127.96 25.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.64 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.672 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -76.22 141.15 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.95 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.409 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 50.6 t80 -120.98 150.26 41.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.518 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.74 114.5 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 mt -92.75 134.51 27.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.82 154.06 28.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.622 2.215 . . . . 0.0 112.405 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -60.49 -26.75 67.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.07 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -56.96 -32.81 66.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.409 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 76' ' ' MET . 57.9 m-85 -106.03 -9.71 16.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.799 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.95 -33.8 52.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.17 77.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 76.28 3.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.658 0.266 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 33.0 Cg_exo -59.72 148.23 88.84 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.635 2.223 . . . . 0.0 112.303 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.44 ' CG ' HG21 ' A' ' 74' ' ' VAL . 6.9 Cg_exo -72.57 159.24 49.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.59 133.26 94.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 27.6 Cg_endo -62.9 -22.24 73.7 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.129 . . . . 0.0 112.417 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 m 52.97 28.46 6.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.75 122.83 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.06 -24.01 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.177 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.07 -35.81 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.96 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 44' ' ' VAL . 43.6 t -85.05 123.67 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 157.03 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.2 mm -112.2 118.58 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.934 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.94 129.48 45.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 125' ' ' ARG . 5.7 tt0 -95.38 -152.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.608 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 6.4 mtt180 67.92 71.85 0.32 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.727 0.299 . . . . 0.0 111.458 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 38.3 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.93 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -97.7 -145.31 18.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.427 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -144.15 145.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.324 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.3 m -103.91 118.93 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.499 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.908 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.5 m -140.72 170.38 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.379 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.549 ' CE2' HD22 ' A' ' 155' ' ' LEU . 5.0 m-85 -107.32 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.329 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 98.1 p -130.23 136.28 49.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -131.09 139.15 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.344 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -116.88 140.59 49.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.32 173.55 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.23 -30.01 8.07 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.555 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.02 118.0 12.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.59 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 177' ' ' LYS . 23.7 m-85 -79.46 121.77 25.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -113.87 150.89 32.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.278 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -106.36 -59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.68 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 94' ' ' LEU . 27.4 tt0 -152.02 -67.73 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -33.78 73.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.8 t70 -67.76 -34.59 77.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.8 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.4 OUTLIER -62.56 -40.25 96.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.54 0.686 . . . . 0.0 109.742 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.89 -38.72 37.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.709 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.26 -33.8 72.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.795 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.415 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.0 m-70 -70.12 -46.1 65.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -62.14 -32.88 73.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.4 m -62.99 -43.99 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.401 ' CB ' HG11 ' A' ' 29' ' ' VAL . 3.9 mt-30 -62.45 -46.07 90.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.694 ' HB3' HD11 ' A' ' 187' ' ' LEU . 11.2 tp -59.1 -39.68 83.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.83 -48.11 82.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.308 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.5 m -62.23 -45.27 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.166 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 31' ' ' TYR . 4.1 m -57.53 -44.56 85.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.614 ' CD1' HD12 ' A' ' 187' ' ' LEU . 12.4 mt -72.89 -17.01 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.143 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.79 -38.06 14.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 111.445 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.63 -14.18 82.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.465 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -93.89 176.38 2.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.806 0.303 . . . . 0.0 111.064 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.465 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 13.4 Cg_exo -70.02 -1.04 8.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.25 143.0 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.708 0.29 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 16.1 m -130.39 2.06 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.766 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.95 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 8.0 m-85 56.92 159.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.62 -80.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.24 38.6 1.23 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.276 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.13 71.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 110.713 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 166' ' ' VAL . 14.0 p -161.76 124.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.852 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.5 p90 -126.0 175.0 8.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.729 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 68.3 m-85 -119.6 162.03 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 94.6 m -130.82 130.86 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.016 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 83' ' ' SER . . . -132.02 156.02 46.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -114.55 78.29 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -119.9 -174.43 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.3 154.94 0.11 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.88 129.78 10.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.525 2.15 . . . . 0.0 112.41 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 123.17 7.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.531 2.154 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -97.16 31.04 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.722 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' CE2' ' A' ' 138' ' ' TYR . 9.1 mptt -144.67 178.49 1.43 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 177' ' ' LYS . 35.0 Cg_exo -56.53 -162.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.286 1.991 . . . . 0.0 112.345 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 178' ' ' PRO . 52.0 m-85 55.18 -169.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -141.11 42.06 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.499 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.16 166.18 25.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.38 . . . . 0.0 111.12 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.37 156.05 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 44.7 m-80 -133.11 138.39 46.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 111.469 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -146.09 157.29 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.628 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.804 HG13 ' CD2' ' A' ' 167' ' ' TYR . 10.6 t -134.85 114.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.888 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 44.0 m0 -109.33 121.53 45.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.207 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.852 HD23 ' HB3' ' A' ' 167' ' ' TYR . 72.2 mt -94.53 140.08 30.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.666 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.908 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.3 t -87.08 123.59 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.3 150.34 40.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.95 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 1.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.834 0.349 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 2' ' ' LEU . 1.2 pp -119.9 152.79 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.97 95.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -131.47 36.89 3.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.9 168.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.247 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -90.37 108.24 19.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -120.96 150.91 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -84.17 137.63 33.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.48 102.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -154.85 -67.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.06 -153.01 39.29 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -81.27 130.77 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 138.99 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.82 124.94 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.04 120.0 37.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.0 m0 61.43 154.4 0.11 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.26 168.02 22.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.511 2.141 . . . . 0.0 112.258 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.2 t90 60.32 92.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -138.77 116.07 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 23' ' ' THR . 23.8 t -74.29 112.88 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.802 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.98 -9.42 37.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.478 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.83 158.95 7.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.843 0.354 . . . . 0.0 110.937 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.41 ' CG2' HG11 ' A' ' 20' ' ' VAL . 79.1 p -152.64 164.22 38.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.8 -137.25 13.22 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . 133.04 -170.38 22.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.518 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' HG23 ' A' ' 154' ' ' THR . 6.0 mtpt -78.56 162.04 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 0.0 110.839 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -25.21 66.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.78 -32.64 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.04 122.51 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.068 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.44 147.63 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.433 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 8.4 p90 -139.17 155.74 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.59 128.8 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -86.75 127.29 34.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.11 134.45 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.06 127.43 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.48 128.55 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.61 -66.84 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.61 178.34 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.528 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.48 -111.14 1.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtmt -92.01 157.61 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 23.4 m-85 -137.4 157.38 46.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -101.94 135.3 43.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 38.7 p -137.31 151.49 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.509 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG23 HD12 ' A' ' 62' ' ' ILE . 22.0 t -131.66 125.96 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.703 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -95.88 130.27 42.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.26 116.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.018 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.58 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -111.81 176.86 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.974 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.03 31.01 1.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -152.36 138.2 11.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.8 -160.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.432 2.088 . . . . 0.0 112.205 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.945 HG13 ' CD1' ' A' ' 98' ' ' LEU . 62.3 t -90.28 -48.07 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.13 -45.12 74.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -46.38 74.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.94 92.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.3 mt -57.11 -35.46 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -62.67 -29.91 70.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.12 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 tp10 -89.84 -32.9 16.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.316 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -72.89 -43.85 62.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.475 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.598 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 9.4 mmt -57.69 -44.05 99.19 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 59' ' ' MET . 42.9 Cg_endo -69.06 -36.26 13.02 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.984 1.789 . . . . 0.0 112.207 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -70.16 -43.6 70.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.653 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 44' ' ' VAL . 9.4 tt -77.91 -27.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.328 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -37.14 84.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.037 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -58.78 -37.1 75.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 19.1 t80 -67.12 -56.43 10.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.612 HG11 ' CE2' ' A' ' 102' ' ' PHE . 31.9 m -65.87 -30.72 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.8 -100.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 64.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.509 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -147.76 65.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -145.1 165.5 28.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.717 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.1 m-20 -90.02 46.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -145.8 4.57 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.677 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.52 32.01 5.3 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.747 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 108' ' ' PHE . 1.4 p -96.66 140.57 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.879 -0.66 . . . . 0.0 111.67 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.4 49.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.421 ' HE3' ' HD2' ' A' ' 105' ' ' PRO . 14.3 ptm -52.17 -48.89 64.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.59 -161.85 35.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.547 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 tpt -92.23 147.74 22.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.636 HG22 HG23 ' A' ' 80' ' ' VAL . 7.2 m -151.37 120.8 6.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.636 HG23 HG22 ' A' ' 79' ' ' THR . 14.0 t 64.27 136.43 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.56 130.69 34.54 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.27 1.98 . . . . 0.0 112.184 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.671 HG11 ' CD2' ' A' ' 102' ' ' PHE . 32.9 m -88.91 154.05 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.321 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 t -117.89 173.73 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -131.8 154.21 49.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.003 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.04 136.82 32.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.402 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' CE1' ' A' ' 167' ' ' TYR . 23.9 m -132.89 132.98 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.173 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -106.27 98.16 18.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.808 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.3 Cg_endo -75.59 138.89 22.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -90.26 161.77 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.86 -19.12 62.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.2 -5.87 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.65 -3.44 78.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.882 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.48 139.52 51.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.6 mt -80.14 144.09 33.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -96.98 48.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.82 96.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -179.64 107.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.945 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.8 tt -142.82 128.13 18.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.489 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -115.54 115.65 26.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.248 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -74.24 141.35 16.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 0.0 111.594 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HA ' HG22 ' A' ' 43' ' ' THR . 13.8 m95 -121.64 126.05 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.276 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CD2' HG11 ' A' ' 82' ' ' VAL . 52.9 t80 -110.13 155.18 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 111.612 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 107.88 15.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.585 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.434 HG13 ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.13 139.68 92.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD2' HG13 ' A' ' 104' ' ' ILE . 32.5 Cg_endo -64.35 153.99 73.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.489 2.126 . . . . 0.0 112.319 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -56.63 -26.8 56.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.284 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.446 ' HB3' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -56.98 -32.81 66.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 74' ' ' VAL . 11.3 m-85 -116.8 20.22 14.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.426 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -55.09 -33.85 63.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.46 -25.82 67.13 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.01 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -177.73 107.95 0.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.736 0.268 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 108' ' ' PHE . 52.6 Cg_endo -69.08 161.12 47.16 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.41 2.074 . . . . 0.0 112.187 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.512 ' CG ' HG11 ' A' ' 74' ' ' VAL . 10.2 Cg_exo -70.7 150.49 62.58 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.584 2.189 . . . . 0.0 112.003 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . . . -66.98 114.13 16.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 58.8 Cg_endo -73.04 165.95 31.36 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.352 2.034 . . . . 0.0 112.335 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.2 m -127.68 33.19 4.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.739 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -125.71 114.44 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.91 -26.53 62.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.12 -26.93 33.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 117' ' ' ASP . 42.9 t -84.89 115.5 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.13 156.93 19.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.817 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.16 127.4 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -98.76 160.16 14.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -147.45 129.15 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 63.55 123.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -169.08 -80.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.8 110.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.369 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.49 142.91 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 111.253 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 m -107.86 119.03 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -129.55 161.11 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.382 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 151' ' ' LEU . 5.3 m-85 -107.93 138.23 44.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 p -108.75 142.39 39.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.1 t -129.68 139.0 51.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -116.86 130.44 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.95 144.59 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.09 95.66 1.99 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.52 159.0 28.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -72.17 174.87 6.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.34 144.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.108 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.33 -60.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 94' ' ' LEU . 70.9 tt0 -159.85 -66.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.58 70.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.491 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.93 -34.89 78.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.945 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -41.62 99.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 109.893 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.95 -38.8 38.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.559 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.03 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.897 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -67.76 -41.93 82.55 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.798 0.333 . . . . 0.0 111.044 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.001 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -67.79 -39.48 84.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 131' ' ' TYR . 7.9 tp -57.95 -43.39 86.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . 18.0 mtt85 -59.83 -40.0 87.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.368 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' OE1' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -68.97 -42.54 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.51 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' ' 26' ' ' LYS . 97.9 m -57.58 -49.46 76.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.85 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 162' ' ' TYR . 11.5 mt -75.12 -10.36 59.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.74 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.481 ' OE1' HG22 ' A' ' 153' ' ' THR . 9.4 pt-20 -47.55 -29.0 2.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.787 0.327 . . . . 0.0 111.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -98.51 26.68 22.87 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.587 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.9 p -146.05 160.51 42.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.77 -5.54 17.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.95 2.433 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.75 119.8 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -103.57 157.28 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.755 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.432 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -156.02 -176.02 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -115.5 156.77 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.56 -4.02 10.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.713 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.673 ' OD1' HG12 ' A' ' 166' ' ' VAL . 2.0 p30 -81.92 -22.78 36.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.609 0.242 . . . . 0.0 111.255 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.673 HG12 ' OD1' ' A' ' 165' ' ' ASP . 14.9 p -160.46 158.11 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 111.406 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.9 p90 -166.25 163.13 17.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.538 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 10.0 m-85 -112.94 158.82 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.671 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.4 m -142.25 158.93 43.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.61 139.28 49.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 172' ' ' TYR . . . 172.25 144.96 4.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 171' ' ' GLY . 80.5 m-85 -159.4 -177.93 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 62.57 145.76 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.54 162.84 37.27 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.55 2.167 . . . . 0.0 112.34 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.63 138.71 32.65 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.547 2.165 . . . . 0.0 112.315 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 -52.88 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -121.13 151.68 55.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 179' ' ' TYR . 31.0 Cg_endo -63.76 -13.96 40.05 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.601 2.201 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' CD2' ' HG2' ' A' ' 178' ' ' PRO . 13.1 p90 -147.62 31.54 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.986 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -84.64 -43.24 6.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.287 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -127.57 139.08 52.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.278 . . . . 0.0 110.663 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -111.3 154.89 23.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.065 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -108.92 157.98 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.517 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.47 145.53 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.287 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.671 HG13 ' SG ' ' A' ' 169' ' ' CYS . 17.7 t -124.99 133.49 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.564 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -107.76 121.54 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 130' ' ' VAL . 21.8 mt -97.08 134.53 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.576 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.96 119.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -69.76 140.69 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.604 ' HB3' ' OG1' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 1.0 111.141 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.803 0.335 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.31 -43.37 8.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.07 87.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.5 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -96.89 -39.18 9.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.769 0.318 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -59.94 117.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 126.96 39.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.35 141.46 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.5 p -74.89 150.04 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 31.55 5.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.59 78.28 1.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.6 -120.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.458 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -105.21 126.34 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -123.39 126.08 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.38 145.45 48.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.046 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.414 HG21 ' OD1' ' A' ' 106' ' ' ASN . 3.2 m -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.781 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.495 ' HB3' ' CD ' ' A' ' 17' ' ' PRO . 13.8 t-105 -169.17 -60.52 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.379 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 16' ' ' TRP . 9.4 Cg_endo -52.53 102.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.312 2.008 . . . . 0.0 112.175 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.79 -177.25 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.026 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 108.53 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.957 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.24 115.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.53 -2.4 38.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -170.24 165.85 8.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.28 -175.93 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.69 152.79 17.34 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -155.34 178.1 32.16 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.64 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -78.85 158.48 28.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.49 -29.16 69.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -89.86 -31.01 17.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 150' ' ' GLN . 22.1 t -145.98 117.02 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 m -95.33 137.45 34.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.04 162.13 35.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -144.94 140.69 28.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.35 126.58 34.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.921 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.99 127.91 39.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.91 135.08 50.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -159.9 79.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HG3' ' CE2' ' A' ' 41' ' ' PHE . 8.8 mp0 -142.25 137.33 30.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.14 -99.74 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.91 -59.99 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 104' ' ' ILE . 24.5 mttm -109.33 145.88 35.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 37' ' ' GLU . 5.2 m-85 -137.58 147.34 44.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 139.07 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.55 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 16.6 p -137.35 155.33 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.983 0.421 . . . . 0.0 111.7 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 62' ' ' ILE . 21.5 t -135.3 125.82 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -95.83 132.93 40.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 58' ' ' ALA . 22.4 t -138.32 122.45 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.86 170.53 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.24 38.72 1.72 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -152.56 128.16 5.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.895 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.71 -167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.412 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 HD13 ' A' ' 98' ' ' LEU . 36.5 t -78.54 -60.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.195 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.72 -44.78 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.48 -46.31 83.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.832 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.94 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.841 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -58.7 -35.94 73.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -66.37 -32.98 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 tp10 -87.19 -41.74 13.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.14 -37.01 66.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 10.9 mmt -57.85 -44.03 99.08 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.5 Cg_endo -70.09 -32.52 17.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.919 1.746 . . . . 0.0 112.16 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -70.25 -45.16 67.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 HG23 ' A' ' 44' ' ' VAL . 1.1 tt -77.48 -36.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.249 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.645 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 mtt -66.21 -41.88 89.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.761 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -58.85 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.727 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -67.88 -46.62 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 63' ' ' MET . 32.3 m -69.85 -27.77 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.32 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.32 99.63 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.98 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 69' ' ' THR . 3.7 t -164.19 88.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -113.06 -12.49 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.14 40.9 8.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.966 0.413 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -147.76 -46.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.42 30.45 4.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.009 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 108' ' ' PHE . 27.0 m -100.44 153.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.333 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.12 81.43 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mtt -63.1 -48.05 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.46 53.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.6 tpt 62.39 147.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 80' ' ' VAL . 7.3 m -164.02 130.67 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 79' ' ' THR . 36.7 t 64.02 136.67 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 80' ' ' VAL . 22.0 Cg_endo -61.12 134.06 50.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.454 2.102 . . . . 0.0 112.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.22 136.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.241 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.01 160.29 19.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.357 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -127.03 154.27 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.106 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -90.17 136.7 32.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 98' ' ' LEU . 33.7 m -132.23 123.7 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -98.31 102.98 15.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.767 ' HA ' HD23 ' A' ' 94' ' ' LEU . 85.6 Cg_endo -77.5 140.76 19.37 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.485 2.124 . . . . 0.0 112.271 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.35 163.0 14.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -15.9 63.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.354 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -85.23 4.22 35.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.589 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 90.67 -16.04 59.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.849 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -95.84 162.93 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 88' ' ' PRO . 95.9 mt -92.91 171.72 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -103.82 157.8 16.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -80.51 61.06 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -161.96 109.24 1.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -125.97 146.16 49.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.236 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.26 115.72 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.339 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -81.19 141.36 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -121.67 132.16 54.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 19.3 t80 -121.57 134.86 55.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.016 0.436 . . . . 0.0 111.377 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.65 118.06 34.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 40' ' ' LYS . 28.1 mt -84.44 136.35 40.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.7 Cg_endo -65.68 154.25 74.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 109' ' ' GLN . 34.2 m120 -51.6 -26.63 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -56.9 -32.9 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HE2' HG11 ' A' ' 74' ' ' VAL . 32.7 m-85 -116.04 -1.09 12.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 106' ' ' ASN . 1.2 pp0? -54.06 -34.26 59.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.815 0.341 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.58 -34.04 88.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.765 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.91 84.08 0.52 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.316 . . . . 0.0 110.972 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 32.5 Cg_exo -58.97 160.37 18.62 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.174 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 3.5 Cg_exo -73.98 152.13 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.686 2.257 . . . . 0.0 112.004 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 121.11 79.54 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.318 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 119.9 6.2 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.473 2.115 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -64.55 -39.81 94.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.407 ' CB ' HG23 ' A' ' 120' ' ' VAL . 2.0 m-20 -58.32 112.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.402 . . . . 0.0 110.875 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -26.73 61.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -81.73 -28.81 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 44' ' ' VAL . 39.2 t -85.28 115.91 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -120.83 156.95 30.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 40' ' ' LYS . 24.6 mm -103.44 131.37 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.95 129.93 45.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -89.01 126.44 35.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.8 ttm180 58.05 -173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 10.2 tt0 84.86 78.08 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 169.41 52.81 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.195 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.98 142.99 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -119.22 134.0 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.051 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 187' ' ' LEU . 36.0 m -139.7 164.61 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.675 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -107.77 133.48 52.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.265 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -105.76 140.23 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.273 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -130.99 139.13 49.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.74 130.31 56.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.645 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 31.5 p90 -139.29 -177.81 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.56 110.87 1.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.469 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -176.74 -133.28 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.4 103.31 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.753 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.06 150.11 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.98 -47.89 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.683 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.509 ' CG ' HD12 ' A' ' 94' ' ' LEU . 72.1 tt0 -162.05 -69.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.511 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.62 72.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.522 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.95 -34.98 78.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.011 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -40.6 98.17 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.3 t -53.76 -38.71 36.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.54 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.45 -37.86 74.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.774 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.645 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -70.23 -43.69 70.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.891 0.377 . . . . 0.0 110.804 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.28 -32.92 72.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.615 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -68.47 -43.36 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.681 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 29' ' ' VAL . 2.7 tp-100 -61.88 -46.1 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.425 ' HG ' HD12 ' A' ' 187' ' ' LEU . 13.3 tp -61.45 -36.95 81.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.42 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.17 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.5 m -69.08 -34.86 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.64 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.431 HG22 ' CE1' ' A' ' 31' ' ' TYR . 5.0 m -57.51 -47.03 83.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.857 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 31' ' ' TYR . 6.4 mt -72.51 -21.21 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.89 -44.91 20.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.335 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.92 35.26 4.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.695 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.2 p -146.32 156.47 49.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.747 0.308 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 -11.05 29.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.696 2.264 . . . . 0.0 112.701 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.23 139.68 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 0.0 111.158 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.2 m -100.51 140.87 34.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.731 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -159.6 156.9 28.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -90.43 136.65 32.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.29 56.98 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.17 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.85 -23.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.12 143.79 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.913 0.387 . . . . 0.0 111.271 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.637 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.2 p90 -142.88 174.07 10.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.8 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 94.9 m-85 -113.79 152.57 30.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.15 146.1 49.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.93 133.38 44.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 167.32 77.07 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.465 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -61.12 -32.95 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 110.787 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.57 120.51 60.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.85 131.2 19.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.416 2.077 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.14 90.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.404 2.069 . . . . 0.0 112.234 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ttt -174.88 149.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.64 113.47 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 179' ' ' TYR . 85.2 Cg_endo -74.76 -145.22 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.651 2.234 . . . . 0.0 111.693 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.6 m-85 66.39 39.34 4.01 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 123.37 106.25 1.78 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.907 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -139.03 138.86 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.62 0.248 . . . . 0.0 110.484 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -137.5 130.99 31.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.405 . . . . 0.0 111.278 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 7.2 m-80 -133.0 138.97 47.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.632 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -142.92 145.98 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 111.241 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.09 134.44 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.7 m0 -108.07 121.62 45.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.274 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.679 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.4 mt -96.35 139.37 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.433 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.85 129.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 11.6 tttm -88.46 48.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.252 -0.88 . . . . 1.0 111.472 179.817 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.791 0.329 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -69.78 -178.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.5 64.97 0.68 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.34 70.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 0.0 110.851 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.52 108.13 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.49 133.05 34.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -124.84 174.11 8.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -63.82 147.29 52.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.734 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.21 -56.18 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.65 -31.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.359 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.43 -113.77 3.71 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.595 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 m -107.06 123.29 48.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.25 146.36 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -112.8 124.82 53.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.639 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -97.01 133.36 41.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.29 76.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.03 125.22 13.27 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.479 2.12 . . . . 0.0 112.304 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.8 t90 62.4 81.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.82 ' CG ' ' HB3' ' A' ' 35' ' ' ALA . 8.0 pt20 -128.58 111.48 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.177 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.424 HG11 HG23 ' A' ' 23' ' ' THR . 29.2 t -74.47 112.82 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.586 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.26 -4.03 46.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.27 158.85 6.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.809 0.338 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.424 HG23 HG11 ' A' ' 20' ' ' VAL . 3.0 p -153.29 174.15 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.65 168.96 8.01 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.47 -162.23 28.24 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.691 ' HD2' HG23 ' A' ' 154' ' ' THR . 7.7 mttt -78.39 157.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.932 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -66.56 -26.27 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.96 -34.97 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.08 110.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.6 m -95.16 148.3 22.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -138.5 153.11 48.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 23' ' ' THR . 1.3 mt-10 -146.37 130.45 17.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.18 114.88 23.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 147.52 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.82 ' HB3' ' CG ' ' A' ' 19' ' ' GLN . . . -124.98 130.74 52.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -144.01 144.91 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.32 89.19 3.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -148.63 3.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.89 -111.85 0.69 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.99 152.72 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.343 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -137.7 153.73 49.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 124.0 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 123' ' ' GLU . 81.8 p -112.7 131.94 55.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.418 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.521 HG23 HD12 ' A' ' 62' ' ' ILE . 21.7 t -131.06 125.41 57.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.768 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.1 135.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.566 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.6 t -138.31 116.82 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 173.81 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.23 28.05 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.358 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -152.73 121.58 3.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.71 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.477 2.118 . . . . 0.0 112.177 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.99 HG13 HD13 ' A' ' 98' ' ' LEU . 49.0 t -62.03 -52.83 55.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -63.44 -45.25 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.1 -46.03 75.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.86 -45.14 90.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.34 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -58.34 -35.41 71.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 mtm105 -63.12 -31.55 72.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 109.942 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.7 tp10 -86.97 -33.47 19.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.147 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.71 -40.67 63.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.76 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.507 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.3 mmt -57.61 -44.02 99.23 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 23.3 Cg_exo -64.58 -42.93 14.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.257 1.972 . . . . 0.0 111.913 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.2 -41.28 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.521 HD12 HG23 ' A' ' 44' ' ' VAL . 2.3 tt -76.26 -42.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.372 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -65.04 -31.76 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -69.75 -29.81 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.434 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -71.37 -42.81 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 102' ' ' PHE . 33.8 m -65.96 -28.17 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.11 93.34 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.67 -40.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.37 84.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.726 ' ND2' HG22 ' A' ' 74' ' ' VAL . 34.2 p-10 -125.02 0.43 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.401 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 61.75 39.05 14.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 -47.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.38 52.03 3.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.726 HG22 ' ND2' ' A' ' 70' ' ' ASN . 27.8 m -101.06 -178.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.99 78.47 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.6 mtp -82.0 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.364 . . . . 0.0 110.735 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 78' ' ' MET . . . 75.72 46.13 15.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.759 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 17.8 mmt 67.47 -62.08 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.563 0.221 . . . . 0.0 111.498 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m 78.75 -60.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.94 158.11 76.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.052 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 130.77 36.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.395 2.063 . . . . 0.0 112.118 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 102' ' ' PHE . 6.1 m -87.24 154.06 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.321 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 t -130.72 160.23 34.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.61 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -121.3 154.3 36.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.213 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.43 136.65 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.813 ' HB ' HD22 ' A' ' 94' ' ' LEU . 15.7 m -124.81 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -113.24 93.82 27.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.39 138.79 62.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.598 2.199 . . . . 0.0 112.077 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.97 171.95 9.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.94 -22.11 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.41 -6.07 59.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.442 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.46 -16.05 61.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.767 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.45 133.5 33.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.813 HD22 ' HB ' ' A' ' 86' ' ' VAL . 13.3 mt -62.41 -30.0 70.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.57 -175.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -80.67 90.23 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.34 100.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.99 HD13 HG13 ' A' ' 51' ' ' VAL . 1.6 tt -144.13 135.53 25.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 111.365 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.442 ' HD2' ' CD1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -119.53 115.79 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.032 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.4 t -78.54 141.15 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 99' ' ' LYS . 18.5 m95 -122.39 138.61 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.5 t80 -119.47 146.18 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 111.485 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -102.04 111.1 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.718 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.0 mt -92.25 136.34 25.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 38.0 Cg_endo -66.36 154.16 75.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.57 2.18 . . . . 0.0 112.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -55.46 -26.71 43.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.323 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -56.84 -32.89 66.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.22 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -100.54 -4.7 28.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.54 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -45.42 72.69 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.761 0.315 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.13 -26.58 43.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.633 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.74 91.55 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.19 161.1 41.77 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.383 2.055 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 141.75 42.26 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.311 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.0 121.43 79.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.37 141.55 71.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.442 2.095 . . . . 0.0 112.275 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 84.4 p -90.58 -33.4 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -86.98 125.18 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.78 -22.15 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.223 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -31.36 30.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 117' ' ' ASP . 26.0 t -85.44 123.93 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -127.86 156.92 41.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -102.67 111.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HG3' HG21 ' A' ' 43' ' ' THR . 4.7 mm-40 -100.38 130.04 46.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 113.1 24.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.97 126.09 50.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.96 60.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.314 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.77 161.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.96 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -144.25 148.95 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.935 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -103.85 118.67 37.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.581 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 188' ' ' VAL . 13.3 m -143.34 160.65 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.295 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.581 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER -107.89 143.66 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.101 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.9 p -105.96 148.45 27.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.465 ' HB ' HD13 ' A' ' 151' ' ' LEU . 7.5 t -130.46 139.82 50.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.418 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.26 125.24 51.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.156 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 15.2 p90 -143.04 -169.6 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.421 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -46.58 138.48 7.96 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.83 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.17 170.32 55.08 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.722 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 61.05 100.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -127.2 152.93 46.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -105.62 -82.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 94' ' ' LEU . 53.5 tt0 -154.83 -61.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.93 -33.83 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.61 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.99 -34.96 77.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.987 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -42.4 96.32 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.917 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.2 t -53.9 -38.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.671 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.12 70.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.716 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 18.3 m170 -70.06 -46.1 65.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.82 -32.92 73.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -73.01 -42.16 63.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -46.06 89.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 133' ' ' THR . 11.6 tp -61.24 -37.07 81.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.5 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -43.2 93.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -68.94 -34.18 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.95 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 26' ' ' LYS . 5.3 m -57.49 -49.28 76.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.581 HD11 ' CE1' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -73.94 -13.92 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.352 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -46.62 -37.61 8.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.4 36.98 3.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 17.6 p -146.19 155.07 50.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.49 -7.75 21.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.839 2.359 . . . . 0.0 112.622 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 127.11 30.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.905 0.383 . . . . 0.0 111.28 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 190' ' ' ALA . 4.9 m -102.52 141.83 34.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -155.03 -177.94 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.988 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.82 -58.44 2.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.27 -16.48 57.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.941 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.82 -87.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.723 0.262 . . . . 0.0 111.015 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.06 138.4 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.841 0.353 . . . . 0.0 111.63 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.888 ' HB3' HD23 ' A' ' 187' ' ' LEU . 48.7 p90 -144.96 174.7 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.359 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.719 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 58.1 m-85 -119.38 161.99 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.669 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 m -139.36 151.65 46.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 128.45 38.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.168 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.76 -130.27 2.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.804 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 64.46 -101.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.909 0.083 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.41 ' CB ' ' HD2' ' A' ' 174' ' ' PRO . 0.2 OUTLIER 52.55 171.77 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 111.315 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 173' ' ' ASP . 72.8 Cg_endo -76.7 129.65 11.01 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.433 2.089 . . . . 0.0 112.124 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.68 136.12 34.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.492 2.128 . . . . 0.0 112.431 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.96 116.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.66 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.44 163.6 37.41 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.4 2.067 . . . . 0.0 112.254 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 60.01 34.53 21.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.28 32.31 1.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -128.27 144.09 51.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.96 127.19 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -120.69 148.94 43.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -142.81 155.62 44.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 133' ' ' THR . 9.3 t -129.6 115.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.462 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.49 124.4 50.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.968 0.413 . . . . 0.0 110.968 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 167' ' ' TYR . 8.1 mt -91.19 140.34 29.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.6 t -74.75 126.76 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -177.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 1.0 111.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.87 -31.55 45.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.79 -90.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.535 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.4 mtt -140.75 177.8 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.939 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 tt -68.1 -30.52 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.014 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -105.83 139.78 39.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -121.91 126.01 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 p -80.03 130.09 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.91 41.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -63.62 166.23 7.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.49 -91.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.68 124.81 45.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.9 t -139.05 145.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.5 139.54 53.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -97.97 131.93 43.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -78.49 151.92 77.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.2 -28.15 34.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.558 2.172 . . . . 0.0 112.232 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -162.63 110.79 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.09 118.3 12.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.49 113.63 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 129' ' ' THR . 12.4 mt -95.03 -14.56 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.503 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -169.63 164.06 10.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 p -152.23 -178.35 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.764 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.98 -125.43 7.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 131.97 -95.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.626 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -161.52 163.98 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.3 69.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.77 -35.16 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.315 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.18 108.07 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.364 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.34 140.89 31.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -138.68 162.31 34.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.775 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -143.83 127.7 17.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -86.29 115.01 23.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -132.93 129.39 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.93 139.18 42.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 m -138.28 -178.23 5.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER 63.74 134.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.0 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.24 -41.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.64 -118.51 3.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.65 142.74 51.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.882 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 37' ' ' GLU . 49.9 m-85 -137.69 161.85 35.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -100.95 140.3 35.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.766 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.8 p -133.76 137.87 45.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 111.146 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.925 HG23 HD12 ' A' ' 62' ' ' ILE . 11.3 t -125.94 125.89 68.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -95.98 127.7 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 58' ' ' ALA . 11.6 t -138.17 116.92 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -109.11 176.51 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.819 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.25 30.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.319 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -152.63 121.91 3.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.82 -179.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.464 2.109 . . . . 0.0 112.246 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.3 t -61.87 -55.26 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.315 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.74 -43.82 92.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -46.06 75.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.186 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.15 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.271 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.6 mt -58.77 -35.59 73.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -63.81 -34.58 78.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.96 0.41 . . . . 0.0 109.964 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.6 tp10 -87.14 -28.81 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.63 -42.7 61.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.558 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.712 ' HE1' HG11 ' A' ' 82' ' ' VAL . 7.5 mmt -57.76 -43.6 98.83 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.65 -43.5 38.32 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.105 1.87 . . . . 0.0 111.863 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -70.37 -42.18 72.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 44' ' ' VAL . 1.3 tt -76.22 -35.12 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.476 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mtp -66.31 -31.97 73.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -64.3 -47.6 78.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 21.3 t80 -60.26 -53.92 51.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.594 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.788 HG21 ' HG3' ' A' ' 78' ' ' MET . 29.3 m -66.24 -28.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.012 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.78 -89.05 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.356 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.62 55.06 0.47 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.536 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' THR . 21.1 m -126.69 38.14 4.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.841 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -126.58 167.24 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.98 10.46 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.28 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -92.56 -30.4 15.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 43.29 38.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 113' ' ' PRO . 31.3 m -101.27 -178.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.21 88.4 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.1 mtm -96.71 107.57 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.66 -24.67 12.92 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.749 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.788 ' HG3' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER 65.89 147.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 111.05 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -93.48 168.78 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.483 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 17.6 t -85.84 -45.9 0.6 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.512 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD2' HG22 ' A' ' 79' ' ' THR . 24.2 Cg_exo -63.63 144.69 90.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.309 2.006 . . . . 0.0 112.025 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.712 HG11 ' HE1' ' A' ' 59' ' ' MET . 10.4 t -152.98 143.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.4 p -117.21 146.08 43.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.711 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -128.98 154.4 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.195 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -99.69 136.69 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.453 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HD12 ' A' ' 98' ' ' LEU . 22.6 m -125.24 135.3 64.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -103.0 95.79 7.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.297 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.803 ' HA ' HD23 ' A' ' 94' ' ' LEU . 74.4 Cg_endo -74.55 148.89 38.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.082 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 171.99 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -6.16 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.415 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 91.22 -16.04 59.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.751 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.7 p -81.3 113.03 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.811 0.338 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -73.07 148.97 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -125.85 68.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mttt 56.07 -163.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 69.4 109.45 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.759 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.7 tt -144.07 134.41 24.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -110.51 115.57 29.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.725 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.3 t -78.8 141.21 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 111.508 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -119.48 121.91 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 64.8 t80 -105.59 155.41 19.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.614 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -116.04 107.8 15.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.7 mt -79.46 136.59 56.04 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.267 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 104' ' ' ILE . 27.7 Cg_endo -62.09 154.13 64.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.322 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -55.57 -27.47 49.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -62.68 -33.21 74.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -107.26 -14.48 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -53.15 -44.04 67.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.741 0.305 . . . . 0.0 111.061 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.16 66.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.455 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.78 91.18 0.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 160.98 47.69 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.542 2.161 . . . . 0.0 112.266 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.687 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.6 Cg_exo -70.85 149.87 60.66 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.697 2.265 . . . . 0.0 111.973 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.21 111.71 7.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 32.2 Cg_exo -59.59 167.39 6.65 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.506 2.138 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.5 m -145.92 34.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.6 123.61 17.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.0 -26.01 61.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.0 -30.52 31.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.39 114.01 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 150.98 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.4 132.72 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.78 160.12 14.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -149.4 140.82 23.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.082 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.57 18.27 9.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.27 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.11 160.21 32.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.92 119.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.458 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.23 143.9 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.756 HG21 HD12 ' A' ' 21' ' ' LEU . 28.1 m -103.87 123.54 47.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.512 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.905 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.9 m -133.13 170.16 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.008 0.433 . . . . 0.0 111.729 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.751 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -134.46 125.94 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.945 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.4 p -105.76 143.88 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.104 0.478 . . . . 0.0 111.785 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -122.69 139.28 54.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.086 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -116.63 143.64 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.54 ' CE1' ' CD2' ' A' ' 147' ' ' HIS . 13.2 p90 -143.14 -46.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.603 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.99 -131.32 1.62 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -148.37 33.12 1.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB3' ' A' ' 178' ' ' PRO . 4.7 m-85 -107.04 62.15 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 183' ' ' ASN . . . -136.5 135.57 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 71.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.867 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.514 ' HG2' HD12 ' A' ' 94' ' ' LEU . 27.1 tt0 64.36 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.24 63.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.02 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 2.1 t70 -69.06 -34.88 75.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.174 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.469 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.9 OUTLIER -62.75 -38.95 92.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.466 0.65 . . . . 0.0 109.652 179.203 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.2 t -53.91 -38.99 38.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.597 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.45 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.801 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.54 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 22.1 m80 -68.74 -40.91 79.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.21 -32.75 72.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.78 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -62.95 -44.14 96.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.01 -46.04 90.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.706 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 151' ' ' LEU . 8.1 tp -59.23 -42.23 90.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -59.29 -48.07 83.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.401 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.4 m -63.76 -47.01 82.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.173 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 31' ' ' TYR . 6.7 m -57.82 -40.96 81.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.755 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.496 HD11 ' CE1' ' A' ' 131' ' ' TYR . 11.5 mt -72.73 -14.57 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.491 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.77 126.9 11.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.67 34.72 11.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.206 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 16.1 p -145.55 159.89 46.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.561 0.22 . . . . 0.0 110.66 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 5.7 Cg_endo -47.88 -22.95 3.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.868 2.379 . . . . 0.0 112.541 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.751 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -56.58 106.13 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 53.4 m -101.94 -0.66 33.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.735 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 9.3 m-85 59.67 147.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.52 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.68 -173.5 4.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.54 62.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.776 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.64 75.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.762 0.315 . . . . 0.0 111.389 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.7 p -161.72 81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.233 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.483 ' CZ ' HG21 ' A' ' 86' ' ' VAL . 45.5 p90 -99.54 166.22 11.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.846 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.804 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 16.5 m-85 -115.6 161.95 17.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 67.3 m -121.33 130.85 53.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 184' ' ' GLU . . . -132.07 156.33 46.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -121.08 121.41 4.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.72 79.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.783 0.325 . . . . 0.0 111.289 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.4 142.78 0.19 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.928 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -86.02 110.38 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.918 2.412 . . . . 0.0 112.778 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.412 ' HB2' ' HG3' ' A' ' 178' ' ' PRO . 9.0 Cg_exo -71.33 -155.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.873 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.79 51.37 2.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.958 0.409 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.587 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 0.3 OUTLIER 48.91 50.63 9.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.804 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 177' ' ' LYS . 69.5 Cg_endo -88.57 -59.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.583 2.188 . . . . 0.0 112.171 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 178' ' ' PRO . 0.0 OUTLIER -151.93 -163.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.187 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -97.04 45.7 1.77 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.429 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -139.03 163.01 33.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 111.385 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 147.58 36.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 4.2 m-80 -133.16 134.97 44.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.965 0.412 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 4.6 mt-10 -146.01 157.12 43.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.11 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 144' ' ' TYR . 11.3 t -136.68 138.03 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.808 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -140.78 121.79 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 167' ' ' TYR . 11.8 mt -91.57 140.09 30.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.905 ' HA ' HG12 ' A' ' 130' ' ' VAL . 6.6 t -75.69 131.0 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.403 ' CG ' ' CE2' ' A' ' 131' ' ' TYR . 32.2 mtpt -74.34 150.16 40.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.36 -0.829 . . . . 1.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.869 0.366 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.6 tp -162.4 -44.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.81 -172.64 44.13 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.49 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -117.19 -33.75 4.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.715 0.293 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt 67.13 118.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.094 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 140.03 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.09 132.99 55.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -71.57 156.82 38.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.998 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -69.21 70.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.05 -89.3 2.11 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.347 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -98.07 125.0 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.769 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.2 m -136.34 145.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -129.68 125.0 34.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 p -101.92 132.36 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.47 81.08 17.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.84 -61.68 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.514 2.143 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.14 175.6 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -123.39 108.22 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.02 112.94 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.4 -9.7 29.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -169.9 163.15 9.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -152.16 -173.28 4.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.7 -114.63 4.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 116.19 -112.03 2.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.57 162.69 30.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -30.21 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.195 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -90.66 -35.06 15.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.192 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.21 110.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.907 0.384 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.9 m -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.2 p90 -138.78 158.84 43.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 23' ' ' THR . 6.1 mt-10 -143.98 138.68 28.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.79 117.56 25.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -131.98 144.04 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.05 110.29 13.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.3 t -82.58 151.57 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.03 139.53 49.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.32 -106.96 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.2 -60.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -104.46 134.46 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.002 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -137.63 153.14 49.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.89 117.97 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.2 p -112.7 133.49 54.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.323 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.654 HG23 HD12 ' A' ' 62' ' ' ILE . 21.8 t -125.95 125.45 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -100.81 133.93 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.48 116.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.41 175.79 5.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.21 34.21 0.66 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.509 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -152.17 135.46 9.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.83 -158.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.528 2.152 . . . . 0.0 112.207 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.4 t -87.11 -53.53 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.24 -43.23 87.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -46.42 74.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.99 92.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 84' ' ' PHE . 4.3 mt -57.76 -35.24 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -62.65 -30.93 71.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.979 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.7 tp10 -88.18 -33.19 18.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.55 -43.21 60.46 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.655 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.0 mmt -57.75 -43.63 98.86 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.5 Cg_exo -57.28 -45.6 33.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.106 1.87 . . . . 0.0 112.262 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -70.33 -42.59 71.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.518 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.654 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.48 -32.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.446 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -41.06 91.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -40.88 91.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 64.8 t80 -59.63 -50.7 72.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 63' ' ' MET . 34.7 m -66.0 -27.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.66 104.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.01 -54.33 0.51 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -144.99 87.75 1.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -110.9 -29.17 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.0 m-20 84.63 -22.09 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.582 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -32.09 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.65 64.24 1.01 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.414 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' HG2' ' A' ' 113' ' ' PRO . 18.2 m -139.61 141.06 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.53 55.62 0.58 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.347 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.405 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -58.61 -34.75 71.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.67 -159.38 42.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 mtt -97.55 112.98 24.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.359 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 HG23 ' A' ' 80' ' ' VAL . 12.5 m -111.01 122.87 48.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 79' ' ' THR . 22.0 t 63.85 141.6 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 33.7 Cg_exo -59.75 130.82 36.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.272 1.981 . . . . 0.0 112.257 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' A' ' 102' ' ' PHE . 7.0 m -87.29 139.28 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.9 149.75 36.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.566 ' HD2' HD11 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -123.99 144.34 49.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -82.72 140.44 33.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.663 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 29.1 m -109.95 -28.09 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.44 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' HG21 ' A' ' 166' ' ' VAL . 96.8 m-85 55.91 91.77 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.529 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HA ' HD23 ' A' ' 94' ' ' LEU . 71.9 Cg_endo -77.18 141.61 20.83 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.637 2.224 . . . . 0.0 112.007 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.61 166.15 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.36 -15.89 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.278 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 3.48 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 86.92 -1.84 86.94 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.976 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 p -131.52 161.72 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.86 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.2 mt -87.54 154.32 20.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.531 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -140.57 84.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 45.53 93.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.6 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.71 101.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.555 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.683 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -143.72 143.87 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.91 115.66 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.914 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.563 HG21 ' HB1' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -86.68 137.35 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.579 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -117.96 141.04 48.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.307 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.677 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 48.5 t80 -124.2 151.47 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.975 0.417 . . . . 0.0 111.388 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtp180 -115.96 107.84 15.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.654 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.406 HG23 ' HD2' ' A' ' 105' ' ' PRO . 28.1 mt -82.08 136.4 47.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 104' ' ' ILE . 28.3 Cg_endo -62.32 154.14 65.61 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.555 2.17 . . . . 0.0 112.334 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -52.48 -26.8 13.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.15 66.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 110.976 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.618 ' HE2' HG11 ' A' ' 74' ' ' VAL . 88.9 m-85 -115.95 -9.75 11.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.33 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.08 -48.08 71.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.765 0.317 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -26.54 56.33 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 t -174.5 88.08 0.33 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 44.0 Cg_endo -68.36 160.45 49.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.552 2.168 . . . . 0.0 112.353 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.681 ' HG2' HG21 ' A' ' 74' ' ' VAL . 5.0 Cg_exo -74.19 159.29 44.25 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 112.026 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.34 111.24 6.19 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.978 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 65' ' ' TYR . 60.8 Cg_endo -72.62 162.36 41.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.513 2.142 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.52 179.73 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.66 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.46 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -16.88 30.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.1 p -80.2 -28.57 38.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.673 0.273 . . . . 0.0 111.213 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.62 114.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 111.157 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 156.97 32.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.19 125.25 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.9 129.94 45.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -89.14 125.27 34.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.9 OUTLIER 58.9 -177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.8 tt0 83.09 76.99 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.5 -175.12 50.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -143.99 143.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.249 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.9 m -115.31 118.98 34.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 188' ' ' VAL . 36.0 m -144.11 163.99 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.434 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -107.78 137.85 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.212 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -105.87 146.47 29.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 0.0 111.56 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -131.19 139.23 49.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.438 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -116.6 132.09 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -139.72 156.28 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.36 33.57 5.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -107.02 -36.48 2.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 178' ' ' PRO . 16.4 m-85 63.83 133.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.19 -175.86 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -133.59 -66.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.563 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.7 tt0 -141.72 -72.92 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.82 75.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -34.56 77.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -40.33 96.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.568 0.699 . . . . 0.0 109.807 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -53.84 -38.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.668 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.29 -35.78 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.719 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -70.17 -42.45 72.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.0 m -63.4 -42.28 98.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.801 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.16 94.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.871 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 187' ' ' LEU . 8.2 tp -60.55 -40.45 91.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -42.38 94.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.8 m -68.64 -35.72 77.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 41.5 m -57.61 -49.09 77.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 5.6 mt -73.62 -11.12 60.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.259 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -47.03 -43.16 19.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.59 36.56 3.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 30.8 p -145.64 154.29 52.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 48.3 Cg_endo -68.78 -10.79 30.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.621 2.214 . . . . 0.0 112.633 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 126.86 29.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.4 m -101.95 160.08 14.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -155.27 151.46 28.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.035 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -55.5 -56.53 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.295 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.91 50.96 11.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.103 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 -22.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.452 HG21 ' CE1' ' A' ' 87' ' ' PHE . 12.8 p -158.81 141.95 5.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.7 ' HB3' HD23 ' A' ' 187' ' ' LEU . 12.2 p90 -140.79 166.59 24.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 36.2 m-85 -118.37 159.38 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.405 ' O ' ' CE1' ' A' ' 84' ' ' PHE . 42.9 m -127.53 130.89 49.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.99 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -107.9 142.98 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.96 86.94 0.19 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -176.0 68.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -152.2 152.82 30.19 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.91 109.18 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.598 2.199 . . . . 0.0 112.352 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -92.25 -172.68 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.907 2.405 . . . . 0.0 112.352 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -60.42 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.354 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 13.3 pttt 179.24 60.54 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 177' ' ' LYS . 43.0 Cg_endo -94.17 -68.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.012 2.475 . . . . 0.0 112.299 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.448 ' CZ ' ' HG2' ' A' ' 181' ' ' ARG . 26.4 p90 -149.98 -44.92 0.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.12 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.83 -48.91 0.03 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.016 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 179' ' ' TYR . 12.0 ptt180 -124.05 167.55 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.286 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.51 164.45 12.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -108.67 145.23 35.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.18 157.19 43.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.473 HG13 ' HD2' ' A' ' 167' ' ' TYR . 21.4 t -139.22 114.9 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.428 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 5.6 m0 -110.03 124.35 51.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 ' HB3' ' A' ' 167' ' ' TYR . 63.5 mt -91.65 140.41 29.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.471 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.677 ' HA ' HG12 ' A' ' 130' ' ' VAL . 24.2 t -74.58 123.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.937 0.399 . . . . 0.0 111.168 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 7.0 tttp -72.07 149.81 44.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.173 -0.918 . . . . 1.0 111.089 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.21 177.8 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -141.85 63.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.374 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.19 150.17 22.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mt -134.36 -48.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.51 140.01 32.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -121.03 128.94 53.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.951 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -82.02 141.57 33.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.24 167.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.81 -43.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.43 -129.93 11.24 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.233 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -106.99 124.22 49.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 110.382 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.59 133.98 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -140.5 126.28 19.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 m -92.45 127.15 37.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 62.89 146.98 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HG2' ' CE3' ' A' ' 18' ' ' TRP . 71.9 Cg_endo -77.01 -3.42 13.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' A' ' 17' ' ' PRO . 3.5 p90 -130.55 176.81 7.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.87 110.77 12.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.28 112.98 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 35' ' ' ALA . 8.7 mt -86.92 -19.12 29.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.78 167.08 9.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.784 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -168.69 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.57 -118.69 5.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.28 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 99.72 158.81 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.74 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -78.8 163.69 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.6 -29.83 69.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.031 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -35.35 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.102 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.24 107.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.277 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 64.1 m -100.58 157.95 16.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.9 p90 -139.49 160.97 38.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.9 125.74 12.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -86.1 135.1 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 136.34 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -122.96 126.5 47.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.86 163.46 27.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.56 -77.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.99 -174.14 54.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.522 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.89 -89.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mptt -96.84 137.68 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.808 0.337 . . . . 0.0 110.857 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 24.0 m-85 -137.49 157.66 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.065 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.99 140.21 29.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.0 p -133.44 131.83 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 111.252 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.605 HG23 HD12 ' A' ' 62' ' ' ILE . 23.2 t -126.62 125.49 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.906 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.97 139.48 34.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.1 t -138.24 118.04 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.11 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 166.93 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.55 33.85 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.93 123.6 3.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.771 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.85 -69.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.332 2.021 . . . . 0.0 112.353 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG13 ' CD1' ' A' ' 98' ' ' LEU . 45.0 t -156.5 -63.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.05 -45.14 79.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -67.09 -46.15 75.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.012 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.822 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.96 -42.25 89.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.281 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.861 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.2 mt -56.88 -35.31 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.08 -31.56 72.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -88.12 -34.01 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.75 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.64 -42.46 61.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.762 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.473 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 22.9 mmt -57.67 -43.81 99.05 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 39.3 Cg_exo -60.52 -43.45 33.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.433 2.089 . . . . 0.0 112.313 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -70.22 -43.63 70.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.27 -41.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.612 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.52 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.87 -31.88 73.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.01 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 63' ' ' MET . 20.3 mmtt -66.34 -32.27 73.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.975 0.417 . . . . 0.0 110.324 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 90.4 t80 -67.9 -32.6 73.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.597 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.591 HG11 ' CE2' ' A' ' 102' ' ' PHE . 18.1 m -90.08 -10.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.66 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.2 44.47 2.81 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.836 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.11 44.98 51.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.999 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -126.91 61.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -111.93 -22.3 11.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.191 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.25 4.57 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.1 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -94.02 -29.59 15.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.18 37.73 4.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.187 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.744 HG21 ' HG3' ' A' ' 113' ' ' PRO . 28.4 m -98.48 -178.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.078 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.29 76.1 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.413 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.1 mtp -96.13 106.17 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 29.59 11.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt 61.25 156.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 80' ' ' VAL . 4.8 m -164.65 124.99 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.07 137.3 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 80' ' ' VAL . 19.2 Cg_endo -60.06 147.73 91.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.583 2.189 . . . . 0.0 112.098 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.93 153.76 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.519 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.444 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 1.8 t -135.69 168.16 19.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.418 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.861 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.07 154.1 49.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -97.06 136.68 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.45 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 166' ' ' VAL . 28.7 m -123.14 141.9 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.003 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -115.21 89.81 22.05 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.089 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.725 ' HA ' HD23 ' A' ' 94' ' ' LEU . 19.4 Cg_exo -65.99 149.66 85.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.68 2.253 . . . . 0.0 112.188 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.7 161.87 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.27 -19.71 55.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -5.97 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.364 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.05 66.78 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 m -94.57 155.17 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 88' ' ' PRO . 16.5 mt -105.72 131.46 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -82.06 170.93 14.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 65.99 5.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -144.35 96.03 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.564 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.85 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -122.94 136.96 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.242 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 115.87 19.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.301 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.75 HG21 ' HB1' ' A' ' 58' ' ' ALA . 1.7 t -87.37 116.82 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.174 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -98.16 142.02 30.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.822 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.9 t80 -123.88 145.6 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 6.5 ptp180 -108.75 110.51 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 108' ' ' PHE . 21.9 mt -89.59 137.78 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HD2' HG23 ' A' ' 104' ' ' ILE . 7.8 Cg_endo -49.91 154.04 5.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 2.6 m120 -58.79 -27.04 64.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.301 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -61.19 -33.01 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.488 ' HB2' HG22 ' A' ' 104' ' ' ILE . 72.6 m-85 -102.01 -8.98 21.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.751 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.73 -34.2 58.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.798 0.332 . . . . 0.0 111.093 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.57 -33.36 81.57 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.1 p -177.5 98.1 0.23 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.583 0.23 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.36 152.97 75.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.744 ' HG3' HG21 ' A' ' 74' ' ' VAL . 56.2 Cg_endo -71.41 159.0 52.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.602 2.201 . . . . 0.0 112.44 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.43 118.38 56.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 47.6 Cg_endo -68.37 146.71 69.75 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.422 2.081 . . . . 0.0 112.365 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -77.34 -40.05 45.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.865 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -77.81 114.89 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.021 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.59 -19.11 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 m -80.65 -17.06 52.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.321 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HB3' ' A' ' 117' ' ' ASP . 35.7 t -84.74 113.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 157.02 18.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.931 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 mm -122.56 123.5 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.82 129.85 45.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.56 130.95 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 60.33 111.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.98 90.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.48 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.381 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.66 142.94 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.21 42.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.89 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -132.77 168.63 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.554 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 12.4 m-85 -107.73 160.24 15.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.0 p -124.4 130.32 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.252 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.478 ' HB ' HD13 ' A' ' 151' ' ' LEU . 9.4 t -131.08 138.31 49.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.705 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -122.13 142.65 50.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CZ ' ' CD2' ' A' ' 147' ' ' HIS . 20.4 p90 -152.11 167.76 27.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.47 96.94 1.82 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.7 15.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -95.89 -177.66 4.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -157.41 148.56 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.265 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -134.35 65.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.654 ' HG2' HD12 ' A' ' 94' ' ' LEU . 12.3 tt0 67.33 -72.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.027 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.13 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.37 -34.88 76.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -62.9 -39.12 93.54 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.427 0.632 . . . . 0.0 109.881 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.5 t -54.03 -38.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.457 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.24 69.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.715 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.445 ' CD2' ' CZ ' ' A' ' 135' ' ' PHE . 4.0 m-70 -70.1 -45.33 67.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.82 72.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.0 m -69.31 -38.24 78.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -44.81 91.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 31' ' ' TYR . 12.4 tp -58.02 -38.35 76.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.394 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -61.28 -43.82 98.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -61.71 -40.34 94.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.018 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.7 m -57.82 -46.14 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.779 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.419 HD13 ' HB1' ' A' ' 160' ' ' ALA . 7.7 mt -73.65 -10.34 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.796 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.8 OUTLIER -47.3 106.03 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 141.18 -39.05 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -94.9 -179.15 0.9 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.491 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.9 Cg_endo -85.52 35.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.414 2.076 . . . . 0.0 112.803 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -60.47 109.24 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.241 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.83 165.71 11.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -154.7 16.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.713 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.681 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 3.6 mt-30 53.52 -83.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.6 0.238 . . . . 0.0 111.397 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -127.84 34.36 3.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.78 25.54 12.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.681 0.277 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 86' ' ' VAL . 14.5 p -79.71 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.103 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 187' ' ' LEU . 50.2 p90 -140.4 -176.72 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.696 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 44.8 m-85 -119.25 159.83 23.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 3.7 m -134.6 152.8 52.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.89 155.91 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 134.05 174.34 13.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 59' ' ' MET . 4.1 t80 -166.82 -67.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.688 0.28 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 91.5 m-20 -72.3 139.26 81.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.092 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 24.1 Cg_exo -63.26 -177.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.15 126.98 23.2 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.551 2.167 . . . . 0.0 112.206 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.48 -44.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -129.4 105.83 17.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.18 37.48 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.755 2.303 . . . . 0.0 112.833 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -150.33 -47.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 110.813 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -70.33 -44.11 60.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.422 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.76 145.22 37.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.852 0.358 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 163.95 31.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.78 149.39 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.73 148.6 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.408 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.557 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.2 t -135.11 116.27 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.93 125.5 51.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.386 . . . . 0.0 111.103 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 167' ' ' TYR . 73.0 mt -91.68 137.23 32.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HA ' HG12 ' A' ' 130' ' ' VAL . 23.5 t -74.89 131.18 35.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -101.43 103.54 14.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.186 -0.911 . . . . 1.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.775 0.321 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.39 35.48 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.844 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.99 -78.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.532 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 mpp? 62.95 122.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.878 0.37 . . . . 0.0 110.837 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.74 -30.53 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.215 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.43 34.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -123.77 137.09 54.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -73.82 142.47 46.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.17 100.07 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -79.19 -161.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.24 -86.79 1.1 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.8 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -107.04 124.51 49.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.23 142.43 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 111.338 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -140.92 127.75 20.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 t -86.34 120.8 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 62.71 145.28 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 18' ' ' TRP . 50.0 Cg_exo -55.36 136.28 72.93 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.474 2.116 . . . . 0.0 112.239 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.472 ' CG ' ' O ' ' A' ' 17' ' ' PRO . 13.8 p90 46.02 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.545 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -139.16 110.34 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.64 125.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.19 -16.53 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.392 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -169.75 165.41 9.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -152.05 -176.55 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.72 -110.86 2.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.4 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 105.65 -133.01 11.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.563 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -161.56 165.41 28.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.737 0.303 . . . . 0.0 110.809 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.45 -29.44 69.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.79 -35.14 15.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.223 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.21 108.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.1 140.31 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -139.24 161.96 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.17 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG2' HG22 ' A' ' 23' ' ' THR . 26.1 mt-10 -147.24 130.23 16.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.71 121.76 29.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 133.37 34.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.76 113.3 19.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -127.63 156.21 42.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.0 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.22 84.31 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.54 -151.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.8 -86.11 1.88 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.9 mttm -123.62 149.1 45.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -137.58 153.58 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -106.08 132.0 52.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.793 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 101' ' ' TRP . 65.0 p -112.53 140.43 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.79 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 17.6 t -128.44 125.47 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -100.07 134.06 43.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.652 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 54' ' ' ALA . 11.3 t -138.19 116.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.9 0.381 . . . . 0.0 111.208 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.99 167.03 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 t0 58.84 31.79 21.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -151.15 124.93 4.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.794 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.76 -67.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.282 1.988 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.458 ' O ' HD23 ' A' ' 55' ' ' LEU . 61.1 t -156.2 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.805 0.335 . . . . 0.0 111.183 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.85 -40.86 73.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.79 -46.44 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 110.335 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -60.74 -36.81 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.387 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.821 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -56.79 -35.7 69.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.945 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -64.79 -28.33 69.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.621 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.7 tp10 -86.89 -43.57 12.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.517 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 44' ' ' VAL . . . -73.34 -33.7 65.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.605 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 23.6 mmt -58.03 -43.85 98.82 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -66.44 -30.95 43.41 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.952 1.768 . . . . 0.0 112.12 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -38.81 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.427 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 44' ' ' VAL . 36.2 mm -77.65 -38.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.783 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -46.09 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -64.43 -30.41 71.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -65.35 -47.37 76.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 15.7 m -84.25 -30.22 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.53 -115.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.04 47.3 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.443 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 4.9 m -152.68 76.19 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -134.09 11.32 3.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.352 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.09 30.21 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -148.68 -47.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.56 33.62 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 m -100.66 149.7 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.13 76.3 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mtp -60.09 -42.92 95.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.387 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.09 -126.77 13.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmt -120.55 146.65 46.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 105' ' ' PRO . 1.1 m -157.14 107.82 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 21.1 t 64.12 141.67 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 34.5 Cg_exo -59.73 130.79 36.68 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.323 2.016 . . . . 0.0 112.133 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 m -87.36 136.71 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.6 p -126.15 163.44 23.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.821 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -133.0 153.41 51.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.718 0.294 . . . . 0.0 111.3 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.99 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -89.55 136.86 32.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.145 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.807 HG12 HD12 ' A' ' 98' ' ' LEU . 31.6 m -120.06 136.71 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.44 96.82 14.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 94' ' ' LEU . 80.5 Cg_endo -77.23 135.72 15.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -90.26 172.07 9.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.63 -15.98 63.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.12 -6.24 59.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.386 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.08 -16.01 56.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.998 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -96.54 117.13 30.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD12 ' OE2' ' A' ' 141' ' ' GLU . 6.9 mt -56.5 114.48 2.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -57.56 172.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -80.53 73.76 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 117.27 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.603 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 86' ' ' VAL . 1.1 tt -144.05 140.15 29.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.453 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -123.92 115.91 22.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.79 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 3.2 p -98.72 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CD2' HG22 ' A' ' 43' ' ' THR . 25.4 m95 -113.03 142.28 45.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.492 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 85.8 t80 -108.8 160.71 15.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 111.362 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 108.01 15.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.544 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.524 HD12 ' HB2' ' A' ' 40' ' ' LYS . 33.0 mt -80.54 136.68 52.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.516 ' HA ' HG21 ' A' ' 79' ' ' THR . 29.0 Cg_endo -62.87 154.04 69.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.699 2.266 . . . . 0.0 112.597 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -58.72 -26.68 64.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.302 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -32.83 65.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.65 9.3 29.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.788 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -55.43 -42.81 74.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.64 -34.04 68.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 100.77 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.541 0.21 . . . . 0.0 110.934 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.29 160.76 47.58 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.363 2.042 . . . . 0.0 112.257 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.68 153.38 54.12 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.692 2.261 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.66 119.01 62.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.05 146.69 36.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.329 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 t -88.04 -33.54 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.796 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -87.75 122.43 31.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -22.23 47.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -81.66 -25.85 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.796 HG23 ' HB3' ' A' ' 117' ' ' ASP . 31.1 t -85.21 125.48 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.099 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -121.79 157.05 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.419 ' CG2' ' HD2' ' A' ' 40' ' ' LYS . 26.5 mm -111.67 121.75 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.92 160.29 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.6 151.25 33.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.022 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.2 ttt180 62.33 166.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.3 tm-20 83.49 129.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.64 155.33 16.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.438 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.11 142.92 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -110.07 118.8 37.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.666 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 188' ' ' VAL . 28.1 m -140.36 166.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.261 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.827 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -107.81 137.72 45.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.2 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 p -105.95 143.1 34.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -131.05 139.19 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.628 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.95 141.44 48.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.028 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.544 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 52.0 p90 -161.43 134.64 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.89 91.56 1.69 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.19 177.32 44.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.98 160.13 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -160.96 133.38 6.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.75 76.55 1.59 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' OE2' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 67.53 -71.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.104 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -33.92 62.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.194 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 4.8 m-20 -68.48 -37.56 80.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -62.95 -41.02 99.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.322 0.582 . . . . 0.0 110.08 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.99 -38.64 37.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.245 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.28 70.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.806 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.544 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 21.4 m80 -70.16 -44.57 68.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.83 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.806 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.3 m -70.58 -43.3 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -58.96 -46.17 88.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 187' ' ' LEU . 13.3 tp -62.4 -41.75 98.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -46.17 89.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.724 HG23 ' OE1' ' A' ' 156' ' ' GLU . 98.1 m -61.85 -43.63 98.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.999 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.495 HG22 ' HE2' ' A' ' 31' ' ' TYR . 2.9 m -57.82 -38.85 76.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.859 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -16.6 61.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.881 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.724 ' OE1' HG23 ' A' ' 153' ' ' THR . 47.1 mt-10 -46.94 144.16 2.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.838 0.352 . . . . 0.0 111.269 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.7 -30.89 8.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.103 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 1.2 p -94.93 176.15 2.46 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.1 Cg_endo -85.77 12.22 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.562 2.174 . . . . 0.0 112.916 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.827 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -59.35 116.29 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 162' ' ' TYR . 1.2 m -100.1 175.44 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -155.47 22.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.595 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 48.66 -87.74 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.504 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -120.96 29.14 5.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.245 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 69.3 21.18 7.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.641 0.258 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.6 p -80.23 139.0 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 111.061 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.895 ' HB3' HD23 ' A' ' 187' ' ' LEU . 24.8 p90 -139.27 178.11 7.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.99 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 97.4 m-85 -119.6 151.4 38.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 m -126.87 130.91 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -113.27 129.19 56.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.73 -164.91 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.693 0.282 . . . . 0.0 110.7 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -50.92 163.0 0.52 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.26 170.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.282 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.41 92.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.576 2.184 . . . . 0.0 112.596 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -32.44 14.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -144.36 143.25 21.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.26 34.73 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.86 2.374 . . . . 0.0 112.839 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -149.74 -46.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.781 0.324 . . . . 0.0 110.928 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.16 60.59 4.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.04 140.75 51.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.774 0.321 . . . . 0.0 110.941 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.03 132.92 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -126.47 133.98 51.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -142.96 156.4 44.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.626 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.5 t -138.98 116.14 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -107.76 121.86 45.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' A' ' 167' ' ' TYR . 43.0 mt -92.91 136.01 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.9 t -74.74 131.53 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 36.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.242 -0.885 . . . . 1.0 111.369 179.846 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpp . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.851 0.358 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.52 129.1 45.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.94 -137.78 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.0 mtm 62.82 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 0.0 111.055 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 tp -166.29 144.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -100.37 137.64 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.41 139.21 39.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.98 152.72 21.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -104.93 -9.53 17.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.324 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 61.8 32.01 18.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 -83.23 0.39 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 p -96.68 134.75 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.711 0.291 . . . . 0.0 110.841 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.98 118.19 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.141 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -140.65 151.02 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.762 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -88.59 119.75 29.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 176.48 73.18 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.12 60.91 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.898 2.399 . . . . 0.0 112.752 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' A' ' 18' ' ' TRP . 6.4 p90 -82.6 134.28 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.701 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.38 107.7 10.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.36 119.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.51 -3.93 21.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.498 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.14 166.88 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -152.34 -57.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.82 170.0 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.63 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.53 -85.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.5 162.99 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -66.53 -33.21 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -33.2 16.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.97 141.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.33 154.47 50.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.574 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.07 159.77 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.43 121.8 12.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.52 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 39.0 mt-10 -87.02 132.07 33.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -141.98 130.9 23.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.46 124.38 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 p -127.74 -178.33 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.45 167.65 14.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.15 167.29 38.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.61 -85.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -100.9 146.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 110.888 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 6.2 m-85 -137.59 148.04 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 123.49 37.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.697 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -112.64 136.59 52.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.793 ' CG2' HD11 ' A' ' 62' ' ' ILE . 22.9 t -125.96 125.54 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.64 131.32 44.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.154 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 54' ' ' ALA . 12.5 t -138.46 116.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.009 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.424 HG23 ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.22 167.1 13.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.98 23.45 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -152.55 133.22 7.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.3 -177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.518 2.145 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 55' ' ' LEU . 48.3 t -62.71 -70.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -56.15 -40.61 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.92 -46.85 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 110.36 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 46' ' ' VAL . . . -62.35 -36.71 83.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.18 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.974 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -56.91 -35.43 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.074 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -63.57 -27.91 69.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.712 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 tp10 -87.62 -44.35 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.19 -37.28 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.612 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 mmt -57.75 -43.79 98.97 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 59' ' ' MET . 30.8 Cg_endo -65.01 -29.49 57.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.763 1.642 . . . . 0.0 112.062 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HE2' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -70.18 -37.42 75.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.373 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.793 HD11 ' CG2' ' A' ' 44' ' ' VAL . 29.8 mm -77.32 -44.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -43.97 97.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -65.07 -30.69 71.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.7 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.63 -56.87 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.566 HG12 ' SD ' ' A' ' 76' ' ' MET . 26.8 m -72.61 -30.14 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.22 -90.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.405 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.13 71.71 0.24 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 52.4 m -153.52 47.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -110.97 -22.36 11.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.52 2.34 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.475 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -93.55 -35.78 12.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.819 0.343 . . . . 0.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.14 29.98 8.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.42 165.99 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.84 0.353 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.96 2.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.566 ' SD ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 63.76 135.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.917 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.21 169.48 32.65 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.57 155.95 17.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' HG13 ' A' ' 80' ' ' VAL . 97.8 m -135.43 -45.07 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -156.58 164.07 22.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.1 Cg_endo -59.46 130.62 36.48 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.123 1.882 . . . . 0.0 111.668 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.529 HG11 ' HD2' ' A' ' 102' ' ' PHE . 3.6 m -87.58 126.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.889 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 170' ' ' ALA . 16.0 m -119.82 153.14 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.986 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.974 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.62 154.12 33.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 111.591 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -87.18 136.8 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.613 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.897 HG12 HD12 ' A' ' 98' ' ' LEU . 28.8 m -129.47 132.51 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -99.41 100.32 10.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.793 ' HA ' HD23 ' A' ' 94' ' ' LEU . 72.4 Cg_endo -73.99 140.95 29.17 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.515 2.143 . . . . 0.0 112.279 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.11 158.6 17.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.839 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -19.04 61.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.239 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -85.55 -6.07 59.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.44 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.573 ' HA2' HG11 ' A' ' 145' ' ' VAL . . . 96.03 -3.6 64.7 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.018 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -99.98 153.31 19.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 88' ' ' PRO . 58.0 mt -97.42 132.55 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 174.07 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.793 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -80.42 -13.99 58.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.275 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 47' ' ' THR . 0.3 OUTLIER -82.8 123.85 29.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.762 0.315 . . . . 0.0 111.038 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.897 HD12 HG12 ' A' ' 86' ' ' VAL . 2.2 tt -144.05 127.95 17.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 115.9 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.783 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 4.5 p -96.5 139.91 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.445 ' CD2' ' CG2' ' A' ' 43' ' ' THR . 24.9 m95 -116.85 142.37 47.02 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 62.2 t80 -112.51 161.11 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.807 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HG2' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.59 107.92 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.864 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 40' ' ' LYS . 38.1 mt -84.4 137.2 39.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.463 ' HD2' HG23 ' A' ' 104' ' ' ILE . 19.8 Cg_endo -60.32 152.78 64.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.586 2.191 . . . . 0.0 112.388 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 24.5 p-10 -62.07 -26.81 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.259 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -56.76 -42.58 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.279 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -95.87 5.5 51.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.462 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -55.01 -45.93 75.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.739 0.304 . . . . 0.0 111.187 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.06 -26.03 40.7 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.688 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 p -177.09 90.14 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.64 0.257 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 43.9 Cg_endo -68.19 146.72 70.9 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.12 . . . . 0.0 112.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.87 157.4 58.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.497 2.132 . . . . 0.0 111.998 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.95 126.51 92.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HB2' HG11 ' A' ' 120' ' ' VAL . 86.2 Cg_endo -81.23 6.11 5.81 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.642 2.228 . . . . 0.0 113.007 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m 58.12 -177.2 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.781 0.324 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 120' ' ' VAL . 24.0 t0 62.01 117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -20.2 42.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.281 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.6 t -81.07 -31.72 34.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.9 t -85.49 118.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.938 0.399 . . . . 0.0 111.153 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.05 157.21 41.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.0 mm -110.69 112.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -98.9 130.12 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -88.58 91.42 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.36 152.89 39.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.86 166.48 21.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.73 172.29 4.06 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -138.31 143.03 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -108.73 123.22 48.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.515 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 187' ' ' LEU . 13.7 m -131.32 169.76 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.966 0.412 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 7.5 m-85 -107.79 137.14 46.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.82 135.53 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.5 t -128.87 139.08 52.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.0 148.01 41.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.552 ' CZ ' ' ND2' ' A' ' 183' ' ' ASN . 22.4 p90 -172.26 -176.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -99.04 -145.2 18.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.37 163.88 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.539 ' CE1' ' O ' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -109.85 141.81 42.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -125.43 159.34 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.466 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -45.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.686 ' CG ' HD12 ' A' ' 94' ' ' LEU . 32.9 tt0 -167.35 -66.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.485 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.69 73.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.493 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.89 79.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -40.76 98.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 109.909 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.573 HG11 ' HA2' ' A' ' 92' ' ' GLY . 45.6 t -53.85 -38.75 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.707 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -34.73 71.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.778 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 135' ' ' PHE . 4.8 m-70 -70.22 -46.09 65.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.02 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.84 74.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.7 m -70.43 -49.98 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.01 -38.65 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.803 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.71 ' HB3' HD11 ' A' ' 187' ' ' LEU . 12.0 tp -58.48 -39.01 78.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -41.35 89.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -41.02 83.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.458 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.574 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.74 -43.71 85.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.533 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 31' ' ' TYR . 2.6 mt -73.02 -13.24 61.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -47.01 -47.15 22.21 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.71 -33.06 62.36 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.446 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.411 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 26.0 p -94.51 167.75 12.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 110.744 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.411 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 0.9 OUTLIER -83.75 40.46 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.197 2.598 . . . . 0.0 112.695 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.29 170.66 1.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.676 HG22 ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -138.56 163.95 30.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 1.2 m-85 -156.23 175.2 14.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -92.93 -55.34 3.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.03 -74.0 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.399 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -159.66 71.08 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.7 p -160.81 136.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.295 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.476 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.1 p90 -139.61 -177.83 5.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 25.7 m-85 -120.66 156.39 31.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.3 131.0 46.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' OG ' ' A' ' 83' ' ' SER . . . -119.66 130.21 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.31 -71.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.616 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CG ' ' O ' ' A' ' 172' ' ' TYR . 5.2 t80 57.62 41.63 25.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 110.825 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.6 p30 169.35 161.12 0.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.305 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HB2' ' HG3' ' A' ' 178' ' ' PRO . 82.0 Cg_exo -41.4 97.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.58 2.186 . . . . 0.0 112.502 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.539 ' O ' ' CE1' ' A' ' 138' ' ' TYR . 15.1 Cg_exo -68.41 -148.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.935 2.423 . . . . 0.0 112.877 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.401 ' HB3' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER 62.37 -87.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.074 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt 173.15 75.73 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.685 0.279 . . . . 0.0 110.832 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 179' ' ' TYR . 83.9 Cg_endo -80.42 -40.28 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.664 2.242 . . . . 0.0 111.751 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 178' ' ' PRO . 54.0 p90 -149.54 -45.3 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 179' ' ' TYR . . . -165.52 44.99 0.28 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.431 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.66 165.26 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -142.1 159.46 42.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.875 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.552 ' ND2' ' CZ ' ' A' ' 135' ' ' PHE . 8.7 p-10 -119.9 133.84 55.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.781 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -146.26 147.4 31.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.225 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 167' ' ' TYR . 17.3 t -118.84 129.73 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.441 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' HB3' HG21 ' A' ' 130' ' ' VAL . 46.0 m0 -107.9 121.56 45.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.735 ' O ' HG12 ' A' ' 130' ' ' VAL . 73.4 mt -97.33 139.96 32.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 38.4 t -74.94 128.92 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -100.63 125.91 47.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.676 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 mtm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.793 0.33 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.81 -73.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.994 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.8 -148.47 27.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.607 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 168.72 19.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.856 0.36 . . . . 0.0 110.779 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 tt -167.73 47.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.94 122.59 48.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.819 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -128.56 169.16 14.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -68.82 130.65 43.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.5 -38.08 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.17 84.69 7.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.97 -116.53 1.06 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.467 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -75.79 125.05 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.89 141.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.41 143.56 49.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 t -115.46 131.06 57.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -106.58 162.94 18.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -167.99 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 112.351 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -52.71 99.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -129.55 112.91 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.039 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.09 112.86 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.37 -7.15 39.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.725 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.4 167.17 8.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.388 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 p -151.64 -178.59 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.761 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.19 -104.04 0.97 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.44 -94.8 0.55 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.683 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -160.43 163.03 33.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 0.0 110.791 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -66.44 -30.56 70.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.033 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.61 -35.23 15.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 150' ' ' GLN . 3.5 m -146.27 115.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.384 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -95.98 145.2 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -140.92 162.26 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 127.27 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.562 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.433 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 17.2 mt-10 -85.86 126.3 33.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 129' ' ' THR . 8.3 ptp180 -142.03 128.04 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.62 122.16 47.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.7 p -132.14 149.96 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -71.66 -63.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.38 -77.85 1.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.45 -89.78 1.12 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 11.0 mptt -114.67 146.28 41.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -137.63 140.17 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.75 115.9 28.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.115 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.3 p -112.77 155.48 24.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 112.004 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.6 t -136.7 125.9 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -96.07 130.35 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.402 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.0 t -138.27 116.72 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.58 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.89 32.15 2.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -153.15 127.57 4.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.24 -169.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.476 2.117 . . . . 0.0 112.224 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.806 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.9 t -72.5 -53.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.211 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.89 -43.68 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.03 -46.17 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.91 -41.28 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.703 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.0 mt -57.46 -35.57 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -62.92 -35.12 79.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.927 0.394 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 tp10 -87.49 -28.29 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.388 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.783 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.33 -45.17 56.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.679 ' CE ' HG11 ' A' ' 82' ' ' VAL . 34.1 mmt -57.61 -43.46 98.86 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.0 Cg_exo -57.96 -41.55 67.48 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.07 1.847 . . . . 0.0 112.067 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -70.29 -45.5 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.351 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.1 tt -75.59 -27.84 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.418 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -38.67 88.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.907 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -69.24 -56.38 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.41 -29.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.11 -124.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.622 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.17 48.01 0.98 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -142.94 62.54 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -108.99 -24.12 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 79.31 -3.47 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.668 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 -40.56 10.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.84 67.6 1.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.45 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.519 HG21 ' HG3' ' A' ' 113' ' ' PRO . 25.4 m -138.88 -179.45 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.81 117.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.388 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 1.3 mtm -112.73 -161.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.32 -37.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 63.18 120.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.046 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.537 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -60.3 167.86 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.633 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.541 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 13.5 t -87.25 -48.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.404 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 66.7 Cg_endo -91.42 130.38 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.512 2.141 . . . . 0.0 112.528 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' CE ' ' A' ' 59' ' ' MET . 34.4 t -92.86 152.31 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.01 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.6 p -125.1 145.93 49.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.664 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.703 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -132.93 153.99 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.937 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 99' ' ' LYS . . . -95.04 136.67 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 HD12 ' A' ' 98' ' ' LEU . 27.7 m -131.34 126.83 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 166' ' ' VAL . 43.3 m-85 -97.8 99.62 7.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 122.35 9.43 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.39 2.06 . . . . 0.0 112.105 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -89.74 170.81 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.35 -15.81 62.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -0.1 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.23 67.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.887 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.5 p -122.82 160.12 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.518 HD12 ' HG3' ' A' ' 141' ' ' GLU . 5.8 mt -79.09 160.42 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 44.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 52.5 28.36 5.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.326 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -117.49 99.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.806 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.5 tt -127.56 127.73 44.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.978 0.418 . . . . 0.0 111.48 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 85' ' ' ALA . 11.3 ptmt -117.58 116.62 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.469 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.783 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -66.79 141.47 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -120.37 119.17 32.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 61.6 t80 -106.02 153.78 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -112.77 121.83 45.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 105' ' ' PRO . 33.5 mt -96.91 136.75 21.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.6 154.1 56.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.555 2.17 . . . . 0.0 112.357 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.57 -26.85 65.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -56.94 -45.22 82.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.041 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 64.3 m-85 -94.62 -9.79 33.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.395 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.46 -37.4 62.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.11 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -28.88 72.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -171.66 75.93 0.5 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.769 0.319 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.9 Cg_exo -57.05 154.58 32.57 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.533 2.155 . . . . 0.0 112.355 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG3' HG21 ' A' ' 74' ' ' VAL . 5.6 Cg_exo -74.31 152.14 44.08 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.685 2.257 . . . . 0.0 112.094 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.35 93.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.44 135.82 22.9 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.316 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -91.45 50.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.028 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -162.2 118.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.93 -21.75 45.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.193 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 p -81.71 -31.67 32.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.1 t -85.78 122.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.968 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -124.84 152.57 43.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.7 mm -105.09 117.62 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.82 137.06 37.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 104.5 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -169.07 73.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.938 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 30.9 tt0 82.23 139.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.065 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -70.34 -179.96 27.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.241 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.05 142.9 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 111.433 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 5.6 m -112.75 126.74 55.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.331 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 188' ' ' VAL . 22.8 m -133.96 157.49 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 111.54 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' A' ' 155' ' ' LEU . 12.0 m-85 -107.72 141.8 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.7 p -111.91 126.99 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.882 0.372 . . . . 0.0 111.136 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.7 t -123.69 138.82 54.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -116.83 143.68 45.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CE2' ' CD2' ' A' ' 147' ' ' HIS . 12.8 p90 -142.15 -44.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.26 109.47 0.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.1 -137.04 2.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CE1' ' HG2' ' A' ' 175' ' ' PRO . 41.6 m-85 -145.56 92.35 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.89 136.02 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -105.04 -48.44 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.518 ' HG3' HD12 ' A' ' 94' ' ' LEU . 1.6 tm-20 -166.24 -68.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.694 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.82 67.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -67.98 -34.98 77.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.1 -40.48 96.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 109.998 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.72 -38.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.541 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.1 73.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.761 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.625 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 26.0 m80 -70.02 -41.42 74.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.761 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.85 73.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.4 m -63.02 -42.62 99.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.708 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB3' HG11 ' A' ' 29' ' ' VAL . 57.4 mm-40 -59.07 -45.94 89.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.593 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.9 tp -61.51 -39.68 91.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.25 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -59.12 -36.32 75.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.271 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -46.2 68.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -49.11 77.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.789 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 131' ' ' TYR . 11.5 mt -74.02 -9.12 58.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.431 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -47.55 -43.24 24.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.261 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.4 -15.08 77.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.762 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 p -93.65 169.23 10.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.003 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 7.9 Cg_exo -72.78 0.58 7.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.046 2.498 . . . . 0.0 112.913 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.12 121.91 11.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.204 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 1.1 m -101.38 -2.21 31.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.115 0.483 . . . . 0.0 111.077 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 50.92 16.26 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.054 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.649 ' H ' ' HB2' ' A' ' 190' ' ' ALA . 1.0 OUTLIER 65.11 -75.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.162 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.58 -78.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.74 68.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 166' ' ' VAL . 11.0 p -161.91 122.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.632 ' HB3' HD23 ' A' ' 187' ' ' LEU . 37.0 p90 -132.91 170.21 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.858 ' CE2' HG22 ' A' ' 188' ' ' VAL . 18.5 m-85 -112.74 157.16 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' CYS . . . . . 0.44 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.7 m -133.56 130.95 39.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.27 52.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.84 -153.69 15.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -141.52 -174.83 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.83 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.26 153.64 9.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.421 ' HA ' ' HD2' ' A' ' 175' ' ' PRO . 58.2 Cg_endo -71.19 108.14 2.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.776 2.317 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.461 ' HG2' ' CE1' ' A' ' 138' ' ' TYR . 23.0 Cg_endo -62.97 -165.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.318 2.012 . . . . 0.0 112.586 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.5 mmm -129.65 -45.18 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 108.71 36.06 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -165.77 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.44 2.093 . . . . 0.0 112.167 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 61.68 28.7 17.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.33 33.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -133.05 166.86 21.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.29 . . . . 0.0 110.724 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -142.15 126.29 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.943 0.401 . . . . 0.0 111.408 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -132.94 133.9 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.33 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.88 157.11 43.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.732 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.44 HG13 ' SG ' ' A' ' 169' ' ' CYS . 39.0 t -124.55 139.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.48 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.677 ' CE3' HG21 ' A' ' 130' ' ' VAL . 24.9 m0 -107.62 121.49 44.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.086 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.632 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.2 mt -98.75 133.41 43.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.743 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 168' ' ' TYR . 25.7 t -75.8 118.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.05 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -79.95 147.25 31.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.277 -0.868 . . . . 1.0 111.098 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.37 116.79 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -134.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mmt -130.02 122.39 28.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.26 -58.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.39 123.18 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -105.01 133.61 49.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.04 128.9 35.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -168.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -85.5 -82.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.5 -137.44 30.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.722 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -91.24 127.38 36.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.74 144.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -140.97 135.89 31.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 t -83.91 133.59 34.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -150.64 146.73 19.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.413 ' HB2' ' CE3' ' A' ' 18' ' ' TRP . 58.1 Cg_endo -71.57 -45.36 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.434 2.09 . . . . 0.0 112.299 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.413 ' CE3' ' HB2' ' A' ' 17' ' ' PRO . 6.3 p90 -165.0 166.43 19.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -125.47 109.69 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.03 115.15 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.14 -16.24 20.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.417 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 t -169.72 167.05 9.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -151.86 -175.82 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.72 -173.2 47.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 172.44 -93.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.608 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' VAL . 1.2 mtmm -161.28 166.39 27.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.849 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -66.62 -31.66 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.294 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -31.33 17.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.278 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.7 t -146.03 142.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -134.74 148.82 50.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.724 ' CD2' HD21 ' A' ' 155' ' ' LEU . 1.9 p90 -139.17 162.2 35.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.31 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 23' ' ' THR . 4.5 mt-10 -144.54 122.27 11.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -85.98 118.37 25.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.994 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.07 127.93 35.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.58 128.2 55.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.3 p -100.19 158.93 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -60.2 -52.08 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.96 -158.05 22.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.86 -173.29 20.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 104' ' ' ILE . 25.3 mttt -98.49 149.8 22.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -137.65 153.93 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -93.96 140.03 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.592 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -112.46 143.55 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.08 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.758 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.1 t -132.17 125.32 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.65 140.09 36.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.2 t -138.42 123.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.313 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 167.04 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 t0 51.2 33.91 10.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.413 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.6 128.5 5.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.711 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.46 -69.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.357 2.038 . . . . 0.0 112.585 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 98' ' ' LEU . 48.4 t -156.12 -66.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.82 0.343 . . . . 0.0 111.287 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.91 -45.08 78.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.09 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.6 -42.7 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.852 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.95 -44.01 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.916 HD11 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.97 -35.41 69.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -62.48 -33.44 74.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -87.73 -29.29 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.158 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' CA ' HG11 ' A' ' 44' ' ' VAL . . . -73.51 -43.47 59.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.726 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -57.6 -43.87 99.14 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.3 Cg_exo -60.22 -37.33 83.83 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.176 1.918 . . . . 0.0 111.784 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -70.38 -44.9 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -76.13 -28.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.211 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.13 74.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.662 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.8 ttmt -65.43 -39.82 92.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.658 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.82 -57.9 7.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' CE2' ' A' ' 102' ' ' PHE . 28.6 m -67.06 -29.61 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -137.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.84 35.26 4.89 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 69' ' ' THR . 32.5 m -125.09 32.72 5.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 5.5 p30 -88.25 -16.58 32.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.278 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 1.5 m-20 82.44 -9.25 1.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -93.04 -36.74 12.55 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.75 43.17 6.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.02 163.56 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.75 58.2 0.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -74.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.967 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.95 -118.08 4.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.61 118.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.344 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -67.93 145.51 54.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 16.8 t -67.57 -53.52 22.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.466 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 69.9 Cg_endo -73.54 146.94 40.01 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.209 1.939 . . . . 0.0 112.183 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 59' ' ' MET . 45.4 t -153.54 125.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 t -114.98 145.98 41.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.038 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CE2' HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -128.59 149.31 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.764 0.316 . . . . 0.0 111.636 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.787 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -88.22 136.81 32.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.523 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.764 HG12 HD12 ' A' ' 98' ' ' LEU . 34.3 m -125.47 139.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.216 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 2.4 m-85 -108.99 103.92 53.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.029 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 94' ' ' LEU . 53.3 Cg_endo -69.36 137.65 37.13 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.397 2.065 . . . . 0.0 112.243 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -89.88 171.98 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.036 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.04 -15.88 62.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.394 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.49 -1.07 55.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.491 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.03 -6.77 82.68 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.867 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 m -119.74 171.5 8.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.937 0.398 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.2 OUTLIER -112.27 96.88 6.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -95.0 102.23 14.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.77 86.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.597 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 175.5 81.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.922 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.9 tt -144.1 135.56 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 111.493 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.48 115.63 20.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.758 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 6.0 p -91.74 136.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.123 0.487 . . . . 0.0 111.888 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 24.7 m95 -110.58 142.27 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.81 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 66' ' ' VAL . 32.7 t80 -105.78 145.54 31.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 102' ' ' PHE . 7.1 ttt180 -95.66 113.62 25.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 40' ' ' LYS . 35.9 mt -90.75 136.65 27.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.38 153.99 56.26 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.532 2.155 . . . . 0.0 112.238 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 t30 -57.65 -26.88 62.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.268 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.85 -47.11 81.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.431 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -90.25 1.31 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -54.78 -39.75 68.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 111.041 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.58 -34.06 68.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.609 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.6 p -178.35 93.53 0.22 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.83 161.07 10.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.567 2.178 . . . . 0.0 112.179 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.71 155.85 61.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.255 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 112.33 9.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.0 158.34 14.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.355 2.036 . . . . 0.0 112.292 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -116.12 -37.77 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 120' ' ' VAL . 1.4 t70 -74.01 125.81 29.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -24.5 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 -30.67 31.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 117' ' ' ASP . 33.6 t -85.32 115.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 157.02 38.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 124.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 133.81 45.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -88.47 130.74 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -132.06 22.52 4.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ARG . 2.5 pt-20 30.28 42.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.79 159.87 3.24 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -142.19 146.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.219 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.1 m -103.94 120.29 40.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -138.9 163.26 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.321 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 151' ' ' LEU . 11.0 m-85 -107.76 128.44 54.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 m -105.82 135.69 46.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -129.56 139.1 51.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.756 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -116.91 153.83 31.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.37 -177.96 6.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.54 93.03 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.541 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 177.2 149.96 8.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 177.98 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.335 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.86 156.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -133.34 -72.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -152.4 -46.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.775 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -71.85 -33.83 68.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.58 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.5 -35.03 78.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.874 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.23 -40.82 98.53 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.999 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.3 t -53.83 -38.58 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.561 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.27 -34.78 73.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.554 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.669 ' HB2' HG21 ' A' ' 185' ' ' VAL . 24.5 m170 -70.18 -42.87 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.88 -32.92 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.759 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 m -72.22 -41.59 66.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.35 -43.34 92.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.712 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' TYR . 18.4 tp -59.04 -44.6 91.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.555 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -46.76 88.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.302 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -46.21 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.55 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.63 -45.86 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.629 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.724 HD21 ' CD2' ' A' ' 31' ' ' TYR . 48.0 mt -73.26 -9.92 59.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.329 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.58 -42.06 22.97 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.048 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.09 -27.11 71.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 6.9 p -93.98 163.55 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.595 0.236 . . . . 0.0 110.643 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 85.0 Cg_endo -82.92 20.08 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.72 2.28 . . . . 0.0 112.967 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.96 148.14 31.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.091 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.549 HG21 ' OXT' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -101.19 176.57 5.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.51 158.2 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.39 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.27 -36.05 14.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.48 49.29 74.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -158.42 -42.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 111.122 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.0 p -160.12 137.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.264 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 86' ' ' VAL . 6.4 p90 -129.21 172.18 11.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.787 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 51.9 m-85 -112.98 155.42 24.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.26 149.26 41.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -118.89 125.59 49.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -122.64 -4.1 9.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.896 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 62.8 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.771 0.32 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -123.3 136.76 27.43 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.74 164.52 7.58 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 112.386 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.73 118.91 5.87 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.672 2.248 . . . . 0.0 112.215 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -176.98 -46.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -106.83 92.57 7.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.06 168.62 21.42 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.486 2.124 . . . . 0.0 112.127 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 60.18 75.54 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.72 42.95 0.16 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.559 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.31 156.35 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.28 124.01 22.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -120.82 135.25 55.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -143.81 154.16 43.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' A' ' 147' ' ' HIS . 25.2 t -124.6 129.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.43 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.2 m0 -107.89 121.61 45.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.917 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 130' ' ' VAL . 14.2 mt -94.13 134.93 36.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 130' ' ' VAL . 25.5 t -81.22 120.38 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -88.67 115.12 25.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.549 ' OXT' HG21 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.187 -0.911 . . . . 1.0 111.145 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.62 156.69 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 110.45 0.23 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.545 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.48 131.89 43.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -138.86 27.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -115.02 107.96 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -126.44 141.56 51.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.1 t -85.64 156.5 20.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -99.86 105.07 16.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.74 116.31 30.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.39 -97.27 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -101.37 125.87 48.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.982 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.72 130.55 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -136.05 124.85 23.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.8 p -116.06 129.13 56.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.767 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 4.8 t-105 -69.7 -51.8 15.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 16' ' ' TRP . 66.6 Cg_endo -85.92 -171.46 0.87 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.655 2.236 . . . . 0.0 112.37 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -107.26 139.86 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -120.81 108.0 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 ' HD3' ' A' ' 34' ' ' ARG . 40.4 t -74.54 112.95 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.461 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 mt -93.99 -17.61 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.4 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -169.96 162.1 9.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -151.99 179.43 8.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 135.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.423 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' CA ' ' CE1' ' A' ' 31' ' ' TYR . . . -145.11 -149.62 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.443 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 158.97 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.947 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -29.38 69.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.9 -32.36 16.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.09 110.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.4 155.61 16.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.58 156.85 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -147.04 124.38 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.765 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -86.2 117.39 24.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.696 ' HD3' HG22 ' A' ' 20' ' ' VAL . 2.9 mmm-85 -139.26 128.66 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 109.72 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 p -151.23 85.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.03 167.85 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.28 110.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.94 -154.54 25.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.459 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' ILE . 14.5 mttt -104.72 150.86 24.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 3.6 m-85 -137.71 163.46 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.013 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.52 140.37 29.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.503 HG21 ' HE2' ' A' ' 99' ' ' LYS . 41.0 p -131.07 132.09 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.833 -179.133 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 120' ' ' VAL . 63.2 t -130.88 125.39 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.212 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.12 138.76 33.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 111.418 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 54' ' ' ALA . 4.1 t -138.5 116.96 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.79 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.78 168.35 9.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.33 31.11 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG12 ' A' ' 46' ' ' VAL . 31.4 mtmt -153.28 117.77 2.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.997 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.28 -173.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.467 2.111 . . . . 0.0 112.137 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 98' ' ' LEU . 61.3 t -61.28 -57.6 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -59.29 -45.23 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.16 -46.44 74.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.62 -45.06 93.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.802 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.3 mt -58.85 -35.17 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -62.06 -30.7 71.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.042 0.449 . . . . 0.0 109.906 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.0 tp10 -86.79 -37.51 17.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.161 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.68 -29.97 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.462 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.617 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 5.2 mmt -57.43 -43.63 99.12 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 59' ' ' MET . 33.3 Cg_endo -64.69 -47.35 5.46 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.635 1.557 . . . . 0.0 111.835 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -70.47 -32.81 70.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.704 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.612 HD11 HG23 ' A' ' 44' ' ' VAL . 16.9 mm -77.1 -43.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.424 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.09 -45.3 81.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.735 179.778 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -59.98 -29.83 68.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 37.0 t80 -58.54 -41.36 85.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.806 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.536 HG11 ' CE2' ' A' ' 102' ' ' PHE . 14.2 m -85.61 -30.65 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.75 -105.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.46 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.62 67.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -155.49 52.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 4.6 p30 -110.96 -15.3 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.179 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 2.5 t70 83.63 -13.86 0.73 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.607 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 4.9 53.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.29 32.93 5.41 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.448 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 113' ' ' PRO . 3.1 p -96.83 155.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.688 -0.756 . . . . 0.0 111.821 -177.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.79 108.51 1.77 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.185 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -104.72 -77.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.356 . . . . 0.0 111.072 -179.706 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 -144.81 16.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.33 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.45 128.59 37.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 80' ' ' VAL . 5.6 m -139.0 119.86 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.525 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.72 137.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.938 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 80' ' ' VAL . 17.8 Cg_endo -59.86 143.7 99.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.334 2.023 . . . . 0.0 112.16 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.71 137.53 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.414 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.69 157.27 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.802 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.99 154.15 32.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.19 136.61 33.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.094 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.57 HG12 HG22 ' A' ' 51' ' ' VAL . 5.9 m -125.85 92.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.175 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 166' ' ' VAL . 17.1 m-85 -70.75 112.24 12.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.95 167.24 9.69 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.682 2.255 . . . . 0.0 112.419 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.36 172.19 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.78 -21.34 18.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.315 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.14 -6.14 59.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 -16.06 61.96 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.95 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -84.44 165.17 18.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.971 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 ' OH ' ' A' ' 167' ' ' TYR . 54.8 mt -90.85 167.17 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.56 81.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 50.77 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.346 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 68.57 104.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' CD2' ' A' ' 84' ' ' PHE . 2.3 tt -140.67 127.97 21.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HE2' HG21 ' A' ' 43' ' ' THR . 1.3 tttt -109.48 116.05 31.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.716 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -77.58 141.09 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.231 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -122.08 128.38 51.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.793 179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CE2' HG11 ' A' ' 66' ' ' VAL . 36.7 t80 -113.05 130.93 55.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 -83.9 115.18 22.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 40' ' ' LYS . 30.3 mt -97.77 139.26 21.22 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 154.06 25.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.391 2.061 . . . . 0.0 112.361 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.26 -26.89 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -32.95 70.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.423 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 19.5 m-85 -93.16 -17.71 23.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.517 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -33.65 53.21 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.67 -30.11 62.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.95 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 m -150.53 77.42 8.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.572 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 36.2 Cg_endo -65.37 149.23 88.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.602 2.202 . . . . 0.0 112.161 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HB3' HG11 ' A' ' 74' ' ' VAL . 12.5 Cg_exo -70.86 158.94 54.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.634 2.223 . . . . 0.0 112.116 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 70' ' ' ASN . . . -67.7 136.58 92.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 59.6 Cg_endo -72.52 -20.15 23.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.436 2.091 . . . . 0.0 112.41 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.73 -67.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.04 125.88 25.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.69 -22.53 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 p -81.86 -32.68 31.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 44' ' ' VAL . 31.3 t -85.36 116.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.2 156.58 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.38 116.08 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -98.82 144.84 27.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -89.43 51.64 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -76.12 120.45 21.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 177.16 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.97 156.69 23.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 pt -143.93 154.02 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -107.86 126.66 52.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.8 m -135.33 159.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.401 ' CD2' HD21 ' A' ' 155' ' ' LEU . 11.0 m-85 -107.7 129.45 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 p -105.92 128.84 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 0.0 111.061 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.9 t -129.7 139.19 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -116.9 147.83 41.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 1.0 OUTLIER -137.59 -57.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.88 -109.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.655 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . 175.02 78.37 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -176.84 106.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.46 134.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.277 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -106.53 -38.69 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.741 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.414 ' HG2' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -176.18 -61.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.85 71.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.63 -34.91 76.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.939 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.7 OUTLIER -63.44 -39.04 93.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.579 0.704 . . . . 0.0 110.131 179.138 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 94' ' ' LEU . 48.7 t -53.66 -38.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.87 75.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 185' ' ' VAL . 13.7 m170 -70.35 -44.11 68.83 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.07 -32.9 72.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -68.57 -42.74 77.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.863 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -61.97 -46.05 90.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 151' ' ' LEU . 12.1 tp -59.2 -41.57 88.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.623 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -59.61 -47.73 84.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.268 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 95.3 m -62.48 -45.56 92.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 31' ' ' TYR . 17.1 m -57.61 -38.92 75.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.401 HD21 ' CD2' ' A' ' 131' ' ' TYR . 92.1 mt -74.02 -16.5 61.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 153' ' ' THR . 8.2 pt-20 -48.69 -28.41 3.54 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.792 0.33 . . . . 0.0 111.331 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.89 -17.94 62.34 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.583 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -92.51 170.97 8.18 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.607 0.241 . . . . 0.0 110.801 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.4 Cg_endo -80.95 14.26 2.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.651 2.234 . . . . 0.0 113.151 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.72 132.43 53.83 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.707 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 69.3 m -102.06 -2.29 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.488 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 59.5 m-85 57.44 124.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.39 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.454 ' HG3' HG12 ' A' ' 188' ' ' VAL . 1.3 mm-40 -66.94 -173.92 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.89 61.88 0.94 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.877 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.35 70.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.438 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.3 p -161.9 119.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.244 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.816 ' HB3' HD23 ' A' ' 187' ' ' LEU . 3.7 p90 -133.55 177.17 7.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.754 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 186' ' ' TRP . 13.5 m-85 -126.27 151.07 47.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.084 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 71.2 m -140.07 153.53 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.05 55.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.49 154.85 11.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.473 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -153.66 161.87 41.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.6 143.92 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.88 169.31 22.46 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.567 2.178 . . . . 0.0 112.34 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.44 110.85 2.96 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.658 2.238 . . . . 0.0 112.334 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -150.07 -70.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -79.8 111.35 20.76 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 177' ' ' LYS . 23.4 Cg_exo -65.72 146.62 84.36 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.692 2.261 . . . . 0.0 112.09 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.12 76.49 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -138.29 -65.81 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.462 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -122.87 160.69 25.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.29 146.49 35.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 2.1 m120 -109.41 135.51 50.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.0 147.93 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 147' ' ' HIS . 24.2 t -128.84 116.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.89 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.56 121.88 43.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.984 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 167' ' ' TYR . 13.0 mt -91.09 140.06 30.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.855 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.8 t -79.15 120.43 30.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -65.53 153.57 41.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 2.7 tp60 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.803 0.335 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -73.81 113.68 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.36 -6.29 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 t -169.86 167.23 9.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.29 -176.6 5.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 125.51 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -128.91 -101.03 0.99 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.705 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -161.06 160.62 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -66.89 -29.7 69.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -35.49 15.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.3 107.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.28 137.81 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.8 p90 -138.93 162.23 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -145.18 137.18 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.728 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.96 114.88 23.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -131.75 128.0 37.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -106.92 124.85 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.7 m -106.4 134.79 48.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.98 110.87 11.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.58 -143.67 6.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.36 -60.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -130.01 145.57 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -138.25 154.36 49.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.77 118.72 31.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.0 p -112.46 132.01 55.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.29 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' ILE . 39.5 t -125.76 125.11 67.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.92 137.65 35.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 54' ' ' ALA . 14.8 t -138.61 116.58 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 170.49 7.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 47.4 31.41 1.88 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.395 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -152.65 132.36 7.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 35.2 Cg_exo -57.7 -157.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.481 2.121 . . . . 0.0 112.161 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.927 HG13 ' CD1' ' A' ' 98' ' ' LEU . 69.6 t -84.52 -57.56 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.1 -43.38 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.14 -45.49 76.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.63 -45.14 89.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.1 mt -57.24 -34.99 69.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -63.31 -33.19 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 109.904 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 12.5 tp10 -87.94 -31.73 19.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.282 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -74.94 -40.41 60.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.444 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' ILE . 10.8 mmt -57.36 -45.16 99.92 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.1 Cg_exo -58.06 -45.13 33.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.263 1.975 . . . . 0.0 112.145 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -70.32 -41.76 72.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.461 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 44' ' ' VAL . 3.2 tt -76.53 -31.9 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.476 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -66.45 -42.1 88.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HD3' HG21 ' A' ' 69' ' ' THR . 15.5 mttp -60.09 -33.25 71.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -68.77 -41.99 78.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.0 m -81.31 -30.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.15 -103.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.14 69.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.525 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 69' ' ' THR . 90.0 m -164.27 63.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.76 5.23 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.459 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 46.97 9.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -148.24 -46.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 37.16 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.457 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 113' ' ' PRO . 26.8 m -100.23 160.1 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.68 75.11 0.3 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 mtp -74.26 -55.46 6.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.851 0.358 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -93.26 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.51 172.41 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 m -164.0 110.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 49.79 166.1 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.673 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD2' HG12 ' A' ' 80' ' ' VAL . 21.0 Cg_endo -61.7 149.32 90.4 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.981 . . . . 0.0 112.25 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.431 HG21 ' HE1' ' A' ' 59' ' ' MET . 1.3 t -86.18 153.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -120.22 145.84 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.491 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -124.6 154.44 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.52 136.25 36.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.315 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 167' ' ' TYR . 3.8 m -128.09 129.93 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -102.47 95.78 6.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' CE1' ' A' ' 167' ' ' TYR . 61.7 Cg_endo -73.0 134.73 21.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.222 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.94 170.32 10.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -17.51 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.245 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -6.22 59.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.737 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.89 -1.71 85.3 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.89 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -121.75 136.88 54.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.813 0.34 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.578 HD12 ' CG ' ' A' ' 141' ' ' GLU . 35.0 mt -59.1 171.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.52 47.63 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 54.94 83.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -178.22 109.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.927 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.9 tt -144.11 138.25 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.23 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 5.3 tttp -119.62 115.76 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.437 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -81.69 117.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.564 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -98.73 132.16 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.542 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.755 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.3 t80 -114.01 136.08 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.46 107.88 19.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.421 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.1 mt -83.71 136.16 42.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.0 Cg_endo -64.96 154.23 74.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.497 2.131 . . . . 0.0 112.322 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -53.95 -27.65 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -58.84 -45.53 89.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -98.71 -15.07 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.273 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -36.03 60.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.804 0.335 . . . . 0.0 111.109 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.4 -33.2 76.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.64 75.39 2.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.722 0.296 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.1 Cg_exo -57.1 159.72 14.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.583 2.189 . . . . 0.0 112.275 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.74 148.26 58.3 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.69 2.26 . . . . 0.0 112.011 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.44 112.36 9.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.95 144.63 35.66 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.352 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -103.76 -31.18 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' HG23 ' A' ' 120' ' ' VAL . 3.1 m-20 -80.94 122.03 26.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.83 -23.79 54.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 m -81.98 -28.54 32.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 117' ' ' ASP . 27.7 t -85.19 115.58 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -121.72 149.81 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.7 mm -113.04 126.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.85 129.11 45.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 144.13 25.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER 56.0 173.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.119 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 15.4 tp10 86.71 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.3 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -91.31 158.66 25.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.015 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -128.29 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 35' ' ' ALA . 48.7 m -122.2 119.02 30.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.292 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 187' ' ' LEU . 35.1 m -134.11 165.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.723 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -107.5 136.4 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.13 179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -105.69 141.17 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.073 0.463 . . . . 0.0 111.37 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.3 t -130.33 139.64 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.586 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -116.31 124.98 51.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.97 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 14.3 p90 -131.78 165.13 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.17 79.55 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.19 175.62 43.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.36 164.28 13.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.792 0.329 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -169.72 120.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.207 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -105.87 -65.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.81 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.578 ' CG ' HD12 ' A' ' 94' ' ' LEU . 7.5 tt0 -146.73 -70.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.5 70.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.65 -34.97 78.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.29 -40.45 95.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.437 0.637 . . . . 0.0 109.98 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.737 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -52.95 -38.26 28.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.658 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.67 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.647 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.5 m-70 -70.09 -42.39 72.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.757 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.56 -32.94 73.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -68.41 -40.38 81.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -60.05 -46.11 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 31' ' ' TYR . 8.1 tp -58.71 -42.19 88.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.47 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.3 m -63.02 -41.58 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.417 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 31' ' ' TYR . 6.6 m -57.29 -49.14 77.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.705 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 0.8 OUTLIER -73.67 -10.24 59.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.296 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -46.83 -35.47 6.35 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.17 31.13 7.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.8 p -145.83 165.13 22.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 -2.81 12.29 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.909 2.406 . . . . 0.0 112.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.5 124.6 19.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -102.22 175.68 5.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.648 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -157.45 -177.13 6.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.817 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -79.3 -76.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.2 -18.07 2.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.076 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -158.01 27.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.925 0.362 . . . . 0.0 111.613 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -161.95 132.59 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.486 ' HA ' HG23 ' A' ' 188' ' ' VAL . 27.7 p90 -149.73 168.17 24.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.656 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 98.3 m-85 -112.82 155.24 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.152 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 185' ' ' VAL . 1.3 m -132.79 154.0 50.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.02 136.31 47.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.791 0.329 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -108.86 134.09 52.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -138.26 143.1 39.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.7 t -123.2 121.88 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.619 ' CZ2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.056 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.736 ' O ' HG12 ' A' ' 130' ' ' VAL . 10.6 mt -91.17 139.97 30.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.561 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' CE2' ' A' ' 168' ' ' TYR . 15.2 t -74.61 118.69 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -76.83 127.83 33.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.226 -0.892 . . . . 1.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.81 0.338 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.3 115.26 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -96.44 0.13 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -170.35 161.27 8.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -152.37 -45.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.48 136.41 49.27 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -136.9 175.45 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.542 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 161.09 27.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.341 . . . . 0.0 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -66.56 -32.84 74.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.7 -35.05 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 29' ' ' VAL . 6.9 m -146.07 110.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.054 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -95.51 154.85 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.1 p90 -139.39 158.31 44.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -145.14 121.89 11.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.92 131.23 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -139.91 130.65 25.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.29 120.17 40.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 m -131.98 136.41 47.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -114.75 77.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.39 -161.92 2.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.525 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.28 -86.39 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -113.28 149.17 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.886 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -137.61 156.99 47.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.93 140.28 29.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.53 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 24.9 p -135.67 131.87 36.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.975 0.417 . . . . 0.0 111.5 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 120' ' ' VAL . 39.8 t -128.01 125.41 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.436 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.99 136.0 38.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.4 116.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.778 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 168.17 9.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.88 33.06 3.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.526 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -153.2 121.65 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.89 -161.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.502 2.135 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 141' ' ' GLU . 28.7 t -74.21 -58.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 -44.98 82.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.212 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.13 -46.0 75.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.26 89.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.634 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -32.52 74.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 tp10 -87.57 -40.36 14.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.15 -37.57 66.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 11.9 mmt -57.78 -44.12 99.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' MET . 49.3 Cg_endo -70.35 -36.67 8.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -70.09 -43.28 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 44' ' ' VAL . 5.2 tt -77.08 -26.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -39.26 90.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -59.19 -31.06 68.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.23 -49.18 46.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.1 m -75.31 -30.82 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.188 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.89 -99.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.25 35.7 0.76 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 69' ' ' THR . 21.0 m -119.67 30.27 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 110.929 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.774 HD21 HG22 ' A' ' 74' ' ' VAL . 40.7 p-10 -88.9 -14.43 36.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 78.67 -1.68 2.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -93.78 -44.25 8.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.848 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.62 39.45 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 70' ' ' ASN . 27.0 m -100.27 -178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 88.14 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -83.21 -45.87 13.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.14 -82.55 1.54 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.87 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.794 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.14 -164.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.96 156.42 2.59 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.264 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.99 135.21 61.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 112.17 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 102' ' ' PHE . 25.4 m -86.0 145.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.343 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.454 ' HG ' ' HH2' ' A' ' 186' ' ' TRP . 1.1 p -115.49 174.01 6.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.654 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -127.51 154.46 45.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.38 136.73 32.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.435 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.0 m -131.85 109.25 15.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CD2' HG23 ' A' ' 166' ' ' VAL . 11.9 m-85 -83.95 111.32 31.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.4 Cg_endo -80.67 127.87 6.57 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.162 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 164.21 14.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.41 -15.74 62.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.361 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -5.95 59.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.523 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.512 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 96.59 -2.06 62.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.08 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -121.41 -169.85 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 141' ' ' GLU . 88.4 mt -105.81 169.52 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.714 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.31 34.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.142 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp 51.08 26.7 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.11 122.29 31.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 84' ' ' PHE . 1.1 tt -133.84 139.99 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 111.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.4 mtpt -118.06 115.75 25.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.133 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.9 t -78.77 116.72 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.764 0.316 . . . . 0.0 111.252 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -97.23 142.12 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.773 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.71 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 20.4 t80 -127.11 148.81 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.987 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -105.82 110.4 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.91 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -75.69 130.39 79.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.41 154.06 20.62 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.461 2.107 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -27.07 65.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -64.74 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 74' ' ' VAL . 4.9 m-85 -108.16 -2.95 19.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.677 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -33.68 57.63 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.721 0.296 . . . . 0.0 111.23 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.09 -33.97 75.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.79 89.44 0.7 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.276 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 23.5 Cg_exo -63.23 160.2 35.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 112.251 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.93 153.29 63.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.597 2.198 . . . . 0.0 111.919 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 110.84 5.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 132.36 40.27 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 0.0 112.061 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 t -94.99 46.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.668 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -149.31 112.72 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.98 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.01 -23.54 54.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -82.17 -30.32 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.7 t -85.37 114.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.03 150.33 27.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 42' ' ' ALA . 26.0 mm -118.17 127.98 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 129.95 45.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -88.76 139.94 29.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.5 mtm105 62.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -169.14 -167.9 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.49 89.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.386 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.422 HD12 HG13 ' A' ' 130' ' ' VAL . 2.1 pp -135.2 146.41 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.3 m -104.0 133.3 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.372 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.894 HG12 ' HA ' ' A' ' 188' ' ' VAL . 34.1 m -136.94 169.32 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.633 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -136.15 129.58 31.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 p -105.63 149.05 26.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 111.587 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.8 t -130.7 139.34 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.64 133.68 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.01 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.506 ' CD2' ' CE1' ' A' ' 147' ' ' HIS . 5.0 p90 -127.81 -46.27 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.59 149.63 10.33 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.73 -170.22 17.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -133.11 123.78 26.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -112.65 174.69 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -75.7 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -153.37 -61.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.774 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.93 -33.78 65.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.604 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.5 t70 -68.21 -34.92 77.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.049 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -40.51 95.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.458 0.647 . . . . 0.0 110.087 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.69 -38.57 35.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.88 77.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.715 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.506 ' CE1' ' CD2' ' A' ' 135' ' ' PHE . 47.3 m-70 -70.18 -46.01 65.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -62.13 -33.0 73.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.2 m -67.83 -38.25 82.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.93 -35.78 73.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.571 HD23 HD12 ' A' ' 187' ' ' LEU . 7.6 tp -59.22 -40.68 86.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -60.99 -42.49 98.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.266 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.2 m -64.05 -41.81 97.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -49.23 77.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.692 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.54 -9.05 58.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -47.04 -36.37 7.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.821 0.343 . . . . 0.0 111.215 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -96.34 36.09 4.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 15.8 p -145.29 168.28 12.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.3 Cg_endo -85.16 17.83 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.253 2.635 . . . . 0.0 112.794 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 170.98 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.849 0.356 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -136.66 -178.07 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.503 ' H ' HG22 ' A' ' 161' ' ' THR . 12.6 m-85 -155.11 138.05 15.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 190' ' ' ALA . 3.3 mm-40 -63.31 -68.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.1 -79.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.56 69.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 87' ' ' PHE . 9.9 p -161.94 131.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.296 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.858 ' HB3' HD23 ' A' ' 187' ' ' LEU . 7.1 p90 -140.77 170.62 15.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.507 ' CE2' HG22 ' A' ' 188' ' ' VAL . 24.7 m-85 -117.83 136.76 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.0 m -111.32 144.04 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.54 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -120.91 144.03 48.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -137.41 142.97 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 111.372 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.2 t -128.76 114.91 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -117.73 121.95 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.648 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -92.65 140.93 29.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.565 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.8 t -73.89 118.81 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.947 0.404 . . . . 0.0 111.269 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.36 145.69 25.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.267 -0.873 . . . . 1.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.838 0.351 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.24 112.92 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.02 -22.81 18.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 t -169.85 167.03 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.868 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 p -151.41 174.58 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 123.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . -124.69 -55.56 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.549 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tptt -161.85 167.68 24.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.702 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -32.27 73.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.1 -35.33 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.356 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 154' ' ' THR . 3.3 m -146.32 115.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 111.574 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 158.55 15.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.766 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 4.7 p90 -138.87 155.72 47.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -146.73 130.91 17.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.07 116.41 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.03 131.69 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.5 119.54 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.14 103.13 8.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.56 129.85 50.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.97 144.46 16.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.76 178.72 16.87 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.92 141.97 50.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 8.8 m-85 -137.54 154.32 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.969 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.1 122.84 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -112.67 132.14 55.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.794 HG21 ' HB ' ' A' ' 62' ' ' ILE . 16.6 t -125.91 125.51 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -95.72 134.9 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.391 . . . . 0.0 111.264 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 54' ' ' ALA . 9.6 t -138.45 116.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.8 166.96 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.991 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.78 27.67 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -152.64 129.42 5.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.68 -78.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.607 2.205 . . . . 0.0 112.675 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.5 t -146.73 -62.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.749 0.309 . . . . 0.0 111.236 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.57 -45.33 81.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.21 -46.28 74.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.04 -45.07 91.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.2 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.9 mt -56.91 -35.3 68.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.407 ' HB3' ' NH1' ' A' ' 56' ' ' ARG . 1.2 ttp-105 -63.04 -32.16 73.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.008 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -86.87 -32.94 19.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.24 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.728 ' CB ' HG21 ' A' ' 100' ' ' VAL . . . -73.22 -37.13 66.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.43 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 30.2 mmt -57.8 -44.09 99.16 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 51.3 Cg_endo -70.29 -41.19 3.79 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.938 1.758 . . . . 0.0 111.986 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -70.21 -39.53 75.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.794 ' HB ' HG21 ' A' ' 44' ' ' VAL . 9.3 tt -77.55 -40.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.683 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.471 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.5 -31.58 72.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.063 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' HG21 ' A' ' 69' ' ' THR . 1.0 OUTLIER -58.84 -29.92 67.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.58 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 122' ' ' ILE . 13.7 t80 -75.36 -50.96 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.8 m -66.03 -29.7 47.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.19 -166.9 2.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.46 54.85 4.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 30.5 m -141.45 33.44 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -88.51 164.49 15.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 4.7 t0 -92.43 48.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -148.67 -46.63 0.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.38 34.09 3.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 108' ' ' PHE . 17.5 m -100.46 176.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.6 -67.64 1.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mtt 62.55 146.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.25 -121.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.596 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 -45.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' HD2' ' A' ' 81' ' ' PRO . 1.4 m 61.02 112.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 3.9 t -65.86 -46.43 65.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 79' ' ' THR . 29.4 Cg_exo -62.03 140.77 86.17 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.473 2.115 . . . . 0.0 112.123 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 t -153.78 144.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.282 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 t -115.73 145.95 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.489 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.1 154.21 50.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.87 136.66 32.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.484 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG23 ' CE1' ' A' ' 167' ' ' TYR . 17.7 m -135.57 133.49 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 5.8 m-85 -104.45 97.67 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.301 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.2 Cg_endo -79.65 138.91 13.83 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.88 172.0 8.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.09 -29.12 67.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -86.36 -6.14 59.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.97 -2.06 78.9 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 124.41 41.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 88' ' ' PRO . 15.6 mt -66.81 161.24 24.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -118.58 45.78 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt 61.26 -169.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.74 114.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.736 HD11 ' CD2' ' A' ' 84' ' ' PHE . 1.3 tt -143.6 130.66 20.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.5 tttp -108.04 115.89 30.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.728 HG21 ' CB ' ' A' ' 58' ' ' ALA . 3.3 t -85.44 116.91 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.309 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -96.01 131.49 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 15.9 t80 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.267 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.58 110.27 22.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.411 HG23 ' HD2' ' A' ' 105' ' ' PRO . 40.6 mt -90.68 136.29 28.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.226 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' A' ' 104' ' ' ILE . 31.7 Cg_endo -63.6 154.18 70.53 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.454 2.103 . . . . 0.0 112.344 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.86 -26.94 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -56.81 -38.29 72.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.956 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.55 ' HE2' HG11 ' A' ' 74' ' ' VAL . 85.9 m-85 -113.02 -13.05 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -53.14 -47.13 68.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 111.179 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.08 -25.94 54.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 t -171.4 89.41 0.45 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.769 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 122' ' ' ILE . 45.0 Cg_endo -67.9 151.43 78.16 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 0.0 112.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 11.2 Cg_exo -70.79 155.85 61.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.61 2.206 . . . . 0.0 112.111 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -67.5 111.75 8.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.993 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.89 158.06 26.28 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.405 2.07 . . . . 0.0 112.261 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.93 -31.19 11.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.52 114.81 13.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -24.5 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.12 -33.03 29.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.885 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 61' ' ' LYS . 38.6 t -85.43 121.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 157.04 39.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.538 HG21 ' HG3' ' A' ' 112' ' ' PRO . 29.3 mm -107.25 129.31 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -98.86 130.7 45.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.43 16.81 8.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.43 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.91 132.46 23.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -168.57 86.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.15 92.82 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.51 145.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.88 130.8 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 187' ' ' LEU . 26.2 m -143.84 164.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.317 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 4.3 m-85 -107.8 135.43 49.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.8 p -105.68 133.65 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 139.25 52.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.86 138.87 51.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 20.7 p90 -153.32 29.64 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.99 -76.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 138' ' ' TYR . . . 134.62 79.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 137' ' ' GLY . 63.6 m-85 -157.18 82.45 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.322 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.43 26.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.219 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.65 66.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 63.6 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.52 58.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -67.27 -35.97 80.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.105 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.02 -40.52 98.0 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.444 0.64 . . . . 0.0 109.94 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.78 -38.88 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.497 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.81 -35.03 69.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.826 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 40.0 m-70 -68.94 -38.8 79.68 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -61.3 -32.93 72.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.743 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.7 m -72.86 -43.3 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -59.51 -36.65 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 151' ' ' LEU . 12.5 tp -58.1 -43.63 87.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -59.37 -47.51 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 94.6 m -60.91 -41.99 97.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.356 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 29' ' ' VAL . 6.7 m -57.67 -48.97 78.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 mt -72.89 -11.22 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -46.87 129.74 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.241 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.68 9.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.476 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 4.3 p -94.76 173.75 4.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.54 0.21 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 4.4 Cg_exo -77.57 13.97 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.012 2.474 . . . . 0.0 112.939 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.93 130.44 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.334 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.08 172.68 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 152' ' ' ARG . 5.3 m-85 -155.68 160.24 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -104.11 -51.83 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.51 53.66 7.31 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.264 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -158.7 -37.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.596 0.236 . . . . 0.0 111.275 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 12.5 p -159.2 140.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 111.424 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.7 p90 -142.88 170.43 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.09 143.81 43.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.3 m -119.42 137.94 53.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.03 156.09 46.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.075 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.896 0.379 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -108.95 145.57 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -145.7 154.42 42.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.93 124.48 73.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.641 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.06 122.26 46.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.106 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 130' ' ' VAL . 62.3 mt -91.6 140.35 29.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.65 118.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -75.05 116.25 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.17 -0.919 . . . . 1.0 110.986 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -74.3 113.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 35' ' ' ALA . 6.8 mt -86.42 -24.33 25.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -169.98 167.1 9.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -151.6 168.07 26.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.82 -175.67 21.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.426 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.89 -106.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -161.02 167.44 26.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.0 110.916 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -66.6 -28.02 68.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.43 -33.12 16.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.094 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.99 142.38 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -135.12 139.84 44.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 155' ' ' LEU . 1.2 p90 -138.36 162.22 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.726 ' HG2' HG22 ' A' ' 23' ' ' THR . 74.7 mt-10 -144.53 126.46 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.0 129.43 34.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -140.71 135.82 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -112.74 130.08 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.242 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.13 -50.05 21.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.07 70.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.68 29.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.95 139.6 5.02 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HD3' ' CG ' ' A' ' 112' ' ' PRO . 15.8 mttm -92.0 146.68 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -137.54 161.23 36.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 140.3 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.655 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -133.49 131.88 40.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.476 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 120' ' ' VAL . 20.8 t -132.88 125.68 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.679 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.94 132.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.272 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.7 t -138.41 116.87 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 175.43 5.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t0 48.41 28.25 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.436 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.97 133.97 8.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 28.6 Cg_endo -62.46 -165.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.474 2.116 . . . . 0.0 112.099 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 98' ' ' LEU . 42.6 t -74.83 -48.81 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.333 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.71 -45.17 83.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.231 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -67.23 -46.15 74.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.258 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD22 ' CE ' ' A' ' 59' ' ' MET . 3.2 mt -56.97 -35.55 69.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.259 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 tp10 -87.21 -34.15 19.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.355 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.799 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.7 -41.77 62.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.633 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -57.63 -43.95 99.17 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -57.47 -47.15 23.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.107 1.872 . . . . 0.0 112.189 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -70.43 -41.95 72.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.828 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 59' ' ' MET . 6.2 tt -76.09 -37.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 66' ' ' VAL . 58.5 mtp -66.32 -40.48 89.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -59.6 -31.06 69.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.99 -50.09 17.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.804 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' CE2' ' A' ' 102' ' ' PHE . 22.1 m -72.54 -29.52 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.404 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.12 -64.33 2.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.626 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.1 76.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -164.52 55.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 110.747 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.53 6.73 6.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.366 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 58.47 18.56 5.75 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.448 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -95.2 -43.47 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.11 24.32 8.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.474 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -101.08 -178.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.62 -55.46 0.39 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 61.7 mtp 62.64 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.657 0.265 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.79 80.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.656 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 55.28 -176.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.624 ' O ' HG13 ' A' ' 80' ' ' VAL . 1.6 t 179.87 -39.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 103' ' ' ARG . 2.4 m -162.23 163.67 18.3 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.855 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -59.21 149.65 79.14 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.29 1.994 . . . . 0.0 111.898 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.33 137.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.684 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 m -119.11 145.86 45.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.07 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -133.15 154.28 50.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.694 0.283 . . . . 0.0 111.452 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.97 136.67 32.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.534 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' A' ' 167' ' ' TYR . 5.2 m -130.25 130.81 65.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 10.6 m-85 -102.51 97.43 8.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.19 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.7 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.1 Cg_endo -75.18 139.8 24.24 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.507 2.138 . . . . 0.0 112.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -90.18 161.92 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.41 -21.97 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.23 -6.19 59.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.42 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.63 -16.09 60.99 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.829 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -98.66 133.35 43.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 88' ' ' PRO . 71.0 mt -57.89 178.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -143.37 44.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 62.1 -166.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.74 108.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.702 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 84' ' ' PHE . 3.7 tt -141.35 139.52 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.12 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -115.78 115.89 27.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.525 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.1 t -82.23 116.86 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.536 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -100.23 137.96 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.809 ' CE2' HG11 ' A' ' 66' ' ' VAL . 24.8 t80 -127.07 132.44 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.684 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.694 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -94.34 109.75 21.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.36 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 108' ' ' PHE . 31.8 mt -82.19 139.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.468 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 79' ' ' THR . 50.5 Cg_exo -53.34 154.14 15.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.624 2.216 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -57.68 -31.02 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.42 -47.13 87.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 104' ' ' ILE . 26.9 m-85 -90.9 -13.49 33.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.199 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -53.19 -43.69 67.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 111.08 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.75 -27.43 66.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t -167.27 85.87 0.8 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 42.8 Cg_endo -68.02 152.26 76.86 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.613 2.209 . . . . 0.0 112.307 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.92 156.24 60.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.01 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.83 110.89 6.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 122' ' ' ILE . 69.1 Cg_endo -74.04 145.0 34.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.304 2.003 . . . . 0.0 112.453 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -86.12 -176.41 5.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 64.16 120.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.995 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.4 -16.89 25.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.599 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.6 m -80.16 -34.72 37.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 111.233 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 44' ' ' VAL . 38.5 t -85.42 113.83 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.149 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -128.06 157.13 41.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 115' ' ' PRO . 27.8 mm -106.1 129.09 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.85 129.83 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 18.88 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.342 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -69.58 164.35 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -70.91 169.11 15.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.64 176.27 4.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.68 145.25 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.0 m -103.99 118.93 37.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.769 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.18 166.74 21.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.494 ' HB2' HD21 ' A' ' 151' ' ' LEU . 3.7 m-85 -107.83 133.42 52.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.583 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 p -105.89 122.29 45.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.977 0.417 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.484 ' HB ' HD13 ' A' ' 151' ' ' LEU . 5.6 t -116.38 139.1 50.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.732 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -116.99 154.16 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -166.87 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.64 127.93 4.49 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.64 147.0 4.49 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -67.14 118.21 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.58 126.04 45.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 -43.43 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.556 ' CD ' HD12 ' A' ' 94' ' ' LEU . 28.2 tt0 -176.04 -66.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.62 -33.77 66.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -67.67 -34.9 77.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.074 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.67 -40.49 95.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.093 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.8 t -53.75 -38.86 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.549 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.56 -33.45 69.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.648 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -70.11 -44.43 68.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.89 72.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.4 m -67.44 -38.0 83.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.468 ' O ' HG22 ' A' ' 153' ' ' THR . 11.5 mt-30 -64.61 -36.25 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 131' ' ' TYR . 11.9 tp -70.03 -37.17 75.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 110.437 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.01 -48.08 63.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 150' ' ' GLN . 4.2 t -61.25 -40.96 96.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.472 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 98.3 m -57.52 -47.08 82.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.695 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.677 HD21 ' CE2' ' A' ' 31' ' ' TYR . 83.4 mt -72.75 -13.79 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.312 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.18 115.38 1.08 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.84 18.03 8.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.559 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.1 p -146.58 165.15 20.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.57 -13.25 35.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.765 2.31 . . . . 0.0 112.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -57.5 110.51 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -102.48 -177.74 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.534 ' H ' HG22 ' A' ' 161' ' ' THR . 0.0 OUTLIER -156.82 20.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.332 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 67.72 -66.58 0.21 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.162 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.35 48.88 2.93 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.116 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -158.05 -33.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.505 0.193 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 14.0 p -159.13 138.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.548 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 86' ' ' VAL . 15.0 p90 -136.99 171.55 14.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.779 ' CE2' HG22 ' A' ' 188' ' ' VAL . 37.5 m-85 -112.87 150.83 31.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.18 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.3 m -129.92 157.79 41.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.07 139.35 49.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.555 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.771 0.32 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -130.97 133.84 46.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -146.14 157.06 43.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.49 126.24 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.825 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -107.91 121.69 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.155 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 167' ' ' TYR . 12.7 mt -94.41 134.3 37.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.805 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 168' ' ' TYR . 21.5 t -74.88 118.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -63.58 139.35 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.201 -0.904 . . . . 1.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.28 113.19 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.031 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.99 -27.78 18.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -170.09 167.09 8.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -151.65 160.52 43.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.44 71.85 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.364 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.97 -132.24 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.607 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.28 164.89 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -66.49 -28.7 68.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 -34.47 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 118.82 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 p -95.38 130.69 42.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 6.2 p90 -138.53 154.57 48.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -145.19 135.03 23.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.66 124.7 33.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 136.84 30.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.21 130.41 56.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.38 164.78 25.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.03 73.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.58 118.44 6.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.569 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.37 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.571 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' O ' HD12 ' A' ' 104' ' ' ILE . 11.5 mttt -111.01 147.93 33.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.74 153.29 49.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.13 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . . . -94.39 119.11 32.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.5 p -112.66 147.31 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.861 HG23 HD12 ' A' ' 62' ' ' ILE . 23.0 t -131.82 125.97 56.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.153 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -95.95 131.54 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.693 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 17.5 t -138.18 116.98 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 169.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.738 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 79.59 -49.11 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.492 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HB3' ' N ' ' A' ' 54' ' ' ALA . 19.5 mttt -85.65 141.63 36.43 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 110.877 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.51 -80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.481 2.121 . . . . 0.0 112.626 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.939 HG13 ' CD1' ' A' ' 98' ' ' LEU . 43.0 t -142.65 -66.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.851 0.358 . . . . 0.0 111.334 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.76 -45.33 78.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -46.07 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.77 -41.12 85.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 55' ' ' LEU . 5.7 mt -57.1 -35.07 68.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.013 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -31.28 71.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.285 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 34.2 tp10 -87.81 -33.66 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.12 -38.83 66.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.631 ' HE1' HG21 ' A' ' 82' ' ' VAL . 6.9 mmt -57.72 -43.97 99.12 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.8 Cg_endo -70.14 -37.62 8.03 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.994 1.796 . . . . 0.0 112.128 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -70.14 -42.68 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.861 HD12 HG23 ' A' ' 44' ' ' VAL . 1.5 tt -77.71 -28.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -41.06 90.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -58.93 -31.21 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 40.9 t80 -70.59 -53.35 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.503 HG21 ' CG ' ' A' ' 78' ' ' MET . 27.1 m -67.25 -26.36 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.288 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.0 -126.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.645 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.06 68.2 0.52 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 69' ' ' THR . 28.7 m -155.11 52.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' OD1' ' CD1' ' A' ' 65' ' ' TYR . 2.6 m-80 -112.2 22.47 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 t70 54.56 34.34 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.027 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -148.3 -61.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.29 81.92 1.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.47 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 113' ' ' PRO . 5.3 m -139.63 146.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.37 71.77 0.7 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.6 mtp -62.24 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.03 120.49 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.503 ' CG ' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -75.57 154.14 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.594 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.87 148.2 25.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 21.7 t -56.75 -47.7 98.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.413 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.4 Cg_endo -80.91 154.76 19.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.36 2.04 . . . . 0.0 112.499 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.631 HG21 ' HE1' ' A' ' 59' ' ' MET . 41.7 t -153.91 138.74 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.465 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 29.6 t -115.63 149.21 38.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.759 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.06 154.23 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -89.15 136.69 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 94' ' ' LEU . 30.7 m -134.68 128.75 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.195 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -98.61 99.33 7.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.724 ' HA ' HD23 ' A' ' 94' ' ' LEU . 54.2 Cg_endo -69.24 128.01 15.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.471 2.114 . . . . 0.0 112.248 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.13 168.06 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -19.63 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.185 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.45 2.95 42.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.487 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 145' ' ' VAL . . . 91.0 -15.45 60.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.878 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.84 177.63 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 88' ' ' PRO . 53.6 mt -114.37 -12.91 12.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.62 165.53 0.2 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.003 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -80.52 88.13 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.22 110.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.643 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.4 tt -143.97 128.62 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.449 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -110.98 115.66 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.082 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.677 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -71.46 141.12 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -120.85 124.03 44.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 66' ' ' VAL . 57.5 t80 -108.17 153.68 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.127 0.489 . . . . 0.0 111.69 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.1 109.18 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.493 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 112' ' ' PRO . 33.3 mt -83.04 139.12 42.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.314 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.61 154.21 16.56 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 112.314 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -27.46 56.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -59.53 -47.14 86.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.92 -8.28 31.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -53.4 -36.16 61.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.16 -28.57 73.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 t -177.03 88.12 0.25 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 104' ' ' ILE . 34.0 Cg_exo -59.17 161.27 16.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.229 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.619 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.5 Cg_exo -70.82 154.75 63.38 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.634 2.223 . . . . 0.0 111.864 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 114.58 19.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.2 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 65' ' ' TYR . 48.6 Cg_exo -55.17 178.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 35.78 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.9 120.89 11.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.89 -26.8 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.003 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.2 t -82.01 -34.79 29.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -85.43 117.16 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.23 152.82 40.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.3 mm -107.98 133.77 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.86 157.25 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.79 167.71 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -66.71 171.06 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -169.91 -38.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.63 107.18 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.95 142.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.354 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 82.0 m -107.31 132.08 53.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.508 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 187' ' ' LEU . 34.8 m -142.33 149.51 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 5.6 m-85 -107.78 132.41 53.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.198 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.7 p -105.61 144.41 32.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.48 . . . . 0.0 111.637 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.7 t -130.85 139.13 50.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.8 138.78 51.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 39.1 p90 -143.58 -178.67 6.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.789 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.58 88.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.46 -176.44 40.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -58.73 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.11 164.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -132.84 -75.51 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.632 ' HB2' HD12 ' A' ' 94' ' ' LEU . 9.9 pt-20 -139.8 -48.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.97 66.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.09 -35.0 77.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.022 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -63.87 -39.8 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.041 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 92' ' ' GLY . 61.5 t -53.85 -38.61 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.345 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.76 74.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.597 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.496 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.23 -46.05 65.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.878 0.37 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.94 -33.09 73.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.746 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -71.14 -37.94 72.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -59.01 -39.61 82.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.5 tp -58.35 -40.99 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.523 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -62.74 -45.24 93.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -40.73 98.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.191 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.0 m -57.65 -49.2 77.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.511 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -74.0 -9.25 58.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -47.16 -32.72 4.57 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.788 0.328 . . . . 0.0 111.282 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.42 28.29 12.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 71.5 p -145.84 159.29 47.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.312 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.5 Cg_endo -79.58 8.43 3.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 113.029 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.53 137.36 57.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.194 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -100.88 151.57 21.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.0 OUTLIER -158.64 171.18 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -112.36 102.54 10.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.45 65.01 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.046 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -157.69 -27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.4 p -158.27 141.4 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.892 0.377 . . . . 0.0 111.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 31.1 p90 -146.64 168.24 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.534 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 35.6 m-85 -114.38 144.06 43.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.177 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.14 142.81 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.08 154.34 49.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.572 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -108.94 152.88 24.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.06 147.12 31.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.9 118.12 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.84 123.27 48.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.734 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.0 mt -91.43 140.61 29.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.516 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 190' ' ' ALA . 17.7 t -73.98 131.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.801 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -73.02 -0.94 15.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 188' ' ' VAL . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 1.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.763 0.315 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.32 112.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -84.9 -12.07 54.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.415 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.8 159.03 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.85 155.35 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.79 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.85 145.02 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.368 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.431 ' HA3' ' CD1' ' A' ' 31' ' ' TYR . . . -135.88 -146.63 5.29 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.478 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.732 ' HD3' HG23 ' A' ' 154' ' ' THR . 1.6 mtpt -78.37 164.48 24.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.407 . . . . 0.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.54 -26.45 67.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.02 -32.32 16.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.92 111.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.188 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -95.78 141.76 28.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.35 162.13 35.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -145.57 126.16 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.33 122.51 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -123.95 135.28 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.11 121.03 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.194 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.52 173.46 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.88 -47.19 26.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -178.03 28.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.87 -127.32 2.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.426 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -102.95 139.14 38.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -137.58 148.68 46.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.16 28.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.636 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 p -112.82 149.52 32.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 62' ' ' ILE . 41.9 t -128.92 125.61 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -97.38 130.93 44.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.18 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 58' ' ' ALA . 17.4 t -138.25 116.84 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 175.92 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 43.08 36.38 0.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.565 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 14.8 mttt -152.43 134.15 8.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 37.6 Cg_exo -57.22 -157.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.757 HG13 HD13 ' A' ' 98' ' ' LEU . 38.8 t -84.75 -53.25 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -68.15 -44.98 74.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -46.26 81.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.202 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.26 90.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.75 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.2 mt -57.49 -35.28 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -31.67 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 tp10 -87.66 -32.59 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.18 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.65 -42.63 61.13 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.791 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.0 mmt -57.6 -43.54 98.93 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.8 Cg_exo -59.77 -45.16 26.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.248 1.965 . . . . 0.0 111.953 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 120' ' ' VAL . 19.6 mttp -70.32 -40.47 74.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.445 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.722 ' HB ' HG21 ' A' ' 44' ' ' VAL . 7.1 tt -76.57 -40.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 0.0 111.494 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.516 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.27 -31.8 72.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -63.67 -29.84 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -74.04 -30.63 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 63' ' ' MET . 15.0 m -89.74 -31.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.97 -74.16 0.95 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.573 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.07 71.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 116' ' ' SER . 5.3 m -160.59 70.35 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -119.65 -5.63 10.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.452 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.85 39.81 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -144.4 -45.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.64 31.98 1.54 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.25 145.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.85 4.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.451 ' HG2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 62.87 143.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.4 -119.5 3.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -156.85 -171.56 3.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 103' ' ' ARG . 8.3 t -159.13 -163.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.8 m -45.04 161.99 0.22 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.3 Cg_endo -59.31 132.38 46.24 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.186 1.924 . . . . 0.0 111.863 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 102' ' ' PHE . 33.8 m -84.81 146.81 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 p -115.41 173.91 6.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.75 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.7 154.16 44.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.931 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . . . -87.23 136.58 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.486 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 98' ' ' LEU . 27.2 m -131.86 112.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.816 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE2' HG21 ' A' ' 166' ' ' VAL . 4.4 m-85 -93.35 107.13 23.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.24 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.62 156.29 28.02 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.562 2.175 . . . . 0.0 112.189 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.05 168.34 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -22.27 47.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -85.88 -6.04 59.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.712 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.21 -16.07 61.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.806 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 130.07 47.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -72.09 177.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.02 81.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.57 -166.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.054 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 64.6 96.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.757 HD13 HG13 ' A' ' 51' ' ' VAL . 1.7 tt -144.03 127.86 17.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 85' ' ' ALA . 20.6 ptmt -110.59 115.8 30.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -73.38 141.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.332 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -116.38 141.97 47.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.679 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.659 ' CD2' HG11 ' A' ' 82' ' ' VAL . 54.1 t80 -125.0 159.87 30.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.587 ' O ' HG21 ' A' ' 79' ' ' THR . 2.5 mtt85 -115.97 108.09 15.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.323 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.7 mt -85.5 136.41 37.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.297 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 24.6 Cg_endo -61.45 152.02 75.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.359 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -57.23 -26.98 61.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -47.1 82.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.197 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CE2' ' HG2' ' A' ' 76' ' ' MET . 3.2 m-85 -89.18 -16.24 31.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -54.4 -39.05 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.781 0.324 . . . . 0.0 111.197 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.91 79.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 p -159.97 71.67 3.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 110.63 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 32.5 Cg_exo -58.37 139.03 88.98 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.551 2.167 . . . . 0.0 112.324 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 13.0 Cg_exo -70.54 149.27 61.67 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.598 2.199 . . . . 0.0 112.036 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 124.57 89.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.12 170.49 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.383 2.055 . . . . 0.0 112.269 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.591 ' CB ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -113.14 -40.03 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 131.46 35.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -57.71 -22.46 46.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.105 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -81.97 -31.97 30.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 44' ' ' VAL . 33.5 t -85.64 114.02 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.052 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.59 157.0 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.7 mm -107.57 117.59 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -98.98 136.39 39.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.826 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.7 49.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -71.89 -132.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -177.91 4.0 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.79 153.57 20.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.858 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.96 148.78 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.407 HG21 ' HD2' ' A' ' 189' ' ' LYS . 9.7 m -103.9 130.46 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 187' ' ' LEU . 29.4 m -144.81 170.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.48 133.08 41.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.626 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -105.96 137.78 43.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.046 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -124.87 139.05 54.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -116.91 141.38 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -153.62 -50.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.45 170.59 38.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -112.94 67.59 0.24 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.48 100.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 147' ' ' HIS . . . -160.33 163.98 32.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -61.66 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -161.12 -61.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.657 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.84 -33.8 72.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.412 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -67.33 -34.74 77.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.8 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.4 OUTLIER -63.03 -42.05 99.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.513 0.673 . . . . 0.0 109.82 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 92' ' ' GLY . 42.5 t -54.02 -38.8 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.717 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.02 68.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.752 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.516 ' HB2' HG21 ' A' ' 185' ' ' VAL . 18.5 m170 -70.0 -39.7 75.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.819 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.01 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.761 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -67.42 -39.92 85.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.08 -45.95 89.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 151' ' ' LEU . 11.5 tp -63.1 -40.45 97.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -44.22 96.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -65.17 -41.16 94.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.532 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.732 HG23 ' HD3' ' A' ' 26' ' ' LYS . 86.4 m -57.64 -48.05 80.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 12.7 mt -73.22 -16.63 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -47.23 -40.18 15.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.45 32.11 6.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.65 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 51.9 p -146.09 166.7 16.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.8 Cg_exo -75.86 4.72 4.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.031 2.487 . . . . 0.0 112.812 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.47 125.37 22.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.87 HG22 ' HB3' ' A' ' 190' ' ' ALA . 2.7 m -101.78 152.63 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.553 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.616 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -158.42 173.88 15.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.276 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -85.76 -67.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.76 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.062 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.11 -28.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.62 0.247 . . . . 0.0 111.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.612 HG21 ' CE2' ' A' ' 87' ' ' PHE . 14.6 p -157.98 137.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -135.82 179.34 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.542 ' CE2' HG22 ' A' ' 188' ' ' VAL . 25.8 m-85 -116.27 150.78 37.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 m -124.04 136.94 54.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.54 125.06 52.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.781 0.324 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.45 141.07 45.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -145.97 153.01 40.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 147' ' ' HIS . 21.6 t -119.0 133.15 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.957 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -107.65 121.71 45.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.555 ' O ' HG12 ' A' ' 130' ' ' VAL . 36.9 mt -94.03 139.2 31.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 168' ' ' TYR . 43.0 t -83.37 127.26 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.05 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HD2' HG21 ' A' ' 129' ' ' THR . 1.4 mtpt -73.76 160.43 31.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.286 -0.864 . . . . 1.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.823 0.345 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -74.2 112.97 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.56 -16.33 22.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -169.66 166.96 9.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.85 -173.89 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.041 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.98 -119.53 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 98.82 132.45 7.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.774 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 168.69 19.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.729 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -26.88 67.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.28 -35.13 15.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.23 113.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.887 0.375 . . . . 0.0 111.194 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' CA ' ' A' ' 25' ' ' GLY . 1.3 m -98.22 143.68 28.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.674 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.8 p90 -138.55 158.92 43.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.7 132.24 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -86.32 120.04 27.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.6 148.65 44.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.65 116.61 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.61 127.32 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.17 -172.93 2.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.708 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.31 -19.99 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.735 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.19 -90.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.54 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.592 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -93.87 141.16 28.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.776 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -137.63 155.02 49.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.427 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.74 115.9 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.403 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 17.5 p -112.67 147.41 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.998 0.427 . . . . 0.0 111.482 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.69 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.0 t -130.29 125.66 60.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.939 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -98.68 140.98 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 54' ' ' ALA . 21.8 t -138.38 116.79 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 167.25 10.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 46.23 35.41 2.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.439 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -152.78 142.92 15.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.761 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 53.6 Cg_endo -68.58 -163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.403 2.069 . . . . 0.0 112.107 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.878 HG13 ' CD1' ' A' ' 98' ' ' LEU . 47.1 t -81.04 -54.31 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.59 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -61.18 -45.52 94.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.488 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 5.4 tt0 -67.33 -42.9 82.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.23 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 46' ' ' VAL . . . -58.61 -44.8 90.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.425 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.714 HD11 ' CE1' ' A' ' 84' ' ' PHE . 5.3 mt -56.92 -35.63 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.761 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -33.02 74.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 17.1 tp10 -88.42 -30.89 19.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.384 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.32 -44.8 58.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.5 mmt -57.68 -43.88 99.09 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 31.9 Cg_exo -58.9 -46.09 24.98 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.17 1.913 . . . . 0.0 112.221 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -70.29 -41.39 73.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.707 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG21 ' A' ' 44' ' ' VAL . 11.0 tt -76.41 -35.06 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 111.586 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.42 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.4 mtt -66.28 -36.59 83.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -49.01 79.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 23.1 t80 -58.45 -54.11 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 102' ' ' PHE . 33.7 m -66.48 -28.29 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.5 -141.12 0.89 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.614 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.51 43.22 1.92 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.3 m -131.19 87.13 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.39 143.32 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -73.59 -9.16 58.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -91.21 -39.82 11.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.04 62.4 1.01 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.409 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.68 HG23 ' HG3' ' A' ' 76' ' ' MET . 30.0 m -139.66 159.48 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.92 -46.13 38.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.68 ' HG3' HG23 ' A' ' 74' ' ' VAL . 5.2 mtp 61.43 117.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 111.051 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.72 127.62 25.73 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.402 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.48 176.05 8.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 18.7 p -147.63 114.05 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 31.2 m -57.61 -33.11 15.72 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 11.1 Cg_exo -71.48 152.3 60.05 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.082 1.855 . . . . 0.0 111.823 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 59' ' ' MET . 21.7 t -153.07 147.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 111.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 t -143.02 145.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.646 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.831 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.25 154.15 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -85.51 136.72 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 110.481 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 167' ' ' TYR . 15.4 m -136.1 141.0 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -108.63 107.97 60.51 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.35 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HA ' HD23 ' A' ' 94' ' ' LEU . 81.8 Cg_endo -80.02 129.49 7.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.549 2.166 . . . . 0.0 112.391 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.82 158.43 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -28.78 69.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -2.69 58.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.432 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.45 57.3 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.969 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.02 163.21 28.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.646 HD12 ' HG2' ' A' ' 141' ' ' GLU . 19.5 mt -117.51 -9.51 10.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.417 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 62.47 153.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 110.958 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -80.78 88.34 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.035 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.72 118.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.878 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.2 tt -143.94 135.8 26.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -123.25 115.67 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.203 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.2 t -81.98 141.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.308 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -120.23 131.25 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 62' ' ' ILE . 56.5 t80 -110.08 161.25 15.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.464 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' O ' ' CE2' ' A' ' 102' ' ' PHE . 40.9 mmt-85 -116.08 121.57 42.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.64 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 40' ' ' LYS . 40.5 mt -102.22 137.01 19.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.21 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' HG23 ' A' ' 104' ' ' ILE . 32.6 Cg_endo -64.23 154.09 72.87 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.511 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -26.55 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.269 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -56.6 -47.02 80.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.07 -5.04 41.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.321 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -54.39 -47.73 72.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.9 -26.08 39.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.99 91.38 0.3 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.92 150.85 73.67 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.417 2.078 . . . . 0.0 112.22 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.631 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.83 152.97 64.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.633 2.222 . . . . 0.0 112.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.54 127.97 93.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.095 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 74.5 Cg_endo -75.53 169.71 21.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.521 2.147 . . . . 0.0 112.401 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 -31.8 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.667 ' HB3' HG23 ' A' ' 120' ' ' VAL . 2.7 t70 -79.18 116.17 19.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.68 -19.64 41.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.85 -22.01 40.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.209 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 117' ' ' ASP . 69.7 t -84.77 113.9 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -108.11 147.62 30.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.27 123.89 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.78 142.73 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.46 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -169.3 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -43.89 109.28 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.966 0.413 . . . . 0.0 111.594 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.16 56.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.719 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.67 168.57 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.72 142.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.6 m -111.04 119.8 40.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.691 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 188' ' ' VAL . 21.4 m -138.86 168.74 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.255 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.453 ' CE2' HD13 ' A' ' 155' ' ' LEU . 10.8 m-85 -107.73 141.1 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.526 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.7 p -105.96 127.93 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.281 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.441 ' CG2' HD22 ' A' ' 151' ' ' LEU . 1.5 t -125.1 137.11 54.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.644 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.84 125.01 45.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.919 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 8.5 p90 -123.06 -41.67 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.99 84.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . -147.09 -89.21 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.6 OUTLIER -175.71 108.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.0 110.814 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 144' ' ' TYR . . . -105.66 132.72 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 58.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.646 ' HG2' HD12 ' A' ' 94' ' ' LEU . 1.2 tm-20 67.16 -72.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.86 76.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -67.84 -34.77 77.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.982 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 139' ' ' ALA . 1.2 m-85 -62.63 -39.53 94.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.439 0.638 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.593 HG22 HD21 ' A' ' 94' ' ' LEU . 21.4 t -53.87 -38.82 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.477 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.68 -35.61 70.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.787 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 47.4 m-70 -70.05 -42.7 72.54 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.925 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -32.92 72.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.694 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.4 m -69.64 -39.28 77.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.714 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.83 -46.01 91.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.674 HD11 ' HB3' ' A' ' 31' ' ' TYR . 13.9 tp -58.57 -40.67 83.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.656 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.06 95.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.3 m -64.84 -39.37 93.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.364 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -45.67 84.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.822 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.455 HD23 ' CE2' ' A' ' 31' ' ' TYR . 15.6 mt -72.78 -17.83 61.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.258 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.96 111.56 0.41 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.171 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 106.25 30.37 4.46 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.289 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.472 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 64.6 p -145.23 168.07 12.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.7 0.286 . . . . 0.0 110.807 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 16.5 Cg_exo -67.93 -3.43 10.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.808 2.339 . . . . 0.0 112.978 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.29 124.56 18.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.339 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -99.57 176.32 5.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.32 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 161' ' ' THR . 3.5 m-85 -154.58 161.25 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.035 0.445 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -92.87 -172.26 2.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.819 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.81 63.19 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 57.08 77.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.743 0.306 . . . . 0.0 111.308 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 166' ' ' VAL . 13.9 p -161.37 112.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.604 ' HB3' HD23 ' A' ' 187' ' ' LEU . 13.8 p90 -119.14 173.28 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.724 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 69.3 m-85 -112.89 150.49 31.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.81 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.82 149.62 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.564 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.837 0.351 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.94 152.54 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.06 154.84 42.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.07 128.35 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.424 ' HB3' HG21 ' A' ' 130' ' ' VAL . 40.7 m0 -108.04 122.0 45.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.368 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.1 mt -93.09 134.49 35.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.535 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 130' ' ' VAL . 43.4 t -74.76 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -107.51 111.97 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.227 -0.892 . . . . 1.0 111.028 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.775 0.321 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.0 112.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.73 -10.88 25.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.354 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -170.01 164.83 9.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.33 . . . . 0.0 110.966 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.487 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -151.9 -49.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.96 137.64 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.462 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -139.11 -156.16 6.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -78.4 158.37 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.51 -27.38 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -90.11 -35.01 15.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.08 114.82 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -95.38 150.8 19.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.5 p90 -139.05 160.32 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' THR . 3.1 mp0 -143.33 124.97 14.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -85.86 122.1 29.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 129' ' ' THR . 11.3 ptm180 -130.3 128.13 40.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.35 132.77 55.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.1 p -139.65 162.22 35.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.85 170.91 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.935 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.8 -119.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.01 -170.76 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -99.34 137.72 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' HD3' ' A' ' 103' ' ' ARG . 10.8 m-85 -137.49 159.85 40.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -103.29 127.07 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.7 p -112.79 131.79 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' ILE . 39.0 t -127.7 125.35 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.59 139.92 31.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.2 t -138.28 116.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.52 168.35 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 t0 47.56 28.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -152.87 115.72 2.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.41 -172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.507 2.138 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.525 ' HA ' HD13 ' A' ' 98' ' ' LEU . 40.3 t -59.71 -62.24 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.542 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -45.08 79.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -67.1 -45.36 77.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.169 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.872 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.69 -44.42 90.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.344 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.96 -35.75 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.743 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -64.79 -32.17 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.944 0.402 . . . . 0.0 110.479 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.5 tp10 -87.8 -35.45 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.821 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.52 -42.02 62.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -57.64 -44.11 99.27 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.0 Cg_exo -63.95 -40.29 28.48 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.243 1.962 . . . . 0.0 111.76 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -70.14 -43.39 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.736 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.35 -34.16 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.318 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.6 mmt -66.28 -37.83 86.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 110.957 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.2 81.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 62.5 t80 -68.99 -42.1 76.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 102' ' ' PHE . 30.3 m -82.24 -23.37 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.32 -82.09 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.79 51.86 0.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -132.06 92.21 3.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.769 0.318 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -155.09 170.81 20.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.59 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 14.9 p30 -96.09 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -148.33 -47.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.31 42.96 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.26 174.07 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 111.182 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.1 116.41 1.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.528 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 30.6 mtp -112.56 -161.7 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.69 -120.37 1.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -56.43 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.735 ' O ' HG12 ' A' ' 80' ' ' VAL . 2.1 m 60.45 102.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.991 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 79' ' ' THR . 9.7 p 53.78 142.72 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.801 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 80' ' ' VAL . 31.2 Cg_exo -59.79 138.2 81.4 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.304 2.003 . . . . 0.0 112.128 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.9 m -86.01 153.96 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.649 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.26 167.6 13.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.18 140.52 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.162 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.497 ' HB2' ' HE1' ' A' ' 168' ' ' TYR . . . -76.7 136.65 39.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.432 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.616 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.6 m -131.38 102.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.857 0.361 . . . . 0.0 111.09 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -70.7 111.76 10.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.628 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.5 Cg_endo -87.94 137.85 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.724 2.283 . . . . 0.0 112.503 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.11 155.14 18.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.839 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.28 -19.0 61.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -85.24 -6.02 59.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.491 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.94 -1.94 59.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -95.56 165.39 12.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.348 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 88' ' ' PRO . 55.0 mt -112.2 140.64 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 163.09 24.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -79.95 -11.83 59.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 124.7 33.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.703 0.287 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.7 141.21 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.067 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -121.88 115.98 23.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -90.63 128.12 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.329 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -103.37 142.07 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.708 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 66' ' ' VAL . 62.9 t80 -126.07 150.73 47.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 0.0 111.519 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' CE2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -108.77 108.04 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.514 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 40' ' ' LYS . 34.5 mt -80.25 136.05 53.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.343 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 30.5 Cg_endo -63.56 154.23 70.08 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.664 2.242 . . . . 0.0 112.511 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 69.3 m-80 -55.87 -26.87 49.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.284 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -56.98 -40.38 76.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.405 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 40.5 m-85 -101.86 -8.07 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.749 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -53.95 -37.58 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.332 . . . . 0.0 111.055 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.23 -31.13 61.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -174.53 85.37 0.34 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.4 Cg_exo -56.88 145.53 83.8 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.6 Cg_exo -70.88 151.85 63.0 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.489 2.126 . . . . 0.0 112.081 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . . . -67.33 111.59 7.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 33.0 Cg_exo -58.36 158.87 21.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.479 2.119 . . . . 0.0 112.192 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -110.44 30.83 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 120' ' ' VAL . 37.3 m-20 -130.26 112.15 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.02 -29.07 65.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.3 -27.54 32.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 117' ' ' ASP . 29.5 t -85.11 125.47 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 157.11 33.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.408 ' CG2' ' HG2' ' A' ' 40' ' ' LYS . 20.7 mm -105.73 119.48 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.83 21.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.51 156.07 39.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 58.8 103.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.24 -66.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 111.184 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.3 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.088 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.409 HD13 ' HE2' ' A' ' 168' ' ' TYR . 1.5 pt -129.26 142.98 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.007 0.432 . . . . 0.0 111.629 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 34' ' ' ARG . 84.0 m -115.42 128.98 56.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.252 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 188' ' ' VAL . 35.8 m -134.47 160.02 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 111.737 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.432 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.93 136.3 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.205 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.1 p -105.67 131.08 53.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 111.396 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -125.34 139.25 53.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -116.85 137.17 52.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 6.1 p90 -134.57 140.75 46.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.36 93.9 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 159.1 161.1 10.86 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.581 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -65.79 167.86 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.52 147.99 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -135.79 -175.91 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.616 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.2 tt0 -58.35 -69.43 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.83 72.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.688 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.15 -34.85 78.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.031 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.77 -40.75 98.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.87 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.76 -38.88 36.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.61 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.53 -36.27 70.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.919 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 48.0 m-70 -70.14 -43.28 71.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.901 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.92 72.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 m -65.55 -37.84 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -58.76 -45.83 88.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 187' ' ' LEU . 11.0 tp -58.59 -38.79 78.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -64.29 -43.25 95.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -68.13 -38.57 82.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 56.1 m -57.49 -49.08 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 131' ' ' TYR . 47.3 mt -73.56 -19.5 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.17 102.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 113.08 32.7 2.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.3 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.0 p -145.52 165.42 21.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.82 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 32.6 Cg_exo -58.06 -17.33 30.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.666 2.244 . . . . 0.0 112.674 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.28 41.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.94 -171.21 1.93 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.933 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.746 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 6.6 m-85 -155.43 154.0 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.06 -164.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -56.68 -86.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.17 77.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.3 p -161.67 132.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.879 ' HB3' HD23 ' A' ' 187' ' ' LEU . 14.7 p90 -141.17 163.63 32.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.508 ' CE2' HG22 ' A' ' 188' ' ' VAL . 22.1 m-85 -112.94 157.49 21.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.532 ' SG ' HG13 ' A' ' 185' ' ' VAL . 11.1 m -143.87 136.98 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.01 138.53 48.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.026 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.89 0.376 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -115.63 133.89 55.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.585 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.36 156.89 44.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.532 HG13 ' SG ' ' A' ' 169' ' ' CYS . 29.3 t -121.43 114.85 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.11 125.68 51.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.346 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.3 mt -92.54 140.51 29.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.593 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' VAL . 18.6 t -74.59 131.14 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.358 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -79.95 163.43 24.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.206 -0.902 . . . . 1.0 111.096 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 111.101 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.55 113.0 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mt -96.67 -12.94 23.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.442 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.48 166.29 10.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 p -152.47 -176.78 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.47 141.95 1.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.422 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -154.67 -173.74 23.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -78.81 158.98 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -66.59 -30.38 70.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.06 -35.03 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.6 m -146.08 107.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.006 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 5.7 p -97.29 156.14 16.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p90 -140.12 162.05 36.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 28.2 mt-10 -145.52 136.38 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.77 130.8 34.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 127.98 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -112.58 139.1 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 111.255 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -133.71 132.21 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.794 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.67 149.21 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 118.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' CA ' ' HG3' ' A' ' 109' ' ' GLN . . . 141.92 148.93 5.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.603 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HG2' HG22 ' A' ' 122' ' ' ILE . 2.2 mttm -105.36 158.18 16.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.854 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -137.63 157.6 46.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.94 140.3 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.434 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.9 p -137.03 143.43 42.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.687 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 62' ' ' ILE . 21.3 t -129.25 125.87 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.687 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -95.85 131.18 42.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.024 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.34 116.85 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.435 HG23 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -107.32 169.04 8.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 47.46 37.86 6.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 mttm -152.5 137.38 10.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.869 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 32.3 Cg_exo -57.89 -160.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.509 2.14 . . . . 0.0 112.278 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 46.2 t -92.76 -63.38 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.28 -42.83 92.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.9 -45.96 76.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.99 75.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.3 mt -58.31 -35.4 71.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.27 -33.61 74.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.5 tp10 -87.48 -28.67 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.811 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.57 -44.01 58.37 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.602 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.0 mmt -57.67 -43.46 98.81 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.92 -45.54 23.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.23 1.953 . . . . 0.0 111.884 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -70.34 -42.25 72.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.661 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.753 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.04 -37.48 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -31.77 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.001 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 63' ' ' MET . 4.2 mtmm -60.89 -29.96 69.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.385 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -73.13 -49.05 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 63' ' ' MET . 14.9 m -66.01 -22.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.44 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.81 83.18 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.97 -43.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 t -172.43 100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.016 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.647 HD21 HG22 ' A' ' 74' ' ' VAL . 14.3 p-10 -127.34 3.36 6.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.22 41.15 17.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -148.31 -50.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.89 43.96 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG22 HD21 ' A' ' 70' ' ' ASN . 12.9 m -100.92 -179.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 117.68 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.337 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.1 mtp -120.15 118.43 30.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.42 -26.19 50.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.3 ttt 63.92 132.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 t -58.13 177.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -95.29 -54.79 0.22 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.204 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 76.2 Cg_endo -93.86 130.35 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.645 2.23 . . . . 0.0 112.585 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' CE ' ' A' ' 59' ' ' MET . 53.6 t -93.07 148.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.43 148.95 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.05 154.25 50.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.201 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.36 136.69 34.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 98' ' ' LEU . 30.0 m -129.39 134.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.071 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -111.04 95.79 26.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.28 164.3 32.95 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -90.23 172.28 8.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.52 -22.16 20.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.292 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.46 -6.12 59.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.466 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.14 61.51 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.883 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -174.73 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.776 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mt -123.54 164.31 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -161.0 87.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp 51.96 -167.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD3' HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER 63.19 99.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.1 tt -144.08 128.01 17.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.167 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 115.57 29.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.973 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.811 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -71.68 141.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.731 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.9 m95 -119.35 130.99 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.13 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.5 t80 -114.76 158.9 21.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 111.63 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -116.08 107.9 15.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.482 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mt -84.92 137.1 38.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.356 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.31 154.09 25.06 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 3.9 m-20 -58.24 -26.89 63.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -47.12 87.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.482 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -86.31 -11.06 53.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.598 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.83 -42.81 68.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.634 0.255 . . . . 0.0 111.017 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.86 -29.05 58.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.8 85.48 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.607 0.242 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 40' ' ' LYS . 30.8 Cg_exo -60.82 160.94 23.27 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.573 2.182 . . . . 0.0 112.239 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.41 155.66 32.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.861 2.374 . . . . 0.0 111.972 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.08 22.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.97 168.6 22.66 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.377 2.051 . . . . 0.0 112.392 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.2 p -110.25 168.92 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' VAL . 4.4 t70 66.74 126.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.75 -16.01 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.66 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -79.81 -29.14 40.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.68 0.276 . . . . 0.0 111.253 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.4 t -85.73 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -123.02 156.92 33.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.467 HG22 ' HG2' ' A' ' 40' ' ' LYS . 11.9 mm -113.71 128.46 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.8 153.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.27 179.86 6.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -58.66 98.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.67 -21.86 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.9 74.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 188' ' ' VAL . 1.1 pp -138.55 145.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -103.78 137.45 41.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -139.17 145.63 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.496 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.4 OUTLIER -107.79 128.81 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.4 p -105.51 142.29 35.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.141 0.496 . . . . 0.0 111.707 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.0 t -127.67 139.6 52.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 125.0 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.404 . . . . 0.0 111.023 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 12.5 p90 -131.03 -177.88 4.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -117.58 130.22 8.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.566 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.31 -177.37 20.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.568 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -94.43 166.9 11.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -177.18 121.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.245 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.22 -73.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.778 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -141.4 -47.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.785 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -73.03 -33.95 66.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 110.605 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -35.09 76.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.927 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -64.22 -39.08 93.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.245 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 141' ' ' GLU . 57.4 t -53.63 -38.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.452 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.2 70.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.78 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.499 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.7 m-70 -70.0 -42.79 72.58 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.807 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.94 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.4 m -67.66 -39.44 84.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.704 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.25 -46.05 92.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 tp -58.28 -38.88 77.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -64.12 -42.56 96.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.5 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.7 m -69.15 -37.07 78.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.4 m -57.54 -38.9 75.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 162' ' ' TYR . 32.1 mt -72.4 -22.71 61.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.23 95.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.216 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.93 33.12 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 p -145.54 155.26 53.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 36.3 Cg_endo -65.09 -12.99 37.33 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.615 2.21 . . . . 0.0 112.605 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.496 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -58.41 159.8 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 156.54 47.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CD1' HD13 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -154.48 155.81 35.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -79.38 -61.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.03 -16.69 58.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.687 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.58 -27.47 34.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.066 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 166' ' ' VAL . 8.4 p -160.76 118.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.797 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.3 p90 -119.03 171.38 8.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.625 ' CE2' HG22 ' A' ' 188' ' ' VAL . 33.5 m-85 -113.15 140.16 48.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.82 147.58 35.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 184' ' ' GLU . . . -132.04 127.82 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.582 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.907 0.384 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -108.93 158.01 18.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.515 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.825 ' CG ' ' HB3' ' A' ' 170' ' ' ALA . 0.7 OUTLIER -141.38 144.18 34.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.7 124.64 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.727 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.14 132.37 54.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 111.725 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 167' ' ' TYR . 16.8 mt -92.33 140.21 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.656 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 130' ' ' VAL . 19.6 t -74.69 131.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.462 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 69.1 tttt -69.53 154.21 42.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 1.0 111.077 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.675 0.274 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.11 112.83 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.857 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.88 -12.99 22.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.79 167.09 9.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.69 154.49 36.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.23 164.26 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -161.17 -58.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -161.95 164.48 28.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.785 0.326 . . . . 0.0 110.748 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -33.74 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -91.08 -35.29 14.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CB ' ' A' ' 150' ' ' GLN . 3.5 m -146.44 108.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.83 0.348 . . . . 0.0 111.723 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.31 158.06 16.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 154' ' ' THR . 0.2 OUTLIER -139.07 162.35 35.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.92 0.39 . . . . 0.0 111.114 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.76 132.85 21.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -85.98 126.96 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.97 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.93 127.35 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -152.88 96.18 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.48 -50.65 72.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.77 -119.77 19.57 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.622 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.96 -119.46 1.01 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -91.91 159.34 15.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.832 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 102' ' ' PHE . 38.4 m-85 -137.44 148.93 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.042 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.81 140.34 29.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 66.5 p -132.1 136.02 46.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 111.576 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.517 HG21 ' HB ' ' A' ' 62' ' ' ILE . 39.9 t -125.9 125.56 68.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.662 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -96.88 131.45 43.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.095 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 54' ' ' ALA . 16.6 t -138.26 116.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.002 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.41 174.11 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.51 25.99 3.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.398 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -152.95 130.02 5.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.06 177.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.313 2.009 . . . . 0.0 112.23 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 82.7 t -62.2 -57.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.024 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -58.24 -45.25 88.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.17 -46.21 74.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.91 -45.0 91.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.194 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.8 mt -57.1 -35.59 69.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.77 -31.81 73.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.1 tp10 -87.27 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.672 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.47 -42.66 61.62 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.509 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.0 mmt -57.69 -44.15 99.27 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.3 Cg_exo -63.29 -40.54 31.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.21 1.94 . . . . 0.0 111.718 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -70.24 -44.03 69.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.035 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.5 tt -76.1 -31.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -42.79 87.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.6 mttt -58.92 -42.27 89.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 7.0 t80 -59.63 -50.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.54 -27.62 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.37 -105.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.594 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.46 67.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.4 HG21 ' HD3' ' A' ' 64' ' ' LYS . 68.6 m -164.4 71.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 0.0 110.761 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -134.94 10.41 3.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.372 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 57.05 38.94 29.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 111.025 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -52.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.46 79.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.552 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.697 HG22 HD21 ' A' ' 70' ' ' ASN . 26.8 m -139.0 143.65 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.896 0.379 . . . . 0.0 111.169 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.87 -42.66 94.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.419 ' HA ' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 65.48 -76.4 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.89 -23.16 8.37 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.412 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 64.46 162.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.04 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.76 HG22 ' HD2' ' A' ' 81' ' ' PRO . 7.8 m -122.29 131.63 54.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 1.5 t -68.43 -53.05 18.6 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.76 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.3 Cg_endo -81.1 130.78 7.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.417 2.078 . . . . 0.0 112.354 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -154.37 134.61 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.975 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 1.8 t -114.96 167.99 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -126.91 154.22 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.729 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.35 136.57 33.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.307 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.69 HG12 HD12 ' A' ' 98' ' ' LEU . 33.3 m -131.28 128.35 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 111.132 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -98.95 104.25 24.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 94' ' ' LEU . 41.4 Cg_endo -66.84 128.31 18.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.412 2.074 . . . . 0.0 112.202 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -90.29 156.88 17.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -66.02 -15.9 63.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.314 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.04 5.18 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.552 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.59 -16.0 60.16 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.752 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 162.87 13.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 88' ' ' PRO . 27.1 mt -87.8 -4.91 58.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.509 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 62.33 162.34 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -80.75 84.15 6.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -175.68 106.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.7 tt -138.22 127.96 25.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.64 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.672 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -76.22 141.15 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.95 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.409 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 50.6 t80 -120.98 150.26 41.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.518 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.74 114.5 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 mt -92.75 134.51 27.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.82 154.06 28.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.622 2.215 . . . . 0.0 112.405 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -60.49 -26.75 67.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.07 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -56.96 -32.81 66.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.409 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 76' ' ' MET . 57.9 m-85 -106.03 -9.71 16.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.799 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.95 -33.8 52.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.17 77.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 76.28 3.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.658 0.266 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 33.0 Cg_exo -59.72 148.23 88.84 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.635 2.223 . . . . 0.0 112.303 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.44 ' CG ' HG21 ' A' ' 74' ' ' VAL . 6.9 Cg_exo -72.57 159.24 49.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.59 133.26 94.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 27.6 Cg_endo -62.9 -22.24 73.7 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.129 . . . . 0.0 112.417 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 m 52.97 28.46 6.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.75 122.83 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.06 -24.01 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.177 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.07 -35.81 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.96 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 44' ' ' VAL . 43.6 t -85.05 123.67 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 157.03 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.2 mm -112.2 118.58 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.934 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.94 129.48 45.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 125' ' ' ARG . 5.7 tt0 -95.38 -152.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.608 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 6.4 mtt180 67.92 71.85 0.32 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.727 0.299 . . . . 0.0 111.458 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 38.3 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.93 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -97.7 -145.31 18.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.427 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -144.15 145.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.324 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.3 m -103.91 118.93 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.499 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.908 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.5 m -140.72 170.38 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.379 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.549 ' CE2' HD22 ' A' ' 155' ' ' LEU . 5.0 m-85 -107.32 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.329 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 98.1 p -130.23 136.28 49.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -131.09 139.15 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.344 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -116.88 140.59 49.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.32 173.55 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.23 -30.01 8.07 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.555 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.02 118.0 12.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.59 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.46 121.77 25.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -113.87 150.89 32.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.278 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -106.36 -59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.68 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 94' ' ' LEU . 27.4 tt0 -152.02 -67.73 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -33.78 73.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.8 t70 -67.76 -34.59 77.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.8 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.4 OUTLIER -62.56 -40.25 96.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.54 0.686 . . . . 0.0 109.742 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.89 -38.72 37.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.709 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.26 -33.8 72.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.795 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.415 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.0 m-70 -70.12 -46.1 65.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -62.14 -32.88 73.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.4 m -62.99 -43.99 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.401 ' CB ' HG11 ' A' ' 29' ' ' VAL . 3.9 mt-30 -62.45 -46.07 90.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.694 ' HB3' HD11 ' A' ' 187' ' ' LEU . 11.2 tp -59.1 -39.68 83.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.83 -48.11 82.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.308 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.5 m -62.23 -45.27 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.166 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 31' ' ' TYR . 4.1 m -57.53 -44.56 85.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.614 ' CD1' HD12 ' A' ' 187' ' ' LEU . 12.4 mt -72.89 -17.01 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.143 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.79 -38.06 14.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 111.445 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.63 -14.18 82.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.465 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -93.89 176.38 2.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.806 0.303 . . . . 0.0 111.064 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.465 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 13.4 Cg_exo -70.02 -1.04 8.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.25 143.0 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.708 0.29 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 16.1 m -130.39 2.06 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.766 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.95 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 8.0 m-85 56.92 159.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.62 -80.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.24 38.6 1.23 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.276 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.13 71.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 110.713 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 166' ' ' VAL . 14.0 p -161.76 124.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.852 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.5 p90 -126.0 175.0 8.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.729 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 68.3 m-85 -119.6 162.03 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 94.6 m -130.82 130.86 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.016 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 83' ' ' SER . . . -132.02 156.02 46.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.674 0.273 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 44.7 m-80 -133.11 138.39 46.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 111.469 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -146.09 157.29 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.628 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.804 HG13 ' CD2' ' A' ' 167' ' ' TYR . 10.6 t -134.85 114.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.888 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 44.0 m0 -109.33 121.53 45.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.207 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.852 HD23 ' HB3' ' A' ' 167' ' ' TYR . 72.2 mt -94.53 140.08 30.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.666 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.908 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.3 t -87.08 123.59 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.3 150.34 40.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.95 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 1.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.76 0.314 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 23' ' ' THR . 23.8 t -74.29 112.88 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.802 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.98 -9.42 37.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.478 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.83 158.95 7.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.843 0.354 . . . . 0.0 110.937 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.41 ' CG2' HG11 ' A' ' 20' ' ' VAL . 79.1 p -152.64 164.22 38.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.8 -137.25 13.22 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . 133.04 -170.38 22.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.518 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' HG23 ' A' ' 154' ' ' THR . 6.0 mtpt -78.56 162.04 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 0.0 110.839 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -25.21 66.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.78 -32.64 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.04 122.51 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.068 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.44 147.63 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.433 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 8.4 p90 -139.17 155.74 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.59 128.8 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -86.75 127.29 34.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.11 134.45 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.06 127.43 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.48 128.55 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.61 -66.84 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.61 178.34 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.528 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.48 -111.14 1.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtmt -92.01 157.61 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 23.4 m-85 -137.4 157.38 46.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -101.94 135.3 43.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 38.7 p -137.31 151.49 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.509 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.665 HG23 HD12 ' A' ' 62' ' ' ILE . 22.0 t -131.66 125.96 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.703 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -95.88 130.27 42.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.26 116.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.018 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.58 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -111.81 176.86 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.974 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.03 31.01 1.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -152.36 138.2 11.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.8 -160.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.432 2.088 . . . . 0.0 112.205 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.945 HG13 ' CD1' ' A' ' 98' ' ' LEU . 62.3 t -90.28 -48.07 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.13 -45.12 74.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -46.38 74.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.94 92.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.3 mt -57.11 -35.46 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -62.67 -29.91 70.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.12 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 tp10 -89.84 -32.9 16.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.316 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -72.89 -43.85 62.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.475 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.598 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 9.4 mmt -57.69 -44.05 99.19 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 59' ' ' MET . 42.9 Cg_endo -69.06 -36.26 13.02 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.984 1.789 . . . . 0.0 112.207 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -70.16 -43.6 70.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.653 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 44' ' ' VAL . 9.4 tt -77.91 -27.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.328 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -37.14 84.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.037 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -58.78 -37.1 75.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 19.1 t80 -67.12 -56.43 10.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.612 HG11 ' CE2' ' A' ' 102' ' ' PHE . 31.9 m -65.87 -30.72 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.8 -100.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 64.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.509 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -147.76 65.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.1 165.5 28.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.717 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.1 m-20 -90.02 46.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -145.8 4.57 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.677 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.52 32.01 5.3 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.747 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 108' ' ' PHE . 1.4 p -96.66 140.57 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.879 -0.66 . . . . 0.0 111.67 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.4 49.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.421 ' HE3' ' HD2' ' A' ' 105' ' ' PRO . 14.3 ptm -52.17 -48.89 64.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.59 -161.85 35.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.547 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 tpt -92.23 147.74 22.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.636 HG22 HG23 ' A' ' 80' ' ' VAL . 7.2 m -151.37 120.8 6.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.636 HG23 HG22 ' A' ' 79' ' ' THR . 14.0 t 64.27 136.43 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.56 130.69 34.54 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.27 1.98 . . . . 0.0 112.184 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.671 HG11 ' CD2' ' A' ' 102' ' ' PHE . 32.9 m -88.91 154.05 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.321 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 t -117.89 173.73 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -131.8 154.21 49.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.003 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.04 136.82 32.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.402 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' CE1' ' A' ' 167' ' ' TYR . 23.9 m -132.89 132.98 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.173 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -106.27 98.16 18.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.808 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.3 Cg_endo -75.59 138.89 22.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -90.26 161.77 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.86 -19.12 62.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.2 -5.87 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.65 -3.44 78.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.882 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.48 139.52 51.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.6 mt -80.14 144.09 33.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.98 48.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.82 96.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -179.64 107.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.945 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.8 tt -142.82 128.13 18.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.489 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -115.54 115.65 26.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.248 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -74.24 141.35 16.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 0.0 111.594 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HA ' HG22 ' A' ' 43' ' ' THR . 13.8 m95 -121.64 126.05 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.276 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CD2' HG11 ' A' ' 82' ' ' VAL . 52.9 t80 -110.13 155.18 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 111.612 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 107.88 15.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.585 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.434 HG13 ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.13 139.68 92.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD2' HG13 ' A' ' 104' ' ' ILE . 32.5 Cg_endo -64.35 153.99 73.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.489 2.126 . . . . 0.0 112.319 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -56.63 -26.8 56.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.284 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.446 ' HB3' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -56.98 -32.81 66.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 74' ' ' VAL . 11.3 m-85 -116.8 20.22 14.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.426 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -55.09 -33.85 63.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.46 -25.82 67.13 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.01 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -177.73 107.95 0.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.736 0.268 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 108' ' ' PHE . 52.6 Cg_endo -69.08 161.12 47.16 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.41 2.074 . . . . 0.0 112.187 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.512 ' CG ' HG11 ' A' ' 74' ' ' VAL . 10.2 Cg_exo -70.7 150.49 62.58 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.584 2.189 . . . . 0.0 112.003 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . . . -66.98 114.13 16.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 58.8 Cg_endo -73.04 165.95 31.36 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.352 2.034 . . . . 0.0 112.335 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.2 m -127.68 33.19 4.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.739 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -125.71 114.44 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.91 -26.53 62.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.12 -26.93 33.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 117' ' ' ASP . 42.9 t -84.89 115.5 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.13 156.93 19.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.817 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.16 127.4 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -98.76 160.16 14.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -147.45 129.15 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 63.55 123.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -169.08 -80.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.8 110.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.369 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.49 142.91 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 111.253 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 m -107.86 119.03 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -129.55 161.11 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.382 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 151' ' ' LEU . 5.3 m-85 -107.93 138.23 44.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 p -108.75 142.39 39.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.1 t -129.68 139.0 51.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -116.86 130.44 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.95 144.59 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.09 95.66 1.99 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.52 159.0 28.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -72.17 174.87 6.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.529 ' HB3' ' ND2' ' A' ' 183' ' ' ASN . . . -175.34 144.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.33 -60.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 94' ' ' LEU . 70.9 tt0 -159.85 -66.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.58 70.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.491 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.93 -34.89 78.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.945 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -41.62 99.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 109.893 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.95 -38.8 38.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.559 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.03 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.897 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -67.76 -41.93 82.55 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.798 0.333 . . . . 0.0 111.044 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.001 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -67.79 -39.48 84.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 131' ' ' TYR . 7.9 tp -57.95 -43.39 86.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . 18.0 mtt85 -59.83 -40.0 87.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.368 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' OE1' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -68.97 -42.54 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.51 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' ' 26' ' ' LYS . 97.9 m -57.58 -49.46 76.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.85 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 162' ' ' TYR . 11.5 mt -75.12 -10.36 59.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.74 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.481 ' OE1' HG22 ' A' ' 153' ' ' THR . 9.4 pt-20 -47.55 -29.0 2.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.787 0.327 . . . . 0.0 111.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -98.51 26.68 22.87 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.587 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.9 p -146.05 160.51 42.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.77 -5.54 17.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.95 2.433 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.75 119.8 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -103.57 157.28 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.755 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.432 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -156.02 -176.02 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -115.5 156.77 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.56 -4.02 10.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.713 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.673 ' OD1' HG12 ' A' ' 166' ' ' VAL . 2.0 p30 -81.92 -22.78 36.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.609 0.242 . . . . 0.0 111.255 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.673 HG12 ' OD1' ' A' ' 165' ' ' ASP . 14.9 p -160.46 158.11 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 111.406 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.9 p90 -166.25 163.13 17.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.538 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 10.0 m-85 -112.94 158.82 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.671 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.4 m -142.25 158.93 43.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.61 139.28 49.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 139' ' ' ALA . 72.5 m-20 -108.92 157.98 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.517 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.47 145.53 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.287 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.671 HG13 ' SG ' ' A' ' 169' ' ' CYS . 17.7 t -124.99 133.49 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.564 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -107.76 121.54 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 130' ' ' VAL . 21.8 mt -97.08 134.53 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.576 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.96 119.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -69.76 140.69 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.604 ' HB3' ' OG1' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 1.0 111.141 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.878 0.37 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.24 115.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.53 -2.4 38.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -170.24 165.85 8.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.28 -175.93 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.69 152.79 17.34 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -155.34 178.1 32.16 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.64 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -78.85 158.48 28.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.49 -29.16 69.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -89.86 -31.01 17.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 150' ' ' GLN . 22.1 t -145.98 117.02 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 m -95.33 137.45 34.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.04 162.13 35.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -144.94 140.69 28.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.35 126.58 34.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.921 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.99 127.91 39.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.91 135.08 50.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -159.9 79.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HG3' ' CE2' ' A' ' 41' ' ' PHE . 8.8 mp0 -142.25 137.33 30.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.14 -99.74 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.91 -59.99 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 104' ' ' ILE . 24.5 mttm -109.33 145.88 35.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 37' ' ' GLU . 5.2 m-85 -137.58 147.34 44.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 139.07 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.55 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 16.6 p -137.35 155.33 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.983 0.421 . . . . 0.0 111.7 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 62' ' ' ILE . 21.5 t -135.3 125.82 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -95.83 132.93 40.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 58' ' ' ALA . 22.4 t -138.32 122.45 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.86 170.53 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.24 38.72 1.72 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -152.56 128.16 5.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.895 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.71 -167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.412 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 HD13 ' A' ' 98' ' ' LEU . 36.5 t -78.54 -60.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.195 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.72 -44.78 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.48 -46.31 83.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.832 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.94 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.841 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -58.7 -35.94 73.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -66.37 -32.98 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 tp10 -87.19 -41.74 13.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.14 -37.01 66.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 10.9 mmt -57.85 -44.03 99.08 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.5 Cg_endo -70.09 -32.52 17.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.919 1.746 . . . . 0.0 112.16 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -70.25 -45.16 67.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 HG23 ' A' ' 44' ' ' VAL . 1.1 tt -77.48 -36.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.249 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.645 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 mtt -66.21 -41.88 89.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.761 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -58.85 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.727 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -67.88 -46.62 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 63' ' ' MET . 32.3 m -69.85 -27.77 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.32 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.32 99.63 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.98 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 69' ' ' THR . 3.7 t -164.19 88.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -113.06 -12.49 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.14 40.9 8.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.966 0.413 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -147.76 -46.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.42 30.45 4.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.009 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 108' ' ' PHE . 27.0 m -100.44 153.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.333 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.12 81.43 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mtt -63.1 -48.05 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.46 53.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.6 tpt 62.39 147.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 80' ' ' VAL . 7.3 m -164.02 130.67 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 79' ' ' THR . 36.7 t 64.02 136.67 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 80' ' ' VAL . 22.0 Cg_endo -61.12 134.06 50.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.454 2.102 . . . . 0.0 112.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.22 136.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.241 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.01 160.29 19.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.357 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -127.03 154.27 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.106 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -90.17 136.7 32.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 98' ' ' LEU . 33.7 m -132.23 123.7 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -98.31 102.98 15.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.767 ' HA ' HD23 ' A' ' 94' ' ' LEU . 85.6 Cg_endo -77.5 140.76 19.37 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.485 2.124 . . . . 0.0 112.271 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.35 163.0 14.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -15.9 63.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.354 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -85.23 4.22 35.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.589 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 90.67 -16.04 59.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.849 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -95.84 162.93 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 88' ' ' PRO . 95.9 mt -92.91 171.72 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -103.82 157.8 16.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -80.51 61.06 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -161.96 109.24 1.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -125.97 146.16 49.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.236 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.26 115.72 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.339 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -81.19 141.36 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -121.67 132.16 54.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 19.3 t80 -121.57 134.86 55.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.016 0.436 . . . . 0.0 111.377 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.65 118.06 34.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 40' ' ' LYS . 28.1 mt -84.44 136.35 40.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.7 Cg_endo -65.68 154.25 74.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 109' ' ' GLN . 34.2 m120 -51.6 -26.63 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -56.9 -32.9 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HE2' HG11 ' A' ' 74' ' ' VAL . 32.7 m-85 -116.04 -1.09 12.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 106' ' ' ASN . 1.2 pp0? -54.06 -34.26 59.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.815 0.341 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.58 -34.04 88.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.765 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.91 84.08 0.52 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.316 . . . . 0.0 110.972 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 32.5 Cg_exo -58.97 160.37 18.62 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.174 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 3.5 Cg_exo -73.98 152.13 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.686 2.257 . . . . 0.0 112.004 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 121.11 79.54 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.318 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 119.9 6.2 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.473 2.115 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -64.55 -39.81 94.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.407 ' CB ' HG23 ' A' ' 120' ' ' VAL . 2.0 m-20 -58.32 112.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.402 . . . . 0.0 110.875 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -26.73 61.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -81.73 -28.81 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 44' ' ' VAL . 39.2 t -85.28 115.91 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -120.83 156.95 30.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 40' ' ' LYS . 24.6 mm -103.44 131.37 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.95 129.93 45.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -89.01 126.44 35.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.8 ttm180 58.05 -173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 10.2 tt0 84.86 78.08 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 169.41 52.81 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.195 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.98 142.99 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -119.22 134.0 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.051 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 187' ' ' LEU . 36.0 m -139.7 164.61 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.675 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -107.77 133.48 52.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.265 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -105.76 140.23 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.273 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -130.99 139.13 49.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.74 130.31 56.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 31.5 p90 -139.29 -177.81 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.56 110.87 1.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.469 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -176.74 -133.28 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.4 103.31 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.753 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.06 150.11 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.98 -47.89 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.683 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.509 ' CG ' HD12 ' A' ' 94' ' ' LEU . 72.1 tt0 -162.05 -69.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.511 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.62 72.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.522 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.95 -34.98 78.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.011 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -40.6 98.17 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.3 t -53.76 -38.71 36.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.54 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.45 -37.86 74.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.774 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 24.0 m-70 -70.23 -43.69 70.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.891 0.377 . . . . 0.0 110.804 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.28 -32.92 72.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.615 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -68.47 -43.36 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.681 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 29' ' ' VAL . 2.7 tp-100 -61.88 -46.1 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.425 ' HG ' HD12 ' A' ' 187' ' ' LEU . 13.3 tp -61.45 -36.95 81.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.42 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.17 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.5 m -69.08 -34.86 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.64 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.431 HG22 ' CE1' ' A' ' 31' ' ' TYR . 5.0 m -57.51 -47.03 83.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.857 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 31' ' ' TYR . 6.4 mt -72.51 -21.21 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.89 -44.91 20.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.335 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.92 35.26 4.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.695 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.2 p -146.32 156.47 49.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.747 0.308 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 -11.05 29.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.696 2.264 . . . . 0.0 112.701 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.23 139.68 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 0.0 111.158 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.2 m -100.51 140.87 34.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.731 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -159.6 156.9 28.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -90.43 136.65 32.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.29 56.98 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.17 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.85 -23.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.12 143.79 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.913 0.387 . . . . 0.0 111.271 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.637 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.2 p90 -142.88 174.07 10.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.8 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 94.9 m-85 -113.79 152.57 30.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.15 146.1 49.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.93 133.38 44.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.465 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.952 0.405 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 7.2 m-80 -133.0 138.97 47.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.632 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -142.92 145.98 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 111.241 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.09 134.44 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.7 m0 -108.07 121.62 45.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.274 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.679 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.4 mt -96.35 139.37 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.433 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.85 129.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 11.6 tttm -88.46 48.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.252 -0.88 . . . . 1.0 111.472 179.817 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.82 ' CG ' ' HB3' ' A' ' 35' ' ' ALA . 8.0 pt20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.802 0.334 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.424 HG11 HG23 ' A' ' 23' ' ' THR . 29.2 t -74.47 112.82 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.586 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.26 -4.03 46.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.27 158.85 6.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.809 0.338 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.424 HG23 HG11 ' A' ' 20' ' ' VAL . 3.0 p -153.29 174.15 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.65 168.96 8.01 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.47 -162.23 28.24 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.691 ' HD2' HG23 ' A' ' 154' ' ' THR . 7.7 mttt -78.39 157.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.932 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -66.56 -26.27 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.96 -34.97 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.08 110.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.6 m -95.16 148.3 22.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -138.5 153.11 48.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 23' ' ' THR . 1.3 mt-10 -146.37 130.45 17.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.18 114.88 23.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 147.52 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.82 ' HB3' ' CG ' ' A' ' 19' ' ' GLN . . . -124.98 130.74 52.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -144.01 144.91 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.32 89.19 3.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -148.63 3.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.89 -111.85 0.69 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.99 152.72 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.343 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -137.7 153.73 49.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 124.0 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 123' ' ' GLU . 81.8 p -112.7 131.94 55.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.418 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.521 HG23 HD12 ' A' ' 62' ' ' ILE . 21.7 t -131.06 125.41 57.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.768 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.1 135.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.566 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.6 t -138.31 116.82 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 173.81 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.23 28.05 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.358 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -152.73 121.58 3.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.71 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.477 2.118 . . . . 0.0 112.177 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.99 HG13 HD13 ' A' ' 98' ' ' LEU . 49.0 t -62.03 -52.83 55.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -63.44 -45.25 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.1 -46.03 75.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.86 -45.14 90.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.34 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -58.34 -35.41 71.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 mtm105 -63.12 -31.55 72.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 109.942 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.7 tp10 -86.97 -33.47 19.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.147 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.71 -40.67 63.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.76 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.507 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.3 mmt -57.61 -44.02 99.23 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 23.3 Cg_exo -64.58 -42.93 14.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.257 1.972 . . . . 0.0 111.913 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.2 -41.28 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.521 HD12 HG23 ' A' ' 44' ' ' VAL . 2.3 tt -76.26 -42.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.372 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -65.04 -31.76 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -69.75 -29.81 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.434 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -71.37 -42.81 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 102' ' ' PHE . 33.8 m -65.96 -28.17 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.11 93.34 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.67 -40.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.37 84.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.726 ' ND2' HG22 ' A' ' 74' ' ' VAL . 34.2 p-10 -125.02 0.43 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.401 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 61.75 39.05 14.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 -47.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.38 52.03 3.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.726 HG22 ' ND2' ' A' ' 70' ' ' ASN . 27.8 m -101.06 -178.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.99 78.47 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.6 mtp -82.0 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.364 . . . . 0.0 110.735 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 78' ' ' MET . . . 75.72 46.13 15.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.759 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 17.8 mmt 67.47 -62.08 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.563 0.221 . . . . 0.0 111.498 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m 78.75 -60.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.94 158.11 76.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.052 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 130.77 36.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.395 2.063 . . . . 0.0 112.118 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 102' ' ' PHE . 6.1 m -87.24 154.06 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.321 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 t -130.72 160.23 34.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.61 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -121.3 154.3 36.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.213 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.43 136.65 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.813 ' HB ' HD22 ' A' ' 94' ' ' LEU . 15.7 m -124.81 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -113.24 93.82 27.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.39 138.79 62.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.598 2.199 . . . . 0.0 112.077 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.97 171.95 9.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.94 -22.11 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.41 -6.07 59.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.442 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.46 -16.05 61.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.767 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.45 133.5 33.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.813 HD22 ' HB ' ' A' ' 86' ' ' VAL . 13.3 mt -62.41 -30.0 70.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.57 -175.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -80.67 90.23 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.34 100.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.99 HD13 HG13 ' A' ' 51' ' ' VAL . 1.6 tt -144.13 135.53 25.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 111.365 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.442 ' HD2' ' CD1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -119.53 115.79 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.032 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.4 t -78.54 141.15 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 99' ' ' LYS . 18.5 m95 -122.39 138.61 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.5 t80 -119.47 146.18 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 111.485 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -102.04 111.1 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.718 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.0 mt -92.25 136.34 25.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 38.0 Cg_endo -66.36 154.16 75.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.57 2.18 . . . . 0.0 112.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -55.46 -26.71 43.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.323 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -56.84 -32.89 66.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.22 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -100.54 -4.7 28.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.54 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -45.42 72.69 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.761 0.315 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.13 -26.58 43.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.633 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.74 91.55 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.19 161.1 41.77 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.383 2.055 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 141.75 42.26 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.311 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.0 121.43 79.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.37 141.55 71.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.442 2.095 . . . . 0.0 112.275 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 84.4 p -90.58 -33.4 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -86.98 125.18 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.78 -22.15 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.223 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -31.36 30.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 117' ' ' ASP . 26.0 t -85.44 123.93 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -127.86 156.92 41.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -102.67 111.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HG3' HG21 ' A' ' 43' ' ' THR . 4.7 mm-40 -100.38 130.04 46.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 113.1 24.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.97 126.09 50.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.96 60.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.314 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.77 161.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.96 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -144.25 148.95 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.935 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -103.85 118.67 37.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.581 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 188' ' ' VAL . 13.3 m -143.34 160.65 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.295 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.581 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER -107.89 143.66 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.101 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.9 p -105.96 148.45 27.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.465 ' HB ' HD13 ' A' ' 151' ' ' LEU . 7.5 t -130.46 139.82 50.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.418 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.26 125.24 51.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.156 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 15.2 p90 -143.04 -169.6 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.421 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -46.58 138.48 7.96 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.83 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.17 170.32 55.08 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.722 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 61.05 100.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -127.2 152.93 46.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -105.62 -82.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 94' ' ' LEU . 53.5 tt0 -154.83 -61.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.93 -33.83 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.61 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.99 -34.96 77.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.987 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -42.4 96.32 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.917 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.2 t -53.9 -38.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.671 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.12 70.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.716 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 18.3 m170 -70.06 -46.1 65.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.82 -32.92 73.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -73.01 -42.16 63.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -46.06 89.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 133' ' ' THR . 11.6 tp -61.24 -37.07 81.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.5 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -43.2 93.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -68.94 -34.18 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.95 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 26' ' ' LYS . 5.3 m -57.49 -49.28 76.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.581 HD11 ' CE1' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -73.94 -13.92 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.352 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -46.62 -37.61 8.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.4 36.98 3.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 17.6 p -146.19 155.07 50.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.49 -7.75 21.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.839 2.359 . . . . 0.0 112.622 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 127.11 30.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.905 0.383 . . . . 0.0 111.28 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 190' ' ' ALA . 4.9 m -102.52 141.83 34.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -155.03 -177.94 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.988 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.82 -58.44 2.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.27 -16.48 57.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.941 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.82 -87.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.723 0.262 . . . . 0.0 111.015 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.06 138.4 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.841 0.353 . . . . 0.0 111.63 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.888 ' HB3' HD23 ' A' ' 187' ' ' LEU . 48.7 p90 -144.96 174.7 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.359 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.719 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 58.1 m-85 -119.38 161.99 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.669 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 m -139.36 151.65 46.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 128.45 38.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.168 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.804 179.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -120.69 148.94 43.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -142.81 155.62 44.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 133' ' ' THR . 9.3 t -129.6 115.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.462 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.49 124.4 50.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.968 0.413 . . . . 0.0 110.968 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 167' ' ' TYR . 8.1 mt -91.19 140.34 29.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.6 t -74.75 126.76 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -177.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 1.0 111.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.776 0.322 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.49 113.63 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 129' ' ' THR . 12.4 mt -95.03 -14.56 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.503 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -169.63 164.06 10.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 p -152.23 -178.35 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.764 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.98 -125.43 7.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 131.97 -95.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.626 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -161.52 163.98 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.3 69.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.77 -35.16 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.315 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.18 108.07 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.364 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.34 140.89 31.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -138.68 162.31 34.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.775 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -143.83 127.7 17.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -86.29 115.01 23.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -132.93 129.39 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.93 139.18 42.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 m -138.28 -178.23 5.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER 63.74 134.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.0 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.24 -41.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.64 -118.51 3.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.65 142.74 51.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.882 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 37' ' ' GLU . 49.9 m-85 -137.69 161.85 35.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -100.95 140.3 35.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.766 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.8 p -133.76 137.87 45.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 111.146 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.925 HG23 HD12 ' A' ' 62' ' ' ILE . 11.3 t -125.94 125.89 68.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -95.98 127.7 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 58' ' ' ALA . 11.6 t -138.17 116.92 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -109.11 176.51 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.819 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.25 30.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.319 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -152.63 121.91 3.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.82 -179.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.464 2.109 . . . . 0.0 112.246 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.3 t -61.87 -55.26 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.315 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.74 -43.82 92.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -46.06 75.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.186 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.15 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.271 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.6 mt -58.77 -35.59 73.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -63.81 -34.58 78.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.96 0.41 . . . . 0.0 109.964 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.6 tp10 -87.14 -28.81 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.63 -42.7 61.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.558 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.712 ' HE1' HG11 ' A' ' 82' ' ' VAL . 7.5 mmt -57.76 -43.6 98.83 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.65 -43.5 38.32 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.105 1.87 . . . . 0.0 111.863 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -70.37 -42.18 72.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 44' ' ' VAL . 1.3 tt -76.22 -35.12 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.476 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mtp -66.31 -31.97 73.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -64.3 -47.6 78.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 21.3 t80 -60.26 -53.92 51.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.594 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.788 HG21 ' HG3' ' A' ' 78' ' ' MET . 29.3 m -66.24 -28.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.012 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.78 -89.05 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.356 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.62 55.06 0.47 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.536 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' THR . 21.1 m -126.69 38.14 4.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.841 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -126.58 167.24 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.98 10.46 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.28 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -92.56 -30.4 15.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 43.29 38.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 113' ' ' PRO . 31.3 m -101.27 -178.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.21 88.4 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.1 mtm -96.71 107.57 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.66 -24.67 12.92 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.749 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.788 ' HG3' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER 65.89 147.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 111.05 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -93.48 168.78 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.483 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 17.6 t -85.84 -45.9 0.6 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.512 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD2' HG22 ' A' ' 79' ' ' THR . 24.2 Cg_exo -63.63 144.69 90.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.309 2.006 . . . . 0.0 112.025 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.712 HG11 ' HE1' ' A' ' 59' ' ' MET . 10.4 t -152.98 143.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.4 p -117.21 146.08 43.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.711 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -128.98 154.4 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.195 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -99.69 136.69 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.453 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HD12 ' A' ' 98' ' ' LEU . 22.6 m -125.24 135.3 64.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -103.0 95.79 7.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.297 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.803 ' HA ' HD23 ' A' ' 94' ' ' LEU . 74.4 Cg_endo -74.55 148.89 38.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.082 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 171.99 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -6.16 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.415 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 91.22 -16.04 59.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.751 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.7 p -81.3 113.03 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.811 0.338 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -73.07 148.97 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -125.85 68.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mttt 56.07 -163.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 69.4 109.45 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.759 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.7 tt -144.07 134.41 24.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -110.51 115.57 29.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.725 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.3 t -78.8 141.21 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 111.508 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -119.48 121.91 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 64.8 t80 -105.59 155.41 19.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.614 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -116.04 107.8 15.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.7 mt -79.46 136.59 56.04 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.267 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 104' ' ' ILE . 27.7 Cg_endo -62.09 154.13 64.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.322 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -55.57 -27.47 49.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -62.68 -33.21 74.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -107.26 -14.48 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -53.15 -44.04 67.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.741 0.305 . . . . 0.0 111.061 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.16 66.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.455 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.78 91.18 0.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 160.98 47.69 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.542 2.161 . . . . 0.0 112.266 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.687 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.6 Cg_exo -70.85 149.87 60.66 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.697 2.265 . . . . 0.0 111.973 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.21 111.71 7.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 32.2 Cg_exo -59.59 167.39 6.65 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.506 2.138 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.5 m -145.92 34.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.6 123.61 17.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.0 -26.01 61.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.0 -30.52 31.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.39 114.01 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 150.98 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.4 132.72 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.78 160.12 14.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -149.4 140.82 23.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.082 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.57 18.27 9.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.27 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.11 160.21 32.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.92 119.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.458 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.23 143.9 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.756 HG21 HD12 ' A' ' 21' ' ' LEU . 28.1 m -103.87 123.54 47.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.512 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.905 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.9 m -133.13 170.16 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.008 0.433 . . . . 0.0 111.729 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.751 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -134.46 125.94 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.945 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.4 p -105.76 143.88 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.104 0.478 . . . . 0.0 111.785 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -122.69 139.28 54.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.086 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -116.63 143.64 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 13.2 p90 -143.14 -46.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.603 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.99 -131.32 1.62 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -148.37 33.12 1.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.04 62.15 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 183' ' ' ASN . . . -136.5 135.57 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 71.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.867 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.514 ' HG2' HD12 ' A' ' 94' ' ' LEU . 27.1 tt0 64.36 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.24 63.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.02 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 2.1 t70 -69.06 -34.88 75.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.174 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.469 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.9 OUTLIER -62.75 -38.95 92.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.466 0.65 . . . . 0.0 109.652 179.203 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.2 t -53.91 -38.99 38.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.597 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.45 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.801 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 37.1 m-70 -68.74 -40.91 79.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.21 -32.75 72.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.78 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -62.95 -44.14 96.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.01 -46.04 90.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.706 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 151' ' ' LEU . 8.1 tp -59.23 -42.23 90.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -59.29 -48.07 83.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.401 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.4 m -63.76 -47.01 82.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.173 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 31' ' ' TYR . 6.7 m -57.82 -40.96 81.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.755 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.496 HD11 ' CE1' ' A' ' 131' ' ' TYR . 11.5 mt -72.73 -14.57 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.491 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.77 126.9 11.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.67 34.72 11.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.206 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 16.1 p -145.55 159.89 46.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.561 0.22 . . . . 0.0 110.66 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 5.7 Cg_endo -47.88 -22.95 3.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.868 2.379 . . . . 0.0 112.541 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.751 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -56.58 106.13 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 53.4 m -101.94 -0.66 33.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.735 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 9.3 m-85 59.67 147.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.52 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.68 -173.5 4.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.54 62.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.776 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.64 75.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.762 0.315 . . . . 0.0 111.389 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.7 p -161.72 81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.233 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.483 ' CZ ' HG21 ' A' ' 86' ' ' VAL . 45.5 p90 -99.54 166.22 11.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.846 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.804 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 16.5 m-85 -115.6 161.95 17.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 67.3 m -121.33 130.85 53.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 184' ' ' GLU . . . -132.07 156.33 46.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.33 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 4.2 m-80 -133.16 134.97 44.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.965 0.412 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 4.6 mt-10 -146.01 157.12 43.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.11 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 144' ' ' TYR . 11.3 t -136.68 138.03 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.808 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -140.78 121.79 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 167' ' ' TYR . 11.8 mt -91.57 140.09 30.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.905 ' HA ' HG12 ' A' ' 130' ' ' VAL . 6.6 t -75.69 131.0 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.403 ' CG ' ' CE2' ' A' ' 131' ' ' TYR . 32.2 mtpt -74.34 150.16 40.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.36 -0.829 . . . . 1.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.02 112.94 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.4 -9.7 29.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -169.9 163.15 9.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -152.16 -173.28 4.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.7 -114.63 4.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 116.19 -112.03 2.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.57 162.69 30.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -30.21 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.195 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -90.66 -35.06 15.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.192 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.21 110.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.907 0.384 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.9 m -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.2 p90 -138.78 158.84 43.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 23' ' ' THR . 6.1 mt-10 -143.98 138.68 28.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.79 117.56 25.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -131.98 144.04 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.05 110.29 13.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.3 t -82.58 151.57 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.03 139.53 49.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.32 -106.96 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.2 -60.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -104.46 134.46 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.002 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -137.63 153.14 49.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.89 117.97 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.2 p -112.7 133.49 54.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.323 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.654 HG23 HD12 ' A' ' 62' ' ' ILE . 21.8 t -125.95 125.45 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -100.81 133.93 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.48 116.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.41 175.79 5.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.21 34.21 0.66 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.509 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -152.17 135.46 9.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.83 -158.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.528 2.152 . . . . 0.0 112.207 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.4 t -87.11 -53.53 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.24 -43.23 87.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -46.42 74.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.99 92.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 84' ' ' PHE . 4.3 mt -57.76 -35.24 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -62.65 -30.93 71.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.979 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.7 tp10 -88.18 -33.19 18.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.55 -43.21 60.46 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.655 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.0 mmt -57.75 -43.63 98.86 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.5 Cg_exo -57.28 -45.6 33.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.106 1.87 . . . . 0.0 112.262 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -70.33 -42.59 71.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.518 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.654 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.48 -32.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.446 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -41.06 91.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -40.88 91.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 64.8 t80 -59.63 -50.7 72.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 63' ' ' MET . 34.7 m -66.0 -27.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.66 104.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.01 -54.33 0.51 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -144.99 87.75 1.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -110.9 -29.17 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.0 m-20 84.63 -22.09 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.582 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -32.09 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.65 64.24 1.01 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.414 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' HG2' ' A' ' 113' ' ' PRO . 18.2 m -139.61 141.06 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.53 55.62 0.58 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.347 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.405 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -58.61 -34.75 71.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.67 -159.38 42.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 mtt -97.55 112.98 24.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.359 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 HG23 ' A' ' 80' ' ' VAL . 12.5 m -111.01 122.87 48.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 79' ' ' THR . 22.0 t 63.85 141.6 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 33.7 Cg_exo -59.75 130.82 36.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.272 1.981 . . . . 0.0 112.257 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' A' ' 102' ' ' PHE . 7.0 m -87.29 139.28 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.9 149.75 36.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.566 ' HD2' HD11 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -123.99 144.34 49.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -82.72 140.44 33.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.663 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 29.1 m -109.95 -28.09 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.44 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' HG21 ' A' ' 166' ' ' VAL . 96.8 m-85 55.91 91.77 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.529 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HA ' HD23 ' A' ' 94' ' ' LEU . 71.9 Cg_endo -77.18 141.61 20.83 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.637 2.224 . . . . 0.0 112.007 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.61 166.15 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.36 -15.89 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.278 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 3.48 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 86.92 -1.84 86.94 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.976 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 p -131.52 161.72 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.86 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.2 mt -87.54 154.32 20.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.531 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -140.57 84.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 45.53 93.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.6 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.71 101.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.555 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.683 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -143.72 143.87 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.91 115.66 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.914 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.563 HG21 ' HB1' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -86.68 137.35 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.579 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -117.96 141.04 48.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.307 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.677 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 48.5 t80 -124.2 151.47 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.975 0.417 . . . . 0.0 111.388 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtp180 -115.96 107.84 15.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.654 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.406 HG23 ' HD2' ' A' ' 105' ' ' PRO . 28.1 mt -82.08 136.4 47.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 104' ' ' ILE . 28.3 Cg_endo -62.32 154.14 65.61 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.555 2.17 . . . . 0.0 112.334 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -52.48 -26.8 13.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.15 66.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 110.976 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.618 ' HE2' HG11 ' A' ' 74' ' ' VAL . 88.9 m-85 -115.95 -9.75 11.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.33 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.08 -48.08 71.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.765 0.317 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -26.54 56.33 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 t -174.5 88.08 0.33 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 44.0 Cg_endo -68.36 160.45 49.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.552 2.168 . . . . 0.0 112.353 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.681 ' HG2' HG21 ' A' ' 74' ' ' VAL . 5.0 Cg_exo -74.19 159.29 44.25 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 112.026 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.34 111.24 6.19 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.978 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 65' ' ' TYR . 60.8 Cg_endo -72.62 162.36 41.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.513 2.142 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.52 179.73 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.66 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.46 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -16.88 30.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.1 p -80.2 -28.57 38.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.673 0.273 . . . . 0.0 111.213 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.62 114.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 111.157 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 156.97 32.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.19 125.25 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.9 129.94 45.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -89.14 125.27 34.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.9 OUTLIER 58.9 -177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.8 tt0 83.09 76.99 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.5 -175.12 50.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -143.99 143.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.249 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.9 m -115.31 118.98 34.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 188' ' ' VAL . 36.0 m -144.11 163.99 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.434 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -107.78 137.85 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.212 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -105.87 146.47 29.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 0.0 111.56 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -131.19 139.23 49.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.438 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -116.6 132.09 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 4.3 p90 -139.72 156.28 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.36 33.57 5.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -107.02 -36.48 2.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.83 133.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.19 -175.86 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -133.59 -66.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.563 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.7 tt0 -141.72 -72.92 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.82 75.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -34.56 77.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -40.33 96.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.568 0.699 . . . . 0.0 109.807 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -53.84 -38.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.668 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.29 -35.78 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.719 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.509 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.17 -42.45 72.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.0 m -63.4 -42.28 98.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.801 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.16 94.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.871 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 187' ' ' LEU . 8.2 tp -60.55 -40.45 91.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -42.38 94.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.8 m -68.64 -35.72 77.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 41.5 m -57.61 -49.09 77.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 5.6 mt -73.62 -11.12 60.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.259 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -47.03 -43.16 19.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.59 36.56 3.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 30.8 p -145.64 154.29 52.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 48.3 Cg_endo -68.78 -10.79 30.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.621 2.214 . . . . 0.0 112.633 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 126.86 29.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.4 m -101.95 160.08 14.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -155.27 151.46 28.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.035 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -55.5 -56.53 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.295 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.91 50.96 11.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.103 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 -22.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.452 HG21 ' CE1' ' A' ' 87' ' ' PHE . 12.8 p -158.81 141.95 5.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.7 ' HB3' HD23 ' A' ' 187' ' ' LEU . 12.2 p90 -140.79 166.59 24.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 36.2 m-85 -118.37 159.38 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.405 ' O ' ' CE1' ' A' ' 84' ' ' PHE . 42.9 m -127.53 130.89 49.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.99 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -107.9 142.98 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.62 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.772 0.32 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -108.67 145.23 35.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.18 157.19 43.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.473 HG13 ' HD2' ' A' ' 167' ' ' TYR . 21.4 t -139.22 114.9 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.428 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 5.6 m0 -110.03 124.35 51.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 ' HB3' ' A' ' 167' ' ' TYR . 63.5 mt -91.65 140.41 29.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.471 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.677 ' HA ' HG12 ' A' ' 130' ' ' VAL . 24.2 t -74.58 123.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.937 0.399 . . . . 0.0 111.168 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 7.0 tttp -72.07 149.81 44.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.173 -0.918 . . . . 1.0 111.089 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.743 0.306 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.28 112.98 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 35' ' ' ALA . 8.7 mt -86.92 -19.12 29.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.78 167.08 9.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.784 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -168.69 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.57 -118.69 5.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.28 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 99.72 158.81 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.74 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -78.8 163.69 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.6 -29.83 69.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.031 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -35.35 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.102 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.24 107.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.277 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 64.1 m -100.58 157.95 16.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.9 p90 -139.49 160.97 38.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.9 125.74 12.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -86.1 135.1 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 136.34 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -122.96 126.5 47.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.86 163.46 27.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.56 -77.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.99 -174.14 54.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.522 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.89 -89.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mptt -96.84 137.68 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.808 0.337 . . . . 0.0 110.857 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 24.0 m-85 -137.49 157.66 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.065 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.99 140.21 29.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.0 p -133.44 131.83 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 111.252 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.605 HG23 HD12 ' A' ' 62' ' ' ILE . 23.2 t -126.62 125.49 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.906 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.97 139.48 34.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.1 t -138.24 118.04 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.11 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 166.93 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.55 33.85 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.93 123.6 3.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.771 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.85 -69.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.332 2.021 . . . . 0.0 112.353 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG13 ' CD1' ' A' ' 98' ' ' LEU . 45.0 t -156.5 -63.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.05 -45.14 79.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -67.09 -46.15 75.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.012 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.822 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.96 -42.25 89.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.281 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.861 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.2 mt -56.88 -35.31 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.08 -31.56 72.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -88.12 -34.01 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.75 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.64 -42.46 61.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.762 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.473 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 22.9 mmt -57.67 -43.81 99.05 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 39.3 Cg_exo -60.52 -43.45 33.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.433 2.089 . . . . 0.0 112.313 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -70.22 -43.63 70.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.27 -41.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.612 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.52 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.87 -31.88 73.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.01 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 63' ' ' MET . 20.3 mmtt -66.34 -32.27 73.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.975 0.417 . . . . 0.0 110.324 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 90.4 t80 -67.9 -32.6 73.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.597 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.591 HG11 ' CE2' ' A' ' 102' ' ' PHE . 18.1 m -90.08 -10.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.66 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.2 44.47 2.81 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.836 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.11 44.98 51.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.999 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -126.91 61.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -111.93 -22.3 11.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.191 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.25 4.57 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.1 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -94.02 -29.59 15.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.18 37.73 4.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.187 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.744 HG21 ' HG3' ' A' ' 113' ' ' PRO . 28.4 m -98.48 -178.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.078 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.29 76.1 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.413 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.1 mtp -96.13 106.17 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 29.59 11.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt 61.25 156.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 80' ' ' VAL . 4.8 m -164.65 124.99 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.07 137.3 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 80' ' ' VAL . 19.2 Cg_endo -60.06 147.73 91.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.583 2.189 . . . . 0.0 112.098 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.93 153.76 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.519 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.444 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 1.8 t -135.69 168.16 19.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.418 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.861 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.07 154.1 49.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -97.06 136.68 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.45 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 166' ' ' VAL . 28.7 m -123.14 141.9 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.003 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -115.21 89.81 22.05 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.089 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.725 ' HA ' HD23 ' A' ' 94' ' ' LEU . 19.4 Cg_exo -65.99 149.66 85.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.68 2.253 . . . . 0.0 112.188 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.7 161.87 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.27 -19.71 55.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -5.97 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.364 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.05 66.78 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 m -94.57 155.17 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 88' ' ' PRO . 16.5 mt -105.72 131.46 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -82.06 170.93 14.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 65.99 5.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -144.35 96.03 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.564 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.85 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -122.94 136.96 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.242 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 115.87 19.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.301 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.75 HG21 ' HB1' ' A' ' 58' ' ' ALA . 1.7 t -87.37 116.82 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.174 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -98.16 142.02 30.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.822 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.9 t80 -123.88 145.6 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 6.5 ptp180 -108.75 110.51 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 108' ' ' PHE . 21.9 mt -89.59 137.78 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HD2' HG23 ' A' ' 104' ' ' ILE . 7.8 Cg_endo -49.91 154.04 5.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 m-80 -58.79 -27.04 64.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.301 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -61.19 -33.01 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.488 ' HB2' HG22 ' A' ' 104' ' ' ILE . 72.6 m-85 -102.01 -8.98 21.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.751 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.73 -34.2 58.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.798 0.332 . . . . 0.0 111.093 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.57 -33.36 81.57 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.1 p -177.5 98.1 0.23 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.583 0.23 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.36 152.97 75.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.744 ' HG3' HG21 ' A' ' 74' ' ' VAL . 56.2 Cg_endo -71.41 159.0 52.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.602 2.201 . . . . 0.0 112.44 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.43 118.38 56.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 47.6 Cg_endo -68.37 146.71 69.75 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.422 2.081 . . . . 0.0 112.365 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -77.34 -40.05 45.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.865 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -77.81 114.89 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.021 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.59 -19.11 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 m -80.65 -17.06 52.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.321 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HB3' ' A' ' 117' ' ' ASP . 35.7 t -84.74 113.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 157.02 18.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.931 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 mm -122.56 123.5 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.82 129.85 45.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.56 130.95 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 60.33 111.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.98 90.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.48 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.381 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.66 142.94 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.21 42.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.89 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -132.77 168.63 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.554 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 12.4 m-85 -107.73 160.24 15.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.0 p -124.4 130.32 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.252 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.478 ' HB ' HD13 ' A' ' 151' ' ' LEU . 9.4 t -131.08 138.31 49.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.705 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -122.13 142.65 50.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -152.11 167.76 27.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.47 96.94 1.82 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.7 15.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -95.89 -177.66 4.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 147' ' ' HIS . . . -157.41 148.56 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.265 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -134.35 65.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.654 ' HG2' HD12 ' A' ' 94' ' ' LEU . 12.3 tt0 67.33 -72.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.027 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.13 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.37 -34.88 76.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -62.9 -39.12 93.54 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.427 0.632 . . . . 0.0 109.881 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.5 t -54.03 -38.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.457 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.24 69.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.715 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.572 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 35.8 m170 -70.1 -45.33 67.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.82 72.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.0 m -69.31 -38.24 78.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -44.81 91.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 31' ' ' TYR . 12.4 tp -58.02 -38.35 76.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.394 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -61.28 -43.82 98.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -61.71 -40.34 94.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.018 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.7 m -57.82 -46.14 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.779 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.419 HD13 ' HB1' ' A' ' 160' ' ' ALA . 7.7 mt -73.65 -10.34 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.796 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.8 OUTLIER -47.3 106.03 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 141.18 -39.05 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -94.9 -179.15 0.9 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.9 Cg_endo -85.52 35.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.414 2.076 . . . . 0.0 112.803 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -60.47 109.24 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.241 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.83 165.71 11.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -154.7 16.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.713 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.681 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 3.6 mt-30 53.52 -83.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.6 0.238 . . . . 0.0 111.397 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -127.84 34.36 3.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.78 25.54 12.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.681 0.277 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 86' ' ' VAL . 14.5 p -79.71 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.103 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 187' ' ' LEU . 50.2 p90 -140.4 -176.72 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.696 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 44.8 m-85 -119.25 159.83 23.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 3.7 m -134.6 152.8 52.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.89 155.91 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.926 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.759 0.314 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.78 149.39 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.73 148.6 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.408 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.557 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.2 t -135.11 116.27 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.93 125.5 51.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.386 . . . . 0.0 111.103 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 167' ' ' TYR . 73.0 mt -91.68 137.23 32.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HA ' HG12 ' A' ' 130' ' ' VAL . 23.5 t -74.89 131.18 35.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -101.43 103.54 14.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.186 -0.911 . . . . 1.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.844 0.354 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.64 125.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.19 -16.53 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.392 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -169.75 165.41 9.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -152.05 -176.55 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.72 -110.86 2.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.4 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 105.65 -133.01 11.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.563 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -161.56 165.41 28.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.737 0.303 . . . . 0.0 110.809 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.45 -29.44 69.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.79 -35.14 15.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.223 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.21 108.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.1 140.31 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -139.24 161.96 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.17 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG2' HG22 ' A' ' 23' ' ' THR . 26.1 mt-10 -147.24 130.23 16.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.71 121.76 29.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 133.37 34.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.76 113.3 19.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -127.63 156.21 42.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.0 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.22 84.31 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.54 -151.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.8 -86.11 1.88 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.9 mttm -123.62 149.1 45.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -137.58 153.58 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -106.08 132.0 52.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.793 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 101' ' ' TRP . 65.0 p -112.53 140.43 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.79 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 17.6 t -128.44 125.47 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -100.07 134.06 43.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.652 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 54' ' ' ALA . 11.3 t -138.19 116.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.9 0.381 . . . . 0.0 111.208 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.99 167.03 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 t0 58.84 31.79 21.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -151.15 124.93 4.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.794 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.76 -67.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.282 1.988 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.458 ' O ' HD23 ' A' ' 55' ' ' LEU . 61.1 t -156.2 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.805 0.335 . . . . 0.0 111.183 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.85 -40.86 73.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.79 -46.44 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 110.335 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -60.74 -36.81 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.387 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.821 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -56.79 -35.7 69.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.945 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -64.79 -28.33 69.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.621 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.7 tp10 -86.89 -43.57 12.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.517 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 44' ' ' VAL . . . -73.34 -33.7 65.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.605 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 23.6 mmt -58.03 -43.85 98.82 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -66.44 -30.95 43.41 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.952 1.768 . . . . 0.0 112.12 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -38.81 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.427 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 44' ' ' VAL . 36.2 mm -77.65 -38.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.783 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -46.09 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -64.43 -30.41 71.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -65.35 -47.37 76.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 15.7 m -84.25 -30.22 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.53 -115.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.04 47.3 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.443 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 4.9 m -152.68 76.19 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -134.09 11.32 3.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.352 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.09 30.21 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -148.68 -47.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.56 33.62 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 m -100.66 149.7 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.13 76.3 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mtp -60.09 -42.92 95.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.387 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.09 -126.77 13.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmt -120.55 146.65 46.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 105' ' ' PRO . 1.1 m -157.14 107.82 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 21.1 t 64.12 141.67 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 34.5 Cg_exo -59.73 130.79 36.68 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.323 2.016 . . . . 0.0 112.133 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 m -87.36 136.71 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.6 p -126.15 163.44 23.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.821 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -133.0 153.41 51.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.718 0.294 . . . . 0.0 111.3 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.99 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -89.55 136.86 32.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.145 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.807 HG12 HD12 ' A' ' 98' ' ' LEU . 31.6 m -120.06 136.71 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.44 96.82 14.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 94' ' ' LEU . 80.5 Cg_endo -77.23 135.72 15.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -90.26 172.07 9.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.63 -15.98 63.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.12 -6.24 59.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.386 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.08 -16.01 56.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.998 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -96.54 117.13 30.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.464 HD12 ' OE2' ' A' ' 141' ' ' GLU . 6.9 mt -56.5 114.48 2.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -57.56 172.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -80.53 73.76 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 117.27 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.603 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 86' ' ' VAL . 1.1 tt -144.05 140.15 29.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.453 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -123.92 115.91 22.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.79 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 3.2 p -98.72 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CD2' HG22 ' A' ' 43' ' ' THR . 25.4 m95 -113.03 142.28 45.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.492 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 85.8 t80 -108.8 160.71 15.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 111.362 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 108.01 15.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.544 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.524 HD12 ' HB2' ' A' ' 40' ' ' LYS . 33.0 mt -80.54 136.68 52.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.516 ' HA ' HG21 ' A' ' 79' ' ' THR . 29.0 Cg_endo -62.87 154.04 69.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.699 2.266 . . . . 0.0 112.597 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -58.72 -26.68 64.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.302 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -32.83 65.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.65 9.3 29.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.788 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -55.43 -42.81 74.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.64 -34.04 68.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 100.77 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.541 0.21 . . . . 0.0 110.934 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.29 160.76 47.58 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.363 2.042 . . . . 0.0 112.257 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.68 153.38 54.12 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.692 2.261 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.66 119.01 62.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.05 146.69 36.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.329 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 t -88.04 -33.54 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.796 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -87.75 122.43 31.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -22.23 47.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -81.66 -25.85 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.796 HG23 ' HB3' ' A' ' 117' ' ' ASP . 31.1 t -85.21 125.48 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.099 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -121.79 157.05 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.419 ' CG2' ' HD2' ' A' ' 40' ' ' LYS . 26.5 mm -111.67 121.75 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.92 160.29 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.6 151.25 33.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.022 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.2 ttt180 62.33 166.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.3 tm-20 83.49 129.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.64 155.33 16.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.438 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.11 142.92 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -110.07 118.8 37.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.666 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 188' ' ' VAL . 28.1 m -140.36 166.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.261 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.827 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -107.81 137.72 45.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.2 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 p -105.95 143.1 34.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -131.05 139.19 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.628 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.95 141.44 48.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.028 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 52.0 p90 -161.43 134.64 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.89 91.56 1.69 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.19 177.32 44.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.98 160.13 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -160.96 133.38 6.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.75 76.55 1.59 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' OE2' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 67.53 -71.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.104 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -33.92 62.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.194 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 4.8 m-20 -68.48 -37.56 80.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -62.95 -41.02 99.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.322 0.582 . . . . 0.0 110.08 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.99 -38.64 37.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.245 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.28 70.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.806 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-70 -70.16 -44.57 68.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.83 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.806 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.3 m -70.58 -43.3 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -58.96 -46.17 88.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 187' ' ' LEU . 13.3 tp -62.4 -41.75 98.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -46.17 89.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.724 HG23 ' OE1' ' A' ' 156' ' ' GLU . 98.1 m -61.85 -43.63 98.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.999 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.495 HG22 ' HE2' ' A' ' 31' ' ' TYR . 2.9 m -57.82 -38.85 76.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.859 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -16.6 61.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.881 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.724 ' OE1' HG23 ' A' ' 153' ' ' THR . 47.1 mt-10 -46.94 144.16 2.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.838 0.352 . . . . 0.0 111.269 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.7 -30.89 8.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.103 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 1.2 p -94.93 176.15 2.46 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.1 Cg_endo -85.77 12.22 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.562 2.174 . . . . 0.0 112.916 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.827 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -59.35 116.29 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 162' ' ' TYR . 1.2 m -100.1 175.44 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -155.47 22.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.595 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 48.66 -87.74 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.504 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -120.96 29.14 5.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.245 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 69.3 21.18 7.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.641 0.258 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.6 p -80.23 139.0 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 111.061 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.895 ' HB3' HD23 ' A' ' 187' ' ' LEU . 24.8 p90 -139.27 178.11 7.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.99 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 97.4 m-85 -119.6 151.4 38.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 m -126.87 130.91 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -113.27 129.19 56.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.583 -179.936 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.898 0.38 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -126.47 133.98 51.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -142.96 156.4 44.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.626 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.5 t -138.98 116.14 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -107.76 121.86 45.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' A' ' 167' ' ' TYR . 43.0 mt -92.91 136.01 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.9 t -74.74 131.53 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 36.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.242 -0.885 . . . . 1.0 111.369 179.846 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.839 0.352 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.36 119.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.51 -3.93 21.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.498 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.14 166.88 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -152.34 -57.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.82 170.0 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.63 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.53 -85.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.5 162.99 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -66.53 -33.21 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -33.2 16.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.97 141.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.33 154.47 50.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.574 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.07 159.77 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.43 121.8 12.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.52 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 39.0 mt-10 -87.02 132.07 33.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -141.98 130.9 23.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.46 124.38 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 p -127.74 -178.33 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.45 167.65 14.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.15 167.29 38.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.61 -85.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -100.9 146.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 110.888 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 6.2 m-85 -137.59 148.04 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 123.49 37.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.697 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -112.64 136.59 52.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.793 ' CG2' HD11 ' A' ' 62' ' ' ILE . 22.9 t -125.96 125.54 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.64 131.32 44.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.154 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 54' ' ' ALA . 12.5 t -138.46 116.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.009 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.424 HG23 ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.22 167.1 13.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.98 23.45 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -152.55 133.22 7.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.3 -177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.518 2.145 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 55' ' ' LEU . 48.3 t -62.71 -70.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -56.15 -40.61 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.92 -46.85 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 110.36 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 46' ' ' VAL . . . -62.35 -36.71 83.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.18 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.974 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -56.91 -35.43 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.074 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -63.57 -27.91 69.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.712 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 tp10 -87.62 -44.35 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.19 -37.28 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.612 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 mmt -57.75 -43.79 98.97 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 59' ' ' MET . 30.8 Cg_endo -65.01 -29.49 57.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.763 1.642 . . . . 0.0 112.062 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HE2' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -70.18 -37.42 75.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.373 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.793 HD11 ' CG2' ' A' ' 44' ' ' VAL . 29.8 mm -77.32 -44.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -43.97 97.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -65.07 -30.69 71.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.7 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.63 -56.87 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.566 HG12 ' SD ' ' A' ' 76' ' ' MET . 26.8 m -72.61 -30.14 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.22 -90.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.405 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.13 71.71 0.24 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 52.4 m -153.52 47.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -110.97 -22.36 11.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.52 2.34 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.475 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -93.55 -35.78 12.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.819 0.343 . . . . 0.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.14 29.98 8.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.42 165.99 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.84 0.353 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.96 2.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.566 ' SD ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 63.76 135.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.917 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.21 169.48 32.65 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.57 155.95 17.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' HG13 ' A' ' 80' ' ' VAL . 97.8 m -135.43 -45.07 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -156.58 164.07 22.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.1 Cg_endo -59.46 130.62 36.48 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.123 1.882 . . . . 0.0 111.668 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.529 HG11 ' HD2' ' A' ' 102' ' ' PHE . 3.6 m -87.58 126.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.889 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 170' ' ' ALA . 16.0 m -119.82 153.14 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.986 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.974 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.62 154.12 33.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 111.591 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -87.18 136.8 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.613 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.897 HG12 HD12 ' A' ' 98' ' ' LEU . 28.8 m -129.47 132.51 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -99.41 100.32 10.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.793 ' HA ' HD23 ' A' ' 94' ' ' LEU . 72.4 Cg_endo -73.99 140.95 29.17 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.515 2.143 . . . . 0.0 112.279 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.11 158.6 17.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.839 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -19.04 61.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.239 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -85.55 -6.07 59.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.44 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.573 ' HA2' HG11 ' A' ' 145' ' ' VAL . . . 96.03 -3.6 64.7 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.018 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -99.98 153.31 19.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 88' ' ' PRO . 58.0 mt -97.42 132.55 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 174.07 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.793 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -80.42 -13.99 58.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.275 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 47' ' ' THR . 0.3 OUTLIER -82.8 123.85 29.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.762 0.315 . . . . 0.0 111.038 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.897 HD12 HG12 ' A' ' 86' ' ' VAL . 2.2 tt -144.05 127.95 17.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 115.9 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.783 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 4.5 p -96.5 139.91 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.445 ' CD2' ' CG2' ' A' ' 43' ' ' THR . 24.9 m95 -116.85 142.37 47.02 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 62.2 t80 -112.51 161.11 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.807 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HG2' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.59 107.92 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.864 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 40' ' ' LYS . 38.1 mt -84.4 137.2 39.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.463 ' HD2' HG23 ' A' ' 104' ' ' ILE . 19.8 Cg_endo -60.32 152.78 64.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.586 2.191 . . . . 0.0 112.388 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 24.5 p-10 -62.07 -26.81 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.259 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -56.76 -42.58 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.279 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -95.87 5.5 51.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.462 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -55.01 -45.93 75.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.739 0.304 . . . . 0.0 111.187 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.06 -26.03 40.7 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.688 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 p -177.09 90.14 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.64 0.257 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 43.9 Cg_endo -68.19 146.72 70.9 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.12 . . . . 0.0 112.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.87 157.4 58.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.497 2.132 . . . . 0.0 111.998 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.95 126.51 92.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HB2' HG11 ' A' ' 120' ' ' VAL . 86.2 Cg_endo -81.23 6.11 5.81 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.642 2.228 . . . . 0.0 113.007 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m 58.12 -177.2 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.781 0.324 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 120' ' ' VAL . 24.0 t0 62.01 117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -20.2 42.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.281 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.6 t -81.07 -31.72 34.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.9 t -85.49 118.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.938 0.399 . . . . 0.0 111.153 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.05 157.21 41.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.0 mm -110.69 112.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -98.9 130.12 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -88.58 91.42 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.36 152.89 39.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.86 166.48 21.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.73 172.29 4.06 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -138.31 143.03 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -108.73 123.22 48.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.515 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 187' ' ' LEU . 13.7 m -131.32 169.76 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.966 0.412 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 7.5 m-85 -107.79 137.14 46.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.82 135.53 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.5 t -128.87 139.08 52.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.0 148.01 41.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 183' ' ' ASN . 22.4 p90 -172.26 -176.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -99.04 -145.2 18.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.37 163.88 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.85 141.81 42.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.727 ' HB2' ' HE1' ' A' ' 147' ' ' HIS . . . -125.43 159.34 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -45.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.686 ' CG ' HD12 ' A' ' 94' ' ' LEU . 32.9 tt0 -167.35 -66.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.485 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.69 73.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.493 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.89 79.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -40.76 98.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 109.909 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.573 HG11 ' HA2' ' A' ' 92' ' ' GLY . 45.6 t -53.85 -38.75 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.707 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -34.73 71.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.778 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.727 ' HE1' ' HB2' ' A' ' 139' ' ' ALA . 24.2 m170 -70.22 -46.09 65.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.02 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.84 74.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.7 m -70.43 -49.98 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.01 -38.65 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.803 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.71 ' HB3' HD11 ' A' ' 187' ' ' LEU . 12.0 tp -58.48 -39.01 78.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -41.35 89.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -41.02 83.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.458 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.574 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.74 -43.71 85.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.533 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 31' ' ' TYR . 2.6 mt -73.02 -13.24 61.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -47.01 -47.15 22.21 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.71 -33.06 62.36 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.446 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.411 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 26.0 p -94.51 167.75 12.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 110.744 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.411 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 0.9 OUTLIER -83.75 40.46 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.197 2.598 . . . . 0.0 112.695 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.29 170.66 1.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.676 HG22 ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -138.56 163.95 30.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 1.2 m-85 -156.23 175.2 14.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -92.93 -55.34 3.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.03 -74.0 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.399 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -159.66 71.08 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.7 p -160.81 136.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.295 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.476 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.1 p90 -139.61 -177.83 5.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 25.7 m-85 -120.66 156.39 31.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.3 131.0 46.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' OG ' ' A' ' 83' ' ' SER . . . -119.66 130.21 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.616 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.774 0.321 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 135' ' ' PHE . 2.9 p30 -119.9 133.84 55.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.781 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -146.26 147.4 31.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.225 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 167' ' ' TYR . 17.3 t -118.84 129.73 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.441 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' HB3' HG21 ' A' ' 130' ' ' VAL . 46.0 m0 -107.9 121.56 45.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.735 ' O ' HG12 ' A' ' 130' ' ' VAL . 73.4 mt -97.33 139.96 32.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 38.4 t -74.94 128.92 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -100.63 125.91 47.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.676 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.694 0.283 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.09 112.86 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.37 -7.15 39.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.725 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.4 167.17 8.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.388 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 p -151.64 -178.59 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.761 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.19 -104.04 0.97 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.44 -94.8 0.55 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.683 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -160.43 163.03 33.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 0.0 110.791 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -66.44 -30.56 70.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.033 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.61 -35.23 15.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 150' ' ' GLN . 3.5 m -146.27 115.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.384 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -95.98 145.2 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -140.92 162.26 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 127.27 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.562 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.433 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 17.2 mt-10 -85.86 126.3 33.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 129' ' ' THR . 8.3 ptp180 -142.03 128.04 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.62 122.16 47.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.7 p -132.14 149.96 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -71.66 -63.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.38 -77.85 1.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.45 -89.78 1.12 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 11.0 mptt -114.67 146.28 41.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -137.63 140.17 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.75 115.9 28.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.115 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.3 p -112.77 155.48 24.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 112.004 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.6 t -136.7 125.9 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -96.07 130.35 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.402 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.0 t -138.27 116.72 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.58 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.89 32.15 2.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -153.15 127.57 4.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.24 -169.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.476 2.117 . . . . 0.0 112.224 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.806 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.9 t -72.5 -53.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.211 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.89 -43.68 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.03 -46.17 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.91 -41.28 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.703 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.0 mt -57.46 -35.57 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -62.92 -35.12 79.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.927 0.394 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 tp10 -87.49 -28.29 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.388 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.783 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.33 -45.17 56.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.679 ' CE ' HG11 ' A' ' 82' ' ' VAL . 34.1 mmt -57.61 -43.46 98.86 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.0 Cg_exo -57.96 -41.55 67.48 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.07 1.847 . . . . 0.0 112.067 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -70.29 -45.5 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.351 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.1 tt -75.59 -27.84 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.418 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -38.67 88.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.907 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -69.24 -56.38 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.41 -29.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.11 -124.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.622 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.17 48.01 0.98 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -142.94 62.54 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -108.99 -24.12 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 79.31 -3.47 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.668 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 -40.56 10.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.84 67.6 1.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.45 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.519 HG21 ' HG3' ' A' ' 113' ' ' PRO . 25.4 m -138.88 -179.45 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.81 117.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.388 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 1.3 mtm -112.73 -161.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.32 -37.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 63.18 120.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.046 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.537 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -60.3 167.86 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.633 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.541 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 13.5 t -87.25 -48.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.404 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 66.7 Cg_endo -91.42 130.38 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.512 2.141 . . . . 0.0 112.528 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' CE ' ' A' ' 59' ' ' MET . 34.4 t -92.86 152.31 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.01 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.6 p -125.1 145.93 49.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.664 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.703 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -132.93 153.99 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.937 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 99' ' ' LYS . . . -95.04 136.67 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 HD12 ' A' ' 98' ' ' LEU . 27.7 m -131.34 126.83 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 166' ' ' VAL . 43.3 m-85 -97.8 99.62 7.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 122.35 9.43 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.39 2.06 . . . . 0.0 112.105 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -89.74 170.81 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.35 -15.81 62.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -0.1 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.23 67.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.887 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.5 p -122.82 160.12 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.518 HD12 ' HG3' ' A' ' 141' ' ' GLU . 5.8 mt -79.09 160.42 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 44.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 52.5 28.36 5.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.326 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -117.49 99.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.806 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.5 tt -127.56 127.73 44.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.978 0.418 . . . . 0.0 111.48 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 85' ' ' ALA . 11.3 ptmt -117.58 116.62 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.469 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.783 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -66.79 141.47 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -120.37 119.17 32.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 61.6 t80 -106.02 153.78 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -112.77 121.83 45.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 105' ' ' PRO . 33.5 mt -96.91 136.75 21.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.6 154.1 56.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.555 2.17 . . . . 0.0 112.357 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.57 -26.85 65.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -56.94 -45.22 82.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.041 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 64.3 m-85 -94.62 -9.79 33.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.395 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.46 -37.4 62.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.11 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -28.88 72.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -171.66 75.93 0.5 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.769 0.319 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.9 Cg_exo -57.05 154.58 32.57 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.533 2.155 . . . . 0.0 112.355 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG3' HG21 ' A' ' 74' ' ' VAL . 5.6 Cg_exo -74.31 152.14 44.08 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.685 2.257 . . . . 0.0 112.094 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.35 93.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.44 135.82 22.9 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.316 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -91.45 50.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.028 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -162.2 118.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.93 -21.75 45.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.193 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 p -81.71 -31.67 32.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.1 t -85.78 122.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.968 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -124.84 152.57 43.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.7 mm -105.09 117.62 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.82 137.06 37.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 104.5 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -169.07 73.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.938 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 30.9 tt0 82.23 139.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.065 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -70.34 -179.96 27.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.241 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.05 142.9 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 111.433 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 5.6 m -112.75 126.74 55.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.331 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 188' ' ' VAL . 22.8 m -133.96 157.49 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 111.54 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' A' ' 155' ' ' LEU . 12.0 m-85 -107.72 141.8 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.7 p -111.91 126.99 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.882 0.372 . . . . 0.0 111.136 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.7 t -123.69 138.82 54.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -116.83 143.68 45.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 12.8 p90 -142.15 -44.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.26 109.47 0.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.1 -137.04 2.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -145.56 92.35 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.933 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.89 136.02 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -105.04 -48.44 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.518 ' HG3' HD12 ' A' ' 94' ' ' LEU . 1.6 tm-20 -166.24 -68.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.694 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.82 67.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -67.98 -34.98 77.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.1 -40.48 96.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 109.998 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.72 -38.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.541 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.1 73.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.761 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.493 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 44.0 m-70 -70.02 -41.42 74.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.761 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.85 73.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.4 m -63.02 -42.62 99.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.708 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB3' HG11 ' A' ' 29' ' ' VAL . 57.4 mm-40 -59.07 -45.94 89.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.593 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.9 tp -61.51 -39.68 91.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.25 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -59.12 -36.32 75.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.271 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -46.2 68.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -49.11 77.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.789 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 131' ' ' TYR . 11.5 mt -74.02 -9.12 58.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.431 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -47.55 -43.24 24.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.261 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.4 -15.08 77.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.762 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 p -93.65 169.23 10.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.003 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 7.9 Cg_exo -72.78 0.58 7.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.046 2.498 . . . . 0.0 112.913 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.12 121.91 11.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.204 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 1.1 m -101.38 -2.21 31.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.115 0.483 . . . . 0.0 111.077 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 50.92 16.26 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.054 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.649 ' H ' ' HB2' ' A' ' 190' ' ' ALA . 1.0 OUTLIER 65.11 -75.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.162 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.58 -78.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.74 68.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 166' ' ' VAL . 11.0 p -161.91 122.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.632 ' HB3' HD23 ' A' ' 187' ' ' LEU . 37.0 p90 -132.91 170.21 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.858 ' CE2' HG22 ' A' ' 188' ' ' VAL . 18.5 m-85 -112.74 157.16 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . 0.44 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.7 m -133.56 130.95 39.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.27 52.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.943 0.401 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -132.94 133.9 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.33 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.88 157.11 43.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.732 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.44 HG13 ' SG ' ' A' ' 169' ' ' CYS . 39.0 t -124.55 139.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.48 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.677 ' CE3' HG21 ' A' ' 130' ' ' VAL . 24.9 m0 -107.62 121.49 44.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.086 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.632 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.2 mt -98.75 133.41 43.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.743 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 168' ' ' TYR . 25.7 t -75.8 118.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.05 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -79.95 147.25 31.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.277 -0.868 . . . . 1.0 111.098 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.03 115.15 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.14 -16.24 20.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.417 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 t -169.72 167.05 9.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -151.86 -175.82 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.72 -173.2 47.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 172.44 -93.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.608 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' VAL . 1.2 mtmm -161.28 166.39 27.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.849 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -66.62 -31.66 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.294 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -31.33 17.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.278 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.7 t -146.03 142.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -134.74 148.82 50.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.724 ' CD2' HD21 ' A' ' 155' ' ' LEU . 1.9 p90 -139.17 162.2 35.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.31 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 23' ' ' THR . 4.5 mt-10 -144.54 122.27 11.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -85.98 118.37 25.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.994 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.07 127.93 35.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.58 128.2 55.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.3 p -100.19 158.93 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -60.2 -52.08 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.96 -158.05 22.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.86 -173.29 20.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 104' ' ' ILE . 25.3 mttt -98.49 149.8 22.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -137.65 153.93 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -93.96 140.03 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.592 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -112.46 143.55 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.08 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.758 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.1 t -132.17 125.32 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.65 140.09 36.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.2 t -138.42 123.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.313 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 167.04 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 t0 51.2 33.91 10.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.413 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.6 128.5 5.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.711 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.46 -69.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.357 2.038 . . . . 0.0 112.585 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 98' ' ' LEU . 48.4 t -156.12 -66.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.82 0.343 . . . . 0.0 111.287 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.91 -45.08 78.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.09 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.6 -42.7 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.852 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.95 -44.01 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.916 HD11 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.97 -35.41 69.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -62.48 -33.44 74.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -87.73 -29.29 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.158 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' CA ' HG11 ' A' ' 44' ' ' VAL . . . -73.51 -43.47 59.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.726 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -57.6 -43.87 99.14 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.3 Cg_exo -60.22 -37.33 83.83 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.176 1.918 . . . . 0.0 111.784 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -70.38 -44.9 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -76.13 -28.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.211 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.13 74.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.662 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.8 ttmt -65.43 -39.82 92.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.658 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.82 -57.9 7.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' CE2' ' A' ' 102' ' ' PHE . 28.6 m -67.06 -29.61 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -137.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.84 35.26 4.89 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 69' ' ' THR . 32.5 m -125.09 32.72 5.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 5.5 p30 -88.25 -16.58 32.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.278 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 1.5 m-20 82.44 -9.25 1.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -93.04 -36.74 12.55 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.75 43.17 6.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.02 163.56 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.75 58.2 0.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -74.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.967 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.95 -118.08 4.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.61 118.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.344 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -67.93 145.51 54.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 16.8 t -67.57 -53.52 22.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.466 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 69.9 Cg_endo -73.54 146.94 40.01 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.209 1.939 . . . . 0.0 112.183 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 59' ' ' MET . 45.4 t -153.54 125.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 t -114.98 145.98 41.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.038 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CE2' HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -128.59 149.31 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.764 0.316 . . . . 0.0 111.636 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.787 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -88.22 136.81 32.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.523 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.764 HG12 HD12 ' A' ' 98' ' ' LEU . 34.3 m -125.47 139.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.216 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 2.4 m-85 -108.99 103.92 53.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.029 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 94' ' ' LEU . 53.3 Cg_endo -69.36 137.65 37.13 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.397 2.065 . . . . 0.0 112.243 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -89.88 171.98 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.036 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.04 -15.88 62.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.394 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.49 -1.07 55.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.491 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.4 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.03 -6.77 82.68 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.867 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 m -119.74 171.5 8.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.937 0.398 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.2 OUTLIER -112.27 96.88 6.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -95.0 102.23 14.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.77 86.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.597 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 175.5 81.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.922 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.9 tt -144.1 135.56 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 111.493 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.48 115.63 20.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.758 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 6.0 p -91.74 136.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.123 0.487 . . . . 0.0 111.888 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 24.7 m95 -110.58 142.27 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.81 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 66' ' ' VAL . 32.7 t80 -105.78 145.54 31.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 102' ' ' PHE . 7.1 ttt180 -95.66 113.62 25.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 40' ' ' LYS . 35.9 mt -90.75 136.65 27.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.38 153.99 56.26 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.532 2.155 . . . . 0.0 112.238 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 t30 -57.65 -26.88 62.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.268 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.85 -47.11 81.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.431 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -90.25 1.31 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -54.78 -39.75 68.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 111.041 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.58 -34.06 68.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.609 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.6 p -178.35 93.53 0.22 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.83 161.07 10.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.567 2.178 . . . . 0.0 112.179 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.71 155.85 61.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.255 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 112.33 9.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.0 158.34 14.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.355 2.036 . . . . 0.0 112.292 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -116.12 -37.77 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 120' ' ' VAL . 1.4 t70 -74.01 125.81 29.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -24.5 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 -30.67 31.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 117' ' ' ASP . 33.6 t -85.32 115.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 157.02 38.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 124.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 133.81 45.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -88.47 130.74 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -132.06 22.52 4.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ARG . 2.5 pt-20 30.28 42.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.79 159.87 3.24 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -142.19 146.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.219 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.1 m -103.94 120.29 40.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -138.9 163.26 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.321 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 151' ' ' LEU . 11.0 m-85 -107.76 128.44 54.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 m -105.82 135.69 46.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -129.56 139.1 51.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.756 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -116.91 153.83 31.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.37 -177.96 6.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.54 93.03 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.541 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 177.2 149.96 8.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 177.98 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.335 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.86 156.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -133.34 -72.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -152.4 -46.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.775 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -71.85 -33.83 68.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.58 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.5 -35.03 78.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.874 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.23 -40.82 98.53 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.999 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.3 t -53.83 -38.58 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.561 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.27 -34.78 73.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.554 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.669 ' HB2' HG21 ' A' ' 185' ' ' VAL . 24.5 m170 -70.18 -42.87 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.88 -32.92 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.759 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 m -72.22 -41.59 66.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.35 -43.34 92.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.712 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' TYR . 18.4 tp -59.04 -44.6 91.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.555 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -46.76 88.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.302 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -46.21 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.55 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.63 -45.86 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.629 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.724 HD21 ' CD2' ' A' ' 31' ' ' TYR . 48.0 mt -73.26 -9.92 59.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.329 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.58 -42.06 22.97 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.048 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.09 -27.11 71.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 6.9 p -93.98 163.55 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.595 0.236 . . . . 0.0 110.643 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 85.0 Cg_endo -82.92 20.08 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.72 2.28 . . . . 0.0 112.967 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.96 148.14 31.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.091 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.549 HG21 ' OXT' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -101.19 176.57 5.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.51 158.2 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.39 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.27 -36.05 14.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.48 49.29 74.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -158.42 -42.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 111.122 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.0 p -160.12 137.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.264 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 86' ' ' VAL . 6.4 p90 -129.21 172.18 11.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.787 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 51.9 m-85 -112.98 155.42 24.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.26 149.26 41.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -118.89 125.59 49.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.896 179.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.869 0.366 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -120.82 135.25 55.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -143.81 154.16 43.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' A' ' 147' ' ' HIS . 25.2 t -124.6 129.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.43 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.2 m0 -107.89 121.61 45.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.917 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 130' ' ' VAL . 14.2 mt -94.13 134.93 36.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 130' ' ' VAL . 25.5 t -81.22 120.38 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -88.67 115.12 25.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.549 ' OXT' HG21 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.187 -0.911 . . . . 1.0 111.145 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 ' HD3' ' A' ' 34' ' ' ARG . 40.4 t -74.54 112.95 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.461 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 mt -93.99 -17.61 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.4 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -169.96 162.1 9.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -151.99 179.43 8.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 135.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.423 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.437 ' CA ' ' CE1' ' A' ' 31' ' ' TYR . . . -145.11 -149.62 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.443 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 158.97 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.947 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -29.38 69.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.9 -32.36 16.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.09 110.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.4 155.61 16.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.58 156.85 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -147.04 124.38 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.765 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -86.2 117.39 24.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.696 ' HD3' HG22 ' A' ' 20' ' ' VAL . 2.9 mmm-85 -139.26 128.66 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 109.72 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 p -151.23 85.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.03 167.85 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.28 110.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.94 -154.54 25.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.459 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' ILE . 14.5 mttt -104.72 150.86 24.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 3.6 m-85 -137.71 163.46 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.013 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.52 140.37 29.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.503 HG21 ' HE2' ' A' ' 99' ' ' LYS . 41.0 p -131.07 132.09 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.833 -179.133 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 120' ' ' VAL . 63.2 t -130.88 125.39 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.212 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.12 138.76 33.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 111.418 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 54' ' ' ALA . 4.1 t -138.5 116.96 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.79 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.78 168.35 9.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.33 31.11 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG12 ' A' ' 46' ' ' VAL . 31.4 mtmt -153.28 117.77 2.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.997 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.28 -173.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.467 2.111 . . . . 0.0 112.137 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 98' ' ' LEU . 61.3 t -61.28 -57.6 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -59.29 -45.23 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.16 -46.44 74.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.62 -45.06 93.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.802 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.3 mt -58.85 -35.17 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -62.06 -30.7 71.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.042 0.449 . . . . 0.0 109.906 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.0 tp10 -86.79 -37.51 17.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.161 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.68 -29.97 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.462 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.617 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 5.2 mmt -57.43 -43.63 99.12 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 59' ' ' MET . 33.3 Cg_endo -64.69 -47.35 5.46 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.635 1.557 . . . . 0.0 111.835 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -70.47 -32.81 70.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.704 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.612 HD11 HG23 ' A' ' 44' ' ' VAL . 16.9 mm -77.1 -43.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.424 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.09 -45.3 81.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.735 179.778 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -59.98 -29.83 68.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 37.0 t80 -58.54 -41.36 85.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.806 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.536 HG11 ' CE2' ' A' ' 102' ' ' PHE . 14.2 m -85.61 -30.65 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.75 -105.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.46 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.62 67.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -155.49 52.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 4.6 p30 -110.96 -15.3 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.179 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 2.5 t70 83.63 -13.86 0.73 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.607 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 4.9 53.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.29 32.93 5.41 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.448 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 113' ' ' PRO . 3.1 p -96.83 155.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.688 -0.756 . . . . 0.0 111.821 -177.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.79 108.51 1.77 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.185 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -104.72 -77.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.356 . . . . 0.0 111.072 -179.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 -144.81 16.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.33 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.45 128.59 37.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 80' ' ' VAL . 5.6 m -139.0 119.86 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.525 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.72 137.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.938 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 80' ' ' VAL . 17.8 Cg_endo -59.86 143.7 99.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.334 2.023 . . . . 0.0 112.16 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.71 137.53 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.414 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.69 157.27 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.802 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.99 154.15 32.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.19 136.61 33.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.094 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.57 HG12 HG22 ' A' ' 51' ' ' VAL . 5.9 m -125.85 92.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.175 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 166' ' ' VAL . 17.1 m-85 -70.75 112.24 12.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.95 167.24 9.69 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.682 2.255 . . . . 0.0 112.419 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.36 172.19 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.78 -21.34 18.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.315 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.14 -6.14 59.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 -16.06 61.96 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.95 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -84.44 165.17 18.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.971 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 ' OH ' ' A' ' 167' ' ' TYR . 54.8 mt -90.85 167.17 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.56 81.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 50.77 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.346 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 68.57 104.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' CD2' ' A' ' 84' ' ' PHE . 2.3 tt -140.67 127.97 21.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HE2' HG21 ' A' ' 43' ' ' THR . 1.3 tttt -109.48 116.05 31.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.716 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -77.58 141.09 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.231 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -122.08 128.38 51.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.793 179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CE2' HG11 ' A' ' 66' ' ' VAL . 36.7 t80 -113.05 130.93 55.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 -83.9 115.18 22.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 40' ' ' LYS . 30.3 mt -97.77 139.26 21.22 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 154.06 25.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.391 2.061 . . . . 0.0 112.361 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.26 -26.89 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -32.95 70.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.423 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 19.5 m-85 -93.16 -17.71 23.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.517 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -33.65 53.21 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.67 -30.11 62.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.95 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 m -150.53 77.42 8.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.572 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 36.2 Cg_endo -65.37 149.23 88.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.602 2.202 . . . . 0.0 112.161 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HB3' HG11 ' A' ' 74' ' ' VAL . 12.5 Cg_exo -70.86 158.94 54.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.634 2.223 . . . . 0.0 112.116 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 70' ' ' ASN . . . -67.7 136.58 92.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 59.6 Cg_endo -72.52 -20.15 23.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.436 2.091 . . . . 0.0 112.41 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.73 -67.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.04 125.88 25.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.69 -22.53 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 p -81.86 -32.68 31.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 44' ' ' VAL . 31.3 t -85.36 116.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.2 156.58 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.38 116.08 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -98.82 144.84 27.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -89.43 51.64 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -76.12 120.45 21.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 177.16 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.97 156.69 23.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 pt -143.93 154.02 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -107.86 126.66 52.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.8 m -135.33 159.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.401 ' CD2' HD21 ' A' ' 155' ' ' LEU . 11.0 m-85 -107.7 129.45 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 p -105.92 128.84 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 0.0 111.061 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.9 t -129.7 139.19 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -116.9 147.83 41.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 1.0 OUTLIER -137.59 -57.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.88 -109.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.655 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . 175.02 78.37 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -176.84 106.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.46 134.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.277 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -106.53 -38.69 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.741 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.414 ' HG2' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -176.18 -61.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.85 71.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.63 -34.91 76.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.939 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.7 OUTLIER -63.44 -39.04 93.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.579 0.704 . . . . 0.0 110.131 179.138 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 94' ' ' LEU . 48.7 t -53.66 -38.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.87 75.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 185' ' ' VAL . 13.7 m170 -70.35 -44.11 68.83 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.07 -32.9 72.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -68.57 -42.74 77.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.863 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -61.97 -46.05 90.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 151' ' ' LEU . 12.1 tp -59.2 -41.57 88.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.623 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -59.61 -47.73 84.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.268 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 95.3 m -62.48 -45.56 92.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 31' ' ' TYR . 17.1 m -57.61 -38.92 75.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.401 HD21 ' CD2' ' A' ' 131' ' ' TYR . 92.1 mt -74.02 -16.5 61.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 153' ' ' THR . 8.2 pt-20 -48.69 -28.41 3.54 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.792 0.33 . . . . 0.0 111.331 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.89 -17.94 62.34 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.583 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -92.51 170.97 8.18 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.607 0.241 . . . . 0.0 110.801 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.4 Cg_endo -80.95 14.26 2.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.651 2.234 . . . . 0.0 113.151 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.72 132.43 53.83 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.707 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 69.3 m -102.06 -2.29 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.488 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 59.5 m-85 57.44 124.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.39 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.454 ' HG3' HG12 ' A' ' 188' ' ' VAL . 1.3 mm-40 -66.94 -173.92 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.89 61.88 0.94 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.877 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.35 70.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.438 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.3 p -161.9 119.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.244 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.816 ' HB3' HD23 ' A' ' 187' ' ' LEU . 3.7 p90 -133.55 177.17 7.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.754 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 186' ' ' TRP . 13.5 m-85 -126.27 151.07 47.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.084 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 71.2 m -140.07 153.53 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.05 55.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.473 179.967 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.876 0.369 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 2.1 m120 -109.41 135.51 50.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.0 147.93 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 147' ' ' HIS . 24.2 t -128.84 116.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.89 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.56 121.88 43.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.984 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 167' ' ' TYR . 13.0 mt -91.09 140.06 30.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.855 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.8 t -79.15 120.43 30.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -65.53 153.57 41.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.839 0.352 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 26.6 mt 63.83 29.6 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.5 -125.49 29.18 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.703 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 21.73 14.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 111.207 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -98.99 37.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.054 0.455 . . . . 0.0 110.587 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 mtm105 -94.75 141.57 28.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.305 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.545 ' O ' HD22 ' A' ' 9' ' ' LEU . 9.1 m-80 -101.44 176.15 5.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 126.62 27.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.982 0.42 . . . . 0.0 110.695 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 7' ' ' ASN . 0.1 OUTLIER -169.83 -150.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.703 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.493 ' CB ' ' O ' ' A' ' 9' ' ' LEU . 1.3 t80 92.33 -37.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.878 0.471 . . . . 0.0 111.071 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.1 -72.23 0.59 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.085 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.63 123.21 48.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.28 146.11 26.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.94 0.4 . . . . 0.0 111.581 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -113.14 124.87 53.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.637 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.9 p -115.95 119.76 36.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -68.14 145.66 97.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.708 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 18' ' ' TRP . 19.8 Cg_endo -60.59 -18.61 55.73 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.459 2.106 . . . . 0.0 112.235 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 17' ' ' PRO . 19.0 p90 -151.3 142.9 23.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.97 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.605 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 2.7 tp60 -110.79 107.81 17.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.8 t -73.81 113.68 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.36 -6.29 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.3 t -169.86 167.23 9.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.29 -176.6 5.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.958 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 125.51 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -128.91 -101.03 0.99 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.705 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -161.06 160.62 30.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -66.89 -29.7 69.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.064 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.34 -35.49 15.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.3 107.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.28 137.81 36.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.699 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.8 p90 -138.93 162.23 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -145.18 137.18 25.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.728 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.96 114.88 23.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 18' ' ' TRP . 6.3 ptm180 -131.75 128.0 37.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.865 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -106.92 124.85 50.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.7 m -106.4 134.79 48.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -130.98 110.87 11.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.58 -143.67 6.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.36 -60.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.488 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -130.01 145.57 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.917 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -138.25 154.36 49.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.77 118.72 31.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.0 p -112.46 132.01 55.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.29 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 62' ' ' ILE . 39.5 t -125.76 125.11 67.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.605 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -96.92 137.65 35.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 54' ' ' ALA . 14.8 t -138.61 116.58 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.75 170.49 7.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.105 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 47.4 31.41 1.88 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.395 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -152.65 132.36 7.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 35.2 Cg_exo -57.7 -157.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.481 2.121 . . . . 0.0 112.161 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.927 HG13 ' CD1' ' A' ' 98' ' ' LEU . 69.6 t -84.52 -57.56 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.054 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.1 -43.38 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.14 -45.49 76.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.63 -45.14 89.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.247 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.1 mt -57.24 -34.99 69.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.85 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -63.31 -33.19 74.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 109.904 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 12.5 tp10 -87.94 -31.73 19.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.282 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -74.94 -40.41 60.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.444 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' ILE . 10.8 mmt -57.36 -45.16 99.92 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.1 Cg_exo -58.06 -45.13 33.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.263 1.975 . . . . 0.0 112.145 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -70.32 -41.76 72.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.461 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 44' ' ' VAL . 3.2 tt -76.53 -31.9 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.476 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -66.45 -42.1 88.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HD3' HG21 ' A' ' 69' ' ' THR . 15.5 mttp -60.09 -33.25 71.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -68.77 -41.99 78.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.742 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.0 m -81.31 -30.12 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.163 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.15 -103.97 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.507 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.14 69.95 0.47 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.525 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 69' ' ' THR . 90.0 m -164.27 63.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.892 0.377 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.76 5.23 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.459 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.17 46.97 9.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -148.24 -46.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.956 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 37.16 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.457 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 113' ' ' PRO . 26.8 m -100.23 160.1 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 111.136 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.68 75.11 0.3 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.491 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.9 mtp -74.26 -55.46 6.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.851 0.358 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.86 -93.26 1.8 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.51 172.41 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 110.902 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.575 ' O ' HG23 ' A' ' 80' ' ' VAL . 69.0 m -164.0 110.67 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 79' ' ' THR . 0.0 OUTLIER 49.79 166.1 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.673 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.556 ' HD2' HG12 ' A' ' 80' ' ' VAL . 21.0 Cg_endo -61.7 149.32 90.4 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.272 1.981 . . . . 0.0 112.25 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.431 HG21 ' HE1' ' A' ' 59' ' ' MET . 1.3 t -86.18 153.64 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.272 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -120.22 145.84 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.491 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -124.6 154.44 40.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.09 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.52 136.25 36.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.315 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 167' ' ' TYR . 3.8 m -128.09 129.93 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -102.47 95.78 6.48 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' CE1' ' A' ' 167' ' ' TYR . 61.7 Cg_endo -73.0 134.73 21.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.566 2.177 . . . . 0.0 112.222 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.94 170.32 10.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -17.51 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.245 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.59 -6.22 59.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.452 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.737 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.89 -1.71 85.3 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.89 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.3 m -121.75 136.88 54.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.813 0.34 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.578 HD12 ' CG ' ' A' ' 141' ' ' GLU . 35.0 mt -59.1 171.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.52 47.63 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.06 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 54.94 83.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -178.22 109.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.927 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.9 tt -144.11 138.25 28.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.23 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 5.3 tttp -119.62 115.76 24.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.437 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -81.69 117.03 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.564 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -98.73 132.16 44.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.542 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.755 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 39.3 t80 -114.01 136.08 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.242 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.46 107.88 19.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.421 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.1 mt -83.71 136.16 42.34 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.0 Cg_endo -64.96 154.23 74.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.497 2.131 . . . . 0.0 112.322 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -53.95 -27.65 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -58.84 -45.53 89.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -98.71 -15.07 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.273 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -36.03 60.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.804 0.335 . . . . 0.0 111.109 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.4 -33.2 76.8 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.64 75.39 2.37 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.722 0.296 . . . . 0.0 110.77 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.1 Cg_exo -57.1 159.72 14.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.583 2.189 . . . . 0.0 112.275 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.48 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.74 148.26 58.3 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.69 2.26 . . . . 0.0 112.011 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.44 112.36 9.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.977 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.95 144.63 35.66 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.366 2.044 . . . . 0.0 112.352 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -103.76 -31.18 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.43 ' HB3' HG23 ' A' ' 120' ' ' VAL . 3.1 m-20 -80.94 122.03 26.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.83 -23.79 54.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 m -81.98 -28.54 32.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.983 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 117' ' ' ASP . 27.7 t -85.19 115.58 27.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.031 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -121.72 149.81 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.988 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.7 mm -113.04 126.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.85 129.11 45.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.58 144.13 25.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER 56.0 173.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.119 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 15.4 tp10 86.71 90.79 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.3 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -91.31 158.66 25.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.015 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -128.29 142.68 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 111.645 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 35' ' ' ALA . 48.7 m -122.2 119.02 30.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.292 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 187' ' ' LEU . 35.1 m -134.11 165.6 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.947 0.403 . . . . 0.0 111.723 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -107.5 136.4 47.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.13 179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -105.69 141.17 37.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.073 0.463 . . . . 0.0 111.37 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.3 t -130.33 139.64 50.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.586 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -116.31 124.98 51.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.97 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 14.3 p90 -131.78 165.13 24.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -102.17 79.55 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.19 175.62 43.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.528 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 175' ' ' PRO . 3.2 m-85 -91.36 164.28 13.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.792 0.329 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -169.72 120.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.207 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -105.87 -65.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.81 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.578 ' CG ' HD12 ' A' ' 94' ' ' LEU . 7.5 tt0 -146.73 -70.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.691 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.5 70.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.65 -34.97 78.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.29 -40.45 95.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.437 0.637 . . . . 0.0 109.98 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.737 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -52.95 -38.26 28.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.658 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.67 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.647 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.5 m-70 -70.09 -42.39 72.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.757 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.56 -32.94 73.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -68.41 -40.38 81.29 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.744 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -60.05 -46.11 90.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.714 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.699 HD11 ' HB3' ' A' ' 31' ' ' TYR . 8.1 tp -58.71 -42.19 88.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.653 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -47.32 86.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.47 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.3 m -63.02 -41.58 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.417 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.572 HG22 ' CE1' ' A' ' 31' ' ' TYR . 6.6 m -57.29 -49.14 77.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.705 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 0.8 OUTLIER -73.67 -10.24 59.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.296 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -46.83 -35.47 6.35 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 111.303 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.17 31.13 7.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.486 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 19.8 p -145.83 165.13 22.05 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.961 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 -2.81 12.29 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.909 2.406 . . . . 0.0 112.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.5 124.6 19.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -102.22 175.68 5.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.648 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -157.45 -177.13 6.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.817 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -79.3 -76.64 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.2 -18.07 2.7 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.076 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -158.01 27.48 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.925 0.362 . . . . 0.0 111.613 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -161.95 132.59 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.92 0.39 . . . . 0.0 111.572 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.486 ' HA ' HG23 ' A' ' 188' ' ' VAL . 27.7 p90 -149.73 168.17 24.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.656 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 98.3 m-85 -112.82 155.24 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.152 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 185' ' ' VAL . 1.3 m -132.79 154.0 50.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.02 136.31 47.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -172.69 -65.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.77 -67.88 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.796 0.331 . . . . 0.0 111.053 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.94 135.97 87.42 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.68 152.49 33.18 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.527 2.152 . . . . 0.0 112.4 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.436 ' HB2' ' CD2' ' A' ' 138' ' ' TYR . 60.6 Cg_endo -72.84 85.58 1.15 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.522 2.148 . . . . 0.0 112.253 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.3 mtp -120.85 -76.33 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.81 120.21 62.2 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.65 177.12 7.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.425 2.084 . . . . 0.0 112.291 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 59.73 19.82 8.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.07 -19.76 0.22 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.196 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -108.58 148.58 30.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpp_? -131.5 125.49 32.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.815 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -108.86 134.09 52.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -138.26 143.1 39.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.043 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.7 t -123.2 121.88 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.619 ' CZ2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -109.59 128.81 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.056 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.736 ' O ' HG12 ' A' ' 130' ' ' VAL . 10.6 mt -91.17 139.97 30.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.561 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.6 HG22 ' CE2' ' A' ' 168' ' ' TYR . 15.2 t -74.61 118.69 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -76.83 127.83 33.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.226 -0.892 . . . . 1.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.914 0.387 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.407 HD13 ' H ' ' A' ' 3' ' ' GLY . 0.2 OUTLIER -82.76 156.73 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.407 ' H ' HD13 ' A' ' 2' ' ' LEU . . . -161.43 74.13 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.53 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.6 ttp -102.22 152.58 20.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.45 132.76 66.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.59 133.42 52.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.78 126.53 55.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.535 ' HB3' HD12 ' A' ' 9' ' ' LEU . 1.2 m -88.11 156.0 19.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD12 ' HB3' ' A' ' 8' ' ' SER . 2.8 mp 59.93 173.08 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.7 32.58 20.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.04 -89.49 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.523 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 t -64.79 127.63 32.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.81 142.71 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.06 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -132.73 151.01 52.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.4 t -96.94 119.98 36.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.499 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -102.47 164.63 15.3 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.522 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 16' ' ' TRP . 28.9 Cg_endo -63.24 112.42 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.449 2.099 . . . . 0.0 112.142 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.7 t90 62.47 69.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.898 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -123.84 114.81 20.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.3 115.26 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -96.44 0.13 49.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.444 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 t -170.35 161.27 8.04 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.792 0.33 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.3 p -152.37 -45.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.48 136.41 49.27 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -136.9 175.45 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.542 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 161.09 27.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.815 0.341 . . . . 0.0 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -66.56 -32.84 74.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.7 -35.05 16.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 29' ' ' VAL . 6.9 m -146.07 110.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.054 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -95.51 154.85 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.1 p90 -139.39 158.31 44.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -145.14 121.89 11.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.92 131.23 34.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -139.91 130.65 25.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.29 120.17 40.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.068 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 m -131.98 136.41 47.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -114.75 77.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.855 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.39 -161.92 2.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.525 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -121.28 -86.39 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -113.28 149.17 34.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.372 . . . . 0.0 110.886 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -137.61 156.99 47.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.902 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.71 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.93 140.28 29.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.53 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 24.9 p -135.67 131.87 36.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.975 0.417 . . . . 0.0 111.5 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 120' ' ' VAL . 39.8 t -128.01 125.41 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.436 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -96.99 136.0 38.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.894 0.378 . . . . 0.0 111.534 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -138.4 116.85 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.778 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 168.17 9.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.88 33.06 3.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.526 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -153.2 121.65 3.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.89 -161.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.502 2.135 . . . . 0.0 112.361 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 141' ' ' GLU . 28.7 t -74.21 -58.94 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.342 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.71 -44.98 82.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.212 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -67.13 -46.0 75.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.87 -42.26 89.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.22 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.634 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -32.52 74.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.553 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 18.9 tp10 -87.57 -40.36 14.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.15 -37.57 66.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 11.9 mmt -57.78 -44.12 99.19 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' MET . 49.3 Cg_endo -70.35 -36.67 8.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.983 1.789 . . . . 0.0 112.249 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -70.09 -43.28 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.913 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 44' ' ' VAL . 5.2 tt -77.08 -26.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -39.26 90.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -59.19 -31.06 68.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.23 -49.18 46.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 27.1 m -75.31 -30.82 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.188 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.89 -99.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.53 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.25 35.7 0.76 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 69' ' ' THR . 21.0 m -119.67 30.27 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.868 0.366 . . . . 0.0 110.929 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.774 HD21 HG22 ' A' ' 74' ' ' VAL . 40.7 p-10 -88.9 -14.43 36.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 78.67 -1.68 2.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -93.78 -44.25 8.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 110.848 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.62 39.45 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.774 HG22 HD21 ' A' ' 70' ' ' ASN . 27.0 m -100.27 -178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.32 88.14 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.404 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -83.21 -45.87 13.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.14 -82.55 1.54 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.522 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.87 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.794 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.14 -164.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 m -51.96 156.42 2.59 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.264 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.99 135.21 61.4 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.131 . . . . 0.0 112.17 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 102' ' ' PHE . 25.4 m -86.0 145.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.343 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.454 ' HG ' ' HH2' ' A' ' 186' ' ' TRP . 1.1 p -115.49 174.01 6.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.654 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.693 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -127.51 154.46 45.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.38 136.73 32.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.435 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.0 m -131.85 109.25 15.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.464 ' CD2' HG23 ' A' ' 166' ' ' VAL . 11.9 m-85 -83.95 111.32 31.98 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.4 Cg_endo -80.67 127.87 6.57 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.545 2.164 . . . . 0.0 112.162 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.88 164.21 14.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.41 -15.74 62.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.361 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.69 -5.95 59.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.523 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.512 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 96.59 -2.06 62.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.08 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -121.41 -169.85 1.93 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.317 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 141' ' ' GLU . 88.4 mt -105.81 169.52 8.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.714 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.31 34.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.142 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp 51.08 26.7 2.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.267 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.11 122.29 31.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.678 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 84' ' ' PHE . 1.1 tt -133.84 139.99 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 111.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 1.4 mtpt -118.06 115.75 25.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.133 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.9 t -78.77 116.72 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.764 0.316 . . . . 0.0 111.252 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -97.23 142.12 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.773 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.71 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 20.4 t80 -127.11 148.81 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.987 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -105.82 110.4 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.91 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.4 mm -75.69 130.39 79.16 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.41 154.06 20.62 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.461 2.107 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.08 -27.07 65.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.989 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -64.74 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.988 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' HE2' HG11 ' A' ' 74' ' ' VAL . 4.9 m-85 -108.16 -2.95 19.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.677 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -33.68 57.63 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.721 0.296 . . . . 0.0 111.23 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.09 -33.97 75.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.79 89.44 0.7 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.681 0.276 . . . . 0.0 110.924 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 23.5 Cg_exo -63.23 160.2 35.86 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 112.251 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.93 153.29 63.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.597 2.198 . . . . 0.0 111.919 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 110.84 5.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.54 132.36 40.27 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 0.0 112.061 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 t -94.99 46.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.991 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.668 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -149.31 112.72 4.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.98 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.01 -23.54 54.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -82.17 -30.32 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.7 t -85.37 114.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.022 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.03 150.33 27.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 42' ' ' ALA . 26.0 mm -118.17 127.98 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 129.95 45.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -88.76 139.94 29.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.5 mtm105 62.1 150.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -169.14 -167.9 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.99 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.49 89.47 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.386 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.422 HD12 HG13 ' A' ' 130' ' ' VAL . 2.1 pp -135.2 146.41 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.94 0.4 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.3 m -104.0 133.3 49.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.372 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.894 HG12 ' HA ' ' A' ' 188' ' ' VAL . 34.1 m -136.94 169.32 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.633 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -136.15 129.58 31.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.042 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 p -105.63 149.05 26.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.154 0.502 . . . . 0.0 111.587 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.8 t -130.7 139.34 50.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.478 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.64 133.68 55.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 0.0 111.01 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.506 ' CD2' ' CE1' ' A' ' 147' ' ' HIS . 5.0 p90 -127.81 -46.27 1.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.59 149.63 10.33 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.73 -170.22 17.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -133.11 123.78 26.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -112.65 174.69 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.4 -75.7 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -153.37 -61.79 0.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.774 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -55.93 -33.78 65.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.604 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.5 t70 -68.21 -34.92 77.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.049 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -40.51 95.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.458 0.647 . . . . 0.0 110.087 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.69 -38.57 35.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.38 -36.88 77.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.715 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.506 ' CE1' ' CD2' ' A' ' 135' ' ' PHE . 47.3 m-70 -70.18 -46.01 65.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.822 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -62.13 -33.0 73.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.2 m -67.83 -38.25 82.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.93 -35.78 73.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.731 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.571 HD23 HD12 ' A' ' 187' ' ' LEU . 7.6 tp -59.22 -40.68 86.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.542 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -60.99 -42.49 98.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.266 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 92.2 m -64.05 -41.81 97.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.451 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -49.23 77.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.692 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.54 -9.05 58.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -47.04 -36.37 7.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.821 0.343 . . . . 0.0 111.215 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -96.34 36.09 4.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.466 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 15.8 p -145.29 168.28 12.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.3 Cg_endo -85.16 17.83 1.69 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.253 2.635 . . . . 0.0 112.794 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 170.98 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.849 0.356 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -136.66 -178.07 5.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.503 ' H ' HG22 ' A' ' 161' ' ' THR . 12.6 m-85 -155.11 138.05 15.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.952 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 190' ' ' ALA . 3.3 mm-40 -63.31 -68.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.1 -79.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.56 69.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.741 0.305 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.464 HG23 ' CD2' ' A' ' 87' ' ' PHE . 9.9 p -161.94 131.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.296 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.858 ' HB3' HD23 ' A' ' 187' ' ' LEU . 7.1 p90 -140.77 170.62 15.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.507 ' CE2' HG22 ' A' ' 188' ' ' VAL . 24.7 m-85 -117.83 136.76 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 2.0 m -111.32 144.04 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.07 145.54 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 101.37 99.29 2.38 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -122.31 130.93 53.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -154.72 142.1 13.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.11 123.42 7.25 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.228 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.83 109.81 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.457 2.105 . . . . 0.0 112.492 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mmm -151.32 -55.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.792 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.44 118.59 15.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.05 175.31 9.98 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.528 2.152 . . . . 0.0 112.327 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 59.95 34.83 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.184 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -155.6 22.93 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.767 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.0 23.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -139.05 123.89 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -120.91 144.03 48.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.547 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -137.41 142.97 41.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 111.372 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 148' ' ' ALA . 21.2 t -128.76 114.91 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -117.73 121.95 42.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.648 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -92.65 140.93 29.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.565 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 130' ' ' VAL . 14.8 t -73.89 118.81 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.947 0.404 . . . . 0.0 111.269 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -88.36 145.69 25.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.861 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.267 -0.873 . . . . 1.0 111.093 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.847 0.356 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.37 -61.69 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.79 -161.07 29.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.4 mtm -163.12 129.42 3.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.89 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 5' ' ' ILE . 2.1 tt -103.79 85.11 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.79 121.99 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -118.24 160.34 21.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -71.69 139.64 49.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.3 mt -142.29 -68.9 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.64 109.87 21.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.803 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.04 -102.54 2.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.542 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.6 m -102.7 129.78 49.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.788 0.328 . . . . 0.0 110.962 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.02 139.08 40.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -112.98 150.99 31.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 p -96.47 119.95 35.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -136.69 165.72 32.99 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.6 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 18' ' ' TRP . 18.0 Cg_endo -59.59 115.32 2.52 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.547 2.165 . . . . 0.0 111.938 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' PRO . 4.2 p90 54.21 123.94 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.285 0.564 . . . . 0.0 111.429 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.6 109.18 13.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.0 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.24 112.92 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.3 mt -94.02 -22.81 18.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.9 t -169.85 167.03 9.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.868 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 p -151.41 174.58 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 123.2 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . -124.69 -55.56 0.18 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.549 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tptt -161.85 167.68 24.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.804 0.335 . . . . 0.0 110.702 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -32.27 73.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -91.1 -35.33 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.356 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 154' ' ' THR . 3.3 m -146.32 115.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.765 0.317 . . . . 0.0 111.574 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -98.56 158.55 15.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.766 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 4.7 p90 -138.87 155.72 47.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.081 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -146.73 130.91 17.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.07 116.41 24.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.03 131.69 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.5 119.54 39.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.14 103.13 8.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.56 129.85 50.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.97 144.46 16.77 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.76 178.72 16.87 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.476 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.92 141.97 50.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 110.917 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 8.8 m-85 -137.54 154.32 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.969 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.1 122.84 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -112.67 132.14 55.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.794 HG21 ' HB ' ' A' ' 62' ' ' ILE . 16.6 t -125.91 125.51 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.534 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -95.72 134.9 38.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.391 . . . . 0.0 111.264 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 54' ' ' ALA . 9.6 t -138.45 116.92 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.8 166.96 10.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.991 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.78 27.67 17.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -152.64 129.42 5.53 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.68 -78.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.607 2.205 . . . . 0.0 112.675 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.5 t -146.73 -62.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.749 0.309 . . . . 0.0 111.236 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -56.57 -45.33 81.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.21 -46.28 74.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.04 -45.07 91.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.2 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.9 mt -56.91 -35.3 68.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' HB3' ' NH1' ' A' ' 56' ' ' ARG . 1.2 ttp-105 -63.04 -32.16 73.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 110.008 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -86.87 -32.94 19.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.24 179.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.728 ' CB ' HG21 ' A' ' 100' ' ' VAL . . . -73.22 -37.13 66.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.43 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 30.2 mmt -57.8 -44.09 99.16 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 51.3 Cg_endo -70.29 -41.19 3.79 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.938 1.758 . . . . 0.0 111.986 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.427 ' O ' HG21 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -70.21 -39.53 75.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.157 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.794 ' HB ' HG21 ' A' ' 44' ' ' VAL . 9.3 tt -77.55 -40.75 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.683 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.471 ' HA ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.5 -31.58 72.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.063 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' CE ' HG21 ' A' ' 69' ' ' THR . 1.0 OUTLIER -58.84 -29.92 67.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.58 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 122' ' ' ILE . 13.7 t80 -75.36 -50.96 14.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.8 m -66.03 -29.7 47.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.165 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.19 -166.9 2.97 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.46 54.85 4.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 30.5 m -141.45 33.44 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -88.51 164.49 15.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 4.7 t0 -92.43 48.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.803 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -148.67 -46.63 0.15 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.38 34.09 3.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 108' ' ' PHE . 17.5 m -100.46 176.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 111.095 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.6 -67.64 1.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mtt 62.55 146.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.25 -121.89 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.596 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.01 -45.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' HD2' ' A' ' 81' ' ' PRO . 1.4 m 61.02 112.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.494 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 3.9 t -65.86 -46.43 65.37 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.253 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 79' ' ' THR . 29.4 Cg_exo -62.03 140.77 86.17 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.473 2.115 . . . . 0.0 112.123 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 t -153.78 144.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.282 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.2 t -115.73 145.95 42.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.489 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.1 154.21 50.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.87 136.66 32.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.484 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG23 ' CE1' ' A' ' 167' ' ' TYR . 17.7 m -135.57 133.49 51.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 5.8 m-85 -104.45 97.67 12.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.301 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.2 Cg_endo -79.65 138.91 13.83 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.88 172.0 8.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.824 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.09 -29.12 67.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -86.36 -6.14 59.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.359 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.97 -2.06 78.9 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 124.41 41.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 110.928 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 88' ' ' PRO . 15.6 mt -66.81 161.24 24.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -118.58 45.78 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt 61.26 -169.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.74 114.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.736 HD11 ' CD2' ' A' ' 84' ' ' PHE . 1.3 tt -143.6 130.66 20.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 2.5 tttp -108.04 115.89 30.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.728 HG21 ' CB ' ' A' ' 58' ' ' ALA . 3.3 t -85.44 116.91 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.309 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -96.01 131.49 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 15.9 t80 -111.94 140.42 46.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.267 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.58 110.27 22.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.411 HG23 ' HD2' ' A' ' 105' ' ' PRO . 40.6 mt -90.68 136.29 28.14 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.226 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' A' ' 104' ' ' ILE . 31.7 Cg_endo -63.6 154.18 70.53 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.454 2.103 . . . . 0.0 112.344 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -51.86 -26.94 11.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -56.81 -38.29 72.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.956 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.55 ' HE2' HG11 ' A' ' 74' ' ' VAL . 85.9 m-85 -113.02 -13.05 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -53.14 -47.13 68.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 111.179 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.08 -25.94 54.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.538 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.1 t -171.4 89.41 0.45 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.644 0.259 . . . . 0.0 110.769 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.538 ' HG3' HG21 ' A' ' 122' ' ' ILE . 45.0 Cg_endo -67.9 151.43 78.16 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.538 2.159 . . . . 0.0 112.379 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 11.2 Cg_exo -70.79 155.85 61.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.61 2.206 . . . . 0.0 112.111 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . . . -67.5 111.75 8.3 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.993 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.89 158.06 26.28 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.405 2.07 . . . . 0.0 112.261 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.93 -31.19 11.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.52 114.81 13.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.855 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -24.5 56.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.12 -33.03 29.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.885 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 61' ' ' LYS . 38.6 t -85.43 121.27 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.42 157.04 39.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.538 HG21 ' HG3' ' A' ' 112' ' ' PRO . 29.3 mm -107.25 129.31 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -98.86 130.7 45.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.43 16.81 8.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.43 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.91 132.46 23.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.834 0.35 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -168.57 86.31 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -130.15 92.82 0.31 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.51 145.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.325 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.88 130.8 51.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.603 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 187' ' ' LEU . 26.2 m -143.84 164.58 14.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.317 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 4.3 m-85 -107.8 135.43 49.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.8 p -105.68 133.65 50.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.895 0.379 . . . . 0.0 110.994 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 t -127.47 139.25 52.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.927 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -116.86 138.87 51.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 20.7 p90 -153.32 29.64 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.99 -76.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.488 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 138' ' ' TYR . . . 134.62 79.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 137' ' ' GLY . 63.6 m-85 -157.18 82.45 0.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.775 0.322 . . . . 0.0 110.85 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.43 26.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.219 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.65 66.49 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 63.6 -77.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.52 58.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -67.27 -35.97 80.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.105 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.02 -40.52 98.0 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.444 0.64 . . . . 0.0 109.94 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 23.0 t -53.78 -38.88 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.497 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.81 -35.03 69.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.826 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 40.0 m-70 -68.94 -38.8 79.68 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.878 0.37 . . . . 0.0 110.868 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 187' ' ' LEU . . . -61.3 -32.93 72.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.743 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.7 m -72.86 -43.3 62.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -59.51 -36.65 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 151' ' ' LEU . 12.5 tp -58.1 -43.63 87.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.688 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG3' ' CE1' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -59.37 -47.51 85.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 94.6 m -60.91 -41.99 97.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.356 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 29' ' ' VAL . 6.7 m -57.67 -48.97 78.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.749 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 mt -72.89 -11.22 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -46.87 129.74 11.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.241 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.68 9.32 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.476 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 4.3 p -94.76 173.75 4.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.54 0.21 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 4.4 Cg_exo -77.57 13.97 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.012 2.474 . . . . 0.0 112.939 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.93 130.44 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.334 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.08 172.68 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 152' ' ' ARG . 5.3 m-85 -155.68 160.24 40.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.945 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -104.11 -51.83 3.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.971 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.51 53.66 7.31 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.264 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -158.7 -37.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.596 0.236 . . . . 0.0 111.275 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 12.5 p -159.2 140.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 111.424 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.545 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.7 p90 -142.88 170.43 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.561 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.09 143.81 43.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 9.3 m -119.42 137.94 53.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.527 ' HB2' ' CZ2' ' A' ' 186' ' ' TRP . . . -132.03 156.09 46.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.075 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 127.66 -101.8 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.485 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.91 94.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.789 0.328 . . . . 0.0 110.939 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 3.2 p30 -147.42 135.26 10.67 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 31.9 Cg_exo -58.38 146.7 88.85 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.393 2.062 . . . . 0.0 112.344 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 17.0 Cg_exo -66.95 64.57 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.104 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 2.7 mtm -135.27 106.92 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.981 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.8 mttm 60.79 114.38 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.2 -16.89 49.78 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.436 2.091 . . . . 0.0 112.525 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -90.48 106.96 18.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.876 0.37 . . . . 0.0 110.968 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 158.53 -74.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.423 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -111.0 158.61 18.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.724 0.297 . . . . 0.0 110.799 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.06 145.33 34.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.097 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -108.95 145.57 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -145.7 154.42 42.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.952 0.406 . . . . 0.0 111.181 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 15.4 t -118.93 124.48 73.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.641 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.537 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.06 122.26 46.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.106 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 130' ' ' VAL . 62.3 mt -91.6 140.35 29.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.505 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.65 118.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.39 . . . . 0.0 111.186 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -75.05 116.25 15.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.17 -0.919 . . . . 1.0 110.986 -179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.15 -49.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.25 103.49 1.76 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.457 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -101.34 -30.13 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.31 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 pt -58.54 167.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -87.66 136.02 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.26 163.17 30.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -76.07 150.32 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.1 123.56 26.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -151.49 -45.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.014 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.56 -132.93 52.81 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -103.31 129.8 50.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -120.59 136.42 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.99 138.58 50.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 m -105.06 134.93 47.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.99 112.76 45.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.6 -60.92 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.411 2.074 . . . . 0.0 112.249 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -79.28 165.78 22.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -136.86 113.09 9.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -74.3 113.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.997 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 35' ' ' ALA . 6.8 mt -86.42 -24.33 25.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.5 m -169.98 167.1 9.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -151.6 168.07 26.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.82 -175.67 21.67 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.426 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.89 -106.36 0.25 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.646 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -161.02 167.44 26.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.0 110.916 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -66.6 -28.02 68.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.318 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.43 -33.12 16.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.094 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.3 t -145.99 142.38 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.929 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -135.12 139.84 44.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' CE2' HD21 ' A' ' 155' ' ' LEU . 1.2 p90 -138.36 162.22 34.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.971 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.726 ' HG2' HG22 ' A' ' 23' ' ' THR . 74.7 mt-10 -144.53 126.46 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.0 129.43 34.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -140.71 135.82 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -112.74 130.08 56.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.242 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.13 -50.05 21.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.07 70.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.68 29.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.95 139.6 5.02 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HD3' ' CG ' ' A' ' 112' ' ' PRO . 15.8 mttm -92.0 146.68 23.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -137.54 161.23 36.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 140.3 29.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.655 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.2 p -133.49 131.88 40.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.993 0.425 . . . . 0.0 111.476 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 120' ' ' VAL . 20.8 t -132.88 125.68 52.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.679 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.94 132.64 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 111.272 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.7 t -138.41 116.87 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.826 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 175.43 5.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t0 48.41 28.25 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.436 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.97 133.97 8.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 53' ' ' GLU . 28.6 Cg_endo -62.46 -165.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.474 2.116 . . . . 0.0 112.099 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 98' ' ' LEU . 42.6 t -74.83 -48.81 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.333 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.71 -45.17 83.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.231 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -67.23 -46.15 74.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.126 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.407 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.258 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD22 ' CE ' ' A' ' 59' ' ' MET . 3.2 mt -56.97 -35.55 69.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -32.84 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.955 0.407 . . . . 0.0 110.259 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 tp10 -87.21 -34.15 19.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.355 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.799 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.7 -41.77 62.15 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.633 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -57.63 -43.95 99.17 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.4 Cg_exo -57.47 -47.15 23.11 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.107 1.872 . . . . 0.0 112.189 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -70.43 -41.95 72.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.828 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.633 HG22 ' HA ' ' A' ' 59' ' ' MET . 6.2 tt -76.09 -37.03 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.496 ' HA ' HG22 ' A' ' 66' ' ' VAL . 58.5 mtp -66.32 -40.48 89.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.785 0.326 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -59.6 -31.06 69.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -74.99 -50.09 17.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.804 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' CE2' ' A' ' 102' ' ' PHE . 22.1 m -72.54 -29.52 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.404 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.12 -64.33 2.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.626 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.1 76.53 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -164.52 55.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 110.747 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.53 6.73 6.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.366 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t70 58.47 18.56 5.75 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.448 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -95.2 -43.47 8.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.916 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.11 24.32 8.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.474 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.6 m -101.08 -178.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.841 0.353 . . . . 0.0 111.094 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.62 -55.46 0.39 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 61.7 mtp 62.64 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.657 0.265 . . . . 0.0 110.904 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.79 80.45 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.656 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 55.28 -176.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.123 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.624 ' O ' HG13 ' A' ' 80' ' ' VAL . 1.6 t 179.87 -39.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.694 HG21 ' HB3' ' A' ' 103' ' ' ARG . 2.4 m -162.23 163.67 18.3 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.855 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.0 Cg_endo -59.21 149.65 79.14 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.29 1.994 . . . . 0.0 111.898 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.33 137.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.684 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.3 m -119.11 145.86 45.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.07 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HB2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -133.15 154.28 50.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.694 0.283 . . . . 0.0 111.452 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.97 136.67 32.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.534 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' A' ' 167' ' ' TYR . 5.2 m -130.25 130.81 65.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.955 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 10.6 m-85 -102.51 97.43 8.92 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.19 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.7 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.1 Cg_endo -75.18 139.8 24.24 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.507 2.138 . . . . 0.0 112.148 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -90.18 161.92 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.969 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.41 -21.97 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -85.23 -6.19 59.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.42 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.63 -16.09 60.99 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.829 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 m -98.66 133.35 43.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.775 0.321 . . . . 0.0 110.975 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 88' ' ' PRO . 71.0 mt -57.89 178.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -143.37 44.59 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt 62.1 -166.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.74 108.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.702 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 84' ' ' PHE . 3.7 tt -141.35 139.52 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.12 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -115.78 115.89 27.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.525 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.799 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.1 t -82.23 116.86 27.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.536 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -100.23 137.96 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.297 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.809 ' CE2' HG11 ' A' ' 66' ' ' VAL . 24.8 t80 -127.07 132.44 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.965 0.412 . . . . 0.0 111.684 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.694 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -94.34 109.75 21.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.36 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 108' ' ' PHE . 31.8 mt -82.19 139.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.468 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 79' ' ' THR . 50.5 Cg_exo -53.34 154.14 15.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.624 2.216 . . . . 0.0 112.409 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -57.68 -31.02 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.42 -47.13 87.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.823 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 104' ' ' ILE . 26.9 m-85 -90.9 -13.49 33.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.199 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -53.19 -43.69 67.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.745 0.307 . . . . 0.0 111.08 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.75 -27.43 66.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.455 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t -167.27 85.87 0.8 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 42.8 Cg_endo -68.02 152.26 76.86 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.613 2.209 . . . . 0.0 112.307 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.92 156.24 60.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.01 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.83 110.89 6.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' HG3' HD11 ' A' ' 122' ' ' ILE . 69.1 Cg_endo -74.04 145.0 34.81 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.304 2.003 . . . . 0.0 112.453 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -86.12 -176.41 5.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 64.16 120.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.995 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -59.4 -16.89 25.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.599 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.6 m -80.16 -34.72 37.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 111.233 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 44' ' ' VAL . 38.5 t -85.42 113.83 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.149 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -128.06 157.13 41.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.451 HD11 ' HG3' ' A' ' 115' ' ' PRO . 27.8 mm -106.1 129.09 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.85 129.83 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.77 18.88 7.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.342 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -69.58 164.35 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 110.907 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -70.91 169.11 15.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -60.64 176.27 4.3 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.68 145.25 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.828 0.347 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.0 m -103.99 118.93 37.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.769 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.18 166.74 21.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.203 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.494 ' HB2' HD21 ' A' ' 151' ' ' LEU . 3.7 m-85 -107.83 133.42 52.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.583 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 p -105.89 122.29 45.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.977 0.417 . . . . 0.0 111.149 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.484 ' HB ' HD13 ' A' ' 151' ' ' LEU . 5.6 t -116.38 139.1 50.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.732 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -116.99 154.16 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -166.87 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.939 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.64 127.93 4.49 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.465 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 152.64 147.0 4.49 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -67.14 118.21 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.736 0.303 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -123.58 126.04 45.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.076 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.59 -43.43 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.556 ' CD ' HD12 ' A' ' 94' ' ' LEU . 28.2 tt0 -176.04 -66.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.62 -33.77 66.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.811 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -67.67 -34.9 77.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.074 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.67 -40.49 95.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.093 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.8 t -53.75 -38.86 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.549 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.56 -33.45 69.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.648 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -70.11 -44.43 68.98 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.89 72.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.4 m -67.44 -38.0 83.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.956 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.468 ' O ' HG22 ' A' ' 153' ' ' THR . 11.5 mt-30 -64.61 -36.25 83.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 131' ' ' TYR . 11.9 tp -70.03 -37.17 75.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.043 0.449 . . . . 0.0 110.437 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -69.01 -48.08 63.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 150' ' ' GLN . 4.2 t -61.25 -40.96 96.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.472 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 98.3 m -57.52 -47.08 82.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.695 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.677 HD21 ' CE2' ' A' ' 31' ' ' TYR . 83.4 mt -72.75 -13.79 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.312 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.18 115.38 1.08 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.235 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.84 18.03 8.13 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.559 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 22.1 p -146.58 165.15 20.74 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.57 -13.25 35.33 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.765 2.31 . . . . 0.0 112.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -57.5 110.51 0.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 111.267 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -102.48 -177.74 3.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.667 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.534 ' H ' HG22 ' A' ' 161' ' ' THR . 0.0 OUTLIER -156.82 20.47 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.332 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 67.72 -66.58 0.21 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.162 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.35 48.88 2.93 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.116 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -158.05 -33.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.505 0.193 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 87' ' ' PHE . 14.0 p -159.13 138.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.888 0.375 . . . . 0.0 111.548 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 86' ' ' VAL . 15.0 p90 -136.99 171.55 14.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.779 ' CE2' HG22 ' A' ' 188' ' ' VAL . 37.5 m-85 -112.87 150.83 31.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.18 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 23.3 m -129.92 157.79 41.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.77 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.07 139.35 49.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.37 -144.02 3.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.555 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -142.26 -174.26 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.964 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.51 168.84 1.58 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -52.04 152.52 14.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.554 2.169 . . . . 0.0 112.338 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.61 127.77 25.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.565 2.176 . . . . 0.0 112.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 1.3 ttt -160.25 -54.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.94 92.87 47.92 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 179' ' ' TYR . 32.0 Cg_exo -57.8 -160.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.514 2.143 . . . . 0.0 112.202 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 178' ' ' PRO . 48.3 m-85 60.06 94.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 104.38 50.9 0.95 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.491 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 138.92 49.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.329 . . . . 0.0 110.831 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -133.21 128.07 35.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -130.97 133.84 46.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.775 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -146.14 157.06 43.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.49 126.24 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.825 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -107.91 121.69 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.155 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 167' ' ' TYR . 12.7 mt -94.41 134.3 37.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.805 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 168' ' ' TYR . 21.5 t -74.88 118.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.213 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -63.58 139.35 58.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.201 -0.904 . . . . 1.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.806 0.336 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.66 158.51 23.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.813 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.38 -78.22 1.08 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -56.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 110.952 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -64.05 117.55 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.29 118.81 37.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.965 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.76 126.96 55.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -87.99 129.37 35.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.98 -72.73 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 59.8 -177.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.975 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.73 -97.78 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.273 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 t -101.82 124.93 48.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 110.725 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.07 122.05 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.218 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -133.08 147.96 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.5 p -111.66 120.05 40.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CG ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -129.9 165.56 32.53 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 16' ' ' TRP . 20.6 Cg_endo -60.85 -54.1 2.18 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -117.88 142.12 47.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.55 118.32 27.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.28 113.19 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.031 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 mt -90.99 -27.78 18.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.025 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.1 t -170.09 167.09 8.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -151.65 160.52 43.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.885 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.44 71.85 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.364 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.97 -132.24 0.28 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.607 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.28 164.89 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.902 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -66.49 -28.7 68.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.2 -34.47 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.07 118.82 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.0 p -95.38 130.69 42.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 31' ' ' TYR . 6.2 p90 -138.53 154.57 48.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.977 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -145.19 135.03 23.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.896 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -86.66 124.7 33.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 136.84 30.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.21 130.41 56.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.38 164.78 25.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.03 73.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.58 118.44 6.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.569 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.37 -97.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.571 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' O ' HD12 ' A' ' 104' ' ' ILE . 11.5 mttt -111.01 147.93 33.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.777 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.74 153.29 49.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.13 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . . . -94.39 119.11 32.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.637 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.5 p -112.66 147.31 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.945 0.402 . . . . 0.0 111.265 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.861 HG23 HD12 ' A' ' 62' ' ' ILE . 23.0 t -131.82 125.97 56.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.153 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -95.95 131.54 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.693 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 17.5 t -138.18 116.98 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 169.61 8.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.738 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 79.59 -49.11 0.39 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.492 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HB3' ' N ' ' A' ' 54' ' ' ALA . 19.5 mttt -85.65 141.63 36.43 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 110.877 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.51 -80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.481 2.121 . . . . 0.0 112.626 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.939 HG13 ' CD1' ' A' ' 98' ' ' LEU . 43.0 t -142.65 -66.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.851 0.358 . . . . 0.0 111.334 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -55.76 -45.33 78.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.02 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -46.07 74.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.684 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.77 -41.12 85.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 55' ' ' LEU . 5.7 mt -57.1 -35.07 68.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.013 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -31.28 71.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.916 0.389 . . . . 0.0 110.285 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 34.2 tp10 -87.81 -33.66 18.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.251 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.12 -38.83 66.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.427 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.631 ' HE1' HG21 ' A' ' 82' ' ' VAL . 6.9 mmt -57.72 -43.97 99.12 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.8 Cg_endo -70.14 -37.62 8.03 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.994 1.796 . . . . 0.0 112.128 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -70.14 -42.68 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.861 HD12 HG23 ' A' ' 44' ' ' VAL . 1.5 tt -77.71 -28.04 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -41.06 90.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.035 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -58.93 -31.21 68.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.966 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 40.9 t80 -70.59 -53.35 16.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.503 HG21 ' CG ' ' A' ' 78' ' ' MET . 27.1 m -67.25 -26.36 36.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.288 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.0 -126.4 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.645 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -126.06 68.2 0.52 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 69' ' ' THR . 28.7 m -155.11 52.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' OD1' ' CD1' ' A' ' 65' ' ' TYR . 2.6 m-80 -112.2 22.47 14.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 t70 54.56 34.34 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.027 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -148.3 -61.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.29 81.92 1.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.47 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.619 HG21 ' CG ' ' A' ' 113' ' ' PRO . 5.3 m -139.63 146.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.131 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.37 71.77 0.7 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 25.6 mtp -62.24 -63.51 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.969 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.03 120.49 2.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.49 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.503 ' CG ' HG21 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -75.57 154.14 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.594 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -102.87 148.2 25.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 21.7 t -56.75 -47.7 98.56 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.413 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.594 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.4 Cg_endo -80.91 154.76 19.94 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.36 2.04 . . . . 0.0 112.499 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.631 HG21 ' HE1' ' A' ' 59' ' ' MET . 41.7 t -153.91 138.74 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.465 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 29.6 t -115.63 149.21 38.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.152 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.759 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.06 154.23 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.737 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -89.15 136.69 32.88 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' HB ' HD22 ' A' ' 94' ' ' LEU . 30.7 m -134.68 128.75 51.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.195 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -98.61 99.33 7.33 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.724 ' HA ' HD23 ' A' ' 94' ' ' LEU . 54.2 Cg_endo -69.24 128.01 15.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.471 2.114 . . . . 0.0 112.248 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.13 168.06 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -19.63 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.185 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.45 2.95 42.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.487 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' HG21 ' A' ' 145' ' ' VAL . . . 91.0 -15.45 60.87 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.878 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.84 177.63 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.316 . . . . 0.0 110.95 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 88' ' ' PRO . 53.6 mt -114.37 -12.91 12.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.383 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.62 165.53 0.2 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 111.003 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -80.52 88.13 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.22 110.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.643 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.4 tt -143.97 128.62 18.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 0.0 111.449 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -110.98 115.66 29.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.082 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.677 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -71.46 141.12 17.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -120.85 124.03 44.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 66' ' ' VAL . 57.5 t80 -108.17 153.68 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.127 0.489 . . . . 0.0 111.69 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' NH2' ' CH2' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.1 109.18 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.493 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 112' ' ' PRO . 33.3 mt -83.04 139.12 42.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.314 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.61 154.21 16.56 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.428 2.085 . . . . 0.0 112.314 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -27.46 56.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -59.53 -47.14 86.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -96.92 -8.28 31.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.469 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -53.4 -36.16 61.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.16 -28.57 73.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 t -177.03 88.12 0.25 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.652 0.263 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.469 ' HB3' HD13 ' A' ' 104' ' ' ILE . 34.0 Cg_exo -59.17 161.27 16.69 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.531 2.154 . . . . 0.0 112.229 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.619 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.5 Cg_exo -70.82 154.75 63.38 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.634 2.223 . . . . 0.0 111.864 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 114.58 19.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.2 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 65' ' ' TYR . 48.6 Cg_exo -55.17 178.0 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.34 2.027 . . . . 0.0 112.244 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 35.78 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.918 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -143.9 120.89 11.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.89 -26.8 62.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.003 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.2 t -82.01 -34.79 29.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 38.1 t -85.43 117.16 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.072 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.23 152.82 40.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 16.3 mm -107.98 133.77 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -98.86 157.25 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.79 167.71 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.985 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptt-85 -66.71 171.06 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.068 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -169.91 -38.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.63 107.18 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.294 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 pt -131.95 142.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 111.354 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 82.0 m -107.31 132.08 53.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.508 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 187' ' ' LEU . 34.8 m -142.33 149.51 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 5.6 m-85 -107.78 132.41 53.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.198 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.7 p -105.61 144.41 32.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.48 . . . . 0.0 111.637 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.7 t -130.85 139.13 50.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.8 138.78 51.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.496 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 39.1 p90 -143.58 -178.67 6.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.789 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.58 88.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.46 -176.44 40.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.593 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.82 -58.73 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 110.91 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.11 164.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -132.84 -75.51 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.632 ' HB2' HD12 ' A' ' 94' ' ' LEU . 9.9 pt-20 -139.8 -48.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.736 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.97 66.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.427 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.09 -35.0 77.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.022 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -63.87 -39.8 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.041 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.631 HG21 ' O ' ' A' ' 92' ' ' GLY . 61.5 t -53.85 -38.61 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.345 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.76 74.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.597 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.496 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.23 -46.05 65.27 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-O 120.878 0.37 . . . . 0.0 110.828 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.94 -33.09 73.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.746 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -71.14 -37.94 72.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -59.01 -39.61 82.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.722 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.5 tp -58.35 -40.99 83.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.523 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.443 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -62.74 -45.24 93.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.137 179.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.7 -40.73 98.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.191 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.0 m -57.65 -49.2 77.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.511 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -74.0 -9.25 58.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -47.16 -32.72 4.57 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.788 0.328 . . . . 0.0 111.282 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.42 28.29 12.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 71.5 p -145.84 159.29 47.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.312 . . . . 0.0 110.64 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.5 Cg_endo -79.58 8.43 3.96 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 113.029 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.53 137.36 57.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.194 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -100.88 151.57 21.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.683 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.0 OUTLIER -158.64 171.18 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.886 0.374 . . . . 0.0 111.235 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 0.8 OUTLIER -112.36 102.54 10.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.45 65.01 3.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.046 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -157.69 -27.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.4 p -158.27 141.4 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.892 0.377 . . . . 0.0 111.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 31.1 p90 -146.64 168.24 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.534 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 35.6 m-85 -114.38 144.06 43.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.177 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.14 142.81 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.08 154.34 49.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.7 55.94 1.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.572 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.3 105.66 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -109.07 166.03 11.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 20.6 Cg_endo -60.86 139.85 87.3 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.448 2.098 . . . . 0.0 112.178 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 174' ' ' PRO . 23.5 Cg_exo -63.79 73.54 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.486 2.124 . . . . 0.0 112.275 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 -46.37 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.761 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.55 92.47 20.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.79 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.63 -35.3 29.48 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.505 2.137 . . . . 0.0 112.281 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -90.93 89.26 7.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.956 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.26 -41.93 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.525 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 167.04 10.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.21 163.33 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -108.94 152.88 24.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.06 147.12 31.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.986 0.422 . . . . 0.0 111.255 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.9 118.12 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.42 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.84 123.27 48.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.048 0.451 . . . . 0.0 111.484 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.734 ' O ' HG12 ' A' ' 130' ' ' VAL . 5.0 mt -91.43 140.61 29.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.516 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 190' ' ' ALA . 17.7 t -73.98 131.03 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.801 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -73.02 -0.94 15.26 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 188' ' ' VAL . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.273 -0.87 . . . . 1.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.23 144.29 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.019 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.96 92.72 0.38 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.462 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.5 ptm -96.61 166.1 11.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.619 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.6 mt 68.56 12.48 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.512 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 ttp85 -115.09 107.93 15.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -108.63 164.15 12.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -69.47 134.28 48.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mt -71.67 82.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.45 90.16 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 -82.51 1.11 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.542 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.27 132.8 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.933 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.06 117.95 13.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -116.02 146.7 41.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.054 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.3 t -115.98 142.02 47.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.966 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.92 98.92 32.73 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.24 149.54 64.01 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.435 2.09 . . . . 0.0 112.32 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -63.66 174.98 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.995 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.01 107.93 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.93 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.32 112.94 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -84.9 -12.07 54.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.415 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.8 159.03 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 0.0 110.99 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.85 155.35 37.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.79 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.85 145.02 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.368 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.431 ' HA3' ' CD1' ' A' ' 31' ' ' TYR . . . -135.88 -146.63 5.29 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.478 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.732 ' HD3' HG23 ' A' ' 154' ' ' THR . 1.6 mtpt -78.37 164.48 24.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.407 . . . . 0.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.54 -26.45 67.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.012 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -90.02 -32.32 16.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.92 111.66 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.188 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -95.78 141.76 28.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.35 162.13 35.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -145.57 126.16 14.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.797 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -86.33 122.51 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -123.95 135.28 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.11 121.03 34.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.194 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.52 173.46 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.88 -47.19 26.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.859 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -178.03 28.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.87 -127.32 2.4 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.426 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' CG ' ' HG2' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -102.95 139.14 38.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -137.58 148.68 46.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.56 116.16 28.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.636 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 p -112.82 149.52 32.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 62' ' ' ILE . 41.9 t -128.92 125.61 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -97.38 130.93 44.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.18 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 58' ' ' ALA . 17.4 t -138.25 116.84 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.22 175.92 5.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.113 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p30 43.08 36.38 0.94 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.565 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 14.8 mttt -152.43 134.15 8.4 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 37.6 Cg_exo -57.22 -157.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.757 HG13 HD13 ' A' ' 98' ' ' LEU . 38.8 t -84.75 -53.25 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.084 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -68.15 -44.98 74.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -46.26 81.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.202 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.86 -43.26 90.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.141 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.75 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.2 mt -57.49 -35.28 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -31.67 72.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.089 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 tp10 -87.66 -32.59 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.18 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.65 -42.63 61.13 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.791 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.0 mmt -57.6 -43.54 98.93 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.8 Cg_exo -59.77 -45.16 26.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.248 1.965 . . . . 0.0 111.953 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 120' ' ' VAL . 19.6 mttp -70.32 -40.47 74.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.445 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.722 ' HB ' HG21 ' A' ' 44' ' ' VAL . 7.1 tt -76.57 -40.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.773 0.32 . . . . 0.0 111.494 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.516 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.27 -31.8 72.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 63' ' ' MET . 0.1 OUTLIER -63.67 -29.84 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -74.04 -30.63 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 63' ' ' MET . 15.0 m -89.74 -31.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.229 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.97 -74.16 0.95 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.573 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.07 71.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 116' ' ' SER . 5.3 m -160.59 70.35 0.4 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -119.65 -5.63 10.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.452 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.85 39.81 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.832 0.349 . . . . 0.0 110.814 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -144.4 -45.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.64 31.98 1.54 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.0 m -100.25 145.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.85 4.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.417 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.451 ' HG2' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 62.87 143.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.892 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -117.4 -119.5 3.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -156.85 -171.56 3.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.725 0.298 . . . . 0.0 110.782 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 103' ' ' ARG . 8.3 t -159.13 -163.63 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.823 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.8 m -45.04 161.99 0.22 Allowed Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.3 Cg_endo -59.31 132.38 46.24 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.186 1.924 . . . . 0.0 111.863 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 102' ' ' PHE . 33.8 m -84.81 146.81 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 36.6 p -115.41 173.91 6.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.75 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.7 154.16 44.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.931 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . . . -87.23 136.58 32.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 0.0 110.486 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 98' ' ' LEU . 27.2 m -131.86 112.27 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.816 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE2' HG21 ' A' ' 166' ' ' VAL . 4.4 m-85 -93.35 107.13 23.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.24 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.62 156.29 28.02 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.562 2.175 . . . . 0.0 112.189 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.05 168.34 12.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.964 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -22.27 47.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -85.88 -6.04 59.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.712 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.21 -16.07 61.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.806 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 130.07 47.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.481 HD22 ' HB ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -72.09 177.02 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.02 81.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.57 -166.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.054 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tttt 64.6 96.43 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.757 HD13 HG13 ' A' ' 51' ' ' VAL . 1.7 tt -144.03 127.86 17.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 85' ' ' ALA . 20.6 ptmt -110.59 115.8 30.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -73.38 141.15 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.332 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -116.38 141.97 47.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.679 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.659 ' CD2' HG11 ' A' ' 82' ' ' VAL . 54.1 t80 -125.0 159.87 30.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.587 ' O ' HG21 ' A' ' 79' ' ' THR . 2.5 mtt85 -115.97 108.09 15.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.323 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 32.7 mt -85.5 136.41 37.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.297 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 24.6 Cg_endo -61.45 152.02 75.78 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.67 2.247 . . . . 0.0 112.359 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -57.23 -26.98 61.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -47.1 82.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.197 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CE2' ' HG2' ' A' ' 76' ' ' MET . 3.2 m-85 -89.18 -16.24 31.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.31 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -54.4 -39.05 66.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.781 0.324 . . . . 0.0 111.197 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.91 79.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.1 p -159.97 71.67 3.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 110.63 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 32.5 Cg_exo -58.37 139.03 88.98 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.551 2.167 . . . . 0.0 112.324 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 13.0 Cg_exo -70.54 149.27 61.67 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.598 2.199 . . . . 0.0 112.036 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 124.57 89.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.12 170.49 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.383 2.055 . . . . 0.0 112.269 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.591 ' CB ' HG22 ' A' ' 69' ' ' THR . 0.2 OUTLIER -113.14 -40.03 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.912 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.17 131.46 35.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -57.71 -22.46 46.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.105 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -81.97 -31.97 30.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 44' ' ' VAL . 33.5 t -85.64 114.02 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.052 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.59 157.0 41.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 26.7 mm -107.57 117.59 53.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -98.98 136.39 39.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.826 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.7 49.53 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -71.89 -132.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.96 -177.91 4.0 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.885 0.374 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.79 153.57 20.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.858 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.96 148.78 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.407 HG21 ' HD2' ' A' ' 189' ' ' LYS . 9.7 m -103.9 130.46 51.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.852 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 187' ' ' LEU . 29.4 m -144.81 170.12 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.107 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.48 133.08 41.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.626 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 p -105.96 137.78 43.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.046 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -124.87 139.05 54.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.813 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -116.91 141.38 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -153.62 -50.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.45 170.59 38.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -112.94 67.59 0.24 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.51 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.48 100.22 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.85 0.357 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 147' ' ' HIS . . . -160.33 163.98 32.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -61.66 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.785 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -161.12 -61.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.657 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.84 -33.8 72.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.412 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -67.33 -34.74 77.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.8 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.4 OUTLIER -63.03 -42.05 99.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.513 0.673 . . . . 0.0 109.82 178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.712 HG11 ' O ' ' A' ' 92' ' ' GLY . 42.5 t -54.02 -38.8 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.717 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.02 68.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.752 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.516 ' HB2' HG21 ' A' ' 185' ' ' VAL . 18.5 m170 -70.0 -39.7 75.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.819 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.29 -33.01 73.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.761 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -67.42 -39.92 85.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -59.08 -45.95 89.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 151' ' ' LEU . 11.5 tp -63.1 -40.45 97.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -44.22 96.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -65.17 -41.16 94.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.532 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.732 HG23 ' HD3' ' A' ' 26' ' ' LYS . 86.4 m -57.64 -48.05 80.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 12.7 mt -73.22 -16.63 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -47.23 -40.18 15.81 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 111.394 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -94.45 32.11 6.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.65 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.448 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 51.9 p -146.09 166.7 16.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.73 0.3 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.448 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 2.8 Cg_exo -75.86 4.72 4.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.031 2.487 . . . . 0.0 112.812 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 155' ' ' LEU . . . -57.47 125.37 22.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.87 HG22 ' HB3' ' A' ' 190' ' ' ALA . 2.7 m -101.78 152.63 20.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.553 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.616 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 0.0 OUTLIER -158.42 173.88 15.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.276 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -85.76 -67.01 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.04 51.76 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.062 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.11 -28.8 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.62 0.247 . . . . 0.0 111.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.612 HG21 ' CE2' ' A' ' 87' ' ' PHE . 14.6 p -157.98 137.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.832 0.349 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -135.82 179.34 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.542 ' CE2' HG22 ' A' ' 188' ' ' VAL . 25.8 m-85 -116.27 150.78 37.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 46.4 m -124.04 136.94 54.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.54 125.06 52.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 122.17 140.69 5.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -154.0 36.52 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.75 136.26 37.02 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.963 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.11 158.56 33.92 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.511 2.141 . . . . 0.0 112.385 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.97 136.14 26.79 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.567 2.178 . . . . 0.0 112.35 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 3.4 mtm -168.34 -64.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -153.12 134.75 8.63 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.18 -176.14 1.23 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.323 2.015 . . . . 0.0 112.317 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 60.22 68.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -173.98 -54.93 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.4 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -115.52 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.825 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -139.71 141.13 36.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.45 141.07 45.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -145.97 153.01 40.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 147' ' ' HIS . 21.6 t -119.0 133.15 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.957 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -107.65 121.71 45.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.555 ' O ' HG12 ' A' ' 130' ' ' VAL . 36.9 mt -94.03 139.2 31.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.794 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.542 HG22 ' CE2' ' A' ' 168' ' ' TYR . 43.0 t -83.37 127.26 39.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.05 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.407 ' HD2' HG21 ' A' ' 129' ' ' THR . 1.4 mtpt -73.76 160.43 31.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.87 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.286 -0.864 . . . . 1.0 111.141 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.651 0.262 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.682 ' N ' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -121.19 173.2 7.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.16 -167.56 28.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.473 ' O ' HG13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 60.19 -166.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.529 0.204 . . . . 0.0 110.831 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 4' ' ' MET . 1.7 pt 30.7 86.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.386 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 114.86 23.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -117.6 146.89 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 143.32 27.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.37 164.21 19.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.807 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -70.03 125.02 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.49 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.44 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.5 p -99.21 125.09 44.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.791 0.329 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.04 128.94 31.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.83 124.9 17.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 t -116.1 132.51 56.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -177.06 82.38 0.25 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.952 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.68 166.5 25.44 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.653 2.235 . . . . 0.0 112.391 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -173.68 163.5 4.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.022 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.26 109.14 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 t -74.2 112.97 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -95.56 -16.33 22.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 t -169.66 166.96 9.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.85 -173.89 4.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.041 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.98 -119.53 3.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.225 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 98.82 132.45 7.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.774 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 168.69 19.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 0.0 110.729 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -26.88 67.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.28 -35.13 15.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.23 113.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.887 0.375 . . . . 0.0 111.194 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' CA ' ' A' ' 25' ' ' GLY . 1.3 m -98.22 143.68 28.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.674 ' HB3' HD11 ' A' ' 151' ' ' LEU . 3.8 p90 -138.55 158.92 43.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.04 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -146.7 132.24 18.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -86.32 120.04 27.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.6 148.65 44.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.65 116.61 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.061 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 m -96.61 127.32 42.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.17 -172.93 2.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.708 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.31 -19.99 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.735 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.19 -90.39 1.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.54 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.592 ' O ' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -93.87 141.16 28.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.776 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -137.63 155.02 49.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.427 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.74 115.9 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.403 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 17.5 p -112.67 147.41 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.998 0.427 . . . . 0.0 111.482 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.69 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.0 t -130.29 125.66 60.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.939 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -98.68 140.98 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.01 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 54' ' ' ALA . 21.8 t -138.38 116.79 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.01 167.25 10.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t0 46.23 35.41 2.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.439 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -152.78 142.92 15.22 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.761 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 53.6 Cg_endo -68.58 -163.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.403 2.069 . . . . 0.0 112.107 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.878 HG13 ' CD1' ' A' ' 98' ' ' LEU . 47.1 t -81.04 -54.31 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.59 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -61.18 -45.52 94.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.488 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 50' ' ' PRO . 5.4 tt0 -67.33 -42.9 82.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.23 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 46' ' ' VAL . . . -58.61 -44.8 90.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.425 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.714 HD11 ' CE1' ' A' ' 84' ' ' PHE . 5.3 mt -56.92 -35.63 69.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.761 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.88 -33.02 74.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.922 0.391 . . . . 0.0 110.068 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 17.1 tp10 -88.42 -30.89 19.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.384 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.32 -44.8 58.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.583 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.5 mmt -57.68 -43.88 99.09 Favored Pre-proline 0 N--CA 1.466 0.342 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 31.9 Cg_exo -58.9 -46.09 24.98 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.17 1.913 . . . . 0.0 112.221 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -70.29 -41.39 73.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.707 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG21 ' A' ' 44' ' ' VAL . 11.0 tt -76.41 -35.06 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 111.586 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.42 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.4 mtt -66.28 -36.59 83.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.821 0.343 . . . . 0.0 110.871 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.93 -49.01 79.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.836 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 23.1 t80 -58.45 -54.11 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.852 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.574 HG11 ' CE1' ' A' ' 102' ' ' PHE . 33.7 m -66.48 -28.29 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.5 -141.12 0.89 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.614 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.51 43.22 1.92 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.3 m -131.19 87.13 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.806 0.336 . . . . 0.0 110.882 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.39 143.32 32.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -73.59 -9.16 58.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tptt -91.21 -39.82 11.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.04 62.4 1.01 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.409 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.68 HG23 ' HG3' ' A' ' 76' ' ' MET . 30.0 m -139.66 159.48 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.92 -46.13 38.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.68 ' HG3' HG23 ' A' ' 74' ' ' VAL . 5.2 mtp 61.43 117.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.776 0.322 . . . . 0.0 111.051 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.72 127.62 25.73 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.402 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.48 176.05 8.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 111.022 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 18.7 p -147.63 114.05 5.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.48 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 81' ' ' PRO . 31.2 m -57.61 -33.11 15.72 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 11.1 Cg_exo -71.48 152.3 60.05 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.082 1.855 . . . . 0.0 111.823 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 ' HE3' ' A' ' 59' ' ' MET . 21.7 t -153.07 147.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 111.433 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 t -143.02 145.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.646 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.831 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -133.25 154.15 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.815 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -85.51 136.72 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 110.481 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 167' ' ' TYR . 15.4 m -136.1 141.0 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.952 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -108.63 107.97 60.51 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.35 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HA ' HD23 ' A' ' 94' ' ' LEU . 81.8 Cg_endo -80.02 129.49 7.94 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.549 2.166 . . . . 0.0 112.391 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -90.82 158.43 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -28.78 69.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -2.69 58.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.432 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.45 57.3 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.969 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.02 163.21 28.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.748 0.308 . . . . 0.0 110.957 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.646 HD12 ' HG2' ' A' ' 141' ' ' GLU . 19.5 mt -117.51 -9.51 10.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.417 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 62.47 153.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.35 . . . . 0.0 110.958 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -80.78 88.34 5.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.035 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.72 118.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.878 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.2 tt -143.94 135.8 26.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.965 0.412 . . . . 0.0 111.248 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -123.25 115.67 22.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.203 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.2 t -81.98 141.26 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.308 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -120.23 131.25 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.552 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 62' ' ' ILE . 56.5 t80 -110.08 161.25 15.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.464 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' O ' ' CE2' ' A' ' 102' ' ' PHE . 40.9 mmt-85 -116.08 121.57 42.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.64 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 40' ' ' LYS . 40.5 mt -102.22 137.01 19.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.21 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' HG23 ' A' ' 104' ' ' ILE . 32.6 Cg_endo -64.23 154.09 72.87 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 112.511 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -26.55 64.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.269 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -56.6 -47.02 80.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -96.07 -5.04 41.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.321 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -54.39 -47.73 72.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.364 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.9 -26.08 39.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.99 91.38 0.3 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.92 150.85 73.67 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.417 2.078 . . . . 0.0 112.22 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.631 ' CG ' HG21 ' A' ' 74' ' ' VAL . 11.3 Cg_exo -70.83 152.97 64.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.633 2.222 . . . . 0.0 112.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.54 127.97 93.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.095 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 74.5 Cg_endo -75.53 169.71 21.79 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.521 2.147 . . . . 0.0 112.401 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 -31.8 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.667 ' HB3' HG23 ' A' ' 120' ' ' VAL . 2.7 t70 -79.18 116.17 19.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.68 -19.64 41.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.85 -22.01 40.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.209 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.667 HG23 ' HB3' ' A' ' 117' ' ' ASP . 69.7 t -84.77 113.9 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -108.11 147.62 30.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 24.4 mm -104.27 123.89 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.233 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.78 142.73 29.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.46 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -169.3 2.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.6 ttp-105 -43.89 109.28 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.966 0.413 . . . . 0.0 111.594 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -169.16 56.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.719 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -56.67 168.57 3.56 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pp -140.72 142.86 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.6 m -111.04 119.8 40.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.691 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.748 HG12 ' HA ' ' A' ' 188' ' ' VAL . 21.4 m -138.86 168.74 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.255 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.453 ' CE2' HD13 ' A' ' 155' ' ' LEU . 10.8 m-85 -107.73 141.1 39.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.526 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.7 p -105.96 127.93 53.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.281 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.441 ' CG2' HD22 ' A' ' 151' ' ' LEU . 1.5 t -125.1 137.11 54.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.644 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.84 125.01 45.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.919 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 8.5 p90 -123.06 -41.67 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.945 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.99 84.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . -147.09 -89.21 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.6 OUTLIER -175.71 108.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.932 0.396 . . . . 0.0 110.814 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 144' ' ' TYR . . . -105.66 132.72 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.189 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 58.49 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.785 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.646 ' HG2' HD12 ' A' ' 94' ' ' LEU . 1.2 tm-20 67.16 -72.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.86 76.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -67.84 -34.77 77.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.982 179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 139' ' ' ALA . 1.2 m-85 -62.63 -39.53 94.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.439 0.638 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.593 HG22 HD21 ' A' ' 94' ' ' LEU . 21.4 t -53.87 -38.82 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.477 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.68 -35.61 70.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.787 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 47.4 m-70 -70.05 -42.7 72.54 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.925 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.35 -32.92 72.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.694 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.4 m -69.64 -39.28 77.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.714 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.83 -46.01 91.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.675 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.674 HD11 ' HB3' ' A' ' 31' ' ' TYR . 13.9 tp -58.57 -40.67 83.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.656 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.06 95.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.338 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.3 m -64.84 -39.37 93.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.364 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.35 -45.67 84.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.822 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.455 HD23 ' CE2' ' A' ' 31' ' ' TYR . 15.6 mt -72.78 -17.83 61.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.258 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.96 111.56 0.41 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.171 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 106.25 30.37 4.46 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.289 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.472 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 64.6 p -145.23 168.07 12.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.7 0.286 . . . . 0.0 110.807 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 16.5 Cg_exo -67.93 -3.43 10.5 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.808 2.339 . . . . 0.0 112.978 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.29 124.56 18.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.339 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.448 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -99.57 176.32 5.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.32 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 161' ' ' THR . 3.5 m-85 -154.58 161.25 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.035 0.445 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -92.87 -172.26 2.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.819 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.81 63.19 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 57.08 77.14 0.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.743 0.306 . . . . 0.0 111.308 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 166' ' ' VAL . 13.9 p -161.37 112.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.604 ' HB3' HD23 ' A' ' 187' ' ' LEU . 13.8 p90 -119.14 173.28 7.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.724 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 69.3 m-85 -112.89 150.49 31.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.81 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.1 m -125.84 132.04 52.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.82 149.62 38.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -178.21 162.37 29.77 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.564 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -99.25 -70.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.351 . . . . 0.0 110.89 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -120.5 160.31 44.49 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.06 154.57 74.12 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.542 2.161 . . . . 0.0 112.275 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.01 87.33 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.543 2.162 . . . . 0.0 112.273 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.87 -38.27 3.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.33 138.02 30.5 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.41 170.88 18.61 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.499 2.133 . . . . 0.0 112.401 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 61.98 121.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.013 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.5 29.08 12.71 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.9 139.03 41.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.783 0.325 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 130.9 30.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.94 152.54 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.918 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.06 154.84 42.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.078 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.07 128.35 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.424 ' HB3' HG21 ' A' ' 130' ' ' VAL . 40.7 m0 -108.04 122.0 45.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.368 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.659 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.1 mt -93.09 134.49 35.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.535 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 130' ' ' VAL . 43.4 t -74.76 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -107.51 111.97 24.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.227 -0.892 . . . . 1.0 111.028 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.861 0.362 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 tt -138.38 142.15 39.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.31 -100.65 0.24 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 32.5 mtt 60.5 95.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 pt -97.01 97.38 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.189 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.39 119.33 37.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -133.35 128.63 36.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.6 t -83.33 135.48 34.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tt -169.3 82.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -150.31 97.88 2.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.804 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.02 -116.05 0.66 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.2 m -88.73 126.66 35.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.374 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.15 145.57 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.77 132.32 52.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -115.8 129.5 56.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.16 102.25 8.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.57 143.9 58.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.477 2.118 . . . . 0.0 112.246 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.0 t90 56.63 92.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.971 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -135.09 108.43 7.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.985 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.6 t -74.0 112.99 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.796 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.73 -10.88 25.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.354 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.3 t -170.01 164.83 9.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.792 0.33 . . . . 0.0 110.966 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.487 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.6 OUTLIER -151.9 -49.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.96 137.64 46.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.462 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -139.11 -156.16 6.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -78.4 158.37 28.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.51 -27.38 67.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -90.11 -35.01 15.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.0 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.08 114.82 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.0 t -95.38 150.8 19.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.5 p90 -139.05 160.32 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.097 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HG2' HG22 ' A' ' 23' ' ' THR . 3.1 mp0 -143.33 124.97 14.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -85.86 122.1 29.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 129' ' ' THR . 11.3 ptm180 -130.3 128.13 40.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.35 132.77 55.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.1 p -139.65 162.22 35.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.85 170.91 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.935 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.8 -119.96 0.13 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.48 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.01 -170.76 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.536 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.643 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -99.34 137.72 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' HD3' ' A' ' 103' ' ' ARG . 10.8 m-85 -137.49 159.85 40.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.675 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -103.29 127.07 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.7 p -112.79 131.79 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.277 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 62' ' ' ILE . 39.0 t -127.7 125.35 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.583 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.59 139.92 31.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.872 HG11 ' HA ' ' A' ' 54' ' ' ALA . 5.2 t -138.28 116.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.073 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.52 168.35 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.6 t0 47.56 28.99 1.3 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.489 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -152.87 115.72 2.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.937 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.41 -172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.507 2.138 . . . . 0.0 112.479 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.525 ' HA ' HD13 ' A' ' 98' ' ' LEU . 40.3 t -59.71 -62.24 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.542 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -45.08 79.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -67.1 -45.36 77.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.169 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.872 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.69 -44.42 90.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.344 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.817 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.96 -35.75 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.743 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -64.79 -32.17 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.944 0.402 . . . . 0.0 110.479 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.5 tp10 -87.8 -35.45 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.821 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.52 -42.02 62.3 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.477 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -57.64 -44.11 99.27 Favored Pre-proline 0 N--CA 1.464 0.25 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.519 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.0 Cg_exo -63.95 -40.29 28.48 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.243 1.962 . . . . 0.0 111.76 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -70.14 -43.39 71.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.198 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.736 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.35 -34.16 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.318 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.6 mmt -66.28 -37.83 86.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.863 0.363 . . . . 0.0 110.957 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.2 81.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 62.5 t80 -68.99 -42.1 76.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 102' ' ' PHE . 30.3 m -82.24 -23.37 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.317 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.32 -82.09 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.562 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.79 51.86 0.42 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -132.06 92.21 3.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.769 0.318 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -155.09 170.81 20.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.59 ' OD2' ' HB3' ' A' ' 114' ' ' ALA . 14.9 p30 -96.09 42.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -148.33 -47.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.31 42.96 1.81 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.459 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.3 m -100.26 174.07 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.788 0.328 . . . . 0.0 111.182 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.1 116.41 1.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.528 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 30.6 mtp -112.56 -161.7 0.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 110.577 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -141.69 -120.37 1.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -56.43 1.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.735 ' O ' HG12 ' A' ' 80' ' ' VAL . 2.1 m 60.45 102.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.991 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 79' ' ' THR . 9.7 p 53.78 142.72 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.331 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.801 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 80' ' ' VAL . 31.2 Cg_exo -59.79 138.2 81.4 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.304 2.003 . . . . 0.0 112.128 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.9 m -86.01 153.96 3.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.649 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.26 167.6 13.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.421 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.817 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.18 140.52 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.162 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.497 ' HB2' ' HE1' ' A' ' 168' ' ' TYR . . . -76.7 136.65 39.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.432 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.616 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 3.6 m -131.38 102.91 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.857 0.361 . . . . 0.0 111.09 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -70.7 111.76 10.77 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.628 ' HA ' HD23 ' A' ' 94' ' ' LEU . 92.5 Cg_endo -87.94 137.85 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.724 2.283 . . . . 0.0 112.503 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -91.11 155.14 18.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.839 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.28 -19.0 61.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -85.24 -6.02 59.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.375 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.491 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 97.94 -1.94 59.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.9 t -95.56 165.39 12.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.832 0.348 . . . . 0.0 111.067 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 88' ' ' PRO . 55.0 mt -112.2 140.64 46.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.63 163.09 24.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -79.95 -11.83 59.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.248 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 124.7 33.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.703 0.287 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.525 HD13 ' HA ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.7 141.21 49.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.067 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -121.88 115.98 23.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.591 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -90.63 128.12 42.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.329 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.6 m95 -103.37 142.07 34.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.708 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 66' ' ' VAL . 62.9 t80 -126.07 150.73 47.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 0.0 111.519 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' CE2' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -108.77 108.04 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.514 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 40' ' ' LYS . 34.5 mt -80.25 136.05 53.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.343 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 30.5 Cg_endo -63.56 154.23 70.08 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.664 2.242 . . . . 0.0 112.511 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 69.3 m-80 -55.87 -26.87 49.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.284 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -56.98 -40.38 76.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.405 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 40.5 m-85 -101.86 -8.07 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.749 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.3 OUTLIER -53.95 -37.58 64.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.332 . . . . 0.0 111.055 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.23 -31.13 61.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -174.53 85.37 0.34 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 39.4 Cg_exo -56.88 145.53 83.8 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.619 2.212 . . . . 0.0 112.212 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.6 Cg_exo -70.88 151.85 63.0 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.489 2.126 . . . . 0.0 112.081 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB3' ' OD2' ' A' ' 71' ' ' ASP . . . -67.33 111.59 7.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 33.0 Cg_exo -58.36 158.87 21.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.479 2.119 . . . . 0.0 112.192 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 m -110.44 30.83 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.705 ' HB3' HG23 ' A' ' 120' ' ' VAL . 37.3 m-20 -130.26 112.15 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.02 -29.07 65.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.3 -27.54 32.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 117' ' ' ASP . 29.5 t -85.11 125.47 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.153 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.99 157.11 33.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.408 ' CG2' ' HG2' ' A' ' 40' ' ' LYS . 20.7 mm -105.73 119.48 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 150.83 21.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.51 156.07 39.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 58.8 103.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.24 -66.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.061 0.458 . . . . 0.0 111.184 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.3 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.088 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.409 HD13 ' HE2' ' A' ' 168' ' ' TYR . 1.5 pt -129.26 142.98 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.007 0.432 . . . . 0.0 111.629 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 34' ' ' ARG . 84.0 m -115.42 128.98 56.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.252 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 188' ' ' VAL . 35.8 m -134.47 160.02 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.087 0.47 . . . . 0.0 111.737 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.432 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -107.93 136.3 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.205 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.1 p -105.67 131.08 53.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.913 0.387 . . . . 0.0 111.396 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 t -125.34 139.25 53.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -116.85 137.17 52.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 6.1 p90 -134.57 140.75 46.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.36 93.9 1.24 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.525 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 159.1 161.1 10.86 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.581 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.456 ' CE1' ' HA ' ' A' ' 175' ' ' PRO . 82.2 m-85 -65.79 167.86 8.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.52 147.99 31.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.212 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -135.79 -175.91 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.616 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.2 tt0 -58.35 -69.43 0.18 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.83 72.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.688 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.15 -34.85 78.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.031 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.77 -40.75 98.25 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.523 0.678 . . . . 0.0 109.87 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 92' ' ' GLY . 19.2 t -53.76 -38.88 36.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.61 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.53 -36.27 70.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.919 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 48.0 m-70 -70.14 -43.28 71.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.901 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.92 72.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.735 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 79.9 m -65.55 -37.84 87.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -58.76 -45.83 88.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 187' ' ' LEU . 11.0 tp -58.59 -38.79 78.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 0.3 OUTLIER -64.29 -43.25 95.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.522 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 91.1 m -68.13 -38.57 82.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.752 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 56.1 m -57.49 -49.08 77.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 131' ' ' TYR . 47.3 mt -73.56 -19.5 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.17 102.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.894 0.378 . . . . 0.0 111.162 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 113.08 32.7 2.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.3 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 44.0 p -145.52 165.42 21.46 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.82 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 32.6 Cg_exo -58.06 -17.33 30.91 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.666 2.244 . . . . 0.0 112.674 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.39 129.28 41.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.623 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.94 -171.21 1.93 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.933 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.746 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 6.6 m-85 -155.43 154.0 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.06 -164.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -56.68 -86.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.17 77.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.3 p -161.67 132.37 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.879 ' HB3' HD23 ' A' ' 187' ' ' LEU . 14.7 p90 -141.17 163.63 32.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.508 ' CE2' HG22 ' A' ' 188' ' ' VAL . 22.1 m-85 -112.94 157.49 21.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.101 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.532 ' SG ' HG13 ' A' ' 185' ' ' VAL . 11.1 m -143.87 136.98 27.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.01 138.53 48.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.026 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 172' ' ' TYR . . . 168.19 155.52 9.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 171' ' ' GLY . 5.7 m-85 -165.8 91.31 0.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 0.0 110.955 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -140.06 134.86 15.94 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 89.0 Cg_endo -78.52 132.8 11.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.144 . . . . 0.0 112.271 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.456 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 70.4 Cg_exo -51.82 -25.25 20.57 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.473 2.115 . . . . 0.0 112.428 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.6 mtt -59.87 -44.87 93.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 115.37 65.6 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.832 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 -7.88 21.29 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.477 2.118 . . . . 0.0 112.652 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -148.49 121.08 8.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.777 0.322 . . . . 0.0 110.864 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.04 -70.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.504 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.05 167.06 10.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -112.11 132.1 55.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.058 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -115.63 133.89 55.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.585 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -143.36 156.89 44.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.532 HG13 ' SG ' ' A' ' 169' ' ' CYS . 29.3 t -121.43 114.85 44.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.562 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.11 125.68 51.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.346 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.3 mt -92.54 140.51 29.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.593 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' VAL . 18.6 t -74.59 131.14 35.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.358 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -79.95 163.43 24.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.813 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.206 -0.902 . . . . 1.0 111.096 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtt . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.735 0.302 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.09 166.97 10.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.28 -121.74 4.48 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.567 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.5 35.48 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.874 0.369 . . . . 0.0 110.963 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 5' ' ' ILE . 23.3 mm -98.92 40.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -77.01 129.22 35.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.26 150.7 39.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 m -87.93 132.93 34.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 -45.12 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 62.79 18.3 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.21 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.0 -78.69 0.47 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.008 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 p -106.93 124.87 50.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.677 0.275 . . . . 0.0 110.494 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.84 142.39 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.376 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -134.91 124.9 25.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -92.05 120.2 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.025 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.29 126.2 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.995 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.99 -41.35 2.77 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.045 . . . . 0.0 112.202 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -131.56 -178.07 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.725 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -126.87 113.17 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.0 t -74.55 113.0 12.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 mt -96.67 -12.94 23.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.442 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.48 166.29 10.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.388 . . . . 0.0 110.91 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 p -152.47 -176.78 5.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.47 141.95 1.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.422 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -154.67 -173.74 23.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -78.81 158.98 28.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -66.59 -30.38 70.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.06 -35.03 16.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.876 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.6 m -146.08 107.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.006 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 5.7 p -97.29 156.14 16.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.012 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p90 -140.12 162.05 36.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 131' ' ' TYR . 28.2 mt-10 -145.52 136.38 24.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.577 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -85.77 130.8 34.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 111.142 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 127.98 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.655 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 19' ' ' GLN . . . -112.58 139.1 48.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.935 0.397 . . . . 0.0 111.255 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.3 m -133.71 132.21 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.794 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.67 149.21 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 118.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' CA ' ' HG3' ' A' ' 109' ' ' GLN . . . 141.92 148.93 5.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.603 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.467 ' HG2' HG22 ' A' ' 122' ' ' ILE . 2.2 mttm -105.36 158.18 16.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 110.854 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -137.63 157.6 46.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.94 140.3 29.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.434 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.9 p -137.03 143.43 42.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 111.687 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 62' ' ' ILE . 21.3 t -129.25 125.87 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.687 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -95.85 131.18 42.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.024 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -138.34 116.85 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.435 HG23 ' HD3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -107.32 169.04 8.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 47.46 37.86 6.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 9.1 mttm -152.5 137.38 10.86 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.869 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 32.3 Cg_exo -57.89 -160.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.509 2.14 . . . . 0.0 112.278 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 46.2 t -92.76 -63.38 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.28 -42.83 92.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.9 -45.96 76.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.971 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.85 -36.99 75.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.761 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.3 mt -58.31 -35.4 71.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.27 -33.61 74.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.938 0.399 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.5 tp10 -87.48 -28.67 21.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.811 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.57 -44.01 58.37 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.602 ' HA ' HG22 ' A' ' 62' ' ' ILE . 32.0 mmt -57.67 -43.46 98.81 Favored Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.92 -45.54 23.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.23 1.953 . . . . 0.0 111.884 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -70.34 -42.25 72.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.661 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.753 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.04 -37.48 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -31.77 72.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.34 . . . . 0.0 111.001 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 63' ' ' MET . 4.2 mtmm -60.89 -29.96 69.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 110.385 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -73.13 -49.05 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.0 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 63' ' ' MET . 14.9 m -66.01 -22.91 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.44 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.81 83.18 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -178.97 -43.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 t -172.43 100.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 0.0 111.016 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.647 HD21 HG22 ' A' ' 74' ' ' VAL . 14.3 p-10 -127.34 3.36 6.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.404 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.22 41.15 17.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.974 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -148.31 -50.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.89 43.96 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG22 HD21 ' A' ' 70' ' ' ASN . 12.9 m -100.92 -179.77 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.92 117.68 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.337 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.1 mtp -120.15 118.43 30.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.42 -26.19 50.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.3 ttt 63.92 132.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.7 t -58.13 177.32 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.771 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -95.29 -54.79 0.22 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.204 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 76.2 Cg_endo -93.86 130.35 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.645 2.23 . . . . 0.0 112.585 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.569 HG11 ' CE ' ' A' ' 59' ' ' MET . 53.6 t -93.07 148.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -127.43 148.95 50.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -133.05 154.25 50.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.201 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.36 136.69 34.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.229 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG12 HD12 ' A' ' 98' ' ' LEU . 30.0 m -129.39 134.15 64.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.071 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -111.04 95.79 26.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.28 164.3 32.95 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -90.23 172.28 8.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.688 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -55.52 -22.16 20.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.292 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -85.46 -6.12 59.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.466 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.14 61.51 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.883 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.03 -174.73 4.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 110.776 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mt -123.54 164.31 19.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.657 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -161.0 87.97 0.74 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp 51.96 -167.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.217 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD3' HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER 63.19 99.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.1 tt -144.08 128.01 17.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.167 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 115.57 29.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.973 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.811 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -71.68 141.3 16.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 0.0 111.731 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.9 m95 -119.35 130.99 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.13 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 60.5 t80 -114.76 158.9 21.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.059 0.457 . . . . 0.0 111.63 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 ttt85 -116.08 107.9 15.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.482 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.4 mt -84.92 137.1 38.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.356 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.31 154.09 25.06 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.572 2.181 . . . . 0.0 112.288 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 3.9 m-20 -58.24 -26.89 63.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -47.12 87.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.482 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -86.31 -11.06 53.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.598 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.83 -42.81 68.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.634 0.255 . . . . 0.0 111.017 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.86 -29.05 58.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.8 85.48 0.24 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.607 0.242 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 40' ' ' LYS . 30.8 Cg_exo -60.82 160.94 23.27 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.573 2.182 . . . . 0.0 112.239 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.41 155.66 32.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.861 2.374 . . . . 0.0 111.972 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.42 115.08 22.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.97 168.6 22.66 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.377 2.051 . . . . 0.0 112.392 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.2 p -110.25 168.92 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.419 ' HB3' HG23 ' A' ' 120' ' ' VAL . 4.4 t70 66.74 126.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.75 -16.01 24.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.66 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -79.81 -29.14 40.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.68 0.276 . . . . 0.0 111.253 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.4 t -85.73 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.371 . . . . 0.0 111.092 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -123.02 156.92 33.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.467 HG22 ' HG2' ' A' ' 40' ' ' LYS . 11.9 mm -113.71 128.46 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.8 153.6 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.27 179.86 6.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.931 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptt-85 -58.66 98.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.67 -21.86 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.9 74.27 0.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 188' ' ' VAL . 1.1 pp -138.55 145.17 28.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.787 0.327 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -103.78 137.45 41.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.234 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -139.17 145.63 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.914 0.388 . . . . 0.0 111.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.496 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.4 OUTLIER -107.79 128.81 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.178 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.4 p -105.51 142.29 35.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.141 0.496 . . . . 0.0 111.707 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.0 t -127.67 139.6 52.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 125.0 51.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.404 . . . . 0.0 111.023 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.499 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 12.5 p90 -131.03 -177.88 4.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -117.58 130.22 8.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.566 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 139.31 -177.37 20.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.568 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -94.43 166.9 11.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.805 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -177.18 121.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.245 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.22 -73.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.778 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -141.4 -47.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.785 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -73.03 -33.95 66.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 110.605 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -35.09 76.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.927 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -64.22 -39.08 93.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.245 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 141' ' ' GLU . 57.4 t -53.63 -38.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.452 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.2 70.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.78 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.499 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 48.7 m-70 -70.0 -42.79 72.58 Favored 'General case' 0 C--O 1.23 0.058 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.807 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.94 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.4 m -67.66 -39.44 84.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.704 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.25 -46.05 92.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.748 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.4 tp -58.28 -38.88 77.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.62 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.447 ' HG3' ' CE2' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -64.12 -42.56 96.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.5 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.7 m -69.15 -37.07 78.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.683 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.4 m -57.54 -38.9 75.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 162' ' ' TYR . 32.1 mt -72.4 -22.71 61.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.084 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.23 95.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.216 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 114.93 33.12 1.73 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.418 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 64.9 p -145.54 155.26 53.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.676 0.274 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 36.3 Cg_endo -65.09 -12.99 37.33 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.615 2.21 . . . . 0.0 112.605 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.496 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -58.41 159.8 5.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 156.54 47.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.592 ' CD1' HD13 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -154.48 155.81 35.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -79.38 -61.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.03 -16.69 58.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.687 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.58 -27.47 34.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.066 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 166' ' ' VAL . 8.4 p -160.76 118.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.797 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.3 p90 -119.03 171.38 8.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.625 ' CE2' HG22 ' A' ' 188' ' ' VAL . 33.5 m-85 -113.15 140.16 48.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.163 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 3.4 m -111.82 147.58 35.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.825 ' HB3' ' CG ' ' A' ' 184' ' ' GLU . . . -132.04 127.82 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.71 103.69 0.24 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.582 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -131.13 105.87 7.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 0.0 110.888 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -162.69 147.03 9.24 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.61 125.47 9.55 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.557 2.171 . . . . 0.0 112.299 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.78 94.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.413 2.075 . . . . 0.0 112.283 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.67 -65.19 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.04 149.09 70.02 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.07 -54.3 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.529 2.153 . . . . 0.0 112.283 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -91.5 108.72 20.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.95 -53.49 0.16 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.88 167.0 10.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.84 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -141.19 146.15 36.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.127 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -108.93 158.01 18.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.515 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.825 ' CG ' ' HB3' ' A' ' 170' ' ' ALA . 0.7 OUTLIER -141.38 144.18 34.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 42.7 t -131.7 124.64 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.351 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.727 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -122.14 132.37 54.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 111.725 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 167' ' ' TYR . 16.8 mt -92.33 140.21 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.656 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 130' ' ' VAL . 19.6 t -74.69 131.07 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 111.462 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 69.1 tttt -69.53 154.21 42.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.88 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.307 -0.854 . . . . 1.0 111.077 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.675 0.274 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 mp -82.23 -31.89 30.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.854 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.02 -175.13 25.94 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.433 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.0 ttt -124.97 99.98 6.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -90.74 -31.52 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -78.67 119.32 21.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -131.65 156.87 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -80.4 151.8 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.8 31.38 3.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.016 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.44 16.18 25.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.235 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.72 -100.1 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.627 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -106.97 124.93 50.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.746 0.307 . . . . 0.0 110.829 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -136.63 146.1 29.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.56 125.53 44.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.9 m -85.05 136.72 33.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.825 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -126.81 80.16 71.18 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.798 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.62 155.74 21.19 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.67 2.247 . . . . 0.0 112.405 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -62.67 -179.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -111.15 111.52 22.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -74.11 112.83 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.857 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.88 -12.99 22.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.437 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.79 167.09 9.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.69 154.49 36.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.827 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.23 164.26 5.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.446 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -161.17 -58.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -161.95 164.48 28.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.785 0.326 . . . . 0.0 110.748 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.5 -33.74 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -91.08 -35.29 14.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG11 ' CB ' ' A' ' 150' ' ' GLN . 3.5 m -146.44 108.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.83 0.348 . . . . 0.0 111.723 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.31 158.06 16.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.643 ' CE2' HG22 ' A' ' 154' ' ' THR . 0.2 OUTLIER -139.07 162.35 35.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.92 0.39 . . . . 0.0 111.114 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.76 132.85 21.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -85.98 126.96 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.991 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.97 28.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.93 127.35 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.1 t -152.88 96.18 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.48 -50.65 72.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.77 -119.77 19.57 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.622 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.96 -119.46 1.01 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -91.91 159.34 15.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 0.0 110.832 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 102' ' ' PHE . 38.4 m-85 -137.44 148.93 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.042 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.818 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.81 140.34 29.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.483 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 66.5 p -132.1 136.02 46.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 111.576 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.517 HG21 ' HB ' ' A' ' 62' ' ' ILE . 39.9 t -125.9 125.56 68.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.662 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -96.88 131.45 43.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.095 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 54' ' ' ALA . 16.6 t -138.26 116.84 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.002 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.41 174.11 6.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.51 25.99 3.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.398 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -152.95 130.02 5.74 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.06 177.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.313 2.009 . . . . 0.0 112.23 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.95 HG13 ' CD1' ' A' ' 98' ' ' LEU . 82.7 t -62.2 -57.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.024 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -58.24 -45.25 88.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.051 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.17 -46.21 74.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.91 -45.0 91.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.194 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.8 mt -57.1 -35.59 69.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -63.77 -31.81 73.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.05 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.1 tp10 -87.27 -30.03 21.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.208 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.672 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.47 -42.66 61.62 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.509 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.0 mmt -57.69 -44.15 99.27 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 24.3 Cg_exo -63.29 -40.54 31.71 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.21 1.94 . . . . 0.0 111.718 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -70.24 -44.03 69.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.035 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.5 tt -76.1 -31.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.174 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -42.79 87.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.6 mttt -58.92 -42.27 89.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 7.0 t80 -59.63 -50.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -72.54 -27.62 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.37 -105.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.594 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -135.46 67.29 0.55 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.657 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.4 HG21 ' HD3' ' A' ' 64' ' ' LYS . 68.6 m -164.4 71.54 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 0.0 110.761 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.697 HD21 HG22 ' A' ' 74' ' ' VAL . 0.5 OUTLIER -134.94 10.41 3.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.372 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 57.05 38.94 29.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.815 0.34 . . . . 0.0 111.025 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -52.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.46 79.86 1.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.552 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.697 HG22 HD21 ' A' ' 70' ' ' ASN . 26.8 m -139.0 143.65 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.896 0.379 . . . . 0.0 111.169 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.87 -42.66 94.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.418 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.419 ' HA ' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER 65.48 -76.4 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.828 0.347 . . . . 0.0 110.908 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 119.89 -23.16 8.37 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.412 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 64.46 162.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.04 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.76 HG22 ' HD2' ' A' ' 81' ' ' PRO . 7.8 m -122.29 131.63 54.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 1.5 t -68.43 -53.05 18.6 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.76 ' HD2' HG22 ' A' ' 79' ' ' THR . 84.3 Cg_endo -81.1 130.78 7.49 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.417 2.078 . . . . 0.0 112.354 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -154.37 134.61 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.975 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 170' ' ' ALA . 1.8 t -114.96 167.99 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -126.91 154.22 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.729 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -92.35 136.57 33.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.307 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.69 HG12 HD12 ' A' ' 98' ' ' LEU . 33.3 m -131.28 128.35 61.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 111.132 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -98.95 104.25 24.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.993 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.702 ' HA ' HD23 ' A' ' 94' ' ' LEU . 41.4 Cg_endo -66.84 128.31 18.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.412 2.074 . . . . 0.0 112.202 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -90.29 156.88 17.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.087 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -66.02 -15.9 63.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.314 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.04 5.18 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.552 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.59 -16.0 60.16 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.752 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 162.87 13.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 88' ' ' PRO . 27.1 mt -87.8 -4.91 58.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.509 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 62.33 162.34 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.782 0.325 . . . . 0.0 110.911 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -80.75 84.15 6.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.873 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -175.68 106.82 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.834 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG13 ' A' ' 51' ' ' VAL . 5.7 tt -138.22 127.96 25.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.64 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.672 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.8 t -76.22 141.15 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.381 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -116.95 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.409 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.818 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 50.6 t80 -120.98 150.26 41.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.518 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.74 114.5 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 mt -92.75 134.51 27.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.286 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.82 154.06 28.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.622 2.215 . . . . 0.0 112.405 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -60.49 -26.75 67.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.07 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -56.96 -32.81 66.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.409 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 76' ' ' MET . 57.9 m-85 -106.03 -9.71 16.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.799 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -52.95 -33.8 52.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.65 -34.17 77.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 76.28 3.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.658 0.266 . . . . 0.0 110.872 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 33.0 Cg_exo -59.72 148.23 88.84 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.635 2.223 . . . . 0.0 112.303 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.44 ' CG ' HG21 ' A' ' 74' ' ' VAL . 6.9 Cg_exo -72.57 159.24 49.37 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.59 133.26 94.21 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 27.6 Cg_endo -62.9 -22.24 73.7 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.493 2.129 . . . . 0.0 112.417 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 m 52.97 28.46 6.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -151.75 122.83 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.921 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.06 -24.01 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.177 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.07 -35.81 28.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.96 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 44' ' ' VAL . 43.6 t -85.05 123.67 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 157.03 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.2 mm -112.2 118.58 58.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.934 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.94 129.48 45.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 125' ' ' ARG . 5.7 tt0 -95.38 -152.18 0.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.608 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 6.4 mtt180 67.92 71.85 0.32 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.727 0.299 . . . . 0.0 111.458 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 38.3 -161.14 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.93 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -97.7 -145.31 18.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.427 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -144.15 145.43 21.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 111.324 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.3 m -103.91 118.93 37.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.499 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.908 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.5 m -140.72 170.38 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.379 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.549 ' CE2' HD22 ' A' ' 155' ' ' LEU . 5.0 m-85 -107.32 160.03 15.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.329 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 98.1 p -130.23 136.28 49.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 111.664 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -131.09 139.15 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.344 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -116.88 140.59 49.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 111.225 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.32 173.55 13.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -96.23 -30.01 8.07 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.555 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.02 118.0 12.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.59 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CE2' ' HB3' ' A' ' 177' ' ' LYS . 23.7 m-85 -79.46 121.77 25.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -113.87 150.89 32.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.278 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -106.36 -59.92 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.68 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.6 ' HG3' HD12 ' A' ' 94' ' ' LEU . 27.4 tt0 -152.02 -67.73 0.17 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.576 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.49 -33.78 73.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 110.254 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.492 ' HB3' ' HB1' ' A' ' 139' ' ' ALA . 9.8 t70 -67.76 -34.59 77.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.8 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.437 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.4 OUTLIER -62.56 -40.25 96.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.54 0.686 . . . . 0.0 109.742 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.89 -38.72 37.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.709 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.26 -33.8 72.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.795 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.415 ' HB3' HG21 ' A' ' 185' ' ' VAL . 42.0 m-70 -70.12 -46.1 65.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -62.14 -32.88 73.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.4 m -62.99 -43.99 97.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.401 ' CB ' HG11 ' A' ' 29' ' ' VAL . 3.9 mt-30 -62.45 -46.07 90.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.641 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.694 ' HB3' HD11 ' A' ' 187' ' ' LEU . 11.2 tp -59.1 -39.68 83.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.462 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.83 -48.11 82.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.308 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 97.5 m -62.23 -45.27 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.166 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 31' ' ' TYR . 4.1 m -57.53 -44.56 85.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.676 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.614 ' CD1' HD12 ' A' ' 187' ' ' LEU . 12.4 mt -72.89 -17.01 61.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.143 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.79 -38.06 14.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 111.445 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.63 -14.18 82.7 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.465 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -93.89 176.38 2.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.806 0.303 . . . . 0.0 111.064 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.465 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 13.4 Cg_exo -70.02 -1.04 8.03 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.25 143.0 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.708 0.29 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.738 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 16.1 m -130.39 2.06 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.766 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.95 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 8.0 m-85 56.92 159.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.047 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.62 -80.04 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.24 38.6 1.23 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.276 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.13 71.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.961 0.41 . . . . 0.0 110.713 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 166' ' ' VAL . 14.0 p -161.76 124.13 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.088 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.852 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.5 p90 -126.0 175.0 8.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.729 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 68.3 m-85 -119.6 162.03 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 94.6 m -130.82 130.86 44.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.016 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 83' ' ' SER . . . -132.02 156.02 46.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -114.55 78.29 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -119.9 -174.43 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.793 0.33 . . . . 0.0 110.911 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 61.3 154.94 0.11 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.88 129.78 10.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.525 2.15 . . . . 0.0 112.41 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.1 123.17 7.63 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.531 2.154 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -97.16 31.04 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.026 0.441 . . . . 0.0 110.722 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' CE2' ' A' ' 138' ' ' TYR . 9.1 mptt -144.67 178.49 1.43 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 177' ' ' LYS . 35.0 Cg_exo -56.53 -162.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.286 1.991 . . . . 0.0 112.345 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 178' ' ' PRO . 52.0 m-85 55.18 -169.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.868 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -141.11 42.06 1.21 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.499 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.16 166.18 25.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.897 0.38 . . . . 0.0 111.12 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.37 156.05 39.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.437 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 44.7 m-80 -133.11 138.39 46.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.914 0.387 . . . . 0.0 111.469 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -146.09 157.29 43.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.628 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.804 HG13 ' CD2' ' A' ' 167' ' ' TYR . 10.6 t -134.85 114.94 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.888 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 44.0 m0 -109.33 121.53 45.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.207 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.852 HD23 ' HB3' ' A' ' 167' ' ' TYR . 72.2 mt -94.53 140.08 30.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.666 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.908 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.3 t -87.08 123.59 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.3 150.34 40.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.959 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.95 ' HB2' ' O ' ' A' ' 162' ' ' TYR . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.263 -0.875 . . . . 1.0 111.126 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.834 0.349 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 2' ' ' LEU . 1.2 pp -119.9 152.79 36.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.97 95.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -131.47 36.89 3.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 110.916 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.9 168.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.247 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -90.37 108.24 19.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -120.96 150.91 40.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.844 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -84.17 137.63 33.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.48 102.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -154.85 -67.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.06 -153.01 39.29 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.1 p -81.27 130.77 35.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 138.99 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.82 124.94 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.04 120.0 37.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 8.0 m0 61.43 154.4 0.11 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.26 168.02 22.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.511 2.141 . . . . 0.0 112.258 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.2 t90 60.32 92.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -138.77 116.07 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 23' ' ' THR . 23.8 t -74.29 112.88 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.802 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.98 -9.42 37.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.478 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.83 158.95 7.66 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.843 0.354 . . . . 0.0 110.937 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.41 ' CG2' HG11 ' A' ' 20' ' ' VAL . 79.1 p -152.64 164.22 38.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.8 -137.25 13.22 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 31' ' ' TYR . . . 133.04 -170.38 22.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.518 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' HG23 ' A' ' 154' ' ' THR . 6.0 mtpt -78.56 162.04 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 0.0 110.839 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.54 -25.21 66.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.78 -32.64 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.04 122.51 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.068 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.44 147.63 23.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.433 ' CE2' ' HA2' ' A' ' 25' ' ' GLY . 8.4 p90 -139.17 155.74 47.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -146.59 128.8 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -86.75 127.29 34.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.11 134.45 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.06 127.43 53.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.48 128.55 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.61 -66.84 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.61 178.34 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.528 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.48 -111.14 1.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.424 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtmt -92.01 157.61 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 23.4 m-85 -137.4 157.38 46.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.281 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -101.94 135.3 43.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.509 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 38.7 p -137.31 151.49 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 111.509 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.665 HG23 HD12 ' A' ' 62' ' ' ILE . 22.0 t -131.66 125.96 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.703 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -95.88 130.27 42.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.92 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -138.26 116.79 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.018 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.58 HG23 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -111.81 176.86 4.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.974 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.03 31.01 1.41 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 mttm -152.36 138.2 11.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.92 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.8 -160.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.432 2.088 . . . . 0.0 112.205 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.945 HG13 ' CD1' ' A' ' 98' ' ' LEU . 62.3 t -90.28 -48.07 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.13 -45.12 74.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.027 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -46.38 74.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.969 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.94 92.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.3 mt -57.11 -35.46 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -62.67 -29.91 70.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.12 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.5 tp10 -89.84 -32.9 16.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.316 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -72.89 -43.85 62.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.475 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.598 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 9.4 mmt -57.69 -44.05 99.19 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 59' ' ' MET . 42.9 Cg_endo -69.06 -36.26 13.02 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.984 1.789 . . . . 0.0 112.207 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -70.16 -43.6 70.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.653 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 44' ' ' VAL . 9.4 tt -77.91 -27.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.328 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -37.14 84.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.037 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -58.78 -37.1 75.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 19.1 t80 -67.12 -56.43 10.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.612 HG11 ' CE2' ' A' ' 102' ' ' PHE . 31.9 m -65.87 -30.72 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.8 -100.07 0.13 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 64.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.509 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -147.76 65.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.1 165.5 28.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.717 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.1 m-20 -90.02 46.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -145.8 4.57 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.677 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.52 32.01 5.3 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.124 -1.036 . . . . 0.0 110.747 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.554 HG21 ' CE2' ' A' ' 108' ' ' PHE . 1.4 p -96.66 140.57 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.879 -0.66 . . . . 0.0 111.67 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.4 49.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.478 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.421 ' HE3' ' HD2' ' A' ' 105' ' ' PRO . 14.3 ptm -52.17 -48.89 64.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.59 -161.85 35.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.547 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 tpt -92.23 147.74 22.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.98 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.636 HG22 HG23 ' A' ' 80' ' ' VAL . 7.2 m -151.37 120.8 6.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.636 HG23 HG22 ' A' ' 79' ' ' THR . 14.0 t 64.27 136.43 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.897 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.56 130.69 34.54 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.27 1.98 . . . . 0.0 112.184 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.671 HG11 ' CD2' ' A' ' 102' ' ' PHE . 32.9 m -88.91 154.05 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.321 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 t -117.89 173.73 6.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.756 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -131.8 154.21 49.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.003 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -93.04 136.82 32.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.402 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' CE1' ' A' ' 167' ' ' TYR . 23.9 m -132.89 132.98 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.173 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -106.27 98.16 18.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.808 ' HA ' HD23 ' A' ' 94' ' ' LEU . 73.3 Cg_endo -75.59 138.89 22.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -90.26 161.77 15.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.86 -19.12 62.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.2 -5.87 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.351 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.65 -3.44 78.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.882 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.48 139.52 51.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.38 . . . . 0.0 110.891 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.6 mt -80.14 144.09 33.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.75 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.98 48.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.82 96.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.58 ' HD2' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -179.64 107.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.564 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.945 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.8 tt -142.82 128.13 18.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.489 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -115.54 115.65 26.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.248 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.3 t -74.24 141.35 16.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 0.0 111.594 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HA ' HG22 ' A' ' 43' ' ' THR . 13.8 m95 -121.64 126.05 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.276 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.671 ' CD2' HG11 ' A' ' 82' ' ' VAL . 52.9 t80 -110.13 155.18 22.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 111.612 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 107.88 15.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.585 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.434 HG13 ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -68.13 139.68 92.82 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HD2' HG13 ' A' ' 104' ' ' ILE . 32.5 Cg_endo -64.35 153.99 73.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.489 2.126 . . . . 0.0 112.319 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -56.63 -26.8 56.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.284 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.446 ' HB3' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -56.98 -32.81 66.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.414 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.554 ' CE2' HG21 ' A' ' 74' ' ' VAL . 11.3 m-85 -116.8 20.22 14.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.426 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -55.09 -33.85 63.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.81 0.338 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.46 -25.82 67.13 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.01 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -177.73 107.95 0.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.736 0.268 . . . . 0.0 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 108' ' ' PHE . 52.6 Cg_endo -69.08 161.12 47.16 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.41 2.074 . . . . 0.0 112.187 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.512 ' CG ' HG11 ' A' ' 74' ' ' VAL . 10.2 Cg_exo -70.7 150.49 62.58 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.584 2.189 . . . . 0.0 112.003 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . . . -66.98 114.13 16.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.075 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 58.8 Cg_endo -73.04 165.95 31.36 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.352 2.034 . . . . 0.0 112.335 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 75.2 m -127.68 33.19 4.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.739 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -125.71 114.44 18.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.956 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.91 -26.53 62.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.12 -26.93 33.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 117' ' ' ASP . 42.9 t -84.89 115.5 26.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.13 156.93 19.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.817 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.16 127.4 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -98.76 160.16 14.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.801 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -147.45 129.15 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 mtt-85 63.55 123.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -169.08 -80.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.8 110.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.369 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.49 142.91 38.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 111.253 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 m -107.86 119.03 38.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -129.55 161.11 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.382 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.428 ' HB2' HD21 ' A' ' 151' ' ' LEU . 5.3 m-85 -107.93 138.23 44.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 p -108.75 142.39 39.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.964 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.1 t -129.68 139.0 51.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -116.86 130.44 56.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.992 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.95 144.59 23.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.09 95.66 1.99 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.52 159.0 28.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -72.17 174.87 6.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.951 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.529 ' HB3' ' ND2' ' A' ' 183' ' ' ASN . . . -175.34 144.39 0.7 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -134.33 -60.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 94' ' ' LEU . 70.9 tt0 -159.85 -66.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.58 70.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.491 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.93 -34.89 78.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.945 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.02 -41.62 99.58 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 109.893 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.95 -38.8 38.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.559 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.75 -32.03 67.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.897 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.1 m170 -67.76 -41.93 82.55 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-O 120.798 0.333 . . . . 0.0 111.044 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.001 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -67.79 -39.48 84.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.3 -44.53 92.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 131' ' ' TYR . 7.9 tp -57.95 -43.39 86.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.703 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.41 ' HA ' ' CE2' ' A' ' 162' ' ' TYR . 18.0 mtt85 -59.83 -40.0 87.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.368 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.481 HG22 ' OE1' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -68.97 -42.54 76.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.51 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' ' 26' ' ' LYS . 97.9 m -57.58 -49.46 76.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.85 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' CD1' ' CE1' ' A' ' 162' ' ' TYR . 11.5 mt -75.12 -10.36 59.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.74 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.481 ' OE1' HG22 ' A' ' 153' ' ' THR . 9.4 pt-20 -47.55 -29.0 2.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.787 0.327 . . . . 0.0 111.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -98.51 26.68 22.87 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.587 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 50.9 p -146.05 160.51 42.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.79 0.328 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.77 -5.54 17.28 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.95 2.433 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.75 119.8 7.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 111.323 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -103.57 157.28 17.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.755 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.432 ' CE1' ' CD1' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -156.02 -176.02 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -115.5 156.77 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.728 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.56 -4.02 10.99 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.713 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.673 ' OD1' HG12 ' A' ' 166' ' ' VAL . 2.0 p30 -81.92 -22.78 36.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.609 0.242 . . . . 0.0 111.255 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.673 HG12 ' OD1' ' A' ' 165' ' ' ASP . 14.9 p -160.46 158.11 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.928 0.394 . . . . 0.0 111.406 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.579 ' CE1' HG23 ' A' ' 86' ' ' VAL . 14.9 p90 -166.25 163.13 17.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.538 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 10.0 m-85 -112.94 158.82 19.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.968 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.671 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.4 m -142.25 158.93 43.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.61 139.28 49.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 172' ' ' TYR . . . 172.25 144.96 4.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.452 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 171' ' ' GLY . 80.5 m-85 -159.4 -177.93 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 62.57 145.76 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.54 162.84 37.27 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.55 2.167 . . . . 0.0 112.34 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.63 138.71 32.65 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.547 2.165 . . . . 0.0 112.315 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 -52.88 0.71 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -121.13 151.68 55.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.417 ' HG2' ' CD2' ' A' ' 179' ' ' TYR . 31.0 Cg_endo -63.76 -13.96 40.05 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.601 2.201 . . . . 0.0 112.514 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.417 ' CD2' ' HG2' ' A' ' 178' ' ' PRO . 13.1 p90 -147.62 31.54 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.986 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -84.64 -43.24 6.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.287 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -127.57 139.08 52.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.278 . . . . 0.0 110.663 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -111.3 154.89 23.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.065 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 139' ' ' ALA . 72.5 m-20 -108.92 157.98 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.517 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.47 145.53 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.287 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.671 HG13 ' SG ' ' A' ' 169' ' ' CYS . 17.7 t -124.99 133.49 69.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.564 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -107.76 121.54 44.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.306 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 130' ' ' VAL . 21.8 mt -97.08 134.53 40.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.576 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.96 119.07 21.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.099 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 63.0 tttt -69.76 140.69 53.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.604 ' HB3' ' OG1' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.243 -0.884 . . . . 1.0 111.141 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.803 0.335 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.31 -43.37 8.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.07 87.76 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.5 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.4 mmt -96.89 -39.18 9.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.769 0.318 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -59.94 117.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.022 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.21 126.96 39.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.35 141.46 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.5 p -74.89 150.04 39.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 31.55 5.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -125.59 78.28 1.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.6 -120.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.458 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 m -105.21 126.34 51.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.875 0.369 . . . . 0.0 110.965 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -123.39 126.08 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.38 145.45 48.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.046 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.414 HG21 ' OD1' ' A' ' 106' ' ' ASN . 3.2 m -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.781 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.495 ' HB3' ' CD ' ' A' ' 17' ' ' PRO . 13.8 t-105 -169.17 -60.52 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.379 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 16' ' ' TRP . 9.4 Cg_endo -52.53 102.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.312 2.008 . . . . 0.0 112.175 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.79 -177.25 0.23 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.026 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.87 108.53 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.957 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.24 115.28 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.53 -2.4 38.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.474 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -170.24 165.85 8.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.814 0.34 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.28 -175.93 5.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.69 152.79 17.34 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.444 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . -155.34 178.1 32.16 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.64 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -78.85 158.48 28.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -66.49 -29.16 69.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -89.86 -31.01 17.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.737 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 150' ' ' GLN . 22.1 t -145.98 117.02 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.897 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.7 m -95.33 137.45 34.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -139.04 162.13 35.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -144.94 140.69 28.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -86.35 126.58 34.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.921 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.99 127.91 39.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -108.91 135.08 50.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -159.9 79.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HG3' ' CE2' ' A' ' 41' ' ' PHE . 8.8 mp0 -142.25 137.33 30.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.867 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.14 -99.74 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.91 -59.99 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 104' ' ' ILE . 24.5 mttm -109.33 145.88 35.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.901 0.381 . . . . 0.0 110.809 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 37' ' ' GLU . 5.2 m-85 -137.58 147.34 44.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.87 139.07 31.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.55 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 16.6 p -137.35 155.33 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.983 0.421 . . . . 0.0 111.7 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 62' ' ' ILE . 21.5 t -135.3 125.82 44.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.808 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -95.83 132.93 40.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.164 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 58' ' ' ALA . 22.4 t -138.32 122.45 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.86 170.53 8.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.24 38.72 1.72 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.705 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -152.56 128.16 5.01 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.895 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.71 -167.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.493 2.129 . . . . 0.0 112.412 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 HD13 ' A' ' 98' ' ' LEU . 36.5 t -78.54 -60.25 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.195 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.72 -44.78 90.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.119 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -64.48 -46.31 83.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.832 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.94 75.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.841 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -58.7 -35.94 73.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.034 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -66.37 -32.98 74.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 tp10 -87.19 -41.74 13.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.14 -37.01 66.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.589 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 10.9 mmt -57.85 -44.03 99.08 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 59' ' ' MET . 47.5 Cg_endo -70.09 -32.52 17.06 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.919 1.746 . . . . 0.0 112.16 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -70.25 -45.16 67.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.917 HD12 HG23 ' A' ' 44' ' ' VAL . 1.1 tt -77.48 -36.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.249 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.645 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.8 mtt -66.21 -41.88 89.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.761 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -58.85 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.727 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -67.88 -46.62 71.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.753 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 63' ' ' MET . 32.3 m -69.85 -27.77 34.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.32 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -166.32 99.63 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.98 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.387 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 69' ' ' THR . 3.7 t -164.19 88.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.798 0.332 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -113.06 -12.49 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.14 40.9 8.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.966 0.413 . . . . 0.0 110.659 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -147.76 -46.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.42 30.45 4.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.009 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 108' ' ' PHE . 27.0 m -100.44 153.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.333 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.12 81.43 0.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.1 mtt -63.1 -48.05 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.834 0.349 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.46 53.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.6 tpt 62.39 147.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 80' ' ' VAL . 7.3 m -164.02 130.67 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.627 HG23 HG22 ' A' ' 79' ' ' THR . 36.7 t 64.02 136.67 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' HG13 ' A' ' 80' ' ' VAL . 22.0 Cg_endo -61.12 134.06 50.49 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.454 2.102 . . . . 0.0 112.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.22 136.41 23.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.241 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.01 160.29 19.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.357 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.841 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -127.03 154.27 44.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.106 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.505 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -90.17 136.7 32.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.346 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.75 HG12 HD12 ' A' ' 98' ' ' LEU . 33.7 m -132.23 123.7 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -98.31 102.98 15.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.767 ' HA ' HD23 ' A' ' 94' ' ' LEU . 85.6 Cg_endo -77.5 140.76 19.37 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.485 2.124 . . . . 0.0 112.271 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.35 163.0 14.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.935 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -15.9 63.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.354 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -85.23 4.22 35.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.589 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 90.67 -16.04 59.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.849 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 m -95.84 162.93 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.769 0.319 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 88' ' ' PRO . 95.9 mt -92.91 171.72 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.89 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -103.82 157.8 16.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -80.51 61.06 4.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -161.96 109.24 1.37 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.746 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -125.97 146.16 49.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.236 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.26 115.72 19.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.339 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -81.19 141.36 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.228 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -121.67 132.16 54.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 19.3 t80 -121.57 134.86 55.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.016 0.436 . . . . 0.0 111.377 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.65 118.06 34.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.761 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 40' ' ' LYS . 28.1 mt -84.44 136.35 40.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 104' ' ' ILE . 36.7 Cg_endo -65.68 154.25 74.63 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 109' ' ' GLN . 34.2 m120 -51.6 -26.63 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.339 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -56.9 -32.9 66.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.431 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' HE2' HG11 ' A' ' 74' ' ' VAL . 32.7 m-85 -116.04 -1.09 12.56 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 106' ' ' ASN . 1.2 pp0? -54.06 -34.26 59.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.815 0.341 . . . . 0.0 111.267 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.58 -34.04 88.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.765 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.91 84.08 0.52 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.316 . . . . 0.0 110.972 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 32.5 Cg_exo -58.97 160.37 18.62 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.174 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 3.5 Cg_exo -73.98 152.13 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.686 2.257 . . . . 0.0 112.004 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 121.11 79.54 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.318 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 119.9 6.2 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.473 2.115 . . . . 0.0 112.297 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.2 t -64.55 -39.81 94.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.407 ' CB ' HG23 ' A' ' 120' ' ' VAL . 2.0 m-20 -58.32 112.82 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.402 . . . . 0.0 110.875 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.55 -26.73 61.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.172 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -81.73 -28.81 33.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.988 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 44' ' ' VAL . 39.2 t -85.28 115.91 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -120.83 156.95 30.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 40' ' ' LYS . 24.6 mm -103.44 131.37 52.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -98.95 129.93 45.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -89.01 126.44 35.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.8 ttm180 58.05 -173.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.98 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 10.2 tt0 84.86 78.08 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.062 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -80.18 169.41 52.81 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.195 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.98 142.99 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 111.675 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.4 m -119.22 134.0 55.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.051 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 187' ' ' LEU . 36.0 m -139.7 164.61 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.675 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -107.77 133.48 52.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.265 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -105.76 140.23 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.006 0.432 . . . . 0.0 111.273 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.1 t -130.99 139.13 49.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -116.74 130.31 56.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.066 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 31.5 p90 -139.29 -177.81 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.56 110.87 1.46 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.469 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -176.74 -133.28 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.4 103.31 1.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.753 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.06 150.11 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.226 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.98 -47.89 0.79 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.683 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.509 ' CG ' HD12 ' A' ' 94' ' ' LEU . 72.1 tt0 -162.05 -69.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.511 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.96 -33.62 72.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.522 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.95 -34.98 78.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.011 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -40.6 98.17 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.938 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.3 t -53.76 -38.71 36.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.54 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.45 -37.86 74.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.774 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 24.0 m-70 -70.23 -43.69 70.1 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.891 0.377 . . . . 0.0 110.804 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.552 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.28 -32.92 72.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.615 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -68.47 -43.36 77.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.681 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 29' ' ' VAL . 2.7 tp-100 -61.88 -46.1 90.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.425 ' HG ' HD12 ' A' ' 187' ' ' LEU . 13.3 tp -61.45 -36.95 81.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.42 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -41.17 91.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.594 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 86.5 m -69.08 -34.86 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.64 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.431 HG22 ' CE1' ' A' ' 31' ' ' TYR . 5.0 m -57.51 -47.03 83.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.857 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 31' ' ' TYR . 6.4 mt -72.51 -21.21 61.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.89 -44.91 20.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.335 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.92 35.26 4.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.695 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 35.2 p -146.32 156.47 49.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.747 0.308 . . . . 0.0 111.006 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 -11.05 29.92 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.696 2.264 . . . . 0.0 112.701 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.23 139.68 52.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 0.0 111.158 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.2 m -100.51 140.87 34.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.731 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -159.6 156.9 28.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -90.43 136.65 32.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.035 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.29 56.98 0.45 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.17 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -157.85 -23.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.12 143.79 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.913 0.387 . . . . 0.0 111.271 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.637 ' HB3' HD23 ' A' ' 187' ' ' LEU . 30.2 p90 -142.88 174.07 10.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.8 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 94.9 m-85 -113.79 152.57 30.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.15 146.1 49.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -131.93 133.38 44.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.116 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 167.32 77.07 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.465 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -61.12 -32.95 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 110.787 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.57 120.51 60.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.85 131.2 19.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.416 2.077 . . . . 0.0 112.17 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.14 90.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.404 2.069 . . . . 0.0 112.234 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 11.2 ttt -174.88 149.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 62.64 113.47 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 179' ' ' TYR . 85.2 Cg_endo -74.76 -145.22 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.651 2.234 . . . . 0.0 111.693 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.6 m-85 66.39 39.34 4.01 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 123.37 106.25 1.78 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.907 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -139.03 138.86 37.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.62 0.248 . . . . 0.0 110.484 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -137.5 130.99 31.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.405 . . . . 0.0 111.278 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 135' ' ' PHE . 7.2 m-80 -133.0 138.97 47.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.632 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -142.92 145.98 33.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 111.241 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.09 134.44 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.612 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.55 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.7 m0 -108.07 121.62 45.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.274 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.679 ' O ' HG12 ' A' ' 130' ' ' VAL . 13.4 mt -96.35 139.37 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.433 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.85 129.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 11.6 tttm -88.46 48.55 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.252 -0.88 . . . . 1.0 111.472 179.817 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.791 0.329 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mp -69.78 -178.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.5 64.97 0.68 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.34 70.43 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.982 0.42 . . . . 0.0 110.851 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mt -128.52 108.13 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.006 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.49 133.05 34.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -124.84 174.11 8.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -63.82 147.29 52.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.734 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.21 -56.18 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.169 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.65 -31.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.359 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.43 -113.77 3.71 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.595 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 m -107.06 123.29 48.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.25 146.36 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -112.8 124.82 53.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.639 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -97.01 133.36 41.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.8 155.29 76.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.03 125.22 13.27 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.479 2.12 . . . . 0.0 112.304 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 3.8 t90 62.4 81.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.82 ' CG ' ' HB3' ' A' ' 35' ' ' ALA . 8.0 pt20 -128.58 111.48 13.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.177 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.424 HG11 HG23 ' A' ' 23' ' ' THR . 29.2 t -74.47 112.82 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.586 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.26 -4.03 46.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.27 158.85 6.95 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.809 0.338 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.424 HG23 HG11 ' A' ' 20' ' ' VAL . 3.0 p -153.29 174.15 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.65 168.96 8.01 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.47 -162.23 28.24 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.691 ' HD2' HG23 ' A' ' 154' ' ' THR . 7.7 mttt -78.39 157.89 28.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.932 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 pm0 -66.56 -26.27 67.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.96 -34.97 15.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.08 110.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.6 m -95.16 148.3 22.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.4 p90 -138.5 153.11 48.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.976 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 23' ' ' THR . 1.3 mt-10 -146.37 130.45 17.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.18 114.88 23.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 147.52 48.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.82 ' HB3' ' CG ' ' A' ' 19' ' ' GLN . . . -124.98 130.74 52.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.131 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -144.01 144.91 31.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.32 89.19 3.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.37 -148.63 3.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.89 -111.85 0.69 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.99 152.72 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.819 0.343 . . . . 0.0 110.848 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -137.7 153.73 49.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 124.0 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 123' ' ' GLU . 81.8 p -112.7 131.94 55.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.418 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.521 HG23 HD12 ' A' ' 62' ' ' ILE . 21.7 t -131.06 125.41 57.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.768 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.1 135.08 44.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.566 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.6 t -138.31 116.82 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.065 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 173.81 6.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.23 28.05 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.358 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -152.73 121.58 3.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.001 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.71 -176.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.477 2.118 . . . . 0.0 112.177 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.99 HG13 HD13 ' A' ' 98' ' ' LEU . 49.0 t -62.03 -52.83 55.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -63.44 -45.25 91.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.1 -46.03 75.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.86 -45.14 90.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.34 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD11 ' CE1' ' A' ' 84' ' ' PHE . 3.2 mt -58.34 -35.41 71.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.5 mtm105 -63.12 -31.55 72.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.97 0.414 . . . . 0.0 109.942 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 9.7 tp10 -86.97 -33.47 19.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.147 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.71 -40.67 63.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.76 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.507 ' HA ' HG22 ' A' ' 62' ' ' ILE . 6.3 mmt -57.61 -44.02 99.23 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 23.3 Cg_exo -64.58 -42.93 14.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.257 1.972 . . . . 0.0 111.913 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.2 -41.28 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.203 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.521 HD12 HG23 ' A' ' 44' ' ' VAL . 2.3 tt -76.26 -42.55 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.372 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.618 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -65.04 -31.76 73.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -69.75 -29.81 67.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.434 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -71.37 -42.81 67.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 102' ' ' PHE . 33.8 m -65.96 -28.17 43.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.208 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.11 93.34 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.569 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.67 -40.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.37 84.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.726 ' ND2' HG22 ' A' ' 74' ' ' VAL . 34.2 p-10 -125.02 0.43 7.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.401 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 61.75 39.05 14.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.54 -47.44 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.38 52.03 3.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.726 HG22 ' ND2' ' A' ' 70' ' ' ASN . 27.8 m -101.06 -178.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.817 0.342 . . . . 0.0 111.133 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.99 78.47 0.35 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 86.6 mtp -82.0 -65.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.364 . . . . 0.0 110.735 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 78' ' ' MET . . . 75.72 46.13 15.27 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.759 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 17.8 mmt 67.47 -62.08 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.563 0.221 . . . . 0.0 111.498 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.5 m 78.75 -60.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.94 158.11 76.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.052 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.8 130.77 36.45 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.395 2.063 . . . . 0.0 112.118 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 102' ' ' PHE . 6.1 m -87.24 154.06 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.321 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 t -130.72 160.23 34.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.61 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -121.3 154.3 36.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.213 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.719 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -95.43 136.65 35.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.813 ' HB ' HD22 ' A' ' 94' ' ' LEU . 15.7 m -124.81 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -113.24 93.82 27.96 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.185 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.39 138.79 62.0 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.598 2.199 . . . . 0.0 112.077 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.97 171.95 9.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.986 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.94 -22.11 59.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.41 -6.07 59.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.442 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.46 -16.05 61.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.767 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.45 133.5 33.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.855 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.813 HD22 ' HB ' ' A' ' 86' ' ' VAL . 13.3 mt -62.41 -30.0 70.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 62.57 -175.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -80.67 90.23 5.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.34 100.17 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.792 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.99 HD13 HG13 ' A' ' 51' ' ' VAL . 1.6 tt -144.13 135.53 25.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 111.365 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.442 ' HD2' ' CD1' ' A' ' 101' ' ' TRP . 0.0 OUTLIER -119.53 115.79 24.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.032 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.4 t -78.54 141.15 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.571 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 99' ' ' LYS . 18.5 m95 -122.39 138.61 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.478 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.682 ' CE2' HG11 ' A' ' 66' ' ' VAL . 38.5 t80 -119.47 146.18 45.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 111.485 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -102.04 111.1 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.718 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.0 mt -92.25 136.34 25.83 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 104' ' ' ILE . 38.0 Cg_endo -66.36 154.16 75.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.57 2.18 . . . . 0.0 112.437 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -55.46 -26.71 43.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.323 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -56.84 -32.89 66.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.22 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -100.54 -4.7 28.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.54 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -45.42 72.69 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.761 0.315 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.13 -26.58 43.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.633 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.74 91.55 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.631 0.253 . . . . 0.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.19 161.1 41.77 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.383 2.055 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 141.75 42.26 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.754 2.303 . . . . 0.0 112.311 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.0 121.43 79.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.37 141.55 71.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.442 2.095 . . . . 0.0 112.275 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 84.4 p -90.58 -33.4 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -86.98 125.18 33.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.78 -22.15 45.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.223 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -31.36 30.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.95 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 117' ' ' ASP . 26.0 t -85.44 123.93 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -127.86 156.92 41.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -102.67 111.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.21 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HG3' HG21 ' A' ' 43' ' ' THR . 4.7 mm-40 -100.38 130.04 46.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.63 113.1 24.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.97 126.09 50.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.807 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.96 60.68 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.314 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.77 161.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.96 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.9 pt -144.25 148.95 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.935 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.8 m -103.85 118.67 37.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.581 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 188' ' ' VAL . 13.3 m -143.34 160.65 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.295 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.581 ' CE1' HD11 ' A' ' 155' ' ' LEU . 0.5 OUTLIER -107.89 143.66 36.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.101 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.9 p -105.96 148.45 27.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.074 0.464 . . . . 0.0 111.495 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.465 ' HB ' HD13 ' A' ' 151' ' ' LEU . 7.5 t -130.46 139.82 50.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.418 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.26 125.24 51.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.082 0.468 . . . . 0.0 111.156 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 15.2 p90 -143.04 -169.6 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.421 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -46.58 138.48 7.96 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.83 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.17 170.32 55.08 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.722 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 61.05 100.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.739 0.304 . . . . 0.0 110.932 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -127.2 152.93 46.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -105.62 -82.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 94' ' ' LEU . 53.5 tt0 -154.83 -61.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.779 0.323 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.93 -33.83 62.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.61 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.99 -34.96 77.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.987 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -42.4 96.32 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.917 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.2 t -53.9 -38.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.671 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.12 70.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.716 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 18.3 m170 -70.06 -46.1 65.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB2' ' CE2' ' A' ' 167' ' ' TYR . . . -61.82 -32.92 73.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.773 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.9 m -73.01 -42.16 63.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -46.06 89.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' A' ' 133' ' ' THR . 11.6 tp -61.24 -37.07 81.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.5 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -43.2 93.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -68.94 -34.18 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.95 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.691 HG23 ' HD2' ' A' ' 26' ' ' LYS . 5.3 m -57.49 -49.28 76.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.581 HD11 ' CE1' ' A' ' 131' ' ' TYR . 0.5 OUTLIER -73.94 -13.92 60.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.352 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -46.62 -37.61 8.43 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.327 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.4 36.98 3.62 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 17.6 p -146.19 155.07 50.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.49 -7.75 21.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.839 2.359 . . . . 0.0 112.622 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.17 127.11 30.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.905 0.383 . . . . 0.0 111.28 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 190' ' ' ALA . 4.9 m -102.52 141.83 34.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.708 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.7 OUTLIER -155.03 -177.94 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.988 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -88.82 -58.44 2.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 90.27 -16.48 57.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.941 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.82 -87.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.723 0.262 . . . . 0.0 111.015 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.06 138.4 19.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.841 0.353 . . . . 0.0 111.63 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.888 ' HB3' HD23 ' A' ' 187' ' ' LEU . 48.7 p90 -144.96 174.7 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.359 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.719 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 58.1 m-85 -119.38 161.99 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.043 0.449 . . . . 0.0 111.669 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 15.5 m -139.36 151.65 46.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.03 128.45 38.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.168 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 153.76 -130.27 2.9 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.804 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 64.46 -101.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.909 0.083 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.41 ' CB ' ' HD2' ' A' ' 174' ' ' PRO . 0.2 OUTLIER 52.55 171.77 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.858 0.361 . . . . 0.0 111.315 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 173' ' ' ASP . 72.8 Cg_endo -76.7 129.65 11.01 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.433 2.089 . . . . 0.0 112.124 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.68 136.12 34.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.492 2.128 . . . . 0.0 112.431 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.96 116.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.1 mttm 59.66 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.44 163.6 37.41 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.4 2.067 . . . . 0.0 112.254 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 60.01 34.53 21.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.28 32.31 1.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -128.27 144.09 51.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.96 127.19 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -120.69 148.94 43.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -142.81 155.62 44.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 133' ' ' THR . 9.3 t -129.6 115.1 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.865 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.462 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -108.49 124.4 50.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.968 0.413 . . . . 0.0 110.968 -179.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.888 HD23 ' HB3' ' A' ' 167' ' ' TYR . 8.1 mt -91.19 140.34 29.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.6 t -74.75 126.76 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.229 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -177.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.249 -0.882 . . . . 1.0 111.094 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.87 -31.55 45.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.79 -90.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.535 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.4 mtt -140.75 177.8 7.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.862 0.363 . . . . 0.0 110.939 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 tt -68.1 -30.52 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.014 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -105.83 139.78 39.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -121.91 126.01 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.765 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 p -80.03 130.09 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.91 41.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -63.62 166.23 7.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 166.49 -91.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.343 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.68 124.81 45.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.9 t -139.05 145.97 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.5 139.54 53.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.79 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -97.97 131.93 43.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -78.49 151.92 77.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.2 -28.15 34.36 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.558 2.172 . . . . 0.0 112.232 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -162.63 110.79 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.09 118.3 12.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.4 t -74.49 113.63 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.756 HD12 HG21 ' A' ' 129' ' ' THR . 12.4 mt -95.03 -14.56 24.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.503 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 t -169.63 164.06 10.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.821 0.343 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.8 p -152.23 -178.35 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.764 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.98 -125.43 7.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 131.97 -95.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.626 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -161.52 163.98 29.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.3 69.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.978 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.77 -35.16 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.315 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.18 108.07 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.364 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.34 140.89 31.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -138.68 162.31 34.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.775 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -143.83 127.7 17.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -86.29 115.01 23.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -132.93 129.39 38.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.93 139.18 42.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 m -138.28 -178.23 5.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.036 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 41' ' ' PHE . 0.3 OUTLIER 63.74 134.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.0 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.24 -41.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.64 -118.51 3.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.65 142.74 51.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.882 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 37' ' ' GLU . 49.9 m-85 -137.69 161.85 35.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -100.95 140.3 35.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.766 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 13.8 p -133.76 137.87 45.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.927 0.394 . . . . 0.0 111.146 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.925 HG23 HD12 ' A' ' 62' ' ' ILE . 11.3 t -125.94 125.89 68.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.102 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -95.98 127.7 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.588 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 58' ' ' ALA . 11.6 t -138.17 116.92 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.286 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -109.11 176.51 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.819 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.25 30.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.319 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -152.63 121.91 3.32 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.82 -179.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.464 2.109 . . . . 0.0 112.246 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.759 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.3 t -61.87 -55.26 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.315 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.74 -43.82 92.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -46.06 75.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.186 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.15 85.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.271 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.6 mt -58.77 -35.59 73.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.869 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -63.81 -34.58 78.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.96 0.41 . . . . 0.0 109.964 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.6 tp10 -87.14 -28.81 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.63 -42.7 61.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.558 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.712 ' HE1' HG11 ' A' ' 82' ' ' VAL . 7.5 mmt -57.76 -43.6 98.83 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 36.9 Cg_exo -59.65 -43.5 38.32 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.105 1.87 . . . . 0.0 111.863 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -70.37 -42.18 72.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 44' ' ' VAL . 1.3 tt -76.22 -35.12 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.476 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 30.9 mtp -66.31 -31.97 73.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -64.3 -47.6 78.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 115' ' ' PRO . 21.3 t80 -60.26 -53.92 51.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.594 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.788 HG21 ' HG3' ' A' ' 78' ' ' MET . 29.3 m -66.24 -28.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.012 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.78 -89.05 0.36 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.356 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.62 55.06 0.47 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.536 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.494 HG22 ' O ' ' A' ' 69' ' ' THR . 21.1 m -126.69 38.14 4.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.427 . . . . 0.0 110.841 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -126.58 167.24 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.98 10.46 26.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.28 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -92.56 -30.4 15.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.39 43.29 38.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.687 HG21 ' HG3' ' A' ' 113' ' ' PRO . 31.3 m -101.27 -178.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.21 88.4 0.2 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 9.1 mtm -96.71 107.57 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.66 -24.67 12.92 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.749 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.788 ' HG3' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER 65.89 147.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.785 0.326 . . . . 0.0 111.05 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -93.48 168.78 10.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.483 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 17.6 t -85.84 -45.9 0.6 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.512 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.546 ' HD2' HG22 ' A' ' 79' ' ' THR . 24.2 Cg_exo -63.63 144.69 90.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.309 2.006 . . . . 0.0 112.025 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.712 HG11 ' HE1' ' A' ' 59' ' ' MET . 10.4 t -152.98 143.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.975 0.417 . . . . 0.0 111.302 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.4 p -117.21 146.08 43.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.627 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.711 ' CD2' HD11 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -128.98 154.4 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.195 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.804 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -99.69 136.69 39.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.453 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.704 HG12 HD12 ' A' ' 98' ' ' LEU . 22.6 m -125.24 135.3 64.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -103.0 95.79 7.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.297 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.803 ' HA ' HD23 ' A' ' 94' ' ' LEU . 74.4 Cg_endo -74.55 148.89 38.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.535 2.157 . . . . 0.0 112.082 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.97 171.99 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -31.43 68.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.44 -6.16 58.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.415 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 91.22 -16.04 59.7 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.751 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.7 p -81.3 113.03 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.811 0.338 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.803 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.9 OUTLIER -73.07 148.97 43.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.778 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -125.85 68.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mttt 56.07 -163.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.031 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HG3' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 69.4 109.45 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.759 ' CD1' HG13 ' A' ' 51' ' ' VAL . 2.7 tt -144.07 134.41 24.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -110.51 115.57 29.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.412 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.725 HG21 ' HB1' ' A' ' 58' ' ' ALA . 3.3 t -78.8 141.21 15.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 111.508 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -119.48 121.91 40.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.427 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 64.8 t80 -105.59 155.41 19.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.614 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -116.04 107.8 15.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.556 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.452 HG23 ' HD2' ' A' ' 105' ' ' PRO . 31.7 mt -79.46 136.59 56.04 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.267 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HD2' HG23 ' A' ' 104' ' ' ILE . 27.7 Cg_endo -62.09 154.13 64.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.322 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -55.57 -27.47 49.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.108 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -62.68 -33.21 74.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -107.26 -14.48 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.37 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -53.15 -44.04 67.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.741 0.305 . . . . 0.0 111.061 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.16 66.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.455 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.78 91.18 0.6 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 0.0 110.737 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 160.98 47.69 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.542 2.161 . . . . 0.0 112.266 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.687 ' HG3' HG21 ' A' ' 74' ' ' VAL . 11.6 Cg_exo -70.85 149.87 60.66 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.697 2.265 . . . . 0.0 111.973 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.21 111.71 7.98 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 65' ' ' TYR . 32.2 Cg_exo -59.59 167.39 6.65 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.506 2.138 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.5 m -145.92 34.26 1.02 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.6 123.61 17.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.0 -26.01 61.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.0 -30.52 31.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.5 t -85.39 114.01 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 150.98 33.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.801 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.4 132.72 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.78 160.12 14.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.793 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -149.4 140.82 23.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.082 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.57 18.27 9.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.27 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.11 160.21 32.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 110.795 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.92 119.35 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.458 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -142.23 143.9 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.165 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.756 HG21 HD12 ' A' ' 21' ' ' LEU . 28.1 m -103.87 123.54 47.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.512 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.905 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.9 m -133.13 170.16 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.008 0.433 . . . . 0.0 111.729 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.751 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -134.46 125.94 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.945 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.4 p -105.76 143.88 33.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.104 0.478 . . . . 0.0 111.785 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -122.69 139.28 54.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.086 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -116.63 143.64 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 147' ' ' HIS . 13.2 p90 -143.14 -46.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.603 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.99 -131.32 1.62 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -148.37 33.12 1.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB3' ' A' ' 178' ' ' PRO . 4.7 m-85 -107.04 62.15 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 183' ' ' ASN . . . -136.5 135.57 38.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 71.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.867 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.514 ' HG2' HD12 ' A' ' 94' ' ' LEU . 27.1 tt0 64.36 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.312 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -34.24 63.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.02 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 2.1 t70 -69.06 -34.88 75.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.174 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.469 ' CD1' HG22 ' A' ' 185' ' ' VAL . 0.9 OUTLIER -62.75 -38.95 92.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.466 0.65 . . . . 0.0 109.652 179.203 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 92' ' ' GLY . 51.2 t -53.91 -38.99 38.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.597 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.93 -36.45 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.801 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 37.1 m-70 -68.74 -40.91 79.59 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.21 -32.75 72.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.78 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -62.95 -44.14 96.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.947 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.01 -46.04 90.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.706 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 151' ' ' LEU . 8.1 tp -59.23 -42.23 90.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -59.29 -48.07 83.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.401 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 88.4 m -63.76 -47.01 82.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.173 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.619 HG22 ' HE2' ' A' ' 31' ' ' TYR . 6.7 m -57.82 -40.96 81.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.755 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.496 HD11 ' CE1' ' A' ' 131' ' ' TYR . 11.5 mt -72.73 -14.57 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.491 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -47.77 126.9 11.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.67 34.72 11.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.206 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 16.1 p -145.55 159.89 46.51 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.561 0.22 . . . . 0.0 110.66 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 5.7 Cg_endo -47.88 -22.95 3.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.868 2.379 . . . . 0.0 112.541 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.751 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -56.58 106.13 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 53.4 m -101.94 -0.66 33.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.735 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 9.3 m-85 59.67 147.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.52 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.68 -173.5 4.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.66 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.54 62.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.776 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.64 75.51 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.762 0.315 . . . . 0.0 111.389 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.7 p -161.72 81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.233 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.483 ' CZ ' HG21 ' A' ' 86' ' ' VAL . 45.5 p90 -99.54 166.22 11.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.846 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.804 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 16.5 m-85 -115.6 161.95 17.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.207 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 67.3 m -121.33 130.85 53.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.722 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 184' ' ' GLU . . . -132.07 156.33 46.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -121.08 121.41 4.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.33 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.72 79.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.783 0.325 . . . . 0.0 111.289 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.4 142.78 0.19 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.928 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -86.02 110.38 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.918 2.412 . . . . 0.0 112.778 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.412 ' HB2' ' HG3' ' A' ' 178' ' ' PRO . 9.0 Cg_exo -71.33 -155.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.873 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.79 51.37 2.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.958 0.409 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.587 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 0.3 OUTLIER 48.91 50.63 9.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.804 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 177' ' ' LYS . 69.5 Cg_endo -88.57 -59.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.583 2.188 . . . . 0.0 112.171 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 178' ' ' PRO . 0.0 OUTLIER -151.93 -163.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.187 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -97.04 45.7 1.77 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.429 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -139.03 163.01 33.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 111.385 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.11 147.58 36.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.253 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 4.2 m-80 -133.16 134.97 44.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.965 0.412 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 4.6 mt-10 -146.01 157.12 43.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.11 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 144' ' ' TYR . 11.3 t -136.68 138.03 46.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.808 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -140.78 121.79 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 167' ' ' TYR . 11.8 mt -91.57 140.09 30.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.905 ' HA ' HG12 ' A' ' 130' ' ' VAL . 6.6 t -75.69 131.0 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.995 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.403 ' CG ' ' CE2' ' A' ' 131' ' ' TYR . 32.2 mtpt -74.34 150.16 40.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.046 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.36 -0.829 . . . . 1.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.869 0.366 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.6 tp -162.4 -44.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.81 -172.64 44.13 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.49 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -117.19 -33.75 4.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.715 0.293 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mt 67.13 118.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.094 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 140.03 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.09 132.99 55.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -71.57 156.82 38.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.998 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.36 -169.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -69.21 70.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.05 -89.3 2.11 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.347 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -98.07 125.0 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.769 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.2 m -136.34 145.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.26 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -129.68 125.0 34.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 p -101.92 132.36 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.028 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.47 81.08 17.98 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.674 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.84 -61.68 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.514 2.143 . . . . 0.0 112.479 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 30.5 p90 -153.14 175.6 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.876 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -123.39 108.22 12.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.02 112.94 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.4 -9.7 29.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.289 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 t -169.9 163.15 9.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.813 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -152.16 -173.28 4.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.7 -114.63 4.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 116.19 -112.03 2.51 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.56 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.57 162.69 30.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -30.21 70.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.195 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -90.66 -35.06 15.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.192 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.21 110.21 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.907 0.384 . . . . 0.0 111.336 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.9 m -97.26 134.26 40.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 1.2 p90 -138.78 158.84 43.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.819 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 23' ' ' THR . 6.1 mt-10 -143.98 138.68 28.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.947 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.79 117.56 25.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -131.98 144.04 50.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.933 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.05 110.29 13.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.3 t -82.58 151.57 26.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.03 139.53 49.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.32 -106.96 0.19 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 162.2 -60.72 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.549 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -104.46 134.46 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.002 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 25.1 m-85 -137.63 153.14 49.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.89 117.97 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.2 p -112.7 133.49 54.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.323 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.654 HG23 HD12 ' A' ' 62' ' ' ILE . 21.8 t -125.95 125.45 68.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -100.81 133.93 44.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.174 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.48 116.75 13.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.41 175.79 5.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.036 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.21 34.21 0.66 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.509 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 mttm -152.17 135.46 9.43 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.83 -158.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.528 2.152 . . . . 0.0 112.207 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 98' ' ' LEU . 39.4 t -87.11 -53.53 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.24 -43.23 87.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -46.42 74.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.99 92.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.014 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 84' ' ' PHE . 4.3 mt -57.76 -35.24 70.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.734 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -62.65 -30.93 71.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.979 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.529 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.7 tp10 -88.18 -33.19 18.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.261 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.55 -43.21 60.46 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.655 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.0 mmt -57.75 -43.63 98.86 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.5 Cg_exo -57.28 -45.6 33.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.106 1.87 . . . . 0.0 112.262 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -70.33 -42.59 71.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.518 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.654 HD12 HG23 ' A' ' 44' ' ' VAL . 1.2 tt -76.48 -32.98 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.446 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.539 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.12 -41.06 91.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 110.715 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -40.88 91.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 64.8 t80 -59.63 -50.7 72.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 63' ' ' MET . 34.7 m -66.0 -27.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.66 104.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.01 -54.33 0.51 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.0 m -144.99 87.75 1.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -110.9 -29.17 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.035 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 6.0 m-20 84.63 -22.09 0.22 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.582 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -32.09 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.65 64.24 1.01 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.414 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' HG2' ' A' ' 113' ' ' PRO . 18.2 m -139.61 141.06 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 111.201 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.53 55.62 0.58 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.347 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.405 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -58.61 -34.75 71.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 110.938 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.67 -159.38 42.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.459 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.4 mtt -97.55 112.98 24.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.359 . . . . 0.0 110.961 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.659 HG22 HG23 ' A' ' 80' ' ' VAL . 12.5 m -111.01 122.87 48.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.736 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 79' ' ' THR . 22.0 t 63.85 141.6 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 33.7 Cg_exo -59.75 130.82 36.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.272 1.981 . . . . 0.0 112.257 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' A' ' 102' ' ' PHE . 7.0 m -87.29 139.28 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.9 149.75 36.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.566 ' HD2' HD11 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -123.99 144.34 49.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.107 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.654 ' HB2' ' CE1' ' A' ' 168' ' ' TYR . . . -82.72 140.44 33.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.663 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 29.1 m -109.95 -28.09 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.44 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' HG21 ' A' ' 166' ' ' VAL . 96.8 m-85 55.91 91.77 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.529 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.86 ' HA ' HD23 ' A' ' 94' ' ' LEU . 71.9 Cg_endo -77.18 141.61 20.83 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.637 2.224 . . . . 0.0 112.007 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.61 166.15 13.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.072 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.36 -15.89 63.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.278 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 3.48 37.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.427 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 86.92 -1.84 86.94 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.976 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.5 p -131.52 161.72 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.869 0.366 . . . . 0.0 111.009 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.86 HD23 ' HA ' ' A' ' 88' ' ' PRO . 1.2 mt -87.54 154.32 20.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.531 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -140.57 84.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.43 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? 45.53 93.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.6 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.71 101.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.555 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.683 ' CD1' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -143.72 143.87 31.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.114 0.483 . . . . 0.0 111.638 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.91 115.66 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.914 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.563 HG21 ' HB1' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -86.68 137.35 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 111.579 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -117.96 141.04 48.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.307 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.677 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 48.5 t80 -124.2 151.47 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.975 0.417 . . . . 0.0 111.388 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 41' ' ' PHE . 7.1 mtp180 -115.96 107.84 15.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.654 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.406 HG23 ' HD2' ' A' ' 105' ' ' PRO . 28.1 mt -82.08 136.4 47.07 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.241 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' A' ' 104' ' ' ILE . 28.3 Cg_endo -62.32 154.14 65.61 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.555 2.17 . . . . 0.0 112.334 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -52.48 -26.8 13.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.222 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.15 66.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 110.976 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.618 ' HE2' HG11 ' A' ' 74' ' ' VAL . 88.9 m-85 -115.95 -9.75 11.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.33 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -54.08 -48.08 71.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.765 0.317 . . . . 0.0 111.213 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.22 -26.54 56.33 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.522 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 t -174.5 88.08 0.33 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 44.0 Cg_endo -68.36 160.45 49.02 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.552 2.168 . . . . 0.0 112.353 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.681 ' HG2' HG21 ' A' ' 74' ' ' VAL . 5.0 Cg_exo -74.19 159.29 44.25 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 112.026 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.34 111.24 6.19 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.978 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 65' ' ' TYR . 60.8 Cg_endo -72.62 162.36 41.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.513 2.142 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.52 179.73 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.66 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.46 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -16.88 30.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.599 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.1 p -80.2 -28.57 38.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.673 0.273 . . . . 0.0 111.213 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.62 114.65 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 111.157 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.29 156.97 32.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.19 125.25 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.134 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.9 129.94 45.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -89.14 125.27 34.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.9 OUTLIER 58.9 -177.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.8 tt0 83.09 76.99 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -84.5 -175.12 50.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.423 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 pt -143.99 143.01 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.861 0.362 . . . . 0.0 111.249 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.9 m -115.31 118.98 34.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.677 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.677 HG12 ' HA ' ' A' ' 188' ' ' VAL . 36.0 m -144.11 163.99 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.434 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CZ ' HD11 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -107.78 137.85 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.212 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.428 ' HA ' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -105.87 146.47 29.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.931 0.396 . . . . 0.0 111.56 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -131.19 139.23 49.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.438 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -116.6 132.09 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 4.3 p90 -139.72 156.28 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.36 33.57 5.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.642 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -107.02 -36.48 2.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 178' ' ' PRO . 16.4 m-85 63.83 133.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.925 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.19 -175.86 3.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -133.59 -66.79 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.563 ' CG ' HD12 ' A' ' 94' ' ' LEU . 67.7 tt0 -141.72 -72.92 0.32 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.562 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.82 75.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 0.0 110.352 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -34.56 77.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -40.33 96.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.568 0.699 . . . . 0.0 109.807 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 92' ' ' GLY . 21.6 t -53.84 -38.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.668 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.29 -35.78 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.719 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.509 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 50.0 m-70 -70.17 -42.45 72.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.816 0.341 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.67 -32.95 73.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.0 m -63.4 -42.28 98.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.801 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -43.16 94.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.871 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 187' ' ' LEU . 8.2 tp -60.55 -40.45 91.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -42.38 94.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.627 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 89.8 m -68.64 -35.72 77.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.458 ' CG2' ' CE1' ' A' ' 31' ' ' TYR . 41.5 m -57.61 -49.09 77.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 131' ' ' TYR . 5.6 mt -73.62 -11.12 60.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.259 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -47.03 -43.16 19.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.781 0.325 . . . . 0.0 111.212 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.59 36.56 3.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.451 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 30.8 p -145.64 154.29 52.04 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 48.3 Cg_endo -68.78 -10.79 30.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.621 2.214 . . . . 0.0 112.633 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.77 126.86 29.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.4 m -101.95 160.08 14.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 162' ' ' TYR . 0.4 OUTLIER -155.27 151.46 28.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.035 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -55.5 -56.53 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.295 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.91 50.96 11.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.103 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 -22.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.452 HG21 ' CE1' ' A' ' 87' ' ' PHE . 12.8 p -158.81 141.95 5.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.7 ' HB3' HD23 ' A' ' 187' ' ' LEU . 12.2 p90 -140.79 166.59 24.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.093 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.654 ' CE1' ' HB2' ' A' ' 85' ' ' ALA . 36.2 m-85 -118.37 159.38 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.686 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.405 ' O ' ' CE1' ' A' ' 84' ' ' PHE . 42.9 m -127.53 130.89 49.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.99 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -107.9 142.98 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.96 86.94 0.19 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -176.0 68.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -152.2 152.82 30.19 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.703 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.91 109.18 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.598 2.199 . . . . 0.0 112.352 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -92.25 -172.68 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.907 2.405 . . . . 0.0 112.352 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -60.42 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.968 0.413 . . . . 0.0 110.354 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 13.3 pttt 179.24 60.54 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.806 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 177' ' ' LYS . 43.0 Cg_endo -94.17 -68.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.012 2.475 . . . . 0.0 112.299 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.448 ' CZ ' ' HG2' ' A' ' 181' ' ' ARG . 26.4 p90 -149.98 -44.92 0.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.12 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.83 -48.91 0.03 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.016 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 179' ' ' TYR . 12.0 ptt180 -124.05 167.55 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.286 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.51 164.45 12.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.93 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -108.67 145.23 35.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.239 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -146.18 157.19 43.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.473 HG13 ' HD2' ' A' ' 167' ' ' TYR . 21.4 t -139.22 114.9 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.428 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 5.6 m0 -110.03 124.35 51.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.153 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.7 HD23 ' HB3' ' A' ' 167' ' ' TYR . 63.5 mt -91.65 140.41 29.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.471 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.677 ' HA ' HG12 ' A' ' 130' ' ' VAL . 24.2 t -74.58 123.6 30.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.937 0.399 . . . . 0.0 111.168 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 162' ' ' TYR . 7.0 tttp -72.07 149.81 44.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.173 -0.918 . . . . 1.0 111.089 -179.961 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mp -139.21 177.8 7.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -141.85 63.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.374 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.19 150.17 22.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.913 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mt -134.36 -48.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.51 140.01 32.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -121.03 128.94 53.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.951 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -82.02 141.57 33.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.24 167.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -176.81 -43.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 46.43 -129.93 11.24 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.233 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -106.99 124.22 49.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.822 0.344 . . . . 0.0 110.382 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.59 133.98 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -140.5 126.28 19.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 m -92.45 127.15 37.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 62.89 146.98 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.816 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HG2' ' CE3' ' A' ' 18' ' ' TRP . 71.9 Cg_endo -77.01 -3.42 13.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.406 ' CE3' ' HG2' ' A' ' 17' ' ' PRO . 3.5 p90 -130.55 176.81 7.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.87 110.77 12.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.28 112.98 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.188 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 35' ' ' ALA . 8.7 mt -86.92 -19.12 29.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.167 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.78 167.08 9.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.784 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.92 -168.69 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.57 -118.69 5.88 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.28 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 99.72 158.81 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.74 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -78.8 163.69 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.6 -29.83 69.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.031 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -35.35 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.102 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.24 107.84 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.277 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 64.1 m -100.58 157.95 16.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.002 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB3' HD11 ' A' ' 151' ' ' LEU . 1.9 p90 -139.49 160.97 38.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.996 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -146.9 125.74 12.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -86.1 135.1 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 136.34 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -122.96 126.5 47.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.046 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.86 163.46 27.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.56 -77.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.99 -174.14 54.96 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.522 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -148.89 -89.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 41' ' ' PHE . 4.1 mptt -96.84 137.68 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.808 0.337 . . . . 0.0 110.857 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 103' ' ' ARG . 24.0 m-85 -137.49 157.66 46.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.065 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -93.99 140.21 29.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.54 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 5.0 p -133.44 131.83 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 111.252 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.605 HG23 HD12 ' A' ' 62' ' ' ILE . 23.2 t -126.62 125.49 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.906 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.97 139.48 34.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.1 t -138.24 118.04 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.11 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.07 166.93 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.55 33.85 17.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.613 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.93 123.6 3.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.771 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.85 -69.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.332 2.021 . . . . 0.0 112.353 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG13 ' CD1' ' A' ' 98' ' ' LEU . 45.0 t -156.5 -63.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.224 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.05 -45.14 79.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.211 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -67.09 -46.15 75.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.911 0.386 . . . . 0.0 111.012 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.822 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.96 -42.25 89.43 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.281 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.861 HD11 ' CE1' ' A' ' 84' ' ' PHE . 2.2 mt -56.88 -35.31 68.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.08 -31.56 72.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -88.12 -34.01 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.295 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.75 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.64 -42.46 61.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.762 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.473 ' N ' ' CD ' ' A' ' 60' ' ' PRO . 22.9 mmt -57.67 -43.81 99.05 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 39.3 Cg_exo -60.52 -43.45 33.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.433 2.089 . . . . 0.0 112.313 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -70.22 -43.63 70.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.456 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD12 HG23 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -76.27 -41.96 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.612 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.52 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.87 -31.88 73.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.01 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 63' ' ' MET . 20.3 mmtt -66.34 -32.27 73.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.975 0.417 . . . . 0.0 110.324 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 90.4 t80 -67.9 -32.6 73.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.597 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.591 HG11 ' CE2' ' A' ' 102' ' ' PHE . 18.1 m -90.08 -10.35 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.66 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -91.2 44.47 2.81 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.836 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.11 44.98 51.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.999 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.5 m -126.91 61.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -111.93 -22.3 11.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.191 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.25 4.57 4.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.1 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -94.02 -29.59 15.14 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.842 0.353 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.18 37.73 4.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.187 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.744 HG21 ' HG3' ' A' ' 113' ' ' PRO . 28.4 m -98.48 -178.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.078 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.29 76.1 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.413 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.1 mtp -96.13 106.17 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.12 29.59 11.88 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt 61.25 156.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.582 HG22 HG23 ' A' ' 80' ' ' VAL . 4.8 m -164.65 124.99 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.07 137.3 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.056 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD2' HG13 ' A' ' 80' ' ' VAL . 19.2 Cg_endo -60.06 147.73 91.95 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.583 2.189 . . . . 0.0 112.098 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.93 153.76 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.519 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.444 ' CB ' ' CH2' ' A' ' 186' ' ' TRP . 1.8 t -135.69 168.16 19.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.418 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.861 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -132.07 154.1 49.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.113 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.696 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -97.06 136.68 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.45 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 166' ' ' VAL . 28.7 m -123.14 141.9 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.003 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -115.21 89.81 22.05 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.089 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.725 ' HA ' HD23 ' A' ' 94' ' ' LEU . 19.4 Cg_exo -65.99 149.66 85.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.68 2.253 . . . . 0.0 112.188 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.7 161.87 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -60.27 -19.71 55.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.223 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -5.97 59.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.364 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.89 -6.05 66.78 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 m -94.57 155.17 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 88' ' ' PRO . 16.5 mt -105.72 131.46 53.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -82.06 170.93 14.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.967 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 65.99 5.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -144.35 96.03 2.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.564 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.85 HD11 ' CD2' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -122.94 136.96 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.242 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 115.87 19.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.301 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.75 HG21 ' HB1' ' A' ' 58' ' ' ALA . 1.7 t -87.37 116.82 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.174 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -98.16 142.02 30.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.822 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.718 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 12.9 t80 -123.88 145.6 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 102' ' ' PHE . 6.5 ptp180 -108.75 110.51 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 108' ' ' PHE . 21.9 mt -89.59 137.78 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.436 ' HD2' HG23 ' A' ' 104' ' ' ILE . 7.8 Cg_endo -49.91 154.04 5.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 m-80 -58.79 -27.04 64.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.301 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -61.19 -33.01 72.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.391 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.488 ' HB2' HG22 ' A' ' 104' ' ' ILE . 72.6 m-85 -102.01 -8.98 21.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.751 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -53.73 -34.2 58.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.798 0.332 . . . . 0.0 111.093 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.57 -33.36 81.57 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.437 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 60.1 p -177.5 98.1 0.23 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.583 0.23 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.36 152.97 75.16 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.453 2.102 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.744 ' HG3' HG21 ' A' ' 74' ' ' VAL . 56.2 Cg_endo -71.41 159.0 52.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.602 2.201 . . . . 0.0 112.44 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.43 118.38 56.13 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 65' ' ' TYR . 47.6 Cg_endo -68.37 146.71 69.75 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.422 2.081 . . . . 0.0 112.365 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -77.34 -40.05 45.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.865 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -77.81 114.89 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.021 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.59 -19.11 35.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.292 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 m -80.65 -17.06 52.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.321 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HB3' ' A' ' 117' ' ' ASP . 35.7 t -84.74 113.98 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.362 . . . . 0.0 111.055 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 157.02 18.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.931 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 mm -122.56 123.5 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.993 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.82 129.85 45.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.56 130.95 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.932 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 60.33 111.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -168.98 90.63 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.48 5.65 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.381 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 pt -122.66 142.94 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.273 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.21 42.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.89 HG12 ' HA ' ' A' ' 188' ' ' VAL . 27.0 m -132.77 168.63 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.554 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 186' ' ' TRP . 12.4 m-85 -107.73 160.24 15.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.373 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.0 p -124.4 130.32 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.034 0.445 . . . . 0.0 111.252 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.478 ' HB ' HD13 ' A' ' 151' ' ' LEU . 9.4 t -131.08 138.31 49.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.705 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -122.13 142.65 50.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -152.11 167.76 27.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -98.47 96.94 1.82 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 163.89 162.7 15.27 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -95.89 -177.66 4.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 147' ' ' HIS . . . -157.41 148.56 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 111.265 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -134.35 65.78 1.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.654 ' HG2' HD12 ' A' ' 94' ' ' LEU . 12.3 tt0 67.33 -72.28 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.027 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.08 -37.13 76.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.37 -34.88 76.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -62.9 -39.12 93.54 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.427 0.632 . . . . 0.0 109.881 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.5 t -54.03 -38.77 38.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.457 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.24 69.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.715 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.572 ' CE1' ' HB2' ' A' ' 139' ' ' ALA . 35.8 m170 -70.1 -45.33 67.16 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.862 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.82 72.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.0 m -69.31 -38.24 78.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -44.81 91.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 31' ' ' TYR . 12.4 tp -58.02 -38.35 76.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.394 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -61.28 -43.82 98.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.179 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -61.71 -40.34 94.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.018 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' CE1' ' A' ' 31' ' ' TYR . 1.7 m -57.82 -46.14 85.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.779 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.419 HD13 ' HB1' ' A' ' 160' ' ' ALA . 7.7 mt -73.65 -10.34 59.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.796 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 153' ' ' THR . 0.8 OUTLIER -47.3 106.03 0.08 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.084 0.469 . . . . 0.0 111.151 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 141.18 -39.05 1.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.926 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.8 OUTLIER -94.9 -179.15 0.9 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.9 Cg_endo -85.52 35.55 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.414 2.076 . . . . 0.0 112.803 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.419 ' HB1' HD13 ' A' ' 155' ' ' LEU . . . -60.47 109.24 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.241 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -101.83 165.71 11.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.442 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 164' ' ' GLY . 0.1 OUTLIER -154.7 16.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.713 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.681 ' HG2' ' HB2' ' A' ' 190' ' ' ALA . 3.6 mt-30 53.52 -83.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.6 0.238 . . . . 0.0 111.397 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -127.84 34.36 3.01 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.288 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 64.78 25.54 12.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.681 0.277 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 86' ' ' VAL . 14.5 p -79.71 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.103 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.905 ' HB3' HD23 ' A' ' 187' ' ' LEU . 50.2 p90 -140.4 -176.72 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.854 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.696 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 44.8 m-85 -119.25 159.83 23.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 3.7 m -134.6 152.8 52.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.89 155.91 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.176 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 134.05 174.34 13.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.407 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 59' ' ' MET . 4.1 t80 -166.82 -67.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.688 0.28 . . . . 0.0 111.154 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 91.5 m-20 -72.3 139.26 81.58 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.092 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 173' ' ' ASP . 24.1 Cg_exo -63.26 -177.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.15 126.98 23.2 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.551 2.167 . . . . 0.0 112.206 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.48 -44.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -129.4 105.83 17.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.785 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -85.18 37.48 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.755 2.303 . . . . 0.0 112.833 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -150.33 -47.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 110.813 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -70.33 -44.11 60.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.422 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.76 145.22 37.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.852 0.358 . . . . 0.0 110.915 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 163.95 31.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.78 149.39 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.73 148.6 39.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.408 . . . . 0.0 111.096 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.557 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.2 t -135.11 116.27 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.767 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.494 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -107.93 125.5 51.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.386 . . . . 0.0 111.103 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 167' ' ' TYR . 73.0 mt -91.68 137.23 32.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.801 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HA ' HG12 ' A' ' 130' ' ' VAL . 23.5 t -74.89 131.18 35.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -101.43 103.54 14.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' A' ' 163' ' ' GLN . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.186 -0.911 . . . . 1.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.775 0.321 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.39 35.48 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.844 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.99 -78.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.532 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 mpp? 62.95 122.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.878 0.37 . . . . 0.0 110.837 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.74 -30.53 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.215 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.21 128.43 34.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -123.77 137.09 54.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -73.82 142.47 46.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.17 100.07 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -79.19 -161.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.805 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.24 -86.79 1.1 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.8 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.3 m -107.04 124.51 49.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.23 142.43 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 111.338 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -140.92 127.75 20.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.866 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 t -86.34 120.8 28.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 62.71 145.28 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' O ' ' CG ' ' A' ' 18' ' ' TRP . 50.0 Cg_exo -55.36 136.28 72.93 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.474 2.116 . . . . 0.0 112.239 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.472 ' CG ' ' O ' ' A' ' 17' ' ' PRO . 13.8 p90 46.02 -173.59 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.545 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -139.16 110.34 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.64 125.46 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.19 -16.53 14.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.392 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -169.75 165.41 9.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.8 OUTLIER -152.05 -176.55 5.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.72 -110.86 2.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.4 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 105.65 -133.01 11.38 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.563 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -161.56 165.41 28.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.737 0.303 . . . . 0.0 110.809 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.45 -29.44 69.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.79 -35.14 15.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.223 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.21 108.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.1 140.31 31.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' HE2' HG22 ' A' ' 154' ' ' THR . 0.8 OUTLIER -139.24 161.96 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.17 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG2' HG22 ' A' ' 23' ' ' THR . 26.1 mt-10 -147.24 130.23 16.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.768 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -86.71 121.76 29.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.073 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.73 133.37 34.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -122.76 113.3 19.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 t -127.63 156.21 42.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.0 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.22 84.31 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.54 -151.71 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.544 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.8 -86.11 1.88 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.512 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.9 mttm -123.62 149.1 45.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.832 0.349 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -137.58 153.58 49.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -106.08 132.0 52.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.793 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 101' ' ' TRP . 65.0 p -112.53 140.43 47.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.79 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 17.6 t -128.44 125.47 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.24 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -100.07 134.06 43.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.652 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.67 HG11 ' HA ' ' A' ' 54' ' ' ALA . 11.3 t -138.19 116.84 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.9 0.381 . . . . 0.0 111.208 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.99 167.03 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 t0 58.84 31.79 21.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -151.15 124.93 4.36 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.794 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.76 -67.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.282 1.988 . . . . 0.0 112.439 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.458 ' O ' HD23 ' A' ' 55' ' ' LEU . 61.1 t -156.2 -72.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.805 0.335 . . . . 0.0 111.183 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.85 -40.86 73.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.163 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.79 -46.44 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 110.335 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -60.74 -36.81 79.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.387 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.821 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -56.79 -35.7 69.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.945 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -64.79 -28.33 69.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.621 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.7 tp10 -86.89 -43.57 12.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.517 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 44' ' ' VAL . . . -73.34 -33.7 65.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.605 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 23.6 mmt -58.03 -43.85 98.82 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -66.44 -30.95 43.41 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.952 1.768 . . . . 0.0 112.12 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -38.81 75.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.427 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 44' ' ' VAL . 36.2 mm -77.65 -38.52 25.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.783 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.94 -46.09 79.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -64.43 -30.41 71.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -65.35 -47.37 76.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 102' ' ' PHE . 15.7 m -84.25 -30.22 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.14 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.53 -115.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.04 47.3 1.03 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.443 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 64' ' ' LYS . 4.9 m -152.68 76.19 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -134.09 11.32 3.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.352 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.09 30.21 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -148.68 -47.26 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.56 33.62 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 m -100.66 149.7 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 0.0 111.126 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.13 76.3 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.438 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mtp -60.09 -42.92 95.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.387 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.09 -126.77 13.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.2 mmt -120.55 146.65 46.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 105' ' ' PRO . 1.1 m -157.14 107.82 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 81' ' ' PRO . 21.1 t 64.12 141.67 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.953 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 80' ' ' VAL . 34.5 Cg_exo -59.73 130.79 36.68 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.323 2.016 . . . . 0.0 112.133 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.9 m -87.36 136.71 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 79.6 p -126.15 163.44 23.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.821 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -133.0 153.41 51.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.718 0.294 . . . . 0.0 111.3 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.99 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -89.55 136.86 32.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.145 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.807 HG12 HD12 ' A' ' 98' ' ' LEU . 31.6 m -120.06 136.71 56.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -106.44 96.82 14.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.216 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' A' ' 94' ' ' LEU . 80.5 Cg_endo -77.23 135.72 15.42 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.217 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -90.26 172.07 9.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.63 -15.98 63.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.12 -6.24 59.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.386 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.08 -16.01 56.64 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.998 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -96.54 117.13 30.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 0.0 110.979 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.464 HD12 ' OE2' ' A' ' 141' ' ' GLU . 6.9 mt -56.5 114.48 2.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.923 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -57.56 172.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -80.53 73.76 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 117.27 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.603 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.807 HD12 HG12 ' A' ' 86' ' ' VAL . 1.1 tt -144.05 140.15 29.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.453 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -123.92 115.91 22.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.305 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.79 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 3.2 p -98.72 138.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.016 0.436 . . . . 0.0 111.658 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CD2' HG22 ' A' ' 43' ' ' THR . 25.4 m95 -113.03 142.28 45.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.492 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 85.8 t80 -108.8 160.71 15.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 111.362 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 108.01 15.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.544 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.524 HD12 ' HB2' ' A' ' 40' ' ' LYS . 33.0 mt -80.54 136.68 52.0 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.516 ' HA ' HG21 ' A' ' 79' ' ' THR . 29.0 Cg_endo -62.87 154.04 69.01 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.699 2.266 . . . . 0.0 112.597 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -58.72 -26.68 64.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.302 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -32.83 65.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -107.65 9.3 29.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.788 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -55.43 -42.81 74.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.777 0.322 . . . . 0.0 111.066 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.64 -34.04 68.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.52 100.77 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.541 0.21 . . . . 0.0 110.934 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.29 160.76 47.58 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.363 2.042 . . . . 0.0 112.257 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.68 153.38 54.12 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.692 2.261 . . . . 0.0 112.15 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.66 119.01 62.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.05 146.69 36.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.329 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.6 t -88.04 -33.54 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.796 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.3 OUTLIER -87.75 122.43 31.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -22.23 47.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.7 t -81.66 -25.85 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.11 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.796 HG23 ' HB3' ' A' ' 117' ' ' ASP . 31.1 t -85.21 125.48 40.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.099 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -121.79 157.05 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.749 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.419 ' CG2' ' HD2' ' A' ' 40' ' ' LYS . 26.5 mm -111.67 121.75 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.92 160.29 14.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.757 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.6 151.25 33.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.022 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 1.2 ttt180 62.33 166.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 1.3 tm-20 83.49 129.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.64 155.33 16.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.438 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.11 142.92 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -110.07 118.8 37.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.666 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 188' ' ' VAL . 28.1 m -140.36 166.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.261 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.827 ' OH ' ' HB1' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -107.81 137.72 45.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.2 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 p -105.95 143.1 34.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -131.05 139.19 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.628 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.95 141.44 48.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.028 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' CE1' ' CE1' ' A' ' 147' ' ' HIS . 52.0 p90 -161.43 134.64 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.89 91.56 1.69 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -171.19 177.32 44.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -100.98 160.13 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.791 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 143' ' ' ASP . . . -160.96 133.38 6.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.07 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.75 76.55 1.59 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.052 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' OE2' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 67.53 -71.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.104 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.97 -33.92 62.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.194 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.452 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 4.8 m-20 -68.48 -37.56 80.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.406 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -62.95 -41.02 99.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.322 0.582 . . . . 0.0 110.08 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.99 -38.64 37.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.245 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.86 -37.28 70.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.806 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.5 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 38.1 m-70 -70.16 -44.57 68.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.83 72.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.806 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.3 m -70.58 -43.3 69.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.779 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -58.96 -46.17 88.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 187' ' ' LEU . 13.3 tp -62.4 -41.75 98.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -46.17 89.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.724 HG23 ' OE1' ' A' ' 156' ' ' GLU . 98.1 m -61.85 -43.63 98.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.999 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.495 HG22 ' HE2' ' A' ' 31' ' ' TYR . 2.9 m -57.82 -38.85 76.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.859 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -16.6 61.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.881 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.724 ' OE1' HG23 ' A' ' 153' ' ' THR . 47.1 mt-10 -46.94 144.16 2.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.838 0.352 . . . . 0.0 111.269 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 98.7 -30.89 8.84 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.103 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 1.2 p -94.93 176.15 2.46 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 83.1 Cg_endo -85.77 12.22 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.562 2.174 . . . . 0.0 112.916 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.827 ' HB1' ' OH ' ' A' ' 131' ' ' TYR . . . -59.35 116.29 3.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.53 HG22 ' H ' ' A' ' 162' ' ' TYR . 1.2 m -100.1 175.44 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -155.47 22.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.595 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 48.66 -87.74 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.504 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 162' ' ' TYR . . . -120.96 29.14 5.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.245 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 69.3 21.18 7.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.641 0.258 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.6 p -80.23 139.0 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.732 0.301 . . . . 0.0 111.061 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.895 ' HB3' HD23 ' A' ' 187' ' ' LEU . 24.8 p90 -139.27 178.11 7.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.99 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 97.4 m-85 -119.6 151.4 38.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 35.0 m -126.87 130.91 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -113.27 129.19 56.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.73 -164.91 1.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.693 0.282 . . . . 0.0 110.7 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -50.92 163.0 0.52 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.021 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.26 170.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.282 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.41 92.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.576 2.184 . . . . 0.0 112.596 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.13 -32.44 14.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.715 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -144.36 143.25 21.34 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.788 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.26 34.73 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.86 2.374 . . . . 0.0 112.839 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -149.74 -46.86 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.781 0.324 . . . . 0.0 110.928 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.16 60.59 4.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.62 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.04 140.75 51.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.774 0.321 . . . . 0.0 110.941 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.03 132.92 25.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -126.47 133.98 51.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -142.96 156.4 44.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.06 0.457 . . . . 0.0 111.059 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.626 HG13 ' CD2' ' A' ' 167' ' ' TYR . 15.5 t -138.98 116.14 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.826 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -107.76 121.86 45.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.041 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' A' ' 167' ' ' TYR . 43.0 mt -92.91 136.01 33.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.575 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 130' ' ' VAL . 21.9 t -74.74 131.53 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.822 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 36.15 1.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.242 -0.885 . . . . 1.0 111.369 179.846 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpp . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.851 0.358 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.52 129.1 45.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.94 -137.78 5.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 68.0 mtm 62.82 -79.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 0.0 111.055 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 tp -166.29 144.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -100.37 137.64 38.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.725 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.41 139.21 39.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.86 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.98 152.72 21.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mp -104.93 -9.53 17.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.324 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 61.8 32.01 18.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.821 0.343 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 -83.23 0.39 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.6 p -96.68 134.75 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.711 0.291 . . . . 0.0 110.841 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.98 118.19 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.141 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -140.65 151.02 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.762 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 t -88.59 119.75 29.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 176.48 73.18 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.12 60.91 5.72 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.898 2.399 . . . . 0.0 112.752 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' CD1' ' A' ' 18' ' ' TRP . 6.4 p90 -82.6 134.28 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.701 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.38 107.7 10.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.167 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.36 119.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.51 -3.93 21.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.498 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.14 166.88 8.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -152.34 -57.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.029 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.82 170.0 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.63 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -167.53 -85.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.5 162.99 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -66.53 -33.21 75.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -33.2 16.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 t -145.97 141.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.33 154.47 50.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.574 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.07 159.77 41.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -143.43 121.8 12.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.52 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 39.0 mt-10 -87.02 132.07 33.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -141.98 130.9 23.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.46 124.38 48.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.123 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 p -127.74 -178.33 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.45 167.65 14.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.15 167.29 38.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.6 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.61 -85.88 1.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.56 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HB3' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -100.9 146.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 110.888 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 6.2 m-85 -137.59 148.04 45.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.844 ' HB3' ' HB3' ' A' ' 102' ' ' PHE . . . -94.11 123.49 37.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.697 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' CD2' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -112.64 136.59 52.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.251 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.793 ' CG2' HD11 ' A' ' 62' ' ' ILE . 22.9 t -125.96 125.54 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.64 131.32 44.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.154 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 54' ' ' ALA . 12.5 t -138.46 116.75 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.009 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.424 HG23 ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -121.22 167.1 13.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.98 23.45 13.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.356 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -152.55 133.22 7.7 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.3 -177.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.518 2.145 . . . . 0.0 112.463 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' HD23 ' A' ' 55' ' ' LEU . 48.3 t -62.71 -70.84 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -56.15 -40.61 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -62.92 -46.85 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 0.0 110.36 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 46' ' ' VAL . . . -62.35 -36.71 83.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.18 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.974 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -56.91 -35.43 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.074 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -63.57 -27.91 69.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.712 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 tp10 -87.62 -44.35 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.693 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.52 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.19 -37.28 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.612 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 28.9 mmt -57.75 -43.79 98.97 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 59' ' ' MET . 30.8 Cg_endo -65.01 -29.49 57.09 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.763 1.642 . . . . 0.0 112.062 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HE2' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -70.18 -37.42 75.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.373 179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.793 HD11 ' CG2' ' A' ' 44' ' ' VAL . 29.8 mm -77.32 -44.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.903 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -43.97 97.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.642 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -65.07 -30.69 71.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.7 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.63 -56.87 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.566 HG12 ' SD ' ' A' ' 76' ' ' MET . 26.8 m -72.61 -30.14 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.22 -90.99 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.405 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.13 71.71 0.24 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 69' ' ' THR . 52.4 m -153.52 47.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -110.97 -22.36 11.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.52 2.34 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.475 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -93.55 -35.78 12.74 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.819 0.343 . . . . 0.0 110.751 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.14 29.98 8.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.5 m -99.42 165.99 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.84 0.353 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.96 2.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.429 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.566 ' SD ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 63.76 135.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.886 0.374 . . . . 0.0 110.917 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.21 169.48 32.65 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.57 155.95 17.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.746 0.308 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.401 ' O ' HG13 ' A' ' 80' ' ' VAL . 97.8 m -135.43 -45.07 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 0.3 OUTLIER -156.58 164.07 22.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 80' ' ' VAL . 19.1 Cg_endo -59.46 130.62 36.48 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.123 1.882 . . . . 0.0 111.668 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.529 HG11 ' HD2' ' A' ' 102' ' ' PHE . 3.6 m -87.58 126.29 41.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.889 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 170' ' ' ALA . 16.0 m -119.82 153.14 36.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.986 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.974 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.62 154.12 33.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 111.591 -179.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -87.18 136.8 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.613 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.897 HG12 HD12 ' A' ' 98' ' ' LEU . 28.8 m -129.47 132.51 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.901 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -99.41 100.32 10.3 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.169 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.793 ' HA ' HD23 ' A' ' 94' ' ' LEU . 72.4 Cg_endo -73.99 140.95 29.17 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.515 2.143 . . . . 0.0 112.279 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.11 158.6 17.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.839 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -19.04 61.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.239 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -85.55 -6.07 59.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.44 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.573 ' HA2' HG11 ' A' ' 145' ' ' VAL . . . 96.03 -3.6 64.7 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.018 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -99.98 153.31 19.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.793 HD23 ' HA ' ' A' ' 88' ' ' PRO . 58.0 mt -97.42 132.55 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.19 174.07 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.793 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -80.42 -13.99 58.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.275 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' CG ' HG23 ' A' ' 47' ' ' THR . 0.3 OUTLIER -82.8 123.85 29.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.762 0.315 . . . . 0.0 111.038 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.897 HD12 HG12 ' A' ' 86' ' ' VAL . 2.2 tt -144.05 127.95 17.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 115.9 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.783 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 4.5 p -96.5 139.91 18.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.445 ' CD2' ' CG2' ' A' ' 43' ' ' THR . 24.9 m95 -116.85 142.37 47.02 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.844 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 62.2 t80 -112.51 161.11 17.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.807 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HG2' HG21 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.59 107.92 16.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.864 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 40' ' ' LYS . 38.1 mt -84.4 137.2 39.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.163 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.463 ' HD2' HG23 ' A' ' 104' ' ' ILE . 19.8 Cg_endo -60.32 152.78 64.4 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.586 2.191 . . . . 0.0 112.388 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 24.5 p-10 -62.07 -26.81 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.259 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -56.76 -42.58 79.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.279 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -95.87 5.5 51.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.462 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -55.01 -45.93 75.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.739 0.304 . . . . 0.0 111.187 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.06 -26.03 40.7 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.688 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 p -177.09 90.14 0.25 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.64 0.257 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 43.9 Cg_endo -68.19 146.72 70.9 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.12 . . . . 0.0 112.198 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 112' ' ' PRO . 10.5 Cg_exo -70.87 157.4 58.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.497 2.132 . . . . 0.0 111.998 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.95 126.51 92.58 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.823 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HB2' HG11 ' A' ' 120' ' ' VAL . 86.2 Cg_endo -81.23 6.11 5.81 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.642 2.228 . . . . 0.0 113.007 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m 58.12 -177.2 0.07 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.781 0.324 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.499 ' HB3' HG23 ' A' ' 120' ' ' VAL . 24.0 t0 62.01 117.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.994 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -20.2 42.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.281 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.6 t -81.07 -31.72 34.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 117' ' ' ASP . 21.9 t -85.49 118.74 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.938 0.399 . . . . 0.0 111.153 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -128.05 157.21 41.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.0 mm -110.69 112.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -98.9 130.12 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -88.58 91.42 8.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.942 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.36 152.89 39.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.86 166.48 21.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.73 172.29 4.06 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -138.31 143.03 33.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.258 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 2.7 m -108.73 123.22 48.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.515 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 187' ' ' LEU . 13.7 m -131.32 169.76 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.966 0.412 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.43 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 7.5 m-85 -107.79 137.14 46.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.82 135.53 47.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.944 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.5 t -128.87 139.08 52.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.01 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -117.0 148.01 41.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.402 ' CZ ' ' OD1' ' A' ' 183' ' ' ASN . 22.4 p90 -172.26 -176.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -99.04 -145.2 18.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.628 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.37 163.88 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.539 ' CE1' ' O ' ' A' ' 175' ' ' PRO . 0.1 OUTLIER -109.85 141.81 42.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 110.97 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.727 ' HB2' ' HE1' ' A' ' 147' ' ' HIS . . . -125.43 159.34 32.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.466 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -45.78 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.648 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.686 ' CG ' HD12 ' A' ' 94' ' ' LEU . 32.9 tt0 -167.35 -66.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.485 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.59 -33.69 73.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.493 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.89 79.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -40.76 98.56 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 109.909 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.573 HG11 ' HA2' ' A' ' 92' ' ' GLY . 45.6 t -53.85 -38.75 37.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.707 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -34.73 71.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.778 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.727 ' HE1' ' HB2' ' A' ' 139' ' ' ALA . 24.2 m170 -70.22 -46.09 65.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.02 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.84 74.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.984 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.7 m -70.43 -49.98 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -59.01 -38.65 79.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.803 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.71 ' HB3' HD11 ' A' ' 187' ' ' LEU . 12.0 tp -58.48 -39.01 78.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.511 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -41.35 89.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -41.02 83.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.458 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.574 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.74 -43.71 85.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.533 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.538 HD23 ' CD2' ' A' ' 31' ' ' TYR . 2.6 mt -73.02 -13.24 61.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.152 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -47.01 -47.15 22.21 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -56.71 -33.06 62.36 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.446 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.411 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 26.0 p -94.51 167.75 12.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.662 0.267 . . . . 0.0 110.744 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.411 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 0.9 OUTLIER -83.75 40.46 0.91 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.197 2.598 . . . . 0.0 112.695 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.29 170.66 1.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.904 0.383 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.676 HG22 ' HB3' ' A' ' 190' ' ' ALA . 0.2 OUTLIER -138.56 163.95 30.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.527 ' O ' ' HB2' ' A' ' 190' ' ' ALA . 1.2 m-85 -156.23 175.2 14.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -92.93 -55.34 3.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.799 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.03 -74.0 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.399 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -159.66 71.08 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 12.7 p -160.81 136.61 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.295 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.476 ' HB3' HD23 ' A' ' 187' ' ' LEU . 19.1 p90 -139.61 -177.83 5.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.582 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 25.7 m-85 -120.66 156.39 31.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.008 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.3 131.0 46.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' OG ' ' A' ' 83' ' ' SER . . . -119.66 130.21 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 169.31 -71.08 0.14 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.616 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.427 ' CG ' ' O ' ' A' ' 172' ' ' TYR . 5.2 t80 57.62 41.63 25.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 110.825 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 4.6 p30 169.35 161.12 0.19 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.305 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HB2' ' HG3' ' A' ' 178' ' ' PRO . 82.0 Cg_exo -41.4 97.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.58 2.186 . . . . 0.0 112.502 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.539 ' O ' ' CE1' ' A' ' 138' ' ' TYR . 15.1 Cg_exo -68.41 -148.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.935 2.423 . . . . 0.0 112.877 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.401 ' HB3' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER 62.37 -87.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.074 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt 173.15 75.73 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-O 120.685 0.279 . . . . 0.0 110.832 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 179' ' ' TYR . 83.9 Cg_endo -80.42 -40.28 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.664 2.242 . . . . 0.0 111.751 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 178' ' ' PRO . 54.0 p90 -149.54 -45.3 0.14 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.415 ' N ' ' CD1' ' A' ' 179' ' ' TYR . . . -165.52 44.99 0.28 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.431 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.66 165.26 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -142.1 159.46 42.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.875 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 175' ' ' PRO . 2.9 p30 -119.9 133.84 55.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.781 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -146.26 147.4 31.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.225 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 167' ' ' TYR . 17.3 t -118.84 129.73 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.441 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' HB3' HG21 ' A' ' 130' ' ' VAL . 46.0 m0 -107.9 121.56 45.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.735 ' O ' HG12 ' A' ' 130' ' ' VAL . 73.4 mt -97.33 139.96 32.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.542 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 38.4 t -74.94 128.92 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.864 0.364 . . . . 0.0 110.983 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -100.63 125.91 47.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.676 ' HB3' HG22 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.27 -0.871 . . . . 1.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 mtm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.793 0.33 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 66.81 -73.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.994 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.8 -148.47 27.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.607 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 168.72 19.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.856 0.36 . . . . 0.0 110.779 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 tt -167.73 47.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.052 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.94 122.59 48.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.819 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -128.56 169.16 14.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -68.82 130.65 43.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.5 -38.08 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.17 84.69 7.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.97 -116.53 1.06 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.467 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -75.79 125.05 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.89 141.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.042 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -122.41 143.56 49.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 t -115.46 131.06 57.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 -106.58 162.94 18.09 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -167.99 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 112.351 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -52.71 99.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.942 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -129.55 112.91 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.039 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 t -74.09 112.86 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.37 -7.15 39.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.725 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.4 167.17 8.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.388 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.6 p -151.64 -178.59 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.761 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.19 -104.04 0.97 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.44 -94.8 0.55 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.683 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -160.43 163.03 33.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 0.0 110.791 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -66.44 -30.56 70.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.033 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.61 -35.23 15.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 150' ' ' GLN . 3.5 m -146.27 115.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.384 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.0 p -95.98 145.2 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -140.92 162.26 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.054 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 127.27 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.562 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.433 ' HG2' ' CD1' ' A' ' 131' ' ' TYR . 17.2 mt-10 -85.86 126.3 33.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 129' ' ' THR . 8.3 ptp180 -142.03 128.04 19.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -111.62 122.16 47.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 26.7 p -132.14 149.96 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -71.66 -63.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.38 -77.85 1.53 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.54 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.45 -89.78 1.12 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.42 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 112' ' ' PRO . 11.0 mptt -114.67 146.28 41.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.349 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -137.63 140.17 40.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.75 115.9 28.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.115 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.3 p -112.77 155.48 24.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 112.004 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG21 ' HB ' ' A' ' 62' ' ' ILE . 17.6 t -136.7 125.9 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.578 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -96.07 130.35 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.402 ' HB ' ' HB1' ' A' ' 54' ' ' ALA . 8.0 t -138.27 116.72 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.58 173.75 6.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.234 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.89 32.15 2.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.427 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -153.15 127.57 4.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.039 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.24 -169.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.476 2.117 . . . . 0.0 112.224 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.806 HG13 ' CD1' ' A' ' 98' ' ' LEU . 44.9 t -72.5 -53.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.211 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.89 -43.68 92.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.214 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.03 -46.17 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.266 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 46' ' ' VAL . . . -58.91 -41.28 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.703 HD11 ' CE1' ' A' ' 84' ' ' PHE . 8.0 mt -57.46 -35.57 70.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -62.92 -35.12 79.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.927 0.394 . . . . 0.0 110.041 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 tp10 -87.49 -28.29 22.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.388 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.783 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.33 -45.17 56.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.679 ' CE ' HG11 ' A' ' 82' ' ' VAL . 34.1 mmt -57.61 -43.46 98.86 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 32.0 Cg_exo -57.96 -41.55 67.48 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.07 1.847 . . . . 0.0 112.067 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -70.29 -45.5 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.351 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 102' ' ' PHE . 7.1 tt -75.59 -27.84 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.418 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -38.67 88.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.828 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.907 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -69.24 -56.38 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.41 -29.1 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.11 -124.79 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.622 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.17 48.01 0.98 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.406 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.0 m -142.94 62.54 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.971 0.415 . . . . 0.0 110.872 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -108.99 -24.12 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.089 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 79.31 -3.47 2.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.668 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 -40.56 10.09 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.92 0.39 . . . . 0.0 110.886 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.84 67.6 1.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.45 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.519 HG21 ' HG3' ' A' ' 113' ' ' PRO . 25.4 m -138.88 -179.45 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 111.171 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.81 117.65 1.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.388 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 1.3 mtm -112.73 -161.87 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.633 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.32 -37.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 tmt? 63.18 120.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 111.046 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.537 HG22 ' HD2' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -60.3 167.86 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.633 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.541 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 13.5 t -87.25 -48.73 0.47 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.404 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 66.7 Cg_endo -91.42 130.38 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.512 2.141 . . . . 0.0 112.528 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' CE ' ' A' ' 59' ' ' MET . 34.4 t -92.86 152.31 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.01 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.6 p -125.1 145.93 49.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.664 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.703 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -132.93 153.99 50.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.937 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.432 ' HB3' ' CG ' ' A' ' 99' ' ' LYS . . . -95.04 136.67 35.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.841 0.353 . . . . 0.0 110.715 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 HD12 ' A' ' 98' ' ' LEU . 27.7 m -131.34 126.83 59.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 166' ' ' VAL . 43.3 m-85 -97.8 99.62 7.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.09 122.35 9.43 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.39 2.06 . . . . 0.0 112.105 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -89.74 170.81 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.039 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.35 -15.81 62.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.98 -0.1 53.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.445 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.23 67.07 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.887 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.5 p -122.82 160.12 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.027 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.518 HD12 ' HG3' ' A' ' 141' ' ' GLU . 5.8 mt -79.09 160.42 27.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.53 44.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.178 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp 52.5 28.36 5.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.326 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -117.49 99.64 7.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.735 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.806 ' CD1' HG13 ' A' ' 51' ' ' VAL . 7.5 tt -127.56 127.73 44.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.978 0.418 . . . . 0.0 111.48 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.432 ' CG ' ' HB3' ' A' ' 85' ' ' ALA . 11.3 ptmt -117.58 116.62 27.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.469 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.783 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.1 t -66.79 141.47 17.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.528 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -120.37 119.17 32.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.332 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.639 ' HB2' HD11 ' A' ' 62' ' ' ILE . 61.6 t80 -106.02 153.78 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.074 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -112.77 121.83 45.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.787 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.433 HG23 ' HD2' ' A' ' 105' ' ' PRO . 33.5 mt -96.91 136.75 21.45 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.6 154.1 56.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.555 2.17 . . . . 0.0 112.357 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.57 -26.85 65.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -56.94 -45.22 82.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.041 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 64.3 m-85 -94.62 -9.79 33.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.395 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -53.46 -37.4 62.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 111.11 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -28.88 72.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.559 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.0 p -171.66 75.93 0.5 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.769 0.319 . . . . 0.0 110.813 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HG2' ' CB ' ' A' ' 40' ' ' LYS . 37.9 Cg_exo -57.05 154.58 32.57 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.533 2.155 . . . . 0.0 112.355 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG3' HG21 ' A' ' 74' ' ' VAL . 5.6 Cg_exo -74.31 152.14 44.08 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.685 2.257 . . . . 0.0 112.094 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.72 129.35 93.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.44 135.82 22.9 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.44 2.093 . . . . 0.0 112.316 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 m -91.45 50.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.028 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.4 OUTLIER -162.2 118.06 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.93 -21.75 45.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.193 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.0 p -81.71 -31.67 32.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.739 0.304 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 117' ' ' ASP . 34.1 t -85.78 122.25 38.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.968 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -124.84 152.57 43.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.7 mm -105.09 117.62 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.82 137.06 37.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 104.5 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -169.07 73.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.938 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 125' ' ' ARG . 30.9 tt0 82.23 139.97 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.065 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -70.34 -179.96 27.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.241 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.05 142.9 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.831 0.348 . . . . 0.0 111.433 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 5.6 m -112.75 126.74 55.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.331 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 188' ' ' VAL . 22.8 m -133.96 157.49 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.894 0.378 . . . . 0.0 111.54 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' A' ' 155' ' ' LEU . 12.0 m-85 -107.72 141.8 38.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.7 p -111.91 126.99 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.882 0.372 . . . . 0.0 111.136 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.7 t -123.69 138.82 54.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -116.83 143.68 45.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.493 ' CD1' ' CE1' ' A' ' 147' ' ' HIS . 12.8 p90 -142.15 -44.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.26 109.47 0.69 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.494 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.1 -137.04 2.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CE1' ' HG2' ' A' ' 175' ' ' PRO . 41.6 m-85 -145.56 92.35 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.89 136.02 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -105.04 -48.44 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.823 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.518 ' HG3' HD12 ' A' ' 94' ' ' LEU . 1.6 tm-20 -166.24 -68.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.694 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.82 67.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -67.98 -34.98 77.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.047 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -64.1 -40.48 96.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 109.998 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.3 t -53.72 -38.55 35.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.541 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.87 -34.1 73.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.761 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.493 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 44.0 m-70 -70.02 -41.42 74.31 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.761 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.85 73.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.4 m -63.02 -42.62 99.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.708 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.675 ' HB3' HG11 ' A' ' 29' ' ' VAL . 57.4 mm-40 -59.07 -45.94 89.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.593 ' HB3' HD12 ' A' ' 187' ' ' LEU . 11.9 tp -61.51 -39.68 91.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.25 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -59.12 -36.32 75.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.271 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -46.2 68.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.268 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -49.11 77.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.789 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.516 HD13 ' CE2' ' A' ' 131' ' ' TYR . 11.5 mt -74.02 -9.12 58.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.431 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -47.55 -43.24 24.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 111.261 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.4 -15.08 77.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.762 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.438 ' HB ' ' CD ' ' A' ' 159' ' ' PRO . 12.3 p -93.65 169.23 10.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.003 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.438 ' CD ' ' HB ' ' A' ' 158' ' ' THR . 7.9 Cg_exo -72.78 0.58 7.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.046 2.498 . . . . 0.0 112.913 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.12 121.91 11.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.204 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.859 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 1.1 m -101.38 -2.21 31.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.115 0.483 . . . . 0.0 111.077 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 50.92 16.26 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.054 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.649 ' H ' ' HB2' ' A' ' 190' ' ' ALA . 1.0 OUTLIER 65.11 -75.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 0.0 111.162 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.58 -78.89 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.74 68.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.947 0.403 . . . . 0.0 111.083 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 166' ' ' VAL . 11.0 p -161.91 122.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.103 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.632 ' HB3' HD23 ' A' ' 187' ' ' LEU . 37.0 p90 -132.91 170.21 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.038 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.858 ' CE2' HG22 ' A' ' 188' ' ' VAL . 18.5 m-85 -112.74 157.16 21.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . 0.44 ' SG ' HG13 ' A' ' 185' ' ' VAL . 1.7 m -133.56 130.95 39.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.757 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -121.37 129.27 52.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.019 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.84 -153.69 15.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -141.52 -174.83 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.83 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.26 153.64 9.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.421 ' HA ' ' HD2' ' A' ' 175' ' ' PRO . 58.2 Cg_endo -71.19 108.14 2.28 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.776 2.317 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.461 ' HG2' ' CE1' ' A' ' 138' ' ' TYR . 23.0 Cg_endo -62.97 -165.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.318 2.012 . . . . 0.0 112.586 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.5 mmm -129.65 -45.18 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.58 108.71 36.06 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -165.77 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.44 2.093 . . . . 0.0 112.167 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 61.68 28.7 17.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.33 33.63 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -133.05 166.86 21.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.708 0.29 . . . . 0.0 110.724 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -142.15 126.29 17.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.943 0.401 . . . . 0.0 111.408 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -132.94 133.9 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.33 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.88 157.11 43.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.732 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.44 HG13 ' SG ' ' A' ' 169' ' ' CYS . 39.0 t -124.55 139.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.48 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.677 ' CE3' HG21 ' A' ' 130' ' ' VAL . 24.9 m0 -107.62 121.49 44.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.086 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.632 HD23 ' HB3' ' A' ' 167' ' ' TYR . 5.2 mt -98.75 133.41 43.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.743 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.858 HG22 ' CE2' ' A' ' 168' ' ' TYR . 25.7 t -75.8 118.95 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.05 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -79.95 147.25 31.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.958 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.859 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.277 -0.868 . . . . 1.0 111.098 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mtt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.776 0.322 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.37 116.79 30.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.46 -134.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mmt -130.02 122.39 28.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.26 -58.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.39 123.18 29.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -105.01 133.61 49.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.04 128.9 35.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.5 -168.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.91 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -85.5 -82.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.5 -137.44 30.32 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.722 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -91.24 127.38 36.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.74 144.73 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -140.97 135.89 31.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.8 t -83.91 133.59 34.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 1.2 m0 -150.64 146.73 19.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.413 ' HB2' ' CE3' ' A' ' 18' ' ' TRP . 58.1 Cg_endo -71.57 -45.36 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.434 2.09 . . . . 0.0 112.299 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.413 ' CE3' ' HB2' ' A' ' 17' ' ' PRO . 6.3 p90 -165.0 166.43 19.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -125.47 109.69 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -74.03 115.15 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.14 -16.24 20.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.417 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 t -169.72 167.05 9.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -151.86 -175.82 5.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.72 -173.2 47.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 31' ' ' TYR . . . 172.44 -93.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.608 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' VAL . 1.2 mtmm -161.28 166.39 27.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.849 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -66.62 -31.66 72.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.294 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -31.33 17.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.278 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.7 t -146.03 142.28 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.4 m -134.74 148.82 50.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.727 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.724 ' CD2' HD21 ' A' ' 155' ' ' LEU . 1.9 p90 -139.17 162.2 35.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.31 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 23' ' ' THR . 4.5 mt-10 -144.54 122.27 11.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.389 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -85.98 118.37 25.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.994 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.07 127.93 35.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.826 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.58 128.2 55.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.3 p -100.19 158.93 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -60.2 -52.08 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.969 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.96 -158.05 22.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.86 -173.29 20.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' O ' HD12 ' A' ' 104' ' ' ILE . 25.3 mttt -98.49 149.8 22.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -137.65 153.93 49.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.778 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -93.96 140.03 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.592 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 p -112.46 143.55 43.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 111.08 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.758 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.1 t -132.17 125.32 54.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.65 140.09 36.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.852 HG11 ' HA ' ' A' ' 54' ' ' ALA . 3.2 t -138.42 123.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.313 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 167.04 9.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.766 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 t0 51.2 33.91 10.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.413 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -151.6 128.5 5.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.711 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.46 -69.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.357 2.038 . . . . 0.0 112.585 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.922 HG13 ' CD1' ' A' ' 98' ' ' LEU . 48.4 t -156.12 -66.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.82 0.343 . . . . 0.0 111.287 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.91 -45.08 78.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.09 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.6 -42.7 91.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.77 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.852 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -58.95 -44.01 91.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.916 HD11 ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -56.97 -35.41 69.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.926 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.1 mtp180 -62.48 -33.44 74.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 4.9 tp10 -87.73 -29.29 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.158 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' CA ' HG11 ' A' ' 44' ' ' VAL . . . -73.51 -43.47 59.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.726 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.539 ' CE ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -57.6 -43.87 99.14 Favored Pre-proline 0 N--CA 1.466 0.354 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 57' ' ' GLU . 38.3 Cg_exo -60.22 -37.33 83.83 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.176 1.918 . . . . 0.0 111.784 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -70.38 -44.9 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.778 HD11 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -76.13 -28.14 18.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.211 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.13 74.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.662 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HD3' HG21 ' A' ' 69' ' ' THR . 1.8 ttmt -65.43 -39.82 92.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.658 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.82 -57.9 7.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' CE2' ' A' ' 102' ' ' PHE . 28.6 m -67.06 -29.61 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.9 -137.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.84 35.26 4.89 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 69' ' ' THR . 32.5 m -125.09 32.72 5.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASP . 5.5 p30 -88.25 -16.58 32.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.278 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 1.5 m-20 82.44 -9.25 1.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.679 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -93.04 -36.74 12.55 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.825 0.345 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.75 43.17 6.16 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.454 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.02 163.56 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.343 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.75 58.2 0.64 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -74.57 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.967 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.95 -118.08 4.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.392 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.61 118.4 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.821 0.344 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -67.93 145.51 54.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 16.8 t -67.57 -53.52 22.14 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.466 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 80' ' ' VAL . 69.9 Cg_endo -73.54 146.94 40.01 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.209 1.939 . . . . 0.0 112.183 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.539 HG11 ' CE ' ' A' ' 59' ' ' MET . 45.4 t -153.54 125.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 t -114.98 145.98 41.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.038 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CE2' HD11 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -128.59 149.31 50.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.764 0.316 . . . . 0.0 111.636 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.787 ' HB2' ' CE2' ' A' ' 168' ' ' TYR . . . -88.22 136.81 32.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.523 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.764 HG12 HD12 ' A' ' 98' ' ' LEU . 34.3 m -125.47 139.73 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.216 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 166' ' ' VAL . 2.4 m-85 -108.99 103.92 53.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.029 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 94' ' ' LEU . 53.3 Cg_endo -69.36 137.65 37.13 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.397 2.065 . . . . 0.0 112.243 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -89.88 171.98 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.036 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.04 -15.88 62.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.394 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.49 -1.07 55.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.491 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.4 ' O ' HG11 ' A' ' 145' ' ' VAL . . . 87.03 -6.77 82.68 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.867 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 m -119.74 171.5 8.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.937 0.398 . . . . 0.0 110.953 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 88' ' ' PRO . 0.2 OUTLIER -112.27 96.88 6.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -95.0 102.23 14.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.343 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.77 86.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.597 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 175.5 81.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.922 ' CD1' HG13 ' A' ' 51' ' ' VAL . 6.9 tt -144.1 135.56 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 111.493 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.48 115.63 20.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.725 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.758 ' CG1' ' HB ' ' A' ' 44' ' ' VAL . 6.0 p -91.74 136.86 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.123 0.487 . . . . 0.0 111.888 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 24.7 m95 -110.58 142.27 42.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.81 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 66' ' ' VAL . 32.7 t80 -105.78 145.54 31.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' O ' ' CE1' ' A' ' 102' ' ' PHE . 7.1 ttt180 -95.66 113.62 25.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 40' ' ' LYS . 35.9 mt -90.75 136.65 27.6 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD2' HG23 ' A' ' 104' ' ' ILE . 20.4 Cg_endo -60.38 153.99 56.26 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.532 2.155 . . . . 0.0 112.238 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 109' ' ' GLN . 1.7 t30 -57.65 -26.88 62.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.268 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.85 -47.11 81.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.431 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -90.25 1.31 56.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.659 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -54.78 -39.75 68.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 111.041 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.58 -34.06 68.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.609 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.6 p -178.35 93.53 0.22 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.83 161.07 10.9 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.567 2.178 . . . . 0.0 112.179 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.71 155.85 61.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.688 2.259 . . . . 0.0 112.255 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 112.33 9.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.116 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.0 158.34 14.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.355 2.036 . . . . 0.0 112.292 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -116.12 -37.77 3.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 120' ' ' VAL . 1.4 t70 -74.01 125.81 29.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.932 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.7 -24.5 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -82.01 -30.67 31.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.629 HG23 ' HB3' ' A' ' 117' ' ' ASP . 33.6 t -85.32 115.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 157.02 38.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 124.75 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 133.81 45.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -88.47 130.74 35.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -132.06 22.52 4.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 125' ' ' ARG . 2.5 pt-20 30.28 42.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.79 159.87 3.24 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -142.19 146.12 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.909 0.385 . . . . 0.0 111.219 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.1 m -103.94 120.29 40.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 187' ' ' LEU . 27.2 m -138.9 163.26 27.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.321 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 151' ' ' LEU . 11.0 m-85 -107.76 128.44 54.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.534 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 m -105.82 135.69 46.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.15 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.9 t -129.56 139.1 51.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.756 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -116.91 153.83 31.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -160.37 -177.96 6.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -114.54 93.03 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.541 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 177.2 149.96 8.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 177.98 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.335 . . . . 0.0 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -175.86 156.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -133.34 -72.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.666 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -152.4 -46.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.775 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' N ' ' HG2' ' A' ' 141' ' ' GLU . . . -71.85 -33.83 68.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.58 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.5 -35.03 78.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.874 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.23 -40.82 98.53 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.999 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 141' ' ' GLU . 48.3 t -53.83 -38.58 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.561 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.27 -34.78 73.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.554 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.669 ' HB2' HG21 ' A' ' 185' ' ' VAL . 24.5 m170 -70.18 -42.87 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.69 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' HG11 ' A' ' 185' ' ' VAL . . . -61.88 -32.92 73.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.759 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 m -72.22 -41.59 66.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.719 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.35 -43.34 92.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.712 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' TYR . 18.4 tp -59.04 -44.6 91.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.555 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -46.76 88.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.302 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -46.21 91.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.55 HG22 ' CE1' ' A' ' 31' ' ' TYR . 88.0 m -57.63 -45.86 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.629 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.724 HD21 ' CD2' ' A' ' 31' ' ' TYR . 48.0 mt -73.26 -9.92 59.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.329 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -47.58 -42.06 22.97 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.048 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.09 -27.11 71.9 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 6.9 p -93.98 163.55 23.39 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.595 0.236 . . . . 0.0 110.643 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 85.0 Cg_endo -82.92 20.08 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.72 2.28 . . . . 0.0 112.967 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.96 148.14 31.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.091 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.549 HG21 ' OXT' ' A' ' 190' ' ' ALA . 0.3 OUTLIER -101.19 176.57 5.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 161' ' ' THR . 6.6 m-85 -155.51 158.2 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.39 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.27 -36.05 14.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 57.48 49.29 74.49 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -158.42 -42.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.811 0.339 . . . . 0.0 111.122 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.702 HG23 ' O ' ' A' ' 86' ' ' VAL . 13.0 p -160.12 137.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.264 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 86' ' ' VAL . 6.4 p90 -129.21 172.18 11.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.787 ' CE2' ' HB2' ' A' ' 85' ' ' ALA . 51.9 m-85 -112.98 155.42 24.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.053 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.26 149.26 41.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -118.89 125.59 49.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -122.64 -4.1 9.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.896 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 62.8 -80.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.771 0.32 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -123.3 136.76 27.43 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.982 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.74 164.52 7.58 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 112.386 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.73 118.91 5.87 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.672 2.248 . . . . 0.0 112.215 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -176.98 -46.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -106.83 92.57 7.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.06 168.62 21.42 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.486 2.124 . . . . 0.0 112.127 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 60.18 75.54 0.4 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.72 42.95 0.16 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.559 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.31 156.35 27.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.848 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.28 124.01 22.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -120.82 135.25 55.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -143.81 154.16 43.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' A' ' 147' ' ' HIS . 25.2 t -124.6 129.8 73.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.001 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.43 ' HB3' HG21 ' A' ' 130' ' ' VAL . 44.2 m0 -107.89 121.61 45.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.917 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 130' ' ' VAL . 14.2 mt -94.13 134.93 36.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 130' ' ' VAL . 25.5 t -81.22 120.38 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -88.67 115.12 25.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.549 ' OXT' HG21 ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.187 -0.911 . . . . 1.0 111.145 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.62 156.69 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 110.45 0.23 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.545 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.48 131.89 43.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.679 HD13 ' H ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -138.86 27.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.294 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -115.02 107.96 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -126.44 141.56 51.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.1 t -85.64 156.5 20.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -99.86 105.07 16.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -111.74 116.31 30.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.885 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.39 -97.27 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.554 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -101.37 125.87 48.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.76 0.314 . . . . 0.0 110.982 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.72 130.55 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -136.05 124.85 23.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.8 p -116.06 129.13 56.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.767 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 17' ' ' PRO . 4.8 t-105 -69.7 -51.8 15.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 16' ' ' TRP . 66.6 Cg_endo -85.92 -171.46 0.87 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.655 2.236 . . . . 0.0 112.37 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 2.8 p90 -107.26 139.86 41.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.49 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -120.81 108.0 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.285 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.696 HG22 ' HD3' ' A' ' 34' ' ' ARG . 40.4 t -74.54 112.95 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.461 179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 mt -93.99 -17.61 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.4 -179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.6 t -169.96 162.1 9.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -151.99 179.43 8.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 135.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.423 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.437 ' CA ' ' CE1' ' A' ' 31' ' ' TYR . . . -145.11 -149.62 5.05 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.443 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 158.97 28.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 0.0 110.947 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -29.38 69.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.9 -32.36 16.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.09 110.58 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.16 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.4 155.61 16.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CE1' HG22 ' A' ' 154' ' ' THR . 1.2 p90 -139.58 156.85 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.043 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -147.04 124.38 11.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.765 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -86.2 117.39 24.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.696 ' HD3' HG22 ' A' ' 20' ' ' VAL . 2.9 mmm-85 -139.26 128.66 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.44 109.72 21.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.5 p -151.23 85.45 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -170.03 167.85 8.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.28 110.11 0.53 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.94 -154.54 25.76 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.459 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.582 ' O ' HD12 ' A' ' 104' ' ' ILE . 14.5 mttt -104.72 150.86 24.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.909 0.385 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 41' ' ' PHE . 3.6 m-85 -137.71 163.46 31.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.013 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.52 140.37 29.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.418 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.503 HG21 ' HE2' ' A' ' 99' ' ' LYS . 41.0 p -131.07 132.09 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.17 0.51 . . . . 0.0 111.833 -179.133 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 120' ' ' VAL . 63.2 t -130.88 125.39 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.212 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -96.12 138.76 33.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.96 0.41 . . . . 0.0 111.418 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.79 HG11 ' HA ' ' A' ' 54' ' ' ALA . 4.1 t -138.5 116.96 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.79 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.78 168.35 9.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.33 31.11 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.583 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG12 ' A' ' 46' ' ' VAL . 31.4 mtmt -153.28 117.77 2.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.997 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.28 -173.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.467 2.111 . . . . 0.0 112.137 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.693 HG13 ' CD1' ' A' ' 98' ' ' LEU . 61.3 t -61.28 -57.6 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.214 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -59.29 -45.23 91.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -67.16 -46.44 74.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -59.62 -45.06 93.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.301 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.802 HD11 ' CE1' ' A' ' 84' ' ' PHE . 1.3 mt -58.85 -35.17 72.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -62.06 -30.7 71.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.042 0.449 . . . . 0.0 109.906 179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 6.0 tp10 -86.79 -37.51 17.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.161 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -73.68 -29.97 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.462 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.617 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 5.2 mmt -57.43 -43.63 99.12 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 59' ' ' MET . 33.3 Cg_endo -64.69 -47.35 5.46 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.635 1.557 . . . . 0.0 111.835 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.7 mtmt -70.47 -32.81 70.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.704 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.612 HD11 HG23 ' A' ' 44' ' ' VAL . 16.9 mm -77.1 -43.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.926 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.424 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.09 -45.3 81.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.735 179.778 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mttp -59.98 -29.83 68.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.822 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 115' ' ' PRO . 37.0 t80 -58.54 -41.36 85.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.806 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.536 HG11 ' CE2' ' A' ' 102' ' ' PHE . 14.2 m -85.61 -30.65 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.75 -105.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.46 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.62 67.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -155.49 52.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 0.0 110.968 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 4.6 p30 -110.96 -15.3 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.179 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 70' ' ' ASN . 2.5 t70 83.63 -13.86 0.73 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.607 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.08 4.9 53.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 46.29 32.93 5.41 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.448 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 113' ' ' PRO . 3.1 p -96.83 155.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.688 -0.756 . . . . 0.0 111.821 -177.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.79 108.51 1.77 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.185 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -104.72 -77.68 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.356 . . . . 0.0 111.072 -179.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 -144.81 16.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.33 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.45 128.59 37.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 80' ' ' VAL . 5.6 m -139.0 119.86 14.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.525 HG23 HG22 ' A' ' 79' ' ' THR . 38.4 t 64.72 137.88 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.938 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HD2' HG13 ' A' ' 80' ' ' VAL . 17.8 Cg_endo -59.86 143.7 99.56 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.334 2.023 . . . . 0.0 112.16 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.71 137.53 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.414 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.69 157.27 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.802 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.99 154.15 32.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 -179.671 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.19 136.61 33.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.094 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.57 HG12 HG22 ' A' ' 51' ' ' VAL . 5.9 m -125.85 92.58 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.076 0.465 . . . . 0.0 111.175 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 166' ' ' VAL . 17.1 m-85 -70.75 112.24 12.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.95 167.24 9.69 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.682 2.255 . . . . 0.0 112.419 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -90.36 172.19 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.78 -21.34 18.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.315 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.14 -6.14 59.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.338 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 -16.06 61.96 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.95 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -84.44 165.17 18.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.874 0.369 . . . . 0.0 110.971 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.623 HD21 ' OH ' ' A' ' 167' ' ' TYR . 54.8 mt -90.85 167.17 12.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.56 81.25 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.135 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 50.77 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.346 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 68.57 104.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.7 HD11 ' CD2' ' A' ' 84' ' ' PHE . 2.3 tt -140.67 127.97 21.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.07 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' HE2' HG21 ' A' ' 43' ' ' THR . 1.3 tttt -109.48 116.05 31.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.226 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.716 HG21 ' HB1' ' A' ' 58' ' ' ALA . 2.7 t -77.58 141.09 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.231 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -122.08 128.38 51.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.793 179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CE2' HG11 ' A' ' 66' ' ' VAL . 36.7 t80 -113.05 130.93 55.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt85 -83.9 115.18 22.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 40' ' ' LYS . 30.3 mt -97.77 139.26 21.22 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 154.06 25.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.391 2.061 . . . . 0.0 112.361 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.26 -26.89 68.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.43 -32.95 70.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.423 ' CZ ' ' HG2' ' A' ' 76' ' ' MET . 19.5 m-85 -93.16 -17.71 23.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.517 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -33.65 53.21 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.877 0.37 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.67 -30.11 62.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.95 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 m -150.53 77.42 8.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.572 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 36.2 Cg_endo -65.37 149.23 88.41 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.602 2.202 . . . . 0.0 112.161 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HB3' HG11 ' A' ' 74' ' ' VAL . 12.5 Cg_exo -70.86 158.94 54.13 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.634 2.223 . . . . 0.0 112.116 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 70' ' ' ASN . . . -67.7 136.58 92.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.999 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.432 ' HA ' ' CD1' ' A' ' 65' ' ' TYR . 59.6 Cg_endo -72.52 -20.15 23.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.436 2.091 . . . . 0.0 112.41 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.73 -67.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.04 125.88 25.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.69 -22.53 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 p -81.86 -32.68 31.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 44' ' ' VAL . 31.3 t -85.36 116.59 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.2 156.58 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.38 116.08 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -98.82 144.84 27.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -89.43 51.64 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -76.12 120.45 21.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 177.16 3.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.97 156.69 23.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 pt -143.93 154.02 15.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -107.86 126.66 52.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' A' ' 188' ' ' VAL . 26.8 m -135.33 159.97 40.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.401 ' CD2' HD21 ' A' ' 155' ' ' LEU . 11.0 m-85 -107.7 129.45 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.618 179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.4 p -105.92 128.84 54.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 0.0 111.061 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.9 t -129.7 139.19 51.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -116.9 147.83 41.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE2' ' CE1' ' A' ' 147' ' ' HIS . 1.0 OUTLIER -137.59 -57.78 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.918 -179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -152.88 -109.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.655 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' TYR . . . 175.02 78.37 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -176.84 106.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.34 . . . . 0.0 110.757 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -174.46 134.94 0.41 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.277 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -106.53 -38.69 6.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.741 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.414 ' HG2' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -176.18 -61.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.85 71.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.844 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -68.63 -34.91 76.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.939 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 183' ' ' ASN . 0.7 OUTLIER -63.44 -39.04 93.42 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.579 0.704 . . . . 0.0 110.131 179.138 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.508 HG22 ' HG ' ' A' ' 94' ' ' LEU . 48.7 t -53.66 -38.72 35.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.001 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.45 -34.87 75.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.751 178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.487 ' HB2' HG21 ' A' ' 185' ' ' VAL . 13.7 m170 -70.35 -44.11 68.83 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.887 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.07 -32.9 72.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.2 m -68.57 -42.74 77.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.863 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -61.97 -46.05 90.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 151' ' ' LEU . 12.1 tp -59.2 -41.57 88.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.623 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -59.61 -47.73 84.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.268 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 95.3 m -62.48 -45.56 92.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 31' ' ' TYR . 17.1 m -57.61 -38.92 75.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.627 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.401 HD21 ' CD2' ' A' ' 131' ' ' TYR . 92.1 mt -74.02 -16.5 61.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.721 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 153' ' ' THR . 8.2 pt-20 -48.69 -28.41 3.54 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.792 0.33 . . . . 0.0 111.331 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.89 -17.94 62.34 Favored Glycine 0 CA--C 1.518 0.229 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.583 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 159' ' ' PRO . 0.1 OUTLIER -92.51 170.97 8.18 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.607 0.241 . . . . 0.0 110.801 -179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 158' ' ' THR . 95.4 Cg_endo -80.95 14.26 2.13 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.651 2.234 . . . . 0.0 113.151 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.72 132.43 53.83 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.963 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.707 ' HB ' ' HB3' ' A' ' 190' ' ' ALA . 69.3 m -102.06 -2.29 29.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.701 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.488 ' C ' ' HB2' ' A' ' 190' ' ' ALA . 59.5 m-85 57.44 124.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.39 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.454 ' HG3' HG12 ' A' ' 188' ' ' VAL . 1.3 mm-40 -66.94 -173.92 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -70.89 61.88 0.94 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.877 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.35 70.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.438 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 166' ' ' VAL . 9.3 p -161.9 119.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.244 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.816 ' HB3' HD23 ' A' ' 187' ' ' LEU . 3.7 p90 -133.55 177.17 7.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.754 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 186' ' ' TRP . 13.5 m-85 -126.27 151.07 47.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.084 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 71.2 m -140.07 153.53 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -120.84 134.05 55.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 175.49 154.85 11.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.473 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -153.66 161.87 41.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.327 . . . . 0.0 110.926 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.6 143.92 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.88 169.31 22.46 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.567 2.178 . . . . 0.0 112.34 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.44 110.85 2.96 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.658 2.238 . . . . 0.0 112.334 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -150.07 -70.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.004 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -79.8 111.35 20.76 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 177' ' ' LYS . 23.4 Cg_exo -65.72 146.62 84.36 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.692 2.261 . . . . 0.0 112.09 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 59.12 76.49 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -138.29 -65.81 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.462 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -122.87 160.69 25.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.29 146.49 35.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.434 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 2.1 m120 -109.41 135.51 50.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.848 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.0 147.93 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 147' ' ' HIS . 24.2 t -128.84 116.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.89 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -116.56 121.88 43.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.984 -179.781 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 167' ' ' TYR . 13.0 mt -91.09 140.06 30.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.855 ' HA ' HG12 ' A' ' 130' ' ' VAL . 4.8 t -79.15 120.43 30.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -65.53 153.57 41.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.707 ' HB3' ' HB ' ' A' ' 161' ' ' THR . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.136 -0.935 . . . . 1.0 111.114 179.936 . . . . . . . . 1 1 . 1 stop_ save_